Citrus Sinensis ID: 037084
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 0.610 | 0.507 | 0.633 | 1e-122 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.563 | 0.291 | 0.404 | 1e-52 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.503 | 0.243 | 0.408 | 1e-51 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.524 | 0.785 | 0.392 | 3e-51 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.513 | 0.250 | 0.421 | 8e-51 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.526 | 0.268 | 0.378 | 4e-50 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.494 | 0.238 | 0.407 | 1e-49 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.541 | 0.284 | 0.382 | 3e-49 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.530 | 0.251 | 0.392 | 3e-49 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.545 | 0.270 | 0.372 | 3e-48 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 206/325 (63%), Positives = 257/325 (79%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
RG + GP+I + I K D+AFL E++LASLEIIG G CG V+KAE+PGS GK+IA+
Sbjct: 317 RGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAV 376
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KK+ QPP A EL + +N+KMRQI+SEI T G I HRNLLPL AHV+RP+CH LVY
Sbjct: 377 KKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVY 436
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E+M+ GSLQDIL DV G +EL W AR++IA G+A+GLEYLHM H P IIHRD+KPANVL
Sbjct: 437 EYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVL 496
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARISDFGLAK MPD T I + VAGT GY+APE++QT ++K DIYSFGV+L
Sbjct: 497 LDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVIL 556
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
+LV+GK P D+FFQ+T+EM++++WMRN+I+SENP AID KL+ G++EQM LVLKIA
Sbjct: 557 GILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIAC 616
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
+CT DDP++RP+SKDVR MLSQIKH
Sbjct: 617 YCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (528), Expect = 1e-52, Method: Compositional matrix adjust.
Identities = 127/314 (40%), Positives = 180/314 (57%), Gaps = 14/314 (4%)
Query: 221 RPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATEL 280
R F DI KE + IIG+GA G+VYKAEV +A+KK+ + P ++
Sbjct: 702 RLCFTAGDILSHIKESN-----IIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDI 756
Query: 281 LNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340
+ I E+ G + HRN++ + +V ++VYE+M NG+L LH
Sbjct: 757 --EDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALH 814
Query: 341 DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
+ DWL+RY +A G+ GL YLH P IIHRDIK N+L+D +EARI+DFG
Sbjct: 815 SKDEKFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFG 874
Query: 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
LAK+M H ++ VAG+ GY+APEY TL I EKSDIYS GV+L LV GK P D
Sbjct: 875 LAKMML--HKNETVSMVAGSYGYIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPS 932
Query: 461 FQYTEEMNMVRWM-RNVISSENPHRAIDSKLLGNGYE--EQMRLVLKIAYFCTSDDPEER 517
F+ + +++V W+ R V +E+ ID+ + G+ E+M L L+IA CT+ P++R
Sbjct: 933 FE--DSIDVVEWIRRKVKKNESLEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDR 990
Query: 518 PSSKDVRCMLSQIK 531
PS +DV ML++ K
Sbjct: 991 PSIRDVITMLAEAK 1004
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 1e-51, Method: Compositional matrix adjust.
Identities = 120/294 (40%), Positives = 175/294 (59%), Gaps = 26/294 (8%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G GACG VYKAE+ G G++IA+KK++ A+ ++EI T
Sbjct: 804 VLGRGACGTVYKAEMSG--GEVIAVKKLNSRGEGAS------------SDNSFRAEISTL 849
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE--LDWLARYRIARG 360
G+I HRN++ L + +LL+YE+M GSL + L +G + LDW ARYRIA G
Sbjct: 850 GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNARYRIALG 906
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A GL YLH RP I+HRDIK N+L+D+ +A + DFGLAKL+ +++ ++ VAG+
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMSAVAGS 965
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
GY+APEY T+ ++EK DIYSFGV+L L+ GK P Q + +V W+R I +
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNM 1022
Query: 481 NPH-RAIDSKLLGNGYE--EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
P D++L N +M LVLKIA FCTS+ P RP+ ++V M+++ +
Sbjct: 1023 IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 119/303 (39%), Positives = 168/303 (55%), Gaps = 24/303 (7%)
Query: 231 FLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINR 290
F+ K L++ +I+G G G VY+ + S A+K++++ +
Sbjct: 68 FMKKTHKLSNKDILGSGGFGTVYRLVIDDS--TTFAVKRLNRGT--------------SE 111
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
+ R E+ I HRN++ L + T P +LL+YE M NGSL LH GR+ LD
Sbjct: 112 RDRGFHRELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALD 167
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
W +RYRIA G A G+ YLH P IIHRDIK +N+L+D MEAR+SDFGLA LM T
Sbjct: 168 WASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKT 227
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
+ T VAGT GY+APEY T + K D+YSFGV+L L+ G+ P DD F + E +V
Sbjct: 228 HVS-TFVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEF-FEEGTKLV 285
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYE--EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528
W++ V+ + ID++L G+ + E+M V IA C +P RP+ +V +L
Sbjct: 286 TWVKGVVRDQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLE 345
Query: 529 QIK 531
IK
Sbjct: 346 YIK 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 8e-51, Method: Compositional matrix adjust.
Identities = 127/301 (42%), Positives = 173/301 (57%), Gaps = 28/301 (9%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
L D+L IIG GA GVVY+A + GS G+ A+KK L+ + N+
Sbjct: 788 LAATDNLDDKYIIGRGAHGVVYRASL-GS-GEEYAVKK----------LIFAEHIRANQN 835
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
M++ EI T G + HRNL+ L+ R + L++Y++M NGSL D+LH +QG LDW
Sbjct: 836 MKR---EIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDW 892
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
AR+ IA G++ GL YLH P IIHRDIKP N+L+D ME I DFGLA+++ D +
Sbjct: 893 SARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDD--ST 950
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ TV GTTGY+APE S++SD+YS+GV+L LV GK D F E++N+V
Sbjct: 951 VSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFP--EDINIVS 1008
Query: 472 WMRNVISS-----ENPHRAIDSK----LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
W+R+V+SS + +D K LL EQ V +A CT PE RPS +D
Sbjct: 1009 WVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRD 1068
Query: 523 V 523
V
Sbjct: 1069 V 1069
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (507), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 115/304 (37%), Positives = 180/304 (59%), Gaps = 24/304 (7%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
L+K D+ I+G+G+ G VYKAE+P G++IA+KK+ N I R+
Sbjct: 718 LSKTDN-----ILGMGSTGTVYKAEMPN--GEIIAVKKLWGK--------NKENGKIRRR 762
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG-RRELD 350
+ +E+ G + HRN++ L T DC +L+YE+M NGSL D+LH + +
Sbjct: 763 KSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAE 822
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
W A Y+IA G+A G+ YLH P I+HRD+KP+N+L+D EAR++DFG+AKL+ T
Sbjct: 823 WTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QT 879
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
++ VAG+ GY+APEY TL + +KSDIYS+GV+L ++ GK + ++ E ++V
Sbjct: 880 DESMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEP--EFGEGNSIV 937
Query: 471 RWMRNVISSENPHRAIDSKLLGNG---YEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
W+R+ + ++ + K +G E+M+ +L+IA CTS P +RP +DV +L
Sbjct: 938 DWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLIL 997
Query: 528 SQIK 531
+ K
Sbjct: 998 QEAK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 197 bits (502), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 119/292 (40%), Positives = 165/292 (56%), Gaps = 29/292 (9%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G GACG VYKA +P Y +A+KK+ N ++EI+T
Sbjct: 809 VVGRGACGTVYKAVLPAGY--TLAVKKLASNHEGGNN---------NNVDNSFRAEILTL 857
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
G I HRN++ L +LL+YE+M GSL +ILHD S LDW R++IA G A
Sbjct: 858 GNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSC---NLDWSKRFKIALGAA 914
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
GL YLH +P I HRDIK N+L+DD EA + DFGLAK++ H++ ++ +AG+ G
Sbjct: 915 QGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSK-SMSAIAGSYG 973
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM--RNVISSE 480
Y+APEY T+ ++EKSDIYS+GV+L L+ GK P Q + +N VR R+ +SS
Sbjct: 974 YIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSS- 1032
Query: 481 NPHRAIDSKLLGNGYEEQ-----MRLVLKIAYFCTSDDPEERPSSKDVRCML 527
+D++L E++ M VLKIA CTS P RPS + V ML
Sbjct: 1033 ---GVLDARLT---LEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 119/311 (38%), Positives = 184/311 (59%), Gaps = 23/311 (7%)
Query: 224 FKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV 283
F DI KE ++ IG+GA G+VYKAE+ S ++A+KK+ + +A ++ +
Sbjct: 690 FTASDILACIKESNM-----IGMGATGIVYKAEMSRS-STVLAVKKLWR---SAADIED- 739
Query: 284 RRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-DV 342
E+ G++ HRN++ L + ++VYEFM NG+L D +H
Sbjct: 740 ------GTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKN 793
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ GR +DW++RY IA G+A GL YLH P +IHRDIK N+L+D ++ARI+DFGLA
Sbjct: 794 AAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLA 853
Query: 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
++M + ++ VAG+ GY+APEY TL + EK DIYS+GV+L L+ G+ P + +
Sbjct: 854 RMM--ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEP--E 909
Query: 463 YTEEMNMVRWMRNVISSE-NPHRAIDSKLLGNGY-EEQMRLVLKIAYFCTSDDPEERPSS 520
+ E +++V W+R I + A+D + Y +E+M LVL+IA CT+ P++RPS
Sbjct: 910 FGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSM 969
Query: 521 KDVRCMLSQIK 531
+DV ML + K
Sbjct: 970 RDVISMLGEAK 980
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 196 bits (499), Expect = 3e-49, Method: Compositional matrix adjust.
Identities = 122/311 (39%), Positives = 172/311 (55%), Gaps = 29/311 (9%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
L D+L IG GA G+VY+A + GS GK+ A+K+ L+ + N+
Sbjct: 821 LAATDNLNEKYTIGRGAHGIVYRASL-GS-GKVYAVKR----------LVFASHIRANQS 868
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
M + EI T G++ HRNL+ L+ R D L++Y +M GSL D+LH VS LDW
Sbjct: 869 MMR---EIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDW 925
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
ARY +A G+A GL YLH P I+HRDIKP N+L+D +E I DFGLA+L+ D +
Sbjct: 926 SARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDD--ST 983
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ TV GTTGY+APE +SD+YS+GV+L LV K D F E ++V
Sbjct: 984 VSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFP--ESTDIVS 1041
Query: 472 WMRNVISSENPH------RAID----SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
W+R+ +SS N + +D +LL + EQ+ V ++A CT DP RP+ +
Sbjct: 1042 WVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMR 1101
Query: 522 DVRCMLSQIKH 532
D +L +KH
Sbjct: 1102 DAVKLLEDVKH 1112
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 193 bits (491), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 117/314 (37%), Positives = 176/314 (56%), Gaps = 24/314 (7%)
Query: 224 FKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV 283
F+K I SL +IG G G+VYKAE+P G ++A+KK+ + E
Sbjct: 758 FQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPN--GDIVAVKKLWKTKDNNEE---- 811
Query: 284 RRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS 343
+ +EI G I HRN++ L + + LL+Y + NG+LQ +L
Sbjct: 812 ----GESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLL---- 863
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
QG R LDW RY+IA G A GL YLH P I+HRD+K N+L+D EA ++DFGLAK
Sbjct: 864 QGNRNLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAK 923
Query: 404 LM---PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
LM P+ H ++ VAG+ GY+APEY T+ I+EKSD+YS+GV+L ++ G+ +
Sbjct: 924 LMMNSPNYHN--AMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEP- 980
Query: 461 FQYTEEMNMVRWMRNVISSENPHRAI-DSKLLG--NGYEEQMRLVLKIAYFCTSDDPEER 517
Q + +++V W++ + + P ++ D KL G + ++M L IA FC + P ER
Sbjct: 981 -QIGDGLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVER 1039
Query: 518 PSSKDVRCMLSQIK 531
P+ K+V +L ++K
Sbjct: 1040 PTMKEVVTLLMEVK 1053
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.610 | 0.513 | 0.696 | 1e-133 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 0.610 | 0.515 | 0.692 | 1e-132 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 0.610 | 0.518 | 0.686 | 1e-131 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 0.610 | 0.511 | 0.68 | 1e-129 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 0.624 | 0.516 | 0.649 | 1e-127 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 0.605 | 0.508 | 0.662 | 1e-127 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 0.610 | 0.515 | 0.667 | 1e-125 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.610 | 0.507 | 0.636 | 1e-122 | |
| 225456834 | 632 | PREDICTED: leucine-rich repeat receptor- | 0.650 | 0.547 | 0.642 | 1e-121 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 0.610 | 0.507 | 0.633 | 1e-120 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1243), Expect = e-133, Method: Compositional matrix adjust.
Identities = 227/326 (69%), Positives = 267/326 (81%), Gaps = 1/326 (0%)
Query: 208 RGGGRYRGPAICARPIFKK-RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIA 266
RGGG+ GPAI + + KK ++AFL KED L++LE+IG G CG VYKAE+PGS GKMIA
Sbjct: 308 RGGGKDSGPAIFSPHLIKKAENLAFLEKEDGLSNLELIGRGGCGEVYKAELPGSNGKMIA 367
Query: 267 IKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV 326
IKKI QPP A EL L+N+KMRQI+SEI T G+I HRNLLPL AHV+RPDCH LV
Sbjct: 368 IKKIVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPDCHCLV 427
Query: 327 YEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386
YEFMKNGSLQDIL DV QG+RELDWLAR+RIA G+ASGLEYLH H P IIHRD+KPANV
Sbjct: 428 YEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSPRIIHRDLKPANV 487
Query: 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL 446
L+DD MEARI+DFGLAK MPD +T + + VAGT GY+APEYHQTL ++K DIYSFGVL
Sbjct: 488 LLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVL 547
Query: 447 LAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIA 506
L VLV+GK P D+FFQ T EM++V+WMRN+++SENP +AID K+ GNG+EEQM LVLKIA
Sbjct: 548 LGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNGFEEQMLLVLKIA 607
Query: 507 YFCTSDDPEERPSSKDVRCMLSQIKH 532
FCT DDP +RP+SKD+RCMLSQIKH
Sbjct: 608 CFCTLDDPRQRPNSKDIRCMLSQIKH 633
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-132, Method: Compositional matrix adjust.
Identities = 225/325 (69%), Positives = 265/325 (81%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
+GGGR GPAI + I + D+AFL K+D LA+LE+IG G CG VYKAE+PGS GKMIAI
Sbjct: 306 KGGGRDGGPAIFSPLIKRAEDLAFLEKDDGLANLEVIGKGGCGEVYKAELPGSNGKMIAI 365
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KKI QPP A EL L+++KMRQI+SEI T G I HRNLLPL AHV+RPDCH LVY
Sbjct: 366 KKIIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCHYLVY 425
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E MKNGSLQD L+ V++GRRELDWLAR+RIA G+ASGLEYLH+ H P IIHRD+KPANVL
Sbjct: 426 ELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRDLKPANVL 485
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARI+DFGLAK MPD T I + VAGT GY+APEYHQTL ++K DIYSFGV+L
Sbjct: 486 LDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVVL 545
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
VLV+GK P D+FFQ T EM++V+WMRN+++SENP +AID KL+GNG EEQM LVLKIA
Sbjct: 546 GVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQMLLVLKIAC 605
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
FCT DDP++RP+SKDVRCMLSQIKH
Sbjct: 606 FCTIDDPKQRPNSKDVRCMLSQIKH 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1221), Expect = e-131, Method: Compositional matrix adjust.
Identities = 223/325 (68%), Positives = 265/325 (81%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
+GGGR GPAI + I K D+AFL K++ LA+LEIIG G CG V+KAE+PGS GKMIA+
Sbjct: 303 KGGGRDVGPAIFSPLIKKAEDLAFLEKDEGLANLEIIGRGGCGEVFKAELPGSNGKMIAV 362
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KKI QPP A EL ++N+KMRQI+SEI T G I HRNLLPL AHV+RPDCH LVY
Sbjct: 363 KKIIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCHYLVY 422
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
EFMKNGSLQD+L+ V++G+RELDWLAR++IA G+ASGLEYLH+ H P IIHRD+KPANVL
Sbjct: 423 EFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRDLKPANVL 482
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARI+DFGLAK MPD T I + VAGT GY+APEYHQTL +EK DIYSFGV+L
Sbjct: 483 LDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDIYSFGVVL 542
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
VLV+GK P D FFQ T E+++V+WMRN++ SENP +AID KL+G+G EEQM LVLKIA
Sbjct: 543 GVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQMLLVLKIAC 602
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
FCT DDP++RPSSKDVRCMLSQIKH
Sbjct: 603 FCTIDDPKQRPSSKDVRCMLSQIKH 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1204), Expect = e-129, Method: Compositional matrix adjust.
Identities = 221/325 (68%), Positives = 260/325 (80%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
+G GR GP I + I K D+AFL KE+ +ASLEIIG G CG VYKAE+PGS GKMIAI
Sbjct: 312 KGRGRKAGPDIYSPLIKKAEDLAFLEKEEGIASLEIIGRGGCGEVYKAELPGSNGKMIAI 371
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KKI QPP EL ++N+KMRQI+SEI T G+I HRNLLPL AHV+RP+CH LVY
Sbjct: 372 KKIVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPECHYLVY 431
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
EFMKNGSLQD L V +G ELDWL+R++I+ G+A+GLEYLHM H P IIHRD+KPAN+L
Sbjct: 432 EFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDLKPANIL 491
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARI+DFGLAK MPD T I + VAGT GY+APEYHQ L ++K DIYS+GV+L
Sbjct: 492 LDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSYGVIL 551
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
VLV+GK P DDFFQ+TEEM++V+WMR +SSENP AI+SKLLGNGYEEQM LVLKIA
Sbjct: 552 GVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLLVLKIAC 611
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
FCT DDP+ERP+SKDVRCMLSQIKH
Sbjct: 612 FCTMDDPKERPNSKDVRCMLSQIKH 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 462 bits (1189), Expect = e-127, Method: Compositional matrix adjust.
Identities = 217/334 (64%), Positives = 265/334 (79%), Gaps = 2/334 (0%)
Query: 199 KALVSALRGRGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVP 258
K +++A++G G + GP+I A + K+ D+AFL ++++LASL++IG G CG VYKAE+P
Sbjct: 302 KLVIAAIKG--GSKNSGPSIFAPKLIKRDDLAFLERDNALASLQLIGKGGCGEVYKAELP 359
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GKM AIKKI QPP A EL+ +++KMRQIKSEI T G I HRNLLPL AHV
Sbjct: 360 EKSGKMFAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVP 419
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
RPDCH LVYE MKNGSLQD+L+ VS G +ELDWL R+ IA G+ASGLEYLHM H P IIH
Sbjct: 420 RPDCHYLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIH 479
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RD+KPANVL+DDGMEARI+DFGLAK MPD T + + VAGT GY+APEYHQTL ++K
Sbjct: 480 RDLKPANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKC 539
Query: 439 DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQ 498
DIY FGVLL VLV+GK P D+FFQ T+EM++V+WM+NV++S+NP AID KLLGNG+EEQ
Sbjct: 540 DIYGFGVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQ 599
Query: 499 MRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
M L LKIA FCT D+P+ERP+SKDVRCMLSQIKH
Sbjct: 600 MLLALKIACFCTMDNPKERPNSKDVRCMLSQIKH 633
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 461 bits (1186), Expect = e-127, Method: Compositional matrix adjust.
Identities = 214/323 (66%), Positives = 262/323 (81%), Gaps = 1/323 (0%)
Query: 211 GRYRGPAICARPIFKK-RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKK 269
G+ G P+ KK D+AFL KED +ASLE+IG G CG VY+AE+PGS GK+IAIKK
Sbjct: 311 GKTDGSLTIYSPLIKKAEDLAFLEKEDGVASLEMIGKGGCGEVYRAELPGSNGKIIAIKK 370
Query: 270 IDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEF 329
I QPPM A EL +N+KMRQ+KSEI G+I HRNLLPL AH+ RPDCH LVYE+
Sbjct: 371 ILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRPDCHYLVYEY 430
Query: 330 MKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389
MKNGSLQDIL V++G RELDWL R+RIA G+A+GLEYLH+ H CIIHRD+KPANVL+D
Sbjct: 431 MKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRDLKPANVLLD 490
Query: 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449
D MEARI+DFGLAK +PD HT + + VAGT GY+APEYHQTL ++K DIYSFGV+LAV
Sbjct: 491 DDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSFGVVLAV 550
Query: 450 LVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFC 509
LV+GK P D+FFQ+T EM++V+W+RNV++SE+P RAID KL+G+G+EEQM LVLKIA FC
Sbjct: 551 LVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQMLLVLKIACFC 610
Query: 510 TSDDPEERPSSKDVRCMLSQIKH 532
T ++P+ERP+SKDVRCML+QIKH
Sbjct: 611 TLENPKERPNSKDVRCMLTQIKH 633
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 456 bits (1172), Expect = e-125, Method: Compositional matrix adjust.
Identities = 217/325 (66%), Positives = 256/325 (78%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
+G GR GP I + I K D+AFL KE+ +ASLEIIG G CG VYKAE+PGS GKMIAI
Sbjct: 307 KGRGRKAGPDIYSPLIKKAEDLAFLEKEEGMASLEIIGRGGCGEVYKAELPGSNGKMIAI 366
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KKI QPP EL ++N+KMRQI+SEI T G+I HRNLLPL AHV+RP CH LVY
Sbjct: 367 KKIIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPGCHYLVY 426
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
EFMKNGSL D L V G ELDWL+R++IA G+A+GLEYLH+ H P IIHRD+KPAN+L
Sbjct: 427 EFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDLKPANIL 486
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARI+DFGLAK MPD T I + VAGT GY+APEYHQ L ++K DIYSFGV+L
Sbjct: 487 LDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSFGVIL 546
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
VLV+GK P +FFQ+TEEM++V+WMR ++SSENP AID+KLLGNGYE+QM LVLKIA
Sbjct: 547 GVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLLVLKIAC 606
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
FCT DDP+ERP+SKDV CMLSQIKH
Sbjct: 607 FCTMDDPKERPNSKDVWCMLSQIKH 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1142), Expect = e-122, Method: Compositional matrix adjust.
Identities = 207/325 (63%), Positives = 259/325 (79%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
RG G+ GP+I + I K D+AFL E++LASLEIIG G CG V+KAE+PGS GK+IA+
Sbjct: 317 RGSGKPSGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAV 376
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KK+ QPP A EL + +N+KMRQI+SEI T G+I HRNLLPL AHV+RP+CH LVY
Sbjct: 377 KKVIQPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLLAHVSRPECHYLVY 436
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E+M+ GSLQDIL DV G +EL W AR++IA G+A+GLEYLHM H P IIHRD+KPANVL
Sbjct: 437 EYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVL 496
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARISDFGLAK+MPD T I + VAGT GY+APE++QT + K DIYSFGV+L
Sbjct: 497 LDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKFTAKCDIYSFGVIL 556
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
+LV+GK P D+FFQ+T+EM++++WMRN+I+SENP AID KL+ G++EQM LVLKIA
Sbjct: 557 GILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQGFDEQMLLVLKIAC 616
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
+CT DDP++RP+SKDVR MLSQIKH
Sbjct: 617 YCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456834|ref|XP_002276125.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 228/355 (64%), Positives = 273/355 (76%), Gaps = 9/355 (2%)
Query: 178 GGVKALVSALMVSEAKGYCGVKALVSALRGRGGGRYRGPAICARPIFKKRDIAFLTKEDS 237
G V +S L+ S KAL+ +RG GG+ GPAI + I K D+AFL K+D
Sbjct: 287 GAVAGCISGLVFSVL-----FKALLVLVRG--GGKESGPAIFSPLIKKAEDLAFLEKDDG 339
Query: 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
LASLEIIG G CG VY+AE+PG GK+IAIKKI QPP A EL L+N+KMRQI+S
Sbjct: 340 LASLEIIGKGGCGEVYRAELPG--GKLIAIKKIVQPPKDAAELAEEDSKLLNKKMRQIRS 397
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
EI T G I HRNLLPL AHV+RP+CH LVYEFMKNGSLQD+L VS+G RELDWLAR+R+
Sbjct: 398 EIQTVGNIRHRNLLPLLAHVSRPNCHYLVYEFMKNGSLQDMLTQVSEGTRELDWLARHRV 457
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
A G+A+GLEYLHM H P IIHRD+KP N+L+DD MEARI+DFGLAK +PD +T + + V
Sbjct: 458 ALGVAAGLEYLHMSHSPRIIHRDLKPGNILLDDDMEARIADFGLAKAVPDANTHVTTSNV 517
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
AGT GY+APEYHQTL ++K DIYSFGVLL VLVVGK P DDFFQ+T EM++V+WM N+
Sbjct: 518 AGTVGYIAPEYHQTLKFTDKCDIYSFGVLLGVLVVGKLPSDDFFQHTAEMSLVKWMANIR 577
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+S++P RAID KL+GNG+EEQM LVLKIA FCT DD + RP+SKDVR MLSQIKH
Sbjct: 578 TSDDPSRAIDRKLMGNGFEEQMLLVLKIACFCTVDDAKIRPNSKDVRTMLSQIKH 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1127), Expect = e-120, Method: Compositional matrix adjust.
Identities = 206/325 (63%), Positives = 257/325 (79%)
Query: 208 RGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAI 267
RG + GP+I + I K D+AFL E++LASLEIIG G CG V+KAE+PGS GK+IA+
Sbjct: 317 RGSEKPPGPSIFSPLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAV 376
Query: 268 KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327
KK+ QPP A EL + +N+KMRQI+SEI T G I HRNLLPL AHV+RP+CH LVY
Sbjct: 377 KKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVY 436
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E+M+ GSLQDIL DV G +EL W AR++IA G+A+GLEYLHM H P IIHRD+KPANVL
Sbjct: 437 EYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVL 496
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+DD MEARISDFGLAK MPD T I + VAGT GY+APE++QT ++K DIYSFGV+L
Sbjct: 497 LDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVIL 556
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAY 507
+LV+GK P D+FFQ+T+EM++++WMRN+I+SENP AID KL+ G++EQM LVLKIA
Sbjct: 557 GILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIAC 616
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
+CT DDP++RP+SKDVR MLSQIKH
Sbjct: 617 YCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 532 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.593 | 0.492 | 0.641 | 3.9e-108 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.531 | 0.275 | 0.410 | 9.4e-53 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.515 | 0.263 | 0.382 | 1.3e-49 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.513 | 0.250 | 0.428 | 4.8e-48 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.503 | 0.243 | 0.408 | 1.7e-47 | |
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.524 | 0.461 | 0.402 | 4.2e-47 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.531 | 0.279 | 0.392 | 4.7e-47 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.530 | 0.251 | 0.392 | 6.2e-47 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.494 | 0.740 | 0.418 | 6.9e-47 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.849 | 0.402 | 0.309 | 1.3e-46 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
Identities = 204/318 (64%), Positives = 255/318 (80%)
Query: 216 PAICARPIFKK-RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPP 274
P+I + P+ KK D+AFL E++LASLEIIG G CG V+KAE+PGS GK+IA+KK+ QPP
Sbjct: 325 PSIFS-PLIKKAEDLAFLENEEALASLEIIGRGGCGEVFKAELPGSNGKIIAVKKVIQPP 383
Query: 275 MAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGS 334
A EL + +N+KMRQI+SEI T G I HRNLLPL AHV+RP+CH LVYE+M+ GS
Sbjct: 384 KDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECHYLVYEYMEKGS 443
Query: 335 LQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394
LQDIL DV G +EL W AR++IA G+A+GLEYLHM H P IIHRD+KPANVL+DD MEA
Sbjct: 444 LQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKPANVLLDDDMEA 503
Query: 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454
RISDFGLAK MPD T I + VAGT GY+APE++QT ++K DIYSFGV+L +LV+GK
Sbjct: 504 RISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSFGVILGILVIGK 563
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDP 514
P D+FFQ+T+EM++++WMRN+I+SENP AID KL+ G++EQM LVLKIA +CT DDP
Sbjct: 564 LPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVLKIACYCTLDDP 623
Query: 515 EERPSSKDVRCMLSQIKH 532
++RP+SKDVR MLSQIKH
Sbjct: 624 KQRPNSKDVRTMLSQIKH 641
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 530 (191.6 bits), Expect = 9.4e-53, Sum P(2) = 9.4e-53
Identities = 120/292 (41%), Positives = 175/292 (59%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
IIG+GA G+VYKAEV +A+KK+ + P ++ + + + I E+
Sbjct: 719 IIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQE--EDEEDDILREVNLL 776
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
G + HRN++ + +V ++VYE+M NG+L LH + DWL+RY +A G+
Sbjct: 777 GGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVV 836
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
GL YLH P IIHRDIK N+L+D +EARI+DFGLAK+M H ++ VAG+ G
Sbjct: 837 QGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMML--HKNETVSMVAGSYG 894
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS-SEN 481
Y+APEY TL I EKSDIYS GV+L LV GK P D F+ + +++V W+R + +E+
Sbjct: 895 YIAPEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFE--DSIDVVEWIRRKVKKNES 952
Query: 482 PHRAIDSKLLGNGYE--EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
ID+ + G+ E+M L L+IA CT+ P++RPS +DV ML++ K
Sbjct: 953 LEEVIDASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAK 1004
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 510 (184.6 bits), Expect = 1.3e-49, Sum P(2) = 1.3e-49
Identities = 112/293 (38%), Positives = 175/293 (59%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
I+G+G+ G VYKAE+P G++IA+KK+ N I R+ + +E+
Sbjct: 724 ILGMGSTGTVYKAEMPN--GEIIAVKKLWGK--------NKENGKIRRRKSGVLAEVDVL 773
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL-DWLARYRIARGM 361
G + HRN++ L T DC +L+YE+M NGSL D+LH + +W A Y+IA G+
Sbjct: 774 GNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGV 833
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
A G+ YLH P I+HRD+KP+N+L+D EAR++DFG+AKL+ T ++ VAG+
Sbjct: 834 AQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI---QTDESMSVVAGSY 890
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481
GY+APEY TL + +KSDIYS+GV+L ++ GK + ++ E ++V W+R+ + ++
Sbjct: 891 GYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEP--EFGEGNSIVDWVRSKLKTKE 948
Query: 482 PHRAIDSKLLGNG---YEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
+ K +G E+M+ +L+IA CTS P +RP +DV +L + K
Sbjct: 949 DVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAK 1001
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 512 (185.3 bits), Expect = 4.8e-48, P = 4.8e-48
Identities = 129/301 (42%), Positives = 173/301 (57%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
L D+L IIG GA GVVY+A + GS G+ A+KK L+ + N+
Sbjct: 788 LAATDNLDDKYIIGRGAHGVVYRASL-GS-GEEYAVKK----------LIFAEHIRANQN 835
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
M K EI T G + HRNL+ L+ R + L++Y++M NGSL D+LH +QG LDW
Sbjct: 836 M---KREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDW 892
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
AR+ IA G++ GL YLH P IIHRDIKP N+L+D ME I DFGLA+++ D +
Sbjct: 893 SARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDD--ST 950
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ TV GTTGY+APE S++SD+YS+GV+L LV GK D F E++N+V
Sbjct: 951 VSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFP--EDINIVS 1008
Query: 472 WMRNVISS--ENPHRA---IDSKL----LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
W+R+V+SS + A +D KL L EQ V +A CT PE RPS +D
Sbjct: 1009 WVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRD 1068
Query: 523 V 523
V
Sbjct: 1069 V 1069
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 507 (183.5 bits), Expect = 1.7e-47, P = 1.7e-47
Identities = 120/294 (40%), Positives = 175/294 (59%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G GACG VYKAE+ G G++IA+KK++ A+ ++EI T
Sbjct: 804 VLGRGACGTVYKAEMSG--GEVIAVKKLNSRGEGASS------------DNSFRAEISTL 849
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE--LDWLARYRIARG 360
G+I HRN++ L + +LL+YE+M GSL + L +G + LDW ARYRIA G
Sbjct: 850 GKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNARYRIALG 906
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A GL YLH RP I+HRDIK N+L+D+ +A + DFGLAKL+ +++ ++ VAG+
Sbjct: 907 AAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-SMSAVAGS 965
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
GY+APEY T+ ++EK DIYSFGV+L L+ GK P Q + +V W+R I +
Sbjct: 966 YGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD---LVNWVRRSIRNM 1022
Query: 481 NPH-RAIDSKLLGNGYE--EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
P D++L N +M LVLKIA FCTS+ P RP+ ++V M+++ +
Sbjct: 1023 IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
|
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 4.2e-47, P = 4.2e-47
Identities = 120/298 (40%), Positives = 167/298 (56%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
+ K +SL +I+G G G VY+ V G A+KKID+ + +
Sbjct: 306 IEKLESLDEEDIVGSGGFGTVYRM-VMNDLGTF-AVKKIDRSRQGSDRVFE--------- 354
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
R++ EI+ G + H NL+ L+ + P LL+Y+++ GSL D+LH+ +Q L+W
Sbjct: 355 -REV--EIL--GSVKHINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNW 409
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
AR +IA G A GL YLH P I+HRDIK +N+L++D +E R+SDFGLAKL+ D
Sbjct: 410 NARLKIALGSARGLAYLHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAH 469
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ T VAGT GY+APEY Q +EKSD+YSFGVLL LV GK P D F +N+V
Sbjct: 470 VT-TVVAGTFGYLAPEYLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIF-VKRGLNVVG 527
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529
WM V+ ID + EE + +L+IA CT +PE RP+ V +L Q
Sbjct: 528 WMNTVLKENRLEDVIDKRCTDVD-EESVEALLEIAERCTDANPENRPAMNQVAQLLEQ 584
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-47, P = 4.7e-47
Identities = 120/306 (39%), Positives = 186/306 (60%)
Query: 233 TKEDSLASLE---IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLIN 289
T D LA ++ +IG+GA G+VYKAE+ S ++A+KK+ + +A ++ +
Sbjct: 691 TASDILACIKESNMIGMGATGIVYKAEMSRS-STVLAVKKLWR---SAADIED------- 739
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-GRRE 348
E+ G++ HRN++ L + ++VYEFM NG+L D +H + GR
Sbjct: 740 GTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLL 799
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
+DW++RY IA G+A GL YLH P +IHRDIK N+L+D ++ARI+DFGLA++M
Sbjct: 800 VDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--A 857
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468
+ ++ VAG+ GY+APEY TL + EK DIYS+GV+L L+ G+ P + ++ E ++
Sbjct: 858 RKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEP--EFGESVD 915
Query: 469 MVRWMRNVISSE-NPHRAIDSKLLGN-GY-EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525
+V W+R I + A+D + GN Y +E+M LVL+IA CT+ P++RPS +DV
Sbjct: 916 IVEWVRRKIRDNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVIS 974
Query: 526 MLSQIK 531
ML + K
Sbjct: 975 MLGEAK 980
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 6.2e-47, P = 6.2e-47
Identities = 122/311 (39%), Positives = 172/311 (55%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
L D+L IG GA G+VY+A + GS GK+ A+K+ L+ + N+
Sbjct: 821 LAATDNLNEKYTIGRGAHGIVYRASL-GS-GKVYAVKR----------LVFASHIRANQS 868
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
M + EI T G++ HRNL+ L+ R D L++Y +M GSL D+LH VS LDW
Sbjct: 869 MMR---EIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDW 925
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
ARY +A G+A GL YLH P I+HRDIKP N+L+D +E I DFGLA+L+ D +
Sbjct: 926 SARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDD--ST 983
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ TV GTTGY+APE +SD+YS+GV+L LV K D F E ++V
Sbjct: 984 VSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFP--ESTDIVS 1041
Query: 472 WMRNVISSENPH------RAID----SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
W+R+ +SS N + +D +LL + EQ+ V ++A CT DP RP+ +
Sbjct: 1042 WVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMR 1101
Query: 522 DVRCMLSQIKH 532
D +L +KH
Sbjct: 1102 DAVKLLEDVKH 1112
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 491 (177.9 bits), Expect = 6.9e-47, P = 6.9e-47
Identities = 115/275 (41%), Positives = 156/275 (56%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G +G + + ID A + LN R + + R E+ I HRN++ L + T
Sbjct: 84 GGFGTVYRLV-IDDSTTFAVKRLN-RGT--SERDRGFHRELEAMADIKHRNIVTLHGYFT 139
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
P +LL+YE M NGSL LH GR+ LDW +RYRIA G A G+ YLH P IIH
Sbjct: 140 SPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRIAVGAARGISYLHHDCIPHIIH 195
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RDIK +N+L+D MEAR+SDFGLA LM T + T VAGT GY+APEY T + K
Sbjct: 196 RDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVS-TFVAGTFGYLAPEYFDTGKATMKG 254
Query: 439 DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEE- 497
D+YSFGV+L L+ G+ P DD F + E +V W++ V+ + ID++L G+ +E
Sbjct: 255 DVYSFGVVLLELLTGRKPTDDEF-FEEGTKLVTWVKGVVRDQREEVVIDNRLRGSSVQEN 313
Query: 498 -QMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
+M V IA C +P RP+ +V +L IK
Sbjct: 314 EEMNDVFGIAMMCLEPEPAIRPAMTEVVKLLEYIK 348
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.3e-46, Sum P(2) = 1.3e-46
Identities = 157/508 (30%), Positives = 245/508 (48%)
Query: 43 FAGEAHIQADLMGWINMLVKIS-EVVDDAVEKQMTNPHVKLWLGELQN-LACDVEYLFDE 100
F+G Q L+ + + + +S + ++ N H+ ++L N L+ ++ F+
Sbjct: 625 FSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFEN 684
Query: 101 FQTEAFRSKLLPLDYDYSTDDEFDSLAKTKVMEIHTRLQGIASQIDSLELTGISGGKSRN 160
S LL ++ Y+ + L T++ + T + ++ G+ GG R+
Sbjct: 685 L------SSLLGCNFSYN--NLTGQLPHTQIFQNMTLTSFLGNK-------GLCGGHLRS 729
Query: 161 VRKRLSTISLVGEAKEYGGVKALVSALMVSEAKGYCGVKALVSALXXXXXXXXXXPAIC- 219
S+ + K G + ++VS G G+ L+ A+ P
Sbjct: 730 CDPSHSSWPHISSLKA-GSARRGRIIIIVSSVIG--GISLLLIAIVVHFLRNPVEPTAPY 786
Query: 220 ---ARPIFKKRDIAFLTKE-----DSLASLE------IIGVGACGVVYKAEVPGSYGKMI 265
P F++ DI F+ KE D L + + I+G GACG VYKA +P GK I
Sbjct: 787 VHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPS--GKTI 844
Query: 266 AIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP--DCH 323
A+KK++ + E N N ++EI+T G+I HRN++ L + + +
Sbjct: 845 AVKKLE----SNREGNNNNS---NNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSN 897
Query: 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383
LL+YE+M GSL ++LH +DW R+ IA G A GL YLH +P IIHRDIK
Sbjct: 898 LLLYEYMSRGSLGELLHGGKS--HSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKS 955
Query: 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443
N+LID+ EA + DFGLAK++ D ++ VAG+ GY+APEY T+ ++EK DIYSF
Sbjct: 956 NNILIDENFEAHVGDFGLAKVI-DMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSF 1014
Query: 444 GVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN-PHRAID---SKLLGNGYEEQM 499
GV+L L+ GK P Q + + W RN I + +D +K+ + M
Sbjct: 1015 GVVLLELLTGKAPVQPLEQGGD---LATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHM 1071
Query: 500 RLVLKIAYFCTSDDPEERPSSKDVRCML 527
V KIA CT P +RP+ ++V ML
Sbjct: 1072 ITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00150657 | hypothetical protein (630 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 532 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-39 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-20 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-11 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 5e-47
Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 38/283 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE +G G+ G VY A + GK++AIK I ++ I + +I EI
Sbjct: 4 LEKLGEGSFGKVYLARDKKT-GKLVAIKVI-------------KKKKIKKDRERILREIK 49
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H N++ L D LV E+ + G L D+L +GR D Y R
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDEARFY--LRQ 105
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ S LEYLH I+HRD+KP N+L+D+ +++DFGLA+ + G ++TT GT
Sbjct: 106 ILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGT 159
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+APE + DI+S GV+L L+ GK PF Q E + +
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKI--GKPKPPFP 217
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
P I E L+ K DPE+R ++++
Sbjct: 218 PPEWDIS--------PEAKDLIRK----LLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G G VY A + GK +AIK I + + + ++ EI
Sbjct: 1 LGEGGFGTVYLARDKKT-GKKVAIKIIKKEDS-------------SSLLEELLREIEILK 46
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
++ H N++ L + LV E+ + GSL+D+L + +L RI +
Sbjct: 47 KLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILE 103
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDG-MEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
GLEYLH IIHRD+KP N+L+D + +++DFGL+KL+ + + T+ GT
Sbjct: 104 GLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158
Query: 423 YVAPE-YHQTLTISEKSDIYSFGVLLAVL 450
Y+APE SEKSDI+S GV+L L
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 9e-39
Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 40/289 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
L +G G+ G VYKA+ G+ GK++A+K + + + + RR + I R++
Sbjct: 4 LRKLGSGSFGTVYKAKHKGT-GKIVAVKILKKRSEKSKKDQTARREIRILRRLS------ 56
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
H N++ L D LV E+ + G L D L L +IA
Sbjct: 57 -------HPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIAL 105
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM--PDGHTRIRITTV 417
+ GLEYLH IIHRD+KP N+L+D+ +I+DFGLAK + TT
Sbjct: 106 QILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL----TTF 158
Query: 418 AGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT Y+APE K D++S GV+L L+ GK PF ++ ++ +R +
Sbjct: 159 VGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG----ENILDQLQLIRRI 214
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525
+ D +G EE L+ K C + DP +RP+++++
Sbjct: 215 LGPPLE---FDEPKWSSGSEEAKDLIKK----CLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (328), Expect = 1e-33
Identities = 83/290 (28%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L +G G+ G VY A K++A+K + + L + + R +R+I+ I
Sbjct: 5 LRKLGEGSFGEVYLARDR----KLVALKVLAKK-------LESKSKEVERFLREIQ---I 50
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
A N++ L LV E++ GSL+D+L + + + A I
Sbjct: 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL-FILAQ 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDG----HTRIRIT 415
+ S LEYLH IIHRDIKP N+L+D DG ++ DFGLAKL+PD +
Sbjct: 110 ILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166
Query: 416 TVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
T GT GY+APE L+ S SDI+S G+ L L+ G PF+ + ++
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226
Query: 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + + + + L+ K + DP+ R SS
Sbjct: 227 ILELPTPSLA-SPLSPSNPELISKAASDLLKK----LLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 1e-32
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 24/232 (10%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E++G G+ G VY A + G+++A+K ++ + E + ++ EI
Sbjct: 6 ELLGRGSFGSVYLALDKDT-GELMAVKSVELSGDSEEE------------LEALEREIRI 52
Query: 302 AGRIWHRNLLP-LQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
+ H N++ + L ++ E++ GSL +L G+ + +Y R
Sbjct: 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKY--TR 108
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ GL YLH I+HRDIK AN+L+D +++DFG AK + D T +V G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 420 TTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
T ++APE +DI+S G + + GK P+ + + +
Sbjct: 166 TPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 85/300 (28%), Positives = 133/300 (44%), Gaps = 64/300 (21%)
Query: 239 ASLEIIGV---GACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ LE + V G+ GVVYK GK+ A+KKI R+ Q+
Sbjct: 1 SDLERVKVLGQGSSGVVYKV-RHKPTGKIYALKKI-----HVDGDEEFRK--------QL 46
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCH---------LLVYEFMKNGSLQDILHDVSQGR 346
E+ + P +V + C+ +V E+M GSL D+L +
Sbjct: 47 LREL----KTLRSCESP---YVVK--CYGAFYKEGEISIVLEYMDGGSLADLL------K 91
Query: 347 RELDW----LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ LA IAR + GL+YLH IIHRDIKP+N+LI+ E +I+DFG++
Sbjct: 92 KVGKIPEPVLAY--IARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGIS 147
Query: 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
K++ + T + T GT Y++PE Q + S +DI+S G+ L +GKFPF
Sbjct: 148 KVLEN--TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP--- 202
Query: 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + M+ + P L + + R + C DP++RPS+ +
Sbjct: 203 -PGQPSFFELMQAICDGPPP------SLPAEEFSPEFRDFISA---CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-31
Identities = 78/289 (26%), Positives = 127/289 (43%), Gaps = 55/289 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-I 299
LE IG G G VYKA + GK +AIK I E + + I +++ K I
Sbjct: 5 LEKIGKGGFGEVYKARHKRT-GKEVAIKVIKLESKEKKEK-IINEIQI---LKKCKHPNI 59
Query: 300 IT-------AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
+ +W +V EF GSL+D+L +Q E +
Sbjct: 60 VKYYGSYLKKDELW------------------IVMEFCSGGSLKDLLKSTNQTLTE-SQI 100
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
A Y + + + GLEYLH IIHRDIK AN+L+ E ++ DFGL+ + D R
Sbjct: 101 A-Y-VCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
+ GT ++APE K+DI+S G+ L GK P+ E+ ++
Sbjct: 156 TM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY-------SELPPMKA 205
Query: 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
+ I++ P + + + +++ ++ C +PE+RP+++
Sbjct: 206 LF-KIATNGPPGLRNPEKWSDEFKDFLKK-------CLQKNPEKRPTAE 246
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-29
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 241 LEIIGVGACGVVYKAE---VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+ +G GA G VYK +A+K + + +R I MR++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARI---MRKLD- 59
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H N++ L T + ++V E+M G L D L +EL
Sbjct: 60 ---------HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSF 108
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
A +A G+EYL + I HRD+ N L+ + + +ISDFGL++ + D V
Sbjct: 109 ALQIARGMEYLE--SKNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYKV 161
Query: 418 AGTTGYV---APEYHQTLTISEKSDIYSFGVLL 447
G + APE + + KSD++SFGVLL
Sbjct: 162 KGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 194
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 29/213 (13%)
Query: 241 LEIIGVGACGVVYKAE---VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+ +G GA G VYK + G +A+K + + + +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-------------IEEFLR 50
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
E ++ H N++ L T + +V E+M+ G L L R +L
Sbjct: 51 EARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSF 107
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
A +A G+EYL + I HRD+ N L+ + + +ISDFGL++ + D
Sbjct: 108 ALQIARGMEYLE--SKNFI-HRDLAARNCLVGENLVVKISDFGLSRDLYDD----DYYRK 160
Query: 418 AGTTGYV---APEYHQTLTISEKSDIYSFGVLL 447
G + APE + + KSD++SFGVLL
Sbjct: 161 RGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLL 193
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 76/307 (24%), Positives = 122/307 (39%), Gaps = 73/307 (23%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLNVRRVLIN--RKMRQIKS 297
+ +G GA G VYK ++ G GK A+K + + R+ + R M+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-----RKDFLKEARVMKKLG- 54
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-----HDVSQGRRELDWL 352
H N++ L T + LV E+M+ G L D L S + L
Sbjct: 55 ---------HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
A +A G+EYL +HRD+ N L+ + + +ISDFGL++ + D
Sbjct: 106 DLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD--- 159
Query: 413 RITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
T G + APE + + KSD++SFGVLL + +G P+ EE
Sbjct: 160 --YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--SNEE 215
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEER 517
+ + L GY RL + ++ C DPE+R
Sbjct: 216 V--------------------LEYLRKGY----RLPKPEYCPDELYELMLSCWQLDPEDR 251
Query: 518 PSSKDVR 524
P+ ++
Sbjct: 252 PTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 36/217 (16%)
Query: 241 LEIIGVGACGVVYKAE---VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+ +G GA G VYK +A+K + + + +
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-------------EEEREEFLE 50
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
E ++ H N++ L T+ + +V E+M G L D L +L ++
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQM 107
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD-------GHT 410
A +A G+EYL + + HRD+ N L+ + + +ISDFGL++ + + G
Sbjct: 108 ALQIAKGMEYLE--SKNFV-HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGG 164
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++ I ++APE + + KSD++SFGVLL
Sbjct: 165 KLPIK-------WMAPESLKDGKFTSKSDVWSFGVLL 194
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 51/291 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
++ IG G+ G VY S GK+ +K+ID M+ E + V I ++++
Sbjct: 5 IKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNMSEKEREDALNEVKI---LKKLN--- 57
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE------LDWLA 353
H N++ +V E+ G L + + + LDW
Sbjct: 58 -------HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ + L+YLH I+HRDIKP N+ + ++ DFG++K++ T
Sbjct: 111 Q------LCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDL 159
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
TV GT Y++PE Q + KSDI+S G +L L K PF+ E + +
Sbjct: 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-----ENLLEL--A 212
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQMR-LVLKIAYFCTSDDPEERPSSKDV 523
++ + P I S+ Y ++R LV DPEERPS +
Sbjct: 213 LKILKGQYP--PIPSQ-----YSSELRNLVSS----LLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 22/218 (10%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
++IG GA GVVYK + G +AIK+I L + ++ I EI
Sbjct: 6 DLIGRGAFGVVYKG-LNLETGDFVAIKQI--------SLEK----IKEEALKSIMQEIDL 52
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ H N++ + D ++ E+ +NGSL+ I+ G +A Y +
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVY--VYQV 108
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
GL YLH +IHRDIK AN+L +++DFG+A + D +V GT
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTP 163
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
++APE + S SDI+S G + L+ G P+ D
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 46/245 (18%)
Query: 242 EIIGVGACGVVYKA-EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+IIG G+ V A E K AIK +L+ R+++ +K++ +K E
Sbjct: 7 KIIGEGSFSTVVLAKEK--ETNKEYAIK-----------ILDKRQLIKEKKVKYVKIEKE 53
Query: 301 TAGRI-WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
R+ H ++ L + V E+ NG L + G + R+ A
Sbjct: 54 VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE 110
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG----------- 408
+ LEYLH IIHRD+KP N+L+D M +I+DFG AK++
Sbjct: 111 -ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 409 -------HTRIRITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFD 458
R R + GT YV+PE L + SD+++ G ++ ++ GK PF
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
Query: 459 DFFQY 463
+Y
Sbjct: 224 GSNEY 228
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 82/291 (28%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
D L L +G G GVV K + GK++A+K I L + + + +R++
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPT-GKIMAVKTI---------RLEINEAIQKQILREL 50
Query: 296 KSEIITAGRIWHRNLLP-----LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
I H+ P A D + + E+M GSL IL QGR
Sbjct: 51 D--------ILHKCNSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKIL-KEVQGRIPER 100
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
L + IA + GL YLH H+ IIHRD+KP+N+L++ + ++ DFG++ + +
Sbjct: 101 ILGK--IAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
+ T GT+ Y+APE Q S KSDI+S G+ L L G+FP+ + +
Sbjct: 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP--PENDPPDGIF 210
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
++ +++ P +L + + + + C DP ERPS K
Sbjct: 211 ELLQYIVNEPPP------RLPSGKFSPDFQDFVNL---CLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 41/287 (14%)
Query: 241 LEIIGVGACGVVYKAE-VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+E+IGVGA VVY A +P + +AIK+ID T + +R+ E+
Sbjct: 6 IEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQ-TSVDELRK------------EV 50
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-HDVSQGRRELDWLARYRIA 358
+ H N++ D LV ++ GSL DI+ +G + +A +
Sbjct: 51 QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT--VL 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI--TT 416
+ + GLEYLH + IHRDIK N+L+ + +I+DFG++ + DG R R T
Sbjct: 109 KEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 417 VAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
GT ++APE Q K+DI+SFG+ L G P+ + ++ +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP-------MKVLML 218
Query: 476 VISSENP--HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ ++ P D K + + + L C DP +RP++
Sbjct: 219 TLQNDPPSLETGADYKKYSKSFRKMISL-------CLQKDPSKRPTA 258
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 18/229 (7%)
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
SEI G++ H N++ L L++E+++ +L ++L R L W R +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRK 784
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
IA G+A L +LH P ++ ++ P ++ID E + L L+
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI--- 840
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
++ YVAPE +T I+EKSDIY FG++L L+ GK P D F ++V W R
Sbjct: 841 ---SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG--SIVEWARYC 895
Query: 477 ISSENPHRAIDSKLLGNG--YEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
S + ID + G+ + ++ V+ +A CT+ DP RP + DV
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 27/219 (12%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IIT 301
+G G+ G V + GK+ A+K + + ++++ +++ +E I++
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYAMKVLKK-----------KKIIKRKEVEHTLTERNILS 48
Query: 302 AGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
RI H ++ L + L LV E+ G L L S+ R + AR+ A
Sbjct: 49 --RINHPFIVKLHYAFQTEE-KLYLVLEYAPGGELFSHL---SKEGRFSEERARFYAAE- 101
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ LEYLH II+RD+KP N+L+D +++DFGLAK + + R T GT
Sbjct: 102 IVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGT 156
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y+APE + D +S GVLL ++ GK PF
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 82/298 (27%), Positives = 129/298 (43%), Gaps = 65/298 (21%)
Query: 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+LE IG GA G VYKA + GK +AIKK+ L + I +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRAT-GKEVAIKKMR---------------LRKQNKELIIN 64
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDIL--HDVSQGRREL 349
EI+ H N+ V D +L +V E+M GSL DI+ + V
Sbjct: 65 EILIMKDCKHPNI------VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR------ 112
Query: 350 DWLARYRIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGL-AKL 404
+ +IA GLEYLH + IHRDIK N+L+ DG +++DFG A+L
Sbjct: 113 --MNEPQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDG-SVKLADFGFAAQL 166
Query: 405 MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464
+ R +V GT ++APE + K DI+S G++ + G+ P+
Sbjct: 167 TKEKSKR---NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE---- 219
Query: 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+R + +I+++ + + + + L C DPE+RPS+++
Sbjct: 220 ---PPLRALF-LITTKGIPPLKNP----EKWSPEFKDFLN---KCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 75/286 (26%), Positives = 128/286 (44%), Gaps = 36/286 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLIN--RKMRQIKSE 298
LE IG G+ G V K S GK++ K+ID M E ++ L++ +R++K
Sbjct: 5 LETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKE----KQQLVSEVNILRELKHP 59
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
I R + R + + +V E+ + G L ++ + R+ ++ +RI
Sbjct: 60 NIV--RYYDRIIDRSNQTL------YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 359 RGMASGLEYLH--MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+ L H ++HRD+KPAN+ +D ++ DFGLAK++ GH T
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL--GHDSSFAKT 169
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT Y++PE ++ EKSDI+S G L+ L PF + + ++
Sbjct: 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK----- 223
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
E R I Y ++ V+K + DP++RPS+++
Sbjct: 224 ---EGKFRRIPY-----RYSSELNEVIK---SMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 80/288 (27%), Positives = 126/288 (43%), Gaps = 53/288 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G+ GVV+K V + ++ A+K+ID M NR+ R+ E I
Sbjct: 5 LNKIGKGSFGVVFKV-VRKADKRVYAMKQIDLSKM-------------NRRERE---EAI 47
Query: 301 TAGRIWHRNLLPLQA-HVTRP-DCHL------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
R+ L L + ++ R + L +V E+ +NG L +L Q R L
Sbjct: 48 DEARV----LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPED 101
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+R + GL +LH I+HRDIK N+ +D +I D G+AKL+ D
Sbjct: 102 QVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
T+ GT Y++PE + +EKSD+++ GV+L GK PFD N
Sbjct: 159 N--TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD-------ANNQGAL 209
Query: 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ +I P + Y +Q+ ++ C + D +RP +
Sbjct: 210 ILKIIRGVFPP-------VSQMYSQQLAQLIDQ---CLTKDYRQRPDT 247
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 31/204 (15%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
EFM GSL I G ++ L + IA + GL YL+ HR I+HRDIKP+N+L
Sbjct: 83 EFMDCGSLDRIYKKG--GPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHRDIKPSNIL 136
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVA----GTTGYVAPEYHQTLTISEKSDIYSF 443
++ + ++ DFG++ + I ++A GT+ Y++PE Q + KSD++S
Sbjct: 137 VNSRGQIKLCDFGVSGEL--------INSIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 444 GVLLAVLVVGKFPF----DDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQM 499
G+ + L +GKFPF D + M ++ ++ ++ P +L + + E +
Sbjct: 189 GISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------RLPSSDFPEDL 242
Query: 500 RLVLKIAYFCTSDDPEERPSSKDV 523
R + C DP ERP+ + +
Sbjct: 243 RDFVDA---CLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G G VY+ V Y +A+K + + M E L V M++IK
Sbjct: 14 LGGGQYGEVYEG-VWKKYSLTVAVKTLKEDTMEVEEFLKEAAV-----MKEIK------- 60
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
H NL+ L TR ++ EFM G+L D L + R+E++ + +A ++S
Sbjct: 61 ---HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISS 115
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT-- 421
+EYL + IHRD+ N L+ + +++DFGL++LM T AG
Sbjct: 116 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFP 168
Query: 422 -GYVAPEYHQTLTISEKSDIYSFGVLL 447
+ APE S KSD+++FGVLL
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLL 195
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 80/312 (25%), Positives = 139/312 (44%), Gaps = 61/312 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E IG GA GVV A + GK +AIKKI P A +R L R+++ ++
Sbjct: 10 IENIGSGAYGVVCSA-IDTRSGKKVAIKKI---PHAFDVPTLAKRTL--RELKILR---- 59
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL----LVYEFMKNGSLQDILHDVSQGRRELDWLAR-- 354
H N++ ++ + P +V + M++ L I+H S + +
Sbjct: 60 ---HFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEEHIRYFL 113
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM---PDGHTR 411
Y++ RG L+Y+H +IHRD+KP+N+L+++ E RI DFG+A+ + P H
Sbjct: 114 YQLLRG----LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 412 IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGK--FPFDDFFQYTEEMN 468
VA T Y APE +L + D++S G + A ++ + FP + Y ++
Sbjct: 167 FMTEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN---YVHQLK 222
Query: 469 MVRWM-----------------RNVISSENPHRAID-SKLLGNGYEEQMRLVLKIAYFCT 510
++ + R I + + + SK+ E + L+ ++ F
Sbjct: 223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF-- 280
Query: 511 SDDPEERPSSKD 522
DPEER + +
Sbjct: 281 --DPEERITVEQ 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 82/300 (27%), Positives = 135/300 (45%), Gaps = 42/300 (14%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQPPMAATELLNVRRVLINRKMR 293
+ + L +G GA G V K + + G + A+K I D P ++L R + IN+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNT-GMIFALKTITTDPNPDLQKQIL--RELEINKS-- 55
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV-SQGRRELDWL 352
KS I + + L + + + E+ + GSL I V +G R + +
Sbjct: 56 -CKSPYIV--KYYGAFLDESSSSIG------IAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+IA + GL YLH IIHRDIKP+N+L+ + ++ DFG++ +
Sbjct: 107 LG-KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL------- 155
Query: 413 RITTVAGT-TG---YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468
+ ++AGT TG Y+APE Q S SD++S G+ L + +FPF + +
Sbjct: 156 -VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP--EGEPPLG 212
Query: 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528
+ + +++ NP D G + E+ + +K C DP RP+ D ML
Sbjct: 213 PIELLSYIVNMPNP-ELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+SL +G G G V+ G+ +A+K + M+ L ++ M+++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGT--TKVAVKTLKPGTMSPEAFLQEAQI-----MKKL 58
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
+ H L+ L A + + +V E+M GSL D L + L L
Sbjct: 59 R----------HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD- 107
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+A +A G+ YL + IHRD+ N+L+ + + +I+DFGLA+L+ D T
Sbjct: 108 -MAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE----YT 159
Query: 416 TVAGT---TGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVV-GKFPF 457
G + APE + TI KSD++SFG+LL +V G+ P+
Sbjct: 160 AREGAKFPIKWTAPEAANYGRFTI--KSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 80/300 (26%), Positives = 127/300 (42%), Gaps = 55/300 (18%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
L L+ +G G GVV+ + G +AIK I + M+ + + +V M ++
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIREGAMSEDDFIEEAKV-----MMKLS 57
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
H NL+ L T+ +V E+M NG L + L + +G+ +WL
Sbjct: 58 ----------HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWL--LD 104
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+ + +EYL IHRD+ N L+ + ++SDFGLA+ + D + T+
Sbjct: 105 MCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTS 157
Query: 417 VAGT---TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF--FQYTEEMNMV 470
GT + PE S KSD++SFGVL+ V GK P++ F + E ++
Sbjct: 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA- 216
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
P A V I Y C + PE+RP+ K +LSQ+
Sbjct: 217 -----GYRLYRPKLAPTE-------------VYTIMYSCWHEKPEDRPAFKK---LLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
IG G G V G Y G+ +A+K + AA L V M ++
Sbjct: 12 ATIGKGEFGDVML----GDYRGQKVAVKCLKDDSTAAQAFLAEASV-----MTTLR---- 58
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H NL+ L V + + +V E+M GSL D L S+GR + + A
Sbjct: 59 ------HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALD 110
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ G+EYL + +HRD+ NVL+ + + A++SDFGLAK G ++
Sbjct: 111 VCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-----P 162
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ APE + S KSD++SFG+LL
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL-QAHV 317
G++GK+ ++K D M A + +N ++ + +R + +E + H L+ L +
Sbjct: 11 GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
+ +L+V + + G D+ + +SQ + + ++ I + LEYLH II
Sbjct: 71 DEENMYLVV-DLLLGG---DLRYHLSQKVKFSEEQVKFWICE-IVLALEYLHSKG---II 122
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
HRDIKP N+L+D+ I+DF +A + T+ +GT GY+APE S
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVA 179
Query: 438 SDIYSFGVLLAVLVVGKFPFD 458
D +S GV + GK P+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 68/230 (29%), Positives = 98/230 (42%), Gaps = 40/230 (17%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+GVG G V +V + A+K + R ++ + I SE
Sbjct: 1 LGVGGFGRVELVKVKSK-NRTFALKCV-----------KKRHIVETGQQEHIFSEKEILE 48
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVY---EFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H ++ L + T D +Y E+ G L IL D G + ++ AR+ IA
Sbjct: 49 ECNHPFIVKL--YRTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFD-EYTARFYIA-C 101
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ EYLH II+RD+KP N+L+D ++ DFG AK + G + T GT
Sbjct: 102 VVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGT 155
Query: 421 TGYVAPEYHQTLTISEK-----SDIYSFGVLLAVLVVGKFPF--DDFFQY 463
YVAPE I K D +S G+LL L+ G+ PF DD
Sbjct: 156 PEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM 200
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-19
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 265 IAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL 324
+A+K + M + L I +K+R H L+ L A T +
Sbjct: 33 VAVKTLKPGTMDPKDFL--AEAQIMKKLR-------------HPKLIQLYAVCTLEEPIY 77
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
+V E MK GSL + L + +L L +A +ASG+ YL + IHRD+
Sbjct: 78 IVTELMKYGSLLEYLQGGAGRALKLPQLID--MAAQVASGMAYLEAQN---YIHRDLAAR 132
Query: 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFG 444
NVL+ + +++DFGLA+++ + R + APE S KSD++SFG
Sbjct: 133 NVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFG 191
Query: 445 VLLAVLVV-GKFPF 457
+LL +V G+ P+
Sbjct: 192 ILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 53/255 (20%)
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
K + + E+ R+ H++L+ L A + + ++ E M+ GSL L +G+ L
Sbjct: 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQ-VLP 102
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD--- 407
+ +A +A G+ YL + IHRD+ N+L+ + + +++DFGLA+L+ +
Sbjct: 103 VASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159
Query: 408 --GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYT 464
+I + APE T S KSD++SFG+LL + G+ P+
Sbjct: 160 LSSDKKIPYK-------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY------- 205
Query: 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPE 515
MN H D + GY R+ + KI C + +PE
Sbjct: 206 PGMNN-------------HEVYD--QITAGY----RMPCPAKCPQEIYKIMLECWAAEPE 246
Query: 516 ERPSSKDVRCMLSQI 530
+RPS K +R L I
Sbjct: 247 DRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 38/232 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKID-QPPMAATELLNVRRVLINRKMRQIKSEIITA 302
IG G G VY A V G+++A+K+I Q T +++I E+
Sbjct: 8 IGGGTFGKVYTA-VNLDTGELMAVKEIRIQDNDPKT-------------IKEIADEMKVL 53
Query: 303 GRIWHRNLLP-LQAHVTRPDCHLLVYEFMK---NGSLQDILHDVSQGRRELDWLARYRIA 358
+ H NL+ V R VY FM+ G+L+++L R LD
Sbjct: 54 ELLKHPNLVKYYGVEVHREK----VYIFMEYCSGGTLEELLE----HGRILDEHVIRVYT 105
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI--RITT 416
+ GL YLH + I+HRDIKPAN+ +D ++ DFG A + + T + + +
Sbjct: 106 LQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 417 VAGTTGYVAPEYHQTLTISEK---SDIYSFGVLLAVLVVGKFP---FDDFFQ 462
+AGT Y+APE +DI+S G ++ + GK P D+ FQ
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 68/233 (29%), Positives = 98/233 (42%), Gaps = 37/233 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E+IG G G VYKA G+++AIK +D E+ +L RK
Sbjct: 11 VEVIGEGTYGKVYKA-RHKKTGQLVAIKIMDIIEDEEEEIKEEYNIL--RKYSN------ 61
Query: 301 TAGRIWHRNLLPLQA------HVTRPDCHLLVYEFMKNGSLQDI---LHDVSQGRRELDW 351
H N+ D LV E GS+ D+ L + +E +W
Sbjct: 62 ------HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE-EW 114
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+A Y I R GL YLH +IHRDIK N+L+ E ++ DFG++ + T
Sbjct: 115 IA-Y-ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD--STL 167
Query: 412 IRITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
R T GT ++APE + +SD++S G+ L GK P D
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 28/221 (12%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII-TA 302
+G G G V +V + GKM A KK+D+ + KM ++ EI+
Sbjct: 1 LGKGGFGEVCAVQVKNT-GKMYACKKLDKKRLKKKS---------GEKMALLEKEILEKV 50
Query: 303 GRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARY--RIAR 359
+ NL A+ HL LV M G L+ +++V + E++ + Y +I
Sbjct: 51 NSPFIVNL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITC 106
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
G+ LH+ H I++RD+KP NVL+DD R+SD GLA + DG T IT AG
Sbjct: 107 GI------LHL-HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAG 156
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
T GY+APE + S D ++ G + +V G+ PF D
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 55/234 (23%), Positives = 96/234 (41%), Gaps = 28/234 (11%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKA--EVPGSYGKM-IAIKKI--DQPPMAATELLNVRRV 286
+ KE L ++++G GA G VYK G K+ +AIK + + P A E+L+
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---- 58
Query: 287 LINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
E + H +++ L + L+ + M G L D + +
Sbjct: 59 -----------EAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVR---NHK 103
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+ +A G+ YL ++HRD+ NVL+ +I+DFGLAKL+
Sbjct: 104 DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
++A E + KSD++S+GV + ++ G P++
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 5e-18
Identities = 68/221 (30%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS----EI 299
+G G G V +V + GKM A KK+D+ +R+ K R+ + E
Sbjct: 1 LGKGGFGEVCACQVKAT-GKMYACKKLDK-----------KRL----KKRKGEQMALNEK 44
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-GRRELDWLARYRIA 358
++ R ++ L D LV M G L+ +++V + G E A + A
Sbjct: 45 KILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEAR--AIFYAA 102
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ + GLE+LH + I++RD+KP NVL+DD RISD GLA + G I A
Sbjct: 103 Q-IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRA 155
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT GY+APE Q D ++ G L ++ G+ PF
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 27/190 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRV---LINRKMRQIKS 297
L IG GA G+V+KA+ + G+ +A+KK+ +RR+ + N+ +R+IK
Sbjct: 5 LGRIGEGAHGIVFKAKDRET-GETVALKKV-----------ALRRLEGGIPNQALREIK- 51
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H ++ L +LV E+M L ++L D R L
Sbjct: 52 ---ALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDE---ERPLPEAQVKSY 104
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
R + G+ Y+H I+HRD+KPAN+LI +I+DFGLA+L + R+ V
Sbjct: 105 MRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 418 AGTTGYVAPE 427
A T Y APE
Sbjct: 162 A-TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 81/286 (28%), Positives = 137/286 (47%), Gaps = 48/286 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR---VLINRKMRQIKS 297
LE IG G+ G VYKA + +++AIK ID A E+ ++++ L Q +S
Sbjct: 6 LECIGKGSFGEVYKAIDKRT-NQVVAIKVIDLEE-AEDEIEDIQQEIQFL-----SQCRS 58
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
IT ++ + L L ++ E+ GS D+L G+ + ++A
Sbjct: 59 PYITK---YYGSFLK--------GSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF-- 102
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
I R + GLEYLH + IHRDIK AN+L+ + + +++DFG++ + T + T
Sbjct: 103 ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNT 157
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT ++APE + EK+DI+S G+ L G+ P D ++ +R + +
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-------LHPMRVLFLI 210
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ P L GN + + + + C + DP+ERPS+K+
Sbjct: 211 PKNNPP------SLEGNKFSKPFKDFVS---LCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 26/293 (8%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
A LE +G GA G VYK + ++A+K+I+ A + R ++ + I
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRER----DKSIGDIV 56
Query: 297 SEI-ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
SE+ I ++ H N++ D +V + ++ L + + + + ++ +
Sbjct: 57 SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
I M L YLH R I+HRD+ P N+++ + + I+DFGLAK ++T
Sbjct: 117 NIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLT 171
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
+V GT Y PE + EK+D+++FG +L + + PF Y+ NM+
Sbjct: 172 SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF-----YST--NMLSLATK 224
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528
++ + + + + Y E + V+ C + D E RP V M+S
Sbjct: 225 IVEAV--YEPLPEGM----YSEDVTDVIT---SCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 8e-18
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E+ LE +G G+ G VYKA + G+++AIK + P+ ++ + I ++Q
Sbjct: 2 EEVFDILEKLGEGSYGSVYKA-IHKETGQVVAIKVV---PVEEDLQEIIKEISI---LKQ 54
Query: 295 IKSEIITA--GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
S I G + L +V E+ GS+ DI+ ++ E +
Sbjct: 55 CDSPYIVKYYGSYFKNTDL------------WIVMEYCGAGSVSDIMKITNKTLTEEEIA 102
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
A I GLEYLH IHRDIK N+L+++ +A+++DFG++ + T
Sbjct: 103 A---ILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMA 154
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
+ TV GT ++APE Q + + K+DI+S G+ + GK P+ D ++ +R
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD-------IHPMRA 207
Query: 473 MRNVISS-----ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + + +P + S N + ++ C DPEERPS+
Sbjct: 208 IFMIPNKPPPTLSDPEKW--SPEF-NDFVKK----------CLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 72/238 (30%), Positives = 105/238 (44%), Gaps = 53/238 (22%)
Query: 237 SLASLE---IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
SL+ LE IG GA G VYK + G++ A+K I VRR
Sbjct: 72 SLSELERVNRIGSGAGGTVYKV-IHRPTGRLYALKVI-----YGNHEDTVRR-------- 117
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCH---------LLVYEFMKNGSLQDILHDVSQ 344
QI EI + H N++ CH ++ EFM GSL+
Sbjct: 118 QICREIEILRDVNHPNVV---------KCHDMFDHNGEIQVLLEFMDGGSLE-------- 160
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
G D +AR + SG+ YLH H I+HRDIKP+N+LI+ +I+DFG++++
Sbjct: 161 GTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217
Query: 405 MPDGHTRIRITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+ T + GT Y++PE + DI+S GV + +G+FPF
Sbjct: 218 L--AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 20/218 (9%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G G+ G VYK + S + A+K++D M+ E + +N EI
Sbjct: 5 LKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKEREDA----VN--------EIR 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ + + +V E+ G L + + R+ + +RI
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL+ LH I+HRD+K AN+L+ +I D G++K++ + T GT
Sbjct: 112 LLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK----TQIGT 164
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
Y+APE + S KSDI+S G LL + PF+
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIK--KIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
E++G G+ G VY+ + G A+K + E + +Q++ EI
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAV-----------KQLEQEI 53
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
++ H N++ D + E + GSL +L + + Y R
Sbjct: 54 ALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLY--TR 109
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRITTVA 418
+ GLEYLH + +HRDIK AN+L+D +++DFG+AK ++ + +
Sbjct: 110 QILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK----SFK 162
Query: 419 GTTGYVAPEY-HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
G+ ++APE Q +DI+S G + + GK P+ + R
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR------ 216
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
S E P I L + +LK C DP RP++
Sbjct: 217 SKELP--PIPDHLSDEAKD----FILK----CLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 69/225 (30%), Positives = 118/225 (52%), Gaps = 19/225 (8%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+IG G+ G VY + S G+++A+K+++ P ++A+ R +L + EI
Sbjct: 7 LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSML-----DALAREIALL 60
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ H N++ D HL ++ E++ GS+ +L++ G E + L R + R +
Sbjct: 61 KELQHENIVQYLGSSLDAD-HLNIFLEYVPGGSVAALLNNY--GAFE-ETLVRNFV-RQI 115
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP----DGHTRIRITTV 417
GL YLH IIHRDIK AN+L+D+ +ISDFG++K + T ++
Sbjct: 116 LKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
G+ ++APE + + + K+DI+S G L+ ++ GK PF D Q
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 65/222 (29%), Positives = 112/222 (50%), Gaps = 18/222 (8%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E+IG G G VY A + + G+M+A+K+++ P A + ++ ++ ++SEI T
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK----ALRSEIET 61
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ H N++ T + + E++ GS+ L + GR E L R+ +
Sbjct: 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQ-LVRF-FTEQV 117
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
GL YLH I+HRD+K N+L+D +ISDFG++K D + + ++ G+
Sbjct: 118 LEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 422 GYVAPE----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
++APE Y Q S K DI+S G ++ + G+ P+ D
Sbjct: 175 FWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 49/229 (21%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKI--DQPPMAATELLNVRRVLINRK-MRQIK--SE 298
+G G VVYKA + G+++AIKKI + A + IN +R+IK E
Sbjct: 8 LGEGTYAVVYKARDKET-GRIVAIKKIKLGERKEA--------KDGINFTALREIKLLQE 58
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD---WLARY 355
+ H N++ L LV+EFM+ L+ ++ D S D ++
Sbjct: 59 L------KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM- 110
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
GLEYLH I+HRD+KP N+LI +++DFGLA+ + ++T
Sbjct: 111 -----TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMT 160
Query: 416 TVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T Y APE Y + D++S G + A L++ PF
Sbjct: 161 HQVVTRWYRAPELLFGARHYGVGV------DMWSVGCIFAELLLRV-PF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 67/223 (30%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+SL ++ +G G G V+ G+ +A+K + M+ L ++ M+++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGN--TKVAVKTLKPGTMSPESFLEEAQI-----MKKL 58
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
+ H L+ L A V+ ++ V E+M GSL D L D +GR L
Sbjct: 59 R----------HDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGR-ALKLPNLV 105
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+A +A+G+ Y+ R IHRD++ AN+L+ DG+ +I+DFGLA+L+ D R
Sbjct: 106 DMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-Q 161
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPF 457
+ APE + KSD++SFG+LL LV G+ P+
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 78/248 (31%), Positives = 117/248 (47%), Gaps = 51/248 (20%)
Query: 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+L +G GA G V A + G+ +AIKK+ +P +A + +R R++R +K
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKT-GRKVAIKKLSRPFQSAI---HAKRTY--RELRLLK--- 69
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
+ H N++ L V P L LV M L +I+ + +L
Sbjct: 70 ----HMDHENVIGL-LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFL 123
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
Y+I RG L+Y+H IIHRD+KP+N+ +++ E +I DFGLA+ HT
Sbjct: 124 V-YQILRG----LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDD 170
Query: 413 RITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDFF-Q 462
+T T Y APE Y+QT+ DI+S G ++A L+ GK FP D Q
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGKTLFPGSDHIDQ 224
Query: 463 YTEEMNMV 470
MN+V
Sbjct: 225 LKRIMNLV 232
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-17
Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 242 EIIGVGACGVVYKA--EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
E+IG G G V + ++PG +AIK + TE ++ R SE
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK---SGYTE----------KQRRDFLSEA 56
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
G+ H N++ L+ VT+ +++ EFM+NG+L L Q + + + R
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLR 113
Query: 360 GMASGLEYL-HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
G+A+G++YL M + +HRD+ N+L++ + ++SDFGL++ + D + T+
Sbjct: 114 GIAAGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 419 G---TTGYVAPEYHQTLTISEKSDIYSFG-VLLAVLVVGKFPFDD 459
G + APE + SD++S+G V+ V+ G+ P+ D
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 65/229 (28%), Positives = 113/229 (49%), Gaps = 27/229 (11%)
Query: 237 SLASLEIIGVGACGVVYKA--EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
+ ++IG G G V++ ++PG +AIK + TE K RQ
Sbjct: 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKP---GYTE-----------KQRQ 51
Query: 295 -IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
SE G+ H N++ L+ VT+ +++ E+M+NG+L L D G E
Sbjct: 52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDG--EFSSYQ 108
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ RG+A+G++YL + +HRD+ N+L++ +E ++SDFGL++++ D
Sbjct: 109 LVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGT 164
Query: 414 ITTVAGTTG--YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
TT G + APE + SD++SFG+++ V+ G+ P+ D
Sbjct: 165 YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
L ++ +G G GVV+ + +AIK I++ M+ + + +V++
Sbjct: 6 LTFMKELGSGQFGVVHLGKWRAQI--KVAIKAINEGAMSEEDFIEEAKVMM--------- 54
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
++ H L+ L T+ +V EFM+NG L + L QG+ D L +
Sbjct: 55 ------KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDML--LSM 105
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ + G+EYL R IHRD+ N L+ ++SDFG+ + + D T+
Sbjct: 106 CQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD----EYTSS 158
Query: 418 AGT---TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWM 473
+G + PE S KSD++SFGVL+ V GK PF+ Y E + M+
Sbjct: 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI--- 214
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
R KL V ++ Y C + PE RP+ ++
Sbjct: 215 ------SRGFRLYRPKLASM-------TVYEVMYSCWHEKPEGRPTFAEL 251
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 53/154 (34%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY--RIARGMASG 364
H L+ L A VT+ + ++ E+M GSL D L G+ L L + +IA GMA
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA-- 117
Query: 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYV 424
Y+ R IHRD++ ANVL+ + + +I+DFGLA+++ D R +
Sbjct: 118 --YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWT 171
Query: 425 APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
APE + + KSD++SFG+LL ++ GK P+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 57/299 (19%)
Query: 225 KKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVR 284
+D+ FL KE +G G GVV + G Y +AIK I + M+ E +
Sbjct: 2 DPKDLTFL-KE--------LGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEA 50
Query: 285 RVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ 344
+V++ + H L+ L T+ +V E+M NG L + L +
Sbjct: 51 KVMMK---------------LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR---E 92
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
+ + + + G+ YL IHRD+ N L+DD ++SDFGL++
Sbjct: 93 HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY 149
Query: 405 MPDGHTRIRITTVAGT---TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
+ D T+ G+ + PE S KSD+++FGVL+ V +GK P++ F
Sbjct: 150 VLDD----EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205
Query: 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
+ + +R PH A + V I Y C + EERP+
Sbjct: 206 NNSETVEKVSQGLR----LYRPHLASEK-------------VYAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 82/295 (27%), Positives = 133/295 (45%), Gaps = 46/295 (15%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
++L ++ +G G G V+ G +AIK + Q M+ L + M+Q+
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGH--TKVAIKSLKQGSMSPEAFLAEANL-----MKQL 58
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL--A 353
+ H L+ L A VT+ ++ + E+M+NGSL D L + ++ L
Sbjct: 59 Q----------HPRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIKLTINKLIDM 107
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+IA GMA ++ R IHRD++ AN+L+ + + +I+DFGLA+L+ D R
Sbjct: 108 AAQIAEGMA----FIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472
+ APE T + KSD++SFG+LL +V G+ P+
Sbjct: 161 -EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG------------- 206
Query: 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
M N +N R N EE L+ C + PEERP+ + +R +L
Sbjct: 207 MTNPEVIQNLERGYRMPRPDNCPEELYELMRL----CWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 43/281 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ--IKSEIIT 301
IG G VVYKA G+++A+KK+ M ++ K RQ +K EI
Sbjct: 10 IGKGQFSVVYKAICLLD-GRVVALKKVQIFEM------------MDAKARQDCLK-EIDL 55
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
++ H N++ A + +V E G L ++ + +R + ++ +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA--- 418
S LE++H R I+HRDIKPANV I ++ D GL + TT A
Sbjct: 116 CSALEHMHS-KR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK------TTAAHSL 166
Query: 419 -GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
GT Y++PE + KSDI+S G LL + + PF Y ++MN+ + +
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKKIE 221
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP 518
+ P L + Y E++R ++ C + DPE+RP
Sbjct: 222 KCDYP------PLPADHYSEELRDLVSR---CINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 76/273 (27%), Positives = 113/273 (41%), Gaps = 42/273 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ I GA G VY A+ + G AIK + + M A V V R + I+ E
Sbjct: 1 LKPISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKN--QVTNVKAERAIMMIQGE-- 55
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ L D LV E++ G ++ + G DW +Y
Sbjct: 56 ------SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQY--IAE 105
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ G+E LH + IIHRDIKP N+LID +++DFGL++ G + GT
Sbjct: 106 VVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENKKFV---GT 156
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF-----DDFFQYTEEMNMVRWMRN 475
Y+APE + + SD +S G ++ + G PF D F + W
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINWPEE 215
Query: 476 VISSENPHRAID--SKLL---------GNGYEE 497
V +P A+D ++LL NGY+E
Sbjct: 216 VKEFCSP-EAVDLINRLLCMDPAKRLGANGYQE 247
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 63/235 (26%), Positives = 95/235 (40%), Gaps = 30/235 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G GVVYKA + G+++AIKKI + +R+IK
Sbjct: 4 LGKIGEGTYGVVYKARDKLT-GEIVAIKKIKLRFESEGIP--------KTALREIKL--- 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L LV+EFM D+ + +R L
Sbjct: 52 -LKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-PDGHTRIRITTVAG 419
+ GL + H H I+HRD+KP N+LI+ +++DFGLA+ T
Sbjct: 107 LLQGLAFCHS-HG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHYVV 160
Query: 420 TTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGK--FPFDDFFQYTEEMNMVR 471
T Y APE S DI+S G + A L+ + FP +++ +
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS---EIDQLFKIF 212
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-16
Identities = 82/286 (28%), Positives = 127/286 (44%), Gaps = 44/286 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G G V+ G+ +AIK + M L +++ +K+R
Sbjct: 14 LGQGCFGEVWMGTWNGT--TKVAIKTLKPGTMMPEAFLQEAQIM--KKLR---------- 59
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
H L+PL A V+ ++ V EFM GSL D L + +L L +A +A
Sbjct: 60 ---HDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIAD 113
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGY 423
G+ Y+ R IHRD++ AN+L+ D + +I+DFGLA+L+ D R +
Sbjct: 114 GMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGAKFPIKW 169
Query: 424 VAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISS-EN 481
APE + KSD++SFG+LL LV G+ P+ MV R V+ E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP---------GMVN--REVLEQVER 218
Query: 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
+R + E M+L C DP+ERP+ + ++ L
Sbjct: 219 GYRMPCPQGCPESLHELMKL-------CWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 7e-16
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+ +G GA Y+A + G ++A+K++ ++E V + ++ EI
Sbjct: 6 QQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEV--------VEALRKEIRL 56
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
R+ H +++ + T D H ++ E+M GS+ +L G + + Y
Sbjct: 57 MARLNHPHIIRMLG-ATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINY--TEQ 111
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKLMPDGHTRIRI--TTV 417
+ GL YLH IIHRD+K AN+LID G RI+DFG A + T +
Sbjct: 112 LLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
GT ++APE + D++S G ++ + K P++
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 9e-16
Identities = 89/319 (27%), Positives = 139/319 (43%), Gaps = 75/319 (23%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG GA GVV A V G+ +AIKKI +L++ +R+L R+IK ++
Sbjct: 5 LKPIGSGAYGVVCSA-VDKRTGRKVAIKKI---SNVFDDLIDAKRIL-----REIK--LL 53
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELD---- 350
R H N++ L + RP +V E M + LH V + + L
Sbjct: 54 RHLR--HENIIGLL-DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHI 105
Query: 351 -WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+ Y+I RG L+YLH + +IHRD+KP+N+L++ + +I DFGLA+ +
Sbjct: 106 QYFL-YQILRG----LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 410 TRIRITT--VAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFD 458
T V T Y APE Y + + DI+S G + A L+ K FP
Sbjct: 158 DEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI------DIWSVGCIFAELLTRKPLFPGR 210
Query: 459 DFFQY------------TEEMNMVR--WMRNVISSENPHRAID-SKLLGNGYEEQMRLVL 503
D+ E++ + RN + S SKL E + L+
Sbjct: 211 DYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLE 270
Query: 504 KIAYFCTSDDPEERPSSKD 522
K+ F DP++R ++ +
Sbjct: 271 KMLVF----DPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 9e-16
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
EIIG G G V + E G+ +A+K I + + A L V+
Sbjct: 12 EIIGEGEFGAVLQGEY---TGQKVAVKNI-KCDVTAQAFLEETAVMTK------------ 55
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ H+NL+ L + ++ V E M G+L + L ++GR + + + + +
Sbjct: 56 ---LHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDV 109
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
A G+EYL ++HRD+ N+L+ + A++SDFGLA++ G ++
Sbjct: 110 AEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PV 161
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
+ APE + S KSD++S+GVLL V G+ P+
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+G+++ ++ A ++L+ +++ +++ + +E I H L+ L
Sbjct: 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
LV E++ G L L GR AR+ A+ + LEYLH I++
Sbjct: 72 DDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYAAQ-VVLALEYLHSLD---IVY 124
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RD+KP N+L+D +I+DFG AK + R T+ GT Y+APE + +
Sbjct: 125 RDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSKGYGKAV 179
Query: 439 DIYSFGVLLAVLVVGKFPFDD 459
D ++ G+L+ ++ G PF D
Sbjct: 180 DWWALGILIYEMLAGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 40/228 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
+ IG G G VYKA G+++A+KKI + P+ A +R + + +K+R
Sbjct: 4 IAQIGEGTYGQVYKAR-NKKTGELVALKKIRMENEKEGFPITA-----IREIKLLQKLR- 56
Query: 295 IKSEIITAGRIWHRNLLPLQAHVT---RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
H N++ L+ VT + ++ V+E+M + L +L +
Sbjct: 57 ------------HPNIVRLKEIVTSKGKGSIYM-VFEYMDH-DLTGLLDSPEV---KFTE 99
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+ + GL+YLH I+HRDIK +N+LI++ +++DFGLA+
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNS 155
Query: 412 IRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T T Y PE T + D++S G +LA L +GK F
Sbjct: 156 ADYTNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 64/248 (25%), Positives = 110/248 (44%), Gaps = 25/248 (10%)
Query: 287 LINRKMRQ--IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ 344
L++ K R IK EI ++ H N++ A + +V E G L ++ +
Sbjct: 40 LMDAKARADCIK-EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKK 98
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
+R + ++ + S LE++H ++HRDIKPANV I ++ D GL +
Sbjct: 99 QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 155
Query: 405 MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464
T ++ GT Y++PE + KSDI+S G LL + + PF Y
Sbjct: 156 FSSKTTAAH--SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YG 208
Query: 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524
++MN+ + + + P L + Y E++R ++ C + DPE+RP D+
Sbjct: 209 DKMNLYSLCKKIEQCDYP------PLPSDHYSEELR---QLVNMCINPDPEKRP---DIT 256
Query: 525 CMLSQIKH 532
+ K
Sbjct: 257 YVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 76/241 (31%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP------PMAATELLNVRRVLINRKMRQ 294
L IG GA G VYKA + G+ +A+KK+ P P++ +R + + ++Q
Sbjct: 4 LAEIGEGAYGTVYKARDLNT-GRFVALKKVRVPLSEEGIPLST-----LREIAL---LKQ 54
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL----- 349
++ H N++ L D+ H + REL
Sbjct: 55 LE-------SFEHPNIV----------------------RLLDVCH-GPRTDRELKLTLV 84
Query: 350 ----DW-LARY---------------RIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389
D LA Y + R + G+++LH HR I+HRD+KP N+L+
Sbjct: 85 FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HR--IVHRDLKPQNILVT 141
Query: 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449
+ +I+DFGLA++ + +T+V T Y APE + + D++S G + A
Sbjct: 142 SDGQVKIADFGLARIYSF---EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE 198
Query: 450 L 450
L
Sbjct: 199 L 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ IG G G VYKA + G+++AIK I + + I+ EI
Sbjct: 8 IQRIGSGTYGDVYKARDIAT-GELVAIKVI---KLEPGD-----------DFEIIQQEIS 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ R D +V E+ GSLQDI R L L + R
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ---VTRGPLSELQIAYVCRE 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
GL YLH + IHRDIK AN+L+ + + +++DFG++ + T + + GT
Sbjct: 110 TLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGT 164
Query: 421 TGYVAPEYHQTLTIS---EKSDIYSFGV 445
++APE K DI++ G+
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 46/233 (19%)
Query: 242 EIIGVGACGVVYKA--EVPGSYGKMIAIK--KIDQPPMAATELLNVRRVLINRKMRQIKS 297
++IG G G V + ++PG +AIK K + L +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL---------------T 54
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
E G+ H N++ L+ VT+ +++ E+M+NGSL L + + +
Sbjct: 55 EASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGM 111
Query: 358 ARGMASGLEYL-HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD--------- 407
RG+ASG++YL M +HRD+ N+L++ + ++SDFGL++ + D
Sbjct: 112 LRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 408 GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
G IR T APE + SD++SFG+++ V+ G+ P+ D
Sbjct: 168 GKIPIRWT---------APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 54/291 (18%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
L ++ IG G G+V+ G + + +AIK I + M+ + + +V++
Sbjct: 4 SELTLVQEIGSGQFGLVWL----GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMM----- 54
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
++ H L+ L T LV+EFM++G L D L +Q R +
Sbjct: 55 ----------KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR--AQ-RGKFSQET 101
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ + G+ YL +IHRD+ N L+ + ++SDFG+ + + D +
Sbjct: 102 LLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD----Q 154
Query: 414 ITTVAGT---TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNM 469
T+ GT + +PE S KSD++SFGVL+ V GK P+++
Sbjct: 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN---------- 204
Query: 470 VRWMRNVISSENP-HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
R V+ + N R +L E M+ C + PE+RPS
Sbjct: 205 -RSNSEVVETINAGFRLYKPRLASQSVYELMQ-------HCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/218 (27%), Positives = 92/218 (42%), Gaps = 40/218 (18%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLNVRRVLINRKMRQIKS 297
+ +G G+ GVV + E S GK+I A+K K D+ + L + I +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL--KEAAIMHSLD---- 54
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H NL+ L V ++V E GSL D L + G + L Y
Sbjct: 55 ---------HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY-- 102
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG--------H 409
A +A+G+ YL IHRD+ N+L+ + +I DFGL + +P H
Sbjct: 103 AVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
Query: 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++ + APE +T T S SD++ FGV L
Sbjct: 160 LKVPF-------AWCAPESLRTRTFSHASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 73/314 (23%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ L L IG GA G V K S G ++A+K+I R + ++ +++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPS-GTIMAVKRI-------------RSTVDEKEQKRL 49
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLV---------------YEFMKNGSLQD--- 337
L+ L + DC +V E M + SL
Sbjct: 50 --------------LMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYK 94
Query: 338 ILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397
+++V + + L + IA L YL + IIHRD+KP+N+L+D ++
Sbjct: 95 YVYEVLKSVIPEEILGK--IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLC 150
Query: 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE---KSDIYSFGVLLAVLVVGK 454
DFG++ + D I T AG Y+APE +SD++S G+ L + GK
Sbjct: 151 DFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQ--MRLVLKIAYFCTSD 512
FP+ + ++ + V+ + P +L N E + V I C
Sbjct: 208 FPYPKW------NSVFDQLTQVVKGDPP-------ILSNSEEREFSPSFVNFINL-CLIK 253
Query: 513 DPEERPSSKDVRCM 526
D +RP K++
Sbjct: 254 DESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G G G V +V + GKM A KK+++ +R+ + +E
Sbjct: 7 VLGKGGFGEVCACQVRAT-GKMYACKKLEK-----------KRIKKRKGESMALNEKQIL 54
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
++ R ++ L D LV M G L+ ++ + + E Y A +
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY--AAEIC 112
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
GLE LH + I++RD+KP N+L+DD RISD GLA +P+G T I GT G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVG 166
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
Y+APE + + D ++ G LL ++ G+ PF
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPM----AATELLNVRRVLINRKMRQIKSE 298
++G G G V +V + GKM A KK+++ + LN +++L ++ S
Sbjct: 7 VLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNEKQIL-----EKVNSR 60
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ + L D LV M G L+ ++++ + + Y A
Sbjct: 61 FVVS----------LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY--A 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ GLE LH R I++RD+KP N+L+DD RISD GLA +P+G T I
Sbjct: 109 AEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRV 162
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
GT GY+APE + + D + G L+ ++ GK PF
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 49/231 (21%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQP----PMAATELLNVRRVLINRKMRQ 294
LE +G G GVVYKA + G+++A+KKI D P A +R + + ++++
Sbjct: 4 LEKLGEGTYGVVYKARDKKT-GEIVALKKIRLDNEEEGIPSTA-----LREISLLKELK- 56
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG--RRELDWL 352
H N++ L + LV+E+ L+ L +
Sbjct: 57 ------------HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-- 101
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
I + GL Y H HR I+HRD+KP N+LI+ +++DFGLA+ G
Sbjct: 102 ---SIMYQLLRGLAYCH-SHR--ILHRDLKPQNILINRDGVLKLADFGLARAF--GIPLR 153
Query: 413 RITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
T T Y APE H + + DI+S G + A ++ GK FP
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGKPLFP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 77/293 (26%), Positives = 127/293 (43%), Gaps = 48/293 (16%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E L IG G+ G VY A + +++AIKK+ + E K +
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNE-----------KWQD 61
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
I E+ ++ H N + + R LV E+ GS DIL + +E++ A
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA- 119
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
I G GL YLH + R IHRDIK N+L+ + +++DFG A L+ ++ +
Sbjct: 120 --ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-- 172
Query: 415 TTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
GT ++APE L + E K D++S G+ L K P + MN
Sbjct: 173 ----GTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNA 219
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + ++ +++P L N + + R + C P++RPSS++
Sbjct: 220 MSALYHIAQNDSP------TLSSNDWSDYFRNFVD---SCLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G G G V +V + GKM A KK+++ +R+ K R+ ++ +
Sbjct: 7 VLGKGGFGEVCACQVRAT-GKMYACKKLEK-----------KRI----KKRKGEAMALNE 50
Query: 303 GRIWH----RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
RI R ++ L D LV M G L+ H + G D A
Sbjct: 51 KRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGNPGFDEQRAIFYA 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT-RIRITTV 417
+ GLE L R I++RD+KP N+L+DD RISD GLA +P+G T R R+
Sbjct: 109 AELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--- 162
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
GT GY+APE + D + G L+ ++ G+ PF
Sbjct: 163 -GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 69/234 (29%), Positives = 111/234 (47%), Gaps = 40/234 (17%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E+ LE IG G+ G VYK + +++AIK ID A E+ ++++ + + Q
Sbjct: 3 EELFTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEE-AEDEIEDIQQEIT--VLSQ 58
Query: 295 IKSEIIT--------AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
S IT ++W ++ E++ GS D+L G
Sbjct: 59 CDSPYITRYYGSYLKGTKLW------------------IIMEYLGGGSALDLL---KPGP 97
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
E ++A I R + GL+YLH + IHRDIK ANVL+ + + +++DFG+A +
Sbjct: 98 LEETYIAT--ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
D T+I+ T GT ++APE + K+DI+S G+ L G+ P D
Sbjct: 153 D--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ---IKSEIITAGRIWHRNLLPLQ- 314
G +G++ A + + A + LN +R L RK + ++ I+ ++ R ++ L
Sbjct: 4 GGFGEVSACQMRATGKLYACKKLNKKR-LKKRKGYEGAMVEKRILA--KVHSRFIVSLAY 60
Query: 315 AHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHR 373
A T+ D C LV M G L+ +++V + + SGLE+LH R
Sbjct: 61 AFQTKTDLC--LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RR 117
Query: 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT 433
II+RD+KP NVL+D+ RISD GLA + DG ++ + AGT G++APE Q
Sbjct: 118 --IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK--GYAGTPGFMAPELLQGEE 173
Query: 434 ISEKSDIYSFGVLLAVLVVGKFPF 457
D ++ GV L ++ + PF
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 36/233 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G+ G+V A S G+ +A+KK+D ELL V+I MR +
Sbjct: 27 IGEGSTGIVCIATDK-STGRQVAVKKMDLRKQQRRELL-FNEVVI---MRDYQ------- 74
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
H N++ + + D +V EF++ G+L DI V+ R + +A + +
Sbjct: 75 ---HPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT--VCLAVLK 126
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG----LAKLMPDGHTRIRITTVAG 419
L +LH +IHRDIK ++L+ ++SDFG ++K +P R ++ G
Sbjct: 127 ALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP------RRKSLVG 177
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP-FDDFFQYTEEMNMVR 471
T ++APE L + DI+S G+++ +V G+ P F++ + M +R
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 69/237 (29%), Positives = 102/237 (43%), Gaps = 55/237 (23%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM-RQIKSEIITA 302
I GA G V+ A+ S G + AIK I + +I + Q+ +E
Sbjct: 1 ISKGAYGRVFLAK-KKSTGDIYAIKVIK------------KADMIRKNQVDQVLTE---- 43
Query: 303 GRIWHRNLLPLQAHVTRP-----------DCHL-LVYEFMKNGSLQDILHDVSQGRRELD 350
R++L + P +L LV E++ G L +L +V G + D
Sbjct: 44 -----RDIL---SQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDED 93
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL------ 404
AR IA + LEYLH IIHRD+KP N+LID +++DFGL+K+
Sbjct: 94 V-ARIYIAE-IVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148
Query: 405 --MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ D + + GT Y+APE S+ D +S G +L +VG PF
Sbjct: 149 INLNDDEKEDK--RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 76/281 (27%), Positives = 119/281 (42%), Gaps = 43/281 (15%)
Query: 241 LEI-IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
LE+ +G G G V+ G+ +AIK + M+ L +V+ +K+R
Sbjct: 10 LEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPEAFLQEAQVM--KKLR------ 59
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
H L+ L A V+ ++ V E+M GSL D L L L A
Sbjct: 60 -------HEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AA 109
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ASG+ Y+ R +HRD++ AN+L+ + + +++DFGLA+L+ D R
Sbjct: 110 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKF 165
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVIS 478
+ APE + KSD++SFG+LL L G+ P+ + R R
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP 225
Query: 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
E P E L+ + C +PEERP+
Sbjct: 226 PECP-------------ESLHDLMCQ----CWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L ++G GA GVV K + G+++AIKK + + +V++ +R++K
Sbjct: 6 LGVVGEGAYGVVLKCRNKAT-GEIVAIKKF----KESEDDEDVKKTA----LREVK---- 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H N++ L+ R LV+E+++ + +L + L A
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQ 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ + Y H IIHRDIKP N+L+ + ++ DFG A+ + +T T
Sbjct: 109 LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVAT 164
Query: 421 TGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGK--FP 456
Y APE L + + + D+++ G ++A L+ G+ FP
Sbjct: 165 RWYRAPE----LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 82/290 (28%), Positives = 138/290 (47%), Gaps = 43/290 (14%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E+ LE IG G+ G V+K + K++AIK ID A E+ ++++ + + Q
Sbjct: 3 EELFTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKIIDLEE-AEDEIEDIQQEIT--VLSQ 58
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLA 353
S +T ++ + L D L ++ E++ GS D+L LD
Sbjct: 59 CDSPYVTK---YYGSYLK--------DTKLWIIMEYLGGGSALDLLEP-----GPLDETQ 102
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
I R + GL+YLH + IHRDIK ANVL+ + E +++DFG+A + D T+I+
Sbjct: 103 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIK 157
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
T GT ++APE + K+DI+S G+ L G+ P + M ++
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL----HPMKVLF-- 211
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+I NP L GN Y + ++ ++ C + +P RP++K++
Sbjct: 212 --LIPKNNP-----PTLEGN-YSKPLKEFVEA---CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
+V E G L ++ + +R + ++ + S +E HM+ R ++HRDIKPA
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--HMHSRR-VMHRDIKPA 135
Query: 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFG 444
NV I ++ D GL + T ++ GT Y++PE + KSDI+S G
Sbjct: 136 NVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMSPERIHENGYNFKSDIWSLG 193
Query: 445 VLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLK 504
LL + + PF Y ++MN+ + + + P L Y E++R +
Sbjct: 194 CLLYEMAALQSPF-----YGDKMNLFSLCQKIEQCDYP------PLPTEHYSEKLR---E 239
Query: 505 IAYFCTSDDPEERPSSKDVRCMLSQIK 531
+ C DP++RP V + Q+
Sbjct: 240 LVSMCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 12/154 (7%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY--RIARGMASG 364
H L+ L A VT+ +++ EFM GSL D L ++ L L + +IA GMA
Sbjct: 60 HDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA-- 116
Query: 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYV 424
++ + IHRD++ AN+L+ + +I+DFGLA+++ D R +
Sbjct: 117 --FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-EGAKFPIKWT 170
Query: 425 APEYHQTLTISEKSDIYSFGVLLA-VLVVGKFPF 457
APE + + KSD++SFG+LL ++ G+ P+
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 43/129 (33%), Positives = 70/129 (54%), Gaps = 10/129 (7%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E M GSL +L GR + L + IA + GL YL H+ I+HRD+KP+N+L
Sbjct: 79 EHMDGGSLDQVLKKA--GRIPENILGKISIA--VLRGLTYLREKHK--IMHRDVKPSNIL 132
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++ E ++ DFG++ + D + GT Y++PE Q + +SDI+S G+ L
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 448 AVLVVGKFP 456
+ +G++P
Sbjct: 189 VEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 235 EDSLASLEIIGVGACGVVYKA--EVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRK 291
+ L ++ +G G G V + G + G+ +A+K + +
Sbjct: 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-------------NHSGEEQH 49
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDC--HLLVYEFMKNGSLQDILHDVSQGRREL 349
+ EI + H N++ + +P L+ E++ +GSL+D L + + L
Sbjct: 50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINL 108
Query: 350 DWLARY--RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407
L + +I +GM +YL IHRD+ N+L++ +ISDFGLAK++P+
Sbjct: 109 KRLLLFSSQICKGM----DYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE 161
Query: 408 GHTRIRITTVAGT-TGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ + + APE +T S SD++SFGV L
Sbjct: 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 2e-14
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G G VY A G+++AIKK+ + + E +N+R V RK+ +
Sbjct: 7 LGDGTFGSVYLARNK-ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE--------- 56
Query: 304 RIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
H N++ L+ V R + L V+E+M+ Q + + + I +
Sbjct: 57 ---HPNIVKLK-EVFRENDELYFVFEYMEGNLYQLM---KDRKGKPFSESVIRSIIYQIL 109
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR--ITTVAGT 420
GL ++H + HRD+KP N+L+ +I+DFGLA+ R R T T
Sbjct: 110 QGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYVST 161
Query: 421 TGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
Y APE T + S DI++ G ++A L + FP
Sbjct: 162 RWYRAPEILLRST-SYSSPVDIWALGCIMAELYTLRPLFP 200
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 65/223 (29%), Positives = 112/223 (50%), Gaps = 31/223 (13%)
Query: 243 IIGVGACGVVY--KAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+IG G G V + ++PG +AIK + TE ++ R SE
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK---AGYTE----------KQRRDFLSEAS 57
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIA 358
G+ H N++ L+ VT+ ++V E+M+NGSL L HD G+ + L +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVG--ML 112
Query: 359 RGMASGLEYLH-MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
RG+ASG++YL M + +HRD+ N+L++ + ++SDFGL++++ D TT
Sbjct: 113 RGIASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTR 167
Query: 418 AGTTG--YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
G + APE + SD++S+G+++ V+ G+ P+
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 48/255 (18%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE----VPGSYGKMIAIKKIDQPPMAATELLNVRRVLIN 289
+ D++ +G GA G V+ E P + +++A+K + +
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA----------- 51
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL--HD------ 341
RK + ++E++T H N++ T D ++V+E+M++G L L H
Sbjct: 52 RKDFEREAELLTN--FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFL 109
Query: 342 --VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
EL +IA +ASG+ YL H +HRD+ N L+ + +I DF
Sbjct: 110 KSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDF 166
Query: 400 GLAK-------LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLV 451
G+++ GHT + I ++ PE + +SD++SFGV+L +
Sbjct: 167 GMSRDVYTTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
Query: 452 VGKFPFDDFFQYTEE 466
GK P ++ + E
Sbjct: 220 YGKQP---WYGLSNE 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKID-QPPMAATELLNVRRVLINRKMRQIKSEIITA 302
IGVGA G VYKA P S G +A+K + Q L VR V + +++
Sbjct: 8 IGVGAYGTVYKARDPHS-GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD------ 60
Query: 303 GRIWHRNLLPLQ-----AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H N++ L + R LV+E + + L+ L V + + +
Sbjct: 61 ----HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKD--L 113
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
R GL++LH CI+HRD+KP N+L+ G + +++DFGLA++ ++ +T V
Sbjct: 114 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPV 167
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448
T Y APE T + D++S G + A
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 27/227 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G G+ G V AE+ G G+ A+K + + VLI+ + E
Sbjct: 1 KVLGKGSFGKVLLAELKGK-GEYFAVKALKKDV-----------VLIDDDVECTMVEKRV 48
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLL-VYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
W L + HL V EF+ G L + H +GR +L Y A
Sbjct: 49 LALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFY--AAE 104
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL++LH II+RD+K NV++D +I+DFG+ K G R +T GT
Sbjct: 105 IVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGT 159
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF-----DDFFQ 462
Y+APE Q L + D +SFGVLL +++G+ PF D+ F+
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E IG GA G VY A + + G+ +AIK+++ EL+ + +L+ MR+ K
Sbjct: 24 FEKIGQGASGTVYTA-IDVATGQEVAIKQMNLQQQPKKELI-INEILV---MRENK---- 74
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ D +V E++ GSL D++ + ++ + R
Sbjct: 75 ------HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 123
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA--RISDFGL-AKLMPDGHTRIRITTV 417
LE+LH +IHRDIK N+L+ GM+ +++DFG A++ P+ R +T+
Sbjct: 124 CLQALEFLHSNQ---VIHRDIKSDNILL--GMDGSVKLTDFGFCAQITPEQSKR---STM 175
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
GT ++APE K DI+S G++ +V G+ P+
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 47/136 (34%), Positives = 75/136 (55%), Gaps = 10/136 (7%)
Query: 323 HLL-VYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381
HL V E++ G D++ + R + AR+ A + GL++LH + II+RD+
Sbjct: 70 HLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAE-IICGLQFLH---KKGIIYRDL 122
Query: 382 KPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIY 441
K NVL+D +I+DFG+ K +G + +T GT Y+APE + +E D +
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKYNESVDWW 180
Query: 442 SFGVLLAVLVVGKFPF 457
SFGVLL +++G+ PF
Sbjct: 181 SFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 4e-14
Identities = 44/129 (34%), Positives = 71/129 (55%), Gaps = 10/129 (7%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E M GSL +L + + E+ L + IA + GL YL H+ I+HRD+KP+N+L
Sbjct: 83 EHMDGGSLDQVLKEAKRIPEEI--LGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNIL 136
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++ E ++ DFG++ + D + GT Y++PE Q S +SDI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 448 AVLVVGKFP 456
L +G++P
Sbjct: 193 VELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 57/297 (19%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E+ LE IG G+ G V+K + +++AIK ID A E+ ++++ + + Q
Sbjct: 3 EELFTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEE-AEDEIEDIQQEIT--VLSQ 58
Query: 295 IKSEIIT--------AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
S +T ++W ++ E++ GS D+L
Sbjct: 59 CDSPYVTKYYGSYLKGTKLW------------------IIMEYLGGGSALDLLR-----A 95
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
D + + + GL+YLH + IHRDIK ANVL+ + + +++DFG+A +
Sbjct: 96 GPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
D T+I+ T GT ++APE Q K+DI+S G+ L G+ P D
Sbjct: 153 D--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD------- 203
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
M+ +R + + + P L G E + + C + DP RP++K++
Sbjct: 204 MHPMRVLFLIPKNNPP------TLTG----EFSKPFKEFIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 6e-14
Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E IG GA G V+ A + + G+ +AIK+I+ EL+ + +L+ M+++K+
Sbjct: 25 EKIGQGASGTVFTA-IDVATGQEVAIKQINLQKQPKKELI-INEILV---MKELKNP--- 76
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
N++ D +V E++ GSL D++ + ++ + R
Sbjct: 77 -------NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCREC 124
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA--RISDFGL-AKLMPDGHTRIRITTVA 418
LE+LH +IHRDIK NVL+ GM+ +++DFG A++ P+ R +T+
Sbjct: 125 LQALEFLHANQ---VIHRDIKSDNVLL--GMDGSVKLTDFGFCAQITPEQSKR---STMV 176
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
GT ++APE K DI+S G++ +V G+ P+
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 65/251 (25%), Positives = 113/251 (45%), Gaps = 40/251 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
LE +G GA G VYK E+ G + +AIK + + + ++ +
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-------------QEFR 56
Query: 297 SEIITAGRIWHRNLLPLQAHVTR--PDCHLLVYEFMKNGSLQDIL------------HDV 342
E + H N++ L T+ P C L +E++ +G L + L
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESGD 114
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ LD IA +A+G+EYL +H +HRD+ N L+ +G+ +ISDFGL+
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 403 KLMPDG-HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
+ + + R++ ++ ++ PE + +SDI+SFGV+L + G P+
Sbjct: 172 RDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG- 229
Query: 461 FQYTEEMNMVR 471
F E + M+R
Sbjct: 230 FSNQEVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G+ G+V A V S GK++A+KK+D ELL V+I R +
Sbjct: 28 IGEGSTGIVCIATVKSS-GKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQ---------- 75
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
H N++ + D +V EF++ G+L DI V+ R + +IA +
Sbjct: 76 ---HENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-----MNEEQIAAVCLA 124
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG----LAKLMPDGHTRIRITTVAG 419
L+ L + H +IHRDIK ++L+ ++SDFG ++K +P R ++ G
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------RRKSLVG 178
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T ++APE L + DI+S G+++ +V G+ P+
Sbjct: 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 40/237 (16%)
Query: 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM 292
+ L +L IG G CG VYK + G ++A+K Q + N +R+L++ +
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKT-GHVMAVK---QMRRTGNKEEN-KRILMDLDV 66
Query: 293 RQIKSE----IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
KS I+ +T D + E M + D L QG
Sbjct: 67 VL-KSHDCPYIVKC----------YGYFITDSDV-FICMELM--STCLDKLLKRIQGPIP 112
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
D L + + + L YL H +IHRD+KP+N+L+D ++ DFG++ + D
Sbjct: 113 EDILGK--MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISE-------KSDIYSFGVLLAVLVVGKFPFD 458
+ R AG Y+APE + + ++D++S G+ L L G+FP+
Sbjct: 169 KAKTR---SAGCAAYMAPE---RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 57/257 (22%)
Query: 225 KKRDIAFLTKEDSLASLEIIGVGACGVVYKAEV----PGSYGKMIAIKKIDQPPMAATEL 280
K+RDI L +E +G GA G V+ AE P ++A+K + P +AA
Sbjct: 3 KRRDI-VLKRE--------LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--- 50
Query: 281 LNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340
RK Q ++E++T + H +++ D ++V+E+MK+G L L
Sbjct: 51 ---------RKDFQREAELLT--NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLR 99
Query: 341 ------------DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388
Q + EL IA +ASG+ YL H +HRD+ N L+
Sbjct: 100 AHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156
Query: 389 DDGMEARISDFGLAKLMPD-------GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIY 441
+ +I DFG+++ + GHT + I ++ PE + +SD++
Sbjct: 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-------WMPPESIMYRKFTTESDVW 209
Query: 442 SFGVLL-AVLVVGKFPF 457
SFGV+L + GK P+
Sbjct: 210 SFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 9e-14
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ IG G+ G +Y A+ S + IK+ID M E K E+I
Sbjct: 5 IKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKE------------KEASKKEVI 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-------RELDWLA 353
++ H N++ A +V E+ G D++ +++ R + L W
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQILSWFV 108
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRI 412
+ ++ GL+++H I+HRDIK N+ + +GM A++ DFG+A+ + D
Sbjct: 109 Q------ISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
T GT Y++PE Q + K+DI+S G +L L K PF+
Sbjct: 160 Y--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHV 317
G+YG++ + + +AA ++++V + +IK EI + HRN+
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 318 TR--PDCH----LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY 371
+ P H LV EF GS+ D++ + + DW+A I R + GL +LH +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEY--- 428
+IHRDIK NVL+ + E ++ DFG++ + T R T GT ++APE
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 429 --HQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ T +SDI+S G+ + G P D
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 20/221 (9%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G GA G VY G+ +A+K++ P + E ++ ++ EI
Sbjct: 8 KLLGQGAFGRVYLC-YDVDTGRELAVKQVPFDP-DSPETKK--------EVNALECEIQL 57
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H ++ R D L ++ E+M GS++D L + + R + R
Sbjct: 58 LKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTR-KYTRQ 112
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR-ITTVAG 419
+ G+EYLH I+HRDIK AN+L D ++ DFG +K + + + +V G
Sbjct: 113 ILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG 169
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
T +++PE K+D++S G + ++ K P+ +F
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 44/129 (34%), Positives = 69/129 (53%), Gaps = 10/129 (7%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E M GSL +L GR L + IA + GL YL H+ I+HRD+KP+N+L
Sbjct: 83 EHMDGGSLDQVLKKA--GRIPEQILGKVSIA--VIKGLTYLREKHK--IMHRDVKPSNIL 136
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++ E ++ DFG++ + D + GT Y++PE Q S +SDI+S G+ L
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
Query: 448 AVLVVGKFP 456
+ +G++P
Sbjct: 193 VEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 39/234 (16%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
D + L+ +G G G VYK + G +A+K+I R L K QI
Sbjct: 1 DEIEVLDELGKGNYGSVYKV-LHRPTGVTMAMKEI-------------RLELDESKFNQI 46
Query: 296 KSEIITAGRIWHRNLLP----LQAHVTRPDCHLLVYEFMKNGSLQDILHD--VSQGRREL 349
E+ I H+ + P + E+M GSL D L+ V+
Sbjct: 47 IMELD----ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPE 101
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
D L R I + GL++L H IIHRD+KP NVL++ + ++ DFG++ +
Sbjct: 102 DVLRR--ITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157
Query: 410 TRIRITTVAGTTGYVAPEY------HQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+ I G Y+APE +Q T + +SD++S G+ + + +G++P+
Sbjct: 158 AKTNI----GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPM----AATELLNVRRVLINRKMRQIKSE 298
++G G G V +V + GKM A K++++ + + LN +++L ++ S+
Sbjct: 7 VLGKGGFGEVCACQVRAT-GKMYACKRLEKKRIKKRKGESMALNEKQIL-----EKVNSQ 60
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ L D LV M G L+ ++++ E + Y A
Sbjct: 61 FVVN----------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY--A 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ GLE LH R ++RD+KP N+L+DD RISD GLA +P+G + I
Sbjct: 109 AEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRV 162
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
GT GY+APE + D + G L+ ++ G+ PF
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 25/265 (9%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++G+ ++ + + + +N+ R L ++ R +EI+ + H N++ H
Sbjct: 11 GAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYYNHFM 69
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
+ L+ E+ G+L D + E + + Y + S + Y+H + I+H
Sbjct: 70 DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ--IVSAVSYIH---KAGILH 124
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RDIK N+ + ++ DFG++K++ G TV GT Y++PE Q + + KS
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKYNFKS 182
Query: 439 DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQ 498
DI++ G +L L+ K FD T +N+V I N + + S Y +
Sbjct: 183 DIWALGCVLYELLTLKRTFDA----TNPLNLV----VKIVQGN-YTPVVS-----VYSSE 228
Query: 499 MRLVLKIAYFCTSDDPEERPSSKDV 523
+ ++ + DPE+RP++ +V
Sbjct: 229 LISLV---HSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 47/245 (19%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++G++ ++K D + A ++L+ ++ ++ +K E+ A I RN+L
Sbjct: 4 GTFGQVYQVRKKDTRRIYAMKVLS-KKEIVAKK------EV--AHTIGERNILVRTLLDE 54
Query: 319 RP-----------DCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE 366
P D L LV ++M G L H +GR D A++ IA + LE
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSED-RAKFYIAE-LVLALE 110
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAP 426
+LH Y I++RD+KP N+L+D + DFGL+K + T GTT Y+AP
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAP 165
Query: 427 EYHQTLTISEKS-----DIYSFGVLLAVLVVGKFPFDDFFQYTEEM------NMVRWMRN 475
E + + EK D +S GVL+ + G PF + + T++M VR+ +N
Sbjct: 166 E----VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--YAEDTQQMYRNIAFGKVRFPKN 219
Query: 476 VISSE 480
V+S E
Sbjct: 220 VLSDE 224
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 74/258 (28%), Positives = 118/258 (45%), Gaps = 38/258 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G+GA G+V A + G+ +AIKKI +P VL R R++K
Sbjct: 15 LQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTP--------VLAKRTYRELK---- 61
Query: 301 TAGRIWHRNLLPLQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ H N++ L P D + V E + LH + R +Y +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYF-VTELLGTD-----LHRLLTSRPLEKQFIQYFLY 115
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ + GL+Y+H ++HRD+KP+N+LI++ + +I DFGLA++ ++T
Sbjct: 116 QIL-RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYV 166
Query: 419 GTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGK--FPFDD----FFQYTEEM-NMV 470
T Y APE T + DI+S G + A ++ GK FP D F T+ +
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226
Query: 471 RWMRNVISSENPHRAIDS 488
+ N I SEN R + S
Sbjct: 227 DDVINTICSENTLRFVQS 244
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 19/186 (10%)
Query: 281 LNVRRVLINRKMRQIK---SEIITAGRIWHRNLLPL-QAHVTRPDCHLLVYEFMKNGSLQ 336
+ + R + Q E R++H N++ L + P V+E++ +L+
Sbjct: 8 IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR 67
Query: 337 DILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGME 393
++L + G L R M L+ L H I+HRD+KP N+++
Sbjct: 68 EVL--AADGA-----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 394 ARISDFGLAKLMPDGH-----TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448
A++ DFG+ L+P T R T V GT Y APE + ++ SD+Y++G++
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180
Query: 449 VLVVGK 454
+ G+
Sbjct: 181 ECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+GK++ ++K D + A + + ++ ++ +E ++ ++PL+
Sbjct: 4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ 63
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
P+ LV F+ G L H +GR +L AR+ A + LE LH ++ +I+
Sbjct: 64 SPEKLYLVLAFINGGEL--FHHLQREGRFDL-SRARFYTAE-LLCALENLHKFN---VIY 116
Query: 379 RDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
RD+KP N+L+D + DFGL KL M D + T GT Y+APE ++
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 438 SDIYSFGVLLAVLVVGKFPFDD 459
D ++ GVLL ++ G PF D
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYD 195
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 69/224 (30%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG GA GVV+ P GK +A+KK+ P L++ +RV R++K ++
Sbjct: 8 IGYGAFGVVWSVTDPRD-GKRVALKKM---PNVFQNLVSCKRVF-----RELK--MLCFF 56
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD--VSQGRRELDW--LARYRIAR 359
+ H N+L + P ++ +Q LH VS D + Y+I R
Sbjct: 57 K--HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-PDGHTRIRITTVA 418
G L+YLH I+HRDIKP N+L++ +I DFGLA++ PD +T
Sbjct: 115 G----LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEV 165
Query: 419 GTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T Y APE H T + DI+S G + A L+ + F
Sbjct: 166 VTQYYRAPEILMGSRHYTSAV----DIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 29/222 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
EI+G G G VYKA + +++A+K I P+ T L +QI SE+
Sbjct: 6 QEILGHGNGGTVYKAYHLLT-RRILAVKVI---PLDITVELQ----------KQIMSELE 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ ++ + + EFM GSL DV R++ RIA
Sbjct: 52 ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL-----DVY---RKIPEHVLGRIAVA 103
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL YL I+HRD+KP+N+L++ + ++ DFG++ + + T GT
Sbjct: 104 VVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----KTYVGT 156
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
Y+APE SD++S G+ L +G+FP+ +
Sbjct: 157 NAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQK 198
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 35/163 (21%)
Query: 323 HL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381
HL LV E+M G L ++L + + + AR+ IA + L+ +H IHRDI
Sbjct: 75 HLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAE-LVLALDSVHKLG---FIHRDI 127
Query: 382 KPANVLIDDGMEARISDFGLAKLMPDGH---------------------------TRIRI 414
KP N+LID +++DFGL K M R+R
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+ GT Y+APE + + D +S GV+L ++ G PF
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 45/128 (35%), Positives = 68/128 (53%), Gaps = 15/128 (11%)
Query: 324 LLVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRI-ARGMASGLEYLHMYHRPCIIHRD 380
L+ E++ GSL+D L H ++ LA+ + A+ + G+ YLH H IHRD
Sbjct: 84 QLIMEYVPLGSLRDYLPKHKLN--------LAQLLLFAQQICEGMAYLHSQH---YIHRD 132
Query: 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT-TGYVAPEYHQTLTISEKSD 439
+ NVL+D+ +I DFGLAK +P+GH R+ + + A E + S SD
Sbjct: 133 LAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASD 192
Query: 440 IYSFGVLL 447
++SFGV L
Sbjct: 193 VWSFGVTL 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 22/219 (10%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ ++G GA G+V+ +I IK+I M E L ++E
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVI-IKQIPVEQMTKDERLA------------AQNECQ 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ + ++V E+ G+L + + + LD I
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLD---EDTILHF 106
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKLMPDGHTRIRITTVAG 419
L LH H I+HRD+K N+L+D M +I DFG++K++ ++ + TV G
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVG 163
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
T Y++PE + ++KSDI++ G +L L K F+
Sbjct: 164 TPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 66/244 (27%), Positives = 110/244 (45%), Gaps = 39/244 (15%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATE----LLNVRRVLINRKMRQIKSE 298
++G G+ G V AE+ G+ ++ A+K + + + + + +RVL
Sbjct: 2 VLGKGSFGKVLLAELKGT-DELYAVKVLKKDVILQDDDVECTMTEKRVLA---------- 50
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
AG+ H L L + D V E++ G D++ + + R + AR+ A
Sbjct: 51 --LAGK--HPFLTQLHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAA 103
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITT 416
+ GL++LH II+RD+K NVL+D +I+DFG+ K ++ T T
Sbjct: 104 E-IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS----T 155
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF-----DDFFQYTEEMNMV- 470
GT Y+APE D ++ GVLL ++ G+ PF D+ FQ E +
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY 215
Query: 471 -RWM 473
RW+
Sbjct: 216 PRWL 219
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 74/244 (30%), Positives = 111/244 (45%), Gaps = 47/244 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G GA G V A + G +AIKK+ +P +EL R R++R +K
Sbjct: 20 LKQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRP--FQSELFAKRAY---RELRLLK---- 69
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ H N++ L V PD L LV FM L ++ + +L
Sbjct: 70 ---HMKHENVIGL-LDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLSEDRIQFLV 124
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
Y++ +G L+Y+H IIHRD+KP N+ +++ E +I DFGLA+ T
Sbjct: 125 -YQMLKG----LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSE 171
Query: 414 ITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPF---DDFFQYTE 465
+T T Y APE H T T+ DI+S G ++A ++ GK F D Q E
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTV----DIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227
Query: 466 EMNM 469
M +
Sbjct: 228 IMKV 231
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 78/297 (26%), Positives = 132/297 (44%), Gaps = 60/297 (20%)
Query: 242 EII---GVGACGVVYKAE--VPGSYG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
EII G GA G VYKA+ G + K+I I+ ++ E+
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-------------- 53
Query: 295 IKSEIITAGRIWHRNLLPL-QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+I++ + H N++ L +A+ +L+ EF G+L I+ ++ +G E
Sbjct: 54 ---DILSECK--HPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQ--I 105
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLMPDGHTRI 412
RY + R M L +LH +IHRD+K N+L+ + +++DFG+ AK T
Sbjct: 106 RY-VCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK---STLQ 158
Query: 413 RITTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
+ T GT ++APE T + K+DI+S G+ L L + P E+
Sbjct: 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP-------HHEL 211
Query: 468 NMVRWMRNVISSENPHRAIDSKLLG-NGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
N +R + ++ SE P L + + LK C DP++RP++ ++
Sbjct: 212 NPMRVLLKILKSEPP------TLDQPSKWSSSFNDFLKS---CLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 68/216 (31%), Positives = 104/216 (48%), Gaps = 41/216 (18%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G +G++ +K D M A + L+ +R+ KM+Q ++ + R +L L V+
Sbjct: 5 GGFGEVYGCRKADTGKMYAMKCLDKKRI----KMKQGETLALN-----ERIMLSL---VS 52
Query: 319 RPDCHLLV---YEFMKNGSLQDILHDVSQGRRELDWLARYRI---------ARGMASGLE 366
DC +V Y F L IL D+ G L+++ + A + GLE
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA----KLMPDGHTRIRITTVAGTTG 422
HM++R +++RD+KPAN+L+D+ RISD GLA K P H + GT G
Sbjct: 112 --HMHNR-FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASV------GTHG 160
Query: 423 YVAPEYHQTLTISEKS-DIYSFGVLLAVLVVGKFPF 457
Y+APE Q + S D +S G +L L+ G PF
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 73/306 (23%), Positives = 120/306 (39%), Gaps = 74/306 (24%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
D L +E +G GA GVV K + G ++A+K+I R +N + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPT-GTIMAVKRI--------------RATVNSQEQ-- 43
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY---------------EFMKNGSLQDILH 340
R L+ L + DC V E M SL
Sbjct: 44 -----------KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDT-SLDKFYK 91
Query: 341 DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
V + +IA + LEYLH + +IHRD+KP+NVLI+ + ++ DFG
Sbjct: 92 KVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
Query: 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE----KSDIYSFGVLLAVLVVGKFP 456
++ + D + T AG Y+APE + KSD++S G+ + L G+FP
Sbjct: 150 ISGYLVDSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
Query: 457 FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYF---CTSDD 513
+D + + ++ V+ +P +L + + F C +
Sbjct: 207 YDSW------KTPFQQLKQVVEEPSP------QLPAEKFSPE------FQDFVNKCLKKN 248
Query: 514 PEERPS 519
+ERP+
Sbjct: 249 YKERPN 254
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 8e-13
Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 44/241 (18%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKK---IDQPPMAATELLNVRRVLIN-RKMRQIKSEI 299
+G G G V KA + GK++AIKK I+ + V I+ +R++K I
Sbjct: 17 LGEGTYGKVEKAYDTLT-GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK--I 73
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
+ I H N++ L D LV + M L+ ++ + L I
Sbjct: 74 MN--EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR----KIRLTESQVKCILL 126
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA----------KLMPDGH 409
+ +GL LH ++ +HRD+ PAN+ I+ +I+DFGLA L D
Sbjct: 127 QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183
Query: 410 T--RIRITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFD 458
R +T+ T Y APE YH + D++S G + A L+ GK FP +
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAV------DMWSVGCIFAELLTGKPLFPGE 237
Query: 459 D 459
+
Sbjct: 238 N 238
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 68/237 (28%), Positives = 109/237 (45%), Gaps = 31/237 (13%)
Query: 230 AFLTKEDS----LASLEI---IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLN 282
TK D+ L+ E+ +G G+ G V A+ G+ G+ AIK L
Sbjct: 5 YMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT-GEYYAIK-----------CLK 52
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
R +L ++++ + E + H ++ + + + EF+ G L H
Sbjct: 53 KREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLR 110
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
GR D +A++ A + EYLH II+RD+KP N+L+D+ +++DFG A
Sbjct: 111 KAGRFPND-VAKFYHAE-LVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
K +PD R T+ GT Y+APE Q+ + D ++ GVLL + G PF D
Sbjct: 166 KKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217
|
Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 71/300 (23%), Positives = 128/300 (42%), Gaps = 70/300 (23%)
Query: 241 LEIIGVGACGVVYKA-EVPGSYGKMIAIKKI--DQPPMAATELLNVRRVLINRKMRQIKS 297
LE+IG GA G VY+ VP G+++A+K I D P +++ +L + Q +
Sbjct: 6 LELIGRGAYGAVYRGKHVPT--GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 298 EIITAG------RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
G R+W ++ E+ + GS++ ++ +
Sbjct: 64 ITKYYGSYLKGPRLW------------------IIMEYAEGGSVRTLM--------KAGP 97
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+A I+ + L L H+ +IHRDIK AN+L+ + ++ DFG+A L+
Sbjct: 98 IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNS 155
Query: 412 IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
+ +T GT ++APE K+DI+S G+ + + G P+
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY------------- 202
Query: 471 RWMRNVISSENPHRAID-------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
S + RA+ +L NGY + +R +A C ++P+ER S++++
Sbjct: 203 -------SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF--VAA-CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 35/232 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E++G G G VYK + G++ AIK +D + + +IK EI
Sbjct: 11 VELVGNGTYGQVYKGRHVKT-GQLAAIKVMD---------------VTGDEEEEIKQEIN 54
Query: 301 TAGRI-WHRNLLPLQAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ HRN+ + D LV EF GS+ D++ + + +W+A
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
I R + GL +LH + +IHRDIK NVL+ + E ++ DFG++ + T R
Sbjct: 115 Y--ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGR 167
Query: 414 ITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
T GT ++APE + T KSD++S G+ + G P D
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-ITAGRIWHRNLLPLQAHV 317
GS+GK++ + + A ++L + +L ++ + I SE + + H L+ L
Sbjct: 6 GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
D V +++ G L + + + R L+ AR+ A +AS L YLH + I+
Sbjct: 66 QTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---IV 118
Query: 378 HRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS 435
+RD+KP N+L+D ++DFGL K + +G T +T GT Y+APE
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT----STFCGTPEYLAPEVLHKQPYD 174
Query: 436 EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
D + G +L ++ G PF + + T EM
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF--YSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 259 GSYGKMIAIKKI---DQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315
GS+GK+ ++KI D + A ++L + + ++R K E R++L A
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KME---------RDIL---A 53
Query: 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQG------RRELDWL---ARYRIARGMASGLE 366
V P L Y F G L IL + G +E+ + ++ +A +A L+
Sbjct: 54 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-LALALD 112
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAP 426
+LH II+RD+KP N+L+D+ +++DFGL+K D + + GT Y+AP
Sbjct: 113 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAP 167
Query: 427 EYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
E ++ +D +SFGVL+ ++ G PF E M M+
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 65/243 (26%), Positives = 98/243 (40%), Gaps = 63/243 (25%)
Query: 244 IGVGACGVVYKAE-VPGSYGKMIAIKKIDQPPMAATEL--LNVRRVLINRKMRQIKSEII 300
IG G G VYKA+ G GK AIKK T + R + + R+++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------- 60
Query: 301 TAGRIWHRNLLPLQ-AHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
H N++ L + D L++++ ++ Q I+ Q +R I
Sbjct: 61 ------HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ-IIKFHRQAKR-------VSIP 106
Query: 359 RGMA--------SGLEYLHMYHRPCIIHRDIKPANVLI-DDGME---ARISDFGLA---- 402
M +G+ YLH ++HRD+KPAN+L+ +G E +I D GLA
Sbjct: 107 PSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 403 ---KLMPDGHTRIRITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGK 454
K + D V T Y APE H T I DI++ G + A L+ +
Sbjct: 164 APLKPLADLD------PVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLE 213
Query: 455 FPF 457
F
Sbjct: 214 PIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 82/308 (26%), Positives = 142/308 (46%), Gaps = 58/308 (18%)
Query: 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKK-IDQPPMAATELLNVRRVLINRKMRQIKSE 298
+L ++G G+ G+V K + + G+++AIKK ++ + + +R + + +++R
Sbjct: 5 NLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR----- 58
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-----DVSQGRRELDWLA 353
H NL+ L R LV+EF+ + L D+ D S+ R+ L
Sbjct: 59 --------HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL---- 106
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
++I RG +E+ H ++ IIHRDIKP N+L+ ++ DFG A+ + +
Sbjct: 107 -FQILRG----IEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVY 157
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGK--FPFD-DFFQYTE 465
VA T Y APE L + + DI++ G L+ ++ G+ FP D D Q
Sbjct: 158 TDYVA-TRWYRAPE----LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212
Query: 466 EM----NMVRWMRNVISSENPHRAI-------DSKLLGNGYEEQMRLVLKIAYFCTSDDP 514
+ N++ + I +NP A + + L + + LVL +A C DP
Sbjct: 213 IIKCLGNLIPRHQE-IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDP 271
Query: 515 EERPSSKD 522
++RPSS
Sbjct: 272 DDRPSSSQ 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 76/294 (25%), Positives = 127/294 (43%), Gaps = 48/294 (16%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E L IG G+ G VY A +++AIKK+ + E K +
Sbjct: 24 EKLFTDLREIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNE-----------KWQD 71
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
I E+ RI H N + + R LV E+ GS D+L + +E++ A
Sbjct: 72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA- 129
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
I G GL YLH ++ +IHRDIK N+L+ + + +++DFG A + ++ +
Sbjct: 130 --ITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-- 182
Query: 415 TTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
GT ++APE L + E K D++S G+ L K P + MN
Sbjct: 183 ----GTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNA 229
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ + ++ +E+P L N + + R C P++RP+S+++
Sbjct: 230 MSALYHIAQNESP------TLQSNEWSDYFR---NFVDSCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E IG GA G VY A + + G+ +AIK+++ EL+ + +L+ MR+ K+
Sbjct: 24 FEKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELI-INEILV---MRENKNP-- 76
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
N++ D +V E++ GSL D++ + ++ + R
Sbjct: 77 --------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR------ 122
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLMPDGHTRIRITTVAG 419
L+ L H +IHRDIK N+L+ +++DFG A++ P+ R +T+ G
Sbjct: 123 --ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 177
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T ++APE K DI+S G++ +V G+ P+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 49/202 (24%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++G++ ++ A +++ + V+ ++ + + +E + H ++ L
Sbjct: 12 GTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW-TE 70
Query: 319 RPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
L ++ E++ G L L + R + + + + LEYLH I+
Sbjct: 71 HDQRFLYMLMEYVPGGELFSYLRN---SGRFSNSTGLFYASE-IVCALEYLHSKE---IV 123
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
+RD+KP N+L+D +++DFG AK + D R T+ GT Y+APE Q+ ++
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKA 178
Query: 438 SDIYSFGVLLAVLVVGKFPFDD 459
D ++ G+L+ ++VG PF D
Sbjct: 179 VDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 76/312 (24%), Positives = 132/312 (42%), Gaps = 52/312 (16%)
Query: 221 RPIFKKRDIA-FLTKEDS---LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMA 276
+ + K +IA K+D L IG G+ G VY A +++A+KK+
Sbjct: 2 KGVVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFA-TNSHTNEVVAVKKMSYSGKQ 60
Query: 277 ATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQ 336
N K + I E+ ++ H N + + + LV E+ GS
Sbjct: 61 -----------TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSAS 108
Query: 337 DILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396
D+L + +E++ A I G GL YLH + +IHRDIK N+L+ + + ++
Sbjct: 109 DLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL 162
Query: 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLV 451
+DFG A ++ + GT ++APE L + E K D++S G+ L
Sbjct: 163 ADFGSASKSSPANSFV------GTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELA 214
Query: 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTS 511
K P + MN + + ++ +++P L N + + R +C
Sbjct: 215 ERKPPLFN-------MNAMSALYHIAQNDSP------TLQSNEWTDSFR---GFVDYCLQ 258
Query: 512 DDPEERPSSKDV 523
P+ERP+S ++
Sbjct: 259 KIPQERPASAEL 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 45/218 (20%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G +G++ +K D M A + L+ +R+ KM+Q ++ + R +L L V+
Sbjct: 5 GGFGEVYGCRKADTGKMYAMKCLDKKRI----KMKQGETLALN-----ERIMLSL---VS 52
Query: 319 RPDCHLLV---YEF-----------MKNGSLQDILHDVSQ----GRRELDWLARYRIARG 360
DC +V Y F + NG D+ + +SQ +E+ + A I
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIIL-- 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
GLE HM++R +++RD+KPAN+L+D+ RISD GLA ++ + GT
Sbjct: 109 ---GLE--HMHNR-FVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGT 158
Query: 421 TGYVAPEYHQTLTISEKS-DIYSFGVLLAVLVVGKFPF 457
GY+APE Q T + S D +S G +L L+ G PF
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 63/261 (24%), Positives = 109/261 (41%), Gaps = 59/261 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS--- 297
L IG G G+VY+A S G+++A+KK+ +M +
Sbjct: 12 LNRIGEGTYGIVYRARDTTS-GEIVALKKV--------------------RMDNERDGIP 50
Query: 298 -----EIITAGRIWHRNLLPLQAHVT--RPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
EI + H N++ L+ V D LV E+ + L +L ++ E
Sbjct: 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSE-- 107
Query: 351 WLARYR-IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL--MPD 407
++ + + + GL+YLH IIHRD+K +N+L+ D +I+DFGLA+ +P
Sbjct: 108 --SQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162
Query: 408 GHTRIRITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
++ T+ Y APE T I D+++ G +LA L+ K
Sbjct: 163 KPMTPKVVTL----WYRAPELLLGCTTYTTAI----DMWAVGCILAELLAHK----PLLP 210
Query: 463 YTEEMNMVRWMRNVISSENPH 483
E+ + + ++ + N
Sbjct: 211 GKSEIEQLDLIIQLLGTPNES 231
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 368 LHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE 427
+H H +IHRDIK AN+L+ ++ DFG +K+ + T GT YVAPE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 428 YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAID 487
+ S+K+D++S GVLL L+ K PFD E M V H+ +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-----ENMEEVM-----------HKTLA 259
Query: 488 SKL--LGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
+ L +M+ +I S DP+ RPSS
Sbjct: 260 GRYDPLPPSISPEMQ---EIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 307 HRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGL 365
H NL+ L + L +V E+M GSL D L S+GR L + + + +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAM 115
Query: 366 EYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVA 425
EYL + +HRD+ NVL+ + A++SDFGL K ++ + A
Sbjct: 116 EYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTA 167
Query: 426 PEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
PE + S KSD++SFG+LL + G+ P+
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
L S IG G+ G+V A + GK +A+KK+D ELL V+I R
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHT-GKQVAVKKMDLRKQQRRELL-FNEVVIMRDYH---- 77
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H N++ + D +V EF++ G+L DI V+ R + +I
Sbjct: 78 ---------HENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTR-----MNEEQI 120
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG----LAKLMPDGHTRIR 413
A S L L H +IHRDIK ++L+ ++SDFG ++K +P +
Sbjct: 121 ATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------K 174
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
++ GT ++APE L + DI+S G+++ ++ G+ P+
Sbjct: 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK++ K+ A ++L + +L ++ I +E + + H L+ L
Sbjct: 6 GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
+ V +++ G L H + + R L+ AR+ A +AS + YLH + II
Sbjct: 66 QTAEKLYFVLDYVNGGEL--FFH-LQRERCFLEPRARFYAAE-VASAIGYLHSLN---II 118
Query: 378 HRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS 435
+RD+KP N+L+D ++DFGL K + P+ T +T GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT----STFCGTPEYLAPEVLRKEPYD 174
Query: 436 EKSDIYSFGVLLAVLVVGKFPF 457
D + G +L ++ G PF
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IITAGRIWHRNLLPLQAH 316
GS+GK++ + + + A ++L +L + + +E I++ R H L L
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQLYCC 64
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
PD V EF+ G D++ + + RR + AR+ A + S L +LH I
Sbjct: 65 FQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-ITSALMFLH---DKGI 117
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
I+RD+K NVL+D +++DFG+ K +T GT Y+APE Q +
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175
Query: 437 KSDIYSFGVLLAVLVVGKFPF-----DDFFQ 462
D ++ GVLL ++ G PF DD F+
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE 366
H L L D V E++ G D++ + + R+ + +R+ A + L
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAE-VTLALM 110
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYV 424
+LH R +I+RD+K N+L+D +++DFG+ K ++ T TT GT Y+
Sbjct: 111 FLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT----TTFCGTPDYI 163
Query: 425 APEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF-----DDFFQ 462
APE Q L D ++ GVL+ ++ G+ PF DD F+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E IG GA G VY A + + G+ +AI++++ EL+ + +L+ MR+ K+
Sbjct: 25 FEKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELI-INEILV---MRENKNP-- 77
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
N++ D +V E++ GSL D++ + ++ + R
Sbjct: 78 --------NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRE 124
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLMPDGHTRIRITTVAG 419
LE+LH +IHRDIK N+L+ +++DFG A++ P+ R +T+ G
Sbjct: 125 CLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVG 178
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T ++APE K DI+S G++ ++ G+ P+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 68/233 (29%), Positives = 110/233 (47%), Gaps = 49/233 (21%)
Query: 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298
SL+ +G GA G V A + G+ +AIKK+ +P +E+ R R++ +K
Sbjct: 18 TSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRP--FQSEIFAKRAY---RELTLLK-- 69
Query: 299 IITAGRIWHRNLLPL-QAHVTRPDCH-----LLVYEFMKNGSLQDIL-HDVSQGRRELDW 351
+ H N++ L + LV +M+ LQ I+ H +S+ +
Sbjct: 70 -----HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDK----- 118
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+Y + + M GL+Y+H IIHRD+KP N+ +++ E +I DFGLA+ H
Sbjct: 119 -VQYLVYQ-MLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HAD 168
Query: 412 IRITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+T T Y APE Y+QT+ DI+S G ++A ++ GK F
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTV------DIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 16/163 (9%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE 366
+ N + L VT H+L+ +++K+G L D+L +G+ L +I R + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGK--LSEAEVKKIIRQLVEALN 123
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGME-ARISDFGLAKLMPDGHTRIRITTVAGTTGYVA 425
LH ++ IIH DIK NVL D + + D+GL K++ T + GT Y +
Sbjct: 124 DLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTP---SCYDGTLDYFS 174
Query: 426 PEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468
PE + D ++ GVL L+ GK PF + EE++
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED--EDEELD 215
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
E + L IG G+ G VY A + +++AIKK+ + N K +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQS-----------NEKWQD 61
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
I E+ ++ H N + + R LV E+ GS D+L + +E++ A
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA- 119
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+ G GL YLH ++ +IHRD+K N+L+ + ++ DFG A +M + +
Sbjct: 120 --VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-- 172
Query: 415 TTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
GT ++APE L + E K D++S G+ L K P + MN
Sbjct: 173 ----GTPYWMAPEV--ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNA 219
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ + ++ +E+P L + E R C P++RP+S
Sbjct: 220 MSALYHIAQNESP------ALQSGHWSEYFR---NFVDSCLQKIPQDRPTS 261
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-ITAGRIWHRNLLPLQAHV 317
GS+GK++ K+ A ++L + VL ++ + I +E + + H L+ L
Sbjct: 6 GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
+ V +F+ G L + + R + AR+ A +AS L YLH + I+
Sbjct: 66 QTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAE-IASALGYLHSIN---IV 118
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV-AGTTGYVAPEYHQTLTISE 436
+RD+KP N+L+D ++DFGL K +G + TT GT Y+APE +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 437 KSDIYSFGVLLAVLVVGKFPF 457
D + G +L ++ G PF
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 49/139 (35%), Positives = 71/139 (51%), Gaps = 28/139 (20%)
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGY 423
GL+Y+H IIHRD+KP+NV +++ E RI DFGLA+ D +T T Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWY 181
Query: 424 VAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDFFQYTEEMNMVRWMR 474
APE Y+QT+ DI+S G ++A L+ GK FP +D+ + + V
Sbjct: 182 RAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235
Query: 475 NV-----ISSENPHRAIDS 488
+ ISSE+ + I S
Sbjct: 236 SPEVLKKISSEHARKYIQS 254
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 42/118 (35%), Positives = 60/118 (50%), Gaps = 14/118 (11%)
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRIT 415
A +A GL +LH II+RD+K NV++D +I+DFG+ K + TR
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---- 159
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD-----DFFQYTEEMN 468
T GT Y+APE + D ++FGVLL ++ G+ PFD + FQ E N
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 64/287 (22%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQPPMAATELLNVRRVLINRKMRQIKSEI 299
E++G GA G VY + G++IA+K++ D + A E ++ +++ E+
Sbjct: 6 EVLGKGAYGTVYCGLT--NQGQLIAVKQVELDTSNVLAAE----------KEYEKLQEEV 53
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ H N++ D + ++ EF+ GS+ IL+ L +
Sbjct: 54 DLLKSLKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYT 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP-----DGHTRIR 413
+ + G+ YLH C++HRDIK NV++ ++ DFG A+ + H+ +
Sbjct: 109 KQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM- 164
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
+ ++ GT ++APE KSDI+S G + + GK P M+ + M
Sbjct: 165 LKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS-------MDRLAAM 217
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ + + + C + D ERPS+
Sbjct: 218 FYIGAHRGLMPRLPDSFSAAAID--------FVTSCLTRDQHERPSA 256
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 40/297 (13%)
Query: 228 DIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL 287
D++ ++ ++ IG G G VYKA + G++ AIK I P
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKAR-NVNTGELAAIKVIKLEP------------- 46
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRR 347
++ EII H N++ R D + EF GSLQDI H
Sbjct: 47 -GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---- 101
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407
L ++R GL YLH + +HRDIK AN+L+ D +++DFG++ +
Sbjct: 102 PLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI-- 156
Query: 408 GHTRIRITTVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464
T + + GT ++APE + ++ DI++ G+ L + P D
Sbjct: 157 TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR 216
Query: 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
M + S+ P + D N + +++ L + +P++RP+++
Sbjct: 217 ALFLMTK------SNFQPPKLKDKMKWSNSFHHFVKMAL-------TKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G+ G+V A S G+ +A+K +D ELL V+I R +
Sbjct: 29 IGEGSTGIVCIAREKHS-GRQVAVKMMDLRKQQRRELL-FNEVVIMRDYQ---------- 76
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS 363
H+N++ + + ++ EF++ G+L DI VSQ R L +IA S
Sbjct: 77 ---HQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTR-----LNEEQIATVCES 125
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLMPDGHTRIRITTVAGTTG 422
L+ L H +IHRDIK ++L+ ++SDFG A++ D R ++ GT
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPY 182
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
++APE + DI+S G+++ +V G+ P+
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 34/226 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E IG G GVVYKA + G+++A+KKI TE V I EI
Sbjct: 5 VEKIGEGTYGVVYKARNKLT-GEVVALKKI----RLDTETEGVPSTAIR--------EIS 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L + + LV+EF+ + L+ + L + Y
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-- 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL + H HR ++HRD+KP N+LI+ +++DFGLA+ G T T
Sbjct: 109 LLQGLAFCHS-HR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVT 163
Query: 421 TGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFD 458
Y APE Y+ T DI+S G + A +V + FP D
Sbjct: 164 LWYRAPEILLGCKYYSTAV-----DIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 62/271 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLIN 289
D + IG G G VYKA G+++A+KK+ + P+ A +R + I
Sbjct: 7 DKFDIIGQIGEGTYGQVYKA-RDKDTGELVALKKVRLDNEKEGFPITA-----IREIKIL 60
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL----------LVYEFMKN---GSLQ 336
R++ HRN++ L+ VT L LV+E+M + G L+
Sbjct: 61 RQLN-------------HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE 107
Query: 337 DILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396
L S+ I M LE L+ H+ +HRDIK +N+L+++ + ++
Sbjct: 108 SGLVHFSEDH----------IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
Query: 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLV 451
+DFGLA+L +R V T Y PE L + E+ D++S G +L L
Sbjct: 158 ADFGLARLYNSEESRPYTNKVI-TLWYRPPE----LLLGEERYGPAIDVWSCGCILGELF 212
Query: 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENP 482
K FQ +E+ + + + S P
Sbjct: 213 TKK----PIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 58/262 (22%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE---IITAGRIWHRNLLPLQA 315
G++G++ +K+D + A + L + VL+ ++ +K+E + A W ++ L
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW---VVRLYY 68
Query: 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPC 375
D V +++ G + +L + G D LAR+ IA + +E +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPED-LARFYIAE-LTCAVESVH---KMG 121
Query: 376 IIHRDIKPANVLIDDGMEARISDFGLA--------------------------------- 402
IHRDIKP N+LID +++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 403 ------KLMP------DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVL 450
+L P H R ++ GT Y+APE ++ D +S GV+L +
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 451 VVGKFPFDDFFQYTEEMNMVRW 472
+VG+ PF +M ++ W
Sbjct: 242 LVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G G+ G V+ AE+ G+ + AIK + + + + +V ++ +++ + E
Sbjct: 1 KMLGKGSFGKVFLAELKGT-NQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLAWE--- 54
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
H L L + V E++ G L + H S + +L Y A +
Sbjct: 55 -----HPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFY--AAEI 105
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAG 419
GL++LH I++RD+K N+L+D +I+DFG+ K ++ D T T G
Sbjct: 106 ICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----CTFCG 158
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T Y+APE + D +SFGVLL +++G+ PF
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 76/295 (25%), Positives = 115/295 (38%), Gaps = 71/295 (24%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIK--KIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
E IG G G VYK + G +A+K + PP + L +L
Sbjct: 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-------- 50
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
H N++ L + +V E + GSL L L +++
Sbjct: 51 -------HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL---QMSL 100
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
A+G+EYL + CI HRD+ N L+ + +ISDFG+++ G I TV+
Sbjct: 101 DAAAGMEYLE--SKNCI-HRDLAARNCLVGENNVLKISDFGMSREEEGG-----IYTVSD 152
Query: 420 TTG-----YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWM 473
+ APE + +SD++S+G+LL +G P+ M
Sbjct: 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY-------------PGM 199
Query: 474 RNVISSENPHRAIDSKLLGNGY---------EEQMRLVLKIAYFCTSDDPEERPS 519
N + E I+S GY EE RL+L+ C + DPE RPS
Sbjct: 200 SNQQTRER----IES-----GYRMPAPQLCPEEIYRLMLQ----CWAYDPENRPS 241
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 62/258 (24%), Positives = 108/258 (41%), Gaps = 54/258 (20%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE---IITAGRIWHRNLLPLQA 315
G++G++ ++K+D + A + L VL+ + +K+E + A W ++ L
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW---VVKLYY 68
Query: 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPC 375
D V +++ G + +L + G E D LAR+ IA + +E +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEED-LARFYIAE-LTCAIESVH---KMG 121
Query: 376 IIHRDIKPANVLIDDGMEARISDFGL---------------------------------- 401
IHRDIKP N+LID +++DFGL
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 402 -AKLMP------DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454
+L P H R ++ GT Y+APE ++ D +S GV+L ++VG+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 455 FPFDDFFQYTEEMNMVRW 472
PF ++ ++ W
Sbjct: 242 PPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+G+ + ++ ++ A + +R + + + E + ++ H N++ +
Sbjct: 11 GSFGRALLVQHVNSDQKYAMK--EIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF- 67
Query: 319 RPDCHL-LVYEFMKNGSLQDILHDVSQGRREL-------DWLARYRIARGMASGLEYLHM 370
D HL +V E+ G D++ + R +L W + M G++++H
Sbjct: 68 EADGHLYIVMEYCDGG---DLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIH- 117
Query: 371 YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ 430
++HRDIK N+ + + ++ DFG A+L+ T GT YV PE +
Sbjct: 118 --EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPPEIWE 173
Query: 431 TLTISEKSDIYSFGVLLAVLVVGKFPF 457
+ + KSDI+S G +L L K PF
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+GK++ K A ++L + +L ++ + I +E RN+L L+ +V
Sbjct: 6 GSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE---------RNVL-LK-NVK 54
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQG---------RRELDWLARYRIARGMASGLEYLH 369
P L Y F L +L V+ G R + AR+ A +AS L YLH
Sbjct: 55 HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-IASALGYLH 113
Query: 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYVAPE 427
+ II+RD+KP N+L+D ++DFGL K + T +T GT Y+APE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT----STFCGTPEYLAPE 166
Query: 428 YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
+ D + G +L ++ G PF + + T EM
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPF--YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 50/151 (33%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
V E++ G D+++ + Q R + A + A +A GL +LH II+RD+K
Sbjct: 78 FVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAE-IAIGLFFLH---SKGIIYRDLKLD 130
Query: 385 NVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443
NV++D +I+DFG+ K M DG + T GT Y+APE + D ++F
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 444 GVLLAVLVVGKFPF-----DDFFQYTEEMNM 469
GVLL ++ G+ PF D+ FQ E N+
Sbjct: 188 GVLLYEMLAGQAPFEGEDEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 17/141 (12%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDW-LARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383
LV E+ G D+L +++ + D +A++ +A + +H H+ +HRDIKP
Sbjct: 78 LVMEYQPGG---DLLSLLNRYEDQFDEDMAQFY----LAELVLAIHSVHQMGYVHRDIKP 130
Query: 384 ANVLIDDGMEARISDFG-LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS---- 438
NVLID +++DFG A+L + + GT Y+APE T+ K
Sbjct: 131 ENVLIDRTGHIKLADFGSAARLTANKM--VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 439 --DIYSFGVLLAVLVVGKFPF 457
D +S GV+ ++ G+ PF
Sbjct: 189 ECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 61/258 (23%), Positives = 112/258 (43%), Gaps = 49/258 (18%)
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD--------- 341
++R + SE ++ H +++ L ++ LL+ E+ K GSL+ L +
Sbjct: 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYL 105
Query: 342 VSQGRRELDWLAR---------------YRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386
S G R +L ++I+RGM YL ++HRD+ NV
Sbjct: 106 GSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ----YLAEMK---LVHRDLAARNV 158
Query: 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL 446
L+ +G + +ISDFGL++ + + + ++ + ++A E + +SD++SFGVL
Sbjct: 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 218
Query: 447 LAVLV-VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKI 505
L +V +G P+ + ++ E P N EE L+L
Sbjct: 219 LWEIVTLGGNPYPGI----APERLFNLLKTGYRMERPE---------NCSEEMYNLMLT- 264
Query: 506 AYFCTSDDPEERPSSKDV 523
C +P++RP+ D+
Sbjct: 265 ---CWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 37/230 (16%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+IG G G VY + S G+ I A+K +++ T+L V + L K I
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR----ITDLEEVEQFL--------KEGI 48
Query: 300 ITAGRIWHRNLLPLQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLA-RYRI 357
I H N+L L + L+V +MK+G L++ + + D + ++
Sbjct: 49 IMKD-FSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV 107
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD-------GHT 410
A+GM EYL +HRD+ N ++D+ +++DFGLA+ + D HT
Sbjct: 108 AKGM----EYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
++ ++A E QT + KSD++SFGVLL ++ G P+ D
Sbjct: 161 GAKL-----PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 205
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 54/209 (25%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRK---MRQIKSEIITAGRIWHRNLLPLQA 315
G++G++ +K + + A ++LN +L + R+ + ++ W L
Sbjct: 12 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL----H 67
Query: 316 HVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRP 374
+ + + +L LV ++ G L +L R + +AR+ +A M ++ +H H
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAE-MVIAIDSVHQLH-- 122
Query: 375 CIIHRDIKPANVLIDDGMEARISDFG-LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT 433
+HRDIKP N+L+D R++DFG KLM DG ++ + GT Y++PE Q +
Sbjct: 123 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPEILQAME 179
Query: 434 ISE-----KSDIYSFGVLLAVLVVGKFPF 457
+ + D +S GV + ++ G+ PF
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 57/265 (21%), Positives = 109/265 (41%), Gaps = 33/265 (12%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+GK I +K + + +N+ + + ++ + + E+ + H N++ Q
Sbjct: 11 GSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHPNIVQYQESFE 69
Query: 319 RPDCHLLVYEFMKNGSLQDILHD----VSQGRRELDWLARYRIARGMASGLEYLHMYHRP 374
+V ++ + G L ++ + + LDW + +A L H
Sbjct: 70 ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKHVHDR 120
Query: 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI 434
I+HRDIK N+ + ++ DFG+A+++ R T GT Y++PE +
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR--TCIGTPYYLSPEICENRPY 178
Query: 435 SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNG 494
+ KSDI++ G +L + K F E NM + +I P +
Sbjct: 179 NNKSDIWALGCVLYEMCTLKHAF-------EAGNMKNLVLKIIRGSYPPVSSH------- 224
Query: 495 YEEQMRLVLKIAYFCTSDDPEERPS 519
Y +R ++ + +P +RPS
Sbjct: 225 YSYDLRNLVSQLF---KRNPRDRPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 65/248 (26%), Positives = 104/248 (41%), Gaps = 67/248 (27%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLIN 289
D L + +G GA G V KAE G + +A+K + ATE
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATE---------- 56
Query: 290 RKMRQIKSEIITAGRIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
+ + + SE+ I H+N++ L T+ +V E+ +G+L+D L + RR
Sbjct: 57 KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRP 112
Query: 349 LDWLAR--------------------YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388
A Y++ARGM E+L + CI HRD+ NVL+
Sbjct: 113 PGEYASPDDPRPPEETLTQKDLVSFAYQVARGM----EFLA--SKKCI-HRDLAARNVLV 165
Query: 389 DDGMEARISDFGLA---------KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSD 439
+ +I+DFGLA + +G ++ ++APE + +SD
Sbjct: 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK---------WMAPEALFDRVYTHQSD 216
Query: 440 IYSFGVLL 447
++SFGVLL
Sbjct: 217 VWSFGVLL 224
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 62/275 (22%), Positives = 120/275 (43%), Gaps = 44/275 (16%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GSYG++ ++ + LN+R R+ + + E ++ H N++ +
Sbjct: 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWE 69
Query: 319 RPDCHL-LVYEFMKNGSLQDILHDVSQGRREL-------DWLARYRIARGMASGLEYLHM 370
D L +V F + G D+ H + + + +L +W + +A L+YLH
Sbjct: 70 GEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHE 120
Query: 371 YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ 430
H I+HRD+K NV + ++ D G+A+++ + +T+ GT Y++PE
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFS 175
Query: 431 TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKL 490
+ KSD+++ G + + K F+ ++MN + + R I+ KL
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFN-----AKDMNSLVY-----------RIIEGKL 219
Query: 491 --LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ Y ++ ++ S PE+RPS K +
Sbjct: 220 PPMPKDYSPELGELIATML---SKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 43/114 (37%), Positives = 62/114 (54%), Gaps = 27/114 (23%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
Y+I RG L+Y+H IIHRD+KP+N+ +++ E +I DFGLA+ HT +
Sbjct: 127 YQILRG----LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEM 174
Query: 415 TTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDD 459
T T Y APE Y+QT+ DI+S G ++A L+ G+ FP D
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 50/238 (21%), Positives = 97/238 (40%), Gaps = 42/238 (17%)
Query: 247 GACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW 306
+ K + ++A+KKI+ + +L ++ EIIT+ ++
Sbjct: 13 LMIVHLAKHK---PTNTLVAVKKINLDSCSKEDLK------------LLQQEIITSRQLQ 57
Query: 307 HRNLLP-LQAHVTRPDCHLLVYEFMKNGSLQDILHDV-SQGRRELDWLARYRIARGMASG 364
H N+LP + + + + ++ V M GS +D+L +G EL + I + + +
Sbjct: 58 HPNILPYVTSFIVDSELYV-VSPLMAYGSCEDLLKTHFPEGLPEL--AIAF-ILKDVLNA 113
Query: 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF---------GLAKLMPDGHTRIRIT 415
L+Y+H IHR +K +++L+ + +S G + + +
Sbjct: 114 LDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK---- 166
Query: 416 TVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF---FQYTEEMN 468
+ +++PE +EKSDIYS G+ L G PF D E++
Sbjct: 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR 224
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 27/175 (15%)
Query: 285 RVLINRKMRQIKSEIITAGRIW----HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340
+ L + K E + + H ++ L V + + +LV E G L L
Sbjct: 29 KTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCKGEPLMLVMELAPLGPLLKYL- 86
Query: 341 DVSQGRRE------LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394
+ RRE + +++A GMA YL H +HRD+ NVL+ + +A
Sbjct: 87 ---KKRREIPVSDLKELA--HQVAMGMA----YLESKH---FVHRDLAARNVLLVNRHQA 134
Query: 395 RISDFGLAKLMPDGHTRIRITTVAGT--TGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ISDFG+++ + G R TT AG + APE S KSD++S+GV L
Sbjct: 135 KISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYGKFSSKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 52/301 (17%)
Query: 244 IGVGACGVVYKAE----VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+G GA G V+ AE +P ++A+K + + +A R+ Q ++E+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA------------RQDFQREAEL 60
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-------HDVSQGRR----E 348
+T + H++++ T L+V+E+M++G L L ++ G +
Sbjct: 61 LTV--LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPD 407
L IA +ASG+ YL H +HRD+ N L+ G+ +I DFG+++ +
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 408 GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
+ R+ T+ ++ PE + +SDI+SFGV+L + GK P+ TE
Sbjct: 176 DYYRVGGRTMLPIR-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ-LSNTEA 233
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526
+ + R + E P R + V I C +P++R KD+
Sbjct: 234 IECITQGREL---ERP-RTCPPE------------VYAIMQGCWQREPQQRMVIKDIHSR 277
Query: 527 L 527
L
Sbjct: 278 L 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+L+ IG GA G+V A G+ +AIKK+ +P T R L+ M+ +
Sbjct: 20 NLKPIGSGAQGIVCAAY-DTVTGQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--- 73
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
H+N++ L +V P L LV E M L V Q +LD
Sbjct: 74 -------HKNIIGL-LNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQ--MDLDHE 118
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+ M G+++LH IIHRD+KP+N+++ +I DFGLA+
Sbjct: 119 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 173
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDD 459
+T T Y APE + E DI+S G ++ ++ G FP D
Sbjct: 174 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 75/289 (25%), Positives = 115/289 (39%), Gaps = 49/289 (16%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
++G G G+VY A S IAIK+I + R ++ + EI
Sbjct: 15 VLGKGTYGIVYAAR-DLSTQVRIAIKEIPERDS--------------RYVQPLHEEIALH 59
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
+ HRN++ + + E + GSL +L G + + + +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQIL 118
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLID--DGMEARISDFG----LAKLMPDGHTRIRITT 416
GL+YLH I+HRDIK NVL++ G+ +ISDFG LA + P T
Sbjct: 119 EGLKYLHDNQ---IVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------CTET 168
Query: 417 VAGTTGYVAPEY--HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
GT Y+APE +DI+S G + + GK PF + + M V +
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK 228
Query: 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
H I L E +L+ C DP++R S+ D+
Sbjct: 229 I-------HPEIPESL----SAEAKNFILR----CFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 43/118 (36%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRITT 416
A ++ GL +LH R II+RD+K NV++D +I+DFG+ K M DG T T
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT---TRT 160
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF-----DDFFQYTEEMNM 469
GT Y+APE + D +++GVLL ++ G+ PF D+ FQ E N+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 27/224 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKID---QPPMAATELLNVRRVLINRKMRQIKS 297
E+IG G+ GVV A + G+ +AIKKI+ + AT +L R + + R +R
Sbjct: 5 QEVIGKGSYGVVCSA-IDTHTGEKVAIKKINDVFEHVSDATRIL--REIKLLRLLRH--P 59
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
+I+ I +LP + D ++ V+E M++ LH V + +L
Sbjct: 60 DIVEIKHI----MLPPSRREFK-DIYV-VFELMESD-----LHQVIKANDDLTPEHHQFF 108
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-PDGHTRIRITT 416
+ L+Y+H + + HRD+KP N+L + + +I DFGLA++ D T I T
Sbjct: 109 LYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165
Query: 417 VAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGK--FP 456
T Y APE + + DI+S G + A ++ GK FP
Sbjct: 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG GA G+V A G +A+KK+ +P T R L+ K
Sbjct: 26 LKPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC-------- 76
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ H+N++ L +V P L LV E M + +L ++H ELD
Sbjct: 77 ----VNHKNIISL-LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIH------MELDHER 124
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ M G+++LH IIHRD+KP+N+++ +I DFGLA+ T
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFM 178
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+T T Y APE + E DI+S G ++ LV G F
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 70/246 (28%), Positives = 113/246 (45%), Gaps = 49/246 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG GA G+V A G +AIKKI P + R +R+IK I+
Sbjct: 10 LSYIGEGAYGMVCSA-THKPTGVKVAIKKIS--PFE-------HQTFCQRTLREIK--IL 57
Query: 301 TAGRIWHRNLLPLQAHVTRPDCH------LLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
R H N++ + + RP +V E M+ L+ + + + + +
Sbjct: 58 R--RFKHENIIGILD-IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQ 109
Query: 355 ---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
Y+I R GL+Y+H + ++HRD+KP+N+L++ + +I DFGLA++ H
Sbjct: 110 YFLYQILR----GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 412 IRITT--VAGTTGYVAPEYHQTLTISEKS---DIYSFGVLLAVLVVGK--FPFDDFFQYT 464
T VA T Y APE L + DI+S G +LA ++ + FP D Y
Sbjct: 163 TGFLTEYVA-TRWYRAPEI--MLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD---YL 216
Query: 465 EEMNMV 470
++N++
Sbjct: 217 HQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 26/234 (11%)
Query: 244 IGVGACGVVYKAE-VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G GA G+V A S + +AIKKI T + + +++L R +R++K
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-------TNVFS-KKILAKRALRELKLLRHFR 59
Query: 303 GRIWHRNLLPL-QAHVTRPDCH--LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
G H+N+ L + P L +YE + L I+ G+ D + I +
Sbjct: 60 G---HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR---SGQPLTDAHFQSFIYQ 113
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR--ITTV 417
+ GL+Y+H + ++HRD+KP N+L++ E +I DFGLA+ + +T
Sbjct: 114 -ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 418 AGTTGYVAPEYHQTLTISEKS-DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
T Y APE + K+ D++S G +LA L+ K P Y +++N +
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 64/246 (26%), Positives = 113/246 (45%), Gaps = 41/246 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG GA G+V A + +AIKKI A ++ +R L R+IK
Sbjct: 13 IGRGAYGIVCSA-KNSETNEKVAIKKIAN---AFDNRIDAKRTL-----REIK----LLR 59
Query: 304 RIWHRNLLPLQAHVTRPDCH------LLVYEFMKNGSLQDILHDVSQGRREL-DWLARYR 356
+ H N++ ++ + P +VYE M LH + + + L D +Y
Sbjct: 60 HLDHENVIAIK-DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYF 113
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+ + + GL+Y+H + ++HRD+KP+N+L++ + +I DFGLA+ + +T
Sbjct: 114 LYQ-LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTE 167
Query: 417 VAGTTGYVAPEYHQTLTISEKS---DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
T Y APE L SE + D++S G + A L+ K F + ++ ++ +
Sbjct: 168 YVVTRWYRAPEL--LLNCSEYTTAIDVWSVGCIFAELLGRK----PLFPGKDYVHQLKLI 221
Query: 474 RNVISS 479
++ S
Sbjct: 222 TELLGS 227
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 7e-10
Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G+ GVV+K + G+++AIKK + + + ++++ + R++R +K
Sbjct: 6 LSKIGEGSYGVVFKCRNRET-GQIVAIKKF----VESEDDPVIKKIAL-REIRMLK---- 55
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
++ H NL+ L V R L LV+E+ + +L+++ + R + +I
Sbjct: 56 ---QLKHPNLVNL-IEVFRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIW 107
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM--PDGHTRIRITTV 417
+ + H ++ CI HRD+KP N+LI + ++ DFG A+++ P T
Sbjct: 108 QTLQAVNFCHKHN--CI-HRDVKPENILITKQGQIKLCDFGFARILTGPGDD----YTDY 160
Query: 418 AGTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVG 453
T Y APE L + + D+++ G + A L+ G
Sbjct: 161 VATRWYRAPE----LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 30/219 (13%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
LV E++ GSL+D L + R LD A + G+EYL + + HRD+
Sbjct: 84 LVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS--KRYV-HRDLATR 137
Query: 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT-TGYVAPEYHQTLTISEKSDIYSF 443
N+L++ +I DFGL K++P ++ + + APE S SD++SF
Sbjct: 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSF 197
Query: 444 GVLLAVLVVGKFPFDDFFQYTEEMNM--VRWMRNVISSENPHRAIDSKLLGNGYEEQMRL 501
GV+L L F Y+++ +MR ++ ++ + I L+ + RL
Sbjct: 198 GVVLYEL----------FTYSDKSCSPPAEFMR-MMGNDKQGQMIVYHLI-ELLKNNGRL 245
Query: 502 ---------VLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
+ I C ++DP +RPS ++ + I+
Sbjct: 246 PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 67/230 (29%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+L+ IG GA G+V A + +AIKK+ +P T R L+ K
Sbjct: 21 NLKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC------- 72
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
+ H+N++ L +V P L LV E M Q I + ELD
Sbjct: 73 -----VNHKNIISL-LNVFTPQKSLEEFQDVYLVMELMDANLCQVI-------QMELDHE 119
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+ M G+++LH IIHRD+KP+N+++ +I DFGLA+ T
Sbjct: 120 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 173
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDF 460
+T T Y APE + E DI+S G ++ +V K FP D+
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 17/139 (12%)
Query: 325 LVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382
+V E+M G L +++ +D+ + W AR+ A + L+ +H IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE-----KW-ARFYTAE-VVLALDAIHSMG---FIHRDVK 169
Query: 383 PANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL----TISEKS 438
P N+L+D +++DFG M D + +R T GT Y++PE ++ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 439 DIYSFGVLLAVLVVGKFPF 457
D +S GV L ++VG PF
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/239 (24%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 294 QIKSEIITAGRIW----HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
+K++ + RI H N++ L T+ +V E ++ G L ++G R L
Sbjct: 35 DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGPR-L 91
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
++ A+G+EYL IHRD+ N L+ + +ISDFG+++ DG
Sbjct: 92 KVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG- 147
Query: 410 TRIRITTVAGTTG--------YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
V +TG + APE S +SD++SFG+LL +G P+ +
Sbjct: 148 -------VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN- 199
Query: 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
+ N + E + + + RL+ + C DP +RPS
Sbjct: 200 ------------LSNQQTREAIEQGVRLPCPELCPDAVYRLMER----CWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 37/173 (21%)
Query: 307 HRNLLP-LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG---------RRELDWLARYR 356
H+N+LP L + + ++Y +M G+L+ L G ++L +A +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA-IQ 125
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMP-------DG 408
IA GM+ YLH +IH+DI N +ID+ ++ +I+D L++ L P D
Sbjct: 126 IACGMS----YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 409 HTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV-VGKFPFDD 459
R ++ ++A E S SD++SFGVLL L+ +G+ P+ +
Sbjct: 179 ENRPVK---------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 47/175 (26%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 289 NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
+++ R +E +T G+ H N++ L+ +TR + ++V E+M NG+L L + +
Sbjct: 47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQ 103
Query: 349 LDWLARYRIARGMASGLEYL-HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407
L + G+ASG++YL M + +H+ + VL++ + +IS F + +
Sbjct: 104 LVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFR---RLQE 156
Query: 408 GHTRIRITTVAGTTG--YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
+ TT++G + + APE Q S SD++SFG+++ V+ G+ P+ D
Sbjct: 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 52/159 (32%), Positives = 81/159 (50%), Gaps = 23/159 (14%)
Query: 323 HL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381
HL +V E+++ G +L ++ G +D +AR A + + LEYLH Y I+HRD+
Sbjct: 75 HLCMVMEYVEGGDCATLLKNI--GALPVD-MARMYFAETVLA-LEYLHNYG---IVHRDL 127
Query: 382 KPANVLIDDGMEARISDFGLAKL--------MPDGH----TR-IRITTVAGTTGYVAPEY 428
KP N+LI +++DFGL+K+ + +GH TR V GT Y+APE
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEV 187
Query: 429 HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
+ D ++ G++L +VG PF F EE+
Sbjct: 188 ILRQGYGKPVDWWAMGIILYEFLVGCVPF--FGDTPEEL 224
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
++ EF G++ I+ ++ +G E I R M L+YLH IIHRD+K
Sbjct: 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSMK---IIHRDLKAG 139
Query: 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE-----KSD 439
NVL+ + +++DFG++ + T R + GT ++APE T+ + K+D
Sbjct: 140 NVLLTLDGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197
Query: 440 IYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQM 499
I+S G+ L + + P E+N +R + + SE P + SK + +
Sbjct: 198 IWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAKSEPPTLSQPSK-----WSMEF 245
Query: 500 RLVLKIAYFCTSDDPEERPSS 520
R LK A PE RPS+
Sbjct: 246 RDFLKTAL---DKHPETRPSA 263
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 54/306 (17%)
Query: 241 LEIIGVGACGVVYKAEV--PG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+E +G A G +YK + PG + +++AIK + ++ + +
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-------------QQWGEFQQ 56
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL------HDVSQGRRE--- 348
E + H N++ L VT+ +++E++ G L + L DV E
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 349 ----LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK- 403
LD IA +A+G+EYL + +H+D+ N+LI + + +ISD GL++
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSRE 173
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQ 462
+ + R++ ++ ++ PE S SDI+SFGV+L + G P+ F
Sbjct: 174 IYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FS 231
Query: 463 YTEEMNMVRWMRNVISSEN-PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
E + MVR + + SE+ P R + + C + P RP K
Sbjct: 232 NQEVIEMVRKRQLLPCSEDCPPR-----------------MYSLMTECWQEGPSRRPRFK 274
Query: 522 DVRCML 527
D+ L
Sbjct: 275 DIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 259 GSYGKMIAIKKI---DQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315
G YGK+ ++K+ D + A ++L +K ++++ TA RN+L
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVL--------KKATIVRNQKDTAHTKAERNILEAVK 58
Query: 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGR------RE---LDWLARYRIARGMASGLE 366
H P L+Y F G L IL +S G RE ++ A + ++ ++ LE
Sbjct: 59 H---PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-ISLALE 114
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAP 426
+LH + II+RD+KP N+L+D +++DFGL K H T GT Y+AP
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAP 169
Query: 427 EYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
E + D +S G L+ ++ G PF
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 27/152 (17%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA--RYRIARGMASG 364
H N++ L T L++ E+ G L + L + L+ L Y++A+GMA
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA-- 155
Query: 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPD------GHTRIRITTV 417
+ + CI HRD+ NVL+ G +I DFGLA+ +M D G+ R+ +
Sbjct: 156 ----FLASKNCI-HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208
Query: 418 AGTTGYVAPE--YHQTLTISEKSDIYSFGVLL 447
++APE ++ T +SD++S+G+LL
Sbjct: 209 -----WMAPESIFNCVYTF--ESDVWSYGILL 233
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 36/230 (15%)
Query: 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+L+ IG GA G+V A + +AIKK+ +P T R L+ K
Sbjct: 28 NLKPIGSGAQGIVCAA-YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC------- 79
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
+ H+N++ L +V P L +V E M Q I + ELD
Sbjct: 80 -----VNHKNIIGL-LNVFTPQKSLEEFQDVYIVMELMDANLCQVI-------QMELDHE 126
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+ M G+++LH IIHRD+KP+N+++ +I DFGLA+ T
Sbjct: 127 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 180
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDF 460
+T T Y APE + E DI+S G ++ ++ G FP D
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 54/254 (21%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
++++G G G V+ + G+ GK+ A+K +D+ M + V+RVL +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGT-GKLFALKVLDKKEM--IKRNKVKRVLTEQ----- 52
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
EI+ + H L L A LV ++ G L +L G+ + +AR+
Sbjct: 53 --EILA--TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARF 107
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
A + LEYLH+ I++RD+KP N+L+ + +SDF L+K +
Sbjct: 108 YAAEVLL-ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 416 ----------------TVA-----------GTTGYVAPEYHQTLTISEKS-----DIYSF 443
T + GT Y+APE IS D ++
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTL 218
Query: 444 GVLLAVLVVGKFPF 457
G+LL ++ G PF
Sbjct: 219 GILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 64/247 (25%), Positives = 99/247 (40%), Gaps = 68/247 (27%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
L +G G G VYKA G+++A+KKI D P+ A +R+
Sbjct: 13 LGKLGEGTFGEVYKA-RQIKTGRVVALKKILMHNEKDGFPITA--------------LRE 57
Query: 295 IKSEIITAGRIWHRNLLPL--------QAHVTRPDCHLLVYEFMK---NGSL--QDILHD 341
IK I+ ++ H N++PL + +V +M +G L +
Sbjct: 58 IK--ILK--KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT 113
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
SQ + + G+ YLH H I+HRDIK AN+LID+ +I+DFGL
Sbjct: 114 ESQIKC---------YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161
Query: 402 AKLM---------PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS-----DIYSFGVLL 447
A+ G + T + T Y PE L + E+ DI+ G +
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE----LLLGERRYTTAVDIWGIGCVF 217
Query: 448 AVLVVGK 454
A + +
Sbjct: 218 AEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKID-QPPMAATELLNVRRVLINRKMRQIKSEIITA 302
IG GA G V+KA + G+ +A+K++ Q L +R V + R + +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE------ 62
Query: 303 GRIWHRNLLPL--QAHVTRPDCH---LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
H N++ L V+R D LV+E + + L L V + + +
Sbjct: 63 ----HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ GL++LH HR ++HRD+KP N+L+ + +++DFGLA++ ++ +T+V
Sbjct: 118 Q--LLRGLDFLHS-HR--VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSV 169
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448
T Y APE + + D++S G + A
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 36/203 (17%)
Query: 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383
V E++ G D++ + + R+ + AR+ A ++ L YLH II+RD+K
Sbjct: 72 FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLH---ERGIIYRDLKL 124
Query: 384 ANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIY 441
NVL+D +++D+G+ K L P T +T GT Y+APE + D +
Sbjct: 125 DNVLLDSEGHIKLTDYGMCKEGLRPGDTT----STFCGTPNYIAPEILRGEDYGFSVDWW 180
Query: 442 SFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL 501
+ GVL+ ++ G+ PFD V SS+NP + + L E+Q+R+
Sbjct: 181 ALGVLMFEMMAGRSPFDI----------------VGSSDNPDQNTEDYLFQVILEKQIRI 224
Query: 502 VLKIAYFCTS-------DDPEER 517
++ S DP+ER
Sbjct: 225 PRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++GK+I +K+ A ++L ++ ++ +E H L L+
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 65
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
D V E+ G L +S+ R + AR+ A + S L+YLH +++
Sbjct: 66 THDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 119
Query: 379 RDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
RD+K N+++D +I+DFGL K + DG T + T GT Y+APE +
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRA 176
Query: 438 SDIYSFGVLLAVLVVGKFPF 457
D + GV++ ++ G+ PF
Sbjct: 177 VDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 75/236 (31%), Positives = 110/236 (46%), Gaps = 43/236 (18%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQP----PMAATELLNVRRVLIN 289
D +E IG G GVVYKA + + IA+KKI +Q P A +R + +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVT-NETIALKKIRLEQEDEGVPSTA-----IREISLL 55
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQ---DILHDVSQGR 346
++M+ H N++ LQ V LV+E++ + L+ D D ++
Sbjct: 56 KEMQ-------------HGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNP 101
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA-RISDFGLAKLM 405
R + Y+I RG+A Y H HR ++HRD+KP N+LID A +++DFGLA+
Sbjct: 102 RLIKTYL-YQILRGIA----YCHS-HR--VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153
Query: 406 PDGHTRIRITTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFD 458
G T T Y APE + S DI+S G + A +V K FP D
Sbjct: 154 --GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 38/238 (15%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+IG G G VY A P + +A+KKI E L+ +L R +R+ K I A
Sbjct: 9 LIGKGGMGEVYLAYDPVC-SRRVALKKI-------REDLSENPLLKKRFLREAK---IAA 57
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR-------Y 355
I H ++P+ + + D +++ +L+ +L V Q LA
Sbjct: 58 DLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL----------- 404
I + + +EY+H ++HRD+KP N+L+ E I D+G A
Sbjct: 117 SIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173
Query: 405 ---MPDG-HTRIRIT-TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+ ++ + I + GT Y+APE + SE +DIY+ GV+L ++ FP+
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++GK+I +++ A ++L ++ ++ +E H L L+
Sbjct: 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 65
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
D V E+ G L +S+ R + AR+ A + S LEYLH +++
Sbjct: 66 THDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---VVY 118
Query: 379 RDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
RDIK N+++D +I+DFGL K + DG T + T GT Y+APE +
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 438 SDIYSFGVLLAVLVVGKFPF 457
D + GV++ ++ G+ PF
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 34/236 (14%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKA-EVP-GSYGKM-IAIKKIDQP--PMAATELLNVRRV 286
+ KE L ++++G GA G VYK VP G K+ +AIK +++ P A E ++
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMD---- 58
Query: 287 LINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH---DVS 343
E + + H +L+ L P L V + M +G L D +H D
Sbjct: 59 -----------EALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNI 106
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ L+W + IA+GM +++ R ++HRD+ NVL+ +I+DFGLA+
Sbjct: 107 GSQLLLNWCVQ--IAKGM------MYLEERR-LVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFD 458
L+ ++A E + +SD++S+GV + ++ G P+D
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 14/113 (12%)
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG-LAKLMPDGHT 410
+AR+ +A M ++ +H +HRDIKP NVL+D R++DFG +L+ DG
Sbjct: 103 MARFYLAE-MVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158
Query: 411 RIRITTVA-GTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVGKFPF 457
+ + VA GT Y++PE Q + + D +S GV + ++ G+ PF
Sbjct: 159 Q---SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 33/170 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQ-----PPMAATELLNVRRVLINRKMR 293
+E IG G GVVYKA + G+++A+KKI + P A +R + + +++
Sbjct: 4 VEKIGEGTYGVVYKARDKLT-GEIVALKKIRLETEDEGVPSTA------IREISLLKELN 56
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
H N++ L V + LV+EF+ + L+ + + +
Sbjct: 57 -------------HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIK 102
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
Y + G+ Y H HR ++HRD+KP N+LID +++DFGLA+
Sbjct: 103 SYLYQ--LLQGIAYCHS-HR--VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 4e-09
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 52/233 (22%)
Query: 241 LEIIGVGACGVVYKAEV----PGSYGKMIAIKKI-DQPPMAATELLNVRRVLINRKMRQI 295
+E +G G VYK + PG + +AIK + D+ E +
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE--------------EF 55
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL------------HDVS 343
K E + R+ H N++ L VT+ +++ + + L + L D
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-- 401
+ L+ I +A+G+E+L +H ++H+D+ NVL+ D + +ISD GL
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR 172
Query: 402 -------AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
KLM + IR +++PE S SDI+S+GV+L
Sbjct: 173 EVYAADYYKLMGNSLLPIR---------WMSPEAIMYGKFSIDSDIWSYGVVL 216
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 68/309 (22%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G V KA+ + GK AIK + + + ++ N+R + R++
Sbjct: 7 IGEGTFSEVLKAQSRKT-GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP--------- 56
Query: 304 RIWHRNLLPLQAHV--TRPDCHLLVYEFMKNGSLQDI-LHDVSQGRRELDWLARYRIARG 360
H N+L L + + LV+E M D+ L+++ +GR+ L R+
Sbjct: 57 ---HPNILRLIEVLFDRKTGRLALVFELM------DMNLYELIKGRKRP--LPEKRVKSY 105
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
M L+ L HR I HRDIKP N+LI D +++DFG + + +++ T T
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGI---YSKPPYTEYIST 161
Query: 421 TGYVAPEYHQTLT---ISEKSDIYSFG-VLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
Y APE LT K DI++ G V +L + FP F T E++ + + +V
Sbjct: 162 RWYRAPEC--LLTDGYYGPKMDIWAVGCVFFEILSL--FP---LFPGTNELDQIAKIHDV 214
Query: 477 ISSENPHRAID---------------------SKLLGNGYEEQMRLVLK-IAYFCTSDDP 514
+ + P + KLL N E + L+ K +AY DP
Sbjct: 215 LGT--PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAY-----DP 267
Query: 515 EERPSSKDV 523
+ER ++K
Sbjct: 268 DERITAKQA 276
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 45/174 (25%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM-RQIKSEIITA 302
I GA G VY + K+ A+K + + M IN+ M Q+++E
Sbjct: 12 ISRGAFGKVYLGR-KKNNSKLYAVKVVKKADM------------INKNMVHQVQAE---- 54
Query: 303 GRIWHRNLLPLQAHVTRPDC-HL-----------LVYEFMKNGSLQDILHDVSQGRRELD 350
R+ L L P HL LV E++ G ++ +LH E+
Sbjct: 55 -----RDALALS---KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM- 105
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
A I+ +A L+YLH R IIHRD+KP N+LI + +++DFGL+K+
Sbjct: 106 --AVKYISE-VALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 18/172 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G+YG + + + +AA +++ + I+ EI H N++
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA---RGMASGLEYLHMYHRPC 375
+ + E+ GSLQDI H L+ +IA R GL YLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 376 IIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE 427
+HRDIK AN+L+ D + +++DFG+A + T + + GT ++APE
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 11/200 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++GK+I +++ A ++L ++ ++ +E H L L+
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ 65
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
D V E++ G L +S+ R + R+ A + S L+YLH I++
Sbjct: 66 TKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAE-IVSALDYLHSGK---IVY 118
Query: 379 RDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
RD+K N+++D +I+DFGL K + D T + T GT Y+APE +
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 438 SDIYSFGVLLAVLVVGKFPF 457
D + GV++ ++ G+ PF
Sbjct: 176 VDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 6e-09
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 21/170 (12%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K DS LE +G G+ VYK + + GK++A+K I T +R + + ++
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVN-GKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
H N++ L + + LV+E++ Q + D G + +
Sbjct: 62 -------------HANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVK 106
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + GL Y+H + I+HRD+KP N+LI D E +++DFGLA+
Sbjct: 107 LFLFQ--LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 69/231 (29%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-- 298
L ++G G G V AE + G++ AIK L ++ ++ + E
Sbjct: 4 LAVLGRGHFGKVLLAEYKKT-GELYAIK-----------ALKKGDIIARDEVESLMCEKR 51
Query: 299 -IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-DVSQGRRELDWLARYR 356
TA H L+ L A D V E+ G L +H DV R A +
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-----AVFY 106
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRIT 415
A + GL+YLH I++RD+K N+L+D +I+DFGL K M G R +
Sbjct: 107 AAC-VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RTS 159
Query: 416 TVAGTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGKFPF--DD 459
T GT ++APE ++E S D + GVL+ ++VG+ PF DD
Sbjct: 160 TFCGTPEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383
LV E++ G D++ + + R+ + AR+ A + L +LH II+RD+K
Sbjct: 72 FLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLH---ERGIIYRDLKL 124
Query: 384 ANVLIDDGMEARISDFGLAK--LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIY 441
NVL+D +++D+G+ K L P T +T GT Y+APE + D +
Sbjct: 125 DNVLLDADGHIKLTDYGMCKEGLGPGDTT----STFCGTPNYIAPEILRGEEYGFSVDWW 180
Query: 442 SFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHR 484
+ GVL+ ++ G+ PF D +MN ++ VI E P R
Sbjct: 181 ALGVLMFEMMAGRSPF-DIITDNPDMNTEDYLFQVI-LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G+YGK+ ++K+ T L +VL +K ++ RN+L HV
Sbjct: 11 GAYGKVFLVRKVTGHD---TGKLYAMKVL--QKAALVQKAKTVEHTRTERNVL---EHVR 62
Query: 319 R-PDCHLLVYEFMKNGSLQDILHDVSQG-------RRELDWLARYRIARG-MASGLEYLH 369
+ P L Y F L IL VS G +R+ R G + LE+LH
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122
Query: 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH 429
+ I++RDIK N+L+D ++DFGL+K + R + GT Y+APE
Sbjct: 123 ---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEYMAPEII 178
Query: 430 QTLTISEKS-DIYSFGVLLAVLVVGKFPF 457
+ K+ D +S G+L+ L+ G PF
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 12/112 (10%)
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG-LAKLMPDGHT 410
+AR+ IA M + +H H +HRDIKP NVL+D R++DFG K+ DG
Sbjct: 103 MARFYIAE-MVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-- 156
Query: 411 RIRITTVAGTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVGKFPF 457
++ + GT Y++PE Q + + D +S GV + ++ G+ PF
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 52/201 (25%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 259 GSYGKMI--AIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316
GS+G++I K D PP+A + ++ +++ + SE I H + L
Sbjct: 41 GSFGRVILATYKNEDFPPVAIKRFEKSK-IIKQKQVDHVFSERKILNYINHPFCVNLYGS 99
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
LV EF+ G L + +R + + + A+ + EYL + I
Sbjct: 100 FKDESYLYLVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQ-IVLIFEYLQSLN---I 152
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
++RD+KP N+L+D +++DFG AK++ R T+ GT Y+APE + +
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGK 207
Query: 437 KSDIYSFGVLLAVLVVGKFPF 457
+D ++ G+ + ++VG PF
Sbjct: 208 AADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 20/222 (9%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G GA G VY G+ +A+K++ P + ++++ ++ EI
Sbjct: 8 KLLGQGAFGRVYLC-YDADTGRELAVKQVQFDPESPE---------TSKEVNALECEIQL 57
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLL--VYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
+ H ++ + P L E M GS++D L S G + +Y R
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKY--TR 113
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRITTVA 418
+ G+ YLH I+HRDIK AN+L D ++ DFG +K L + + +V
Sbjct: 114 QILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
GT +++PE K+DI+S G + ++ K P+ +F
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 45/235 (19%)
Query: 244 IGVGACGVVYKAEV----PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
+G GA G V+ AE P ++A+K + A RK ++E+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA------------RKDFHREAEL 60
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD-------VSQGR--RELD 350
+T + H +++ D ++V+E+MK+G L L +++G EL
Sbjct: 61 LT--NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK------- 403
IA+ +A+G+ YL H +HRD+ N L+ + + +I DFG+++
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
GHT + I ++ PE + +SD++S GV+L + GK P+
Sbjct: 176 YRVGGHTMLPIR-------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 60/216 (27%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 259 GSYGKMIAIKKI---DQPPMAATELLNVRRVLINRK-MRQIKSEIITAGRIWHRNLLPLQ 314
G+YGK+ ++K+ D + A ++L ++ K ++E R +L
Sbjct: 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTE---------RQVL--- 58
Query: 315 AHVTRPDCHLLV---YEFMKNGSLQDILHDVSQG-------RRELDWLARYRIARG-MAS 363
V R C LV Y F + L IL V+ G +RE + R+ +
Sbjct: 59 EAVRR--CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVL 116
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGY 423
L++LH II+RDIK N+L+D ++DFGL+K R + GT Y
Sbjct: 117 ALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEY 172
Query: 424 VAPEYHQTLTISEKS--DIYSFGVLLAVLVVGKFPF 457
+APE + + D +S GVL L+ G PF
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 18/144 (12%)
Query: 321 DCHL-LVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
D +L +V E+M G L +++ +DV + W Y +A L H +I
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA-----LDAIHSMGLI 164
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT---- 433
HRD+KP N+L+D +++DFG M D +R T GT Y++PE ++
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 434 ISEKSDIYSFGVLLAVLVVGKFPF 457
+ D +S GV L ++VG PF
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 43/140 (30%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 325 LVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382
+V E+M G L +++ +DV + W AR+ A + + L H IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KW-ARFYTAEVVLA----LDAIHSMGFIHRDVK 169
Query: 383 PANVLIDDGMEARISDFGLA-KLMPDGHTRIRITTVAGTTGYVAPEYHQTLT----ISEK 437
P N+L+D +++DFG K+ +G +R T GT Y++PE ++ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 438 SDIYSFGVLLAVLVVGKFPF 457
D +S GV L ++VG PF
Sbjct: 228 CDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 11/135 (8%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
V EF+ G D++ + + R+ + AR+ A + L+ H II+RD+K
Sbjct: 73 FVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHERGIIYRDLKLD 125
Query: 385 NVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443
NVL+D +++D+G+ K + G T +T GT Y+APE + D ++
Sbjct: 126 NVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182
Query: 444 GVLLAVLVVGKFPFD 458
GVL+ ++ G+ PFD
Sbjct: 183 GVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 61/237 (25%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV-RRVLINRKMRQIKSEIITA 302
+G GA G+V+KA + +++A+KKI AT+ R ++ +++
Sbjct: 15 LGKGAYGIVWKA-IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD-------- 65
Query: 303 GRIWHRNLLPLQAHVTRPDCHL---LVYEFM--------KNGSLQDILHDVSQGRRELDW 351
H N++ L +V + + LV+E+M + L+D+
Sbjct: 66 ----HPNIVKL-LNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK----------- 109
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL---MPDG 408
RY I + L+Y+H + +IHRD+KP+N+L++ +++DFGLA+ + +
Sbjct: 110 --RY-IMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGV-------LLAVLVVGK--FP 456
+T T Y APE I S Y+ GV +L +++GK FP
Sbjct: 164 PENPVLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 50/214 (23%), Positives = 92/214 (42%), Gaps = 31/214 (14%)
Query: 324 LLVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381
+++ FMK+G L L + +L + +A G+EYL + IHRD+
Sbjct: 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDL 139
Query: 382 KPANVLIDDGMEARISDFGLAKLMPDG----HTRIRITTVAGTTGYVAPEYHQTLTISEK 437
N ++ + M ++DFGL+K + G RI V ++A E + K
Sbjct: 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLADRVYTSK 195
Query: 438 SDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYE 496
SD+++FGV + + G+ P+ E + ++R+ + P E
Sbjct: 196 SDVWAFGVTMWEIATRGQTPYPG----VENHEIYDYLRHGNRLKQP-------------E 238
Query: 497 EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ + + + Y C DP++RP+ +R +L I
Sbjct: 239 DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
+E IG G GVVYK + G+++A+KKI + P A +R + + ++++
Sbjct: 5 IEKIGEGTYGVVYKGRNKKT-GQIVAMKKIRLESEEEGVPSTA-----IREISLLKELQ- 57
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR---RELDW 351
H N++ LQ + + L++EF+ + L+ L + +G+ EL
Sbjct: 58 ------------HPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVK 104
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL--MPDGH 409
Y+I +G+ H ++HRD+KP N+LID+ +++DFGLA+ +P
Sbjct: 105 SYLYQILQGIL-------FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--- 154
Query: 410 TRIRITT-VAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGK 454
+R+ T T Y APE S DI+S G + A + K
Sbjct: 155 --VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 16/202 (7%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IITAGRIWHRNLLPLQAH 316
G YG++ KK D + A + + + ++R + +E I+T + L+ L
Sbjct: 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYA 69
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
+ L E++ G + +L+++ + AR+ MA E + H
Sbjct: 70 FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH---ARFY----MAEMFEAVDALHELGY 122
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
IHRD+KP N LID +++DFGL+K +V G+ Y+APE +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDF 177
Query: 437 KSDIYSFGVLLAVLVVGKFPFD 458
D +S G +L + G PF
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 54/216 (25%)
Query: 332 NGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391
+ S + ++ LD R + +A G+++L + CI HRD+ NVL+ DG
Sbjct: 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCI-HRDVAARNVLLTDG 248
Query: 392 MEARISDFGLAK-LMPD------GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFG 444
A+I DFGLA+ +M D G+ R+ + ++APE + +SD++S+G
Sbjct: 249 RVAKICDFGLARDIMNDSNYVVKGNARLPVK-------WMAPESIFDCVYTVQSDVWSYG 301
Query: 445 VLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSK---LLGNGYEEQMR 500
+LL + +GK P+ P ++SK ++ GY QM
Sbjct: 302 ILLWEIFSLGKSPY------------------------PGILVNSKFYKMVKRGY--QMS 335
Query: 501 L-------VLKIAYFCTSDDPEERPSSKDVRCMLSQ 529
+ I C + +P ERP+ + ++ +
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E+M GS++D L + L + R + G+ YLH I+HRDIK AN+L
Sbjct: 86 EYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANIL 138
Query: 388 IDDGMEARISDFGLAK-LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL 446
D ++ DFG +K L + I +V GT +++PE K+D++S G
Sbjct: 139 RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCT 198
Query: 447 LAVLVVGKFPFDDF 460
+ ++ K P+ ++
Sbjct: 199 VVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR------- 359
H+N++ L T+ ++ E+ G+L++ L + RR Y IAR
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQMT 135
Query: 360 ---------GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
+A G+EYL + CI HRD+ NVL+ + +I+DFGLA+ + +
Sbjct: 136 FKDLVSCTYQVARGMEYLA--SQKCI-HRDLAARNVLVTENNVMKIADFGLARDVNNIDY 192
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
+ T ++APE + +SD++SFGVL+ + +G P+
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-DQPPMAATELLNVRRVLINRKMRQIKSEI 299
L ++G GA GVV K + +++AIKK D + +R + + R ++Q
Sbjct: 6 LGVVGEGAYGVVLKCRHKETK-EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ----- 59
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
N++ L+ R LV+E+++ L+ +L ++ G + ++
Sbjct: 60 --------ENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNG------VPPEKVRS 104
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ ++ +H H+ I+HRDIKP N+LI ++ DFG A+ + +G + T
Sbjct: 105 YIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG-SNANYTEYVA 163
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
T Y +PE + D++S G +L L G+ FP
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 26/230 (11%)
Query: 234 KEDSLASLEIIGVGACGVVYKA-EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM 292
KE ++++G GA G VYK +P G+ + I P+A EL R +
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKI------PVAIKEL---REATSPKAN 53
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH---DVSQGRREL 349
++I E + + ++ L + L+ + M G L D + D + L
Sbjct: 54 KEILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 112
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+W +IA+GM YL ++HRD+ NVL+ +I+DFGLAKL+
Sbjct: 113 NWCV--QIAKGM----NYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFD 458
++A E + +SD++S+GV + ++ G P+D
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 52/181 (28%), Positives = 85/181 (46%), Gaps = 25/181 (13%)
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH----LLVYEFMKNGSLQDILHDVSQGRR 347
M+ +K E+I A L ++ V + H L Y F + L ++ + G
Sbjct: 25 MKILKKEVIIAKDEVAHTLT--ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG-- 80
Query: 348 ELDW-LARYRI-----AR----GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397
EL + L+R R+ AR + S L YLH +++RD+K N+++D +I+
Sbjct: 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKIT 137
Query: 398 DFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
DFGL K + DG T + T GT Y+APE + D + GV++ ++ G+ P
Sbjct: 138 DFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
Query: 457 F 457
F
Sbjct: 195 F 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 32/232 (13%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G G V +AE +YG I + DQ A ++L + ++ + + SE+
Sbjct: 20 LGEGCFGQVVRAE---AYG--IDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMK 72
Query: 304 RI-WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-----------DVSQGRREL-- 349
I H+N++ L T+ ++ E+ G+L++ L D+++ E
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 350 --DWLA-RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
D ++ Y++ARGM EYL R CI HRD+ NVL+ + +I+DFGLA+ +
Sbjct: 133 FKDLVSCAYQVARGM----EYLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLARGVH 185
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
D + + ++APE + +SD++SFG+L+ + +G P+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 41/141 (29%), Positives = 67/141 (47%), Gaps = 22/141 (15%)
Query: 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387
E+M GS++D L + G + RY R + G+ YLH I+HRDIK AN+L
Sbjct: 86 EYMPGGSIKDQLK--AYGALTENVTRRY--TRQILQGVSYLH---SNMIVHRDIKGANIL 138
Query: 388 IDDGMEARISDFGLAKLMPDGHTRIR--------ITTVAGTTGYVAPEYHQTLTISEKSD 439
D ++ DFG +K RI+ I +V GT +++PE K+D
Sbjct: 139 RDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKAD 191
Query: 440 IYSFGVLLAVLVVGKFPFDDF 460
++S + ++ K P+ ++
Sbjct: 192 VWSVACTVVEMLTEKPPWAEY 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 30/210 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E++G G G V+K + + K D P + L+ R+L +Q
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARIL-----KQYD----- 50
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
H N++ L T+ +V E + G D L + + + EL + A
Sbjct: 51 -----HPNIVKLIGVCTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDA 102
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG-- 419
A+G+ YL + CI HRD+ N L+ + +ISDFG+++ DG I + +G
Sbjct: 103 AAGMAYLES--KNCI-HRDLAARNCLVGENNVLKISDFGMSRQEDDG-----IYSSSGLK 154
Query: 420 --TTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ APE S +SD++S+G+LL
Sbjct: 155 QIPIKWTAPEALNYGRYSSESDVWSYGILL 184
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 38/173 (21%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM---PD---- 407
+++ARGM E+L R CI HRD+ N+L+ + +I DFGLA+ + PD
Sbjct: 180 FQVARGM----EFLA--SRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 408 GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
G R+ + ++APE + +SD++SFGVLL + +G P+ Q EE
Sbjct: 233 GDARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQIDEE 284
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
R ++ P A + I C ++PE+RP+
Sbjct: 285 --FCRRLKEGTRMRAPEYATPE-------------IYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 28/86 (32%), Positives = 47/86 (54%)
Query: 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT 431
H ++HRD+K AN+ + ++ DFG +K D + ++ GT Y+APE +
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 432 LTISEKSDIYSFGVLLAVLVVGKFPF 457
S+K+D++S GV+L L+ PF
Sbjct: 246 KRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 53/237 (22%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G+ G+V+ A V K +A+KKI T+ +V+ L R+IK II
Sbjct: 13 LGCGSNGLVFSA-VDSDCDKRVAVKKI-----VLTDPQSVKHAL-----REIK--IIR-- 57
Query: 304 RIWHRNLL-----------PLQAHVTRP---DCHLLVYEFMKNGSLQDILHDVSQGR--R 347
R+ H N++ L V + +V E+M+ D+ + + QG
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSE 113
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLM- 405
E L Y++ RG L+Y+H + ++HRD+KPANV I+ + + +I DFGLA+++
Sbjct: 114 EHARLFMYQLLRG----LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 406 PDGHTRIRITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
P + ++ T Y +P + T I D+++ G + A ++ GK F
Sbjct: 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM---ASGLEYLHMYHRPCIIHRD 380
+++ FMK+G L L G +L + + M ASG+EYL IHRD
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQ-YLPTQMLVKFMTDIASGMEYLSSKS---FIHRD 137
Query: 381 IKPANVLIDDGMEARISDFGLAKLMPDG--HTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
+ N ++++ M ++DFGL+K + +G + + RI + ++A E + KS
Sbjct: 138 LAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP--VKWIAIESLADRVYTTKS 195
Query: 439 DIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEE 497
D++SFGV + + G+ P+ E + ++R + P +D
Sbjct: 196 DVWSFGVTMWEIATRGQTPYPG----VENSEIYDYLRQGNRLKQPPDCLDG--------- 242
Query: 498 QMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ + C +P++RPS + +RC L +
Sbjct: 243 ----LYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 68/240 (28%), Positives = 106/240 (44%), Gaps = 34/240 (14%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKK----IDQPPMAATELLNVRRVLINRK 291
D+ LE IG G G VYKA + GK++A+KK +D+ + T L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKAR-DKNTGKLVALKKTRLEMDEEGIPPTALREI-------S 52
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPD---CHLLVYEFMKNGSLQDILHDVSQGRRE 348
+ Q+ SE I R LL ++ HV + LV+E++ + + + S GR
Sbjct: 53 LLQMLSESIYIVR-----LLDVE-HVEEKNGKPSLYLVFEYLDSDLKKFM---DSNGRGP 103
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAK--LM 405
L I M L+ + H+ ++HRD+KP N+L+D +I+D GL + +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 406 PDGHTRIRITTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDFFQ 462
P I T+ Y APE + S DI+S G + A + + FP D Q
Sbjct: 164 PVKSYTHEIVTL----WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
Y++ARGM EYL + CI HRD+ NVL+ + +I+DFGLA+ + + +
Sbjct: 141 YQVARGM----EYLA--SQKCI-HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
T ++APE + +SD++SFGVLL + +G P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 42/142 (29%), Positives = 69/142 (48%), Gaps = 12/142 (8%)
Query: 325 LVYEFMKNGSLQDILHD-VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383
LV E GS+ D++ + +G R + + Y + + GL++LH+ IHRD+K
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM-GLQHLHVNK---TIHRDVKG 152
Query: 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEY---HQTL--TISEKS 438
N+L+ ++ DFG++ + TR+R T GT ++APE Q L T +
Sbjct: 153 NNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARC 210
Query: 439 DIYSFGVLLAVLVVGKFPFDDF 460
D++S G+ L G P D
Sbjct: 211 DVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 56/205 (27%), Positives = 95/205 (46%), Gaps = 44/205 (21%)
Query: 327 YEFMKNGSLQDILHD-VSQGRRELDWLA-RYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
Y+ + ++++L D S+G LD L+ Y++ARGM E+L + C+ HRD+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGM----EFLA--SKNCV-HRDLAAR 266
Query: 385 NVLIDDGMEARISDFGLAK-LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443
NVL+ G +I DFGLA+ +M D + + +T ++APE + SD++S+
Sbjct: 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL-PVKWMAPESIFDNLYTTLSDVWSY 325
Query: 444 GVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKL---LGNGY---- 495
G+LL + +G P+ P +DS + +GY
Sbjct: 326 GILLWEIFSLGGTPY------------------------PGMIVDSTFYNKIKSGYRMAK 361
Query: 496 -EEQMRLVLKIAYFCTSDDPEERPS 519
+ + V I C + +PE+RPS
Sbjct: 362 PDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 61/243 (25%), Positives = 93/243 (38%), Gaps = 34/243 (13%)
Query: 252 VYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311
V K PGS G++ K QP ++ LI + Q + H +++
Sbjct: 70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQ---------NVNHPSVI 120
Query: 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY 371
++ + +V + D+ +++ R L I + + GL YLH
Sbjct: 121 RMKDTLVSGAITCMVLPHYSS----DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA- 175
Query: 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKL---MPDGHTRIRITTVAGTTGYVAPEY 428
R IIHRD+K N+ I+D + I D G A+ P +AGT APE
Sbjct: 176 QR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA------FLGLAGTVETNAPEV 227
Query: 429 HQTLTISEKSDIYSFG-VLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAID 487
+ K+DI+S G VL +L F+D EE V S + I
Sbjct: 228 LARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE--------YVKSCHSHLLKII 279
Query: 488 SKL 490
S L
Sbjct: 280 STL 282
|
Length = 357 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 33/225 (14%)
Query: 242 EIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ-IKSE 298
E +G G G V+ E G + A + QP + A ++L R + + R E
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML---RADVTKTARNDFLKE 67
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
I R+ + N++ L D ++ E+M+NG L L +RE++ + + A
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-----SQREIE--STFTHA 120
Query: 359 RGM---------------ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ ASG++YL + +HRD+ N L+ + +I+DFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 404 -LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
L + RI+ V ++A E + SD+++FGV L
Sbjct: 178 NLYSGDYYRIQGRAVLPIR-WMAWESILLGKFTTASDVWAFGVTL 221
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE +G G VYK + G+++A+K+I T +R + + M+++K
Sbjct: 5 LEKLGEGTYATVYKGRNRTT-GEIVALKEIHLDAEEGTPSTAIREISL---MKELK---- 56
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ L + + +LV+E+M L+ + D R LD
Sbjct: 57 ------HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTVKSFTYQ 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG- 419
+ G+ + H +R ++HRD+KP N+LI+ E +++DFGLA+ I + T +
Sbjct: 109 LLKGIAFCHE-NR--VLHRDLKPQNLLINKRGELKLADFGLARAFG-----IPVNTFSNE 160
Query: 420 --TTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGK 454
T Y AP+ + T S DI+S G ++A ++ G+
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 62/249 (24%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE---IITAGRIWHRNLLPLQA 315
G++G++ K+D + A + L + VL ++ +K+E + A W ++ L
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW---VVKLYY 68
Query: 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL--DWLARYRIARGMASGLEYLHMYHR 373
D V +++ G + +L R E+ + LAR+ IA + +E +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI-----RMEVFPEVLARFYIAE-LTLAIESVH---K 119
Query: 374 PCIIHRDIKPANVLIDDGMEARISDFGL---------AKLMPDG---------------- 408
IHRDIKP N+LID +++DFGL +K G
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 409 --------------------HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448
H R ++ GT Y+APE ++ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 449 VLVVGKFPF 457
++VG+ PF
Sbjct: 240 EMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 55/247 (22%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
+L + +G G G V+ A+ G E L + + L K ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKG-------------IEEEGGETLVLVKALQKTKDENLQ 52
Query: 297 S----EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE---- 348
S E+ ++ H+N++ L + H ++ E+ G L+ L ++ + E
Sbjct: 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKP 111
Query: 349 --LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK--- 403
L + + +A G+++L +HRD+ N L+ E ++S L+K
Sbjct: 112 PPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168
Query: 404 ----------LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVV 452
L+P +R ++APE Q S KSD++SFGVL+ V
Sbjct: 169 NSEYYKLRNALIP-----LR---------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ 214
Query: 453 GKFPFDD 459
G+ PF
Sbjct: 215 GELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 38/238 (15%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATEL---LNVRRVLINR-- 290
D+ +E IG G G VYK G + A+K +D E+ N+ + L N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKD-GSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 291 --KMRQI--KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
K + K++ + G++W LV E GS+ +++ +
Sbjct: 81 VVKFYGMFYKADKLVGGQLW------------------LVLELCNGGSVTELVKGLLICG 122
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+ LD I G GL++LH IIHRD+K N+L+ ++ DFG++ +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 407 DGHTRIRITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
TR+R T GT ++APE + + D++S G+ L G P D
Sbjct: 180 S--TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 50/250 (20%), Positives = 101/250 (40%), Gaps = 41/250 (16%)
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAH---VTRPDCHL-LVYEFMKNGSLQDILHDVSQGRR 347
+ ++EI RI N+L + + L L+ E+ G L+++L +
Sbjct: 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EK 117
Query: 348 ELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+L + + +A GL L+ Y ++P ++++ + L+ + + +I GL K++
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
+ + + + + + TI K DIYS GV+L + GK PF++ E
Sbjct: 175 SPPFK-NVNFMVYFSYKMLNDIFSEYTI--KDDIYSLGVVLWEIFTGKIPFEN-LTTKEI 230
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQM-----RLVLKIAYFCTSDDPEERPSSK 521
++ ++ ++ + I CTS D +RP+ K
Sbjct: 231 YDL--------------------IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270
Query: 522 DVRCMLSQIK 531
++ LS K
Sbjct: 271 EILYNLSLYK 280
|
Length = 283 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 36/176 (20%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+++ARGM E+L R CI HRD+ N+L+ + +I DFGLA+ + +R
Sbjct: 181 FQVARGM----EFLA--SRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF------DDFFQYTEEM 467
+ ++APE + +SD++SFGVLL + +G P+ ++F Q ++
Sbjct: 234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293
Query: 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+R + EN I +L C DP+ERP+ +
Sbjct: 294 TRMR------APENATPEIYRIMLA----------------CWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 63/241 (26%), Positives = 98/241 (40%), Gaps = 43/241 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKM----IAIKKIDQPPMAATELLNVRRVLINRK 291
DS+ L +G GA G VY+ G G +A+K + + E + LI K
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE--- 348
H+N++ L ++ E M G L+ L + ++ R E
Sbjct: 66 FN-------------HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE-NRPRPERPS 111
Query: 349 -LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---GMEARISDFGLAKL 404
L AR +A G +YL H IHRDI N L+ G A+I+DFG+A+
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168
Query: 405 M-------PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFP 456
+ G + I ++ PE + K+D++SFGVLL + +G P
Sbjct: 169 IYRASYYRKGGRAMLPIK-------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
Query: 457 F 457
+
Sbjct: 222 Y 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 32/89 (35%), Positives = 46/89 (51%), Gaps = 12/89 (13%)
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG- 422
G++YL + +HRD+ NVL+ A+ISDFGL+K + + A T G
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGK 159
Query: 423 ----YVAPEYHQTLTISEKSDIYSFGVLL 447
+ APE S KSD++SFGVL+
Sbjct: 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 46/181 (25%), Positives = 77/181 (42%), Gaps = 23/181 (12%)
Query: 289 NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV--------YEFMKNGSLQDILH 340
+R Q+++EI+ GR+ H N+L ++ + ++ Y FM + +
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD---- 259
Query: 341 DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
R L R I + + +EY+H +IHRDIK N+ ++ + + DFG
Sbjct: 260 ---WKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG 312
Query: 401 LAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF-PFD 458
A MP R GT +PE E +DI+S G++L ++ F P
Sbjct: 313 TA--MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370
Query: 459 D 459
D
Sbjct: 371 D 371
|
Length = 501 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-----------HDVSQGRREL----DW 351
H+N++ L T+ ++ E+ G+L++ L ++ +Q E D
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 352 LA-RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
++ Y++ARGM EYL + CI HRD+ NVL+ + +I+DFGLA+ +
Sbjct: 143 VSCAYQVARGM----EYLA--SKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
+ T ++APE + +SD++SFGVLL + +G P+
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 52/237 (21%)
Query: 234 KEDSLASLEIIGVGACGVVY----KAEVPGSYGKMIAIKKI-DQPPMAA-TELLNVRRVL 287
+ + + +G G+ G+VY K V G +AIK + + M E LN V
Sbjct: 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV- 62
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRR 347
M++ + LL + + L+V E M G L+ L + RR
Sbjct: 63 ----MKEFNCHHVV-------RLLGVVSTGQPT---LVVMELMAKGDLKSYL----RSRR 104
Query: 348 ELDWLAR----------YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397
++A +A G+ YL +HRD+ N ++ + + +I
Sbjct: 105 PEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161
Query: 398 DFGLAKLM-------PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
DFG+ + + G + + ++APE + + KSD++SFGV+L
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPVR-------WMAPESLKDGVFTTKSDVWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 52/208 (25%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRK-------MR 293
L IG G G V+KA + +++A+KK+ ++ N K +R
Sbjct: 17 LAKIGQGTFGEVFKARHKKT-KQIVALKKV---------------LMENEKEGFPITALR 60
Query: 294 QIKSEIITAGRIWHRNLLPL---------QAHVTRPDCHLLVYEFMKN---GSLQDILHD 341
+IK I+ + H N++ L + + +L V+EF ++ G L +
Sbjct: 61 EIK--ILQLLK--HENVVNLIEICRTKATPYNRYKGSFYL-VFEFCEHDLAGLLSNKNVK 115
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+ + ++ + + +GL Y+H R I+HRD+K AN+LI +++DFGL
Sbjct: 116 FTLSEIK-------KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL 165
Query: 402 AK--LMPDGHTRIRITTVAGTTGYVAPE 427
A+ + R T T Y PE
Sbjct: 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 39/215 (18%)
Query: 285 RVLINRKMRQIKSEIITAGRIWHRNLLP-LQAHVTRPDCHL-LVYEFMKNGSLQDILHDV 342
R L R+ Q+ E+ + H+N++ + + + + L ++ EF G L +
Sbjct: 49 RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108
Query: 343 SQGRRELDWLARYRIARGMASGLEYLH-MYHRPC---IIHRDIKPANVLIDDGME----- 393
+ +++ A I R + L Y H + P ++HRD+KP N+ + G+
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 394 ------------ARISDFGLAKLMPDGHTRIRITTVA----GTTGYVAPEY--HQTLTIS 435
A+I DFGL+K I I ++A GT Y +PE H+T +
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSK-------NIGIESMAHSCVGTPYYWSPELLLHETKSYD 221
Query: 436 EKSDIYSFGVLLAVLVVGKFPF---DDFFQYTEEM 467
+KSD+++ G ++ L GK PF ++F Q E+
Sbjct: 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 53/235 (22%), Positives = 93/235 (39%), Gaps = 56/235 (23%)
Query: 244 IGVGACGVVYKAE----VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
IG GA G V++A +P M+A+K + + A + + E
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-------------ADFQREA 59
Query: 300 ITAGRIWHRNLLPLQA--HVTRPDCHLLVYEFMKNGSLQDILHDVS-------------- 343
H N++ L V +P C L++E+M G L + L S
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 344 ----QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
L + IA+ +A+G+ YL +HRD+ N L+ + M +I+DF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 174
Query: 400 GLAKLM-------PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
GL++ + + I I ++ PE + +SD++++GV+L
Sbjct: 175 GLSRNIYSADYYKASENDAIPIR-------WMPPESIFYNRYTTESDVWAYGVVL 222
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKA-EVP-GSYGKM-IAIKKI--DQPPMAATELLNVRRV 286
+ KE L ++++G GA G VYK +P G K+ +AIK + + P A E+L+ V
Sbjct: 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 62
Query: 287 LINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH---DVS 343
M + S + LL + T LV + M G L D + D
Sbjct: 63 -----MAGVGSPYVC-------RLLGICLTSTVQ----LVTQLMPYGCLLDYVRENKDRI 106
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ L+W + IA+GM S LE + + +HRD+ NVL+ +I+DFGLA+
Sbjct: 107 GSQDLLNWCVQ--IAKGM-SYLEEVRL------VHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
L+ T ++A E + +SD++S+GV + ++ G P+D
Sbjct: 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 59/268 (22%), Positives = 101/268 (37%), Gaps = 78/268 (29%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
D SL++IG GA +G++ ++K D + A ++L +L ++ I
Sbjct: 1 DDFESLKVIGRGA------------FGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHI 48
Query: 296 KSE---IITAGRIW----------HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
++E ++ A W RNL L+ EF+ G + +L
Sbjct: 49 RAERDILVEADGAWVVKMFYSFQDKRNLY-------------LIMEFLPGGDMMTLL--- 92
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ D L+ +A + + H+ IHRDIKP N+L+D ++SDFGL
Sbjct: 93 ----MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148
Query: 403 KLMPDGH---------------------------------TRIRITTVAGTTGYVAPEYH 429
+ H R + GT Y+APE
Sbjct: 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVF 208
Query: 430 QTLTISEKSDIYSFGVLLAVLVVGKFPF 457
++ D +S GV++ +++G PF
Sbjct: 209 MQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 57/260 (21%), Positives = 104/260 (40%), Gaps = 62/260 (23%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ SL++IG GA +G++ ++K D + A ++L +L ++ I
Sbjct: 1 EDFESLKVIGRGA------------FGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHI 48
Query: 296 KSE---IITAGRIWHRNLL-PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
++E ++ A +W + Q + L+ EF+ G + +L + D
Sbjct: 49 RAERDILVEADSLWVVKMFYSFQDKLNL----YLIMEFLPGGDMMTLL-------MKKDT 97
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH-- 409
L +A + + H+ IHRDIKP N+L+D ++SDFGL + H
Sbjct: 98 LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157
Query: 410 --------------------------------TRIRITTVAGTTGYVAPEYHQTLTISEK 437
++ +TV GT Y+APE ++
Sbjct: 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKL 216
Query: 438 SDIYSFGVLLAVLVVGKFPF 457
D +S GV++ +++G PF
Sbjct: 217 CDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 31/103 (30%), Positives = 56/103 (54%), Gaps = 7/103 (6%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ A +A+G++YL IHRD+ NVL+ + + ++I+DFGL++ ++ T
Sbjct: 123 QFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKT 176
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
++A E + KSD++SFGVLL ++ +G P+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 41/239 (17%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL-DWLARYRIARGMASGL 365
H N+L +LLV EF G L++ L ++ R+A +ASGL
Sbjct: 54 HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL 113
Query: 366 EYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR----ITT--VAG 419
+LH IH D+ N + + +I D+GLA + IT A
Sbjct: 114 LWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLA------LEQYPEDYYITKDCHAV 164
Query: 420 TTGYVAPE----YHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
++APE Q L ++KS+I+S GV + L F Q +++ +
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQPYPDLSDEQV 218
Query: 473 MRNVISSEN---PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528
++ V+ ++ P +D K YE + FC DPE RP++++V +L+
Sbjct: 219 LKQVVREQDIKLPKPQLDLKYSDRWYE--------VMQFCWL-DPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 35/216 (16%)
Query: 324 LLVYEFMKNGSLQDILHDVSQGRR----ELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379
+++ FMK+G L L G L L R+ I +ASG+EYL + IHR
Sbjct: 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIASGMEYLSSKN---FIHR 137
Query: 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSD 439
D+ N ++++ M ++DFGL+K + G + ++A E + SD
Sbjct: 138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD 197
Query: 440 IYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQ 498
+++FGV + ++ G+ P+ V +SE I + L+ +Q
Sbjct: 198 VWAFGVTMWEIMTRGQTPY----------------AGVENSE-----IYNYLIKGNRLKQ 236
Query: 499 ----MRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ V ++ C S +P+ RPS + +R L I
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 29/103 (28%), Positives = 52/103 (50%), Gaps = 7/103 (6%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
A +A G++YL IHRD+ N+L+ + A+I+DFGL++ ++ T
Sbjct: 116 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKT 169
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
++A E + SD++S+GVLL ++ +G P+
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 45/232 (19%)
Query: 230 AFLTKEDSLASLEIIGVGACGVVYKA-EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLI 288
A + KE L L+++G G G V+K +P G I I P+A + +
Sbjct: 1 ARILKETELRKLKLLGSGVFGTVHKGIWIPE--GDSIKI------PVAI-------KTIQ 45
Query: 289 NRKMRQ----IKSEIITAGRIWHRNLLPLQAHVTR-----PDCHL-LVYEFMKNGSLQDI 338
+R RQ I ++ G + H A++ R P L LV + GSL D
Sbjct: 46 DRSGRQTFQEITDHMLAMGSLDH-------AYIVRLLGICPGASLQLVTQLSPLGSLLDH 98
Query: 339 LH---DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395
+ D +R L+W + IA+GM YL + ++HR++ N+L+ +
Sbjct: 99 VRQHRDSLDPQRLLNWCVQ--IAKGMY----YLEEH---RMVHRNLAARNILLKSDSIVQ 149
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
I+DFG+A L+ + + ++A E + +SD++S+GV +
Sbjct: 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 35/223 (15%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL------DWLARYRIARG 360
H ++ A D ++ E+ + L L ++ + L +W + +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
G+ Y+H I+HRD+K N+ + + + +I DFG+++L+ G + TT GT
Sbjct: 118 ---GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL-ATTFTGT 168
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y++PE + KSDI+S G +L + F E N + + ++
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-------EGQNFLSVVLRIVEGP 221
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
P L Y Q+ +++ + DP RPS+ ++
Sbjct: 222 TPS-------LPETYSRQLNSIMQSML---NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 62/229 (27%), Positives = 96/229 (41%), Gaps = 37/229 (16%)
Query: 241 LEIIGVGACGVVYKA-EVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298
L+++G GA G V+ +V G GK+ A+K + + AT + + R RQ+
Sbjct: 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKK----ATIVQKAKTTEHTRTERQVLEH 60
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
I + P L Y F + L IL ++ G R R
Sbjct: 61 IRQS-----------------PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK 103
Query: 359 RG--------MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
+ LE+LH + II+RDIK N+L+D ++DFGL+K +
Sbjct: 104 EQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160
Query: 411 RIRITTVAGTTGYVAPE-YHQTLTISEKS-DIYSFGVLLAVLVVGKFPF 457
R + GT Y+AP+ +K+ D +S GVL+ L+ G PF
Sbjct: 161 E-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 12/106 (11%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+++A+GM E+L R CI HRD+ N+L+ + +I DFGLA+ + +R
Sbjct: 186 FQVAKGM----EFLA--SRKCI-HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238
Query: 415 TTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
++APE + + TI +SD++SFGVLL + +G P+
Sbjct: 239 GDARLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 52/236 (22%), Positives = 103/236 (43%), Gaps = 23/236 (9%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++GK+ + + +AA ++++ + ++ EI H N++ L
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
+ ++ EF G++ ++ ++ + L +I LE L+ H IIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERP------LTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE-- 436
RD+K N+L + +++DFG++ + T R + GT ++APE T +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 437 ---KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSK 489
K+D++S G+ L + + P E+N +R + + SE P A S+
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPH-------HELNPMRVLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 61/235 (25%), Positives = 104/235 (44%), Gaps = 55/235 (23%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS--- 297
L I G GVVY+A G+++A+KK+ KM + K
Sbjct: 10 LNRIEEGTYGVVYRA-RDKKTGEIVALKKL--------------------KMEKEKEGFP 48
Query: 298 -----EIITAGRIWHRNLLPLQAHV--TRPDCHLLVYEFMKNGSLQDILHDVSQGRR--E 348
EI ++ H N++ ++ V + D +V E++++ L+ ++ + Q E
Sbjct: 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE 107
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
+ L ++ G+A H+ H I+HRD+K +N+L+++ +I DFGLA+ G
Sbjct: 108 VKCLM-LQLLSGVA------HL-HDNWILHRDLKTSNLLLNNRGILKICDFGLAREY--G 157
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGK--FP 456
T + T Y APE L + K D++S G + A L+ K FP
Sbjct: 158 SPLKPYTQLVVTLWYRAPE----LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 39/170 (22%), Positives = 78/170 (45%), Gaps = 21/170 (12%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K ++ L+ +G G V+K + ++A+K+I +R V + + ++
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLK 61
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
H N++ L + C LV+E++ + L+ L + + ++
Sbjct: 62 -------------HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG------NLMS 101
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + M L L H+ I+HRD+KP N+LI++ E +++DFGLA+
Sbjct: 102 MHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 43/172 (25%), Positives = 82/172 (47%), Gaps = 34/172 (19%)
Query: 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKM 292
LE IG G G V+KA+ + +++A+K++ + P +A +R + + +++
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVPSSA-----LREICLLKEL 56
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDW 351
+ H+N++ L V D L LV+E+ QD+ ++D
Sbjct: 57 K-------------HKNIVRLY-DVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDP 98
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ GL + H ++ ++HRD+KP N+LI+ E +++DFGLA+
Sbjct: 99 EIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
GL Y H ++HRD+KP N+LI + E +++DFGLA+
Sbjct: 115 GLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 35/104 (33%), Positives = 60/104 (57%), Gaps = 10/104 (9%)
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRITTVAG 419
+A+G+E+L + C+ HRD+ NVLI +G +I DFGLA+ +M D + + +T
Sbjct: 248 VANGMEFLA--SKNCV-HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303
Query: 420 TTGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
++APE ++ T SD++SFG+LL + +G P+ +
Sbjct: 304 PLKWMAPESIFNNLYTTL--SDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 32/122 (26%), Positives = 48/122 (39%), Gaps = 36/122 (29%)
Query: 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT--------------------- 410
H+ IHRDIKP N+L+D ++SDFGL + H
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 411 ---------------RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF 455
R + GT Y+APE +++ D +S GV++ ++VG
Sbjct: 178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237
Query: 456 PF 457
PF
Sbjct: 238 PF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 39/179 (21%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K ++ LE +G G V+K + ++A+K+I +R V + + ++
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKN---------GSLQDILHDVSQ 344
H N++ L V LV+E++ G++ + H+V
Sbjct: 63 -------------HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM-HNVK- 107
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ Y+I RG+A HR ++HRD+KP N+LI++ E +++DFGLA+
Sbjct: 108 -------IFLYQILRGLA-------YCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 3/101 (2%)
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
I R + L YLH IIHRD+K N+ +D+ A + DFG A + +
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
+GT +PE K+DI+S G++L + V
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 285 RVLINRKMRQIKSEIITAGRIWHRNLLPLQAH---VTRPDCHLLVYEFMKNGSLQDILHD 341
+VL N + ++ E++ I H+ P V + +LV E G L L
Sbjct: 28 KVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL-- 85
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
S + E+ + ++ G++YL + +HRD+ NVL+ + A+ISDFGL
Sbjct: 86 -SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGL 141
Query: 402 AKLM--PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+K + D + + R + + APE S +SD++S+G+ +
Sbjct: 142 SKALGADDSYYKAR-SAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 244 IGVGACGVVYKAEVP-GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G G G VYKA+ G + A+K+I+ ++ + R + + R+++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA---CREIALLRELK--------- 56
Query: 303 GRIWHRNLLPLQ----AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
H N++ LQ +H R L Y + D+ H + R ++
Sbjct: 57 ----HPNVISLQKVFLSHADRKVWLLFDY------AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 359 RGMASGLEY-----LHMYHRPCIIHRDIKPANVLI-DDGME---ARISDFGLAKLMPDGH 409
RGM L Y +H H ++HRD+KPAN+L+ +G E +I+D G A+L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 410 TRIR-ITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGK 454
+ + V T Y APE H T I DI++ G + A L+ +
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 59/302 (19%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKM------IAIK--KIDQPPMAATELLNVRRVLINRKMR 293
IG G G VY+ G Y +A+K K P + E + MR
Sbjct: 12 RCIGEGQFGDVYQ----GVYMSPENEKIAVAVKTCKNCTSP-SVREKFLQEAYI----MR 62
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
Q H +++ L +T + V E G L+ L + LD +
Sbjct: 63 QFD----------HPHIVKLIGVITENPVWI-VMELAPLGELRSYL---QVNKYSLDLAS 108
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ +++ L YL +HRDI NVL+ ++ DFGL++ + D + +
Sbjct: 109 LILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYK 164
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRW 472
+ ++APE + SD++ FGV + +L++G PF +
Sbjct: 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-------------QG 211
Query: 473 MRN--VISS-ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529
++N VI EN R M C + DP +RP +++ LS
Sbjct: 212 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSKRPRFTELKAQLSD 264
Query: 530 IK 531
I
Sbjct: 265 IL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
S +LE +G G+ VYK + G+++A+K I +R + + ++
Sbjct: 6 SYLNLEKLGEGSYATVYKG-ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK--- 61
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD----WL 352
H N++ L + + V+E+M D+ + Q L L
Sbjct: 62 ----------HANIVLLHDIIHTKETLTFVFEYMHT----DLAQYMIQHPGGLHPYNVRL 107
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+++ RG+A Y+H H I+HRD+KP N+LI E +++DFGLA+
Sbjct: 108 FMFQLLRGLA----YIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 34/128 (26%), Positives = 62/128 (48%), Gaps = 7/128 (5%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
L+ EF+ +GSL++ L + + +++ + + A + G++YL +HRD+
Sbjct: 85 LIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAAR 138
Query: 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRIT-TVAGTTGYVAPEYHQTLTISEKSDIYSF 443
NVL++ + +I DFGL K + + + + APE SD++SF
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198
Query: 444 GVLLAVLV 451
GV L L+
Sbjct: 199 GVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL---DWLARYRIARGMAS 363
H NLL T +LLV EF G L+ L S + EL D R+A +A
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR--SCRKAELMTPDPTTLQRMACEIAL 111
Query: 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGY 423
GL LH+ H+ IH D+ N L+ + +I D+GL+ + + +
Sbjct: 112 GL--LHL-HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 424 VAPEY----HQTLTI---SEKSDIYSFGVLLAVLV-VGKFPFDDFFQYTEEMNMVRWMRN 475
+APE H L + +++S+++S GV + L +G P+ ++E + +R
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR---HLSDEQVLTYTVR- 224
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRL---VLKIAY---------FCTSDDPEERPSSKDV 523
E+Q++L LK+ FC PE+RPS+++V
Sbjct: 225 --------------------EQQLKLPKPRLKLPLSDRWYEVMQFCWL-QPEQRPSAEEV 263
Query: 524 RCMLS 528
+LS
Sbjct: 264 HLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
IIG G+ GVVY+A + + +AIKK+ Q P L + + L + + +K T
Sbjct: 73 IIGNGSFGVVYEA-ICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYT- 130
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMK-----NGSLQDILHDVSQGRRELDWLARYRI 357
+ +N + +V V+++MK N +L L L Y++
Sbjct: 131 -ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK----------LYSYQL 179
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA-RISDFGLAKLMPDGHTRIRITT 416
R +A Y+H I HRD+KP N+LID ++ DFG AK + G R +
Sbjct: 180 CRALA----YIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVS 229
Query: 417 VAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVG 453
+ Y APE T + D++S G ++A +++G
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 37/178 (20%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K ++ L+ +G G VYK + ++A+K+I +R V + + ++
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLT-DNLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDI--------LHDVSQG 345
H N++ L + LV+E++ Q + +H+V
Sbjct: 63 -------------HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-- 107
Query: 346 RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
L +++ RG L+ HR ++HRD+KP N+LI++ E +++DFGLA+
Sbjct: 108 ------LFLFQLLRG-------LNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 40/184 (21%)
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
Y++A+GM+ + + CI HRD+ N+L+ G +I DFGLA+ + + +
Sbjct: 221 YQVAKGMS------FLASKNCI-HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWM 473
++APE + +SD++S+G+LL + +G P+
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY---------------- 317
Query: 474 RNVISSENPHRAIDS---KLLGNGY-----EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525
P +DS K++ GY E + I C DP +RP+ K +
Sbjct: 318 --------PGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
Query: 526 MLSQ 529
++ Q
Sbjct: 370 LIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 18/193 (9%)
Query: 279 ELLNVRRVLI----NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGS 334
E + VRR+ + N + ++ E+ + H N++P +A + +V FM GS
Sbjct: 26 EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 85
Query: 335 LQD-ILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393
+D I G EL A I +G+ L+Y+H +HR +K +++LI +
Sbjct: 86 AKDLICTHFMDGMSEL---AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGK 139
Query: 394 ARISDFGLAKLMPDGHTRIRIT-----TVAGTTGYVAPE-YHQTLT-ISEKSDIYSFGVL 446
+S M + R+R+ +++PE Q L KSDIYS G+
Sbjct: 140 VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199
Query: 447 LAVLVVGKFPFDD 459
L G PF D
Sbjct: 200 ACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 34/225 (15%)
Query: 244 IGVGACGVVYKAEVP-GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G G G VYKA+ G K A+K+I+ ++ + R + + R+++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA---CREIALLRELK--------- 56
Query: 303 GRIWHRNLLPLQ-AHVTRPDCHL-LVYEFMKNGSLQDI-LHDVSQGRRELDWLARYRIAR 359
H N++ LQ ++ D + L++++ ++ I H S+ ++ L R +
Sbjct: 57 ----HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKS 112
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI-DDGME---ARISDFGLAKLMPDGHTRIR-I 414
+ L+ +H H ++HRD+KPAN+L+ +G E +I+D G A+L + +
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172
Query: 415 TTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGK 454
V T Y APE H T I DI++ G + A L+ +
Sbjct: 173 DPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE 366
H N++ L L E+ +G+L D L + R L+ + IA AS L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLS 122
Query: 367 YLHMYH-------------RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ H + IHRD+ N+L+ + A+I+DFGL++ ++
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 179
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
T ++A E + SD++S+GVLL ++ +G P+
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 18/31 (58%), Positives = 23/31 (74%)
Query: 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
H+ IHRDIKP N+LID G ++SDFGL+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 3/101 (2%)
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
R L +AR + S ++Y+H IIHRDIK NVL++ + + DFG A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ +AGT APE + DI+S G+++
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352
|
Length = 461 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 53/240 (22%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE 366
H N+L +LLV+E+ + G L+ L RR L R+A +A+G+
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVT 113
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR---ITT---VAGT 420
++H ++ +H D+ N + + ++ D+G+ G +R + I T
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI------GPSRYKEDYIETEDDKCVP 164
Query: 421 TGYVAPE----YHQTLTISEK---SDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
++APE +H L +E+ S++++ GV L L F++ Q ++ +
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQPYSHLSDREVL 218
Query: 474 RNVISSEN-----PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528
+VI + P L Y E+ VL+ + PE+R ++++V +L+
Sbjct: 219 NHVIKDQQVKLFKPQ-------LELPYSERWYEVLQFCWL----SPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 4/109 (3%)
Query: 346 RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM 405
+R + I R + ++YLH IIHRDIK N+ I+ + + DFG A
Sbjct: 176 KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFG-AACF 231
Query: 406 PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454
P + AGT APE DI+S G++L +
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 38/233 (16%)
Query: 243 IIGVGACGVVYKAEV-----PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKS 297
+G GA G VY+ PGS +A+K + R+ +++ ++
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-------------RKGATDQEKKEFLK 48
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE------LDW 351
E H N++ L + ++ E M+ G D+L + R E L
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGG---DLLSYLRDARVERFGPPLLTL 105
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID--DGMEAR---ISDFGLAK-LM 405
I +A G YL H IHRD+ N L+ R I DFGLA+ +
Sbjct: 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
Query: 406 PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPF 457
+ R + ++APE + +SD++SFGVL+ +L +G+ P+
Sbjct: 163 KSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 10/89 (11%)
Query: 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379
P C + EFM G + I ++ Q +R+++ + + R + +GL LH R I+HR
Sbjct: 284 PGC---LEEFMMAG--KKIPDNMPQDKRDINVIKG--VMRQVLTGLRKLH---RIGIVHR 333
Query: 380 DIKPANVLIDDGMEARISDFGLAKLMPDG 408
DIKP N+L+ + +I DFG A M G
Sbjct: 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTG 362
|
Length = 507 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 20/225 (8%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKM----IAIKKIDQPPMAATELLNVRRVLINRK 291
L E +G G G V+ E G M +QP + A ++L R N+
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML---REDANKN 61
Query: 292 MRQ-IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL--HD-----VS 343
R EI R+ N++ L A D ++ E+M+NG L L H+
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + +A +ASG++YL + +HRD+ N L+ +I+DFG+++
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 404 LMPDG-HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
+ G + RI+ V +++ E + SD+++FGV L
Sbjct: 179 NLYSGDYYRIQGRAVLPIR-WMSWESILLGKFTTASDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 12/146 (8%)
Query: 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYL 368
N++ L ++ D LV + + G L H + + R+ A M L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWS--HISKFLNIPEECVKRW--AAEMVVALDAL 101
Query: 369 HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEY 428
H R I+ RD+ P N+L+DD +++ F + D + + Y APE
Sbjct: 102 H---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEV 153
Query: 429 HQTLTISEKSDIYSFGVLLAVLVVGK 454
+E D +S G +L L+ GK
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 7e-04
Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 20/224 (8%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL-----INRK 291
L +E +G G G V+ E G + A +L +VL N +
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAEND--NADAPVLVAVKVLRPDASDNAR 63
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-------DVSQ 344
+K E+ R+ N+ L T ++ E+M+NG L L ++
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK- 403
+ L + +A +ASG+ YL + +HRD+ N L+ +I+DFG+++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
L + R++ ++A E + KSD+++FGV L
Sbjct: 180 LYSSDYYRVQGRAPLPIR-WMAWESVLLGKFTTKSDVWAFGVTL 222
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 9/130 (6%)
Query: 324 LLVYEFMKNGSLQDILHDV------SQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
L+V E M +G L+ L + + GR ++A +A G+ YL+ +
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FV 141
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
HRD+ N ++ +I DFG+ + + + + ++APE + +
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS 201
Query: 438 SDIYSFGVLL 447
SD++SFGV+L
Sbjct: 202 SDMWSFGVVL 211
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 20/78 (25%), Positives = 33/78 (42%), Gaps = 13/78 (16%)
Query: 340 HDVSQGRRELDWLARYRIAR----GMASGLEYLHMY---------HRPCIIHRDIKPANV 386
+ +GR+ W YR A+ G + L + P ++H D +P N+
Sbjct: 151 PNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNL 210
Query: 387 LIDDGMEARISDFGLAKL 404
+ID G + D+ LA L
Sbjct: 211 IIDPGRPTGVLDWELATL 228
|
Length = 321 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.9 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.61 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.56 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.04 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.24 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.06 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.54 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.38 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.27 | |
| PLN02236 | 344 | choline kinase | 96.09 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.65 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.46 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.42 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.25 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.71 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.6 | |
| PF05659 | 147 | RPW8: Arabidopsis broad-spectrum mildew resistance | 94.3 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.14 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.69 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.66 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=442.35 Aligned_cols=277 Identities=37% Similarity=0.628 Sum_probs=244.4
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++++|...+.||+|+||.||+|.+. +|..||||++...... . ..+|.+|+.++++++|||+|+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~--~~~~vAVK~~~~~~~~-------------~-~~eF~~Ei~~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLS--DGTVVAVKRLSSNSGQ-------------G-EREFLNEVEILSRLRHPNLVK 135 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEEC--CCCEEEEEEecCCCCc-------------c-hhHHHHHHHHHhcCCCcCccc
Confidence 57899999999999999999999998 5689999988876421 1 356999999999999999999
Q ss_pred ceeEEecCC-ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
|+|||.+.+ +.+||||||++|||.++|+..... +++|..|++|+.++|+||+|||....++||||||||+|||||++
T Consensus 136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~ 213 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED 213 (361)
T ss_pred EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence 999999998 499999999999999999973222 89999999999999999999999998899999999999999999
Q ss_pred CcEEEeccCCcccCCC-CCcceeeecc-ccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPD-GHTRIRITTV-AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+++||+|||+|+..+. .... ... .||.+|+|||+...+..+.|+||||||++++|++||+.|.+.... .....+
T Consensus 214 ~~aKlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l 289 (361)
T KOG1187|consen 214 FNAKLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSL 289 (361)
T ss_pred CCEEccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccH
Confidence 9999999999977665 3222 122 899999999999999999999999999999999999998876442 344559
Q ss_pred HHHHHHHhccCCCccccccccc-CCCcH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLL-GNGYE-EQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+|.+..+..+...+++|+.+. ..+.. .++..+..++..|++.+|..||+|.+|+++|+.+.
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 9999999999999999999987 44444 68999999999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=392.98 Aligned_cols=260 Identities=33% Similarity=0.500 Sum_probs=214.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcE-EEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKM-IAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
.+.+...+.||+|+||+||+|.|+ |+. ||||++........ ....|.+|+.+|++++|||||++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~------------~~~~f~~E~~il~~l~HpNIV~f 104 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDE------------SRKAFRREASLLSRLRHPNIVQF 104 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChH------------HHHHHHHHHHHHHhCCCCCeeeE
Confidence 345566677999999999999998 555 99999988654321 16789999999999999999999
Q ss_pred eeEEecCC-ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+|.|.++. ..++|||||++|+|.++++.. ....+++..+++++.+||+||.|||+.+. ||||||||+|||++.++
T Consensus 105 ~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 105 YGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKG 180 (362)
T ss_pred EEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCC
Confidence 99999987 799999999999999999863 46789999999999999999999999764 99999999999999998
Q ss_pred -cEEEeccCCcccCCCCCcceeeeccccccccccccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 -EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ--TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
++||+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... ...
T Consensus 181 ~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~ 254 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQV 254 (362)
T ss_pred CEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHH
Confidence 99999999998765532 2225578999999999999 56899999999999999999999999987433 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.......+.. ...+..+...+..++..||+.||..||++.+++..|+.+.
T Consensus 255 ---~~~v~~~~~R---------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 255 ---ASAVVVGGLR---------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred ---HHHHHhcCCC---------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1122211111 1112225556888888999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=371.01 Aligned_cols=254 Identities=30% Similarity=0.449 Sum_probs=217.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+++.+..||+|..|+|||+.++.+ ++.+|+|++..... ....+++.+|++++++.+||+||.++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t-~~i~AlK~I~~~~~-------------~~~~~Qi~rEl~il~~~~spyIV~~yg 144 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPT-GKIYALKVILLNID-------------PALQKQILRELEILRSCQSPYIVGFYG 144 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCC-CeEEEEEeecccCC-------------HHHHHHHHHHHHHHhhCCCCCeeeEeE
Confidence 3677788999999999999999876 99999999955422 334578899999999999999999999
Q ss_pred EEecCCc-eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRPDC-HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.|..++. ..|+||||.+|||++++... +.+++...-+|+.++++||.|||. .+ ||||||||+|||++..|+
T Consensus 145 aF~~~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGe 217 (364)
T KOG0581|consen 145 AFYSNGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGE 217 (364)
T ss_pred EEEeCCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCC
Confidence 9999994 99999999999999999763 569999999999999999999996 66 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||||||.++...+... .+.+||..|||||.+++..|+.++||||||++++|+.+|+.||... ......+.+.+
T Consensus 218 VKicDFGVS~~lvnS~a----~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll 291 (364)
T KOG0581|consen 218 VKICDFGVSGILVNSIA----NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELL 291 (364)
T ss_pred EEeccccccHHhhhhhc----ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHH
Confidence 99999999998766522 6789999999999999999999999999999999999999999764 12345666666
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.+..+.- ..+ ....++..++..|+++||.+|||+.++++
T Consensus 292 ~~Iv~~ppP~l------P~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEPPPRL------PEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCCCCCC------Ccc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 66665544321 111 24456888999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=389.43 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=218.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+.+..++.||+|.||.||.|.+++ ...||+|.++..... .+.|.+|+.+|++|+|+|||+
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~--~~~vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV~ 265 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNG--STKVAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLVK 265 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcC--CCcccceEEeccccC---------------hhHHHHHHHHHHhCcccCeEE
Confidence 345668889999999999999999983 458999999886332 367889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
|+|+|..++.+|||||||++|||.++|+. ..+..++..+.+.++.|||+|++||++++ +|||||.++||||++++
T Consensus 266 l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~ 340 (468)
T KOG0197|consen 266 LYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDL 340 (468)
T ss_pred EEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCc
Confidence 99999999999999999999999999986 56778999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||||+...++....+ ....-+..|.|||.+..+.++.+||||||||+||||+| |+.||+.+.. .+
T Consensus 341 ~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------~e 412 (468)
T KOG0197|consen 341 VVKISDFGLARLIGDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------EE 412 (468)
T ss_pred eEEEcccccccccCCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------HH
Confidence 999999999996555543322 33445678999999999999999999999999999999 9999976543 23
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.++.+-.+.+.+ .++.++..+.+++..||+.+|++|||++.+...|+++.
T Consensus 413 v~~~le~GyRlp----------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 413 VLELLERGYRLP----------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HHHHHhccCcCC----------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 333333333222 12345667899999999999999999999999998874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=358.59 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=216.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|.++++||.|+||+||++....+ |..+|.|.++-.... .........|+.+|++|+|||||+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~-g~l~a~K~i~f~~md------------~k~rq~~v~Ei~lLkQL~HpNIVqYy 84 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLD-GKLVALKKIQFGMMD------------AKARQDCVKEISLLKQLNHPNIVQYY 84 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccC-cchhhhhhcchhhcc------------HHHHHHHHHHHHHHHhcCCchHHHHH
Confidence 34699999999999999999988764 999999999865433 44567888999999999999999999
Q ss_pred e-EEecCCc-eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCcEEecCC
Q 037084 315 A-HVTRPDC-HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRP-CIIHRDIKPANVLIDDG 391 (532)
Q Consensus 315 ~-~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~-~ivH~Dlkp~NIll~~~ 391 (532)
+ .+.+.+. ++||||||.+|+|...++..+..++.+++..+|+++.|++.||.++|+..+. .|+||||||.||+|+.+
T Consensus 85 ~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~ 164 (375)
T KOG0591|consen 85 AHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN 164 (375)
T ss_pred HHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC
Confidence 9 4444444 8999999999999999999888899999999999999999999999995322 39999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
|.+|++||||++.+....... ...+|||.||+||.+....|+.+|||||+||++|||+.-++||... ++.+
T Consensus 165 gvvKLGDfGL~r~l~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~ 235 (375)
T KOG0591|consen 165 GVVKLGDFGLGRFLSSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLS 235 (375)
T ss_pred CceeeccchhHhHhcchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHH
Confidence 999999999999987764433 6789999999999999999999999999999999999999999753 3344
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
....+.+. +.+. + ...-.+..+..|+..|+.+||+.||+...++..
T Consensus 236 L~~KI~qg-d~~~-----~---p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 236 LCKKIEQG-DYPP-----L---PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred HHHHHHcC-CCCC-----C---cHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 33333333 2211 1 113455668888889999999999985444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=382.73 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=213.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
..|...+.||+|||+.||.++...+ |+.||+|++....... ....+...+|+++.++|+|||||++++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~t-ge~~A~KvVpk~~l~k-----------~~~reKv~~EIeIHr~L~HpnIV~f~~ 85 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDT-GEVVAVKVVPKKLLKK-----------PKQREKVLNEIEIHRSLKHPNIVQFYH 85 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCC-CcEEEEEEeehHHhcC-----------cchHHHHHHHHHHHHhcCCCcEEeeee
Confidence 5689999999999999999998554 9999999998753221 455678899999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|++.+..|||.|+|++++|..+++. ++++++..+..++.||+.||.|||+.+ |+|||||..|++|+++.++|
T Consensus 86 ~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 86 FFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEE
Confidence 99999999999999999999999874 678999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||||..+....... .+.+|||.|.|||++.....+..+||||+|||||-||.|++||+...- .+-...
T Consensus 159 IgDFGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-------kety~~ 229 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-------KETYNK 229 (592)
T ss_pred ecccceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-------HHHHHH
Confidence 99999999987654332 678999999999999999999999999999999999999999986322 122222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+...+.. .+........+|+..+|++||.+|||+++|++
T Consensus 230 Ik~~~Y~-----------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 230 IKLNEYS-----------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhcCcc-----------cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2111111 11233445888999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=363.06 Aligned_cols=203 Identities=32% Similarity=0.490 Sum_probs=183.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-.+|...+.||+|+||+||+|+++.+ +..||||.+...... ....+.+..|+.+|+.++|||||.|+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~-~~~VAIK~i~~~~l~------------~k~~e~L~~Ei~iLkel~H~nIV~l~ 75 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKS-GTEVAIKCIAKKKLN------------KKLVELLLSEIKILKELKHPNIVRLL 75 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccC-CceEEeeeehhhccC------------HHHHHHHHHHHHHHHhcCCcceeeEE
Confidence 35688888899999999999999976 799999999876422 34456788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC---
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG--- 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~--- 391 (532)
+++..++..|||||||.||+|.++++. ++.+++.....++.|+|.||++||+.+ ||||||||.||||+.+
T Consensus 76 d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~ 148 (429)
T KOG0595|consen 76 DCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARN 148 (429)
T ss_pred EEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCC
Confidence 999999999999999999999999986 447999999999999999999999999 9999999999999865
Q ss_pred ---CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 392 ---MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 392 ---~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
-.+||+|||+|+.+..+... .+.+|++-|||||++..+.|+.|+|+||+|+++|++++|+.||+..
T Consensus 149 ~~~~~LKIADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 149 DTSPVLKIADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CCCceEEecccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 46899999999998765433 5789999999999999999999999999999999999999999853
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=365.64 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=206.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|.+.+.||+|+||.|-+|..+.+ |+.||||+++......... .........+|+++|.+|+|||||++++
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~t-gk~vAiKIi~krk~~~~s~-------~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKT-GKQVAIKIINKRKSTGCSR-------AIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEccc-CcEEEeeeeehhhcccccc-------cccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 4578889999999999999987765 9999999998753222110 0111234679999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC---C
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG---M 392 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 392 (532)
++..++..||||||++||+|.+++-. .+.+.+..-.-+++|++.|+.|||++| |+||||||+|||+..+ .
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence 99999999999999999999999975 345666667889999999999999999 9999999999999766 7
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.+||+|||+|+..+... .+.+.+||+.|.|||++.+.. +..++|+||+||++|-+++|.+||.+..... .+
T Consensus 317 llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---sl 390 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---SL 390 (475)
T ss_pred EEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---cH
Confidence 89999999999877443 237899999999999987664 3348899999999999999999998644321 11
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+ + +..+... +. +....+..++.++++.+||..||++|||+.|+++
T Consensus 391 ~e---Q-I~~G~y~--f~----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 KE---Q-ILKGRYA--FG----PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HH---H-HhcCccc--cc----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11 1 1112211 11 1234456778999999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.80 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=210.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|+.+.++|+|+||+||+++++.+ |+.||||++..+... ....+-..+|+++|++++|||+|.|+.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~T-gqIVAIKkF~Esedd------------~~VkKIAlREIrmLKqLkH~NLVnLiE 68 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDT-GQIVAIKKFVESEDD------------PVVKKIALREIRMLKQLKHENLVNLIE 68 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCc-ccEEEEEeeccCCcc------------HHHHHHHHHHHHHHHhcccchHHHHHH
Confidence 3577888999999999999999876 999999999877533 223456778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|.....++||+|||+. ++.+-|..+ ...++.....+++.|++.|+.|+|+++ +|||||||+|||++.+|.+|
T Consensus 69 VFrrkrklhLVFE~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 69 VFRRKRKLHLVFEYCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVK 141 (396)
T ss_pred HHHhcceeEEEeeecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEE
Confidence 99999999999999976 444444432 344788889999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH---
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR--- 471 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~--- 471 (532)
+||||+|+........ .+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+-|.+....+.-..+..
T Consensus 142 LCDFGFAR~L~~pgd~--YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 142 LCDFGFARTLSAPGDN--YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred eccchhhHhhcCCcch--hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 9999999988754332 377899999999998887 6799999999999999999999999976433211111111
Q ss_pred ----HHHHHhcc-CC-----CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 ----WMRNVISS-EN-----PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ----~~~~~~~~-~~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.-..+... +. .++.-+++-....++....-+++++..|++.||++|++-++++.
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 11 22222333333345556667999999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=349.43 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=206.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|+++++||+|+||.||.++.+++ ++.+|+|+++...... ....+...+|..+|.+++||.||++
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt-~kiYAmKvl~K~~iv~-----------~~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDT-GKIYAMKVLKKKKIVE-----------KKEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEccc-CceeehhhhhhhHhhh-----------hhhHHHHHHHHHHHHhCCCCcEeee
Confidence 356899999999999999999998865 9999999998764322 3346778899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+-.|++++.+|+|+||+.||.|..+|.+ ...+++..+.-++..|+.||.|||+.+ ||||||||+|||||.+|+
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GH 163 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGH 163 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCc
Confidence 9999999999999999999999999975 456889988899999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+||||++..-...... .+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||..... ..+.
T Consensus 164 i~LtDFgL~k~~~~~~~~t--~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~ 234 (357)
T KOG0598|consen 164 IKLTDFGLCKEDLKDGDAT--RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMY 234 (357)
T ss_pred EEEeccccchhcccCCCcc--ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHH
Confidence 9999999999654443322 568999999999999999999999999999999999999999976432 3344
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP 518 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 518 (532)
+.......+ ..+.-......+++...++.||++|.
T Consensus 235 ~~I~~~k~~----------~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 DKILKGKLP----------LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHHhcCcCC----------CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 444333200 00111223477888899999999996
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=378.79 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=219.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
+..+....+.||+|+||.||+|+..+- +...||||.++.... .+...+|++|+++++.++|||
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-------------~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-------------NQARQDFRREAELLAELQHPN 550 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-------------HHHHHHHHHHHHHHHhccCCC
Confidence 456677889999999999999987532 235799999998753 335689999999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------G----RRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
||+|+|.|.+++.+|+|+|||..|+|.+||..... . ..+++..+.+.|+.|||.|+.||-+++ +|||
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHR 627 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHR 627 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---cccc
Confidence 99999999999999999999999999999986432 1 334899999999999999999999999 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||..+|+||.++..|||+||||++.....++........-+++|||||.+.+++||++||||||||+|||+++ |+.||.
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999999999997655443322123445789999999999999999999999999999999 999998
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.... ...++.++ .++. -+-+++++.+++.|+..||+.+|.+||+++||-..|+..
T Consensus 708 glSn----~EVIe~i~----~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 708 GLSN----QEVIECIR----AGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ccch----HHHHHHHH----cCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 7544 22222222 2222 123456778899999999999999999999999999865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.10 Aligned_cols=266 Identities=26% Similarity=0.343 Sum_probs=210.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|+.+++||+|+||.||+|++..+ |+.||+|+++.+... +....-..+||.+|++|.||||++|.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~t-gkivALKKvr~d~~~------------~~~~~t~~REI~ILr~l~HpNIikL~ 182 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLET-GKIVALKKVRFDNEK------------EGFPITAIREIKILRRLDHPNIIKLE 182 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeeccc-CcEEEEEEeecccCC------------CcchHHHHHHHHHHHhcCCCccccee
Confidence 45799999999999999999998765 999999999877532 22234567899999999999999999
Q ss_pred eEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+...+. +.+|||+|||++ +|..++.. ..-.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|
T Consensus 183 eivt~~~~~siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G 255 (560)
T KOG0600|consen 183 EIVTSKLSGSIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNG 255 (560)
T ss_pred eEEEecCCceEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCC
Confidence 999887 689999999965 88888863 4567999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||||+++...... ..+..+.|.+|+|||++.+. .|+...|+||.|||+.||++|++.|+...+.+. ..
T Consensus 256 ~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ----l~ 330 (560)
T KOG0600|consen 256 VLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ----LH 330 (560)
T ss_pred CEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH----HH
Confidence 9999999999987655432 24788999999999988776 699999999999999999999999987544222 12
Q ss_pred HHHHHhccCCCcc----------ccccc-----ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHR----------AIDSK-----LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~----------~~d~~-----l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
-+-.++....... .+.+. ...+.........++|+..+|..||++|.|+.+++.
T Consensus 331 kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 331 KIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 2222222111110 00000 000111223456888999999999999999998874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=360.66 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=215.4
Q ss_pred cccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
....+.+.+.+.||+|.||+||+|.|.+ .||||+++..... ....+.|++|+..+++-+|.||+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt------------~~qlqaFKnEVa~lkkTRH~NIl 451 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPT------------PEQLQAFKNEVAVLKKTRHENIL 451 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc----ceEEEEEecCCCC------------HHHHHHHHHHHHHHhhcchhhhe
Confidence 4456678889999999999999999974 5999999887654 34678999999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
-+.|||.++.. .||+.+|+|.||+.++|- .+..++..+...|+.|+++|+.|||.++ |||||||..||++.++
T Consensus 452 LFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~ 524 (678)
T KOG0193|consen 452 LFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHED 524 (678)
T ss_pred eeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccC
Confidence 99999999877 999999999999999995 3466889999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.|||+||||+................|...|||||++..+ +|+..+||||||+|+|||+||..||.........
T Consensus 525 ~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-- 602 (678)
T KOG0193|consen 525 LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-- 602 (678)
T ss_pred CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--
Confidence 99999999999876655433333566788899999988754 6899999999999999999999999842221000
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
| .+..+... .|. ......++..+.+|+..||..++++||.+.+|+..|+++.
T Consensus 603 ---f---mVGrG~l~--pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 603 ---F---MVGRGYLM--PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred ---E---EecccccC--ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 0 01111100 011 1123456667888889999999999999999999887753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.45 Aligned_cols=266 Identities=25% Similarity=0.362 Sum_probs=207.7
Q ss_pred cccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
+.++|.+.+.||+|+||.||+|.+. ..++..||||++..... ......+.+|+.++.++ +||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~ 71 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-------------ASEHKALMSELKILIHIGNHL 71 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-------------hHHHHHHHHHHHHHHHhccCc
Confidence 4578999999999999999999753 22357899999975421 22245688999999999 899
Q ss_pred CcccceeEEecCC-ceEEEEEeccCCCHHHHHhhhcC-------------------------------------------
Q 037084 309 NLLPLQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQ------------------------------------------- 344 (532)
Q Consensus 309 niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------- 344 (532)
||++++++|...+ ..++||||+++|+|.+++.....
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (338)
T cd05102 72 NVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQP 151 (338)
T ss_pred ceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccc
Confidence 9999999987654 57899999999999999975321
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCC
Q 037084 345 ---------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409 (532)
Q Consensus 345 ---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 409 (532)
...++++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~ 228 (338)
T cd05102 152 STSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP 228 (338)
T ss_pred ccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCc
Confidence 0235788899999999999999999988 9999999999999999999999999998764433
Q ss_pred cceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccc
Q 037084 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDS 488 (532)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 488 (532)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||....... ........ +....
T Consensus 229 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~-~~~~~---- 297 (338)
T cd05102 229 DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKD-GTRMR---- 297 (338)
T ss_pred chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhc-CCCCC----
Confidence 2222234456788999999999899999999999999999997 999997533211 11111111 11110
Q ss_pred cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 489 KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 489 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 298 -----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 298 -----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01122345889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=339.95 Aligned_cols=269 Identities=27% Similarity=0.413 Sum_probs=217.4
Q ss_pred cccccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 230 AFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 230 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
.|....+.|++.+.||.|..++||+|+.... ++.||||++.....+ .....+.+|+..++.++|||
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~-~e~VAIK~inLEkc~-------------~~ld~l~kE~~~msl~~HPN 85 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPT-NEVVAIKIINLEKCN-------------NDLDALRKEVQTMSLIDHPN 85 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeeccc-CCEEEEEEeehhhhh-------------hhHHHHHHHHHHhhhcCCCC
Confidence 3445567899999999999999999999876 799999999887532 22678899999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|++++..|..+..+++||.||.+||+.+.+...-.. .+++..+..|.+++++||.|||++| .||||||+.||||+
T Consensus 86 Iv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~ 160 (516)
T KOG0582|consen 86 IVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILID 160 (516)
T ss_pred cceEEEEEEecceeEEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEc
Confidence 999999999999999999999999999999875433 3899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCccee--eeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIR--ITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
++|.+||+|||.+..+.+...... ..+.+||++|||||++... .|+.|+||||||++..||.+|..||..+.+.
T Consensus 161 ~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-- 238 (516)
T KOG0582|consen 161 SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-- 238 (516)
T ss_pred CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--
Confidence 999999999998776655433222 2567899999999985433 5899999999999999999999999876541
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+-..+.+ .++...-..+..+........+.+++..|++.||++|||++++++
T Consensus 239 -----kvLl~tLqn-~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 -----KVLLLTLQN-DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -----HHHHHHhcC-CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111122222 222111111222223344557888999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.55 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=211.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
-.++|..+++||.|+||+||+|+-..+ |..||||.++..-..-.+ -.=.+|+..|++|+ ||||++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~-~~~VAIK~MK~Kf~s~ee-------------~~nLREvksL~kln~hpniik 73 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKET-GELVAIKKMKKKFYSWEE-------------CMNLREVKSLRKLNPHPNIIK 73 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCC-CceeeHHHHHhhhccHHH-------------HHHHHHHHHHHhcCCCCcchh
Confidence 456899999999999999999987764 899999999876433221 12247999999998 999999
Q ss_pred ceeEEecCC-ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
|..++.+.+ .+|+||||| ..+|.+++++ .+..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+
T Consensus 74 L~Evi~d~~~~L~fVfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~ 146 (538)
T KOG0661|consen 74 LKEVIRDNDRILYFVFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGN 146 (538)
T ss_pred hHHHhhccCceEeeeHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEeccc
Confidence 999999988 899999999 6799999986 2678999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeecccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH-QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
..+||+|||+|+....... .+..+.|.+|+|||++ +.+.|+.+.|+|++|||++|+.+-++-|.+..+.+....+.
T Consensus 147 ~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 147 DVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC 223 (538)
T ss_pred ceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence 9999999999998766543 3788999999999965 55678999999999999999999999998765533322222
Q ss_pred HHHHHHhccCCC-----ccccccc-------ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 471 RWMRNVISSENP-----HRAIDSK-------LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 471 ~~~~~~~~~~~~-----~~~~d~~-------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
+.+...-....+ ...+.-. -...-.+....++.+++..|+..||++|||+.+.++.
T Consensus 224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 221110000000 0000000 0111223466778999999999999999999998863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=321.91 Aligned_cols=265 Identities=26% Similarity=0.312 Sum_probs=212.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||+|.||.||+|++..+ |+.||||+++..... ........+|++.|+.++|+||+.|++
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t-~~~VAIKKIkl~~~k------------dGi~~talREIK~Lqel~h~nIi~LiD 68 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTET-GKRVAIKKIKLGNAK------------DGINRTALREIKLLQELKHPNIIELID 68 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCC-CcEEEEEEeeccccc------------cCccHHHHHHHHHHHHccCcchhhhhh
Confidence 3578889999999999999998875 999999999887432 122355778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|...+.+-||+|||+ .+|+..+++ ....++...+..++.++++|++|+|+.+ |+||||||.|+|++++|.+|
T Consensus 69 ~F~~~~~l~lVfEfm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 69 VFPHKSNLSLVFEFMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred hccCCCceEEEEEecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEE
Confidence 9999999999999995 599999975 4567899999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+|+.+....... +..+.|.+|+|||.+.+. .|+..+|+||.||++.||+-|.+-|.+... .+....+-
T Consensus 142 iADFGLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If 215 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIF 215 (318)
T ss_pred eecccchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHH
Confidence 99999999987665433 455889999999977665 689999999999999999999988865322 22222222
Q ss_pred HHhccCCCccc--------------ccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 475 NVISSENPHRA--------------IDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 475 ~~~~~~~~~~~--------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
..+....+..+ +.........+.....+++++..++..||.+|+|+.++++.
T Consensus 216 ~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 216 RALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22222221111 11111222345566778999999999999999999998863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=345.17 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=203.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.++...+.||+|+||+||++...++ |...|||.+..... ...+.+.+|+.+|++++|||||+++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~-g~~~AvK~v~~~~~--------------~~~~~l~~Ei~iL~~l~~p~IV~~~G 81 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKT-GELMAVKSVELEDS--------------PTSESLEREIRILSRLNHPNIVQYYG 81 (313)
T ss_pred chhhhhccccCccceEEEEEEecCC-Ccceeeeeeecccc--------------hhHHHHHHHHHHHHhCCCCCEEeeCC
Confidence 3577789999999999999988765 89999999877521 11567889999999999999999999
Q ss_pred EEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-CC
Q 037084 316 HVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-GM 392 (532)
Q Consensus 316 ~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-~~ 392 (532)
...... .++++|||+++|||.+++.+. ++ .+++..+..+..|+++||+|||+++ ++||||||+|||++. ++
T Consensus 82 ~~~~~~~~~~~i~mEy~~~GsL~~~~~~~--g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~ 155 (313)
T KOG0198|consen 82 SSSSRENDEYNIFMEYAPGGSLSDLIKRY--GG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNG 155 (313)
T ss_pred ccccccCeeeEeeeeccCCCcHHHHHHHc--CC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCC
Confidence 855544 589999999999999999863 23 6999999999999999999999999 999999999999999 79
Q ss_pred cEEEeccCCcccCCCC-CcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 EARISDFGLAKLMPDG-HTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+||+|||+++..... ..........||+.|||||++.++. ...++||||+||++.||+||++||... ....
T Consensus 156 ~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~ 229 (313)
T KOG0198|consen 156 DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEA 229 (313)
T ss_pred eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchH
Confidence 9999999999876631 1111124678999999999999643 335999999999999999999999763 1122
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
+++-........+ ..+...+.+..+++..|++.+|++|||+++++..
T Consensus 230 ~~~~~ig~~~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 230 EALLLIGREDSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHHHHHhccCCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 2222222222111 2223345668889999999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=351.13 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
..+|...+.||.|+|++|++|+...+ ++.+|||++...- +..+....-...|-.+|.+| .||.|++|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t-~keYAiKVl~K~~-----------Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKAT-GKEYAIKVLDKRY-----------IIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCC-CceeeHhhhhHHH-----------HHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 45799999999999999999998875 9999999987642 22244456677888899999 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+..|++...+|+|+||++||+|.+++++. +.+++.....++.+|+.||+|||+.| ||||||||+|||||++|+
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmh 212 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGH 212 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCc
Confidence 99999999999999999999999999873 56899999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcc---------ee--eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 394 ARISDFGLAKLMPDGHTR---------IR--ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
++|+|||.|+.+...... .. ....+||..|.+||++..+..+..+|+|+|||++|+|+.|.+||....+
T Consensus 213 ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne 292 (604)
T KOG0592|consen 213 IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE 292 (604)
T ss_pred EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH
Confidence 999999999987543211 11 1458999999999999999999999999999999999999999987544
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...-..+.. ++. .+.+..+..+.+|+...|..||++|+|..++-+
T Consensus 293 yliFqkI~~--------------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 293 YLIFQKIQA--------------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHHHHH--------------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 222222211 111 122223355888889999999999999977654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=355.14 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=213.2
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCC---cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYG---KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
...++..+.++||+|+||.||+|.+...++ ..||||..+..... ......+|.+|++++++++|||
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~-----------~~~~~~e~m~EArvMr~l~H~N 222 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL-----------TKEQIKEFMKEARVMRQLNHPN 222 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc-----------cHHHHHHHHHHHHHHHhCCCCC
Confidence 356677777999999999999999986534 23899999863211 1556789999999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
||+++|++.....+++|||+|+||+|.++|... ...++...+.+++.+.|.||+|||+.+ ++||||.++|+|++
T Consensus 223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYS 296 (474)
T ss_pred EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheec
Confidence 999999999999999999999999999999863 336999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||+++...... .......-+..|+|||.+..+.|+.++|||||||++||+.+ |..||.+... ..
T Consensus 297 ~~~~vKISDFGLs~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----~~ 370 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----YE 370 (474)
T ss_pred CCCeEEeCccccccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH----HH
Confidence 99999999999988654211 11112235688999999999999999999999999999999 8899986433 22
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+..++ ...+.... .+...+..+..++..||..+|++||||.++.+.|+.+.
T Consensus 371 v~~kI---~~~~~r~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 371 VKAKI---VKNGYRMP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred HHHHH---HhcCccCC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 33332 11111110 11133455777888999999999999999999998764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=366.63 Aligned_cols=261 Identities=23% Similarity=0.414 Sum_probs=219.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
......+.++||.|.||.||+|+++.. ....||||.++.... ++...+|..|+.+|.+..||||+
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-------------ekqrrdFL~EAsIMGQFdHPNII 693 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-------------EKQRRDFLSEASIMGQFDHPNII 693 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-------------HHHHhhhhhhhhhcccCCCCcEE
Confidence 345567889999999999999998753 135799999998753 56678999999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+|.|+.......+||+|||+||+|+.||+. ....+.+.+...+..+||.|+.||-+.+ +|||||.++|||++.|
T Consensus 694 rLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsn 767 (996)
T KOG0196|consen 694 RLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSN 767 (996)
T ss_pred EEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccc
Confidence 999999999999999999999999999986 3456999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeecccc--ccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAG--TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
..+|++||||++...++.... .++..| +.+|.|||.+...+++.+|||||||+||||.++ |..||.++... +
T Consensus 768 LvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----d 842 (996)
T KOG0196|consen 768 LVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----D 842 (996)
T ss_pred eEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----H
Confidence 999999999999887765221 233333 578999999999999999999999999999887 99999876542 2
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+.-+. ..-++ ..+.+++..+.+|++.||++|-.+||++.+++..|+++-
T Consensus 843 VIkaIe---~gyRL----------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 843 VIKAIE---QGYRL----------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHH---hccCC----------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 222111 12122 223456778999999999999999999999999999863
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=345.96 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=214.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||||+-+.+ .+.||+|.+...... ++..+.+.+|++++++++||||+.+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t-~~~vAik~i~K~gr~------------~k~l~~l~~ev~i~r~lkHpniv~m~e 68 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYT-IQVVAIKFIDKSGRN------------EKELKNLRQEVRILRSLKHPNIVEMLE 68 (808)
T ss_pred cchhHHHHhcCCccceeeecccccc-eeEEEEEEehhcCCc------------hHHHHHHHHHHHHHHhcCCcchhhHHH
Confidence 4688889999999999999987765 899999999876544 344677889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|+...++++|.|||.| +|..++.. ...+++..+..|+.++..||.|||+.+ |+|||+||.|||++.+|.+|
T Consensus 69 sfEt~~~~~vVte~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 69 SFETSAHLWVVTEYAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred hhcccceEEEEehhhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCcee
Confidence 99999999999999966 99999964 567999999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+||||+|+........ .+...|||-|||||+..++.|+..+|.||+||++||+.+|++||-. ..+...++.
T Consensus 141 lcdFg~Ar~m~~~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~ 211 (808)
T KOG0597|consen 141 LCDFGLARAMSTNTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKS 211 (808)
T ss_pred echhhhhhhcccCcee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHH
Confidence 9999999988765432 3678899999999999999999999999999999999999999953 234444555
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+...... ++......+..++...+.+||.+|.|..+++.
T Consensus 212 I~~d~v~-----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 212 ILKDPVK-----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HhcCCCC-----------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 4433221 12345566888999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=321.06 Aligned_cols=241 Identities=24% Similarity=0.304 Sum_probs=204.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|+.++.||.|+||.|.+++.+.+ |..+|+|+++... +...+..+...+|..+|+.+.||.+++++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~-g~yYAmKvL~k~~-----------vVklKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHS-GNYYAMKVLDKQK-----------VVKLKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccC-CceeehhhcCHHH-----------HHHHHHHHHHhhHHHHHhhccCceeEEEE
Confidence 35789999999999999999999875 9999999998753 23355678889999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+.|.+.+.+||||||++||.|.+++++ ..+++.....-++.+|+.||+|||+.+ |++|||||+|||+|.+|++
T Consensus 111 ~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~i 183 (355)
T KOG0616|consen 111 GTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHI 183 (355)
T ss_pred EeeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcE
Confidence 999999999999999999999999986 456889999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+...... -+.+|||.|+|||.++...+..++|.|||||++|||+.|.+||.+..+.....
T Consensus 184 KitDFGFAK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------- 251 (355)
T KOG0616|consen 184 KITDFGFAKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------- 251 (355)
T ss_pred EEEeccceEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH-------
Confidence 999999999876542 57899999999999999999999999999999999999999998754422222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCC
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEER 517 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 517 (532)
.++. ++. .+++-....+.+|+...++.|-++|
T Consensus 252 KI~~-~~v----------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 KILE-GKV----------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHh-Ccc----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1221 111 1122223347778888888888888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=341.01 Aligned_cols=269 Identities=20% Similarity=0.303 Sum_probs=207.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCC---------------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS---------------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~---------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 299 (532)
.++|.+.+.||+|+||.||+|.++.. .+..||+|.+..... ......|.+|+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~ 70 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-------------KNARNDFLKEV 70 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-------------HHHHHHHHHHH
Confidence 35688889999999999999986421 234799999876532 22346788999
Q ss_pred HHHhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---------------CCCCCCHHHHHHHHHHHHHH
Q 037084 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---------------GRRELDWLARYRIARGMASG 364 (532)
Q Consensus 300 ~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~g 364 (532)
.++.+++||||+++++++...+..++||||+++|+|.+++..... ....+++...++++.|++.|
T Consensus 71 ~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 150 (304)
T cd05096 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150 (304)
T ss_pred HHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999865321 12357888999999999999
Q ss_pred HHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHH
Q 037084 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFG 444 (532)
Q Consensus 365 l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 444 (532)
|.|||+.+ ++||||||+||++++++.+||+|||+++...............++..|+|||++.++.++.++||||||
T Consensus 151 l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 227 (304)
T cd05096 151 MKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227 (304)
T ss_pred HHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence 99999998 999999999999999999999999999866443322222344567889999999888999999999999
Q ss_pred HHHHHHHh--CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 445 VLLAVLVV--GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 445 vvl~ellt--g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
+++|||++ +..||..... .................. .....+..+..+.+++..||+.+|.+|||+.+
T Consensus 228 ~~l~el~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTD----EQVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred HHHHHHHHccCCCCCCcCCH----HHHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 99999987 5677765332 122222222211111000 00111223456889999999999999999999
Q ss_pred HHHHHhh
Q 037084 523 VRCMLSQ 529 (532)
Q Consensus 523 vl~~L~~ 529 (532)
|.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.41 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=201.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec--
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR-- 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-- 319 (532)
..||+|++|.||+|.+. |+.||||.++...... ....+.|.+|+.++++++||||+++++++.+
T Consensus 26 ~~i~~g~~~~v~~~~~~---~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN---NKEVIIRTFKKFHKGH-----------KVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred eEEeeCCceEEEEEEEC---CEEEEEEecccccccc-----------HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 67999999999999884 8899999998653221 2234678899999999999999999999876
Q ss_pred --CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCCcEEE
Q 037084 320 --PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 320 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
....++||||+++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+||++++++.+||
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEE
Confidence 3567899999999999999975 34688999999999999999999984 6 889999999999999999999
Q ss_pred eccCCcccCCCCCcceeeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... . +...
T Consensus 165 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~---~~~~ 232 (283)
T PHA02988 165 ICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----K---EIYD 232 (283)
T ss_pred cccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----H---HHHH
Confidence 9999998654432 34568899999999876 6899999999999999999999999976432 1 1122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.....+... . .+...+..+.+++..||+.||++|||+.++++.|++++
T Consensus 233 ~i~~~~~~~-~--------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 233 LIINKNNSL-K--------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHhcCCCC-C--------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 222111110 0 11123456889999999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=349.07 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=206.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.+.+....++.||+|+-|.||+|++. ++.||||+++.-. ..+++-|++|+||||+.
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~---netVAVKKV~elk---------------------ETdIKHLRkLkH~NII~ 176 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH---NETVAVKKVRELK---------------------ETDIKHLRKLKHPNIIT 176 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc---CceehhHHHhhhh---------------------hhhHHHHHhccCcceee
Confidence 34455667789999999999999997 7899999886531 24678899999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+.|+|.....+|||||||+.|.|...|+. +.++.......+..+||.|+.|||.+. |||||||.-||||..+.
T Consensus 177 FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d 249 (904)
T KOG4721|consen 177 FKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDD 249 (904)
T ss_pred EeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccc
Confidence 99999999999999999999999999975 566888888999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||-++...+..+. ....||..|||||++.+.+.++|+|||||||||||||||..||.+..........
T Consensus 250 ~VKIsDFGTS~e~~~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--- 323 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--- 323 (904)
T ss_pred eEEeccccchHhhhhhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec---
Confidence 9999999999887665433 5678999999999999999999999999999999999999999875431111110
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
...... -..+..++.-+.-|++.||+-.|.+||++++++..|+-
T Consensus 324 -----GsNsL~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 324 -----GSNSLH--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -----cCCccc--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 011111 11234455667778889999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=342.09 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=213.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|+++.+||+|+||.||+|+-+.+ |..+|+|+++.+... ..........|-.+|....+|+||+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~T-g~iyAmK~LkKS~M~-----------~~~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDT-GEIYAMKILKKSEML-----------KKNQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccC-CcEEeeecccHHHHH-----------hhhhHHHHHHHHHHhhhcCCCcEEEE
Confidence 357899999999999999999988775 999999999987432 25567888999999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+..|++.+.+||||||+|||++..+|.. ...|++.....++.+++.|+.-||+.| +|||||||+|+|||..|+
T Consensus 207 yYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GH 279 (550)
T KOG0605|consen 207 YYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGH 279 (550)
T ss_pred EEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCC
Confidence 9999999999999999999999999975 567999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCC---------------------Ccce-----e-------------------eeccccccccccccc
Q 037084 394 ARISDFGLAKLMPDG---------------------HTRI-----R-------------------ITTVAGTTGYVAPEY 428 (532)
Q Consensus 394 ~kl~DFGla~~~~~~---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~ 428 (532)
+||+||||+.-+... .... . ....+|||.|+|||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 999999999643110 0000 0 023579999999999
Q ss_pred cccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHH
Q 037084 429 HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYF 508 (532)
Q Consensus 429 ~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 508 (532)
+.+..|+..+|.||+|||+||||.|.+||....+......+..|-..+...... ....+..+||.+
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~r 425 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITR 425 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHH
Confidence 999999999999999999999999999999887777777888886554332211 112558889999
Q ss_pred cCCCCCCCCCC
Q 037084 509 CTSDDPEERPS 519 (532)
Q Consensus 509 cl~~~P~~RPs 519 (532)
|+. ||++|..
T Consensus 426 ll~-d~~~RLG 435 (550)
T KOG0605|consen 426 LLC-DPENRLG 435 (550)
T ss_pred Hhc-CHHHhcC
Confidence 998 9999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=352.10 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=207.7
Q ss_pred cccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
..++|.+.+.||+|+||.||+|.+. ..++..||||+++.... ......+.+|+.++..+ +||
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~Ei~il~~l~~Hp 99 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-------------LTEREALMSELKVLSYLGNHI 99 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-------------cHHHHHHHHHHHHHHHhcCCc
Confidence 4567999999999999999999752 22366899999975432 12235688899999999 899
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------------------------------------
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------------------------------------------- 344 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------- 344 (532)
||++++++|...+..++|||||++|+|.+++.....
T Consensus 100 nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 179 (375)
T cd05104 100 NIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVV 179 (375)
T ss_pred ceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccc
Confidence 999999999999999999999999999999975221
Q ss_pred ---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 345 ---------------------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 345 ---------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~ 256 (375)
T cd05104 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKIC 256 (375)
T ss_pred ccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEe
Confidence 1135788999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... ..+..++.
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~~-- 331 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMIK-- 331 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHHH--
Confidence 9999987654332211123445678999999999999999999999999999998 88998753221 11222221
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+.... .....+.++.+++..||+.||++|||+.++++.|++.
T Consensus 332 --~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 332 --EGYRML---------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --hCccCC---------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111000 0011234588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=372.06 Aligned_cols=264 Identities=23% Similarity=0.384 Sum_probs=218.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
.+.....+.||+|.||.||.|...+.+|. .||||.++.... .+...+|.+|..+++.++||||
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-------------~~~~~~Fl~Ea~~m~~f~HpNi 757 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-------------EQEVSDFLKEALLMSKFDHPNI 757 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-------------HHHHHHHHHHHHHHhcCCCcce
Confidence 45678889999999999999999877665 389998877642 4456899999999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
|+++|+|.+....+|++|||++|+|..||++.+. ....++....+.++.|||+|+.||++++ +|||||.++|+|
T Consensus 758 v~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 758 VSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCL 834 (1025)
T ss_pred eeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhhee
Confidence 9999999999999999999999999999987432 2566889999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~ 466 (532)
|+....+||+|||+|+...+.........-.-...|||||.+..+.++.|+|||||||++||++| |..||.+....
T Consensus 835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--- 911 (1025)
T KOG1095|consen 835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--- 911 (1025)
T ss_pred ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---
Confidence 99999999999999995544433222122234578999999999999999999999999999999 99999875441
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+.+.....+++. ..++.++..+.+++..||+.+|++||++..+++++..+.
T Consensus 912 ----~v~~~~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 912 ----EVLLDVLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ----HHHHHHHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 112223333322 223456677889999999999999999999999888764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.71 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=202.5
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|+||.||+|.+..+ |+.||+|.+....... ......+.+|+.++++++|+|++.+.+++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~~~~iv~~~~~~ 69 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKK-----------RKGEAMALNEKRILEKVNSRFVVSLAYAY 69 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecC-CceEEEEEeeHhhhhh-----------hhhHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence 67788999999999999988764 8999999987543211 12234677899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
.+.+..++|+||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+
T Consensus 70 ~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~ 144 (285)
T cd05631 70 ETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRIS 144 (285)
T ss_pred ccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999888652 3346899999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||++........ .....||..|+|||++.+..++.++|||||||++|+|++|+.||...........+ ....
T Consensus 145 Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~~~ 217 (285)
T cd05631 145 DLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV----DRRV 217 (285)
T ss_pred eCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH----HHHh
Confidence 9999987644322 13457899999999999999999999999999999999999999754321111111 1111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
..... .........+.+++..||+.||.+||+ ++++++
T Consensus 218 ~~~~~----------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 218 KEDQE----------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred hcccc----------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11100 111123345788999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=346.05 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=212.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+...|....+||+|+.|.||.|....+ ++.||||++...... ..+-+.+|+.+|+..+|+|||.+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~-~~~VaiK~m~l~~Q~--------------~keLilnEi~Vm~~~~H~NiVnf 335 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKIST-KQEVAIKRMDLRKQP--------------KKELLLNEILVMRDLHHPNIVNF 335 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccC-CceEEEEEEEeccCC--------------chhhhHHHHHHHHhccchHHHHH
Confidence 345688889999999999999987765 889999999877432 23567899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+..|...+.++.|||||+||+|.|.+.. ..+++.++..|+..+++||+|||.++ |+|||||.+|||++.+|.
T Consensus 336 l~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~ 407 (550)
T KOG0578|consen 336 LDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGS 407 (550)
T ss_pred HHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCc
Confidence 9999999999999999999999999975 34899999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+|..+...... ..+.+||+.|||||++....|+++.||||||++++||+.|.+||-...+ ..-+
T Consensus 408 vKltDFGFcaqi~~~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAl 478 (550)
T KOG0578|consen 408 VKLTDFGFCAQISEEQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRAL 478 (550)
T ss_pred EEEeeeeeeeccccccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHH
Confidence 999999999987665432 2788999999999999999999999999999999999999999964222 1222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+...+.+.. ...+.....+.+++.+||+.|+.+||++.|+++
T Consensus 479 yLIa~ng~P~l--------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 479 YLIATNGTPKL--------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHhhcCCCCc--------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 22223333321 123334556889999999999999999999986
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=331.13 Aligned_cols=259 Identities=22% Similarity=0.331 Sum_probs=206.3
Q ss_pred ccCccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|++.+.||+|+||.||+|.++. ..+..||+|.++.... ......|.+|+..+++++||||++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~ 70 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------------DKQRRGFLAEALTLGQFDHSNIVR 70 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------------HHHHHHHHHHHHHHhcCCCCCcCe
Confidence 3568889999999999999998752 2357899999986532 122357889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++..++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~ 144 (266)
T cd05064 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDL 144 (266)
T ss_pred EEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCC
Confidence 99999999999999999999999999975 2346899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.++++|||.+......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... .+..
T Consensus 145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~ 219 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIK 219 (266)
T ss_pred cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH
Confidence 9999999987654322111 1122345678999999999999999999999999999775 99999754321 1112
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+ . .+... ......+..+.+++..||+.+|++|||++++.+.|+++
T Consensus 220 ~~---~-~~~~~---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AV---E-DGFRL---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HH---H-CCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 1 11110 01122445688899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.70 Aligned_cols=266 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
..++|.+.+.||+|+||.||+|.+... ++..||+|.++.... ......+.+|+.+++.+ +||
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~il~~l~~h~ 102 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------------TDEREALMSELKILSHLGQHK 102 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------------HHHHHHHHHHHHHHHhhccCC
Confidence 346799999999999999999986432 235899999976532 12245688999999999 899
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------------------------------------
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------------------------------------------- 344 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------- 344 (532)
||++++++|...+..++|||||++|+|.++++....
T Consensus 103 nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (374)
T cd05106 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYV 182 (374)
T ss_pred ceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccc
Confidence 999999999999999999999999999999864211
Q ss_pred ----------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCc
Q 037084 345 ----------------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402 (532)
Q Consensus 345 ----------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 402 (532)
...++++....+++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla 259 (374)
T cd05106 183 EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLA 259 (374)
T ss_pred ccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceee
Confidence 1235788899999999999999999988 999999999999999999999999999
Q ss_pred ccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCC
Q 037084 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSEN 481 (532)
Q Consensus 403 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 481 (532)
+...............++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .... ....+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~----~~~~~~ 332 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYK----MVKRGY 332 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHH----HHHccc
Confidence 86644332211123345678999999998899999999999999999997 999997643211 1111 111110
Q ss_pred CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 482 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
... .+ ...+..+.+++..||+.+|.+|||+.++++.|+++-
T Consensus 333 ~~~--~~-------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 QMS--RP-------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred Ccc--CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 000 00 012345888999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=340.54 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=205.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
....|.+.+.||+|+||.|+.|.+..+ |..||+|++......... ......+.+|+.++++++ ||||++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t-~~~vAiKii~~~~~~~~~---------~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLT-GEKVAIKIIDRKKVSSKS---------QKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccC-CCeEEEEEechhcccccc---------cccchhhHHHHHHHHHhccCCCEeE
Confidence 356789999999999999999988765 899999977664211000 012345558999999998 999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC-
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG- 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~- 391 (532)
++.++......|+|||||.||+|.+++.+ ..++.+.....++.|+++|++|+|+.+ |+||||||+|||++.+
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNE 157 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCC
Confidence 99999999999999999999999999975 456888999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCcccCC-CCCcceeeeccccccccccccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMP-DGHTRIRITTVAGTTGYVAPEYHQTLT-IS-EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+++||+|||++.... ... ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++..
T Consensus 158 ~~~Kl~DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------- 227 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------- 227 (370)
T ss_pred CCEEEeccccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-------
Confidence 999999999999874 222 226889999999999999977 75 78999999999999999999998722
Q ss_pred HHHHHHHHhccC-CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 469 MVRWMRNVISSE-NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 469 l~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
.....+...... ..+..+ . ..++..++..|+.++|.+|+|+.+++
T Consensus 228 ~~~l~~ki~~~~~~~p~~~---------~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 VPNLYRKIRKGEFKIPSYL---------L--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHhcCCccCCCCc---------C--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 222222222111 111111 0 45688999999999999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=322.92 Aligned_cols=269 Identities=21% Similarity=0.236 Sum_probs=207.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-+.|+.++.|++|+||.||+|+++.+ ++.||+|+++..... ......-.+|+.+|.+++|||||.+.
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t-~eIVALKr~kmekek------------~GFPItsLREIniLl~~~H~NIV~vk 141 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKT-DEIVALKRLKMEKEK------------EGFPITSLREINILLKARHPNIVEVK 141 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCc-ceeEEeeeccccccc------------CCCcchhHHHHHHHHhcCCCCeeeeE
Confidence 35689999999999999999998875 899999999876422 11123456899999999999999998
Q ss_pred eEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
.+... -+..|+|||||++ +|..++... ..++.......++.|+++|++|||..+ |+||||||+|+|+++.|
T Consensus 142 EVVvG~~~d~iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G 214 (419)
T KOG0663|consen 142 EVVVGSNMDKIYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKG 214 (419)
T ss_pred EEEeccccceeeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCC
Confidence 87754 3678999999965 999999864 357888999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+|+.++..... .+..+.|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|.+..+......+..
T Consensus 215 ~lKiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 215 ILKIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred cEEecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 9999999999998876433 3778899999999988776 589999999999999999999999987544322222222
Q ss_pred HHHHHhccCCCccc----c---------cccccCCCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRA----I---------DSKLLGNGYEE-QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~----~---------d~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+...-...++... + ...+.+.+... ..+.-.+|+...+..||.+|.|+++.++
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11110001111000 0 00011111111 3366788888999999999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=327.04 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=208.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|++.++||+|+||.||+|... ++..||+|.+.... .....+.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT---------------MSVQAFLEEANLMKTLQHDKLVRL 66 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc---------------hhHHHHHHHHHHHHhCCCCCeeeE
Confidence 3567899999999999999999876 46789999987642 123578899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..+++|||+++++|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLM 141 (261)
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCc
Confidence 99999999999999999999999999752 3456889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++.......... .....++..|+|||+..+..++.++|+|||||++|+|++ |..||..... ......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~ 216 (261)
T cd05072 142 CKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN----SDVMSA 216 (261)
T ss_pred EEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH----HHHHHH
Confidence 9999999998765433211 123446778999999998899999999999999999998 9999975322 112222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+. ...... .....+..+.+++.+|++.+|++|||++++.+.|+++
T Consensus 217 ~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 217 LQ---RGYRMP----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HH---cCCCCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11 111110 0112334588899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=332.76 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=210.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCC----CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
++|++.+.||+|+||.||+|.+.... ...||+|.+..... ......|.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-------------~~~~~~~~~ei~~l~~l~h~~i~ 71 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-------------PKVQQEFRQEAELMSDLQHPNIV 71 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-------------HHHHHHHHHHHHHHHhcCCcccc
Confidence 46888999999999999999876431 25799999875432 22346788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++++++...+..+++|||+++++|.+++..... ....+++...+.++.|++.||.|||+.+ ++|+
T Consensus 72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~ 148 (283)
T cd05048 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148 (283)
T ss_pred eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecc
Confidence 999999999999999999999999999975321 1156889999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||++++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999986544322222234566889999999988899999999999999999998 999997
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.... ..+...+. ..... ......+..+.+++..||+.+|.+||++.++++.|+.+
T Consensus 229 ~~~~----~~~~~~i~----~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 229 GFSN----QEVIEMIR----SRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCH----HHHHHHHH----cCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 5432 12222211 11111 11223456688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=346.95 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=211.9
Q ss_pred cccccccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC
Q 037084 230 AFLTKEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI 305 (532)
Q Consensus 230 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 305 (532)
.+..+.++|.+.+.||+|+||.||+|++... .+..||||++..... ......+.+|+.+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~Ei~~l~~l 97 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------------SSEKQALMSELKIMTHL 97 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------------hHHHHHHHHHHHHHHhc
Confidence 3444677899999999999999999987432 235799999976532 22246788999999999
Q ss_pred C-CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC----------------------------------------
Q 037084 306 W-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---------------------------------------- 344 (532)
Q Consensus 306 ~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------------------------- 344 (532)
. ||||++++++|.+.+..|+|||||++|+|.++++....
T Consensus 98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (400)
T cd05105 98 GPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDY 177 (400)
T ss_pred CCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccc
Confidence 5 99999999999999999999999999999999875321
Q ss_pred ----------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037084 345 ----------------------------------------------------GRRELDWLARYRIARGMASGLEYLHMYH 372 (532)
Q Consensus 345 ----------------------------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~ 372 (532)
....+++..+..++.|++.||.|||+.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 257 (400)
T cd05105 178 MDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN 257 (400)
T ss_pred cccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1134788889999999999999999988
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 258 ---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 334 (400)
T cd05105 258 ---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334 (400)
T ss_pred ---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 99999999999999999999999999987644332222234456788999999998899999999999999999997
Q ss_pred -CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 453 -GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 453 -g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
|..||....... .+. .....+... ......+..+.+++..||+.+|++|||+.++.++|+++-
T Consensus 335 ~g~~P~~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 335 LGGTPYPGMIVDS---TFY----NKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CCCCCCcccchhH---HHH----HHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 999997532211 111 111111100 011223456889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=328.31 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=207.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|...+.||+|+||.||+|.+... ++.||+|.+.... .....+.+|+.++++++||||+++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~~K~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT---------------MEVEEFLKEAAVMKEIKHPNLVQLLG 69 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecC-CceEEEEEecCCc---------------hHHHHHHHHHHHHHhCCCCChhheEE
Confidence 4578889999999999999998764 8899999987542 22356888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..+++|||+++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~k 144 (263)
T cd05052 70 VCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVK 144 (263)
T ss_pred EEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEE
Confidence 99999999999999999999999975 23456899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+...
T Consensus 145 l~df~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~ 216 (263)
T cd05052 145 VADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYE 216 (263)
T ss_pred eCCCccccccccceeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHH
Confidence 999999987654322111 22334668999999999999999999999999999998 9999875322 11111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.......+ ......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 217 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 217 LLEKGYRM----------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111111 11112345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.61 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=211.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+...|...+.||+|.||.||+|.+..+ ++.||+|++..... +..++...+|+.+|.+++++||.++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t-~k~vAiKii~Le~~-------------~deIediqqei~~Ls~~~~~~it~y 76 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKT-KKVVAIKIIDLEEA-------------EDEIEDIQQEISVLSQCDSPNITEY 76 (467)
T ss_pred cccccccchhccccccceeeeeeeccc-cceEEEEEechhhc-------------chhhHHHHHHHHHHHhcCcchHHhh
Confidence 345677789999999999999998876 99999999987642 3346788899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+|.+..+..++++||||.||++.+.+.. +..+++..+..|+.++..|+.|||..+ .+|||||+.|||+..+|.
T Consensus 77 ygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~ 149 (467)
T KOG0201|consen 77 YGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGD 149 (467)
T ss_pred hhheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCc
Confidence 9999999999999999999999999964 444577777889999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|++|||.+.......... .+.+||+.|||||++.+..|+.|+||||||++.+||.+|.+|+.+..+...-..
T Consensus 150 vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl----- 222 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL----- 222 (467)
T ss_pred EEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-----
Confidence 9999999998876654332 678999999999999988999999999999999999999999987655111111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+....| |.+.+ .....+.+++..|++.||+.|||+.++++
T Consensus 223 ---Ipk~~P-----P~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 223 ---IPKSAP-----PRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCCCC-----Ccccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 111111 12222 33445888899999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.04 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=201.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|....+ |+.||+|++....... ......+.+|+.++++++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~~ 68 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRIS-EHYYALKVMAIPEVIR-----------LKQEQHVHNEKRVLKEVSHPFIIRLFW 68 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCC-CCEEEEEEEEHHHHhh-----------hHHHHHHHHHHHHHHhCCCCcHhhhHh
Confidence 3688889999999999999988764 8999999987542111 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..++||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 69 TEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred hhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999975 346889999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....
T Consensus 142 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~ 209 (291)
T cd05612 142 LTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEK 209 (291)
T ss_pred EEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence 99999998664432 3457899999999999989999999999999999999999999753321 11112
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
.... ... ........+.+++..||+.||.+||+ ++++++
T Consensus 210 i~~~-~~~----------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 210 ILAG-KLE----------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred HHhC-CcC----------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 1111 110 01111335788999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=335.73 Aligned_cols=202 Identities=27% Similarity=0.418 Sum_probs=177.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||.||++.+..+ |..+|+|.+..... ......+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPS-GLIMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGFY 69 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCC-CcEEEEEEeecccC-------------HHHHHHHHHHHHHHHHCCCCCCCeEE
Confidence 56799999999999999999988764 89999999976421 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ +++||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~ 143 (331)
T cd06649 70 GAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEI 143 (331)
T ss_pred EEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcE
Confidence 999999999999999999999999975 345889999999999999999999852 29999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+|+|||++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 144 kl~Dfg~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 144 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred EEccCccccccccccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999886644321 3457899999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=324.31 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=214.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|+...+ ++.||||.+....... ......+.+|+.++++++|||++++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLD-RKPVALKKVQIFEMMD-----------AKARQDCVKEIDLLKQLNHPNVIKYLD 69 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCC-CCEEEEEEeeccccCC-----------HHHHHHHHHHHHHHHhCCCcceeeeee
Confidence 4688899999999999999988764 8999999876532111 233467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++++||+++++|.+++.........++......++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEE
Confidence 999999999999999999999998764444566889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++......... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ....+...
T Consensus 147 l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08228 147 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQK 219 (267)
T ss_pred ECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHH
Confidence 9999998876543221 1345688899999999888899999999999999999999999864221 22222222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
......+. .........+.+++.+||+.+|++|||+.++++.|++++
T Consensus 220 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCDYPP---------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCCCCC---------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 22111111 011234456889999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=334.76 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=203.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|+++.+ +..||+|++...... ......+.+|+.++++++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKET-KEIVAIKKFKDSEEN------------EEVKETTLRELKMLRTLKQENIVELKE 67 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCC-CcEEEEEEEeccccc------------ccchhhHHHHHHHHHhCCCccccchhh
Confidence 3588899999999999999998764 889999999765321 222456778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||++++++..+.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~k 140 (287)
T cd07848 68 AFRRRGKLYLVFEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLK 140 (287)
T ss_pred hEecCCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEE
Confidence 9999999999999998877765543 2346889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH----
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR---- 471 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~---- 471 (532)
|+|||++......... ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||...........+..
T Consensus 141 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07848 141 LCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219 (287)
T ss_pred EeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9999999876543221 11345789999999999988999999999999999999999999976432111111110
Q ss_pred ----HHHHHhccCCCccccccccc------CCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 ----WMRNVISSENPHRAIDSKLL------GNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ----~~~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+...............+... ..........+.+++..|++.||++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111110000000000000 0011123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=341.85 Aligned_cols=256 Identities=21% Similarity=0.282 Sum_probs=205.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|.+..+ |+.||+|++...... .......+.+|+.++.+++||||++++++
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~ 69 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDT-GEIVALKRMKKSLLF-----------KLNEVRHVLTERDILTTTKSEWLVKLLYA 69 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCC-CCEEEEEEEEHHHHh-----------hhhHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 588899999999999999998764 889999998753211 02234678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..|+||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL 142 (333)
T cd05600 70 FQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKL 142 (333)
T ss_pred EEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999964 346889999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+..|....
T Consensus 143 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 217 (333)
T cd05600 143 TDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217 (333)
T ss_pred EeCcCCcccccc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc
Confidence 999999865442 145679999999999999999999999999999999999999997543211111111111000
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
..... ..........+.+++..|++.+|.+||++.++++.
T Consensus 218 ----~~~~~------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 ----QRPVY------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----cCCCC------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000 00011234567889999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=326.43 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=197.6
Q ss_pred ccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 240 SLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
..+.||.|.||.||+|.+. ...+..|+||.++.... ......|.+|+..+++++||||++++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni~~~~g~ 69 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS-------------EEEEEEFLNEIQILRKLRHPNIVKLYGF 69 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS-------------HHHHHHHHHHHHHHHTHSBTTBE-EEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc-------------cccceeeeeccccccccccccccccccc
Confidence 4578999999999999998 12257899999966432 2335788999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
|...+..++|+|||++|+|.+++... ....+++..++.|+.|++.||.|||+.+ ++|+||+|+||++++++.+||
T Consensus 70 ~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl 144 (259)
T PF07714_consen 70 CIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKL 144 (259)
T ss_dssp EESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEE
T ss_pred cccccccccccccccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 99888899999999999999999873 3567899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||++................+...|+|||.+....++.++||||||+++||+++ |+.||.+... .. ....
T Consensus 145 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~---~~~~ 217 (259)
T PF07714_consen 145 SDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EE---IIEK 217 (259)
T ss_dssp ESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HH---HHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----cc---cccc
Confidence 99999987743332222234557788999999999999999999999999999999 7899875422 12 2222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
......+. .....+..+.+++..||+.+|++|||+.++++.|
T Consensus 218 ~~~~~~~~----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 LKQGQRLP----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHTTEETT----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccce----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22211111 1112334588899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=340.09 Aligned_cols=248 Identities=24% Similarity=0.324 Sum_probs=202.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|++...... .......+.+|+.++.+++||||++++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~ 84 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGT-GEYYAIKCLKKREIL-----------KMKQVQHVAQEKSILMELSHPFIVNMM 84 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEHHHHh-----------hhhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35789999999999999999998764 899999998753211 123356788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..++..++||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 157 (329)
T PTZ00263 85 CSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHV 157 (329)
T ss_pred EEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCE
Confidence 999999999999999999999999975 345788889999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....
T Consensus 158 kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~ 225 (329)
T PTZ00263 158 KVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIYE 225 (329)
T ss_pred EEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHHH
Confidence 999999998764432 3457899999999999999999999999999999999999999753221 1111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVR 524 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl 524 (532)
.... +... ........+.+++..||+.||++||+ +++++
T Consensus 226 ~i~~-~~~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 226 KILA-GRLK----------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred HHhc-CCcC----------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 2211 1110 00112234788999999999999997 56665
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.24 Aligned_cols=256 Identities=19% Similarity=0.219 Sum_probs=207.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
..|.+.+.||+|+||.||+|......+..||+|.+.... ......+.+|+.+++.++||||+++++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--------------~~~~~~~~~E~~~l~~l~Hpniv~~~~ 132 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--------------ERQAAYARSELHCLAACDHFGIVKHFD 132 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--------------HHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 348889999999999999998765446789999875543 223356778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..|+||||+++|+|.+++........++++.....++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 133 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~k 209 (478)
T PTZ00267 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIK 209 (478)
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEE
Confidence 999999999999999999999998764445567899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+++...............||++|+|||++.+..++.++|||||||++|+|++|+.||..... .+.+..
T Consensus 210 L~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~ 282 (478)
T PTZ00267 210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQ 282 (478)
T ss_pred EEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHH
Confidence 9999999876544322222456799999999999999999999999999999999999999975322 122222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ ........+.+++..||+.+|++||++++++.
T Consensus 283 ~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 283 VLYGKYDP----------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHhCCCCC----------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 22211110 01122345888999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=331.52 Aligned_cols=268 Identities=19% Similarity=0.254 Sum_probs=200.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|....+ +..||+|.++..... .....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~ 69 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEE-------------GAPCTAIREVSLLKNLKHANIVTLH 69 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCC-CCEEEEEEecccccC-------------CcchhHHHHHHHHHhCCCCCEeeEE
Confidence 35688899999999999999988764 899999998754211 1124567899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||++ |+|.+++.. ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~ 142 (288)
T cd07871 70 DIIHTERCLTLVFEYLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGEL 142 (288)
T ss_pred EEEcCCCeEEEEEeCCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence 99999999999999996 599998864 2345788999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+....
T Consensus 143 kl~DfG~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 220 (288)
T cd07871 143 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220 (288)
T ss_pred EECcCcceeeccCCCcc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999765433211 134578999999998765 568999999999999999999999997543211111111100
Q ss_pred HH--------HhccCCCcccccccccCC----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RN--------VISSENPHRAIDSKLLGN----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~--------~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ............+..... ..+.....+.+++..|++.||.+|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000000000000000000 01112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=305.52 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=212.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|++.+.||+|-||.||.|+.+.+ +--||+|++..+. +.......++.+|+++-+.|+||||.+++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks-~~IvalKVlfKsq-----------i~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKS-LFIVALKVLFKSQ-----------ILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred hhhccccccccCCccccEeEeeeccC-CcEEEEeeeeHHH-----------HHHhcchhhhhheeEeecccCCccHHhhh
Confidence 46799999999999999999998865 8899999997652 11234457899999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+||.+....||++||.++|+|...|.. +....++......++.|+|.|+.|+|..+ ++||||||+|+|++..+.+
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~l 163 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGEL 163 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCe
Confidence 999999999999999999999999986 34566888888999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|++|||-+...+... ..+.+||..|.|||...+...+..+|+|++|++.||++.|.+||......+....+..
T Consensus 164 kiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k--- 236 (281)
T KOG0580|consen 164 KIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK--- 236 (281)
T ss_pred eccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH---
Confidence 999999987665332 2678999999999999999999999999999999999999999987543222222111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. +. .+++.....+.+++..|+..+|.+|.+..+++.
T Consensus 237 ----~----~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 237 ----V----DL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ----c----cc-------cCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 0 11 112333455889999999999999999999875
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.72 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=205.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..+|+..+.||+|+||.||+|.+..+ |. .||+|.++.... .....++.+|+.+++.++||||
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni 71 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPHV 71 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecC-CCccceeEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCCC
Confidence 45699999999999999999987643 43 499999875421 2234678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
++++++|... ..++++||+++|+|.+++.. ....+++...+.++.|++.||+|||+.+ ++||||||+||++++
T Consensus 72 v~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~ 144 (316)
T cd05108 72 CRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKT 144 (316)
T ss_pred CeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecC
Confidence 9999999874 56799999999999999975 2345889999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..+
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~~~ 220 (316)
T cd05108 145 PQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEI 220 (316)
T ss_pred CCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999997765433222223345678999999999999999999999999999998 9999975322 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... ....+. ..+.+...+.+++..||+.+|++|||+.+++..|..+.
T Consensus 221 ~~~~~---~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 221 SSILE---KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred HHHHh---CCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111 111110 01112345788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=337.96 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=197.3
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|+||.||+|....+ |+.||+|++...... .......+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05571 1 KLLGKGTFGKVILVREKAT-GKYYAMKILKKEVII-----------AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC
Confidence 4699999999999988764 899999998753211 1233456788999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999999999999865 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 481 (532)
++........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..+.. .... +.
T Consensus 142 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~~---~~~~-~~ 211 (323)
T cd05571 142 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKLFE---LILM-EE 211 (323)
T ss_pred CcccccCCCc--ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH----HHHHH---HHHc-CC
Confidence 8754322211 1456799999999999999999999999999999999999999975322 11111 1111 11
Q ss_pred CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 482 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
. .........+.+++..||+.||++|| ++.++++
T Consensus 212 ~----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 I----------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred C----------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1 01112334578899999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=324.88 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=206.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.++ ++..||+|.++.... ....+.+|+.++++++|||++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGTM---------------DPKDFLAEAQIMKKLRHPKLIQL 66 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCcc---------------cHHHHHHHHHHHHHCCCCCccce
Confidence 3456888999999999999999875 367899999876532 23457889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..+++|||+++++|.+++... ....+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 141 (261)
T cd05068 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNI 141 (261)
T ss_pred eEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCC
Confidence 99999999999999999999999999752 2456899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++........... .....+..|+|||++.+..++.++|+||||+++|+|++ |+.||..... ..+..
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~- 215 (261)
T cd05068 142 CKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQ- 215 (261)
T ss_pred EEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH-
Confidence 99999999987753322111 12223457999999999999999999999999999999 9999975322 11111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........ ......+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 216 --~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 216 --QVDQGYRM----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --HHHcCCCC----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11111111 01112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=321.55 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=202.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++.++ ++..+|+|.+..... ....+.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEGAM---------------SEEDFIEEAKVMMKLSHPKLVQLYG 66 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec--cCceEEEEecccCCc---------------cHHHHHHHHHHHHHCCCCCceeEEE
Confidence 45788899999999999999886 467899999875421 1246788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++|+|.++++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 67 ~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05114 67 VCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVK 140 (256)
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEE
Confidence 999999999999999999999998752 235899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++......... .....++..|+|||++.+..++.++|+||||+++|+|++ |+.||..... ......
T Consensus 141 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~-- 213 (256)
T cd05114 141 VSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEM-- 213 (256)
T ss_pred ECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH--
Confidence 99999988654432211 123345668999999998899999999999999999999 8999975332 112222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
......+. .+. .....+.+++.+||+.+|++|||+.++++.|.
T Consensus 214 -i~~~~~~~---~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 214 -ISRGFRLY---RPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -HHCCCCCC---CCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22111111 011 12245889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=340.37 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=203.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+...++..||+|.+...... .......+.+|+.+++.++||||+++
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----------KQKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----------hhhhHHHHHHHHHHHHhCCCCCCcce
Confidence 3467999999999999999999887654578999998643211 12334678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ 169 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGF 169 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 346889999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++....... ....||+.|+|||++.+..++.++|+|||||++|||++|..||...... ...
T Consensus 170 ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~ 237 (340)
T PTZ00426 170 IKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIY 237 (340)
T ss_pred EEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHH
Confidence 9999999998654322 3467999999999999988999999999999999999999999754321 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
..... +... .+......+.+++..|++.+|.+|+ +++++++
T Consensus 238 ~~i~~-~~~~----------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 238 QKILE-GIIY----------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHhc-CCCC----------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11111 1110 0111223477899999999999995 7888765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=324.04 Aligned_cols=260 Identities=22% Similarity=0.378 Sum_probs=208.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|.+... +...||+|.++.... ......|.+|+.++++++||||++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~ 69 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-------------DKQRLDFLTEASIMGQFDHPNIIR 69 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-------------hHHHHHHHHHHHHHHhCCCCCcce
Confidence 35688899999999999999988643 245899999876532 223457888999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..+++|||+++++|.+++.. ....+++..++.++.|++.|+.|||+.+ ++|+||||+||++++++
T Consensus 70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~ 143 (266)
T cd05033 70 LEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNL 143 (266)
T ss_pred EeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 99999999999999999999999999975 2347899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~ 219 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIK 219 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Confidence 999999999998753222222123345678999999999899999999999999999998 9999965322 11222
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+. ...... .....+..+.+++..|++.+|++||++.++++.|+++
T Consensus 220 ~~~---~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 AVE---DGYRLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHH---cCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 221 111111 0112335588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.00 Aligned_cols=263 Identities=19% Similarity=0.332 Sum_probs=206.5
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|++.+.||+|+||.||+|.+.+ .++..||+|.+..... .....++.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~ 70 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-------------MRERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999998653 2356899999865321 122356889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG------RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp 383 (532)
|+++++++..++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||
T Consensus 71 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp 147 (277)
T cd05062 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAA 147 (277)
T ss_pred eeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcch
Confidence 999999999999999999999999999999753221 234688899999999999999999988 99999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
+||++++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 148 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999886544332221123455788999999998899999999999999999999 7889865322
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.. ..........+. .....+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 228 ----~~---~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 ----EQ---VLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ----HH---HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 111111111110 111233468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.98 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=196.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc---CCCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR---IWHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~H~niv~l 313 (532)
+|.+.+.||+|+||.||+|.+...+|..||+|.++...... .....+.+|+.+++. ++||||+++
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~hpniv~~ 69 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE------------GMPLSTIREVAVLRHLETFEHPNVVRL 69 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC------------CchHHHHHHHHHHHhhcccCCCCcceE
Confidence 58888999999999999998865557899999987543211 111234455555554 479999999
Q ss_pred eeEEe-----cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVT-----RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++|. .....++||||++ ++|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~ 143 (290)
T cd07862 70 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILV 143 (290)
T ss_pred EEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEE
Confidence 99985 2456899999995 699999875 23445899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.++.+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|++||...........
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~ 220 (290)
T cd07862 144 TSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220 (290)
T ss_pred cCCCCEEEccccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 9999999999999986654321 1456789999999999888999999999999999999999999986433221112
Q ss_pred HHHHHHHHhccCCCc------ccccccc---cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPH------RAIDSKL---LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~------~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.+..........+. ..+.+.. .....+.....+.+++.+|++.||++|||+.++++
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 211110000000000 0000000 00011123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=327.81 Aligned_cols=263 Identities=21% Similarity=0.339 Sum_probs=209.0
Q ss_pred ccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..+|.+.+.||+|+||.||++.... .++..+|+|.+.... ......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i 69 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------------DNARKDFHREAELLTNLQHEHI 69 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--------------HHHHHHHHHHHHHHHhCCCCCc
Confidence 3468888999999999999997532 235679999987653 2335678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 381 (532)
+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dl 146 (288)
T cd05093 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDL 146 (288)
T ss_pred ceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 9999999999999999999999999999975321 2235899999999999999999999988 999999
Q ss_pred CCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCc
Q 037084 382 KPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDF 460 (532)
Q Consensus 382 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~ 460 (532)
||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~ 226 (288)
T cd05093 147 ATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226 (288)
T ss_pred CcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986644322211133445778999999998899999999999999999998 99998654
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
... .... .... +.... . ....+..+.+++..||+.+|.+|||+.++++.|+++.
T Consensus 227 ~~~----~~~~---~i~~-~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 227 SNN----EVIE---CITQ-GRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CHH----HHHH---HHHc-CCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 321 1111 1111 11110 0 0112345889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=321.56 Aligned_cols=265 Identities=24% Similarity=0.346 Sum_probs=213.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|....+ |..+|||.+....... .....++.+|+.+++.++||||+++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~vK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~ 69 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLD-GVPVALKKVQIFDLMD-----------AKARADCIKEIDLLKQLNHPNVIKYYA 69 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCC-CceEEEEeeeehhhhh-----------HHHHHHHHHHHHHHHHccCCchhhhhh
Confidence 3678889999999999999987654 8999999886542111 233467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..+++|||+++++|.+++.........+++...+.++.+++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 70 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 999999999999999999999999764445567899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||++.......... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||..... ........
T Consensus 147 l~dfg~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~ 219 (267)
T cd08229 147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK 219 (267)
T ss_pred ECcchhhhccccCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhh
Confidence 99999988765433211 345688999999999988899999999999999999999999964221 11122222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
......+ .. ........+.+++..||+.+|++|||+.+|++.++++.
T Consensus 220 ~~~~~~~------~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQCDYP------PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcCCCC------CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 2111111 00 11224456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=336.31 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=207.9
Q ss_pred ccccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
.+.++|++.+.||+|+||.||+|.+.+. +++.||+|+++.... ......+..|+.++.++ +|
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~~E~~~~~~l~~h 70 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------------ASEYKALMTELKILIHIGHH 70 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------------HHHHHHHHHHHHHHHhhccC
Confidence 3566899999999999999999975432 357899999976432 12235677899999999 89
Q ss_pred CCcccceeEEecC-CceEEEEEeccCCCHHHHHhhhcCC-----------------------------------------
Q 037084 308 RNLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQG----------------------------------------- 345 (532)
Q Consensus 308 ~niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------- 345 (532)
|||++++++|... ...++++||+++++|.+++......
T Consensus 71 ~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (337)
T cd05054 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIED 150 (337)
T ss_pred cchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccC
Confidence 9999999988654 5678999999999999998642210
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCC
Q 037084 346 ----------------RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409 (532)
Q Consensus 346 ----------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~ 409 (532)
..++++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~ 227 (337)
T cd05054 151 KSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDP 227 (337)
T ss_pred cchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCc
Confidence 136899999999999999999999988 9999999999999999999999999998765443
Q ss_pred cceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccc
Q 037084 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDS 488 (532)
Q Consensus 410 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 488 (532)
.........++..|+|||++.+..++.++|||||||++|||++ |..||....... .+ ......+....
T Consensus 228 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~~---- 296 (337)
T cd05054 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF----CRRLKEGTRMR---- 296 (337)
T ss_pred chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH----HHHHhccCCCC----
Confidence 3222234556778999999999999999999999999999998 999997532211 11 11111111100
Q ss_pred cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 489 KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 489 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........+.+++..||+.+|++||++.++++.|+++-
T Consensus 297 -----~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 297 -----APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred -----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01122345889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.05 Aligned_cols=267 Identities=27% Similarity=0.386 Sum_probs=205.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|.+.+.||+|.||.|-+|+... +++.||||++.............+........+...+|+.+|++++|||||+|+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4679999999999999999998775 499999999977543322211111111122356889999999999999999999
Q ss_pred eEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
.+..++ +.+|||+|||..|.+...- .....++..+.++++.++..||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999876 6789999999988774332 22333999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCc---ceeeeccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 393 EARISDFGLAKLMPDGHT---RIRITTVAGTTGYVAPEYHQTLT----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
++||+|||.+..+..+.. .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-+....
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~-- 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL-- 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH--
Confidence 999999999987744321 11124578999999999877643 356789999999999999999999764331
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+....+. ...+.-...++..+.+.+|++.+|.+||++|.+..+|..
T Consensus 326 -----~l~~KIv---------n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 -----ELFDKIV---------NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred -----HHHHHHh---------cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 1112211 112222223355677999999999999999999988754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=303.43 Aligned_cols=268 Identities=25% Similarity=0.318 Sum_probs=215.7
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|||+-||+++.-. ++..+|+|++.... .+..+...+|++..++++|||+++
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s-~~~~YAlKkI~c~~--------------~~~~e~~~rEid~~rkf~s~~vl~ 82 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLS-TGHLYALKKILCHS--------------QEDIEEALREIDNHRKFNSPNVLR 82 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccC-cccchhhheeeccc--------------hHHHHHHHHHHHHHHhhCCcchHH
Confidence 456789999999999999999998554 48899999999885 345677889999999999999999
Q ss_pred ceeEEecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 313 LQAHVTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 313 l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
+++++..+. ..||+++|...|||.+.+......+..+++.+.++|+.++++||.+||+.. +++.||||||.|||
T Consensus 83 l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NIL 161 (302)
T KOG2345|consen 83 LVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANIL 161 (302)
T ss_pred HHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeE
Confidence 999885543 489999999999999999987777778999999999999999999999975 57999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcc-------eeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCC
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTR-------IRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPF 457 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~ 457 (532)
+.+.+.+++.|||.++...-.-.. ..-.....|..|+|||.+. +...++++|||||||++|.|+.|..||
T Consensus 162 ls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 162 LSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 999999999999999876432111 0112345688999999875 456789999999999999999999999
Q ss_pred CCcccchhhccHHHHHHHHhccCCCcccccc-cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 458 DDFFQYTEEMNMVRWMRNVISSENPHRAIDS-KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+...+.... ..-.+-. .+.-...+..++.+.+++.+|+++||.+||+..+++..++.+-
T Consensus 242 e~~~~~GgS---------------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 242 ERIYQQGGS---------------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hHHhhcCCe---------------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 864432111 1111111 1111111225677899999999999999999999999998763
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=331.63 Aligned_cols=202 Identities=27% Similarity=0.419 Sum_probs=176.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|++.+.||+|+||.||++.+..+ |..+|+|.+..... ......+.+|+.++++++||||+++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPS-GLIMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGF 68 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCC-CcEEEEEEeecccC-------------HHHHHHHHHHHHHHHHCCCCcccce
Confidence 356899999999999999999988764 88999999876421 2234568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++|...+..++||||+++|+|.+++.. ...+++.....++.+++.||.|||+. + ++|+||||+||++++++
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~ 141 (333)
T cd06650 69 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRG 141 (333)
T ss_pred eEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCC
Confidence 9999999999999999999999999975 34588999999999999999999974 5 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
.+||+|||++........ ....||..|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 142 ~~kL~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 142 EIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CEEEeeCCcchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999876543321 3457899999999999989999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=327.55 Aligned_cols=262 Identities=22% Similarity=0.347 Sum_probs=209.3
Q ss_pred cCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.+|.+.+.||+|+||.||+|.+.. .++..+++|.+.... ......+.+|+..+++++||||+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~ 70 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------------LAARKDFQREAELLTNLQHEHIV 70 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------------HHHHHHHHHHHHHHhcCCCCCcc
Confidence 357788999999999999998643 234579999987653 22345688999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.|++|||+.+ ++||
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~ 147 (291)
T cd05094 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHR 147 (291)
T ss_pred eEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999999975321 2245899999999999999999999998 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||++++++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 227 (291)
T cd05094 148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227 (291)
T ss_pred ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986544332222234556788999999999999999999999999999999 999986
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... ...+. . ..+.... .....+..+.+++.+||+.+|++|||+.+++++|+++.
T Consensus 228 ~~~~~----~~~~~---~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 228 QLSNT----EVIEC---I-TQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred CCCHH----HHHHH---H-hCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 53321 11111 1 1111111 11123456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=320.00 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=198.7
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|+||.||+|.+..+ |+.+|+|.+..... ......+.+|+.++++++||||++++++|...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 66 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRAD-NTPVAVKSCRETLP-------------PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 66 (252)
T ss_pred CccCcccCccEEEEEEecC-CceEEEEecCccCC-------------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC
Confidence 4699999999999998764 89999998865421 223467889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 67 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 140 (252)
T cd05084 67 PIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGM 140 (252)
T ss_pred CeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECcccc
Confidence 99999999999999999964 2346899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+................++..|+|||.+.++.++.++|+||||+++|+|++ |..||..... ..... .....
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~----~~~~~----~~~~~ 212 (252)
T cd05084 141 SREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN----QQTRE----AIEQG 212 (252)
T ss_pred CcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH----HHHHH----HHHcC
Confidence 876543221111112223457999999999999999999999999999998 8899865322 11111 11111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
... ......+..+.+++..|++.+|++|||+.++.++|+.
T Consensus 213 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 213 VRL---------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCC---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 100 1111234568889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=352.06 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=207.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|....+ |+.||||++...... ......+.+|+..+..++|+|++++
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~-g~~vAvK~i~~~~~~------------~~~~~~~~~Ei~~l~~~~h~~iv~~ 96 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSD-GEPFAVKVVDMEGMS------------EADKNRAQAEVCCLLNCDFFSIVKC 96 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCC-CCEEEEEEEecccCC------------HHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 356899999999999999999987654 899999999765332 2334567889999999999999998
Q ss_pred eeEEecCC--------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 314 QAHVTRPD--------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 314 ~~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
...+...+ ..++||||+++|+|.+++.........+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~N 173 (496)
T PTZ00283 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSAN 173 (496)
T ss_pred ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 87775432 357999999999999999865445567899999999999999999999988 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--- 250 (496)
T PTZ00283 174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--- 250 (496)
T ss_pred EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---
Confidence 99999999999999999876543222222456799999999999999999999999999999999999999975321
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.......... ..+.....+.+++..||+.+|.+||++.++++
T Consensus 251 ----~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 251 ----EEVMHKTLAGRYDP----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ----HHHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 22222222211110 11123345888999999999999999999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.51 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=193.8
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||.||+|....+ +..||+|.+...... .......+..|+.++.+++||||+++++++..++..
T Consensus 1 lg~G~~g~Vy~~~~~~~-~~~~aiK~i~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 68 (312)
T cd05585 1 IGKGSFGKVMQVRKRDT-QRIYALKTIRKAHIV-----------SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKL 68 (312)
T ss_pred CCcCCCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeE
Confidence 79999999999988754 889999998643111 123356788899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 69 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 69 YLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 999999999999999965 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ........... .
T Consensus 142 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~-~- 210 (312)
T cd05585 142 LNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEP-L- 210 (312)
T ss_pred cCccCCCc--cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCC-C-
Confidence 64332221 1456799999999999999999999999999999999999999975322 12222222211 1
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
.........+.+++..||+.||.+||+...+
T Consensus 211 ---------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 211 ---------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 0111223457889999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=317.70 Aligned_cols=266 Identities=25% Similarity=0.348 Sum_probs=215.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.... +|+.||+|.++...... ......+.+|+.++++++|+|++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~-----------~~~~~~~~~ei~~l~~~~~~~i~~~~~ 69 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMD-----------AKARQDCLKEIDLLKQLDHPNVIKYLA 69 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccc-----------hhhHHHHHHHHHHHHhCCCCCeeeeee
Confidence 468888999999999999998875 48999999987532211 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVK 146 (267)
T ss_pred eeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEE
Confidence 999999999999999999999999765455567899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ....+....
T Consensus 147 l~d~~~~~~~~~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~ 219 (267)
T cd08224 147 LGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK 219 (267)
T ss_pred EeccceeeeccCCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh
Confidence 99999988664432211 34568899999999998889999999999999999999999986422 222222222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
......+. .........+.+++..||+.+|++|||+.+++++|+++++
T Consensus 220 ~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 220 IEKCDYPP---------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred hhcCCCCC---------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 21111100 0112344568899999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=327.17 Aligned_cols=266 Identities=22% Similarity=0.279 Sum_probs=199.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|....+ |+.||+|++...... .....+.+|+.++++++||||+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~ 68 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVN-GKLVALKVIRLQEEE-------------GTPFTAIREASLLKGLKHANIVLL 68 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCC-CCEEEEEEecccccc-------------ccchhHHHHHHHHhhCCCCCcCeE
Confidence 356799999999999999999988754 899999998754321 112356789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++......++||||+ .++|.+++.. ....++...+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 69 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 141 (303)
T cd07869 69 HDIIHTKETLTLVFEYV-HTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGE 141 (303)
T ss_pred EEEEecCCeEEEEEECC-CcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999 4688888764 2345888899999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+||+|||+++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||....... .....
T Consensus 142 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~ 216 (303)
T cd07869 142 LKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLER 216 (303)
T ss_pred EEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHH
Confidence 99999999875433221 1134678999999998765 457899999999999999999999997643211 11111
Q ss_pred HHHHhccCCC---c-----cccccccc----CCCcH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENP---H-----RAIDSKLL----GNGYE------EQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~---~-----~~~d~~l~----~~~~~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+......... . ..+++... ..... .....+.+++..|++.||++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111110000 0 00000000 00000 01245778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.04 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=209.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|.+.+.||.|+||.||+|.+.. +..+++|.+.... ......+..|+.+++.++||||++++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~~~~i~~~~ 68 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDD--------------LLKQQDFQKEVQALKRLRHKHLISLF 68 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccc--------------hhhHHHHHHHHHHHhcCCCcchhhee
Confidence 4568899999999999999998873 7899999987653 22245678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.. .....+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~ 143 (261)
T cd05148 69 AVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVC 143 (261)
T ss_pred eeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceE
Confidence 999999999999999999999999976 23456899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++.......... ....++..|+|||...+..++.++|+||||+++|+|++ |+.||..... ......+
T Consensus 144 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~ 217 (261)
T cd05148 144 KVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQI 217 (261)
T ss_pred EEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHH
Confidence 999999998765432211 23456778999999988899999999999999999998 8999965322 1122221
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
. ..... ......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 ~---~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 T---AGYRM----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred H---hCCcC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1 11111 01122335588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.74 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=213.2
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
-+|++.+.||+|.||.|-+|..... |+.||||.++.+.... ++..-.+.+|+++++.|+||||+.++.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~s-gR~VAiKsIrKdkIkd-----------eqDlvhIRREIeIMSsLNHPhII~IyE 120 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKS-GREVAIKSIRKDKIKD-----------EQDLVHIRREIEIMSSLNHPHIIQIYE 120 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccC-CcEeehhhhhhhhccc-----------HHHHHHHHHHHHHHhhcCCCceeehhh
Confidence 4689999999999999999987654 9999999998875443 556678899999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|+..+...|||||..+|.|.|++.+ +..+++....+++.||.+++.|.|.++ ++|||||.+|||||.|+++|
T Consensus 121 VFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 121 VFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred hhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCee
Confidence 99999999999999999999999975 567999999999999999999999888 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+||||+.++.+.... ++.+|++-|.+||++.+.+| ++.+|.||||+++|-|+.|..||++.+. ..+ ++
T Consensus 194 IADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~l---vr 263 (668)
T KOG0611|consen 194 IADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRL---VR 263 (668)
T ss_pred eeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHH---HH
Confidence 9999999988776543 68899999999999999988 5789999999999999999999987433 222 22
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
++-.+. . ..++.+....-|+.+|+-.||++|.|+.+|..
T Consensus 264 QIs~Ga-Y-----------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 264 QISRGA-Y-----------REPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred Hhhccc-c-----------cCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 222211 1 11223344777899999999999999999865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=336.76 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=215.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+..+..+||-|.||.||.|.|+.- .-.||||.++.+ ....++|..|+.+++.++|||+|+|+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKED---------------tMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKED---------------TMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhc---------------chhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 3466678899999999999999864 789999999987 445789999999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|.....+|||+|||.+|+|.++|++ .++..++....+.++.||++|++||...+ +|||||..+|+|+.++..+|
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVK 405 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVK 405 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEE
Confidence 99999999999999999999999987 45666888888999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+||||++++..+..... ....-.+.|.|||-+....++.|+|||+|||+|||+.| |..||....- .+. .
T Consensus 406 vADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqV----Y 476 (1157)
T KOG4278|consen 406 VADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQV----Y 476 (1157)
T ss_pred eeccchhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHH----H
Confidence 999999999876543211 12233678999999999999999999999999999998 9999986432 111 1
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.++..+. .-+.+..++..+++|+..||+.+|.+||++.|+.+.+|.+
T Consensus 477 ~LLEkgy---------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 477 GLLEKGY---------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHhccc---------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1222211 1123345667799999999999999999999999999876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.40 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=215.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
..+.+.++||+|.||.|.++... .+..||||.++.... .....+|.+|+++|.+|+||||+.|+|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~-------------~~~r~~F~kEIkiLsqLkhPNIveLvG 602 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDAT-------------KNARNDFLKEIKILSRLKHPNIVELLG 602 (807)
T ss_pred hheehhhhhcCcccceeEEEEec--CceEEEEeecCcccc-------------hhHHHHHHHHHHHHhccCCCCeeEEEe
Confidence 45678899999999999999987 368999999998753 234588999999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|..++.+++++|||++|+|.+|+..+.... +.-....+|+.||+.|++||.+.+ +|||||.++|+|++.++++|
T Consensus 603 VC~~DePicmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iK 677 (807)
T KOG1094|consen 603 VCVQDDPLCMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIK 677 (807)
T ss_pred eeecCCchHHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEE
Confidence 9999999999999999999999998743222 455566779999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCcccchhhccHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV--GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~p~~~~~~~~~~~~l~~~~ 473 (532)
|+|||+++-...+.........+-+.+|||||.+..++++++||||+||+++||+++ ...||..... .+.++-.
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~ 753 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENA 753 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhh
Confidence 999999997655544332245566789999999999999999999999999998765 7789976433 2233322
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
..+....... . ....++-++..+++++..||..+..+|||++++...|++.
T Consensus 754 ~~~~~~~~~~-~-----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 754 GEFFRDQGRQ-V-----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhcCCCCcc-e-----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 2232222111 1 1122445667899999999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=324.79 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=208.7
Q ss_pred ccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..+|.+.+.||+|+||.||+|.+.. .++..||+|.++.... ......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i 70 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-------------NDARKDFEREAELLTNFQHENI 70 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-------------HHHHHHHHHHHHHHHhcCCCCc
Confidence 3468888999999999999998753 2357899999876532 2234678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS----------QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
+++++++......++||||+++++|.+++.... .....+++.....++.|++.|+.|||+.+ ++|||
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~d 147 (280)
T cd05049 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRD 147 (280)
T ss_pred hheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 999999999999999999999999999997632 12345789999999999999999999988 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDD 459 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~ 459 (532)
|||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 148 lkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 148 LATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred cccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999876533322111134456788999999999999999999999999999998 9999865
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
... ......+. .+.... .....+..+.+++..||+.+|++|||+.|+++.|++
T Consensus 228 ~~~----~~~~~~~~----~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 228 LSN----EEVIECIT----QGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCH----HHHHHHHH----cCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 332 12222221 111110 111233558899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=319.14 Aligned_cols=268 Identities=25% Similarity=0.322 Sum_probs=205.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
....|...+.||+|+||.|+.|.+..+ |+.||||.+...-.+ ....++..+|+++|+.++|+||+.+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t-~~~VAIKKi~~~F~~------------~~~akRtlRElklLr~~~HeNIi~l 86 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRT-GEKVAIKKILNPFEN------------QIDAKRTLRELKLLRHLRHENIIGL 86 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCC-CCEeehhhhhhhhhc------------hHHHHHHHHHHHHHHHhcCCCcceE
Confidence 445666689999999999999998876 899999999744221 3335677899999999999999999
Q ss_pred eeEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
.+.+.. -+..|+|+|+| +.+|...++. +..++.....-++.|+++||.|+|+.+ ++||||||+|+++
T Consensus 87 ~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~ 158 (359)
T KOG0660|consen 87 LDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLL 158 (359)
T ss_pred EeecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheee
Confidence 999865 35779999999 7799999974 445889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.+..+||+|||+|+...........+..+.|.+|.|||++. ...|+...||||+||++.||++|++-|.+......-.
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 999999999999999886543333347788999999999654 5579999999999999999999999997654311100
Q ss_pred cHHH----------------HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVR----------------WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~----------------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
-+.+ -++..+.+-.... +.-.....+......++|+.+||..||.+|+|++|.++
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p---~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIP---KQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCC---CCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 0111111110000 00001112233345889999999999999999999875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=323.64 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=204.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
.++|+..+.||+|+||+||+|.+..+ |. .+++|.+..... .....++..|+..++++.||||
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~~~~~l~~l~h~~i 71 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPE-GDSIKIPVAIKTIQDRSG-------------RQTFQEITDHMLAMGSLDHAYI 71 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCC-CCceeeEEEEeecccccc-------------hHHHHHHHHHHHHHhcCCCCCc
Confidence 35688889999999999999988643 44 588888764321 2234577888999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++.. ...++++||+++|+|.+++.. ....+++.....++.|++.||.|||+.+ ++||||||+||++++
T Consensus 72 v~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~ 144 (279)
T cd05111 72 VRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKS 144 (279)
T ss_pred ceEEEEECC-CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcC
Confidence 999999864 557899999999999999975 2346899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+++...............++..|+|||++.++.++.++||||||+++||+++ |..||..... ..+
T Consensus 145 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~ 220 (279)
T cd05111 145 DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEV 220 (279)
T ss_pred CCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999987654332222234567789999999998899999999999999999998 9999975432 112
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+.+ ..+.... .+. .....+.+++..||..+|.+|||+.++++.|..+.
T Consensus 221 ~~~~----~~~~~~~--~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 221 PDLL----EKGERLA--QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHH----HCCCcCC--CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222 1111110 011 12234678899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.30 Aligned_cols=272 Identities=24% Similarity=0.326 Sum_probs=203.9
Q ss_pred ccccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 238 LASLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
|...+.||+|+||+||++... ..++..||+|.+..... ......|.+|+.++++++||||++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 72 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------------QQNTSGWKKEINILKTLYHENIVKYK 72 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 378899999999999887542 23478999999876532 12245688899999999999999999
Q ss_pred eEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++... ...+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~ 144 (283)
T cd05080 73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDR 144 (283)
T ss_pred EEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCC
Confidence 998764 357899999999999999964 24899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.++|+|||+++.......... .....++..|+|||...+..++.++||||||+++|+|++|+.|+....... .....
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~ 222 (283)
T cd05080 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIG 222 (283)
T ss_pred cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhc
Confidence 999999999987654332111 122345667999999988899999999999999999999999986532210 00000
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
+.............++...........+..+.+++..||+.+|++|||++++++.|+++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 0000000000001111111111122344678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=330.70 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=196.0
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|+||.||++....+ |..||+|++...... .......+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~ 68 (323)
T cd05595 1 KLLGKGTFGKVILVREKAT-GRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 68 (323)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence 4699999999999987754 899999998753211 1233456778999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 69 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHH
Confidence 99999999999999988864 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 481 (532)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .
T Consensus 142 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~---~~~~~~~-~ 211 (323)
T cd05595 142 CKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RL---FELILME-E 211 (323)
T ss_pred hccccCCCCc--cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HH---HHHHhcC-C
Confidence 8754322211 13467999999999999999999999999999999999999999753221 11 1111111 1
Q ss_pred CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 482 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
. . ........+.+++..||+.||++|| ++.++++
T Consensus 212 ~------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 I------R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C------C----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 0 0 0111234578899999999999998 7877764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=324.73 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=203.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||+|+||.||++.+..+ ++.||+|.+....... ......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKK-----------RKGEAMALNEKQILEKVNSRFVVSLAYA 68 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCC-CceEEEEEEehhhhhh-----------hhhHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 367789999999999999987654 8999999987542211 2224567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..++||||+++|+|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 69 YETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred ecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEE
Confidence 9999999999999999999998865 23456899999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... ....|+..|+|||++.+..++.++||||+||++|+|++|+.||...... .....+...
T Consensus 144 ~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~----~~~~~~~~~ 216 (285)
T cd05605 144 SDLGLAVEIPEGETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK----VKREEVERR 216 (285)
T ss_pred eeCCCceecCCCCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh----hHHHHHHHH
Confidence 999999876433221 3457899999999999889999999999999999999999999753221 111111111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
..... ..........+.+++..||+.||.+|| +++++++
T Consensus 217 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 217 VKEDQ----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hhhcc----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11111 011122345588899999999999999 7878754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=336.18 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=215.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|..++++|+|+||.++.++++.. ++.+++|.+....... ...+...+|+.++++++|||||.+.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~-~~~~vlK~I~l~~~t~------------~~r~~A~~E~~lis~~~hP~iv~y~d 70 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSD-DKLYVLKKINLEKLTE------------PERRSAIQEMDLLSKLLHPNIVEYKD 70 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccC-CceEEEEEEeccccCc------------hhhHHHHHHHHHHHhccCCCeeeecc
Confidence 5788999999999999999988764 8899999998876543 23346788999999999999999999
Q ss_pred EEecCCc-eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 316 HVTRPDC-HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 316 ~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
.+.+++. .+|||+||+||+|.+.+.+. .+..+++..+++++.|++.|+.|||+.+ |+|||||+.||+++.++.+
T Consensus 71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~V 145 (426)
T KOG0589|consen 71 SFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKV 145 (426)
T ss_pred chhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCce
Confidence 9999998 99999999999999999874 3677999999999999999999999888 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||+|+......... ...+||+.|+.||.+.+.+|..|+|+|||||++|||++-+++|...+. ...+.
T Consensus 146 kLgDfGlaK~l~~~~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ 216 (426)
T KOG0589|consen 146 KLGDFGLAKILNPEDSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELIL 216 (426)
T ss_pred eecchhhhhhcCCchhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHH
Confidence 999999999987765333 578999999999999999999999999999999999999999976432 22222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
...... + ...+.....++..++..|++.+|..||++.+++..
T Consensus 217 ki~~~~-----~-----~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 217 KINRGL-----Y-----SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHhhcc-----C-----CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222211 1 11123344568888999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=340.31 Aligned_cols=249 Identities=28% Similarity=0.373 Sum_probs=209.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
-|++.+.||.|+-|.|-+|++..+ |+.+|||++....... ......+.+|+-+|+-+.|||++.|+++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~T-GqlaaiKii~k~~~~s-----------~s~~~~IerEIviMkLi~HpnVl~LydV 80 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAET-GQLAAIKIIPKRSELS-----------SSQPAGIEREIVIMKLIEHPNVLRLYDV 80 (786)
T ss_pred ceeccccccCCCCceehhhhcccc-cceeEEEeeccccccc-----------cccccchhhhhHHHHHhcCCCeeeeeee
Confidence 377889999999999999998875 9999999997763111 2223567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+++..++|+|.||+++|.|.+++-. ++++++....+++.||..|+.|+|..+ |+||||||+|+|||..+++||
T Consensus 81 we~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKI 153 (786)
T KOG0588|consen 81 WENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKI 153 (786)
T ss_pred eccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEee
Confidence 9999999999999999999999975 567999999999999999999999999 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS-EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||+|..-..+... .+.+|.+-|.+||++.+.+|. .++||||+|||+|.||||+.||++. ++...+..
T Consensus 154 ADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir~LLlK 223 (786)
T KOG0588|consen 154 ADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIRVLLLK 223 (786)
T ss_pred eccceeecccCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHHHHHHH
Confidence 999999876554432 678999999999999999884 6899999999999999999999852 23333333
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... +... .+...+.++.+|+..|+..||..|.|+++|++
T Consensus 224 V~~-G~f~----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 224 VQR-GVFE----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred HHc-Cccc----------CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 222 2211 12334456889999999999999999999986
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.07 Aligned_cols=271 Identities=24% Similarity=0.334 Sum_probs=210.7
Q ss_pred cccccccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 037084 228 DIAFLTKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303 (532)
Q Consensus 228 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 303 (532)
+..+..+.++|.+.+.||+|+||.||+|.+.+ ..+..||+|+++.... ......+.+|+.++.
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~~E~~~l~ 95 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------------SSEKQALMSELKIMS 95 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------------hhHHHHHHHHHHHHH
Confidence 33344556788999999999999999998753 2346899999986532 122346889999999
Q ss_pred cCC-CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------------------------------
Q 037084 304 RIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------------------------------------- 344 (532)
Q Consensus 304 ~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------- 344 (532)
++. ||||++++++|...+..++|+|||++|+|.++++....
T Consensus 96 ~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (401)
T cd05107 96 HLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESD 175 (401)
T ss_pred hcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccC
Confidence 997 99999999999999999999999999999999975321
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 037084 345 --------------------------------------------------------GRRELDWLARYRIARGMASGLEYL 368 (532)
Q Consensus 345 --------------------------------------------------------~~~~l~~~~~~~i~~~ia~gl~~L 368 (532)
....+++.....++.|++.||.||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 255 (401)
T cd05107 176 GGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL 255 (401)
T ss_pred ccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 113467888899999999999999
Q ss_pred HhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHH
Q 037084 369 HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448 (532)
Q Consensus 369 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 448 (532)
|+.+ ++||||||+|||+++++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 256 H~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 256 ASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred hcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 9888 9999999999999999999999999998654332211113345678899999999888999999999999999
Q ss_pred HHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 449 VLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 449 ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
||++ |..||....... ........+... .........+.+++..||+.+|.+||+++++++.|
T Consensus 333 e~l~~g~~P~~~~~~~~-------~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 333 EIFTLGGTPYPELPMNE-------QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHcCCCCCCCCCchH-------HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 899986532211 111111111100 00111235688899999999999999999999999
Q ss_pred hhh
Q 037084 528 SQI 530 (532)
Q Consensus 528 ~~l 530 (532)
+++
T Consensus 397 ~~~ 399 (401)
T cd05107 397 GDL 399 (401)
T ss_pred HHH
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=324.95 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=205.8
Q ss_pred CccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
+|.+.+.||+|+||.||+|..... ....+++|.+..... ......+.+|+.+++.++||||++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~ 67 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------------SSELRDLLSEFNLLKQVNHPHVIK 67 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------------HHHHHHHHHHHHHHhhCCCCCEee
Confidence 367788999999999999986532 135799998876532 122467889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--------------------GRRELDWLARYRIARGMASGLEYLHMYH 372 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~ 372 (532)
+++.|...+..++++||+++++|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 147 (290)
T cd05045 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK 147 (290)
T ss_pred EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999875321 1245889999999999999999999988
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
++||||||+||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 148 ---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t 224 (290)
T cd05045 148 ---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224 (290)
T ss_pred ---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999986544332222233455678999999988889999999999999999998
Q ss_pred -CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 453 -GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 453 -g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
|..||..... ..+..... ..... .........+.+++..|++.+|++||++.++++.|+++
T Consensus 225 ~g~~p~~~~~~----~~~~~~~~----~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 225 LGGNPYPGIAP----ERLFNLLK----TGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred cCCCCCCCCCH----HHHHHHHh----CCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 9999965322 11222211 11100 01112234588899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.06 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=205.6
Q ss_pred ccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
|.+.+.||+|+||.||+|.+.... +..||+|.++..... ......+.+|+..++.++|||++++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 68 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT------------YSEIEEFLSEAACMKDFDHPNVMKLIG 68 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC------------HHHHHHHHHHHHHHHhCCCCCeeeEEe
Confidence 456789999999999999876432 478999998765322 233467889999999999999999999
Q ss_pred EEecCCc------eEEEEEeccCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 316 HVTRPDC------HLLVYEFMKNGSLQDILHDVS--QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 316 ~~~~~~~------~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++..... .++++||+++|+|..++.... .....+++.....++.|++.||.|||+.+ ++||||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil 145 (273)
T cd05035 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCM 145 (273)
T ss_pred eeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEE
Confidence 9876554 689999999999999986532 22346899999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~ 466 (532)
+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05035 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221 (273)
T ss_pred ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654432211123345678999999988899999999999999999999 8899865322
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
..+.++ ......+. .....+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 222 ~~~~~~---~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 222 HEIYDY---LRHGNRLK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHH---HHcCCCCC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 122222 22111111 1122345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=323.88 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=205.2
Q ss_pred cCccccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
++|++.+.||+|+||.||+|.+. ...+..+++|.+..... ......+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~ 71 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-------------PQQWGEFQQEASLMAELHHPNIVC 71 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-------------HHHHHHHHHHHHHHhhCCCCCeee
Confidence 46788899999999999999863 22367899999975432 223457889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
+++++..++..++||||+++++|.+++..... ....+++.....++.|++.||.|||+.+ ++|+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~ 148 (283)
T cd05090 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHK 148 (283)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehh
Confidence 99999999999999999999999999864211 1235788999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999987644322211234456778999999988899999999999999999998 999986
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.... ..+.+.+.. ...+. .....+..+.+++..||+.+|.+||++.++.+.|..
T Consensus 229 ~~~~----~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 229 GFSN----QEVIEMVRK---RQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCH----HHHHHHHHc---CCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 5322 112221111 11110 111223457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=322.08 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=206.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
.++|...+.||+|+||+||+|.+..+ |. +||+|.+..... ......+.+|+.++..++||||
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-~~~~~~~va~K~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~i 71 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPD-GENVKIPVAIKVLRENTS-------------PKANKEILDEAYVMAGVGSPYV 71 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecC-CCccceEEEEEEecCCCC-------------HHHHHHHHHHHHHHHhcCCCCC
Confidence 45788899999999999999987654 44 589999875432 2234568889999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++... ..++++||+++|+|.++++. ....+++.....++.|++.||+|||+.+ ++||||||+||++++
T Consensus 72 ~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~ 144 (279)
T cd05109 72 CRLLGICLTS-TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKS 144 (279)
T ss_pred ceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcC
Confidence 9999999764 56899999999999999975 2346899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||..... ..+
T Consensus 145 ~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~ 220 (279)
T cd05109 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REI 220 (279)
T ss_pred CCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHH
Confidence 99999999999987754433222123345678999999999899999999999999999998 9999975332 222
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..++.. ...+. .....+..+.+++..||+.||++||++.++++.|+++.
T Consensus 221 ~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 221 PDLLEK---GERLP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHHHHC---CCcCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 222221 11110 01123345888999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=332.85 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=196.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|....+ |..||||.+...... ......+.+|+.++++++||||++++++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 67 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHT-GEKVAIKKINDVFEH------------VSDATRILREIKLLRLLRHPDIVEIKHI 67 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCC-CCEEEEEEechhhcc------------chhHHHHHHHHHHHHhCCCCCEeeecce
Confidence 377889999999999999987754 899999998743211 1223567899999999999999999998
Q ss_pred EecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 317 VTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 317 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+...+ ..|+||||| +++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+|||++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~ 139 (338)
T cd07859 68 MLPPSRREFKDIYVVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139 (338)
T ss_pred EeccCCCCCceEEEEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCC
Confidence 86432 479999999 5789998864 345899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCc-ceeeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMPDGHT-RIRITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... .
T Consensus 140 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~----~ 215 (338)
T cd07859 140 CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV----H 215 (338)
T ss_pred CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH----H
Confidence 9999999999986533221 111234678999999998865 67899999999999999999999999753321 1
Q ss_pred HHHHHHHHhccC-----------CCccc---ccc---cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSE-----------NPHRA---IDS---KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~-----------~~~~~---~d~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+....... ..... +.. .......+.....+.+++..||+.+|++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111111110000 00000 000 0000001112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=324.16 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=198.9
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||+||++.+..+ |+.+|+|.+....... ......+..|+.++++++||||+++.+++...+..
T Consensus 1 lg~G~~g~Vy~~~~~~~-~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 68 (280)
T cd05608 1 LGKGGFGEVSACQMRAT-GKLYACKKLNKKRLKK-----------RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDL 68 (280)
T ss_pred CCCCCceeEEEEEEccC-CcEEEEEeeeHHHHhh-----------hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeE
Confidence 79999999999988764 8999999987542111 22345678899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 69 CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred EEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 9999999999999988654444567899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
........ .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......... ......... ..
T Consensus 146 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~-~~- 218 (280)
T cd05608 146 ELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRILND-SV- 218 (280)
T ss_pred ecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhhccc-CC-
Confidence 66543321 134578999999999999999999999999999999999999997532211111 111111111 00
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
......+..+.+++..||+.||++|| +++++++
T Consensus 219 ---------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 ---------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ---------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11122345588899999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=332.85 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|+||.||++....+ |..||+|++...... .......+.+|+.+++.++||||+++.+++...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 68 (328)
T cd05593 1 KLLGKGTFGKVILVREKAS-GKYYAMKILKKEVII-----------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD 68 (328)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence 4699999999999988754 899999998753211 1233467788999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 69 ~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 69 RLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcC
Confidence 99999999999999998864 346899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 481 (532)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . ......... .
T Consensus 142 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~----~---~~~~~~~~~-~ 211 (328)
T cd05593 142 CKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E---KLFELILME-D 211 (328)
T ss_pred CccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH----H---HHHHHhccC-C
Confidence 875433221 11456799999999999998999999999999999999999999975322 1 111111111 1
Q ss_pred CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 482 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
. .+ .......+.+++..||+.||++|| ++.++++
T Consensus 212 ~------~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 212 I------KF----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred c------cC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0 00 111234578899999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=319.94 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=202.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+. ++..+|+|.+..... ....|.+|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSM---------------SEDEFIEEAKVMMKLSHEKLVQLYG 66 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCcc---------------cHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 45788899999999999999876 355799999876532 1246888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..+++|||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~k 140 (256)
T cd05113 67 VCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVK 140 (256)
T ss_pred EEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEE
Confidence 999999999999999999999999752 236899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++........ ......++..|+|||+..+..++.++||||||+++|+|++ |..||...... ....
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~--- 212 (256)
T cd05113 141 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVE--- 212 (256)
T ss_pred ECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH---
Confidence 9999998866443221 1123345678999999998889999999999999999999 99999753321 1111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
......... ........+.+++..||+.+|.+|||+.++++.|+
T Consensus 213 ~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 213 KVSQGLRLY----------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHhcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111111110 01112356889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.36 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=203.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.++++||+|.||.|+++..+++ ++.+|||+++....-. ....+..+.|.+++.-. +||.+++|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~-~e~yAIK~LKK~~Il~-----------~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGT-NEYYAIKVLKKGDILQ-----------RDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCC-CcEEEEEEeeccceec-----------cccHHHHHHHHHHHHHhccCCeEeec
Confidence 46899999999999999999999986 8899999999875332 34456677777777766 69999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+.+|+.++++|+||||+.||++..+. ....+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|+
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCc
Confidence 99999999999999999999954433 3467999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++.--.... +.++.+||+.|+|||++.++.|+..+|.|||||+|||||.|..||...++.+ + .
T Consensus 507 ~kiADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee----~---F 577 (694)
T KOG0694|consen 507 VKIADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE----V---F 577 (694)
T ss_pred EEecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH----H---H
Confidence 99999999997543222 2378999999999999999999999999999999999999999998644421 1 1
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
..++..+. .++...+.+...++.+++..+|++|..+
T Consensus 578 dsI~~d~~-----------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVNDEV-----------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcCCC-----------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22222111 1233445678889999999999999876
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.18 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=204.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|....+ |+.||+|++....... ......+..|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDT-GQVYAMKVLRKSDMIK-----------RNQIAHVRAERDILADADSPWIVKLYY 68 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCC-CCEEEEEEEEHHHHhh-----------ccHHHHHHHHHHHHHhcCCCCccchhh
Confidence 3688899999999999999988764 8999999987532110 233567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..++||||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 69 SFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred heecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 99999999999999999999999975 256899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCC---------------------------cceeeeccccccccccccccccCCCCchhhHHHHHHHHH
Q 037084 396 ISDFGLAKLMPDGH---------------------------TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448 (532)
Q Consensus 396 l~DFGla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 448 (532)
|+|||++....... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999998765432 001123467899999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 037084 449 VLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-SKDVRC 525 (532)
Q Consensus 449 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~ 525 (532)
||++|+.||...........+..|.... ... ........+.+++..|+. +|.+||+ +.++++
T Consensus 222 ell~g~~Pf~~~~~~~~~~~i~~~~~~~----~~p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 222 EMLYGFPPFYSDTLQETYNKIINWKESL----RFP----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hhccCCCCCCCCCHHHHHHHHhccCCcc----cCC----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 9999999997643211111111111000 000 001134557888889997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.86 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=204.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+..... ....|.+|+.++++++||||+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~ 66 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQL 66 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecC--CceEEEEecccCcc---------------CHHHHHHHHHHHHhCCCCCcceE
Confidence 34568999999999999999998763 45799999976421 12467889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+ +..++||||+++|+|.+++... ....+++..+..++.+++.||+|||+.+ ++|+||||+||++++++.
T Consensus 67 ~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~ 140 (262)
T cd05071 67 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLV 140 (262)
T ss_pred EEEECC-CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCc
Confidence 998754 5679999999999999999752 3346789999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||.++......... .....++..|+|||+..+..++.++|+||||+++|+|++ |..||...... ..
T Consensus 141 ~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~--- 212 (262)
T cd05071 141 CKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EV--- 212 (262)
T ss_pred EEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HH---
Confidence 9999999998765443221 123456778999999988899999999999999999999 88898753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.......... ......+..+.+++..|++.+|++|||+.++++.|++.
T Consensus 213 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 213 LDQVERGYRM----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHhcCCCC----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1111111111 01123455688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=324.76 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=208.4
Q ss_pred cccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
..++|.+.+.||+|+||.||+|.+. ..++..||+|.++.... ......+.+|+.+++++ +||
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~ 99 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------------SSEREALMSELKIMSHLGNHE 99 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------------hHHHHHHHHHHHHHHhccCCC
Confidence 4467899999999999999999753 22356899999876431 12346788999999999 899
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
||+++++++...+..++||||+++|+|.++++. .....+++.....++.+++.||.|||+.+ ++|+||||+||++
T Consensus 100 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~ 174 (302)
T cd05055 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLL 174 (302)
T ss_pred CcceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEE
Confidence 999999999999999999999999999999975 22334899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 467 (532)
+.++.++++|||+++...............++..|+|||.+.+..++.++||||+||++|+|++ |..||.......
T Consensus 175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--- 251 (302)
T cd05055 175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--- 251 (302)
T ss_pred cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---
Confidence 9999999999999987654432222233456788999999999999999999999999999998 999987543211
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.... ....+.... ........+.+++..|++.+|++|||+.++++.|+++
T Consensus 252 ~~~~----~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 KFYK----LIKEGYRMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHH----HHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111 111111100 0111234588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.27 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=201.6
Q ss_pred cccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.+.+.||+|+||.||+|.+... +. .+|+|.++..... ......+..|+.+++.++||||++++++
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~-~~~~~~a~k~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICT------------RSEMEDFLSEAVCMKEFDHPNVMRLIGV 68 (272)
T ss_pred ccccccCcccCceEEEeEEccC-CCeeeEEEEecccCcCC------------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4568899999999999988654 43 6999998764321 2335678899999999999999999998
Q ss_pred EecC------CceEEEEEeccCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 317 VTRP------DCHLLVYEFMKNGSLQDILHDVS--QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 317 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+... ...++++||+++|+|.+++.... .....+++.....++.|++.||+|||+.+ ++||||||+||++
T Consensus 69 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~ 145 (272)
T cd05075 69 CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCML 145 (272)
T ss_pred EccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEE
Confidence 7532 24689999999999999885322 22345899999999999999999999988 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 467 (532)
++++.++|+|||+++...............+++.|+|||+..+..++.++|+||||+++|+|++ |+.||..... .
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~ 221 (272)
T cd05075 146 NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----S 221 (272)
T ss_pred cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----H
Confidence 9999999999999987654332111123345778999999999999999999999999999999 8899975322 1
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+ .........+. ..+..+..+.+++..||+.+|++|||+.++++.|+++
T Consensus 222 ~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 222 EI---YDYLRQGNRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HH---HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11111111111 1112334588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.73 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=196.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
...+|.+.+.||+|+||.||+|.+..+ ++.||||++.... ....+|+.+++.++||||+++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~-~~~vAiK~i~~~~------------------~~~~~Ei~il~~l~h~niv~l 124 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDT-SEKVAIKKVLQDP------------------QYKNRELLIMKNLNHINIIFL 124 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCC-CCEEEEEEEecCc------------------chHHHHHHHHHhcCCCCCcce
Confidence 346799999999999999999988754 8899999886542 123468999999999999999
Q ss_pred eeEEecC--------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 314 QAHVTRP--------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 314 ~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
++++... ...++||||++ ++|.+++.........+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 125 ~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~N 200 (440)
T PTZ00036 125 KDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQN 200 (440)
T ss_pred eeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHH
Confidence 8876432 23578999996 5788887654445667999999999999999999999998 9999999999
Q ss_pred EEecCCC-cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 386 VLIDDGM-EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 386 Ill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
||++.++ .+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|.+||......
T Consensus 201 ILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 277 (440)
T PTZ00036 201 LLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277 (440)
T ss_pred EEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999665 6999999999876543321 345789999999987654 6899999999999999999999999764331
Q ss_pred hhhccHHHHH--------HHH---hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 464 TEEMNMVRWM--------RNV---ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 464 ~~~~~l~~~~--------~~~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+.... ... ...-.........+........+.++.+++..||+.+|.+|||+.++++
T Consensus 278 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 278 DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 1111111110 000 0000000000000111111123456889999999999999999999874
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=323.94 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=206.7
Q ss_pred CccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
+|.+.+.||+|+||.||+|.+.++ .+..||+|+++.... ......+..|+.++..++||||++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~~iv~ 72 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-------------GPLREEFKHEAMMRSRLQHPNIVC 72 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-------------HHHHHHHHHHHHHHhcCCCCCcCe
Confidence 577889999999999999987532 257899999986532 122466889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVS------------QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
+++++...+..++++||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ ++|||
T Consensus 73 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~d 149 (283)
T cd05091 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKD 149 (283)
T ss_pred EEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 9999999999999999999999999985321 11245888999999999999999999988 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDD 459 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~ 459 (532)
|||+||++++++.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus 150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 150 LATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred cchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999887644332222234456789999999988899999999999999999998 8889875
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
... . ++.......... ......+..+.+++..||+.+|++||++.++++.|+.
T Consensus 230 ~~~----~---~~~~~i~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 230 YSN----Q---DVIEMIRNRQVL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCH----H---HHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 322 1 222222221111 0112234558899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=319.94 Aligned_cols=256 Identities=27% Similarity=0.421 Sum_probs=205.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|++.++||+|+||.||+|..+ +++.||+|.+..... ....+.+|+.++++++|||++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGSM---------------SPEAFLAEANLMKQLQHPRLVRL 66 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCCC---------------cHHHHHHHHHHHHhcCCcCeeeE
Confidence 3567899999999999999999865 478999999876532 12467889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++. .+..++++||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 67 ~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05067 67 YAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLC 140 (260)
T ss_pred EEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCC
Confidence 99875 4678999999999999999875 33456899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++.......... .....++..|+|||++.+..++.++|+||||+++|++++ |+.||..... .....
T Consensus 141 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~- 214 (260)
T cd05067 141 CKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQ- 214 (260)
T ss_pred EEEccCcceeecCCCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHH-
Confidence 9999999998765332211 123446778999999999899999999999999999999 9999975332 11111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
......... .....+..+.+++.+|++.+|++|||+++++..|+.+
T Consensus 215 --~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 215 --NLERGYRMP----------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred --HHHcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 111111110 0111234588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=335.49 Aligned_cols=206 Identities=24% Similarity=0.359 Sum_probs=176.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|+..+.||+|+||+||+|....+ |+.||+|++...... .......+..|+.++.+++||||+++++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~~~~iv~~~~ 68 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDT-GHVYAMKILRKADML-----------EKEQVGHIRAERDILVEADSLWVVKMFY 68 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCC-CCEEEEEEEEHHHHH-----------HhhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4688899999999999999988764 899999999753211 1233467888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.+.+.+..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 69 SFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred EEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEE
Confidence 99999999999999999999999975 346899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcc---------------------------------eeeeccccccccccccccccCCCCchhhHHH
Q 037084 396 ISDFGLAKLMPDGHTR---------------------------------IRITTVAGTTGYVAPEYHQTLTISEKSDIYS 442 (532)
Q Consensus 396 l~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 442 (532)
|+|||+++........ ......+||+.|+|||++.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 9999998765321100 0012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCc
Q 037084 443 FGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 443 lGvvl~elltg~~p~~~~ 460 (532)
|||++|||++|+.||...
T Consensus 222 lGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred hHHHHHHHHhCCCCCCCC
Confidence 999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=325.19 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=210.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
..++|...+.||+|+||.||++.+... ....+|+|.+..... ......+.+|+.++.++ +||
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~ 76 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-------------EKDLSDLVSEMEMMKMIGKHK 76 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-------------HHHHHHHHHHHHHHHhhcCCC
Confidence 446788899999999999999987632 236899999876422 22345688899999999 899
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS------------QGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 376 (532)
||+++++++...+..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ +
T Consensus 77 ~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---i 153 (293)
T cd05053 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---C 153 (293)
T ss_pred CeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 99999999999999999999999999999997532 23456899999999999999999999988 9
Q ss_pred eecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCC
Q 037084 377 IHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKF 455 (532)
Q Consensus 377 vH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~ 455 (532)
+|+||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 154 vH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 233 (293)
T cd05053 154 IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233 (293)
T ss_pred cccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC
Confidence 9999999999999999999999999987654332221123345678999999988899999999999999999998 999
Q ss_pred CCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 456 PFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 456 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
||..... ..... .......+ .........+.+++..||+.+|++|||+.++++.|+.+-
T Consensus 234 p~~~~~~----~~~~~---~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 234 PYPGIPV----EELFK---LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCCH----HHHHH---HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9875322 11111 11111111 111123456889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.56 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=199.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|++..+ |+.||||++...... .......+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~h~~iv~~~~ 68 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDT-GHIYAMKKLRKSEML-----------EKEQVAHVRAERDILAEADNPWVVKLYY 68 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCCCcceEE
Confidence 3688899999999999999998765 899999999753211 1233466888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 69 SFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred EEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEE
Confidence 99999999999999999999999975 346899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcce------------------------------------eeeccccccccccccccccCCCCchhh
Q 037084 396 ISDFGLAKLMPDGHTRI------------------------------------RITTVAGTTGYVAPEYHQTLTISEKSD 439 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sD 439 (532)
|+|||++.......... .....+||+.|+|||++.+..++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 99999987643211000 001246999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 440 IYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 440 vwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
||||||++|||++|..||........ ........... .+.. .......+.+++..|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~~~~-------~~~i~~~~~~~-~~~~------~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNPQET-------YRKIINWKETL-QFPD------EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCHHHH-------HHHHHcCCCcc-CCCC------CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 99999999999999999976433111 11111111000 0000 00123346778888886 9999998
Q ss_pred ---HHHHHH
Q 037084 520 ---SKDVRC 525 (532)
Q Consensus 520 ---~~evl~ 525 (532)
+.++++
T Consensus 287 ~~~~~~ll~ 295 (364)
T cd05599 287 NNGVNEIKS 295 (364)
T ss_pred CCCHHHHhc
Confidence 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=322.39 Aligned_cols=263 Identities=21% Similarity=0.346 Sum_probs=208.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+... .+..||+|.+..... ......+.+|+.++..++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~ 70 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-------------MRERIEFLNEASVMKEFNCHH 70 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-------------HHHHHHHHHHHHHHHhCCCCc
Confidence 356788899999999999999987632 247899999875531 122356788999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp 383 (532)
|+++++++......++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p 147 (277)
T cd05032 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAA 147 (277)
T ss_pred eeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCh
Confidence 99999999999999999999999999999975332 1234789999999999999999999988 99999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||.....
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 999999999999999999986654332212234556789999999988889999999999999999998 9999965322
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.....+. .....+. .....+..+.+++..||+.+|++|||+.++++.|++
T Consensus 228 ----~~~~~~~---~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 ----EEVLKFV---IDGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----HHHHHHH---hcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1122221 1111110 011124568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=338.32 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=197.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|..++.||+|+||+||+|.+..+ +..||+|++...... .......+.+|+.++++++||||++++++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~-~~~~aiK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~h~~iv~l~~~ 69 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDT-HALYAMKTLRKKDVL-----------NRNQVAHVKAERDILAEADNEWVVKLYYS 69 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHhcCCCCeeeeEEE
Confidence 477889999999999999988764 899999999753211 13345678999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 70 FQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEE
Confidence 9999999999999999999999975 345888889999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCc---------------------------------------------ceeeecccccccccccccccc
Q 037084 397 SDFGLAKLMPDGHT---------------------------------------------RIRITTVAGTTGYVAPEYHQT 431 (532)
Q Consensus 397 ~DFGla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 431 (532)
+|||+++.+..... ........||+.|+|||++.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999864321100 000023579999999999998
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHH--c
Q 037084 432 LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYF--C 509 (532)
Q Consensus 432 ~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--c 509 (532)
..++.++|||||||++|||++|+.||...........+..| ..... +.. ... ....+.+++.. |
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~--~~~--~~~----~s~~~~dli~~ll~ 288 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW------ENTLH--IPP--QVK----LSPEAVDLITKLCC 288 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccccC--CCC--CCC----CCHHHHHHHHHHcc
Confidence 89999999999999999999999999764331111111111 00000 000 001 12335566655 6
Q ss_pred CCCCCCCCCCHHHHHH
Q 037084 510 TSDDPEERPSSKDVRC 525 (532)
Q Consensus 510 l~~~P~~RPs~~evl~ 525 (532)
+..+|..||++.+++.
T Consensus 289 ~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 289 SAEERLGRNGADDIKA 304 (381)
T ss_pred CcccccCCCCHHHHhc
Confidence 6777778999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.12 Aligned_cols=255 Identities=28% Similarity=0.441 Sum_probs=204.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.++++++|||+++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~E~~~l~~l~~~~i~~~~ 67 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTMS---------------PESFLEEAQIMKKLRHDKLVQLY 67 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec--CCceeEEEEecCCCCC---------------HHHHHHHHHHHHhcCCCceEEEE
Confidence 457889999999999999999876 4678999998765321 24588899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.. +..+++|||+++++|.+++.. .....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 68 ~~~~~-~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 68 AVVSE-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVC 141 (260)
T ss_pred eEECC-CCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceE
Confidence 98854 567999999999999999975 23446899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||++........... ....++..|+|||+..+..++.++|+||||+++|+|++ |..||..... ......
T Consensus 142 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~- 215 (260)
T cd05070 142 KIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQ- 215 (260)
T ss_pred EeCCceeeeeccCcccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH-
Confidence 9999999987654332111 22345678999999988899999999999999999999 8999965322 112222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
......+. .....+..+.+++.+|++.+|++|||+.++.+.|+++
T Consensus 216 --~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 216 --VERGYRMP----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred --HHcCCCCC----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 21111110 1112335688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=333.88 Aligned_cols=261 Identities=20% Similarity=0.194 Sum_probs=197.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|.+.+.||+|+||.||++.+..+ ++.||+|.... ..+.+|+.++++++||||++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~-~~~vaiK~~~~--------------------~~~~~E~~il~~l~HpnIv~~~ 149 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKT-CEHVVIKAGQR--------------------GGTATEAHILRAINHPSIIQLK 149 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCC-CCEEEEechhh--------------------hhhHHHHHHHHhCCCCCCCCEe
Confidence 35799999999999999999988764 89999996432 2356899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..+...++|+|++ +++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 150 ~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~v 221 (391)
T PHA03212 150 GTFTYNKFTCLILPRY-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDV 221 (391)
T ss_pred EEEEECCeeEEEEecC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCE
Confidence 9999999999999999 5789888864 346889999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh---ccHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE---MNMVR 471 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~---~~l~~ 471 (532)
||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....
T Consensus 222 kL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 222 CLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred EEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 99999999754332211 124567999999999999999999999999999999999999887432211100 00011
Q ss_pred HHHHHhccCCCcccc-------------------cccccCC--CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAI-------------------DSKLLGN--GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~-------------------d~~l~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+............. .+..... .....+..+.+++..||+.||.+|||++|+++
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111000000000000 0000000 01124557889999999999999999999984
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=315.81 Aligned_cols=272 Identities=24% Similarity=0.287 Sum_probs=207.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC-cccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN-LLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~ 314 (532)
..|..+++||+|+||+||+|+...+ |+.||+|+++..... +..-....+|+.++++++|+| |+.|.
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~-g~~VALKkirl~~~~------------EG~P~taiREisllk~L~~~~~iv~L~ 77 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRT-GKFVALKKIRLEFEE------------EGVPSTAIREISLLKRLSHANHIVRLH 77 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecC-CCEEEEEEEeccccc------------cCCCchhhHHHHHHHHhCCCcceEEEE
Confidence 4577888999999999999998875 899999999877432 111244578999999999999 99999
Q ss_pred eEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++...+ .+++|+||+ .-+|..++.........++...+..++.|+++||+|||+++ |+||||||.|||+
T Consensus 78 dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 78 DVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLI 153 (323)
T ss_pred eeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEE
Confidence 9998877 789999999 66999999874432245677889999999999999999999 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+++|.+||+|||+|+.+.-.... .+..++|.+|+|||++.+. .|++..|+||+||+++||+++++-|..........
T Consensus 154 ~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~ 231 (323)
T KOG0594|consen 154 SSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF 231 (323)
T ss_pred CCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 99999999999999976644332 3678899999999998887 79999999999999999999999998754422111
Q ss_pred cHHHHHHHHhccCCCccccccccc---CC------CcHHHH---HHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLL---GN------GYEEQM---RLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~---~~------~~~~~~---~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.+.+.+...-...++....-+... +. ...... ....+++..|++.+|.+|.|++..+..
T Consensus 232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 121111111111111111001000 00 011111 368889999999999999999998875
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.06 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=210.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC---CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY---GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.++|.+.+.||+|+||.||+|.+.... +..|++|.+..... ......+.+|+.++++++|||++
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni~ 71 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-------------EIQVTLLLQESCLLYGLSHQNIL 71 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC-------------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 467888999999999999999987522 67899999875421 23356788999999999999999
Q ss_pred cceeEEec-CCceEEEEEeccCCCHHHHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQG----RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++++.. +...+++++|+++++|.+++...... ...+++..++.++.+++.||+|||+.+ ++|+||||+||
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~ni 148 (280)
T cd05043 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNC 148 (280)
T ss_pred eEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhE
Confidence 99998876 46789999999999999999764322 256899999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchh
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTE 465 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 465 (532)
++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||.....
T Consensus 149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--- 225 (280)
T cd05043 149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--- 225 (280)
T ss_pred EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---
Confidence 999999999999999986644332222233456778999999998889999999999999999999 9999975322
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+..++.. ...+. .....+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 226 -~~~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 226 -FEMAAYLKD---GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred -HHHHHHHHc---CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222222221 11111 01112346889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=320.03 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=201.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...+++|+|+||.||+|....+ ++.||||+.-.+.. --.+|+.+|+.+.|||||+|.-+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~-~~~vAIKKv~~d~r------------------~knrEl~im~~l~HpNIV~L~~~ 85 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRET-EEEVAIKKVLQDKR------------------YKNRELQIMRKLDHPNIVRLLYF 85 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCC-CceeEEEEecCCCC------------------cCcHHHHHHHhcCCcCeeeEEEE
Confidence 467779999999999999999875 89999999876531 12368999999999999999988
Q ss_pred EecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 317 VTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 317 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
|.... ...+||||||. +|.+.++.....+..++...+.-+..|+++||+|||+.+ |+||||||.|+|+|.+
T Consensus 86 f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~ 161 (364)
T KOG0658|consen 86 FSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPD 161 (364)
T ss_pred EEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCC
Confidence 86542 33589999976 999999876556677888888889999999999999988 9999999999999965
Q ss_pred -CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 -MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 -~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
|.+||||||.|+....+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ..++
T Consensus 162 tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~---~dQL 235 (364)
T KOG0658|consen 162 TGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS---VDQL 235 (364)
T ss_pred CCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH---HHHH
Confidence 99999999999988776544 456778999999987765 699999999999999999999999987433 2222
Q ss_pred HHHHHHHhcc--------CCCc--ccccccccCC-----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISS--------ENPH--RAIDSKLLGN-----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~--------~~~~--~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+. .+.. .++. +.-.+.+... .......++++++.++++.+|++|.++.+++.
T Consensus 236 ~eIik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 236 VEIIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 22221 1111 0110 1111111111 23345567899999999999999999999874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=318.76 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=201.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|.+.+.||+|+||.||+|.++ ++..+|+|.+..... ....|.+|+.++++++||||+++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAM---------------SEDDFIEEAKVMMKLSHPNLVQLYG 66 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec--CCccEEEEEeccCCC---------------CHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 35788899999999999999876 367899999875422 1245778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++|+||+++++|.+++... ...+++.....++.|++.|++|||+.+ ++||||||+||++++++.+|
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 67 VCTKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEE
Confidence 999999999999999999999999752 236899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...... ....
T Consensus 141 l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~--- 212 (256)
T cd05059 141 VSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVE--- 212 (256)
T ss_pred ECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHH---
Confidence 99999998664432211 122234567999999999999999999999999999999 89999753221 1111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.......+ ......+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 213 ~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 213 SVSAGYRL----------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred HHHcCCcC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11111111 011123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.27 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=205.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
.++|.+.+.||+|+||.||+|.+... .+..|++|.+..... ......|..|+.++++++|+||
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i 71 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-------------EQDESDFLMEALIMSKFNHQNI 71 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCCCE
Confidence 46788999999999999999998751 257899998875432 1223568889999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
+++++++.+.+..++||||+++++|.+++..... ....+++..+.+++.|++.||.|||+.+ ++|+||||+||+
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil 148 (277)
T cd05036 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCL 148 (277)
T ss_pred eeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEE
Confidence 9999999999999999999999999999976432 1235899999999999999999999998 999999999999
Q ss_pred ecCCC---cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccc
Q 037084 388 IDDGM---EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQY 463 (532)
Q Consensus 388 l~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~ 463 (532)
++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~- 227 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN- 227 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 98765 599999999987643322111123334568999999998899999999999999999997 9999975322
Q ss_pred hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
..+ ........... .....+..+.+++..|++.+|++|||+.+|++.|++
T Consensus 228 ---~~~---~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 228 ---QEV---MEFVTGGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred ---HHH---HHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111 11111111111 111223568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=315.28 Aligned_cols=252 Identities=27% Similarity=0.378 Sum_probs=205.6
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|.+... |+.|++|.+...... ......+.+|+.++++++|||+++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKAD-KRVYAMKQIDLSKMN------------RREREEAIDEARVLAKLDSSYIIRYYES 67 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCC-CcEEEEEEeehhhCC------------HHHHHHHHHHHHHHHhcCCCCeehheee
Confidence 367778999999999999988754 899999998654222 2334678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++||||+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l 142 (256)
T cd08529 68 FLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKI 142 (256)
T ss_pred eccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEE
Confidence 99999999999999999999999863 3457899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||+++......... ....|++.|+|||+..+..++.++|+||||+++++|++|+.||..... ... ....
T Consensus 143 ~df~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~~ 213 (256)
T cd08529 143 GDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ----GAL---ILKI 213 (256)
T ss_pred cccccceeccCccchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHH---HHHH
Confidence 9999988765443221 345688999999999999999999999999999999999999975332 111 1111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .. .........+.+++.+||+.+|++||++.++++
T Consensus 214 ~~~~-~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 214 IRGV-FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HcCC-CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111 10 111133456899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=321.35 Aligned_cols=268 Identities=24% Similarity=0.346 Sum_probs=204.4
Q ss_pred ccCccccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
+.+|.+.+.||+|+||.||++... ..++..||+|.+.... ......+.+|+.++++++||||+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv 68 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------------AEHLRDFEREIEILKSLQHDNIV 68 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCCCee
Confidence 346888999999999999999753 2347899999987653 23346788999999999999999
Q ss_pred cceeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 312 PLQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 312 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++.+++... ...++|+||+++++|.+++.. .+..+++..+..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 69 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~ 142 (284)
T cd05081 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVE 142 (284)
T ss_pred EEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEEC
Confidence 999987543 467899999999999999974 2346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceee-eccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh---
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRI-TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE--- 465 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--- 465 (532)
+++.++|+|||+++........... ....++..|+|||+..+..++.++|+||||+++|||++|..|+........
T Consensus 143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~ 222 (284)
T cd05081 143 SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMM 222 (284)
T ss_pred CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhc
Confidence 9999999999999877544322111 122234569999999988999999999999999999999877643221000
Q ss_pred --h---ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 466 --E---MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 466 --~---~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. ......+......... .......+..+.+++..||+.+|++|||+.++++.|+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 223 GNDKQGQMIVYHLIELLKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred ccccccccchHHHHHHHhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0 0000111111111100 0111223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=319.70 Aligned_cols=249 Identities=28% Similarity=0.385 Sum_probs=196.2
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||.||++....+ |+.+|+|.+....... ......+..|+.++++++||||+++.+++..+...
T Consensus 1 lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~ 68 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT-GKMYACKKLDKKRLKK-----------KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHL 68 (277)
T ss_pred CCCCCceEEEEEEEccC-CcEEEEEEEcHHHhhc-----------chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeE
Confidence 79999999999988764 8999999986532110 11223455699999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
++||||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 69 CLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred EEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeee
Confidence 999999999999998865 33456899999999999999999999988 9999999999999999999999999988
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
....... .....|+..|+|||++.+..++.++||||+||++|+|++|+.||........ ............ ..
T Consensus 144 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~-~~ 216 (277)
T cd05607 144 ELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTLEDE-VK 216 (277)
T ss_pred ecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhhccc-cc
Confidence 7654322 1445789999999999998999999999999999999999999975432111 111222221111 00
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ........+.+++..||+.||.+||++.++++
T Consensus 217 ~---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 217 F---------EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred c---------ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 0 01123345789999999999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=320.72 Aligned_cols=269 Identities=21% Similarity=0.304 Sum_probs=205.3
Q ss_pred ccCccccceecccCCeEEEEEEeeC---------------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG---------------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~---------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 299 (532)
.++|++.+.||+|+||.||++.+.+ .++..+|+|.+..... ......+.+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-------------~~~~~~~~~E~ 70 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-------------KNARNDFLKEI 70 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-------------HHHHHHHHHHH
Confidence 3568899999999999999986432 1244799999976421 23346788999
Q ss_pred HHHhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037084 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG-------RRELDWLARYRIARGMASGLEYLHMYH 372 (532)
Q Consensus 300 ~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~ 372 (532)
.+++.++||||+++++++...+..++||||+++++|.+++...... ...+++.....++.|++.||+|||+.+
T Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 150 (296)
T cd05095 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN 150 (296)
T ss_pred HHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999999999999999999763221 234788899999999999999999998
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
++|+||||+||++++++.++|+|||+++...............++..|+|||...++.++.++|+|||||++|||++
T Consensus 151 ---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 151 ---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred ---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 99999999999999999999999999986544322111123345678999999888899999999999999999998
Q ss_pred --CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 453 --GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 453 --g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
|..||..............+.. ........ .....++..+.+++.+||+.||++|||+.++++.|++
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFR----DQGRQVYL------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHh----hccccccC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 7788865332111111111111 11000000 0011233568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=314.99 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=206.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|... |+.||+|.+.... ....++.+|+.++++++|+|+++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~ 66 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDS---------------TAAQAFLAEASVMTTLRHPNLVQLL 66 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec---CcEEEEEEeccch---------------hHHHHHHHHHHHHHhcCCcceeeeE
Confidence 456888899999999999999875 7899999998652 1346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 67 GVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred EEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCE
Confidence 999999999999999999999999975 23346899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||+++...... ....++..|+|||++.+..++.++|+||||+++|++++ |..||..... ..+..
T Consensus 142 ~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~-- 210 (256)
T cd05039 142 KVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP-- 210 (256)
T ss_pred EEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH--
Confidence 999999998764322 22344678999999988899999999999999999997 9999975322 11111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........ ......+..+.+++.+||+.+|++|||+++++++|+++
T Consensus 211 --~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 211 --HVEKGYRM---------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --HHhcCCCC---------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111110 01112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=314.66 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=208.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|++++.||+|.-|+||+++++++ +..+|+|++....... .....+...|-++|+.++||.++.|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t-~~~fAmKVmdK~~l~~-----------rkKl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGT-NCLFAMKVMDKESLAS-----------RKKLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCC-CceEEEEEecHHHHhh-----------hhHHHHHHHHHHHHHhcCCCccchhhh
Confidence 5688999999999999999999976 6899999998764332 445678889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.++.....|+|||||+||+|..+++. +..+.++...+.-++..++-||+|||-.| ||+|||||+||||.++|++-
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIM 219 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEE
Confidence 99999999999999999999999987 66778999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCC---------------------------------c---------------------ceeeecccccc
Q 037084 396 ISDFGLAKLMPDGH---------------------------------T---------------------RIRITTVAGTT 421 (532)
Q Consensus 396 l~DFGla~~~~~~~---------------------------------~---------------------~~~~~~~~gt~ 421 (532)
|+||.|+....... . ..+....+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 99999987542100 0 00113457899
Q ss_pred ccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHH
Q 037084 422 GYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL 501 (532)
Q Consensus 422 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 501 (532)
.|+|||++.+...+.++|.|+|||++|||+.|..||.+..... -+.+++.. .+.-...++.+..
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-------Tl~NIv~~---------~l~Fp~~~~vs~~ 363 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-------TLRNIVGQ---------PLKFPEEPEVSSA 363 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-------hHHHHhcC---------CCcCCCCCcchhH
Confidence 9999999999999999999999999999999999998754321 12222221 1111223355677
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 037084 502 VLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 502 l~~l~~~cl~~~P~~RPs 519 (532)
+.+||...|.+||++|..
T Consensus 364 akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 364 AKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred HHHHHHHHhccChhhhhc
Confidence 999999999999999987
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=320.43 Aligned_cols=269 Identities=20% Similarity=0.321 Sum_probs=209.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC---------------CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY---------------GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 299 (532)
..+|.+.+.||+|+||.||+|.+.... +..||+|.+..... ......+.+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~~e~ 70 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------------DNAREDFLKEV 70 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------------HHHHHHHHHHH
Confidence 356888999999999999999876432 24689999886532 22356788999
Q ss_pred HHHhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 037084 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------GRRELDWLARYRIARGMASGLEYLHMYH 372 (532)
Q Consensus 300 ~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~ 372 (532)
.++.+++|||++++++++...+..++++||+++++|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~ 150 (296)
T cd05051 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN 150 (296)
T ss_pred HHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 999999999999999999999999999999999999999976431 1236899999999999999999999988
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
++|+||||+||++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++
T Consensus 151 ---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 151 ---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred ---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 99999999999999999999999999886544332222234556789999999988899999999999999999998
Q ss_pred --CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 453 --GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 453 --g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
|..||..... .................... ......+..+.+++..|++.+|++|||+.++++.|++
T Consensus 228 ~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 228 LCREQPYEHLTD----QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCCCCCCCCcCh----HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 6778864322 11222222211111111100 1112233568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.99 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=209.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
..-++.+.+.|.+|||+.||.|.+.+. |..||+|++-... +.......+|+.++++|+ |||||.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~-~~~~AlKrm~~~d--------------e~~L~~v~~EI~~MK~L~gh~nIV~ 99 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKG-GKKYALKRMYVND--------------EEALNAVKREIDIMKLLSGHKNIVS 99 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCC-CceeeeeeeecCC--------------HHHHHHHHHHHHHHHHhcCCCceee
Confidence 445688899999999999999998853 5999999987763 556788899999999996 999999
Q ss_pred ceeE-Eec---C---CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 313 LQAH-VTR---P---DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 313 l~~~-~~~---~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
+++. ... . -+.+|.||||+||+|-|++..+.+.+ |++..+++|+.++++|+++||.. ++||||||||-+|
T Consensus 100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiEN 176 (738)
T KOG1989|consen 100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIEN 176 (738)
T ss_pred EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhh
Confidence 9993 321 1 25689999999999999998754433 99999999999999999999998 5779999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcc-eee------ecccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCC
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTR-IRI------TTVAGTTGYVAPEYH---QTLTISEKSDIYSFGVLLAVLVVGKF 455 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~ 455 (532)
|||+.+|+.||||||.+.-....... ... -...-|+.|+|||++ .+..+++|+|||+|||+||-|+....
T Consensus 177 vLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 177 VLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred eEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 99999999999999998864433211 000 122358899999965 56789999999999999999999999
Q ss_pred CCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 456 PFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 456 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
||+.... ..+++....-...+.+...+.+||..||++||.+||++-+|+..+-++.+
T Consensus 257 PFe~sg~--------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 257 PFEESGK--------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred CcCcCcc--------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9986321 11111111111235677889999999999999999999999999988753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=331.26 Aligned_cols=250 Identities=29% Similarity=0.411 Sum_probs=195.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|.+..+ |+.||||++..... ......+.+|+.+++.++|+||++++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 138 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPT-GRLYALKVIYGNHE-------------DTVRRQICREIEILRDVNHPNVVKCH 138 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCC-CCEEEEEEEecCCc-------------HHHHHHHHHHHHHHHhCCCCCcceee
Confidence 35688889999999999999988754 89999999865421 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++|+|.+.. ..++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 139 ~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 207 (353)
T PLN00034 139 DMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNV 207 (353)
T ss_pred eEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCE
Confidence 9999999999999999999986432 3456778889999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
||+|||+++........ .....||..|+|||++.. ...+.++|||||||++|||++|+.||..... ...
T Consensus 208 kL~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~----~~~ 281 (353)
T PLN00034 208 KIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ----GDW 281 (353)
T ss_pred EEcccccceeccccccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----ccH
Confidence 99999999876543221 135679999999998743 2345689999999999999999999973221 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............+ .........+.+++..||+.||++|||+.++++
T Consensus 282 ~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 282 ASLMCAICMSQPP----------EAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHHHHhccCCC----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111111110 011123345889999999999999999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.81 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=198.7
Q ss_pred eecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 243 IIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
.||+|+||.||+|.++. .++..+|+|+++..... ......+..|+.++++++||||+++++++.. +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 68 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND------------PALKDELLREANVMQQLDNPYIVRMIGICEA-E 68 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc------------HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence 58999999999997642 24789999998755322 2335678899999999999999999999864 5
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~ 141 (257)
T cd05116 69 SWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGL 141 (257)
T ss_pred CcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcc
Confidence 67899999999999999964 346889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 402 AKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 402 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
+........... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||..... ..+...+. ..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~---~~ 214 (257)
T cd05116 142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIE---SG 214 (257)
T ss_pred ccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH---CC
Confidence 987654432211 122234578999999988889999999999999999998 9999975432 12222221 11
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
..+. .....+..+.+++..||+.||++||++.+|...|+++
T Consensus 215 ~~~~----------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERME----------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1110 1112334588999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=315.88 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=203.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.++++++|||+++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~ 67 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGTM---------------MPEAFLQEAQIMKKLRHDKLVPLY 67 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcC--CceEEEEEcccCCc---------------cHHHHHHHHHHHHhCCCCCeeeEE
Confidence 3568888999999999999998763 45799999875421 124678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.. +..+++|||+++++|.++++. .....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 68 ~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~ 141 (260)
T cd05069 68 AVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVC 141 (260)
T ss_pred EEEcC-CCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeE
Confidence 98854 567999999999999999975 23445899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||++.......... .....++..|+|||+..+..++.++|+||||+++|+|++ |..||..... .....++
T Consensus 142 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~ 216 (260)
T cd05069 142 KIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN----REVLEQV 216 (260)
T ss_pred EECCCccceEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 999999998764432211 123346778999999998899999999999999999999 9999975322 1111221
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.....+ ......+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 217 ---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 217 ---ERGYRM----------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred ---HcCCCC----------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111111 01122345688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.75 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=194.9
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC-Cccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR-NLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~ 315 (532)
+|.+.+.||+|+||.||+|...++ ++.||+|++...... .......+..|..++..+.|+ +|+.+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVII-----------QDDDVECTMVEKRVLALPGKPPFLTQLHS 68 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhcCCCCceeeeEE
Confidence 477889999999999999988764 889999998753211 023346678899999999765 5888999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 69 CFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEE
Confidence 99999999999999999999999864 345889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++........ ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||..... ..+. ..
T Consensus 142 L~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~---~~ 212 (324)
T cd05587 142 IADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELF---QS 212 (324)
T ss_pred EeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHH---HH
Confidence 999999875432221 12456799999999999999999999999999999999999999975332 1111 11
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
... ... .........+.+++..||+.+|.+||+.
T Consensus 213 i~~-~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IME-HNV----------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHc-CCC----------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111 110 0011123457889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=328.44 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ +..||+|+++...... ......+..|..++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~aiK~i~~~~~~~-----------~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~ 68 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKT-RRIYAMKVIKKELVND-----------DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeEeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC
Confidence 4699999999999988764 8999999997542111 22345678899999888 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 69 SRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCc
Confidence 999999999999999998864 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch-hhccHHHHHHHHhcc
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT-EEMNMVRWMRNVISS 479 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~~~l~~~~~~~~~~ 479 (532)
+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... ......++.......
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 142 MCKEGIRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred cccccccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 9875322211 1145679999999999999999999999999999999999999996422111 111222333333222
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC------HHHHH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS------SKDVR 524 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl 524 (532)
.... + +......+.+++..|++.||.+||| +++++
T Consensus 220 ~~~~------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 220 KQIR------I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CCCC------C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 2111 0 1112345788999999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.41 Aligned_cols=265 Identities=23% Similarity=0.316 Sum_probs=209.1
Q ss_pred cccCccccceecccCCeEEEEEEeeC------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
..++|.+.+.||+|+||.||+|.+.. .++..||+|.+..... ......+.+|+.+++.+ +
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~ 79 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-------------EKDLSDLVSEMEMMKMIGK 79 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-------------hHHHHHHHHHHHHHHhhcc
Confidence 45678889999999999999997531 1245799999875421 22346788999999999 8
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||+++++++...+..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+
T Consensus 80 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g-- 157 (304)
T cd05101 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK-- 157 (304)
T ss_pred CCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999999999999999999999999976322 1245788999999999999999999988
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
++||||||+||++++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 158 -ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 236 (304)
T cd05101 158 -CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236 (304)
T ss_pred -eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987654332222233456778999999988889999999999999999998 7
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||..... .++........... .....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 237 ~~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 237 GSPYPGIPV-------EELFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred CCCcccCCH-------HHHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 888864321 12222221111110 11123456888999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=320.38 Aligned_cols=264 Identities=20% Similarity=0.336 Sum_probs=207.2
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|..+. ..+..||+|.+..... ......+.+|+.++++++|||
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~ 70 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-------------LRERIEFLNEASVMKGFTCHH 70 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999997652 2356899999875432 112345788999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp 383 (532)
|+++++++..++..++||||+++|+|.+++..... ....+++.....++.|++.||.|||+.+ ++||||||
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp 147 (288)
T cd05061 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAA 147 (288)
T ss_pred eeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCCh
Confidence 99999999999999999999999999999975321 1345677888999999999999999988 99999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
+||++++++.++++|||+++...............++..|+|||.+.++.++.++|+|||||++|||++ |..||.....
T Consensus 148 ~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 148 RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred heEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999886544322211123345678999999998899999999999999999999 7889865322
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+........+.+. .....+..+.+++..|++.+|++|||+.++++.|++.
T Consensus 228 -------~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 -------EQVLKFVMDGGYLD----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11222222221111 0112235689999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.06 Aligned_cols=248 Identities=27% Similarity=0.339 Sum_probs=193.4
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHH---HhcCCCCCcccce
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT---AGRIWHRNLLPLQ 314 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~H~niv~l~ 314 (532)
|.+.+.||+|+||.||+|.+..+ |+.||||+++...... ......+..|+.+ +++++||||++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~l~~e~~~~~~~~~l~hp~i~~~~ 68 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKT-GELYAIKALKKGDIIA-----------RDEVESLMCEKRIFETANSERHPFLVNLF 68 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhccccCCCChhcee
Confidence 56778999999999999988764 8999999987532111 1223445555544 4677899999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..|+||||+++|+|..+++. ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 69 ACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred eEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcE
Confidence 999999999999999999999988753 45899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... . +...
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~----~---~~~~ 211 (324)
T cd05589 141 KIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE----E---EVFD 211 (324)
T ss_pred EeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH----H---HHHH
Confidence 9999999875432221 11456799999999999999999999999999999999999999975322 1 1112
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
....... . ........+.+++..||+.||.+||+ +.++++
T Consensus 212 ~i~~~~~-~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 SIVNDEV-R----------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhCCC-C----------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2221111 0 01112345788999999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=324.59 Aligned_cols=265 Identities=24% Similarity=0.315 Sum_probs=207.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
..++|.+.+.||+|+||.||+|.+.+. ++..+|+|.+..... ......+..|+.++..+ +
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~ 82 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-------------EKDLSDLISEMEMMKMIGK 82 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-------------hHHHHHHHHHHHHHHHhcC
Confidence 346799999999999999999986432 235799999986421 22345688899999999 7
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-- 160 (307)
T cd05098 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK-- 160 (307)
T ss_pred CCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999999999999999999999999976322 1235899999999999999999999988
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |
T Consensus 161 -i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g 239 (307)
T cd05098 161 -CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239 (307)
T ss_pred -cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999886643321111122334578999999998889999999999999999998 8
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||..... .+...... ..... .........+.+++..||+.+|++|||+.++++.|+++.
T Consensus 240 ~~p~~~~~~-------~~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 240 GSPYPGVPV-------EELFKLLK-EGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred CCCCCcCCH-------HHHHHHHH-cCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 889864321 11111111 11111 111223456888999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=319.71 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=205.5
Q ss_pred ccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..++...+.||+|+||.||++... ..++..+|+|.+.... ......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i 69 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------------ESARQDFQREAELLTVLQHQHI 69 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------------HHHHHHHHHHHHHHhcCCCCCC
Confidence 346778899999999999999753 2236689999987653 2334678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-----------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
+++++++...+..++++||+++++|.+++..... ....+++..++.++.|++.|++|||+.+ ++|+
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~ 146 (280)
T cd05092 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHR 146 (280)
T ss_pred ceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 9999999999999999999999999999975321 1135899999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||++++++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 147 dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 226 (280)
T cd05092 147 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred cccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999999999876543322111123345788999999999999999999999999999998 999986
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
..... .. ........... .....+..+.+++..||+.+|.+||++.++++.|+.
T Consensus 227 ~~~~~----~~---~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 227 QLSNT----EA---IECITQGRELE----------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCCHH----HH---HHHHHcCccCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 53321 11 11111111110 011123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.63 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++....+ |+.||||++...... .......+.+|+.++.+++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~hp~iv~~~~ 68 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDT-GKIYAMKTLLKSEMF-----------KKDQLAHVKAERDVLAESDSPWVVSLYY 68 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCC-CCEEEEEEEEHHHHH-----------HhHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 3688899999999999999988764 899999998643211 1334567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 69 SFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred EEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999965 345888899999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcc------------e---------------------------------eeeccccccccccccccc
Q 037084 396 ISDFGLAKLMPDGHTR------------I---------------------------------RITTVAGTTGYVAPEYHQ 430 (532)
Q Consensus 396 l~DFGla~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~ 430 (532)
|+|||+++.+...... . ......||+.|+|||++.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 9999999643211000 0 001246999999999999
Q ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcC
Q 037084 431 TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCT 510 (532)
Q Consensus 431 ~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl 510 (532)
+..++.++|||||||++|||++|..||...........+..|. .... . + ........+.+++..|+
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~-~--p-----~~~~~s~~~~dli~~lL 287 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWR------ETLY-F--P-----DDIHLSVEAEDLIRRLI 287 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccC------CccC-C--C-----CCCCCCHHHHHHHHHHh
Confidence 9999999999999999999999999997533211111111110 0000 0 0 00112345778888899
Q ss_pred CCCCCCC---CCHHHHHH
Q 037084 511 SDDPEER---PSSKDVRC 525 (532)
Q Consensus 511 ~~~P~~R---Ps~~evl~ 525 (532)
. +|.+| ||+.+++.
T Consensus 288 ~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 288 T-NAENRLGRGGAHEIKS 304 (377)
T ss_pred c-CHhhcCCCCCHHHHhc
Confidence 7 66665 59988875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=333.22 Aligned_cols=256 Identities=21% Similarity=0.265 Sum_probs=202.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||++....+ |+.||+|+++..... .......+..|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~i~~~~~~~~i~~~~~ 68 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLL-----------AQETVSFFEEERDILSISNSPWIPQLQY 68 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCCCcceee
Confidence 3688899999999999999988764 899999999754211 1234567888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..++||||+++|+|.+++... ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 69 AFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred EEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEE
Confidence 999999999999999999999999752 346899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ------TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 143 L~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------ 215 (330)
T cd05601 143 LADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------ 215 (330)
T ss_pred eccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------
Confidence 9999999876544322 224457899999999886 456789999999999999999999999753221
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............... .........+.+++..|++ +|++|||+.+++.
T Consensus 216 -~~~~~i~~~~~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 -KTYNNIMNFQRFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -HHHHHHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 112222211111000 0011223457788888998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.90 Aligned_cols=248 Identities=22% Similarity=0.296 Sum_probs=194.3
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|....+ ++.||+|++....... ......+..|+.++.++ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 68 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKT-ERIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 68 (329)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEhhHhcc-----------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC
Confidence 4699999999999988764 8899999997542111 22345677888888777 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 69 SRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999988864 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch-hhccHHHHHHHHhcc
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT-EEMNMVRWMRNVISS 479 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~-~~~~l~~~~~~~~~~ 479 (532)
+++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... .......++......
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 142 MCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred ccccccCCCCc--cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 98754322211 145679999999999999999999999999999999999999996422111 111222333332222
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
.... .+......+.+++..||+.||++||+.
T Consensus 220 ~~~~----------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 220 KQIR----------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCC----------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2111 111223457889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.94 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=195.6
Q ss_pred ceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|+||.||++.... .+++.||+|++....... .......+..|+.++++++||||+++++++..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~ 71 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----------NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT 71 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----------hhhhHHHHHHHHHHHHhCCCCchhceeeEEec
Confidence 679999999999997642 247899999987532110 02234567889999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
++..|+||||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 72 GGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred CCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999999865 345788888899999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
|+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 145 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~ 215 (323)
T cd05584 145 GLCKESIHEGTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKG 215 (323)
T ss_pred cCCeecccCCCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcC
Confidence 998754332221 1346799999999999998899999999999999999999999975322 1112222211
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
. .. ..+.....+.+++..|++.+|++|| ++.++++
T Consensus 216 ~-~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 K-LN----------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C-CC----------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 10 0111234578899999999999999 7777754
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=321.72 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=202.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
++|.+.+.||+|+||.||+|.+... |. .+++|.++.... ......+.+|+.++.++ +||||++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~ik~~~~~~~-------------~~~~~~~~~E~~~l~~l~~hp~iv~ 67 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKD-GLKMNAAIKMLKEFAS-------------ENDHRDFAGELEVLCKLGHHPNIIN 67 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCC-CCcceeEEEEccccCC-------------HHHHHHHHHHHHHHHhhcCCCchhh
Confidence 4688889999999999999987653 43 578888875321 22345788999999999 7999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
+++++...+..++++||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|||
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~d 144 (297)
T cd05089 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRD 144 (297)
T ss_pred eEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCc
Confidence 99999999999999999999999999975321 1235889999999999999999999988 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDD 459 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~ 459 (532)
|||+||+++.++.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus 145 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 145 LAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred CCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999864322111 112233567999999998899999999999999999997 9999975
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.... +..........+ .........+.+++..||+.+|.+|||++++++.|+++.
T Consensus 222 ~~~~-------~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 222 MTCA-------ELYEKLPQGYRM----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred CCHH-------HHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 4321 111111111110 011123345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=326.33 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=190.3
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc-CCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR-IWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ ++.||+|+++...... ......+..|..++.. .+||||+++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~ 68 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGT-NEFFAIKALKKDVVLE-----------DDDVECTMVERRVLALAWEHPFLTHLFCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhhHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 4699999999999998764 8899999987542110 2223445556666665 4899999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 69 EHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCc
Confidence 999999999999999999864 345889999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . +....... .
T Consensus 142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~---~~~~~i~~-~ 211 (316)
T cd05592 142 MCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----D---ELFDSILN-D 211 (316)
T ss_pred CCeECCCCCCc--cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----H---HHHHHHHc-C
Confidence 99865332211 1456799999999999998999999999999999999999999975332 1 11111111 1
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
.+. ........+.+++..||+.+|++||++.+
T Consensus 212 ~~~----------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 212 RPH----------FPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCC----------CCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 110 11112345778899999999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.48 Aligned_cols=240 Identities=25% Similarity=0.330 Sum_probs=191.9
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ ++.||+|++...... .......+..|..++..+ +||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 68 (320)
T cd05590 1 RVLGKGSFGKVMLARLKES-GRLYAVKVLKKDVIL-----------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP 68 (320)
T ss_pred CeeeeCCCeEEEEEEEcCC-CCEEEEEEEEHHHHh-----------hccHHHHHHHHHHHHHhccCCCchhceeeEEEcC
Confidence 4699999999999988754 899999998753211 022345677788888776 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 69 DRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred CEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCC
Confidence 999999999999999998865 346889999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . ..........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~---~~~~~i~~~~ 212 (320)
T cd05590 142 MCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE----D---DLFEAILNDE 212 (320)
T ss_pred CCeecCcCCCc--ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----H---HHHHHHhcCC
Confidence 98754322211 1456799999999999998999999999999999999999999975332 1 1122222111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
.. ........+.+++..|++.||.+||++
T Consensus 213 -~~----------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 -VV----------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CC----------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 10 011123457889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.67 Aligned_cols=245 Identities=21% Similarity=0.309 Sum_probs=195.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|+||.||++....+ |..||+|++...... .......+..|+.++..++||||+++.+++...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~a~K~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~ 68 (325)
T cd05594 1 KLLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIV-----------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68 (325)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC
Confidence 4699999999999987754 899999998753211 0223456778999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 69 ~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 69 RLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCC
Confidence 99999999999999998864 3468999999999999999999997 67 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ..+ ...... .
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~----~~~---~~~i~~-~ 211 (325)
T cd05594 142 LCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL---FELILM-E 211 (325)
T ss_pred CCeecCCCCcc--cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----HHH---HHHHhc-C
Confidence 98754332221 1346799999999999999999999999999999999999999975322 111 111111 1
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
... + .......+.+++..|++.||++|| ++.++++
T Consensus 212 ~~~------~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 212 EIR------F----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCC------C----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 100 0 111234578899999999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=327.35 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=195.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~ 315 (532)
+|.+.+.||+|+||.||+|....+ +..||+|++....... ......+..|..++..+ +|++|+.+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQ-----------DDDVECTMVEKRVLALSGKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhccCCCeEeeEEE
Confidence 477889999999999999988764 8899999987542110 22334566777888777 5899999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 69 ~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 69 CFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEE
Confidence 99999999999999999999999864 345889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ..+. ..
T Consensus 142 L~DfG~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~---~~ 212 (323)
T cd05616 142 IADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELF---QS 212 (323)
T ss_pred EccCCCceecCCCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHH---HH
Confidence 9999998754332211 1456799999999999999999999999999999999999999975332 1111 11
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
.... ... .+......+.+++..|++.+|++|++.
T Consensus 213 i~~~-~~~----------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEH-NVA----------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhC-CCC----------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111 110 111223457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.80 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=194.9
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|+...+ |+.||+|++...... .......+..|..++..+ +||||+++++++..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~ 68 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGT-DEVYAIKVLKKDVIL-----------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK 68 (321)
T ss_pred CccccCCCeEEEEEEECCC-CCEEEEEEEeHHHhh-----------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 4699999999999988754 889999998753211 023345677788888866 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 69 DRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred CeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999998864 345889999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... . ..........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~---~~~~~i~~~~ 212 (321)
T cd05591 142 MCKEGILNGVT--TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----D---DLFESILHDD 212 (321)
T ss_pred cceecccCCcc--ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----H---HHHHHHHcCC
Confidence 98754332221 1456789999999999999999999999999999999999999975432 1 1122222211
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-------SSKDVRC 525 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~ 525 (532)
.. .+......+.+++..|++.+|++|| ++.++++
T Consensus 213 ~~-----------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 VL-----------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CC-----------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 10 0011234578899999999999999 6777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=314.03 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=205.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.++++++|+|++++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~i~~~ 66 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG---------------SMSVEAFLAEANVMKTLQHDKLVKL 66 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC---------------hhHHHHHHHHHHHHHhcCCCCcceE
Confidence 3567889999999999999999865 4678999998764 2234678889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.+++.+ ...+++|||+++++|.+++.. .....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 67 ~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05073 67 HAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLV 140 (260)
T ss_pred EEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCc
Confidence 999987 778999999999999999975 23456889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++.......... .....++..|+|||++.+..++.++|+|||||++|++++ |..||..... ..+..+
T Consensus 141 ~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~ 215 (260)
T cd05073 141 CKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRA 215 (260)
T ss_pred EEECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence 9999999998765432211 123345678999999998889999999999999999999 9999975322 112222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+. ...... .....+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus 216 ~~----~~~~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 216 LE----RGYRMP---------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred Hh----CCCCCC---------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 11 111110 1122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=318.93 Aligned_cols=268 Identities=21% Similarity=0.280 Sum_probs=204.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCC-------------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHH
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS-------------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 301 (532)
..+|++.+.||+|+||.||++...+. ....||+|.++.... ......|.+|+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~ei~~ 70 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------------KTARNDFLKEIKI 70 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------------HHHHHHHHHHHHH
Confidence 45788999999999999999976531 123599999976432 2234568899999
Q ss_pred HhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037084 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--------GRRELDWLARYRIARGMASGLEYLHMYHR 373 (532)
Q Consensus 302 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 373 (532)
+++++|||++++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 9999999999999999999999999999999999999964211 1134788999999999999999999988
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV- 452 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt- 452 (532)
++|+||||+||++++++.+||+|||++................++..|+|||+..++.++.++|+|||||++|+|++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999986544322111133445778999999998899999999999999999998
Q ss_pred -CCCCCCCcccchhhccHHHHHHHHhcc-CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 453 -GKFPFDDFFQYTEEMNMVRWMRNVISS-ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 453 -g~~p~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
|..||...... ............ ...... ...+..+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 228 ~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDE----QVIENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChH----HHHHHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 66787653321 111111111111 110000 0011123468999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=313.76 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=200.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|+..++||+|+||.||+|.+..+ +..||+|.+..... ......+.+|+.++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~aiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLT-RRILAVKVIPLDIT-------------VELQKQIMSELEILYKCDSPYIIGFYG 66 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCC-CcEEEEEEEecCCC-------------hHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3577889999999999999988764 88999999865421 122356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++++|..+. .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 67 AFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred EEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEE
Confidence 999999999999999999996542 3678888999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++........ ....||..|+|||++.+..++.++|+||||+++|+|++|+.||..............+...
T Consensus 136 l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 211 (279)
T cd06619 136 LCDFGVSTQLVNSIA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC 211 (279)
T ss_pred EeeCCcceecccccc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH
Confidence 999999986644321 3467899999999999989999999999999999999999999754322111111122211
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
...... . .+. .......+.+++..|++.+|++||+++++++.
T Consensus 212 ~~~~~~-~-----~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 212 IVDEDP-P-----VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HhccCC-C-----CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111 1 000 11123457889999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=311.47 Aligned_cols=250 Identities=27% Similarity=0.389 Sum_probs=201.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||++... |..+|+|.++... ....+.+|+.++++++|+|+++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~ 65 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLL 65 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc----------------hHHHHHHHHHHHHhCCCCCeeeEE
Confidence 346888899999999999999765 7889999987542 134688899999999999999999
Q ss_pred eEEe-cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVT-RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++. .++..++++||+++++|.+++.. .....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.
T Consensus 66 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~ 140 (256)
T cd05082 66 GVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNV 140 (256)
T ss_pred EEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCc
Confidence 9764 45678999999999999999975 23345889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
+|++|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..+...
T Consensus 141 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~ 211 (256)
T cd05082 141 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPR 211 (256)
T ss_pred EEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 9999999987554322 23344678999999999899999999999999999998 9999864321 112222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+ . .+.... .....+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 212 ~---~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 V---E-KGYKMD---------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred H---h-cCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 1 111111 1112345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.97 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=201.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|....+ |..||+|.+...... .......+..|+.+++.++||||+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~il~~~~h~~iv~~ 108 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSS-KQVYAMKLLSKFEMI-----------KRSDSAFFWEERDIMAHANSEWIVQL 108 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhhHHHHHHHHHHHHhCCCCCcceE
Confidence 346799999999999999999988764 899999998643111 02234557889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+++..++||||+++|+|.+++.. ..++......++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred EEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCC
Confidence 9999999999999999999999999864 24778888889999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL----TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 181 ~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 252 (370)
T cd05596 181 LKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (370)
T ss_pred EEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------
Confidence 999999999876433221 11356799999999988653 478899999999999999999999975332
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 525 (532)
............... +. ........+.+++..|++.+|.+ |||+.++++
T Consensus 253 ~~~~~~i~~~~~~~~-~~------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 253 VGTYSKIMDHKNSLT-FP------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHHHHHHHcCCCcCC-CC------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111122221111000 00 01123456788999999999988 999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.16 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=204.5
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
+.++|++.+.||+|+||.||+|.+.+ .+++.||||.++.... ......+.+|+.++.++ +||
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~ 71 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHHL 71 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------------hHHHHHHHHHHHHHHhccCCc
Confidence 45679999999999999999997532 3468999999976432 22245688899999999 789
Q ss_pred CcccceeEEecC-CceEEEEEeccCCCHHHHHhhhcC-------------------------------------------
Q 037084 309 NLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQ------------------------------------------- 344 (532)
Q Consensus 309 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------- 344 (532)
||++++++|... ...+++||||++|+|.++++....
T Consensus 72 niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (343)
T cd05103 72 NVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSG 151 (343)
T ss_pred cHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccc
Confidence 999999988654 567899999999999999875211
Q ss_pred --------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 345 --------------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 345 --------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~ 228 (343)
T cd05103 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARD 228 (343)
T ss_pred ccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccc
Confidence 0134788889999999999999999988 99999999999999999999999999987
Q ss_pred CCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 405 MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
..............++..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. .. ....+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~---~~-~~~~~~~~ 301 (343)
T cd05103 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF---CR-RLKEGTRM 301 (343)
T ss_pred cccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HH---HH-HHhccCCC
Confidence 543322222123445678999999988899999999999999999997 999997532210 11 11 11111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.. + .. ....+.+++..||+.+|.+|||+.++++.|+++-
T Consensus 302 ~~--~----~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 302 RA--P----DY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CC--C----CC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 01 1235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=312.75 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=202.3
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|++.+.||+|+||+||++..... ++.+|+|.+....... ........|+.++++++||||+++++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~-~~~~~~K~~~~~~~~~------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~ 67 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKN-GQKVAVKIIDKSEIEE------------EEREENIREIKILRRLRHPNIVQILDVF 67 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTT-TEEEEEEEEESTTHHH------------HHHHHHHHHHHHHHHHTBTTBCHEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCC-CeEEEEEEeccccccc------------cccchhhhhhhccccccccccccccccc
Confidence 56788999999999999998864 8899999999875432 1223344599999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++||||+++++|.+++.. ...+++..++.++.|+++||.+||+.+ ++|+||||+||++++++.++|+
T Consensus 68 ~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~ 140 (260)
T PF00069_consen 68 QDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLI 140 (260)
T ss_dssp EESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEES
T ss_pred cccccccccccccccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 999999999999999999999973 356899999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
|||.+........ ......++..|+|||++. +..++.++|+||+|+++|+|++|..||...........+..-....
T Consensus 141 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 218 (260)
T PF00069_consen 141 DFGSSVKLSENNE--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP 218 (260)
T ss_dssp SGTTTEESTSTTS--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence 9999986422221 225677899999999998 8889999999999999999999999998652111111111111100
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ........+.+++..||+.+|++|||+.++++
T Consensus 219 ~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 219 LPSSSQ-----------QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTT-----------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccc-----------ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00011256899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=326.54 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=198.4
Q ss_pred CccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
+|.+.+.||+|+||.||++.... .+|..||+|++....... .......+..|+.++.++ +||||+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----------KAKTVEHTRTERNVLEHVRQSPFLVTL 70 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----------hhhHHHHHHHHHHHHHhccCCCCcccE
Confidence 47788999999999999997642 247899999986532110 022346678899999999 58999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++|+|.+++.. +..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 71 HYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGH 143 (332)
T ss_pred EEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCC
Confidence 9999999999999999999999999865 345889999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ...
T Consensus 144 ~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~ 219 (332)
T cd05614 144 VVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEV 219 (332)
T ss_pred EEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHH
Confidence 9999999998654332221 1346799999999998765 4788999999999999999999999643221111 111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
........ +.+ .......+.+++..||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~-------~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 220 SRRILKCD-------PPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHHHhcCC-------CCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11121111 111 111234578899999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=365.51 Aligned_cols=261 Identities=30% Similarity=0.501 Sum_probs=215.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
..+...+.||+|+||.||+|.+.. +|..||||.+..... ....|+..+++++|||||++++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~------------------~~~~~~~~l~~l~HpnIv~~~~ 750 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNS------------------IPSSEIADMGKLQHPNIVKLIG 750 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECC-CCcEEEEEEccCCcc------------------ccHHHHHHHhhCCCCCcceEEE
Confidence 456677899999999999998765 489999999875421 1123577889999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+|.+.+..++|||||++|+|.++++. ++|..+.+++.|+++|++|||+.+.++++||||||+||+++.++.++
T Consensus 751 ~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~ 823 (968)
T PLN00113 751 LCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH 823 (968)
T ss_pred EEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceE
Confidence 99999999999999999999999953 88999999999999999999976566699999999999999998888
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+. ||........ ....+|+.|+|||++.+..++.++|||||||++|||+||+.||+... .....+.+|.+.
T Consensus 824 ~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~--~~~~~~~~~~~~ 894 (968)
T PLN00113 824 LR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF--GVHGSIVEWARY 894 (968)
T ss_pred EE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc--CCCCcHHHHHHH
Confidence 76 6655433221 23468899999999999999999999999999999999999996432 234567788776
Q ss_pred HhccCCCcccccccccCC--CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 476 VISSENPHRAIDSKLLGN--GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..........+|+.+... ...+++.++.+++.+||+.+|++||||+++++.|+++.
T Consensus 895 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred hcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 665555556666665433 34567778999999999999999999999999999874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=319.20 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=207.3
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|+..+.||+|+||.||+|.+.+ .++..||+|.+..... ......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~ei~~l~~l~h~~ 69 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-------------ADMQADFQREAALMAEFDHPN 69 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-------------HHHHHHHHHHHHHHHhcCCCc
Confidence 35678899999999999999998753 2468999999876432 223466889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhc------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS------------------QGRRELDWLARYRIARGMASGLEYLHMY 371 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~ 371 (532)
|+++++++...+..++++||+++|+|.+++.... .....+++..++.++.|++.||.|||+.
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~ 149 (288)
T cd05050 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149 (288)
T ss_pred hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999997532 1123578899999999999999999998
Q ss_pred CCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 037084 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 372 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 451 (532)
+ ++||||||+||++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 150 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 150 K---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred C---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 8 9999999999999999999999999987654332211112334567799999999889999999999999999999
Q ss_pred h-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 452 V-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 452 t-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
+ |..||..... .+....... +.... .....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 227 ~~~~~p~~~~~~-------~~~~~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 227 SYGMQPYYGMAH-------EEVIYYVRD-GNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred hCCCCCCCCCCH-------HHHHHHHhc-CCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8 8888864322 122222221 11110 011234568889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=325.43 Aligned_cols=245 Identities=24% Similarity=0.337 Sum_probs=195.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ +..||+|++....... ......+..|..++..+ +||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~ 68 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGT-DELYAVKVLKKDVILQ-----------DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK 68 (318)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHHhh-----------hhHHHHHHHHHHHHHhccCCCCccceeeEEEcC
Confidence 4699999999999988764 8899999987542111 22345667888888887 799999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||++++++.++|+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 69 DRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccC
Confidence 999999999999999998865 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... . .........
T Consensus 142 ~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~----~---~~~~~i~~~- 211 (318)
T cd05570 142 MCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE----D---ELFQSILED- 211 (318)
T ss_pred CCeecCcCCCc--ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH----H---HHHHHHHcC-
Confidence 98753322211 1345789999999999999999999999999999999999999975322 1 111111111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS-----KDVRC 525 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~ 525 (532)
.+. ........+.+++..||+.||++|||+ .++++
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 212 EVR----------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCC----------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 110 011223457889999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=302.17 Aligned_cols=258 Identities=29% Similarity=0.411 Sum_probs=210.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~ 315 (532)
.|...+.||.|..++|-++.++.+ |..+|+|++........... .....+.-.+|+.+|+++ .||||+++.+
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t-~~e~a~kii~~~at~~~~e~------~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKET-GKEFAVKIIDVTATTESGET------PYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hcChHHHhcccchhhhhhhhhccc-ccceeEEEEEecccccCCcc------HHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 466678899999999999988875 88999999866433221110 133456677899999998 7999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+++.+...++|+|.|+.|.|.|+|.. .-.+++....+|+.|+..|++|||..+ ||||||||+|||+|+|.+++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 99999999999999999999999975 567899999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT------LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
|+|||+++....+... ...+|||+|+|||.+.- ..|+..+|.|++||+||-|+.|.+||....+ .-
T Consensus 164 isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----ml- 235 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----ML- 235 (411)
T ss_pred EeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HH-
Confidence 9999999988776543 67899999999997653 3578899999999999999999999975322 11
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+-.++.+++.. .......+......+|+.+|++.||++|.|++|+++
T Consensus 236 ---MLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 ---MLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11222233221 112234455667899999999999999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=310.08 Aligned_cols=258 Identities=21% Similarity=0.335 Sum_probs=204.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||+|++|.||+|....+ +.++|+|.+......... ......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~~lk~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 71 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDT-GRELAVKQVPFDPDSPET---------KKEVNALECEIQLLKNLQHERIVQYYG 71 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCC-CcEEEEEEEeecccchhh---------HHHHHHHHHHHHHHHhCCCCCeeeeEE
Confidence 4688899999999999999987654 899999998754322111 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++|+||+++++|.+++.. ...+++.....++.+++.||.|||+.+ ++|+||+|+||++++++.++
T Consensus 72 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 72 CLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred EEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999875 345888999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++.......... .....++..|+|||++.+..++.++||||+|+++|+|++|+.||...... . . ..
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~--~-~~ 217 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----A--A-IF 217 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----H--H-HH
Confidence 999999876543221111 12346788999999999989999999999999999999999999753221 0 0 11
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
......... .........+.+++..||+.+|.+|||+.++++.
T Consensus 218 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 KIATQPTNP---------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHhccCCCC---------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111111110 1112234458889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.22 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=194.2
Q ss_pred ceecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+.+ .++..+|+|.++..... .....+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 67 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-------------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV 67 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 368999999999998653 23568999998765321 1234688899999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQ-GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
...++||||+++|+|.++++.... .....++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++++||
T Consensus 68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~df 144 (269)
T cd05087 68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDY 144 (269)
T ss_pred CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCc
Confidence 999999999999999999976432 2335677888899999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-------TISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
|++................++..|+|||++.+. .++.++|+||||+++|||++ |+.||...... ....
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~ 220 (269)
T cd05087 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLT 220 (269)
T ss_pred cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHH
Confidence 998765443322222345678889999987642 35789999999999999996 99999754321 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.. ... ......++.+.. .....+.+++..|+ .+|++|||+.+|++.|+
T Consensus 221 ~~---~~~-~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 221 YT---VRE-QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HH---hhc-ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 111 111111111111 12234677888898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.31 Aligned_cols=206 Identities=24% Similarity=0.358 Sum_probs=174.7
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|..++.||+|+||+||+|....+ ++.||+|++..... ........+.+|+.++++++||||+++++.
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~-~~~~aiK~i~~~~~-----------~~~~~~~~~~~E~~il~~~~h~~iv~~~~~ 69 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDT-KALYAMKTLRKKDV-----------LLRNQVAHVKAERDILAEADNEWVVRLYYS 69 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCC-CCEEEEEEEeHHHh-----------hhHHHHHHHHHHHHHHHhCCCCcCCeEEEE
Confidence 478889999999999999988764 89999999875321 113345678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+++..|+|||||++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 70 FQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999975 245788888999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCc---------------------------------------------ceeeecccccccccccccccc
Q 037084 397 SDFGLAKLMPDGHT---------------------------------------------RIRITTVAGTTGYVAPEYHQT 431 (532)
Q Consensus 397 ~DFGla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 431 (532)
+|||++..+..... ........||+.|+|||++.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 99999764321000 000023468999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 432 LTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 432 ~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
..++.++||||+||++|||++|+.||....
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 252 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=323.82 Aligned_cols=244 Identities=27% Similarity=0.387 Sum_probs=192.1
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ ++.||+|+++...... ......+..|..++... +||||+++++++.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~ 68 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGT-NQFFAIKALKKDVVLM-----------DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhhh-----------cchHHHHHHHHHHHHhccCCCcCcceEEEEEeC
Confidence 4699999999999998764 8899999987542110 12234456677777764 999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 69 ENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCC
Confidence 999999999999999999864 346889999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ..+...+. ..
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~~~~~~i~----~~ 211 (316)
T cd05619 142 MCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE----EELFQSIR----MD 211 (316)
T ss_pred cceECCCCCCc--eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH----HHHHHHHH----hC
Confidence 98754322211 1456789999999999998999999999999999999999999975322 11111111 11
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK-DVR 524 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 524 (532)
.+. ........+.+++..||+.+|++||++. ++.
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 NPC----------YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCC----------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 110 0111234578899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=310.10 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=198.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
++||+|+||.||+|... ++..+|+|.++.... ......+.+|+.++++++||||+++++++...+
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 65 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLP-------------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCC-------------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC
Confidence 36999999999999865 578999999876532 122346889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++++|.+++.. ....+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.++++|||+
T Consensus 66 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~ 139 (250)
T cd05085 66 PIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGM 139 (250)
T ss_pred ccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcc
Confidence 99999999999999999864 2345889999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+........... ....++..|+|||++.+..++.++|+||||+++|++++ |..||...... .... . ....
T Consensus 140 ~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~---~-~~~~ 210 (250)
T cd05085 140 SRQEDDGIYSSS-GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QARE---Q-VEKG 210 (250)
T ss_pred ceeccccccccC-CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH---H-HHcC
Confidence 876543322111 22344678999999999899999999999999999998 99999754321 1111 1 1111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
... ......+..+.+++..|++.+|++|||+.++++.|.
T Consensus 211 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 YRM---------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 110 111123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.78 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=196.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|.+++.||+|+||.||+|....+ |+.||||++...... .......+.+|+.++++++||||+++++.
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~-~~~~avK~~~~~~~~-----------~~~~~~~~~~E~~il~~l~h~~iv~~~~~ 69 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDT-NALYAMKTLRKADVL-----------MRNQAAHVKAERDILAEADNEWVVKLYYS 69 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCC-CCEEEEEEEcHHHHH-----------hhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 588899999999999999988765 899999998653211 12334678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+++..++|||||++|+|.+++.. ...++......++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 70 ~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 70 FQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999965 345788888999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCc-----------------------------------------ceeeeccccccccccccccccCCCC
Q 037084 397 SDFGLAKLMPDGHT-----------------------------------------RIRITTVAGTTGYVAPEYHQTLTIS 435 (532)
Q Consensus 397 ~DFGla~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 435 (532)
+|||++..+..... ........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 99999853321000 0001235799999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCC
Q 037084 436 EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPE 515 (532)
Q Consensus 436 ~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~ 515 (532)
.++|||||||++|||++|+.||...........+..|. ... ...... .....+.+++..|+ .+|.
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~~~----~~~~~~----~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE------TTL----HIPSQA----KLSREASDLILRLC-CGAE 287 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC------ccc----cCCCCC----CCCHHHHHHHHHHh-cCHh
Confidence 99999999999999999999997643311111111110 000 000001 12233556666665 4999
Q ss_pred CCC---CHHHHHH
Q 037084 516 ERP---SSKDVRC 525 (532)
Q Consensus 516 ~RP---s~~evl~ 525 (532)
+|+ |+.++++
T Consensus 288 ~R~~~~t~~ell~ 300 (376)
T cd05598 288 DRLGKNGADEIKA 300 (376)
T ss_pred hcCCCCCHHHHhC
Confidence 999 7888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=321.86 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=202.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.++|++.+.||+|+||.||+|.+..+ |. .+++|.+..... ......+.+|+.++.++ +||||+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~-~~~~~~~ik~~~~~~~-------------~~~~~~~~~Ei~~l~~l~~h~~iv 71 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNII 71 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC-CceeeEEEEEecccCC-------------HHHHHHHHHHHHHHHHhcCCCCcc
Confidence 35688889999999999999988653 54 467877764321 23346788899999999 899999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++++++...+..++|+||+++++|.++++.... ....+++..++.++.|++.|++|||+.+ ++||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~ 148 (303)
T cd05088 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHR 148 (303)
T ss_pred eEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999999999999999999999999999975321 1236889999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||++++++.++|+|||++........ .....++..|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 149 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 149 DLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred ccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999999999999999999864322111 122334668999999988889999999999999999998 999996
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
..... +............ ........+.+++.+||+.+|++||++.+++..|+++
T Consensus 226 ~~~~~-------~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 226 GMTCA-------ELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred cCChH-------HHHHHHhcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 53321 1111111110110 0111234578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.23 Aligned_cols=258 Identities=22% Similarity=0.402 Sum_probs=204.8
Q ss_pred CccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
+|.+.+.||+|+||.||+|.+.... +..||||.+..... ......|..|+.++++++||||+++.
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni~~~~ 71 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-------------EKQRRDFLSEASIMGQFDHPNIIHLE 71 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCcCcceEE
Confidence 4778899999999999999987541 23699999876421 23346789999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~ 145 (269)
T cd05065 72 GVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVC 145 (269)
T ss_pred EEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcE
Confidence 999999999999999999999999875 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccc---cccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVA---GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+++|||++................ .+..|+|||++.+..++.++|||||||++||+++ |..||..... ....
T Consensus 146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~ 221 (269)
T cd05065 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVI 221 (269)
T ss_pred EECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHH
Confidence 999999988665432211111111 2457999999999999999999999999999886 9999975322 1222
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.++.. ..... ...+.+..+.+++..||+.+|++||++.+++..|+++
T Consensus 222 ~~i~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 222 NAIEQ---DYRLP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHc---CCcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22221 11110 0112344578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.84 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=205.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
++|...+.||+|+||.||+|.+.... ...+|+|.+..... ......+..|+.++++++|||++++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-------------EKQRQDFLSEASIMGQFSHHNIIRL 71 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-------------HHHHHHHHHHHHHHhcCCCCCeeEE
Confidence 46777899999999999999886432 23799999875421 2234568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.+++...+..++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||||+||++++++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~ 145 (268)
T cd05063 72 EGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLE 145 (268)
T ss_pred EEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCc
Confidence 9999999999999999999999999975 2356899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
++++|||++........... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .+
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~ 218 (268)
T cd05063 146 CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE 218 (268)
T ss_pred EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH
Confidence 99999999986654322111 111223457999999998899999999999999999998 9999964322 12
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+............ ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 219 ~~~~i~~~~~~~~----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 VMKAINDGFRLPA----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHhcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2222221111111 112335688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=313.56 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=206.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.++ ++..+|||.+..... ....+.+|+.++++++|||++++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGTM---------------SPEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCcc---------------CHHHHHHHHHHHhhCCCCCEeee
Confidence 3467889999999999999999876 367899999986532 23567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++......++||||+++++|.+++.. .....+++..+..++.+++.|+.|||+.+ ++|+||||+||++++++.
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~ 141 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLV 141 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCC
Confidence 9999998999999999999999999975 23356899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++++|||++.......... .....++..|+|||.+.+..++.++|+||+|+++|++++ |+.||..... .....
T Consensus 142 ~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~- 215 (261)
T cd05034 142 CKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN----REVLE- 215 (261)
T ss_pred EEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH-
Confidence 9999999988765422111 122334568999999998899999999999999999999 9999965321 11111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
......... .....+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 216 --~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 216 --QVERGYRMP----------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred --HHHcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 111111100 0111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=309.68 Aligned_cols=259 Identities=22% Similarity=0.386 Sum_probs=206.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
.+|.+.+.||+|+||.||+|.+...+ +..+|+|.++.... ......+.+|+.++.+++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~ 70 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-------------EKQRRDFLSEASIMGQFDHPNIIHL 70 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-------------HHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999999875432 34799999876432 2234678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ....+++...+.++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 144 (267)
T cd05066 71 EGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLV 144 (267)
T ss_pred EEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCe
Confidence 9999999999999999999999999975 2346899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
++++|||++........... .....++..|+|||++.+..++.++|+||||+++|++++ |..||..... .....
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~----~~~~~ 220 (267)
T cd05066 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN----QDVIK 220 (267)
T ss_pred EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH----HHHHH
Confidence 99999999987654432111 112233568999999998899999999999999999886 9999975332 11222
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.+. ....+. .....+..+.+++..|++.+|.+|||+.++++.|+++
T Consensus 221 ~~~---~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 221 AIE---EGYRLP----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHh---CCCcCC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 221 111111 0112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.64 Aligned_cols=265 Identities=25% Similarity=0.291 Sum_probs=198.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++.+.||+|+||.||+|.... +|+.||+|.+...... ......+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 67 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVFQN------------LVSCKRVFRELKMLCFFKHDNVLSALDI 67 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC-CCCEEEEEeccccccc------------hHHHHHHHHHHHHHHhCCCCCcCCHhhe
Confidence 47788999999999999998765 4899999998653211 1223567889999999999999999999
Q ss_pred EecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 317 VTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 317 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+...+ ..|+|+||++ ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~ 139 (372)
T cd07853 68 LQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSN 139 (372)
T ss_pred ecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCC
Confidence 98776 7899999995 688887753 356899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++........ ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.
T Consensus 140 ~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 140 CVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999865433221 11345688999999988764 47899999999999999999999997643311111111
Q ss_pred H---------------HHHHHhccC-CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 R---------------WMRNVISSE-NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~---------------~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ ......... ....... . ...........+.+++..|++.||++|||+.++++
T Consensus 219 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLP-V-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchH-H-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0 011111000 0000000 0 00011122456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=328.85 Aligned_cols=242 Identities=22% Similarity=0.315 Sum_probs=193.8
Q ss_pred ceecccCCeEEEEEEee--CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVP--GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|+||.||++... ..+|+.+|+|++...... ......+..|+.++++++||||+++++++..
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 67999999999998753 235889999999753211 1223456789999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
++..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 70 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 70 EGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeec
Confidence 9999999999999999999864 346899999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
|+++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... . .........
T Consensus 143 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~---~~~~~i~~~ 213 (318)
T cd05582 143 GLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----K---ETMTMILKA 213 (318)
T ss_pred cCCcccCCCCCc--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----H---HHHHHHHcC
Confidence 998865443221 1356789999999999988899999999999999999999999975322 1 111111111
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
. . .........+.+++..||+.||++||++.+
T Consensus 214 ~-~----------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 K-L----------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-C----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 0 001112345788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=310.68 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=197.7
Q ss_pred eecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 243 IIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
.||+|+||.||+|.+... .+..||+|++..... ......+.+|+.++++++||||+++++++.. +
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~ 67 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-------------KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E 67 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC-------------hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C
Confidence 389999999999987633 255799999876531 2234678899999999999999999999864 5
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++||||+++++|.+++.. ....+++..+++++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 68 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~ 141 (257)
T cd05115 68 ALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGL 141 (257)
T ss_pred CeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCc
Confidence 78999999999999999864 2456899999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 402 AKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 402 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
+........... .....++..|+|||.+.+..++.++||||||+++|++++ |..||..... . ++.......
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~~~~~~ 214 (257)
T cd05115 142 SKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG----P---EVMSFIEQG 214 (257)
T ss_pred cccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH----H---HHHHHHHCC
Confidence 986544322111 122233578999999988889999999999999999996 9999975432 1 111111111
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
..+ ......+..+.+++..||+.+|++||++.+|.+.|+.+
T Consensus 215 ~~~----------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 215 KRL----------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111 01122345688899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=321.76 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=194.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|..... ++.||+|++....... ......+..|+.++.++ +||||+.+++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 68 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKN-DQIYAMKVVKKELVHD-----------DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT 68 (327)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC
Confidence 4699999999999988764 8899999997642111 23356688899999888 699999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 69 SRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccc
Confidence 999999999999999998864 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......++........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 218 (327)
T cd05617 142 MCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN-PDMNTEDYLFQVILEK 218 (327)
T ss_pred cceeccCCCCc--eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC-cccccHHHHHHHHHhC
Confidence 98753322211 14567999999999999999999999999999999999999999643221 1112222222222211
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
... .+......+.+++..||+.||++||++
T Consensus 219 ~~~----------~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 PIR----------IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCC----------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 110 011123447789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.07 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=221.6
Q ss_pred ccccccccccCccccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc
Q 037084 227 RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR 304 (532)
Q Consensus 227 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 304 (532)
.++..++..+.....++||+|.||+|++|.|...+|+ .||||.++..... .....|.+|+.+|.+
T Consensus 101 ~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-------------~~mddflrEas~M~~ 167 (1039)
T KOG0199|consen 101 IDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-------------AIMDDFLREASHMLK 167 (1039)
T ss_pred CCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-------------hhHHHHHHHHHHHHh
Confidence 3455677888899999999999999999999876665 6999999987643 256889999999999
Q ss_pred CCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 037084 305 IWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 305 l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~ 384 (532)
|+|||+++|+|...+ ....+|+|+++.|||.+.|++ ..+..+.......++.|||.||.||.+++ +|||||..+
T Consensus 168 L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAAR 241 (1039)
T KOG0199|consen 168 LQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAAR 241 (1039)
T ss_pred ccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhh
Confidence 999999999999998 677899999999999999997 55677888999999999999999999999 999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcceeee-ccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRIT-TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
|+||-....+||+||||.+.++.......++ ...-...|+|||.+....++.+||||+|||++|||+| |..||.+...
T Consensus 242 NlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 242 NLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred hheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 9999999999999999999988776554433 2334678999999999999999999999999999999 8899976433
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
..+..-+. ..+. -.....+++.++++++.||.++|.+|||+..+.+.
T Consensus 322 ----~qIL~~iD---~~er----------LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 322 ----IQILKNID---AGER----------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----HHHHHhcc---cccc----------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 22222111 1111 12244577889999999999999999999999744
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.84 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=204.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+..+ |+.||+|++....... .....+|.+|+.++++++||||+++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~t-g~~VAIK~I~~~l~~~-----------e~~~~rflrEi~ILs~L~HPNIVkl~~ 69 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVC-SRRVALKKIREDLSEN-----------PLLKKRFLREAKIAADLIHPGIVPVYS 69 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCC-CcEEEEEEECcccccC-----------HHHHHHHHHHHHHHHhCCCcCcCeEEE
Confidence 4688899999999999999988764 8999999997542211 223467899999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++.+++..+++|||++||+|.+++..... .....++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 70 v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILL 146 (932)
T PRK13184 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILL 146 (932)
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEE
Confidence 99999999999999999999999875321 1234567788999999999999999988 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCc----------------ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 389 DDGMEARISDFGLAKLMPDGHT----------------RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
+.++.++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 147 d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLT 226 (932)
T PRK13184 147 GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226 (932)
T ss_pred cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999987621110 000123569999999999999999999999999999999999
Q ss_pred CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhh
Q 037084 453 GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-SSKDVRCMLSQI 530 (532)
Q Consensus 453 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l 530 (532)
|+.||..... ..+.. .... ..+... ......+..+.+++.+|++.||++|| +++++.+.|+.+
T Consensus 227 G~~PF~~~~~----~ki~~--~~~i--~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 227 LSFPYRRKKG----RKISY--RDVI--LSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCCCCCcch----hhhhh--hhhc--cChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999975221 11100 0000 000000 00122344578899999999999996 567777777654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=317.43 Aligned_cols=267 Identities=25% Similarity=0.295 Sum_probs=194.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc---CCCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR---IWHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~H~niv~l 313 (532)
+|.+.+.||+|+||+||+|.+..+ |+.||+|.++...... .....+.+|+.++.+ ++||||+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~-~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~h~ni~~~ 67 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVQTNED------------GLPLSTVREVALLKRLEAFDHPNIVRL 67 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCC-CcEEEEEEeccCcCCC------------CCchHHHHHHHHHHHhhhcCCCCeeee
Confidence 377889999999999999988765 8999999987542211 011223445555554 479999999
Q ss_pred eeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++... ...+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 68 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili 141 (288)
T cd07863 68 MDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILV 141 (288)
T ss_pred eeeeccccCCCCceEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9988642 45789999996 5899988752 3345899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.++.+||+|||+++........ ....||..|+|||++.+..++.++||||+||++|+|++|++||...........
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 142 TSGGQVKLADFGLARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred CCCCCEEECccCccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 99999999999999876543221 345789999999999988999999999999999999999999975432211111
Q ss_pred HHHHHHHHhccCCC------cccccccc---cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENP------HRAIDSKL---LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~------~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+............+ ...+.+.. .....+.....+.+++..|++.||++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111000000000 00000000 00111233456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=315.34 Aligned_cols=253 Identities=27% Similarity=0.380 Sum_probs=199.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
+++.|...+.||+|+||.||+|.+..+ ++.||+|.+..... ....+.+|+.++.++ +|||+++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~~ 67 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGD---------------EEEEIKQEINMLKKYSHHRNIAT 67 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCC-CcEEEEEEEEcCCc---------------cHHHHHHHHHHHHHhcCCCCeee
Confidence 566788899999999999999988764 89999999876521 224567889999998 7999999
Q ss_pred ceeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 313 LQAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 313 l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++++... ...+++|||+++++|.+++.. .....+++..+..++.|++.|++|||+.+ ++|+||||+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~ni 142 (272)
T cd06637 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNV 142 (272)
T ss_pred EeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHE
Confidence 99998753 357899999999999999975 23356899999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
++++++.++|+|||++......... .....|+..|+|||++. +..++.++|+|||||++|+|++|+.||....
T Consensus 143 li~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 143 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred EECCCCCEEEccCCCceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999999999999998865433221 24567899999999876 3457889999999999999999999996533
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .... ......... . ....+..+.+++.+||+.+|.+|||+.++++
T Consensus 221 ~~~------~~~~--~~~~~~~~~-----~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 PMR------ALFL--IPRNPAPRL-----K---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH------HHHH--HhcCCCCCC-----C---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 211 1110 011111100 0 1112345889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=325.79 Aligned_cols=241 Identities=25% Similarity=0.335 Sum_probs=189.8
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHH-HHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII-TAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||+||+|.+..+ |+.||+|++....... ......+..|.. +++.++||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~ 68 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKAD-GKFYAVKVLQKKAILK-----------KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA 68 (323)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHHhh-----------hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC
Confidence 4699999999999988754 8999999986532111 112234444544 56789999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 69 DKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccC
Confidence 999999999999999999864 346889999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.........
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~ 212 (323)
T cd05575 142 LCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKP 212 (323)
T ss_pred CCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 9875433221 11456799999999999999999999999999999999999999975322 11222222111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 521 (532)
. .+ .+.....+.+++..|++.+|.+||++.
T Consensus 213 -~------~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 -L------RL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -C------CC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 01 111234578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=322.45 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=191.8
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+..+ |..||+|.++..... .......+..|..++... +||||+++++++...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~ 68 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGK-GEYFAVKALKKDVVL-----------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK 68 (316)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC
Confidence 4699999999999998764 899999999753211 012234556677777654 899999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..|+||||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 69 ~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccC
Confidence 999999999999999999864 346889999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||..... ..+. ..... .
T Consensus 142 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~----~~~~---~~~~~-~ 211 (316)
T cd05620 142 MCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE----DELF---ESIRV-D 211 (316)
T ss_pred CCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHH---HHHHh-C
Confidence 9875432221 12456799999999999999999999999999999999999999975322 1111 11111 1
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK-DVR 524 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 524 (532)
.+. ........+.+++..||+.||++||++. ++.
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPH----------YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC----------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 110 0011234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=314.44 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=200.3
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|+..+.||+|+||+||+|.+..+ |+.+|+|.+....... ......+.+|+.++++++|+|++.+.+.+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~ 69 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRAT-GKMYACKRLEKKRIKK-----------RKGESMALNEKQILEKVNSQFVVNLAYAY 69 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCC-CcEEEEEEeehhhhhh-----------hhHHHHHHHHHHHHHHcCCcCceeEEEEE
Confidence 56678899999999999988764 8999999986542211 22235577899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+
T Consensus 70 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 70 ETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred ecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEe
Confidence 9999999999999999999988752 3346999999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||++......... ....|+..|+|||++.+..++.++|+|||||++|+|++|..||........ .........
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~ 218 (285)
T cd05632 145 DLGLAVKIPEGESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVL 218 (285)
T ss_pred cCCcceecCCCCcc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhh
Confidence 99998765433221 345789999999999988999999999999999999999999975322111 111111111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
.... .........+.+++..|++.+|++||+ +.+++.
T Consensus 219 -~~~~----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 219 -ETEE----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -cccc----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1110 011122345788999999999999999 556654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=314.57 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=200.5
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|+..+.||+|+||.||++.+..+ ++.||+|.+....... ......+.+|+.++++++|+|++.+.+.+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~-~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~ 69 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKK-----------RKGESMALNEKQILEKVNSRFVVSLAYAY 69 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCC-CceEEEEEEehhhccc-----------hHHHHHHHHHHHHHHhCCCCCeeeeeEEE
Confidence 66778999999999999988765 8999999986542211 12234567899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 70 ~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 70 ETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 999999999999999999999865 23346899999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||++......... ....|+..|+|||++.+..++.++|+||+|+++|+|++|+.||............ ....
T Consensus 145 Dfg~~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~----~~~~ 217 (285)
T cd05630 145 DLGLAVHVPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----ERLV 217 (285)
T ss_pred eccceeecCCCccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----Hhhh
Confidence 99998765433221 3457899999999999999999999999999999999999999753221100111 1111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
..... .........+.+++..||+.||++||| +.++++
T Consensus 218 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 218 KEVQE----------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhh----------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00000 011112344788999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.97 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=197.7
Q ss_pred ceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEe
Q 037084 242 EIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVT 318 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 318 (532)
+.||+|+||.||+|.+..+ |. .+++|.++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~-~~~~~~~~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 66 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNIINLLGACE 66 (270)
T ss_pred CcCCCCCCceEEEEEEcCC-CCeeEEEEEEccccCC-------------HHHHHHHHHHHHHHHhhccCCCeeeEEEEEe
Confidence 3689999999999988754 43 578898875321 22345788899999999 8999999999999
Q ss_pred cCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 319 RPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
..+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 67 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~ni 143 (270)
T cd05047 67 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 143 (270)
T ss_pred cCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceE
Confidence 99999999999999999999975321 1235789999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchh
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTE 465 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 465 (532)
++++++.+|++|||++....... .......+..|+|||++.+..++.++|+||||+++|||++ |..||.....
T Consensus 144 li~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--- 217 (270)
T cd05047 144 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 217 (270)
T ss_pred EEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence 99999999999999986332111 1122233567999999988899999999999999999997 9999965322
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+............ ........+.+++..||+.+|.+|||+.+++..|+++-
T Consensus 218 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 218 ----AELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----HHHHHHHhCCCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11112111111110 01122345889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=319.76 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=206.8
Q ss_pred cccCccccceecccCCeEEEEEEeeC------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
..++|.+.+.||+|+||.||+|...+ ..+..+|+|.++.... ......+.+|+.++.++ +
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~ 76 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------------DKDLADLISEMELMKLIGK 76 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------------hHHHHHHHHHHHHHHhccC
Confidence 34678889999999999999997532 1245799999875432 22345688899999999 6
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||++++++|...+..++++||+++|+|.+++..... ....+++.....++.|++.||.|||+.+
T Consensus 77 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g-- 154 (314)
T cd05099 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR-- 154 (314)
T ss_pred CCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 99999999999999999999999999999999976321 1245899999999999999999999988
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
++||||||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 155 -i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g 233 (314)
T cd05099 155 -CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG 233 (314)
T ss_pred -eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCC
Confidence 99999999999999999999999999987654322111122234567999999988899999999999999999999 8
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||..... ..+...+ ....... .....+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 234 ~~p~~~~~~----~~~~~~~----~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 234 GSPYPGIPV----EELFKLL----REGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCCCCCH----HHHHHHH----HcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 899865322 1111111 1111110 11122345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=313.72 Aligned_cols=257 Identities=26% Similarity=0.361 Sum_probs=201.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|....+ |+.||+|++..... .....+.+|+.++.+++||||+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~~aik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~ii~~ 71 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHT-GELAAVKIIKLEPG--------------DDFSLIQQEIFMVKECKHCNIVAY 71 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCC-CeEEEEEEEecCcc--------------chHHHHHHHHHHHHhcCCCCeeee
Confidence 356799999999999999999988654 88999999975431 123457789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++|+||+++++|.++++. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.
T Consensus 72 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~ 144 (267)
T cd06646 72 FGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGD 144 (267)
T ss_pred eEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 346889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++|+|||++......... .....|+..|+|||.+. ...++.++|+||+||++|+|++|+.||...........+
T Consensus 145 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~- 221 (267)
T cd06646 145 VKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM- 221 (267)
T ss_pred EEECcCccceeecccccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-
Confidence 999999999866432211 13456889999999874 445788999999999999999999998643221111000
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
...... .+.. .........+.+++..||+.+|++|||++++++.|
T Consensus 222 -------~~~~~~---~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 -------SKSNFQ---PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -------ecCCCC---CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000000 0000 00112345688999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=313.07 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=206.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..+|.+.+.||+|+||.||+|.+..+ |. .+|+|.+..... ......+.+|+..+.+++|||+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~~~~~aik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i 71 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPE-GEKVKIPVAIKVLREETS-------------PKANKEILDEAYVMASVDHPHV 71 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecC-CCCcceEEEEEeccCCCC-------------HHHHHHHHHHHHHHHhCCCCCc
Confidence 45688889999999999999988653 33 699998876532 2234678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
++++++|.. ...++|+||+++|+|.+++.. ....+++.....++.|++.||+|||+.+ ++|+||||+||++++
T Consensus 72 ~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~ 144 (279)
T cd05057 72 VRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKT 144 (279)
T ss_pred ceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcC
Confidence 999999987 788999999999999999975 2345899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
++.++|+|||+++...............++..|+|||.+....++.++|+||||+++||+++ |+.||..... ..+
T Consensus 145 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~ 220 (279)
T cd05057 145 PQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEI 220 (279)
T ss_pred CCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHH
Confidence 99999999999987654332222122334568999999988899999999999999999998 9999976432 112
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...+ ....... .+......+.+++..||..+|..|||+.++++.|+++.
T Consensus 221 ~~~~---~~~~~~~----------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 221 PDLL---EKGERLP----------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred HHHH---hCCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2221 1111110 01112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=315.76 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=202.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||+|+||.||++.+..+ |..+|+|.+..... ......+.+|++++.+++||||+++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 66 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPS-GLIMARKLIHLEIK-------------PAIRNQIIRELKVLHECNSPYIVGFYG 66 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCC-CeEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3688899999999999999988764 88999999875421 223456888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
++..++..++|+||+++++|.+++.. ...+++.....++.|+++||.|||+ .+ ++|+||||+||++++++.+
T Consensus 67 ~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~ 139 (308)
T cd06615 67 AFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEI 139 (308)
T ss_pred EEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcE
Confidence 99999999999999999999999975 2568899999999999999999997 46 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||++........ ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .....+..
T Consensus 140 ~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~ 211 (308)
T cd06615 140 KLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFG 211 (308)
T ss_pred EEccCCCccccccccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch----hhHHHhhc
Confidence 9999999876543321 345788999999999888899999999999999999999999864321 11111111
Q ss_pred HHhccCCCcc--------------------cccccc---cCC-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 475 NVISSENPHR--------------------AIDSKL---LGN-GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 475 ~~~~~~~~~~--------------------~~d~~l---~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.......... ..+... .+. ........+.+++.+||+.+|++|||+.++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 000000 000 001133458899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.66 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=203.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++.+.||+|+||.||++.+..+ +..+|+|.++.... ......+..|+.++++++|||++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 66 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNS-DQKYAMKEIRLPKS-------------SSAVEDSRKEAVLLAKMKHPNIVAFKES 66 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCC-CceEEEEEEEcCcc-------------hHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 367789999999999999988764 88999999865421 2234567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..+++|||+++++|.+++.. .....++......++.|++.||.|||+.+ ++|+||||+||++++++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l 141 (255)
T cd08219 67 FEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKL 141 (255)
T ss_pred EEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEE
Confidence 9999999999999999999998865 23456789999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .......
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~ 212 (255)
T cd08219 142 GDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKV 212 (255)
T ss_pred cccCcceeecccccc--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHH
Confidence 999998866543221 1345688999999999988999999999999999999999999975321 1111111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.. +.... ........+.+++..||+.+|++|||+.+++..
T Consensus 213 ~~-~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 213 CQ-GSYKP---------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred hc-CCCCC---------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11110 011223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.49 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=199.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|....+ +..||+|.++..... .....+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~ 70 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLT-ENLVALKEIRLEHEE-------------GAPCTAIREVSLLKDLKHANIVTLH 70 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCC-CCeEEEEEeeccccC-------------CcchhHHHHHHHHHhCCCCCcceEE
Confidence 35688999999999999999988754 889999998754321 1123466899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 71 DIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGEL 143 (309)
T ss_pred EEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCE
Confidence 999999999999999964 88888764 2345788999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ .....+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+....
T Consensus 144 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 221 (309)
T cd07872 144 KLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221 (309)
T ss_pred EECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999998765433221 134567899999998765 468899999999999999999999997643211111111000
Q ss_pred -------HHHhccCCCccccc-ccc----cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 -------RNVISSENPHRAID-SKL----LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 -------~~~~~~~~~~~~~d-~~l----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+............+ +.. .....+.....+.+++..|++.||.+|||+.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000 000 00011123456789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=324.60 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=190.2
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH-HHHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-ITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||+||+|.+..+ ++.||+|++....... ......+..|. .+++.++||||+++++++...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~ 68 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAE-EKFYAVKVLQKKAILK-----------KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 68 (325)
T ss_pred CeeeeCCCeEEEEEEECCC-CCEEEEEEEEHHHHHh-----------hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC
Confidence 4699999999999988754 8899999987532110 11122333443 456788999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 69 DKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCC
Confidence 999999999999999999865 345778888889999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +.........
T Consensus 142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~~ 212 (325)
T cd05602 142 LCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKP 212 (325)
T ss_pred CCcccccCCCC--cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC
Confidence 98754332211 14567999999999999999999999999999999999999999753321 1112221111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. + .+.....+.+++..|++.+|.+||++.+.+.
T Consensus 213 -~~--~--------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 213 -LQ--L--------KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -cC--C--------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 00 0 1122345788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.01 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=194.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~ 315 (532)
+|...+.||+|+||.||+|....+ |+.||+|++...... .......+..|..++..+. |++|+++.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~ 68 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVI-----------QDDDVECTMVEKRVLALQDKPPFLTQLHS 68 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHHhccCCCchhheee
Confidence 366778999999999999988764 899999998753211 0223456778888888885 577888999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 69 CFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 99999999999999999999999864 345899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+++........ .....||+.|+|||++.+..++.++|+||+||++|+|++|+.||..... ..+. ..
T Consensus 142 L~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~---~~ 212 (323)
T cd05615 142 IADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE----DELF---QS 212 (323)
T ss_pred EeccccccccCCCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH----HHHH---HH
Confidence 9999998754332211 1345689999999999999999999999999999999999999976432 1111 11
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
.... ... ........+.+++..|++.+|.+|++.
T Consensus 213 i~~~-~~~----------~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEH-NVS----------YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhC-CCC----------CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111 100 011123457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=329.77 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=198.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||++.+..+ ++.+|+|++...... .......+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSS-QKVYAMKLLSKFEMI-----------KRSDSAFFWEERDIMAFANSPWVVQL 108 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhhHHHHHHHHHHHHhCCCCCEeeE
Confidence 346799999999999999999998764 889999998643111 02234567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..++..|+|||||++|+|.+++.. ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~ 180 (370)
T cd05621 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGH 180 (370)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 24788889999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+||+|||++........ .......||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||.....
T Consensus 181 ~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------- 252 (370)
T cd05621 181 LKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------- 252 (370)
T ss_pred EEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------
Confidence 99999999987643322 1224567999999999887543 78899999999999999999999975322
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 525 (532)
............... + .........+.+++..|++.+|.+ |||+.++++
T Consensus 253 ~~~~~~i~~~~~~~~-~------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 253 VGTYSKIMDHKNSLN-F------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHHHHHHHhCCcccC-C------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 111122221111000 0 001122345777888888755543 889999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.02 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=204.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|+..+.||+|+||.||+|.+..+ |. .+|+|.+..... ......+.+|+.++++++|||
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~-~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~n 70 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPE-GETVKIPVAIKILNETTG-------------PKANVEFMDEALIMASMDHPH 70 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecC-CCcceeeEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 345788889999999999999988654 43 579998875432 122346888999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|++++++|... ..++++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 71 iv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~ 143 (303)
T cd05110 71 LVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVK 143 (303)
T ss_pred cccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeec
Confidence 99999999764 46799999999999999874 2346889999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..... ..
T Consensus 144 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~ 219 (303)
T cd05110 144 SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----RE 219 (303)
T ss_pred CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH
Confidence 999999999999987654332222233445778999999998899999999999999999997 9999965322 11
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...++.. ...+. ..+.....+.+++..||..+|++||+++++++.|+.+.
T Consensus 220 ~~~~~~~---~~~~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 220 IPDLLEK---GERLP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHHHHHC---CCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222211 11111 01112345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.85 Aligned_cols=265 Identities=21% Similarity=0.192 Sum_probs=198.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
....|.+.+.||+|+||.||+|.+... +..||||.... ..+.+|+.++++++||||+++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~-~~~vavK~~~~--------------------~~~~~E~~iL~~L~HpnIv~l 225 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDY-PQRVVVKAGWY--------------------ASSVHEARLLRRLSHPAVLAL 225 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCC-CCEEEEecccc--------------------cCHHHHHHHHHHCCCCCCCcE
Confidence 345799999999999999999998764 88999996432 234579999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++|||++ .++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 226 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~ 298 (461)
T PHA03211 226 LDVRVVGGLTCLVLPKY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPED 298 (461)
T ss_pred EEEEEECCEEEEEEEcc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCC
Confidence 99999999999999999 5789888864 2346999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch----hhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT----EEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----~~~~l 469 (532)
++|+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+-...... ....+
T Consensus 299 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l 378 (461)
T PHA03211 299 ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378 (461)
T ss_pred EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH
Confidence 99999999987644322211134579999999999999999999999999999999999886653321111 01112
Q ss_pred HHHHHHHhcc-CCCccccc----------------ccccCCC---cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 470 VRWMRNVISS-ENPHRAID----------------SKLLGNG---YEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 470 ~~~~~~~~~~-~~~~~~~d----------------~~l~~~~---~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
...+...... ........ +...... .......+.+|+..||+.||.+|||+.|+++.
T Consensus 379 ~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2222111000 00000000 0000000 00122357889999999999999999999863
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=310.17 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=191.4
Q ss_pred eecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 243 IIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
.||+|+||.||+|..... ....+++|.+..... ......|.+|+..++.++||||+++++++...+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~ 68 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-------------PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI 68 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-------------hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence 589999999999976432 245789998765431 223456888999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQG-RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
..++||||+++|+|.+++...... ....++.....++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg 145 (269)
T cd05042 69 PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYG 145 (269)
T ss_pred ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccc
Confidence 999999999999999999764321 234567888899999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-------LTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++................++..|+|||+... ..++.++|||||||++|||++ |..||...... ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~--- 218 (269)
T cd05042 146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QV--- 218 (269)
T ss_pred cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HH---
Confidence 9875433322221133456778999998643 356889999999999999999 78888753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
......... .....+.+ .......+.+++..|| .+|++|||+++|++.|.
T Consensus 219 ~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVREQD-IKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhhccC-ccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 11111111 1223344666777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=306.31 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=200.0
Q ss_pred ceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|+||.||+|.+...+ +..+|+|.+...... .....+.+|+.+++++.|||++++++++..
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------------AGKKEFLREASVMAQLDHPCIVRLIGVCKG 67 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC
Confidence 46999999999999876543 268999999866421 234678889999999999999999998864
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||..+ ++|+||||+||+++.++.++|+||
T Consensus 68 -~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df 139 (257)
T cd05060 68 -EPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDF 139 (257)
T ss_pred -CceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccc
Confidence 567999999999999999975 236899999999999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHh
Q 037084 400 GLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 400 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|+++.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||..... ..+..++..
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~~-- 213 (257)
T cd05060 140 GMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLES-- 213 (257)
T ss_pred cccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHHc--
Confidence 99987654332211 112223567999999999999999999999999999998 9999975322 222222221
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... .....+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 214 --~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 --GERLP---------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCcCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11100 11122346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.35 Aligned_cols=261 Identities=21% Similarity=0.204 Sum_probs=200.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+|.+.+.||+|+||.||++...+. .+..||+|.+... ..+.+|+.++++++||||+++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------------~~~~~E~~il~~l~h~~iv~~ 151 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------------KTPGREIDILKTISHRAIINL 151 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------------ccHHHHHHHHHhcCCCCccce
Confidence 45699999999999999999976432 3578999988654 124579999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++|||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 152 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~ 223 (392)
T PHA03207 152 IHAYRWKSTVCMVMPKY-KCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPEN 223 (392)
T ss_pred eeeEeeCCEEEEEehhc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCC
Confidence 99999999999999999 5789888843 456899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+
T Consensus 224 ~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~ 303 (392)
T PHA03207 224 AVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303 (392)
T ss_pred EEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH
Confidence 99999999987655433222245679999999999999999999999999999999999999996543221111111111
Q ss_pred HHH----------------------hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNV----------------------ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~----------------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.. .....+.......+.. ......+.+++..|++.+|++|||+.+++.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 304 RCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK---YGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHhccCccccCCccchhHHHHHHhhcccccCCccccchhhc---cCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 110 0000000000000000 012345778899999999999999999985
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=310.94 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=201.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+-|++.+.||+|+||.||+|.+..+ +..+++|.+.... ......+.+|+.+++.++|||+++++
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~-~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~ii~~~ 68 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKET-GVLAAAKVIDTKS--------------EEELEDYMVEIDILASCDHPNIVKLL 68 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCC-CeEEEEEEeCCCC--------------HHHHHHHHHHHHHHHHCCCCCeeeEE
Confidence 34467889999999999999988764 8899999987653 23346788899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++|+||+++++|..++.. ...++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 69 ~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~ 142 (282)
T cd06643 69 DAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDI 142 (282)
T ss_pred EEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCE
Confidence 999999999999999999999998864 2356899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+|+|||++......... .....++..|+|||++. +..++.++|+|||||++|+|++|++||....... ..
T Consensus 143 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~ 217 (282)
T cd06643 143 KLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR---VL 217 (282)
T ss_pred EEccccccccccccccc--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH---HH
Confidence 99999998765433211 13456899999999874 4457889999999999999999999997543211 11
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ......+... . .......+.+++..||+.+|.+|||+.++++
T Consensus 218 ~~----~~~~~~~~~~-~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 218 LK----IAKSEPPTLA-Q-------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HH----HhhcCCCCCC-C-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1111111100 0 1112345888999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=321.84 Aligned_cols=258 Identities=20% Similarity=0.286 Sum_probs=212.7
Q ss_pred cCccccceecccCCeEEEEEEeeCC-CC--cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGS-YG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~-~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
+.....++||.|.||.||+|..... .| -.||||..+.+... ...+.|..|..++++++||||++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-------------d~tekflqEa~iMrnfdHphIik 455 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-------------DDTEKFLQEASIMRNFDHPHIIK 455 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-------------hhHHHHHHHHHHHHhCCCcchhh
Confidence 4456678899999999999987532 23 36899998876432 23578999999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
|+|+|.+ ...+||||.++-|.|..+|.. +...++......++.|++.+|+|||+.. .|||||..+|||+...-
T Consensus 456 LIGv~~e-~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~ 528 (974)
T KOG4257|consen 456 LIGVCVE-QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQ 528 (974)
T ss_pred eeeeeec-cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcc
Confidence 9999997 567999999999999999985 4567899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+|++|||+++...+...... +...-++.|||||.+....++.+||||.|||.+||++. |..||......+...
T Consensus 529 CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~---- 603 (974)
T KOG4257|consen 529 CVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG---- 603 (974)
T ss_pred eeeecccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----
Confidence 999999999999988765432 33445678999999999999999999999999999988 999998643311111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+...-+...++.++..++.|+.+||..+|.+||++.++...|.++.
T Consensus 604 -------------~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 604 -------------HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -------------EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11111112234556677899999999999999999999999998764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=305.44 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=201.8
Q ss_pred ceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|++|.||+|.+....++ .||+|.+...... .....+.+|+..+++++||||+++++++..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC
Confidence 4689999999999998653343 6999999876421 345788899999999999999999999988
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
...++|+||+++++|.+++.... ...+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 68 -~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~df 141 (257)
T cd05040 68 -HPLMMVTELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDF 141 (257)
T ss_pred -CeEEEEEEecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccc
Confidence 88999999999999999997632 156899999999999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHh
Q 037084 400 GLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 400 Gla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|++........... .....++..|+|||++.+..++.++|||||||++|+|++ |..||..... ..+......
T Consensus 142 g~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~-- 215 (257)
T cd05040 142 GLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG----SQILKKIDK-- 215 (257)
T ss_pred cccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHh--
Confidence 99987755332211 123457789999999999999999999999999999998 9999964322 111111111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
..... ......+..+.+++..|++.+|++|||+.++++.|.
T Consensus 216 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGERL---------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCcC---------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11100 011123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=322.37 Aligned_cols=266 Identities=25% Similarity=0.308 Sum_probs=198.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||++....+ |..||+|.+...... ......+.+|+.+++.++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~ 85 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVL-GINVAVKKLSRPFQN------------QTHAKRAYRELVLLKCVNHKNIISL 85 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCC-CceeEEEEecccccc------------hhHHHHHHHHHHHHHhCCCCCEeee
Confidence 346799999999999999999987754 899999999754221 2234567789999999999999999
Q ss_pred eeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++...+ ..|+||||++ ++|.+.++. .+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl 155 (359)
T cd07876 86 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 155 (359)
T ss_pred eeeeccCCCccccceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 99986543 4699999995 467666642 3788888999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 156 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 156 VKSDCTLKILDFGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred ECCCCCEEEecCCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999976533221 144678999999999999999999999999999999999999997543211000
Q ss_pred c---------------HHHHHHHHhccCC-Cc-----cccccccc---CCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 468 N---------------MVRWMRNVISSEN-PH-----RAIDSKLL---GNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 468 ~---------------l~~~~~~~~~~~~-~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
. +...+........ .. +.+..-.. ..........+.+++..||+.||++|||+.|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 312 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHH
Confidence 0 0001111111000 00 00000000 00111123568899999999999999999999
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
++
T Consensus 313 l~ 314 (359)
T cd07876 313 LR 314 (359)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=322.83 Aligned_cols=193 Identities=23% Similarity=0.313 Sum_probs=166.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
...+|.+.+.||+|+||.||+|....+ +..||+|..... ....|+.++++++||||+++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~valK~~~~~--------------------~~~~E~~~l~~l~h~~iv~~ 122 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQ-PDPVVLKIGQKG--------------------TTLIEAMLLQNVNHPSVIRM 122 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCC-CceEEEEeCCcc--------------------ccHHHHHHHHhCCCCCCcCh
Confidence 345799999999999999999998764 789999985443 12358889999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++|+||+ .++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 123 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 195 (357)
T PHA03209 123 KDTLVSGAITCMVLPHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQ 195 (357)
T ss_pred hheEEeCCeeEEEEEcc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999999 5689888864 3456899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~ 457 (532)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 196 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 196 VCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999975433221 13457899999999999999999999999999999999865544
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=321.16 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=207.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
..+|.+.+.||+|+||.||+|.+.+. .+..||+|.+..... ......+.+|+.+++++ +|
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h 77 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-------------DKDLSDLVSEMEMMKMIGKH 77 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-------------HHHHHHHHHHHHHHHhhcCC
Confidence 45688899999999999999976421 123799998875421 22346788999999999 89
Q ss_pred CCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 308 RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPC 375 (532)
Q Consensus 308 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ 375 (532)
|||++++++|...+..++++||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--- 154 (334)
T cd05100 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--- 154 (334)
T ss_pred CCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 9999999999999999999999999999999975321 2345889999999999999999999988
Q ss_pred eeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CC
Q 037084 376 IIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GK 454 (532)
Q Consensus 376 ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~ 454 (532)
++||||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 155 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 234 (334)
T cd05100 155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234 (334)
T ss_pred eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999986654322211123344568999999999999999999999999999998 88
Q ss_pred CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 455 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.||..... .++........... ........+.+++..||+.+|++|||+.++++.|+++.
T Consensus 235 ~p~~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 235 SPYPGIPV-------EELFKLLKEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCCCCH-------HHHHHHHHcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 99865321 22222222111110 11122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=306.71 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=202.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|.+.+.||+|+||.||+|.+. ++..+|+|.+...... ...|.+|+.++++++|||++++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGAMS---------------EEDFIEEAQVMMKLSHPKLVQLYG 66 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCCCC---------------HHHHHHHHHHHHhCCCCCeeeEEE
Confidence 35778899999999999999876 3778999998765321 245788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++......++|+||+++++|.+++.. ....+++..+..++.+++.+++|||+.+ ++|+||||+||+++.++.++
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~ 140 (256)
T cd05112 67 VCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVK 140 (256)
T ss_pred EEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEE
Confidence 99999999999999999999999874 2345889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++.......... .....++.+|+|||++.++.++.++|+||||+++|||++ |..||..... ..+. .
T Consensus 141 l~d~g~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~---~ 212 (256)
T cd05112 141 VSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN----SEVV---E 212 (256)
T ss_pred ECCCcceeecccCcccc-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH----HHHH---H
Confidence 99999988654432211 123345678999999998899999999999999999998 9999975322 1111 1
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
........ ..+.. .+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 213 ~~~~~~~~---~~~~~-------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 213 TINAGFRL---YKPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHhCCCCC---CCCCC-------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11111111 11111 2356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=313.08 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=202.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|...+.||+|+||.||+|.+... +..||+|.+..... ......+.+|+.++++++||||+++++
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRT-KEVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYITRYYG 69 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCC-CeEEEEEEeccccc-------------hHHHHHHHHHHHHHHcCCCCccHhhhc
Confidence 3577788999999999999988654 88999999875421 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..++|+||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 70 SYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred ccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEE
Confidence 99999999999999999999998853 45889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||++......... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.|+...... ....+
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~--- 212 (277)
T cd06642 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLFL--- 212 (277)
T ss_pred EccccccccccCcchh--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHhh---
Confidence 9999998876543221 13456889999999999989999999999999999999999998753221 11111
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... .......+..+.+++..||+.+|++|||+.++++
T Consensus 213 -~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 213 -IPKNSP---------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -hhcCCC---------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111111 0111233456889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=313.98 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=203.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
...+|...+.||+|+||.||+|....+ +..|++|.+..... .....+.+|+.+++.+.|||++++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~v~ik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~v~~~ 82 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNY 82 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCC-CcEEEEEEEecCCc--------------chHHHHHHHHHHHHhCCCCCEeeE
Confidence 446788899999999999999987654 88999999876532 123567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..+...++||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~ 154 (296)
T cd06654 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154 (296)
T ss_pred EEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCC
Confidence 9999999999999999999999999864 34788999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||++......... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.
T Consensus 155 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~--- 226 (296)
T cd06654 155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALY--- 226 (296)
T ss_pred EEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHH---
Confidence 999999998865433211 13457889999999999888999999999999999999999999753221 1111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+. . .........+.+++.+||..+|++|||+.++++
T Consensus 227 -~~~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 227 -LIATNGTPE-L-------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -HHhcCCCCC-C-------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 111111110 0 011223455888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=307.03 Aligned_cols=269 Identities=28% Similarity=0.400 Sum_probs=205.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHh--cCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG--RIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~ 312 (532)
.+.....++||+|+||.||+|.+. ++.||||++... ....|.+|-.+.+ .++|+||++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~---~~~VAVKifp~~-----------------~kqs~~~Ek~Iy~lp~m~h~nIl~ 268 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD---NRLVAVKIFPEQ-----------------EKQSFQNEKNIYSLPGMKHENILQ 268 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc---CceeEEEecCHH-----------------HHHHHHhHHHHHhccCccchhHHH
Confidence 345677899999999999999987 789999999743 3456777766665 458999999
Q ss_pred ceeEEecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeeecCCC
Q 037084 313 LQAHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY------HRPCIIHRDIK 382 (532)
Q Consensus 313 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------~~~~ivH~Dlk 382 (532)
+++.-.... .++||++|.++|||.++|.. ..++|....+|+..+++||+|||+. .+++|+|||||
T Consensus 269 Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlk 343 (534)
T KOG3653|consen 269 FIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLK 343 (534)
T ss_pred hhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccc
Confidence 999887665 78999999999999999975 4699999999999999999999964 36789999999
Q ss_pred CCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCC-CC-----chhhHHHHHHHHHHHHhCCCC
Q 037084 383 PANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-IS-----EKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 383 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~p 456 (532)
+.||||.+++...|+|||+|..+............+||.+|||||++.+.. +. .+.||||+|.|+|||++....
T Consensus 344 SkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 344 SKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred ccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence 999999999999999999999887654444445689999999999987642 22 357999999999999997644
Q ss_pred CC--------Ccccchhh-ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 457 FD--------DFFQYTEE-MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 457 ~~--------~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
+. ..++.+.. .--.+-++.++-..+....+..... ....+..+.+.+..||+.||+.|.|+.-+-+.+
T Consensus 424 ~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 424 ADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred ccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 32 22221111 1122223333222221111111111 125567788999999999999999999998888
Q ss_pred hhhh
Q 037084 528 SQIK 531 (532)
Q Consensus 528 ~~l~ 531 (532)
.++.
T Consensus 501 ~~l~ 504 (534)
T KOG3653|consen 501 AELM 504 (534)
T ss_pred HHHh
Confidence 7764
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=307.73 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=205.6
Q ss_pred ceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|+||.||+|.... ..+..|++|.+...... .....+.+|+..+..++|+|++++++++..
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 67 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------------EERKDFLKEARVMKKLGHPNVVRLLGVCTE 67 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------------hHHHHHHHHHHHHhhcCCCChheeeeeecC
Confidence 469999999999998873 12678999999876422 134678899999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQG-----RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
....++||||+++++|.+++...... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+
T Consensus 68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~ 144 (262)
T cd00192 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVV 144 (262)
T ss_pred CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcE
Confidence 99999999999999999999863221 467999999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||.+................++..|+|||.+.+..++.++||||+|+++|+|++ |..||..... ..+ .
T Consensus 145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~---~ 217 (262)
T cd00192 145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEV---L 217 (262)
T ss_pred EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHH---H
Confidence 9999999987765432222245567889999999998899999999999999999999 6999976422 111 1
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
......... ......+..+.+++..||+.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 EYLRKGYRL----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHcCCCC----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 121111111 111222456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=304.92 Aligned_cols=254 Identities=25% Similarity=0.340 Sum_probs=195.2
Q ss_pred ceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
+.||+|+||.||+|.+... ++..+|+|.+..... ......+.+|+.+++.++|||++++++++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 67 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-------------LEEVEQFLKEGIIMKDFSHPNVLSLLGICLP 67 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-------------HHHHHHHHHHHHHHccCCCCCcceEEEEeec
Confidence 4689999999999987532 246899999864321 2234678889999999999999999998764
Q ss_pred -CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEec
Q 037084 320 -PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISD 398 (532)
Q Consensus 320 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 398 (532)
++..++++||+++|+|.+++... ...+++.....++.|+++||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 68 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~d 141 (262)
T cd05058 68 SEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVAD 141 (262)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence 55679999999999999999752 334677888899999999999999988 99999999999999999999999
Q ss_pred cCCcccCCCCCcc--eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhccHHHHHHH
Q 037084 399 FGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVG-KFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 399 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
||+++........ .......++..|+|||++.+..++.++|||||||++|||++| .+||..... .+....
T Consensus 142 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~ 214 (262)
T cd05058 142 FGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVY 214 (262)
T ss_pred ccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence 9999865432211 111233456789999999888999999999999999999995 566654221 112222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
......+.. ....+..+.+++..||+.+|++||++.++++.|+++.
T Consensus 215 ~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 215 LLQGRRLLQ----------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HhcCCCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 222111110 1112345889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=314.44 Aligned_cols=265 Identities=21% Similarity=0.319 Sum_probs=204.8
Q ss_pred CccccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
.|.+.+.||+|+||.||++.+. ..++..||+|.++.... ......+.+|+.++++++|||++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------------GNHIADLKKEIEILRNLYHENIVKY 71 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-------------HHHHHHHHHHHHHHHhCCCCCeeee
Confidence 4688899999999999999753 23478999999875431 2234678899999999999999999
Q ss_pred eeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 314 QAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 314 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
.+++... ...++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 145 (284)
T cd05079 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145 (284)
T ss_pred eeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCC
Confidence 9999875 567899999999999999864 2346899999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-------
Q 037084 392 MEARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY------- 463 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------- 463 (532)
+.++|+|||+++.......... .....++..|+|||+..+..++.++|+||||+++|+|++++.|.......
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence 9999999999987654332111 12455677899999998888999999999999999999988765432110
Q ss_pred -hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 464 -TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 464 -~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........+.......... ......+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTRLVRVLEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHHHHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011111112111111110 01112345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.16 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=213.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l 313 (532)
.+.|.+.+.||.|.||.||+++.+.+ |+.+|+|.+....... ......+.+|+.+|+++. |||||.+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~t-g~~~A~K~i~k~~~~~-----------~~~~~~v~~Ev~il~~l~~hpniv~l 101 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKST-GKEVACKVIPKRKLRG-----------KEDREDVRREVAILQQLSGHPNIVQL 101 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCC-CceeEEEEeehhhccc-----------cccHHHHHHHHHHHHhccCCCCEEEE
Confidence 45688889999999999999998875 9999999998764321 123467889999999998 9999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC--
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG-- 391 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~-- 391 (532)
.+.++.....++|||+|.||.|.+.+... .+++.....++.|++.++.|||+.+ ++||||||+|+|+...
T Consensus 102 ~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 102 KDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccC
Confidence 99999999999999999999999999863 3999999999999999999999998 9999999999999633
Q ss_pred --CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 --MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 --~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+.+|++|||++...... ......+||+.|+|||++....|+..+|+||+|+++|.|++|.+||..........
T Consensus 174 ~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-- 248 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-- 248 (382)
T ss_pred CCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--
Confidence 47999999999988762 23378899999999999999999999999999999999999999998654321111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... +++ .......+.....+.+++..|+..||.+|+|+.++++
T Consensus 249 -----~i~~-~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 -----AILR-GDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----HHHc-CCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111 211 2223344555677899999999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.20 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=199.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||++.+..+ ++.+|+|++...... .......+.+|+.+++.++||||+++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~-~~~~aiK~i~~~~~~-----------~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMI-----------KRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCC-CcEEEEEEEEHHHhh-----------hhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 357899999999999999999988765 899999998643111 12234567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..++..++||||+++|+|.+++.. ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 24788888899999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.....
T Consensus 181 ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------- 252 (371)
T cd05622 181 LKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------- 252 (371)
T ss_pred EEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------
Confidence 999999999876543221 124567999999999987543 78899999999999999999999975322
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRCM 526 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~ 526 (532)
................. ........+.+++..|+..+|.+ ||++.++++.
T Consensus 253 ~~~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 253 VGTYSKIMNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHHHHcCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11122222211111000 01123445778888899844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.63 Aligned_cols=255 Identities=23% Similarity=0.359 Sum_probs=200.2
Q ss_pred ceecccCCeEEEEEEeeCC-----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 242 EIIGVGACGVVYKAEVPGS-----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+.||+|+||.||+|.+... .+..+|+|.+..... ......+.+|+.++++++||||++++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------------DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-------------hhhHHHHHHHHHHHHhcCCCCeeeEeee
Confidence 3689999999999987532 236899998865421 1234568889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM- 392 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~- 392 (532)
+...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 144 (269)
T cd05044 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGY 144 (269)
T ss_pred ecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCC
Confidence 9999999999999999999999975322 2345789999999999999999999988 99999999999999887
Q ss_pred ----cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhc
Q 037084 393 ----EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEM 467 (532)
Q Consensus 393 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~ 467 (532)
.++++|||+++...............++..|+|||++.++.++.++|||||||++|+|++ |..||..... .
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~ 220 (269)
T cd05044 145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----Q 220 (269)
T ss_pred CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----H
Confidence 899999999986644322211123455788999999999999999999999999999998 9999964322 1
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.....+ .....+ ......+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 221 ~~~~~~---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 EVLQHV---TAGGRL----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHH---hcCCcc----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111 111111 1112234568899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=307.31 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=202.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|++|.||++..... ++.+|+|.+...... ......+.+|+.++++++|||++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTD-GKQYVIKKLNLRNAS------------RRERKAAEQEAQLLSQLKHPNIVAYRES 67 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCC-CcEEEEEEEehhhcC------------HHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 478889999999999999988754 889999998654221 2234568889999999999999999988
Q ss_pred EecC-CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 317 VTRP-DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 317 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+... ...+++|||+++++|.+++... ....+++..+..++.+++.|+++||+.+ ++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~ 142 (257)
T cd08223 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIK 142 (257)
T ss_pred ecCCCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEE
Confidence 7644 4578999999999999999752 3456899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++......... .....+++.|+|||+..+..++.++|+||+|+++++|++|+.||..... ......
T Consensus 143 l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~ 213 (257)
T cd08223 143 VGDLGIARVLENQCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYR 213 (257)
T ss_pred EecccceEEecccCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHH
Confidence 9999999876443221 1345688999999999999999999999999999999999999974321 112222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... +... .........+.+++..|++.+|++|||+.++++
T Consensus 214 ~~~-~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 214 IIE-GKLP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHh-cCCC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 211 1111 111233456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.62 Aligned_cols=259 Identities=25% Similarity=0.394 Sum_probs=207.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||+||++.+... |..||+|++..... ......+.+|+++++.++||||++++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 69 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPT-GTVMAKKVVHIGAK-------------SSVRKQILRELQIMHECRSPYIVSFY 69 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCC-CcEEEEEEEEecCc-------------chHHHHHHHHHHHHHHcCCCCcceEe
Confidence 35688899999999999999988654 88999998865421 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++...+..++||||+++++|.+++.. ...+++.....++.+++.+|.|||+ .+ ++|+||+|+||++++++.
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~ 142 (284)
T cd06620 70 GAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQ 142 (284)
T ss_pred eeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCc
Confidence 999999999999999999999999865 3468999999999999999999997 46 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch----hhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT----EEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~----~~~~l 469 (532)
++|+|||++........ ....|+..|+|||++.+..++.++|+|||||++|+|++|+.||....... ....+
T Consensus 143 ~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~ 218 (284)
T cd06620 143 IKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218 (284)
T ss_pred EEEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH
Confidence 99999999875533221 34578999999999988899999999999999999999999998644321 11223
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
..+.........+. + .....+..+.+++..|++.||++|||+.++++..
T Consensus 219 ~~~~~~~~~~~~~~------~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 219 LDLLQQIVQEPPPR------L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HHHHHHHhhccCCC------C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 33333333221111 0 0112345688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=324.75 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=190.6
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHH-HHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII-TAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|....+ |+.+|+|++....... ......+..|.. +++.++||||+++++++...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~ 68 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLD-GKCYAVKVLQKKIVLN-----------RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT 68 (325)
T ss_pred CceeeCCCeEEEEEEECCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC
Confidence 4699999999999987654 8999999986532110 122334455554 56779999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|..++.. ...+++.....++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 69 EKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecC
Confidence 999999999999999988864 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+.........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~ 212 (325)
T cd05604 142 LCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKP 212 (325)
T ss_pred CcccCCCCCCC--cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCC
Confidence 98754322211 1456799999999999999999999999999999999999999975322 11122222111
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
. .+ .. .....+.+++..|++.+|.+||++.+.+
T Consensus 213 -~--~~----~~----~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 213 -L--VL----RP----GASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -c--cC----CC----CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0 00 11 1234577889999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.60 Aligned_cols=255 Identities=25% Similarity=0.323 Sum_probs=203.1
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.+.+.|++.+.||+|+||.||+|.+..+ +..+++|.+.... ......+.+|+.+++.++|||+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~-~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~ 73 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKET-GALAAAKVIETKS--------------EEELEDYMVEIEILATCNHPYIVK 73 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCC-CceEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCCcEee
Confidence 3456799999999999999999988754 8999999987653 233567888999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++++|..++.. ....+++..+..++.|++.++.|||+.+ ++||||||+||+++.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~ 147 (292)
T cd06644 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDG 147 (292)
T ss_pred eEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCC
Confidence 99999999999999999999999988764 2346899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
.++|+|||++......... .....++..|+|||++. ...++.++|+|||||++|+|++|..||......
T Consensus 148 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---- 221 (292)
T cd06644 148 DIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---- 221 (292)
T ss_pred CEEEccCccceeccccccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----
Confidence 9999999998754332211 13456888999999874 345688999999999999999999999753321
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...........+... ........+.+++..||+.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 222 ---RVLLKIAKSEPPTLS--------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---HHHHHHhcCCCccCC--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111111111100 11123345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=321.92 Aligned_cols=266 Identities=25% Similarity=0.297 Sum_probs=198.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||++..... ++.||||.+...... ......+.+|+.+++.++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~ 81 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIISL 81 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCC-CceEEEEEeCCcccC------------hHHHHHHHHHHHHHHHhCCCchhce
Confidence 356799999999999999999987654 889999999764321 2234567789999999999999999
Q ss_pred eeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++... ...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nil 151 (355)
T cd07874 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 151 (355)
T ss_pred eeeeeccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEE
Confidence 9988644 34699999995 477776642 4788889999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 152 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999986544322 134578999999999999899999999999999999999999997543211110
Q ss_pred cHH---------------HHHHHHhcc-CCCcccccccc-----c---CCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 468 NMV---------------RWMRNVISS-ENPHRAIDSKL-----L---GNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 468 ~l~---------------~~~~~~~~~-~~~~~~~d~~l-----~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
... ..+...... ........+.. . ..........+.+++..|++.||++|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 000 001111100 00000000000 0 00111234567899999999999999999999
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
++
T Consensus 309 l~ 310 (355)
T cd07874 309 LQ 310 (355)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.67 Aligned_cols=207 Identities=25% Similarity=0.369 Sum_probs=176.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|+..+.||+|+||.||++....+ |+.||+|+++..... .......+..|+.++.+++||||+++++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~iv~~~~ 68 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDT-GHIYAMKILRKADML-----------EKEQVAHIRAERDILVEADGAWVVKMFY 68 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEHHHHh-----------hhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3688889999999999999988764 899999999743111 1233567888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.+...+..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 69 SFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred EEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999964 346889999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcc---------------------------------eeeeccccccccccccccccCCCCchhhHHH
Q 037084 396 ISDFGLAKLMPDGHTR---------------------------------IRITTVAGTTGYVAPEYHQTLTISEKSDIYS 442 (532)
Q Consensus 396 l~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 442 (532)
|+|||++......... .......||+.|+|||++.+..++.++|+||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 9999998754321100 0012357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCcc
Q 037084 443 FGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 443 lGvvl~elltg~~p~~~~~ 461 (532)
|||++|||++|+.||....
T Consensus 222 lGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred ccceeeecccCCCCCCCCC
Confidence 9999999999999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=306.16 Aligned_cols=258 Identities=19% Similarity=0.276 Sum_probs=192.4
Q ss_pred ceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|..... ....+++|.+..... ......|.+|+..++.++||||++++++|...
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 67 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-------------SKEQNEFLQQGDPYRILQHPNILQCLGQCVEA 67 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-------------hHHHHHHHHHHHHHhccCCcchhheEEEecCC
Confidence 3699999999999976532 134577787765421 12246788999999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
...++||||+++|+|.++++.........++.....++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 68 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg 144 (268)
T cd05086 68 IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYG 144 (268)
T ss_pred CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccc
Confidence 9999999999999999999864333455777888899999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccccccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-------LTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++................++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~ 217 (268)
T cd05086 145 IGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REV 217 (268)
T ss_pred cccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHH
Confidence 9864322211111134567889999998743 245789999999999999997 5778864322 112
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
....... ......++.+... ....+.+++..|| .+|++||+++++++.|.
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKD-QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhh-cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222211 1222233332222 2234667788899 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=308.67 Aligned_cols=250 Identities=27% Similarity=0.401 Sum_probs=204.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
..|+..+.||+|+||.||+|.+..+ +..||+|.+..... ......+.+|+.++++++||||+++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 69 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRT-QQVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYVTKYYG 69 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccC-CEEEEEEEEecccc-------------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4577888999999999999988754 88999999875421 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..++||||+++++|.+++.. .++++.....++.+++.|++|||+.+ ++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~ 141 (277)
T cd06640 70 SYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred EEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEE
Confidence 99999999999999999999999863 35788899999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||++......... .....++..|+|||++.+..++.++|+|||||++|||++|..||....... .. ..
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~---~~ 212 (277)
T cd06640 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL---FL 212 (277)
T ss_pred EcccccceeccCCccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh---hh
Confidence 9999999776543221 134567889999999998899999999999999999999999997533211 11 10
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.....+ .......+..+.+++..||+.+|++||++.++++.
T Consensus 213 -~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 213 -IPKNNP---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hhcCCC---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111111 12233456678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=310.94 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=201.4
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
...++|++.+.||+|+||.||+|....+ ++.+|+|.+.... .....+.+|+.+++++ +|||++
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~~ik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~i~ 78 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKN-GSKAAVKILDPIH---------------DIDEEIEAEYNILKALSDHPNVV 78 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCC-CceeEEEeecccc---------------chHHHHHHHHHHHHHHhcCCCee
Confidence 3677899999999999999999988764 8899999886532 1124567889999999 799999
Q ss_pred cceeEEe-----cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVT-----RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++++. .++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~ni 155 (286)
T cd06638 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNI 155 (286)
T ss_pred eeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhE
Confidence 9999884 345689999999999999998754444567899999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
++++++.++|+|||++......... .....|++.|+|||++.. ..++.++||||+||++|+|++|+.||....
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred EECCCCCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999998866443221 134578999999998753 457889999999999999999999997543
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
... .+.. .. ........++. .....+.+++..||+.+|++|||+.++++.
T Consensus 234 ~~~---~~~~----~~-~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 234 PMR---ALFK----IP-RNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hhH---HHhh----cc-ccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 211 1111 10 11111111111 123458889999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.78 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=207.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
+++|++-+.||+|.|+.||++.+.. +|+.+|+|+++..... ....+.+.+|+++.+.|+|||||+|.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~-tg~~fa~kiin~~k~~------------~~~~e~l~rEarIC~~LqHP~IvrL~ 76 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLS------------ARDFQKLEREARICRKLQHPNIVRLH 76 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhcc-chHHHHHHHhhhhhhc------------cccHHHHHHHHHHHHhcCCCcEeehh
Confidence 5678999999999999999997665 4999999998765433 33457788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec---CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID---DG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~---~~ 391 (532)
..+.+....|+|+|+|.|++|..-+-. +..+++...-..+.||+++|.|.|..+ |||||+||.|++|- ..
T Consensus 77 ~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~ 149 (355)
T KOG0033|consen 77 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKG 149 (355)
T ss_pred hhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCC
Confidence 999999999999999999999876654 255788888899999999999999999 99999999999994 34
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
--+|++|||+|.....+... ...+|||+|||||++...+|+..+|||+.||++|-|+.|++||.+..+ ..+.+
T Consensus 150 A~vKL~~FGvAi~l~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~----~rlye 222 (355)
T KOG0033|consen 150 AAVKLADFGLAIEVNDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLYE 222 (355)
T ss_pred CceeecccceEEEeCCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH----HHHHH
Confidence 45999999999988844322 567899999999999999999999999999999999999999986333 22222
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+ ... .. -++ +...+....+..+|+.+|+..||.+|.|+.|.+.
T Consensus 223 ~I---~~g-~y--d~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 223 QI---KAG-AY--DYP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HH---hcc-cc--CCC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 21 111 10 011 1233344556889999999999999999998764
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=344.15 Aligned_cols=258 Identities=21% Similarity=0.306 Sum_probs=202.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+++.||+|+||+||+|.+..+ +..+|+|.+...... ......|..|+.++.+++||||++++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~t-g~~vAlKvIk~~~l~------------e~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRT-QEFFCWKAISYRGLK------------EREKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC-CeEEEEEEEeccccC------------HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 45799999999999999999988764 889999998765322 22346788999999999999999999
Q ss_pred eEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEe
Q 037084 315 AHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHR----PCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~----~~ivH~Dlkp~NIll 388 (532)
+++.. ....||||||+++|+|.+++.........+++..++.|+.||+.||.|||+.+. .+|+||||||+||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 98854 356899999999999999998644445679999999999999999999998542 349999999999999
Q ss_pred cC-----------------CCcEEEeccCCcccCCCCCcceeeecccccccccccccccc--CCCCchhhHHHHHHHHHH
Q 037084 389 DD-----------------GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 389 ~~-----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~e 449 (532)
+. .+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 64 335899999999876543221 34578999999998854 458899999999999999
Q ss_pred HHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 450 LVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 450 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
|++|+.||..... ....+..+....... .......+.+|+..||+.+|.+||++.+++.
T Consensus 236 LLTGk~PF~~~~~------~~qli~~lk~~p~lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 236 LCSGKTPFHKANN------FSQLISELKRGPDLP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHCCCCCCcCCc------HHHHHHHHhcCCCCC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999999974322 112222221111100 0112345888999999999999999999983
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=304.75 Aligned_cols=251 Identities=28% Similarity=0.397 Sum_probs=205.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|.+..+ +..+++|.+.... ....+.+|+.++++++|||+++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~----------------~~~~~~~e~~~~~~l~~~~i~~~~ 64 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKET-GQVVAIKVVPVEE----------------DLQEIIKEISILKQCDSPYIVKYY 64 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCC-CcEEEEEEeecHH----------------HHHHHHHHHHHHHhCCCCcEeeee
Confidence 46789999999999999999998754 7899999987541 146788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++......++++||+++++|.+++.. ....+++.....++.|++.|+.|||+.+ ++|+||+|+||++++++.+
T Consensus 65 ~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~ 138 (256)
T cd06612 65 GSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQA 138 (256)
T ss_pred eeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcE
Confidence 999999999999999999999999864 3456899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||++......... .....++..|+|||++.+..++.++||||||+++|+|++|+.||......... .
T Consensus 139 ~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~ 209 (256)
T cd06612 139 KLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------F 209 (256)
T ss_pred EEcccccchhcccCccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------h
Confidence 99999999876544321 13456889999999999989999999999999999999999999754321100 0
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... ..... . ..........+.+++..||+.+|++|||+.++++
T Consensus 210 ~~~-~~~~~-----~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 MIP-NKPPP-----T--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhc-cCCCC-----C--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 00000 0 0011223456888999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.12 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=198.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||+|..... ++.||||++...... ......+.+|+.+++.++||||+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~ii~~ 88 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIIGL 88 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCC-CcEEEEEEeCccccC------------chhHHHHHHHHHHHHhcCCCCcccc
Confidence 356799999999999999999987654 889999999754221 2223567789999999999999999
Q ss_pred eeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++... ...|+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 158 (364)
T cd07875 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 158 (364)
T ss_pred ceeecccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEE
Confidence 9987543 35699999995 577777642 3788889999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++.+||+|||+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 159 l~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 159 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred ECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999986544322 144578999999999999999999999999999999999999997543211111
Q ss_pred cHHH--------H-------HHHHhccCCC------cccccccc---cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 468 NMVR--------W-------MRNVISSENP------HRAIDSKL---LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 468 ~l~~--------~-------~~~~~~~~~~------~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
.+.. + +......... ...+.... ...........+.+++.+|++.||.+|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 1100 0 0000000000 00000000 000111123468899999999999999999999
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
++
T Consensus 316 L~ 317 (364)
T cd07875 316 LQ 317 (364)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=306.89 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=205.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||++....+ |..+|+|.+...... ......+..|+.++++++|||+++++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSD-GKILVWKEIDYGNMT------------EKEKQQLVSEVNILRELKHPNIVRYYDR 67 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCC-CCEEEEEEEecccCC------------HHHHHHHHHHHHHHHhcCCCccceeeee
Confidence 367788999999999999987764 889999998754322 2334678889999999999999999998
Q ss_pred Eec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEecCCC
Q 037084 317 VTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH--RPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 317 ~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlkp~NIll~~~~ 392 (532)
+.. +...+++|||+++++|.+++........++++...+.++.+++.||.|||..+ ..+++|+||+|+||++++++
T Consensus 68 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~ 147 (265)
T cd08217 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147 (265)
T ss_pred eecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC
Confidence 764 35678999999999999999875555677999999999999999999999332 23399999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.++|+|||++.......... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+...
T Consensus 148 ~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~ 221 (265)
T cd08217 148 NVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASK 221 (265)
T ss_pred CEEEecccccccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHH
Confidence 99999999998776543211 345789999999999998899999999999999999999999976431 111111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ ..+.. .......+..+.+++..|++.+|++|||+.+|++
T Consensus 222 ~----~~~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 222 I----KEGKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred H----hcCCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 11111 1112234456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.64 Aligned_cols=241 Identities=18% Similarity=0.265 Sum_probs=187.4
Q ss_pred eecccCCeEEEEEEeeCC-----------------------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH
Q 037084 243 IIGVGACGVVYKAEVPGS-----------------------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~-----------------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 299 (532)
.||+|+||.||+|.+... ....|++|.+.... ......|.+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------------~~~~~~~~~~~ 67 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--------------RDIALAFFETA 67 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--------------HHHHHHHHHHH
Confidence 599999999999976321 12368999886542 22245688899
Q ss_pred HHHhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 300 ~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
.++++++||||++++++|.+.+..++||||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ ++||
T Consensus 68 ~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~ 141 (274)
T cd05076 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHG 141 (274)
T ss_pred HHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCC
Confidence 999999999999999999999999999999999999999864 3456889999999999999999999988 9999
Q ss_pred CCCCCcEEecCCC-------cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHH
Q 037084 380 DIKPANVLIDDGM-------EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 380 Dlkp~NIll~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell 451 (532)
||||+||++++.+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999997644 3899999987644322 23457788999998865 56899999999999999985
Q ss_pred -hCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 452 -VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 452 -tg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
+|..||...... ....+... ..... .. ....+.+++..||+.+|++|||+.++++.|.
T Consensus 216 ~~g~~p~~~~~~~----~~~~~~~~---~~~~~--------~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 216 FDGEVPLKERTPS----EKERFYEK---KHRLP--------EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hCCCCCccccChH----HHHHHHHh---ccCCC--------CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 699999753321 11111111 00100 01 1134788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.47 Aligned_cols=269 Identities=24% Similarity=0.284 Sum_probs=198.6
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|+...+ |..||+|.+...... ......+.+|+.++++++|||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKT-GQIVAMKKIRLESEE------------EGVPSTAIREISLLKELQHPNIVCLQDV 67 (285)
T ss_pred CceEeeEecccCceEEEEEEECCC-CcEEEEEEecccccc------------CCchHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 377789999999999999988654 899999998754211 1123567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..++|+||++ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l 142 (285)
T cd07861 68 LMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKL 142 (285)
T ss_pred EeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEE
Confidence 999999999999996 68988886532 2356899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||++......... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||..................
T Consensus 143 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~ 220 (285)
T cd07861 143 ADFGLARAFGIPVRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT 220 (285)
T ss_pred CcccceeecCCCccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998765433211 1344678899999987654 5789999999999999999999999754321111111000000
Q ss_pred H----hcc----CCCccccc---ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 V----ISS----ENPHRAID---SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~----~~~----~~~~~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ... ......+. ..............+.+++..||+.||++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 221 PTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 000 00000000 00000001113455788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=318.00 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=188.8
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHH-HHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII-TAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|++... |+.||+|++....... ......+..|.. +++.++||||+++++++...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~ 68 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSD-GSFYAVKVLQKKTILK-----------KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA 68 (321)
T ss_pred CeeeeCCCEEEEEEEECCC-CCEEEEEEEEHHHHHH-----------hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC
Confidence 4699999999999988754 8999999987532111 122334445544 67889999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++||||+++|+|.+++.. ...++......++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 69 EKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred CEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCC
Confidence 999999999999999988864 345788888999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||..... ..........
T Consensus 142 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~- 211 (321)
T cd05603 142 LCKEGVEPEET--TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHK- 211 (321)
T ss_pred CCccCCCCCCc--cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcC-
Confidence 98754322211 1456789999999999998999999999999999999999999975321 1122222211
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 521 (532)
... ........+.+++..|++.+|.+||+..
T Consensus 212 ~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 PLQ----------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCC----------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 100 0111234578899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=309.53 Aligned_cols=267 Identities=23% Similarity=0.342 Sum_probs=207.8
Q ss_pred cCccccceecccCCeEEEEEEeeC---CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPG---SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
+.|...+.||+|+||.||+|.+.. .++..+|||.+...... .....|.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~ei~~l~~l~~~~i~~ 70 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------------QHRSDFEREIEILRTLDHENIVK 70 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------------HHHHHHHHHHHHHHhCCCCChhe
Confidence 457778999999999999998642 24789999999865321 23467899999999999999999
Q ss_pred ceeEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++.. ....+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~ 144 (284)
T cd05038 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVES 144 (284)
T ss_pred EEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcC
Confidence 9999987 55789999999999999999752 335899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh---
Q 037084 391 GMEARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE--- 466 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~--- 466 (532)
++.++|+|||++........... .....++..|+|||...+..++.++|+||||+++|||++|..|+.........
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 224 (284)
T cd05038 145 EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224 (284)
T ss_pred CCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence 99999999999987764322211 11234556799999998889999999999999999999999998653221100
Q ss_pred -----ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 467 -----MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 467 -----~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.....+.......... ......+..+.+++.+||+.+|++|||+.+++++|+.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 225 IAQGQMIVTRLLELLKEGERL----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccccccHHHHHHHHHcCCcC----------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 0011111111111110 111223356889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=315.32 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=199.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|...+.||+|+||.||+|.+..+ +..||+|.+...... .....+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI~~~~ 70 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLT-DNLVALKEIRLEHEE-------------GAPCTAIREVSLLKDLKHANIVTLH 70 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCC-CcEEEEEEEeccccc-------------CchhHHHHHHHHHHhcCCCCcceEE
Confidence 35688999999999999999988754 889999998754321 1123466799999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..++..++|+||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 71 DIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGEL 143 (301)
T ss_pred EEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcE
Confidence 99999999999999996 699988865 2346889999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||++......... .....+++.|+|||.+.+. .++.++|||||||++|+|++|++||....... ....+
T Consensus 144 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~----~~~~~ 217 (301)
T cd07873 144 KLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE----QLHFI 217 (301)
T ss_pred EECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 99999998765433221 1345678999999987653 57889999999999999999999997543211 11111
Q ss_pred HHHhccCC---Cccccc---------ccccC----CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSEN---PHRAID---------SKLLG----NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~---~~~~~d---------~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ ....+. +.... ...+.....+.+++.+|++.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11110000 000000 00000 001123446788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=308.95 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=203.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+.++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... ......|..|+.++++++|||++++
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~~ 67 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIES--------------EEELEDFMVEIDILSECKHPNIVGL 67 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCC--------------HHHHHHHHHHHHHHHhCCCCceeEE
Confidence 45679999999999999999998876 48999999987653 2334678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..++..++||||+++++|.+++.. ....+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~ 141 (280)
T cd06611 68 YEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGD 141 (280)
T ss_pred EEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCC
Confidence 9999999999999999999999999875 2346899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
++|+|||++......... .....+++.|+|||.+. ...++.++|+||||+++|+|++|+.||......
T Consensus 142 ~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----- 214 (280)
T cd06611 142 VKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----- 214 (280)
T ss_pred EEEccCccchhhcccccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----
Confidence 999999998765433221 13456899999999874 345778999999999999999999999754321
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+........+. ++ ........+.+++..||+.+|.+||++.++++
T Consensus 215 --~~~~~~~~~~~~~--~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 215 --RVLLKILKSEPPT--LD------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --HHHHHHhcCCCCC--cC------CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1111111111111 00 01122345788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=307.61 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=204.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|.+.... ...|++|....... ....+.+.+|+.++++++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~i~~ 71 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-------------PSVREKFLQEAYIMRQFDHPHIVK 71 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-------------HHHHHHHHHHHHHHHhCCCCchhc
Confidence 356788899999999999999875321 34799998876532 123467889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.. +..++||||+++|+|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++
T Consensus 72 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~ 144 (270)
T cd05056 72 LIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPD 144 (270)
T ss_pred eeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCC
Confidence 9999875 557899999999999999975 2345899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.++++|||+++......... .+...++..|+|||.+....++.++||||||+++|++++ |..||...... ....
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~ 219 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIG 219 (270)
T ss_pred CeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHH
Confidence 99999999998765442211 122334568999999988889999999999999999996 99999754321 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
++ .....+. .....+..+.+++.+|+..+|++|||+.++++.|+++++
T Consensus 220 ~~---~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 220 RI---ENGERLP----------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HH---HcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 1111111 111233468889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=305.11 Aligned_cols=267 Identities=24% Similarity=0.374 Sum_probs=208.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc-CCCCCccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR-IWHRNLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~ 315 (532)
+|.+.+.||+|+||.||+|.+....++.+|+|.+.......... ..........+.+|+.++.+ ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKD----KRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccc----cccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 36778899999999999999886447899999986543211000 00002334567788888875 79999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
++...+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 9999999999999999999999987644455679999999999999999999996 55 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..... .....
T Consensus 154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~ 223 (269)
T cd08528 154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLAT 223 (269)
T ss_pred EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHH
Confidence 999999998765443 12456789999999999998899999999999999999999999964322 11112
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
........ .. ........+.+++.+||+.||++||++.++..++++
T Consensus 224 ~~~~~~~~-~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 KIVEAVYE-PL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhhccCC-cC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 21111110 00 001123458889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=303.83 Aligned_cols=250 Identities=24% Similarity=0.323 Sum_probs=199.5
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
++||+|+||.||++.+.. ++.||+|.+...... .....+.+|+.++++++||||+++++++...+
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 65 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPP-------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ 65 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Confidence 469999999999998763 889999998765321 23457889999999999999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..++|+||+++++|.+++.. ....+++.....++.+++.++.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 66 ~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~ 139 (251)
T cd05041 66 PIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGM 139 (251)
T ss_pred CeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccc
Confidence 99999999999999999965 2346789999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+................++..|+|||.+.++.++.++|+||||+++|+|++ |..||...... .....+. ...
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~~---~~~ 212 (251)
T cd05041 140 SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERIE---SGY 212 (251)
T ss_pred cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHHh---cCC
Confidence 986653322111122334667999999998899999999999999999999 88998654321 1111111 110
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.. ......+..+.+++..|++.+|++|||+.++++.|+.
T Consensus 213 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 RM----------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CC----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 00 0111234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.52 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=195.7
Q ss_pred ccceeccc--CCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 240 SLEIIGVG--ACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 240 ~~~~LG~G--~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
++++||+| +||+||++....+ |+.||+|++...... ......+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~hpniv~~~~~~ 68 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPT-GEYVTVRRINLEACT------------NEMVTFLQGELHVSKLFNHPNIVPYRATF 68 (327)
T ss_pred hhhhccccccceEEEEEEeeccc-CcEEEEEEechhhcc------------HHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 45789999 7899999988765 999999999765321 22345677899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..++|+||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++++
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~ 143 (327)
T cd08227 69 IADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLS 143 (327)
T ss_pred EECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEc
Confidence 9999999999999999999999652 2345899999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcce-----eeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 398 DFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 398 DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
||+.+.......... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~ 220 (327)
T cd08227 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LL 220 (327)
T ss_pred ccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HH
Confidence 998655432211100 0122356778999999876 4588999999999999999999999975322110 00
Q ss_pred HHHHHHhc--------------cCCCcccccc-----------------cccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 471 RWMRNVIS--------------SENPHRAIDS-----------------KLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 471 ~~~~~~~~--------------~~~~~~~~d~-----------------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
........ ........+. .............+.+++..||+.||++|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 00000000 0000000000 0000011223456889999999999999999
Q ss_pred HHHHHH
Q 037084 520 SKDVRC 525 (532)
Q Consensus 520 ~~evl~ 525 (532)
+.++++
T Consensus 301 ~~ell~ 306 (327)
T cd08227 301 ASTLLN 306 (327)
T ss_pred HHHHhc
Confidence 999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=308.67 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=201.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|....+ ++.||+|.++... ......+.+|+.+++.++||||+++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~--------------~~~~~~~~~e~~~~~~l~h~~ii~~ 71 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNT-GELAAIKVIKLEP--------------GEDFAVVQQEIIMMKDCKHSNIVAY 71 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCC-CcEEEEEEEecCc--------------hhHHHHHHHHHHHHHhCCCCCeeeE
Confidence 345788999999999999999988754 8999999987653 1223457789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++|+||+++++|.+++.. ...+++.....++.|++.|+.|||+.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 144 (267)
T cd06645 72 FGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGH 144 (267)
T ss_pred EEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 346899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++|+|||++........ ......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~ 219 (267)
T cd06645 145 VKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LF 219 (267)
T ss_pred EEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HH
Confidence 99999999876543321 114557899999999874 45688999999999999999999999865332110 00
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.............. .......+.+++..|++.+|++|||++++++
T Consensus 220 ----~~~~~~~~~~~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 220 ----LMTKSNFQPPKLKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ----hhhccCCCCCcccc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000000000000 0012345788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=307.15 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=198.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++... +..+|+|.++... ....+.+|+.++++++|||++++.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~---~~~~~iK~~~~~~----------------~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT---GQKVAVKNIKCDV----------------TAQAFLEETAVMTKLHHKNLVRLLG 66 (254)
T ss_pred HHceeeeeeccCCCCceEecccC---CCceEEEeecCcc----------------hHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 45888899999999999999653 7889999987542 1246788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++... ..+++|||+++++|.+++.. .....+++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.++
T Consensus 67 ~~~~~-~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~k 140 (254)
T cd05083 67 VILHN-GLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAK 140 (254)
T ss_pred EEcCC-CcEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEE
Confidence 98764 47999999999999999975 23446899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... .+...
T Consensus 141 l~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~ 208 (254)
T cd05083 141 VSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKE 208 (254)
T ss_pred ECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHH
Confidence 99999987643321 22334568999999998899999999999999999998 9999975332 11111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
.. ..+.... .....+..+.+++..||+.+|++||++.+++..|++
T Consensus 209 ~~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 209 CV-EKGYRME---------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HH-hCCCCCC---------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 1111110 111234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=305.27 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=206.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||.|+||.||.+..... +..+++|.+...... ......+.+|+.++++++|+||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~k~~~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 67 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTED-DSLVVWKEVNLTRLS------------EKERRDALNEIVILSLLQHPNIIAYYNH 67 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCC-CcEEEEEEEeecccc------------hhHHHHHHHHHHHHHhCCCCCeeEEEeE
Confidence 377889999999999999987754 889999998754322 2334568899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..+++|||+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl 142 (256)
T cd08221 68 FMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142 (256)
T ss_pred EecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEE
Confidence 99999999999999999999999752 2456899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....+++.|+|||+..+..++.++|+||||+++|+|++|..||..... .+.....
T Consensus 143 ~d~~~~~~~~~~~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~ 213 (256)
T cd08221 143 GDFGISKILGSEYSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKI 213 (256)
T ss_pred CcCcceEEccccccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 999999876544321 1456789999999999888899999999999999999999999965322 1222222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
... .... ........+.+++..||+.+|++|||+.++++.
T Consensus 214 ~~~-~~~~---------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 214 VQG-NYTP---------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcC-CCCC---------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 211 1111 112234558889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=319.63 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=195.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++....+ ++.||+|++..... ........+.+|+.++..++||||+++++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNT-GQVYAMKILNKWEM-----------LKRAETACFREERDVLVNGDRRWITNLHY 68 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEHHHH-----------hhhhhHHHHHHHHHHHHhCCCCCCCceEE
Confidence 4688899999999999999988764 89999999864211 11223456888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred EEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEE
Confidence 99999999999999999999999964 2346889999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
|+|||++......... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||..... .
T Consensus 143 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~ 214 (331)
T cd05597 143 LADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (331)
T ss_pred EEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------H
Confidence 9999998765443221 1134569999999998863 4578899999999999999999999975322 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCC--CCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTS--DDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~--~~P~~RPs~~evl~ 525 (532)
+............. +.+ .....+..+.+++..|+. .++..||++.+++.
T Consensus 215 ~~~~~i~~~~~~~~-~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 215 ETYGKIMNHKEHFQ-FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHHHHHHcCCCccc-CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 11122221111000 000 111123445666666554 44445889988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=309.09 Aligned_cols=249 Identities=30% Similarity=0.430 Sum_probs=202.9
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||.|+||.||+|.+..+ |+.||+|.+..... ......+.+|+.+++.++|||++++.++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 67 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRT-NQVVAIKVIDLEEA-------------EDEIEDIQQEIQFLSQCRSPYITKYYGS 67 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCC-CeEEEEEEeecccc-------------chHHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence 578889999999999999988754 89999999875421 1223567889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.++...++|+||+++++|.+++.. .++++...+.++.|++.|+.|||+.+ ++|+||+|+||++++++.++|
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l 139 (274)
T cd06609 68 FLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKL 139 (274)
T ss_pred EEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999864 27899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||+++........ .....+++.|+|||++.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 140 ~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~ 210 (274)
T cd06609 140 ADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLI 210 (274)
T ss_pred cccccceeecccccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHh
Confidence 999999877654221 14557888999999999989999999999999999999999999754321 111111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ........ .. .....+.+++..||..+|++|||++++++
T Consensus 211 ~-~~~~~~~~-----~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 211 P-KNNPPSLE-----GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred h-hcCCCCCc-----cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 11111110 01 03345788999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=305.78 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=205.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||.|++|.||++.+..+ ++.+|+|.+..... ......+.+|++++++++||||+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~k~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 66 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNT-GMIFALKTITTDPN-------------PDLQKQILRELEINKSCKSPYIVKYYG 66 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCC-CeEEEEEEEecCCc-------------hHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 3578889999999999999998764 89999999876432 123467889999999999999999999
Q ss_pred EEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+|... +..++||||+++++|.+++.........++......++.|++.||.|||+.+ ++|+||+|+||++++++.
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~ 143 (287)
T cd06621 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQ 143 (287)
T ss_pred EEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCe
Confidence 98653 4689999999999999998765445567899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-hhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY-TEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~-~~~~~l~~~ 472 (532)
++|+|||++........ ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ........+
T Consensus 144 ~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (287)
T cd06621 144 VKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219 (287)
T ss_pred EEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH
Confidence 99999999876543321 2345788999999999999999999999999999999999999754220 011122222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.. ...+ .. .... .........+.+++..||+.+|++|||+.++++
T Consensus 220 ~~~---~~~~-~~-~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 220 IVN---MPNP-EL-KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred Hhc---CCch-hh-ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 221 1111 11 0000 000123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=304.71 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=202.8
Q ss_pred ccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 238 LASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
|.+.+.||+|+||.||+|.+... ++..||||++...... ....+.+.+|+.++++++||||+++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 68 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------------SSDIEEFLREAACMKEFDHPNVIKLIG 68 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------------hHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 45678899999999999987532 3689999999765322 223467889999999999999999999
Q ss_pred EEecCC------ceEEEEEeccCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 316 HVTRPD------CHLLVYEFMKNGSLQDILHDVS--QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 316 ~~~~~~------~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++.... ..+++++|+++|+|.+++.... .....+++.....++.|++.||+|||+.+ ++||||||+||+
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nil 145 (273)
T cd05074 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCM 145 (273)
T ss_pred EEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEE
Confidence 886542 2378999999999999886422 12235788999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~ 466 (532)
+++++.+|++|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |++||.....
T Consensus 146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05074 146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---- 221 (273)
T ss_pred EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----
Confidence 99999999999999987644322211133445678999999998889999999999999999999 8899875332
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+..+. ....... ........+.+++.+|++.+|++|||+.++++.|+++.
T Consensus 222 ~~~~~~~---~~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 222 SEIYNYL---IKGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred HHHHHHH---HcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 1122211 1111111 01123356899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=331.15 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=188.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC------CCC
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI------WHR 308 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~H~ 308 (532)
.++|.+.+.||+|+||+||+|.+... ++.||||+++.... ....+..|+.++..+ .|+
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~-~~~vAvK~i~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~~ 191 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKR-KEYCAVKIVRNVPK---------------YTRDAKIEIQFMEKVRQADPADRF 191 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCC-CeEEEEEEEecchh---------------hHHHHHHHHHHHHHHhhcCcccCc
Confidence 46799999999999999999988754 88999999975321 112333455555444 455
Q ss_pred CcccceeEEecC-CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcE
Q 037084 309 NLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANV 386 (532)
Q Consensus 309 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NI 386 (532)
+++.+++++... +..|+|||++ +++|.+++.. ...+++..+..|+.|++.||.|||+ .+ |+||||||+||
T Consensus 192 ~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NI 263 (467)
T PTZ00284 192 PLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENI 263 (467)
T ss_pred ceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 688899988765 5678999998 7899998865 3468999999999999999999997 47 99999999999
Q ss_pred EecCCC----------------cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHH
Q 037084 387 LIDDGM----------------EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVL 450 (532)
Q Consensus 387 ll~~~~----------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 450 (532)
|++.++ .+||+|||++...... .+...||+.|+|||++.+..++.++|||||||++|||
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 4999999987643322 1456899999999999999999999999999999999
Q ss_pred HhCCCCCCCcccchhhccHHH--------HHHH--------Hhcc-CCCccccccccc----C-CC--cHHHHHHHHHHH
Q 037084 451 VVGKFPFDDFFQYTEEMNMVR--------WMRN--------VISS-ENPHRAIDSKLL----G-NG--YEEQMRLVLKIA 506 (532)
Q Consensus 451 ltg~~p~~~~~~~~~~~~l~~--------~~~~--------~~~~-~~~~~~~d~~l~----~-~~--~~~~~~~l~~l~ 506 (532)
++|+.||...........+.. |... .... .......++... . .. .......+.+|+
T Consensus 339 ltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 999999975432111110100 1000 0000 000000010000 0 00 001124578999
Q ss_pred HHcCCCCCCCCCCHHHHHH
Q 037084 507 YFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 507 ~~cl~~~P~~RPs~~evl~ 525 (532)
..||+.||++|||++|+++
T Consensus 419 ~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHhCCcChhhCCCHHHHhc
Confidence 9999999999999999986
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.14 Aligned_cols=242 Identities=19% Similarity=0.276 Sum_probs=189.1
Q ss_pred ceecccCCeEEEEEEeeCC-----------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 242 EIIGVGACGVVYKAEVPGS-----------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
+.||+|+||.||+|.+... ....|++|.+.... ......|..|+.+++.++||||
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------------~~~~~~~~~~~~~l~~l~hp~i 66 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--------------RDISLAFFETASMMRQVSHKHI 66 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--------------hhHHHHHHHHHHHHHhCCCCCE
Confidence 4689999999999986422 12368999876542 2234568889999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++......++||||+++|+|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.
T Consensus 67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~ 140 (262)
T cd05077 67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAR 140 (262)
T ss_pred eeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEec
Confidence 9999999999999999999999999998864 2346899999999999999999999988 999999999999987
Q ss_pred CCc-------EEEeccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCcc
Q 037084 391 GME-------ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLV-VGKFPFDDFF 461 (532)
Q Consensus 391 ~~~-------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~p~~~~~ 461 (532)
++. ++++|||++...... ....++..|+|||++. +..++.++|||||||++|||+ +|..|+....
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 664 899999998754322 2346788999999886 467899999999999999998 5888886432
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.. .. . ..... ... . .......+.+++..||+.||++||++.++++.|+
T Consensus 215 ~~----~~-~---~~~~~-~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 215 LA----EK-E---RFYEG-QCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hh----HH-H---HHHhc-Ccc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 10 00 0 11111 000 0 0111345788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=305.56 Aligned_cols=252 Identities=27% Similarity=0.396 Sum_probs=213.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+++-|.++++||+|+||.||+|.++.+ |..+|||.+... ....++..|+.++.++..|++|++
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~Es-G~v~AIK~VPV~----------------sDLQEIIKEISIMQQC~S~yVVKY 93 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRES-GHVLAIKKVPVD----------------TDLQEIIKEISIMQQCKSKYVVKY 93 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhcc-CcEEEEEecCcc----------------chHHHHHHHHHHHHHcCCchhhhh
Confidence 456789999999999999999998876 999999998764 345778899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+|.+.....+++|||||..||..|.++. .++++++..+..++...++||+|||... -+|||||+.||||+.+|+
T Consensus 94 YGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~ 167 (502)
T KOG0574|consen 94 YGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGI 167 (502)
T ss_pred hhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccch
Confidence 9999999999999999999999999975 4678999999999999999999999988 899999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
.|++|||.|..+.+.-.. ..+..||+.|||||++..-.|..++|+||+|++..||..|++||.+..+-....
T Consensus 168 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF------ 239 (502)
T KOG0574|consen 168 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF------ 239 (502)
T ss_pred hhhhhccccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE------
Confidence 999999999887664322 267899999999999999999999999999999999999999998755411110
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
++....++-. ..++.-...+-+++..|+-.+|++|.|+-++++
T Consensus 240 --MIPT~PPPTF-------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 240 --MIPTKPPPTF-------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred --eccCCCCCCC-------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 0111112111 123334556889999999999999999988875
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.17 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=205.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|....+ ++.+++|.+.... ......+.+|+.++++++||||++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~--------------~~~~~~~~~e~~~l~~~~h~~i~~~~ 66 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIAT-GELVAIKVIKLEP--------------GDDFEIIQQEISMLKECRHPNIVAYF 66 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCC-CCEEEEEEEEcCc--------------hhhHHHHHHHHHHHHhCCCCChhceE
Confidence 45788899999999999999988754 7899999997653 12346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..+++|||+++++|.+++.. ....++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.+
T Consensus 67 ~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 67 GSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDV 140 (262)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCE
Confidence 999999999999999999999999875 2356889999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+|+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...
T Consensus 141 ~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~---~~~ 215 (262)
T cd06613 141 KLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA---LFL 215 (262)
T ss_pred EECccccchhhhhhhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHH
Confidence 99999998866543211 1345688899999998777 889999999999999999999999975432111 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ +. .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 216 ----~~~~~~~~----~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ----ISKSNFPP----PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ----HHhccCCC----cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10010000 00 0112334556889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=304.02 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=203.0
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|.+...||+|+||.||+|.... ++..+|+|.+.......... .........+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSK-----DRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred ccccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchh-----HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 5667899999999999998765 38899999987654322110 00123456788999999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
.+.+..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEec
Confidence 999999999999999999999965 245888999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcce----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 398 DFGLAKLMPDGHTRI----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 398 DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
|||+++......... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .. +
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~----~ 221 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QA----I 221 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HH----H
Confidence 999998765321110 112345788999999999888999999999999999999999999753221 11 1
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... .+ .........+.+++..||+.+|++||++.++++
T Consensus 222 ~~~~~~~------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 FKIGENA------SP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHhccC------CC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111100 00 111223456888999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=311.69 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=201.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|+..+.||+|+||.||+|.+... ++.||+|.+...... ......+.+|+.+++.++||||+++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 67 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKET-GQIVAIKKFLESEDD------------KMVKKIAMREIRMLKQLRHENLVNLIE 67 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCC-CCEEEEEeHhhccCc------------chhhHHHHHHHHHHHhcCCcchhhHHH
Confidence 3578889999999999999998754 899999998654321 112356788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..++|+||+++++|.++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~ 140 (286)
T cd07846 68 VFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVK 140 (286)
T ss_pred hcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEE
Confidence 99999999999999999999887653 334899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++......... .....++..|+|||++.+ ..++.++||||||+++|+|++|++||...........+..+..
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07846 141 LCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218 (286)
T ss_pred EEeeeeeeeccCCccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence 9999998876443221 134568899999998765 4578899999999999999999999975332111111111111
Q ss_pred HHhccC----CCcccccccccC---------CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSE----NPHRAIDSKLLG---------NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~----~~~~~~d~~l~~---------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... .....++..... ...+.....+.+++..||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 000000000000 011233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=304.20 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=197.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+++++.....||+|+||.||+|.+..+ +..|++|.+.... ......+.+|+.++++++|+||+++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~~k~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~ 70 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLST-QVRIAIKEIPERD--------------SRYVQPLHEEIALHSYLKHRNIVQY 70 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCC-CcEEEEEEecCCC--------------HHHHHHHHHHHHHHHhcCCCCeeee
Confidence 344555557899999999999987754 8899999987653 2234678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL--DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD- 390 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~- 390 (532)
++++..++..++|+||+++++|.+++... ...+ ++..+..++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~ 144 (268)
T cd06624 71 LGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTY 144 (268)
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCC
Confidence 99999999999999999999999999752 2234 78888899999999999999988 999999999999976
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
++.++|+|||++......... .....|++.|+|||++.+.. ++.++|+||||+++|+|++|+.||...... .
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~ 218 (268)
T cd06624 145 SGVVKISDFGTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----Q 218 (268)
T ss_pred CCeEEEecchhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----h
Confidence 679999999998765432221 13446889999999986654 788999999999999999999999643210 0
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+....... ...........+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 AAMFKVGMFKI-----------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhHhhhhhhcc-----------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11111100000 00111223355888999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.87 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=201.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||+|+||.||++.+..+ |..||+|.+..... ......+.+|+.++.+++||||+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~-~~~~a~k~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~i~~~~~ 66 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPT-GVTMAMKEIRLELD-------------ESKFNQIIMELDILHKAVSPYIVDFYG 66 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCC-CcEEEEEEeecccC-------------HHHHHHHHHHHHHHHhcCCCcHHhhhh
Confidence 3588899999999999999988764 89999998875421 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
.+..++..++|+||+++++|..++... .....+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.+
T Consensus 67 ~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~ 142 (286)
T cd06622 67 AFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQV 142 (286)
T ss_pred heecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCE
Confidence 999999999999999999999988752 123468999999999999999999996 46 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT------ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+|+|||++........ ....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... ..
T Consensus 143 ~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~ 214 (286)
T cd06622 143 KLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----AN 214 (286)
T ss_pred EEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hh
Confidence 9999999876643322 3456888999999886543 48899999999999999999999965322 11
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+...... .+. ...+.....+.+++..||+.+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~-~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 215 IFAQLSAIVDG-DPP---------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHHHHhhc-CCC---------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11111111111 111 112234556888999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=310.38 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=202.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|...+.||.|+||.||+|....+ |+.|++|.+..... .....+.+|+.+++.++|||+++++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~ 82 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVAT-GQEVAIKQINLQKQ--------------PKKELIINEILVMKELKNPNIVNFL 82 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCC-CcEEEEEEEecccC--------------chHHHHHHHHHHHHhcCCCceeeee
Confidence 45688899999999999999987654 89999999865421 1235678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++|+||+++++|.+++.. ..+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~ 154 (296)
T cd06655 83 DSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSV 154 (296)
T ss_pred eeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 999999999999999999999998863 35899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||++......... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... .. .
T Consensus 155 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~---~~----~ 225 (296)
T cd06655 155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---AL----Y 225 (296)
T ss_pred EEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----H
Confidence 99999998865443221 134568899999999998889999999999999999999999997643211 11 1
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+. . .........+.+++.+||..+|.+|||+.++++
T Consensus 226 ~~~~~~~~~-~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 226 LIATNGTPE-L-------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHhcCCcc-c-------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111111100 0 011122345778999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=305.70 Aligned_cols=242 Identities=18% Similarity=0.254 Sum_probs=188.9
Q ss_pred ceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 242 EIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.||+|+||.||+|..... ...++++|.+.... ......+..|+.+++.++|||++++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~~e~~~l~~~~h~~iv~~~~ 66 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--------------RNYSESFFEAASMMSQLSHKHLVLNYG 66 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--------------HHHHHHHHHHHHHHHhCCCCChhheee
Confidence 4699999999999987532 12348888875432 223457888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc--
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME-- 393 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 393 (532)
++..++..++||||+++|+|.+++... +..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 67 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 67 VCVCGDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred EEEeCCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccc
Confidence 999999999999999999999999752 346899999999999999999999988 999999999999987765
Q ss_pred ------EEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCcccchh
Q 037084 394 ------ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGK-FPFDDFFQYTE 465 (532)
Q Consensus 394 ------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~-~p~~~~~~~~~ 465 (532)
++++|||++...... ....++..|+|||++.+ ..++.++|+||||+++|+|++|. .|+......
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-- 212 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-- 212 (258)
T ss_pred cCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--
Confidence 699999988654332 33567889999999876 45789999999999999999985 665432221
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
...... ...... +......+.+++..||+.+|++|||++++++.|+
T Consensus 213 --~~~~~~---~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 --KKLQFY---EDRHQL------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHHHH---HccccC------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 011110 011110 1112245889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=318.85 Aligned_cols=260 Identities=26% Similarity=0.344 Sum_probs=196.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||+|....+ +..||||.+...... ......+.+|+.++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRL-RQKVAVKKLSRPFQS------------LIHARRTYRELRLLKHMKHENVIGL 79 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCC-CCEEEEEEeCchhhh------------hHHHHHHHHHHHHHHhcCCCchhhh
Confidence 346799999999999999999987754 889999998754211 1234567789999999999999999
Q ss_pred eeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++... ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil 150 (343)
T cd07878 80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVA 150 (343)
T ss_pred hhhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEE
Confidence 9887543 4568999998 8899888753 35899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+++++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 151 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~- 224 (343)
T cd07878 151 VNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ- 224 (343)
T ss_pred ECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-
Confidence 9999999999999998654432 34578999999998876 5688999999999999999999999975322111
Q ss_pred ccHHHHHHHHhccCCCccccc-----------ccc---c----CCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAID-----------SKL---L----GNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d-----------~~l---~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+..+. ....... ..... ..+ . ..........+.+++..|++.||.+|||+.+++.
T Consensus 225 --~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 225 --LKRIM-EVVGTPS-PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred --HHHHH-HHhCCCC-HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11110 0000000 00000 000 0 0000011234778999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.31 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=198.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++.+..+ ++.||+|.+...... .......+.+|..++..++|+||+.+++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~l~~ 68 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHT-ERIYAMKILNKWEML-----------KRAETACFREERNVLVNGDCQWITTLHY 68 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEeHHHHH-----------hhHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4688899999999999999988764 889999998643111 1223456788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..|+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 69 AFQDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEE
Confidence 999999999999999999999999752 346889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
|+|||++......... ......||+.|+|||++.+ +.++.++|+|||||++|+|++|+.||..... .
T Consensus 143 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~ 214 (331)
T cd05624 143 LADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (331)
T ss_pred EEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------H
Confidence 9999999876543321 1134579999999998875 5678899999999999999999999975322 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 525 (532)
+............ .+ .......+..+.+++..|+...+++ |++++++++
T Consensus 215 ~~~~~i~~~~~~~-~~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 215 ETYGKIMNHEERF-QF-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred HHHHHHHcCCCcc-cC-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1112222111100 00 1111123455777888888765544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=309.42 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=201.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|+..+.||+|+||.||+|.+..+ |+.||+|++...... ....+.+.+|+.++++++|||++++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~~~~~ 67 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRET-GQIVAIKKFVESEDD------------PVIKKIALREIRMLKQLKHPNLVNLIE 67 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCC-CcEEEEEEEeecccC------------ccccHHHHHHHHHHHhCCCCCEeeeee
Confidence 3578889999999999999998754 899999998654211 112345788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++......++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++
T Consensus 68 ~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~ 140 (286)
T cd07847 68 VFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIK 140 (286)
T ss_pred EEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEE
Confidence 99999999999999999888887653 345899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++......... .....++..|+|||++.+ ..++.++|+||||+++|+|++|+.||...........+.....
T Consensus 141 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07847 141 LCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218 (286)
T ss_pred ECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876544321 134567889999998766 4578999999999999999999999975433211111111100
Q ss_pred H-------HhccCCC-cccccccccC-----CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 N-------VISSENP-HRAIDSKLLG-----NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~-------~~~~~~~-~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ....... .....+.... ...+.....+.+++..||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000 0000000000 001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.01 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=202.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
...+|...+.||+|+||.||+|.... +|..||+|.+..... .....+.+|+.+++.++|||++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~i~~~ 81 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNY 81 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCcc--------------chHHHHHHHHHHHHhCCCCCEeeE
Confidence 34678899999999999999998765 489999999876432 123557889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..++..++||||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~ 153 (297)
T cd06656 82 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGS 153 (297)
T ss_pred EEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 9999999999999999999999999864 34788999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||++......... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..........
T Consensus 154 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------ 225 (297)
T cd06656 154 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------ 225 (297)
T ss_pred EEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------
Confidence 999999998765433221 134568899999999999889999999999999999999999996532211000
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+.+. ..........+.+++..||+.+|++||++.++++
T Consensus 226 -~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 -LIATNGTPE--------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -eeccCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001100 0011223345788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=305.63 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=203.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
+.++|.+.+.||+|+||.||+|....+ +..+++|++.... .....+.+|+.+++++ .||||++
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~~k~~~~~~---------------~~~~~~~~e~~~l~~~~~h~~i~~ 67 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMDIIE---------------DEEEEIKEEYNILRKYSNHPNIAT 67 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCC-CcEEEEEEEecCc---------------hhHHHHHHHHHHHHHhcCCCChhe
Confidence 567899999999999999999988754 8899999987653 2235688999999999 7999999
Q ss_pred ceeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 313 LQAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 313 l~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++++.... ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||
T Consensus 68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni 144 (275)
T cd06608 68 FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNI 144 (275)
T ss_pred EEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHE
Confidence 999997655 379999999999999999764434567899999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
++++++.++|+|||++......... .....|+..|+|||++.. ..++.++||||||+++|+|++|..||....
T Consensus 145 ~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 145 LLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred EEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 9999999999999998765433221 134568999999998753 346789999999999999999999997532
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ..+. ..... ..... .........+.+++.+||..||++|||+.++++
T Consensus 223 ~~---~~~~----~~~~~-~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 223 PM---RALF----KIPRN-PPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hH---HHHH----Hhhcc-CCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 21 1111 11111 11110 111224456889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.30 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=197.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|...+.||+|+||.||+|....+ |..|++|.+......... ......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~k~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 71 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDT-GRELAAKQVQFDPESPET---------SKEVSALECEIQLLKNLQHERIVQYYG 71 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCC-CcEEEEEEeecCcCCchh---------HHHHHHHHHHHHHHHHcCCCCeeeEEE
Confidence 3578889999999999999988764 889999998754321110 233567889999999999999999999
Q ss_pred EEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++... ...++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+ ++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~ 144 (266)
T cd06651 72 CLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGN 144 (266)
T ss_pred EEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence 98753 567899999999999999975 235889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++......... .......++..|+|||++.+..++.++|+||+||++|+|++|+.||...... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~ 217 (266)
T cd06651 145 VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AA 217 (266)
T ss_pred EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HH
Confidence 999999998765432111 1113355889999999999988999999999999999999999999753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+........ .+ .........+.+++ .||..+|++||+++++++
T Consensus 218 ~~~~~~~~~-----~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 IFKIATQPT-----NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHhcCCC-----CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111111 01 11122233355555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=319.05 Aligned_cols=259 Identities=20% Similarity=0.246 Sum_probs=197.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++.++.+ ++.+|+|++...... .......+..|+.++..++|+||+++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 68 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNA-DKVFAMKILNKWEML-----------KRAETACFREERDVLVNGDNQWITTLHY 68 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCC-CCEEEEEEEeHHHHH-----------HhhHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 3688899999999999999998764 889999998642111 1223456788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 69 AFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred EEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 2346889999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
|+|||++......... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .
T Consensus 143 L~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~ 214 (332)
T cd05623 143 LADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------V 214 (332)
T ss_pred EeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------H
Confidence 9999998765433221 113467999999999886 34688999999999999999999999975322 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDD--PEERPSSKDVRCM 526 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~ 526 (532)
+............. + ..........+.+++..|+..+ +..||+++++++.
T Consensus 215 ~~~~~i~~~~~~~~-~-----p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 215 ETYGKIMNHKERFQ-F-----PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHHhCCCcccc-C-----CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 22222222111000 0 0111123345677777776544 4447889888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.10 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=201.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||+|... +|..+|+|.+......... .......+.+|+.++++++|+||+++.++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLA--------AEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhh--------HHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 3677889999999999999764 5889999998764322110 12334678999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..++++||+++++|.+++.. ..++++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEe
Confidence 9999999999999999999999965 235789999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCc----ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 397 SDFGLAKLMPDGHT----RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 397 ~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+|||++........ ........|+..|+|||++.+..++.++|+||||+++|+|++|..||........ .
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~--- 217 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA---M--- 217 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---H---
Confidence 99999886532111 1111345688999999999998899999999999999999999999975322111 0
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... +.+ .......+.+++..||+.+|.+||++.++++
T Consensus 218 ~~~~~~~~~~-----~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 218 FYIGAHRGLM-----PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhhhccCCC-----CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000110 111 1123455788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=304.00 Aligned_cols=261 Identities=21% Similarity=0.342 Sum_probs=205.0
Q ss_pred cCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
++|...+.||+|+||.||+|+.... +...|++|.+..... ......+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv 71 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-------------ENLQSEFRRELDMFRKLSHKNVV 71 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-------------hHHHHHHHHHHHHHHhcCCccee
Confidence 5688899999999999999987532 246799998876431 22356788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG-----RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++++.+.+..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Ni 148 (275)
T cd05046 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNC 148 (275)
T ss_pred eeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceE
Confidence 9999999999999999999999999999763321 126899999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchh
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTE 465 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~ 465 (532)
+++.++.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 149 li~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--- 224 (275)
T cd05046 149 LVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--- 224 (275)
T ss_pred EEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---
Confidence 999999999999999875433221 11133456778999999988889999999999999999999 8889864322
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhh
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~ 529 (532)
..... ... ....... .....+..+.+++.+||+.+|++|||+.++++.|.+
T Consensus 225 -~~~~~---~~~-~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 -EEVLN---RLQ-AGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HHHHH---HHH-cCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11111 111 1111100 011233468889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=302.80 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=204.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||+|+||.||++.... +|+.||+|.+...... ......+.+|+.++++++||||+++.++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMS------------PKEREESRKEVAVLSNMKHPNIVQYQES 67 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCC------------hHHHHHHHHHHHHHHhCCCCCeeeeEee
Confidence 37788999999999999998875 4899999998754221 2233578899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++|+||+++++|.+++.. .....+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l 142 (256)
T cd08218 68 FEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKL 142 (256)
T ss_pred ecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999875 22345789999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++.......... ....|++.|+|||+..+..++.++|+|||||++++|++|+.||..... .+.....
T Consensus 143 ~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~ 213 (256)
T cd08218 143 GDFGIARVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKI 213 (256)
T ss_pred eeccceeecCcchhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHH
Confidence 9999998665432211 234678899999999998999999999999999999999999964221 1222222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+. ........+.+++..||+.+|++||++.++++
T Consensus 214 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 214 IRGSYPP----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred hcCCCCC----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2221110 11223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.13 Aligned_cols=200 Identities=25% Similarity=0.332 Sum_probs=162.0
Q ss_pred cceecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 241 LEIIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
.++||+|+||+||+|.... .++..+|+|.+..... ...+.+|+.++++++||||+++++++..
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------------SMSACREIALLRELKHPNVISLQKVFLS 69 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------------cHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence 3689999999999998653 2468999999876431 1345679999999999999999998864
Q ss_pred --CCceEEEEEeccCCCHHHHHhhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe----
Q 037084 320 --PDCHLLVYEFMKNGSLQDILHDVSQ-----GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---- 388 (532)
Q Consensus 320 --~~~~~lV~E~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---- 388 (532)
....++++||+ +++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 70 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~ 145 (317)
T cd07868 70 HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 145 (317)
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCC
Confidence 35678999999 4688888764221 2235889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|+||+||++|+|++|++||...
T Consensus 146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 45678999999999876543221 122456789999999988764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=307.21 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=200.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
+.++|.+.+.||+|+||.||++....+ ++.+|+|.+.... .....+.+|+.++.++ +|||+++
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~-~~~~aik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~ni~~ 83 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKD-GSLAAVKILDPIS---------------DVDEEIEAEYNILQSLPNHPNVVK 83 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCC-CCEEEEEEecccc---------------cHHHHHHHHHHHHHHhcCCCCeEE
Confidence 467899999999999999999987654 8999999987542 1124566788888888 8999999
Q ss_pred ceeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 313 LQAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 313 l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
+++++... +..++|+||+++++|.++++........+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 84 ~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nil 160 (291)
T cd06639 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNIL 160 (291)
T ss_pred EEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEE
Confidence 99998754 3579999999999999998754444567899999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
+++++.++|+|||++.......... ....|+..|+|||.+... .++.++|+|||||++|+|++|+.||.....
T Consensus 161 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 161 LTTEGGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred EcCCCCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 9999999999999988665432211 345688999999987643 368899999999999999999999975432
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ..+. .... ..+....+ .......+.+++..||+.+|++||++.++++
T Consensus 239 ~---~~~~----~~~~-~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 V---KTLF----KIPR-NPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H---HHHH----HHhc-CCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 1111 1111 11111111 1122345889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=309.72 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=203.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++.+.||+|+||.||+|.+..+ ++.||+|.++..... ......+.+|+.++++++|+||++++++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~-~~~v~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 68 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKAT-GEIVAIKKFKESEDD------------EDVKKTALREVKVLRQLRHENIVNLKEA 68 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCC-CcEEEEehhhhhccc------------ccchhHHHHHHHHHHhcCCCCeeehhhe
Confidence 588889999999999999988764 889999998754221 2234678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..+++|||++++.+..+... ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.++|
T Consensus 69 ~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 69 FRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred EEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEE
Confidence 9999999999999988777665542 345899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||++.......... .....++..|+|||++.+. .++.++|+||||+++|+|++|++||...........+......
T Consensus 142 ~d~g~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 220 (288)
T cd07833 142 CDFGFARALRARPASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGP 220 (288)
T ss_pred EeeecccccCCCcccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998765543211 1346788999999999888 8899999999999999999999999754321111111110000
Q ss_pred -------Hhc-cC-----CCcccccccccC-CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 -------VIS-SE-----NPHRAIDSKLLG-NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 -------~~~-~~-----~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .. ......++.... ......+..+.+++..||+.+|++|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 221 LPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 00 000000000000 011123577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.87 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=208.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+...|.-++.||.|+||.||-|++..+ .+.||||.+.-+.... ...-.++..|+..|.+++|||++.+
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n-~evVAIKKMsySGKQs-----------~EKWqDIlKEVrFL~~l~HPntieY 91 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQS-----------NEKWQDILKEVRFLRQLRHPNTIEY 91 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCc-cceeeeeecccccccc-----------HHHHHHHHHHHHHHHhccCCCcccc
Confidence 456688889999999999999988764 8899999998765433 2345678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.|+|......+|||||| -||-.|++.- .++++.+..+..|+.+.+.||+|||+.+ .||||||+.||||++.|.
T Consensus 92 kgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~ 164 (948)
T KOG0577|consen 92 KGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGL 164 (948)
T ss_pred cceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCe
Confidence 99999999999999999 6788888864 4678999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
||++|||.|...... ...+|||.|||||++. .+.|+-++||||+|++..||...++|+-.++. .
T Consensus 165 VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------M 231 (948)
T KOG0577|consen 165 VKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 231 (948)
T ss_pred eeeccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------H
Confidence 999999999875443 5689999999999764 67899999999999999999999999865433 2
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.-+.++...+.| .+. .++-...+.+++..|++.-|.+|||.+++++
T Consensus 232 SALYHIAQNesP------tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 232 SALYHIAQNESP------TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHhcCCC------CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 222233333222 121 2233445778888999999999999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=301.72 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||++....+ +..+|+|.+...... ......+.+|+.++++++|||++++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKAD-QKLVIIKQIPVEQMT------------KDERLAAQNECQVLKLLSHPNIIEYYEN 67 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCC-CcEEEEEEEeccccc------------cHHHHHHHHHHHHHhhCCCCchhheeee
Confidence 377889999999999999988764 889999998765322 2234678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC-CcEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG-MEAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~k 395 (532)
+...+..++|+||+++++|.+++.. .....+++..+..++.+++.++.|||+.+ ++|+||+|+||+++++ +.++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~ 142 (256)
T cd08220 68 FLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVK 142 (256)
T ss_pred EecCCEEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999975 23456899999999999999999999988 9999999999999854 4689
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||++......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......
T Consensus 143 l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~ 212 (256)
T cd08220 143 IGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLK 212 (256)
T ss_pred EccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHH
Confidence 9999999876543221 345688999999999988899999999999999999999999965322 111112
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... . ........+.+++..||+.+|++|||++++++
T Consensus 213 ~~~~~~~-~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 213 IMSGTFA-P---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHhcCCC-C---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111111 0 01113345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.23 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=190.9
Q ss_pred ceecccCCeEEEEEEeeCCCC----------cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 242 EIIGVGACGVVYKAEVPGSYG----------KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g----------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
+.||+|+||.||+|.+..+ + ..+++|.+.... .....|.+|+.++++++||||+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~-~~~~~~~~~~~~~v~~k~~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~ 64 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQ-SDLDIVGPGQEVSVVLKVLGSDH---------------RDSLAFFETASLMSQLSHKHLV 64 (259)
T ss_pred CcccccccceEEEEEEecc-CCccccCCccceeeeeeccccch---------------hhHHHHHHHHHHHHcCCCcchh
Confidence 4699999999999998754 3 358888876542 1146788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.. ...++|+||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 65 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~ 137 (259)
T cd05037 65 KLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARY 137 (259)
T ss_pred heeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecC
Confidence 99999988 7789999999999999999752 226899999999999999999999988 9999999999999988
Q ss_pred C-------cEEEeccCCcccCCCCCcceeeeccccccccccccccccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Q 037084 392 M-------EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVV-GKFPFDDFF 461 (532)
Q Consensus 392 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~p~~~~~ 461 (532)
+ .++|+|||++...... ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||....
T Consensus 138 ~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 138 GLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 7 7999999998865442 234567789999998876 78999999999999999999 577876542
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.. .+........... .+ ....+.+++..||+.+|++|||+.++++.|+
T Consensus 212 ~~-------~~~~~~~~~~~~~---~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 212 SS-------EKERFYQDQHRLP---MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ch-------hHHHHHhcCCCCC---CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 21 1111111111000 00 0156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=303.35 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=203.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...+.||+|+||.||+|.... +|+.+|+|.++.......... .......+.+.+|+.++++++|||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHD----SRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccc----hHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 36677899999999999998765 489999999865422111100 0012234678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEE
Confidence 99999999999999999999999752 46889999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|||+++...............|+..|+|||.+.... ++.++|+||||+++|++++|..||...... .. ..
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~-~~ 222 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AA-MF 222 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HH-HH
Confidence 9999998654432222223456889999999887654 789999999999999999999999643221 11 11
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ....+.. .........+.+++..||+.+|++|||+.++++
T Consensus 223 ~~~~~~-~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 223 KLGNKR-SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred Hhhccc-cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111 1111111 112234566888999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.99 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=198.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.+.+.|++.+.||+|+||.||+|.+... ++.+|+|.+... ......+..|+.++.++ +|||++
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~a~K~~~~~---------------~~~~~~~~~e~~~l~~~~~h~~i~ 76 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKT-GQLAAIKVMDVT---------------EDEEEEIKLEINMLKKYSHHRNIA 76 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCC-CcEEEEEEEecC---------------hHHHHHHHHHHHHHHHhcCCCcEE
Confidence 3556788899999999999999998764 899999998665 22335677889999998 799999
Q ss_pred cceeEEec------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 312 PLQAHVTR------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 312 ~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
++++++.. .+..+++|||+++|+|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~n 151 (282)
T cd06636 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQN 151 (282)
T ss_pred EEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999853 45679999999999999999753 2345788889999999999999999988 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
|++++++.++|+|||++......... .....|+..|+|||.+. +..++.++|+|||||++|+|++|..||...
T Consensus 152 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EEECCCCCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 99999999999999998765432211 13456899999999875 346788999999999999999999999653
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... .... ..... . .....+..+.+++..||+.||.+|||+.++++
T Consensus 230 ~~~~~~~-------~~~~-~~~~~-----~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 230 HPMRALF-------LIPR-NPPPK-----L---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CHHhhhh-------hHhh-CCCCC-----C---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 3211110 0000 11100 0 01123456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.20 Aligned_cols=264 Identities=20% Similarity=0.240 Sum_probs=197.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||+|.+..+ |..+|+|.+...... ......+.+|+.++++++|||+++++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~-g~~~~~k~~~~~~~~------------~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 67 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLYDV 67 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCC-CcEEEEEEeeccccc------------ccCccchhHHHHHHHhcCCCCeeeHHHH
Confidence 367788999999999999988764 899999998754211 1123456789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..++++||++ ++|.+++.. ....+++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 68 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l 140 (284)
T cd07839 68 LHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140 (284)
T ss_pred hccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEE
Confidence 999999999999996 588888764 2346899999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||+++........ .....++..|+|||++.+. .++.++|||||||++|+|++|..|+........ ....+..
T Consensus 141 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~ 215 (284)
T cd07839 141 ADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFR 215 (284)
T ss_pred CccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH---HHHHHHH
Confidence 999999865433221 1345678899999987664 478999999999999999999988643221111 0111100
Q ss_pred Hhcc------------CCC--cccccccc-cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISS------------ENP--HRAIDSKL-LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~------------~~~--~~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... ... ...+.... +....+.....+.+++..||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000 00000000 00111223456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=307.79 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=200.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.....||+|+||.||++....+ +..||||.+.... ......+.+|+..++.++|||++++
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~ii~~ 84 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHT-GKQVAVKKMDLRK--------------QQRRELLFNEVVIMRDYHHENVVDM 84 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCC-CCEEEEEEEecch--------------HHHHHHHHHHHHHHHhCCCCcHHHH
Confidence 345566667899999999999987654 8899999986542 2234568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++.+..++..++||||+++++|.+++.. ..+++.....++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~ 156 (292)
T cd06658 85 YNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGR 156 (292)
T ss_pred HHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCC
Confidence 9999999999999999999999998853 34889999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||++......... .....|+..|+|||...+..++.++|+||||+++|||++|+.||...... ....-+
T Consensus 157 ~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~ 230 (292)
T cd06658 157 IKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRI 230 (292)
T ss_pred EEEccCcchhhccccccc--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999998765433221 13456889999999998889999999999999999999999999753221 111111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.... .. ... ........+.+++..|+..+|.+|||++++++.
T Consensus 231 ~~~~----~~-----~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNL----PP-----RVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcC----CC-----ccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1100 00 000 011123457788899999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=301.41 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=205.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||+|+||.||++.+..+ ++.+|+|.+..... ......+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~-------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPT-GKIMAVKTIRLEIN-------------EAIQKQILRELDILHKCNSPYIVGFYGA 67 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCC-CcEEEEEEEecccC-------------hHHHHHHHHHHHHHHHCCCCchhhhhee
Confidence 577889999999999999988754 89999999876532 1234678889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+...+..++++||+++++|.+++... ...++......++.|++.|++|||+ .+ ++|+||||+||++++++.++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~ 141 (265)
T cd06605 68 FYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIK 141 (265)
T ss_pred eecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999752 2578899999999999999999999 77 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||.+........ ....++..|+|||++.+..++.++|+||||+++|+|++|+.||..... ......+.+..
T Consensus 142 l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~ 215 (265)
T cd06605 142 LCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND--PPDGIFELLQY 215 (265)
T ss_pred EeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc--ccccHHHHHHH
Confidence 999999876543221 226788899999999999999999999999999999999999975422 11222233333
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......+.. ........+.+++..||..+|++|||+.+++.
T Consensus 216 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 216 IVNEPPPRL---------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HhcCCCCCC---------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 332221110 00113455889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=306.47 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=198.7
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||.|+||.||+|....+ |..||||.+...... ......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 67 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTET------------EGVPSTAIREISLLKELNHPNIVKLLDV 67 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCC-CCEEEEEEccccccc------------cccchHHHHHHHHHHhcCCCCCcchhhh
Confidence 477889999999999999988654 889999998754321 1123568889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|
T Consensus 68 ~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l 141 (284)
T cd07860 68 IHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKL 141 (284)
T ss_pred cccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999995 689998875 23456899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||++......... .....++..|+|||++.+.. ++.++|+||||+++|+|+||+.||....... ........
T Consensus 142 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~ 216 (284)
T cd07860 142 ADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRT 216 (284)
T ss_pred eeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHH
Confidence 999998865433221 13445788999999876644 5889999999999999999999997533211 11111111
Q ss_pred HhccC---------------CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSE---------------NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.-... .......... ....+.....+.+++..|++.||++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hCCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000 0000000000 0001112345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.49 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=186.7
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC---CCCCcccceeEEecC
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI---WHRNLLPLQAHVTRP 320 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~ 320 (532)
||+|+||+||+|....+ |..||+|++...... .......+..|..++.+. .||||+++++++...
T Consensus 1 lG~G~~g~Vy~~~~~~~-~~~~avK~~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~ 68 (330)
T cd05586 1 IGKGTFGQVYQVRKKDT-RRIYAMKVLSKKEIV-----------AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD 68 (330)
T ss_pred CCCCCceEEEEEEECCC-CCEEEEEEEeHHHHh-----------hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC
Confidence 79999999999988754 899999998643111 022233445566666655 699999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||
T Consensus 69 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 69 SDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred CeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCC
Confidence 999999999999999999864 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
+++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||..... .+.......
T Consensus 142 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~- 211 (330)
T cd05586 142 LSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAF- 211 (330)
T ss_pred cCcCCCCCCCC--ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHc-
Confidence 98764332221 1456799999999988754 478999999999999999999999975322 111111111
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS----SKDVRC 525 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~ 525 (532)
+... +.. ......+.+++..||+.||.+||+ +.++++
T Consensus 212 ~~~~------~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 212 GKVR------FPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC------CCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1110 000 012345778999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=303.24 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=195.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHH-HhcCCCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT-AGRIWHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~ 314 (532)
++|.+.+.||+|+||.||+|.+..+ |+.||+|+++...... ....+..|+.. ++.++|||+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~-~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~iv~~~ 66 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPT-GTIMAVKRIRATVNSQ-------------EQKRLLMDLDISMRSVDCPYTVTFY 66 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCC-CcEEEEEEEecCCCcH-------------HHHHHHHHHHHHHHHcCCCCeeeee
Confidence 3688889999999999999998764 9999999987653211 11233445554 5667999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++..++..+++|||++ |+|.+++.........+++..++.++.|++.||.|||+. + ++||||||+||+++.++.
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~ 142 (283)
T cd06617 67 GALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQ 142 (283)
T ss_pred EEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCC
Confidence 99999999999999995 789998876444456799999999999999999999986 6 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeecccccccccccccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT----LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+||+|||++........ .+...++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ...
T Consensus 143 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~- 216 (283)
T cd06617 143 VKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQ- 216 (283)
T ss_pred EEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHH-
Confidence 99999999987644321 133568889999998765 44688999999999999999999999643211 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+........+. +. ....+..+.+++..||..+|++|||+.++++
T Consensus 217 ---~~~~~~~~~~~------~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 ---LKQVVEEPSPQ------LP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---HHHHHhcCCCC------CC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111110 00 1113455888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.09 Aligned_cols=199 Identities=28% Similarity=0.383 Sum_probs=176.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-C-----CCc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-H-----RNL 310 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~ni 310 (532)
+|.+.+.||+|+||.|-+|.+.++ ++.||||+++.. .....+-..|+.+|..|+ | -|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T-~e~VAIKIiKN~---------------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~ 250 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKT-GEIVAIKIIKNK---------------KRFLRQAQIEIRILELLNKHDPDDKYNI 250 (586)
T ss_pred EEEEEEEecccccceeEEEEecCC-CcEEEEEeeccC---------------hHHHHHHHHHHHHHHHHhccCCCCCeeE
Confidence 688999999999999999977765 999999999987 445566778999999997 4 379
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
|+++++|...+++|||+|.+ ..+|.++++.+ ....++...+..|+.||+.||..||+.+ |||+||||+||||.+
T Consensus 251 Vrm~d~F~fr~HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 251 VRMLDYFYFRNHLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKD 324 (586)
T ss_pred EEeeeccccccceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeecc
Confidence 99999999999999999999 67999999974 4455899999999999999999999988 999999999999974
Q ss_pred C--CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 391 G--MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 391 ~--~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
. ..+||+|||.|+...... ...+.+..|+|||++.+.+|+.+.|+||||||++||++|.+-|.+..+
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CCcCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 3 469999999999766543 356778899999999999999999999999999999999988876544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=304.06 Aligned_cols=249 Identities=28% Similarity=0.410 Sum_probs=202.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+-|...+.||+|+||.||+|.+... +..+|+|.+..... ......+.+|+..+++++||||+++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~-~~~~aiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 69 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEEA-------------EDEIEDIQQEITVLSQCDSPYVTKYYG 69 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCC-CcEEEEEEeccccc-------------hHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 4577888999999999999987654 88999999865421 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..++||||+++++|.+++.. ..+++.....++.+++.++.|||+.+ ++|+||+|+||+++.++.++
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~ 141 (277)
T cd06641 70 SYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVK 141 (277)
T ss_pred EEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEE
Confidence 99999999999999999999999863 35889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||++......... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... . .+...
T Consensus 142 l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~---~~~~~ 212 (277)
T cd06641 142 LADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----M---KVLFL 212 (277)
T ss_pred Eeecccceecccchhh--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----H---HHHHH
Confidence 9999998766443211 1345688899999999888899999999999999999999999965322 1 11111
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .... ......+..+.+++..||+.+|.+||++.++++
T Consensus 213 ~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 213 IPK-NNPP---------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred Hhc-CCCC---------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111 1111 111223455888999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=301.15 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=198.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|.+.+.||+|+||.||+|....+ |..||+|.+......... ......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~-~~~v~ik~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 71 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADT-GRELAVKQVQFDPESPET---------SKEVNALECEIQLLKNLLHERIVQYYG 71 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCC-CcEEEEEEeecCcCCccc---------HHHHHHHHHHHHHHHhcCCCCeeeEEe
Confidence 4688889999999999999987654 899999998643211110 223567889999999999999999999
Q ss_pred EEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++.+. ...+++|||+++++|.+++.. ...+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 72 CLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGN 144 (265)
T ss_pred EeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCC
Confidence 88764 467899999999999999864 235788889999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++......... .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...... ..
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~- 217 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AA- 217 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HH-
Confidence 999999998865432111 1113456889999999998888999999999999999999999999753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... ...........+.+++..|+. +|++||+++++++
T Consensus 218 ~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 IFKIATQPT---------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HHHHhcCCC---------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111110 011223344567788888885 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=299.66 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=202.2
Q ss_pred cccceecccCCeEEEEEEeeCCC---CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSY---GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+.+.||.|+||.||++.+.... +..||+|.+...... .....+..|+..+.+++|||++++++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-------------QQIEEFLREARIMRKLDHPNIVKLLG 68 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-------------HHHHHHHHHHHHHHhcCCCchheEEE
Confidence 45688999999999999987542 388999999765321 13467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..+++|||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++
T Consensus 69 ~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~ 143 (258)
T smart00219 69 VCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVK 143 (258)
T ss_pred EEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEE
Confidence 9999999999999999999999997521 222899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
++|||++........... ....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||..... ..+ ..
T Consensus 144 l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~---~~ 215 (258)
T smart00219 144 ISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEV---LE 215 (258)
T ss_pred EcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHH---HH
Confidence 999999987665422211 12347789999999988889999999999999999998 8888865221 111 11
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
.......+ ......+..+.+++.+|++.+|++|||+.++++.|
T Consensus 216 ~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRL----------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCC----------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111111 01111345688899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.16 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=202.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|.+..+ |..||+|++...... ......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRET-GETVALKKVALRRLE------------GGIPNQALREIKALQACQHPYVVKLLDV 67 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCC-CceEEEEEEEccccc------------chhhHHHHHHHHHHHhCCCCCCcceeeE
Confidence 377889999999999999988754 899999998765321 1223568899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..++|+||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.++|
T Consensus 68 ~~~~~~~~~v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l 140 (286)
T cd07832 68 FPHGSGFVLVMEYM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKI 140 (286)
T ss_pred EecCCeeEEEeccc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEE
Confidence 99999999999999 99999998752 356899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
+|||++......... ......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||...... ........
T Consensus 141 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~ 215 (286)
T cd07832 141 ADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI----EQLAIVFR 215 (286)
T ss_pred eeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH----HHHHHHHH
Confidence 999999876554321 12445789999999988654 4689999999999999999998888653221 11111111
Q ss_pred HhccCCC------------ccccccc----ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENP------------HRAIDSK----LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~------------~~~~d~~----l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... .....+. ......++....+.+++..|++.+|.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1110000 0000000 000111223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=301.05 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=206.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||.|+||+||+|.... ++..+++|++...... .....+.+|+..++.++|+|++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQ-------------TSVDELRKEVQAMSQCNHPNVVKYYT 66 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcc-------------hHHHHHHHHHHHHHhcCCCCEEEEEE
Confidence 468889999999999999998765 4889999998754321 13467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.+...+..++|+||+++++|.+++..... ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++
T Consensus 67 ~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~ 142 (267)
T cd06610 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVK 142 (267)
T ss_pred EEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEE
Confidence 99999999999999999999999975321 246899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcce--eeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 396 ISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
|+|||++.......... ......|+..|+|||++... .++.++|+||||+++|+|++|+.||...... .....
T Consensus 143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~- 218 (267)
T cd06610 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLML- 218 (267)
T ss_pred EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHH-
Confidence 99999988765543221 11344688999999998877 7899999999999999999999999754321 11111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ +... ......+..+.+++..||+.+|++|||+.++++
T Consensus 219 ---~~~~~~~~--~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 219 ---TLQNDPPS--LETG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---HhcCCCCC--cCCc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111110 0000 011234566889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=297.26 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=200.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|+||.||+|.... ++..|++|.+........ .....+.+.+|+.++++++|||++++++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~---------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQT---------GQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred ccccceeeecCCceEEEEEEcC-CCcEEEEEEEEEcccccc---------chHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 5667889999999999998765 488999999865432111 023356788999999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
......++++||+++++|.+++.. ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~ 144 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLA 144 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEc
Confidence 999999999999999999999975 245889999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
|||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ......
T Consensus 145 d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~ 214 (258)
T cd06632 145 DFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKI 214 (258)
T ss_pred cCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHH
Confidence 999988754433 114566889999999887776 899999999999999999999999754321 111111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... .........+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 215 GRSKELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HhcccCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1101110 011122345788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=299.26 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=203.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||+|+||.||+|.... +|+.+|+|++......... .......+.+|+.++++++||||++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSE--------QEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchh--------HHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 36777899999999999998765 4899999998754321110 02245788999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-cEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-EAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 395 (532)
+.+++..++|+||+++++|.+++.. ..++++.....++.|++.||.|||+.+ ++|+||+|+||+++.++ .++
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999975 346889999999999999999999998 99999999999998776 599
Q ss_pred EeccCCcccCCCCCcce--eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
|+|||++.......... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .......
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~ 220 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLALI 220 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHHH
Confidence 99999988765432111 11234688999999999888899999999999999999999999964322 1111111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ ...........+.+++..|++.+|++|||+.+++.
T Consensus 221 ~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 FKIASATT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHhccCC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111100 01122334456888999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.20 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=201.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||++.+..+ ++.|++|.+....... ......+.+|+.+++.++||||+++++.
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~ 69 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKET-RQRFAMKKINKQNLIL-----------RNQIQQVFVERDILTFAENPFVVSMFCS 69 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCC-CcEEEEEEeehhhhhh-----------HHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 578889999999999999988764 8899999887542111 2334678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..++||||+++++|.+++.. ...+++.....++.+++.|+.|||+.+ ++|+||||+||+++.++.+++
T Consensus 70 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l 142 (305)
T cd05609 70 FETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKL 142 (305)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEE
Confidence 9999999999999999999999965 246899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCc-------------ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 397 SDFGLAKLMPDGHT-------------RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 397 ~DFGla~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
+|||+++....... ........++..|+|||++.+..++.++|+||||+++|+|++|..||.....
T Consensus 143 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~- 221 (305)
T cd05609 143 TDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP- 221 (305)
T ss_pred eeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999874211100 0011234578899999999888999999999999999999999999964321
Q ss_pred hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.++........... +. .....+..+.+++.+||+.+|++||+..++.+.|+
T Consensus 222 ------~~~~~~~~~~~~~~----~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 222 ------EELFGQVISDDIEW----PE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ------HHHHHHHHhcccCC----CC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11222222111000 00 00123445789999999999999999766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=308.59 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=203.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||+|....+ +..+|+|.+....... ......+..|+.++++++||||+++++.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 69 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGT-GKLFALKVLDKKEMIK-----------RNKVKRVLTEQEILATLDHPFLPTLYAS 69 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCC-CcEEEEEEEeccccch-----------HHHHHHHHHHHHHHHhCCCCCchhheee
Confidence 578889999999999999988764 8999999997653221 2245678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++||||+++++|.+++.. .....+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l 144 (316)
T cd05574 70 FQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIML 144 (316)
T ss_pred eecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEE
Confidence 9999999999999999999999875 33456899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcce---------------------------eeeccccccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRI---------------------------RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
+|||++.......... ......||..|+|||++.+..++.++||||||+++|+
T Consensus 145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~ 224 (316)
T cd05574 145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE 224 (316)
T ss_pred eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 9999987653221100 0123468899999999998889999999999999999
Q ss_pred HHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 037084 450 LVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS----SKDVRC 525 (532)
Q Consensus 450 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~ 525 (532)
|++|..||....... . ........ .. ..........+.+++.+||+.+|++||| +.+++.
T Consensus 225 l~~g~~pf~~~~~~~---~----~~~~~~~~-~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 225 MLYGTTPFKGSNRDE---T----FSNILKKE-VT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HhhCCCCCCCCchHH---H----HHHHhcCC-cc--------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999999997533211 1 11111111 10 0011114566899999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=307.44 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=201.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
....|+++++||+||.+.||++... +.+.+|+|.+...... .+...-|.+|+.+|.+| .|.+||+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D------------~qtl~gy~nEI~lL~KLkg~~~IIq 424 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEAD------------NQTLDGYRNEIALLNKLKGHDKIIQ 424 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcC------------HHHHHHHHHHHHHHHHhcCCceEEE
Confidence 4567999999999999999999654 4577888877654332 45678899999999999 6899999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
|++|-..++.+|+||||- ..+|..+|.. .......| .+..+..|++.++.++|+.+ |||.||||.|+|+-+ |
T Consensus 425 L~DYEv~d~~lYmvmE~G-d~DL~kiL~k--~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G 496 (677)
T KOG0596|consen 425 LYDYEVTDGYLYMVMECG-DIDLNKILKK--KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-G 496 (677)
T ss_pred EeeeeccCceEEEEeecc-cccHHHHHHh--ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-e
Confidence 999999999999999987 7799999986 33333445 67789999999999999999 999999999999875 5
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-----------TISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
.+||+|||+|..+..+.........+||+.||+||.+... +.+.+|||||+||+||+|+.|++||+...
T Consensus 497 ~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 497 RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 7999999999999887766666789999999999976533 25689999999999999999999998643
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ...-+..+...+ .++--+.+ .+ ...++++++.||+.||++|||..++++
T Consensus 577 n------~~aKl~aI~~P~--~~Iefp~~-~~-----~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 N------QIAKLHAITDPN--HEIEFPDI-PE-----NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H------HHHHHHhhcCCC--ccccccCC-CC-----chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2 111111111111 11100111 11 122889999999999999999999985
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=299.24 Aligned_cols=266 Identities=26% Similarity=0.380 Sum_probs=206.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR--IWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~ 312 (532)
..+..+.+.||+|.||.||+|.|+ |+.||||++.... ...+.+|.++... |+|+||..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~srd-----------------E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSRD-----------------ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred hheeEEEEEecCccccceeecccc---CCceEEEEecccc-----------------hhhhhhHHHHHHHHHhccchhhh
Confidence 457888999999999999999998 8899999998653 2456667776654 59999999
Q ss_pred ceeEEecC----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCC
Q 037084 313 LQAHVTRP----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH-----MYHRPCIIHRDIKP 383 (532)
Q Consensus 313 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-----~~~~~~ivH~Dlkp 383 (532)
+++.-... ..++||++|.++|||.|||.. ..++....++++..+|.||+||| .+|+|.|.|||||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 99887554 367899999999999999974 56888999999999999999999 45788999999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcc--eeeeccccccccccccccccCC----C--CchhhHHHHHHHHHHHHhCC-
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTLT----I--SEKSDIYSFGVLLAVLVVGK- 454 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDvwSlGvvl~elltg~- 454 (532)
.|||+.+|+...|+|+|||......... ...+..+||.+|||||++...- + -..+||||||.|+||+....
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999877654221 2236789999999999987642 1 23589999999999998632
Q ss_pred ---------CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 455 ---------FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 455 ---------~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.||.+..+.+. -.+-++..+--.+....++.. -...+.+..+.+++..||..||..|.|+-.+-+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DP---s~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDP---SFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCEehhhcCCcccCCCCCC---CHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 67765433211 112233332222222222221 134567888999999999999999999999988
Q ss_pred HHhhhh
Q 037084 526 MLSQIK 531 (532)
Q Consensus 526 ~L~~l~ 531 (532)
.|.++.
T Consensus 499 tl~~l~ 504 (513)
T KOG2052|consen 499 TLAKLS 504 (513)
T ss_pred HHHHHh
Confidence 887764
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.24 Aligned_cols=199 Identities=25% Similarity=0.349 Sum_probs=161.4
Q ss_pred ceecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec-
Q 037084 242 EIIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR- 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~- 319 (532)
.+||+|+||.||+|.... .++..||+|.+..... ...+.+|+.++++++||||+++++++..
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 70 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------------SMSACREIALLRELKHPNVIALQKVFLSH 70 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------------cHHHHHHHHHHHhCCCCCeeeEEEEEecc
Confidence 579999999999998753 2367899999875421 1346689999999999999999999854
Q ss_pred -CCceEEEEEeccCCCHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe----c
Q 037084 320 -PDCHLLVYEFMKNGSLQDILHDVS-----QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI----D 389 (532)
Q Consensus 320 -~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll----~ 389 (532)
+...++|+||++ ++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||++ +
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~ 146 (317)
T cd07867 71 SDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 146 (317)
T ss_pred CCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCC
Confidence 456789999995 58888775321 12235889999999999999999999988 9999999999999 5
Q ss_pred CCCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 390 DGMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||...
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6778999999999876543221 112345789999999988764 5799999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.73 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=201.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||++.+... ++.+|+|.+....... ......+.+|+.++++++||||+++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGS-GKYYALKILSKAKIVK-----------LKQVEHVLNEKRILQSIRHPFLVNLYG 68 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCC-CCEEEEEEEEHHHhhh-----------hhHHHHHHHHHHHHHhCCCCCccceee
Confidence 3588889999999999999988764 8999999986542111 233567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 69 ~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred EEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999975 356889999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++....... ....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||..... . .....
T Consensus 142 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~---~~~~~ 209 (290)
T cd05580 142 ITDFGFAKRVKGRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP----I---QIYEK 209 (290)
T ss_pred EeeCCCccccCCCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----H---HHHHH
Confidence 99999998765441 345689999999999888899999999999999999999999975331 1 11111
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVR 524 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl 524 (532)
.. .+... + .......+.+++..||+.+|.+|| ++++++
T Consensus 210 ~~-~~~~~------~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 210 IL-EGKVR------F----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred Hh-cCCcc------C----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 11 11110 0 111234578899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=304.86 Aligned_cols=270 Identities=23% Similarity=0.254 Sum_probs=200.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|+||.||+|.+..+ |+.||+|.+......... ......+..|+.++++++|+||+++++++
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~-~~~v~iK~~~~~~~~~~~---------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKET-GRIVAIKKIKLGERKEAK---------DGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCC-CcEEEEEEEecccccccc---------chhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 67778999999999999988754 899999999765432100 11234567899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++||||+ +++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~ 144 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLA 144 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEc
Confidence 9999999999999 99999999752 236899999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
|||++.......... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||...........+.......
T Consensus 145 dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~ 222 (298)
T cd07841 145 DFGLARSFGSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222 (298)
T ss_pred cceeeeeccCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence 999998765542211 33456888999998754 457899999999999999999988886533211111111100000
Q ss_pred hcc-----CCCccccccccc-----CCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 477 ISS-----ENPHRAIDSKLL-----GNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 477 ~~~-----~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
... ............ ..........+.+++..||+.+|++|||+.+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 000000000000 00112234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.93 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=210.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
-|.+.+.||+|.|+.|-+|++--+ |..||||++....... -....+.+|++.++-++|||||+||.+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFT-GekVAVKviDKTKlD~------------~st~hlfqEVRCMKLVQHpNiVRLYEV 85 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFT-GEKVAVKVIDKTKLDT------------LSTGHLFQEVRCMKLVQHPNIVRLYEV 85 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcc-cceeEEEEecccccch------------hhhhHHHHHHHHHHHhcCcCeeeeeeh
Confidence 477788999999999999987654 9999999998875432 224567889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe-cCCCcEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI-DDGMEAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~k 395 (532)
......+|||+|.-.+|+|+||+-+ ....+.+....+++.||..++.|.|+.+ +|||||||+|+.+ .+-|-+|
T Consensus 86 iDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 86 IDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred hcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceE
Confidence 9999999999999999999999976 3456899999999999999999999999 9999999999876 5678999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS-EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
++|||++..+..+... ++.+|...|.|||++.+..|+ +++|||||||++|.|++|++||+.....
T Consensus 160 LTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------- 225 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------- 225 (864)
T ss_pred eeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------
Confidence 9999999887665432 788999999999999999886 5789999999999999999999864331
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+....++|-. ...+.....++.+|+..|+..||.+|.|.++++.
T Consensus 226 -----ETLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 -----ETLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----hhhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112222221 1234566778999999999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=295.60 Aligned_cols=253 Identities=31% Similarity=0.449 Sum_probs=207.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++.+.||+|++|.||+|....+ |+.|++|.+...... .....+.+|+..+.+++|||+++++++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~-~~~~~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPT-GKIYALKKIHVDGDE-------------EFRKQLLRELKTLRSCESPYVVKCYGA 67 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCC-CcEEEEEEeccCcch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 578889999999999999998864 899999998776321 234678899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCcEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+...+..++|+||+++++|.+++.. ...++....+.++.|+++|+.|||+ .+ ++|+||+|+||+++.++.++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~ 140 (264)
T cd06623 68 FYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVK 140 (264)
T ss_pred EccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999975 2568999999999999999999999 88 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||++.......... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .
T Consensus 141 l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~---~ 214 (264)
T cd06623 141 IADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQ---A 214 (264)
T ss_pred EccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHH---H
Confidence 99999998765443221 345688999999999999999999999999999999999999976432 11112222 2
Q ss_pred HhccCCCcccccccccCCCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEE-QMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
......+. .... .+..+.+++..|++.+|++|||+.++++.
T Consensus 215 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 215 ICDGPPPS----------LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HhcCCCCC----------CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 22111111 1111 34568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=304.68 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=200.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||+|+||.||+|.++.+ ++.+++|.++..... ......+.+|+.++++++||||+++++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~ 71 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKT-GEIVALKKLKMEKEK------------EGFPITSLREINILLKLQHPNIVTVKE 71 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCC-CcEEEEEEEeecccc------------ccchhhHHHHHHHHHhcCCCCEEEEEE
Confidence 4688889999999999999998754 889999999765321 112245678999999999999999999
Q ss_pred EEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++... +..++||||++ ++|.+++... ...+++.....++.|++.||+|||+.+ ++|+||||+||++++++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~ 144 (293)
T cd07843 72 VVVGSNLDKIYMVMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGI 144 (293)
T ss_pred EEEecCCCcEEEEehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCc
Confidence 98877 88999999996 5999988752 236899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++.......... ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...........+...
T Consensus 145 ~~l~d~g~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 222 (293)
T cd07843 145 LKICDFGLAREYGSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKL 222 (293)
T ss_pred EEEeecCceeeccCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 9999999998765542211 345678899999988754 4689999999999999999999999754321111111110
Q ss_pred HH-----------HHh--ccCCCcccccccccCCCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MR-----------NVI--SSENPHRAIDSKLLGNGYEE-QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~-----------~~~--~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ... ............+....... ....+.+++..||+.+|++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000 00000000001111111111 3556888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=303.76 Aligned_cols=265 Identities=20% Similarity=0.281 Sum_probs=196.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|...+.||+|+||.||+|.... +++.||+|.+....... ....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~ 69 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEG-------------APFTAIREASLLKDLKHANIVTLH 69 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEecccccC-------------CchhHHHHHHHHhhCCCcceeeEE
Confidence 3578889999999999999998765 48999999987543211 123456799999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||++ ++|.+++... ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~ 142 (291)
T cd07844 70 DIIHTKKTLTLVFEYLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGEL 142 (291)
T ss_pred EEEecCCeEEEEEecCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCE
Confidence 99999999999999997 5999988752 346889999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||+++........ .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||......... ....
T Consensus 143 kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~ 217 (291)
T cd07844 143 KLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ---LHKI 217 (291)
T ss_pred EECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH---HHHH
Confidence 99999998754322111 123356889999998765 45789999999999999999999999754311111 1101
Q ss_pred HHHhccCCCc----------------ccccccccCCCcHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPH----------------RAIDSKLLGNGYEE--QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~----------------~~~d~~l~~~~~~~--~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ....+.......+. ....+.+++..|++.+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1100000000 00000000000001 1256788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=304.42 Aligned_cols=248 Identities=21% Similarity=0.355 Sum_probs=197.5
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|.....||+|+||.||+|.... ++..||+|.+..... .....+.+|+.++..++|||++++++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i~~~~~~~ 87 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHQNVVEMYKSY 87 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcC-CCCEEEEEEEEeccc--------------chHHHHHHHHHHHHhCCCCchhhhhhhe
Confidence 4445679999999999998765 488999999865421 1234577899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..++++||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 88 ~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~ 159 (297)
T cd06659 88 LVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159 (297)
T ss_pred eeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEe
Confidence 999999999999999999998753 45889999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||++......... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .. +....
T Consensus 160 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~---~~~~~ 230 (297)
T cd06659 160 DFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QA---MKRLR 230 (297)
T ss_pred echhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH---HHHHh
Confidence 99998765443221 13456899999999999889999999999999999999999999753221 11 11111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ...... .........+.+++..||+.+|++||++.++++
T Consensus 231 ~-~~~~~~-------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 231 D-SPPPKL-------KNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred c-cCCCCc-------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1 111000 001112344788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=297.98 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=202.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||+|..+.. |..+|+|.+...... ......+.+|+.++++++|||+++++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~~~h~~i~~~~~~ 67 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSD-SEHCVIKEIDLTKMP------------VKEKEASKKEVILLAKMKHPNIVTFFAS 67 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCC-CceEEEEEeeHhhcc------------chhhHHHHHHHHHHHhCCCCChhhhhhe
Confidence 367788999999999999988764 889999998654211 1223567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-cEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-EAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 395 (532)
+...+..++|+||+++++|.+++.. .....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++ .++
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~ 142 (257)
T cd08225 68 FQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAK 142 (257)
T ss_pred eccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEE
Confidence 9999999999999999999999975 23345799999999999999999999988 99999999999999876 469
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
++|||.+.......... ....|++.|+|||+..+..++.++|+||||+++++|++|..||..... .++...
T Consensus 143 l~d~~~~~~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~ 213 (257)
T cd08225 143 LGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLK 213 (257)
T ss_pred ecccccchhccCCcccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH
Confidence 99999998765432211 335688999999999888899999999999999999999999964321 222222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... .. ...+.....+.+++.+|++.+|++|||+.++++
T Consensus 214 ~~~~~-~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 214 ICQGY-FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred Hhccc-CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 22211 11 111223346888999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.36 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=200.6
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+.|...+.||+|+||.||+|..... |+.||+|.+....... ......+.+|+.+++.++|||+++
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~-~~~v~iK~~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~h~niv~ 79 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQQLRHPNTIE 79 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCC-CcEEEEEEEeccccCc-----------HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 3456788999999999999999988754 8999999986543221 223457889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+.++|...+..++|+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~ 152 (307)
T cd06607 80 YKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPG 152 (307)
T ss_pred EEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCC
Confidence 9999999999999999996 678777753 2346899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.++|+|||++...... ....+++.|+|||++. ...++.++||||||+++|+|++|+.||......
T Consensus 153 ~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------ 220 (307)
T cd06607 153 TVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------ 220 (307)
T ss_pred CEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------
Confidence 9999999998765332 3456788999999874 456889999999999999999999999653221
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
...........+ . + ........+.+++..||+.+|++||++.+++..
T Consensus 221 -~~~~~~~~~~~~-~-----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 221 -SALYHIAQNDSP-T-----L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -HHHHHHhcCCCC-C-----C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111111111111 0 0 112234568999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=302.26 Aligned_cols=267 Identities=25% Similarity=0.267 Sum_probs=198.4
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|+..+.||.|++|.||+|.+.. +|..||+|++...... ......+.+|+..+++++|||++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~ 67 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETED------------EGVPSTAIREISLLKELNHPNIVRLLDVV 67 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC-CCCEEEEEEeeccccc------------ccchhHHHHHHHHHHhcCCCCccCHhhee
Confidence 4667899999999999998865 4899999998754321 11235677899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..+++|||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 68 ~~~~~~~iv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~ 141 (283)
T cd07835 68 HSENKLYLVFEFL-DLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLA 141 (283)
T ss_pred ccCCeEEEEEecc-CcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEe
Confidence 9999999999999 56999998752 2246899999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
|||++......... .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||...........+.++....
T Consensus 142 df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (283)
T cd07835 142 DFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP 219 (283)
T ss_pred ecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999765433211 1334568899999987654 57899999999999999999999997543211111111110000
Q ss_pred h--------ccCCCcccc---cccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 I--------SSENPHRAI---DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~--------~~~~~~~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ........+ .........+.....+.+++.+|++++|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 000000111223356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=304.40 Aligned_cols=270 Identities=22% Similarity=0.241 Sum_probs=198.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 314 (532)
++|+..+.||+|+||.||+|.+..+ |+.||+|.+...... ......+.+|+.+++.+ +||||++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~-~~~v~lK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~~i~~~~ 67 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNT-GKLVALKKTRLEMDE------------EGIPPTALREISLLQMLSESIYIVRLL 67 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCC-CcEEEEEeehhhccc------------cCCchHHHHHHHHHHHccCCCCcccee
Confidence 3588889999999999999988764 899999998654211 11235677899999999 469999999
Q ss_pred eEEecCCc-----eEEEEEeccCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRPDC-----HLLVYEFMKNGSLQDILHDVSQG-RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++...+. .|+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++
T Consensus 68 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~ 143 (295)
T cd07837 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLV 143 (295)
T ss_pred eeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEE
Confidence 99987665 7999999975 899988754322 456899999999999999999999988 9999999999999
Q ss_pred cC-CCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 389 DD-GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 389 ~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+. ++.++|+|||++......... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.........
T Consensus 144 ~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~ 221 (295)
T cd07837 144 DKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221 (295)
T ss_pred ecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 98 899999999998865432211 133456889999998765 45789999999999999999999999754332111
Q ss_pred ccHHHHHHHHhccCCCcccc-----------cccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAI-----------DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+...+.... ........ .+.......+.....+.+++..|++++|.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 222 LHIFKLLGTPT-EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHhCCCC-hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11111100000 00000000 000000011224456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=299.66 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=198.7
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW---HRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l 313 (532)
.|+..+.||+|+||.||+|.+..+ |..+|+|.+..... ......+.+|+.++++++ |||++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~-~~~~~iK~~~~~~~-------------~~~~~~~~~e~~~l~~l~~~~~~~vi~~ 67 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPT-GRVVALKIINLDTP-------------DDDVSDIQREVALLSQLRQSQPPNITKY 67 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCC-CcEEEEEEecCCCC-------------chhHHHHHHHHHHHHHhccCCCCCeeeE
Confidence 367788999999999999998654 89999999875421 122356778888888886 9999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++......++||||+++++|.+++.. ..+++...+.++.+++.||.|||+.+ ++|+||+|+||++++++.
T Consensus 68 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~ 139 (277)
T cd06917 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGN 139 (277)
T ss_pred eeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCC
Confidence 9999999999999999999999999853 26899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++......... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...... .+
T Consensus 140 ~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~ 210 (277)
T cd06917 140 VKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RA 210 (277)
T ss_pred EEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hh
Confidence 999999999876554321 1345789999999987654 4688999999999999999999999753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .....+. .+... ..+..+.+++..||+.+|++||++.+++.
T Consensus 211 ~~~-~~~~~~~-----~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 211 MML-IPKSKPP-----RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhc-cccCCCC-----CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 1111111 11111 13456888999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.35 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=200.3
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCc
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC 322 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 322 (532)
+||+|.||+||-|++..+ ...+|||.+.... .+....+..|+.+-++|+|+|||+++|.|.+++.
T Consensus 582 VLGKGTYG~VYA~RD~~t-qvrIaIKEIpekd--------------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf 646 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDT-QVRIAIKEIPEKD--------------SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF 646 (1226)
T ss_pred EeecCceeEEEeeccccc-eeEEEeeeccccc--------------chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe
Confidence 599999999999998865 7889999997653 2335667889999999999999999999999999
Q ss_pred eEEEEEeccCCCHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-CCCcEEEecc
Q 037084 323 HLLVYEFMKNGSLQDILHDVSQGRREL--DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDF 399 (532)
Q Consensus 323 ~~lV~E~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DF 399 (532)
+-|.||-+|||||.++|+.. =+++ ++.+.--+.+||++||.|||... |||||||-+|+|++ -.|.+||+||
T Consensus 647 ~kIFMEqVPGGSLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDF 720 (1226)
T KOG4279|consen 647 FKIFMEQVPGGSLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDF 720 (1226)
T ss_pred EEEEeecCCCCcHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEeccc
Confidence 99999999999999999852 2344 77888889999999999999998 99999999999997 5789999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|-++....-. +. ..+..||..|||||++..+. |+.++|||||||++.||.||++||.........+- . +
T Consensus 721 GTsKRLAgin-P~-TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--k-----V 791 (1226)
T KOG4279|consen 721 GTSKRLAGIN-PC-TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--K-----V 791 (1226)
T ss_pred ccchhhccCC-cc-ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--h-----h
Confidence 9988764432 12 25778999999999998874 88999999999999999999999965322111100 0 0
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. .+.-+..+++...++..++++|+.++|.+||++.+++.
T Consensus 792 Gm--------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GM--------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cc--------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 00 01123346677888999999999999999999999874
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=294.98 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=202.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||+|+||.||+|....+ +..|++|.+...... ......+.+|+.++++++|+||++++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~ 67 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDT-GELMAVKEIRIQDND------------PKTIKEIADEMKVLELLKHPNLVKYYGV 67 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCC-CcEEEEEEEECcccc------------hHHHHHHHHHHHHHHhCCCCChhheeee
Confidence 367789999999999999987654 889999998766422 2345778999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++|+||+++++|.+++.. ...+++..+..++.+++.|+.|||+.+ ++|+||+|+||++++++.+||
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl 140 (264)
T cd06626 68 EVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKL 140 (264)
T ss_pred EecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999874 345788999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCccee--eeccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 397 SDFGLAKLMPDGHTRIR--ITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+|||++........... .....++..|+|||++.+.. ++.++||||||+++|++++|+.||..... ....
T Consensus 141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---~~~~-- 215 (264)
T cd06626 141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---EFQI-- 215 (264)
T ss_pred cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---hHHH--
Confidence 99999887655432211 12356788999999988776 88999999999999999999999975321 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ..... + + ........+.+++..||+.+|.+|||+.+++.
T Consensus 216 -~~~~~~-~~~~~-----~-~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 216 -MFHVGA-GHKPP-----I-P-DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -HHHHhc-CCCCC-----C-C-cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 11100 0 0 01112445778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.32 Aligned_cols=252 Identities=24% Similarity=0.322 Sum_probs=206.7
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++.+.||+|+||.||++....+ |..+++|.+...... ......+.+|+.++++++||||+++.++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSD-NQFYALKEVDLGSMS------------QKEREDAVNEIRILASVNHPNIISYKEA 67 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCC-CCEEEEEEEehhhcc------------HHHHHHHHHHHHHHHhCCCCCchhhhhh
Confidence 367789999999999999987754 889999998754322 2234567789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+......++|+||+++++|.+++.........+++..++.++.+++.||+|||+.+ ++|+||+|+||++++++.+++
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl 144 (256)
T cd08530 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144 (256)
T ss_pred hccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEE
Confidence 99999999999999999999999765444567899999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++........ ....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... . +.....
T Consensus 145 ~d~g~~~~~~~~~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~---~~~~~~ 213 (256)
T cd08530 145 GDLGISKVLKKNMA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----Q---DLRYKV 213 (256)
T ss_pred eeccchhhhccCCc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHH
Confidence 99999987765421 345688999999999998999999999999999999999999975332 1 111111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... ..........+.+++..|++.+|++|||+.++++
T Consensus 214 -~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 214 -QRGKY---------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -hcCCC---------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111 1112244566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.94 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=198.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~ 314 (532)
++|...+.||+|+||.||++.+..+ |+.+|+|.+...... .....+.+|+.++.++. ||||++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~-~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~~iv~~~ 69 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPS-GTIMAVKRIRSTVDE-------------KEQKRLLMDLDVVMRSSDCPYIVKFY 69 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCC-CCEEEEEEehhccCh-------------HHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 3567778999999999999988764 899999998754321 22356788999999996 99999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDV-SQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++..++..+++|||++ ++|.++.... ......+++.....++.+++.||+|||+. + ++||||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~ 145 (288)
T cd06616 70 GALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNG 145 (288)
T ss_pred eEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCC
Confidence 99999999999999985 5766654321 12345789999999999999999999974 6 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.++|+|||+++........ ....|+..|+|||++.+. .++.++||||+||++|+|++|+.||.... ..
T Consensus 146 ~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~ 216 (288)
T cd06616 146 NIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SV 216 (288)
T ss_pred cEEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hH
Confidence 9999999999765443221 344688999999998776 68999999999999999999999997532 11
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..-+........+ .+........+..+.+++..||+.+|++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 217 FDQLTQVVKGDPP------ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHhhhcCCCCC------cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112222111111 1111111234556889999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=297.74 Aligned_cols=266 Identities=21% Similarity=0.236 Sum_probs=196.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+.++|.+.+.||+|+||.||+|....+ |..||+|.+...... .....+.+|+.+++.++|+||+++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~ 68 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRIN-GQLVALKVISMKTEE-------------GVPFTAIREASLLKGLKHANIVLL 68 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCC-CcEEEEEEecccCcC-------------CCcHHHHHHHHHHHhcCCCCEeEE
Confidence 456799999999999999999988764 889999998754311 112345689999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.+++..++..++|+||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~ 141 (291)
T cd07870 69 HDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGE 141 (291)
T ss_pred EEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCc
Confidence 999999999999999995 688777754 2345778888899999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||+++........ .....++..|+|||++.+. .++.++||||||+++|+|++|..||....... ..+..
T Consensus 142 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~- 216 (291)
T cd07870 142 LKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEK- 216 (291)
T ss_pred EEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHH-
Confidence 999999998765432211 1334578999999988764 57889999999999999999999997543211 11111
Q ss_pred HHHHhc------------cCCCcccccccccCCCc------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVIS------------SENPHRAIDSKLLGNGY------EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~------------~~~~~~~~d~~l~~~~~------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ................. ......+.+++..|++.||++|||+.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 00000000000000000 011346788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=300.51 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=201.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||++....+ +..||+|.+.... ......+.+|+.++++++|||+++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~hp~i~~~~ 82 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVAT-GQEVAIKQMNLQQ--------------QPKKELIINEILVMRENKHPNIVNYL 82 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCC-CCEEEEEEecccc--------------chHHHHHHHHHHHHhhcCCCCeeehh
Confidence 35788889999999999999976653 8899999986432 12235678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++|+||+++++|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~ 154 (293)
T cd06647 83 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSV 154 (293)
T ss_pred heeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCE
Confidence 999999999999999999999999864 34788999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|+|||++......... .....+++.|+|||.+.+..++.++|+||||+++|++++|+.||..........
T Consensus 155 kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------- 225 (293)
T cd06647 155 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------- 225 (293)
T ss_pred EEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-------
Confidence 99999998765443221 134568899999999988889999999999999999999999997533211100
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.....+.+. ..........+.+++..||+.+|++||++++++..
T Consensus 226 ~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 LIATNGTPE--------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ehhcCCCCC--------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011110 00111234458889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.20 Aligned_cols=273 Identities=22% Similarity=0.253 Sum_probs=199.5
Q ss_pred ccccceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
|.+.+.||+|+||.||+|..... ++..||+|.+....... ......+.+|+.++++++||||++++++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-----------TGISQSACREIALLRELKHENVVSLVEV 70 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-----------cCccHHHHHHHHHHHhcCCCCccceEEE
Confidence 67788999999999999988752 38899999998743110 1123456789999999999999999999
Q ss_pred EecC--CceEEEEEeccCCCHHHHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---
Q 037084 317 VTRP--DCHLLVYEFMKNGSLQDILHDVSQG-RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--- 390 (532)
Q Consensus 317 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--- 390 (532)
+... +..++||||++ ++|.+++...... ...++....+.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~ 146 (316)
T cd07842 71 FLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGP 146 (316)
T ss_pred EeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCC
Confidence 9988 78999999996 4777777643332 237899999999999999999999998 999999999999999
Q ss_pred -CCcEEEeccCCcccCCCCCc-ceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchh--
Q 037084 391 -GMEARISDFGLAKLMPDGHT-RIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE-- 465 (532)
Q Consensus 391 -~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-- 465 (532)
++.+||+|||++........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||........
T Consensus 147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 226 (316)
T cd07842 147 ERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226 (316)
T ss_pred ccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccccc
Confidence 99999999999987654322 1122345678999999987664 578999999999999999999999975433210
Q ss_pred ----hccHHHHHHHHhcc-----------CCCcc---cccccccC-CCcH-------HHHHHHHHHHHHcCCCCCCCCCC
Q 037084 466 ----EMNMVRWMRNVISS-----------ENPHR---AIDSKLLG-NGYE-------EQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 466 ----~~~l~~~~~~~~~~-----------~~~~~---~~d~~l~~-~~~~-------~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
...+...+..+... ..... ........ .... .....+.+++..|++.||++|||
T Consensus 227 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps 306 (316)
T cd07842 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306 (316)
T ss_pred chhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC
Confidence 01111111110000 00000 00000000 0000 23346889999999999999999
Q ss_pred HHHHHH
Q 037084 520 SKDVRC 525 (532)
Q Consensus 520 ~~evl~ 525 (532)
+.++++
T Consensus 307 ~~eil~ 312 (316)
T cd07842 307 AEEALE 312 (316)
T ss_pred HHHHhc
Confidence 999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.48 Aligned_cols=269 Identities=25% Similarity=0.256 Sum_probs=197.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||+|++|.||+|.+..+ |+.||+|.+...... ......+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVT-NETIALKKIRLEQED------------EGVPSTAIREISLLKEMQHGNIVRLQD 68 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCC-CcEEEEEehhhcccc------------ccchHHHHHHHHHHHhccCCCEeeEEE
Confidence 4688889999999999999988764 899999998654321 122356788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-CCcE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEA 394 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 394 (532)
++...+..++||||++ ++|.+++.. .....+++.....++.|++.||+|||+.+ ++|+||+|+||+++. ++.+
T Consensus 69 ~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~ 142 (294)
T PLN00009 69 VVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142 (294)
T ss_pred EEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEE
Confidence 9999999999999995 588888754 23344678888899999999999999988 999999999999985 5679
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++......... .+...+++.|+|||++.+. .++.++||||+|+++|+|++|+.||..............+.
T Consensus 143 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~ 220 (294)
T PLN00009 143 KLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL 220 (294)
T ss_pred EEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999765433211 1345678999999987664 57899999999999999999999997643321111111110
Q ss_pred HHHhccCC-----Cc---ccc---cccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSEN-----PH---RAI---DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~-----~~---~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ .. ... .........+.....+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 00 000 000000011223455888999999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.00 Aligned_cols=268 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|+..+.||+|++|.||+|++..+ |..||||.++..... .....+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~ 66 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTT-GEIVALKEIHLDAEE-------------GTPSTAIREISLMKELKHENIVRLHDV 66 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCC-CeEEEEEEecccccc-------------cchHHHHHHHHHHHhhcCCCEeeeeee
Confidence 477889999999999999998654 899999999765321 112456679999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++||||+++ +|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+++
T Consensus 67 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l 141 (284)
T cd07836 67 IHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKL 141 (284)
T ss_pred EeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEE
Confidence 9999999999999974 8988886532 2356899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH--
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM-- 473 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~-- 473 (532)
+|||++......... .....++..|+|||++.+. .++.++|+||||+++|+|++|+.||...........+....
T Consensus 142 ~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (284)
T cd07836 142 ADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT 219 (284)
T ss_pred eecchhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 999999765433211 1345678899999987654 57899999999999999999999997643321111111110
Q ss_pred ------HHHhccCCCccccc---ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 ------RNVISSENPHRAID---SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ------~~~~~~~~~~~~~d---~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............+. ........+.....+.+++..|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 00000111233456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.78 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=214.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCC----cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYG----KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
.+..+...++||+|+||+||+|.|-.. | .+||+|++..... .+...++..|+..|.++.|||
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~-------------~~~s~e~LdeAl~masldHpn 759 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTS-------------PKASIELLDEALRMASLDHPN 759 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCC-------------chhhHHHHHHHHHHhcCCCch
Confidence 344566778999999999999998654 4 4899999976542 233578899999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++|+|+|.... ..||++|||.|+|.|+++. .+..+.....+.|+.|||+||.|||.+. +|||||.++|||+.
T Consensus 760 l~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVk 832 (1177)
T KOG1025|consen 760 LLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVK 832 (1177)
T ss_pred HHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeec
Confidence 999999999866 7899999999999999986 4667888999999999999999999888 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
...++||.|||+++...............-.+.|||-|.+....|+.++|||||||++||++| |..||+..... .
T Consensus 833 sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~----e 908 (1177)
T KOG1025|consen 833 SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE----E 908 (1177)
T ss_pred CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH----H
Confidence 999999999999999877655443333444678999999999999999999999999999999 99999875441 2
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+.+.++ .+ .+-..++.+..++.-++..||..|++.||+++++...+.++
T Consensus 909 I~dlle----~g---------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 909 IPDLLE----KG---------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred hhHHHh----cc---------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 222211 11 11233455677799999999999999999999999988765
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=296.98 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=200.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...+.||+|++|.||++..... +..+++|.+.... ......+.+|+.++++++|||+++++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~iK~~~~~~--------------~~~~~~~~~e~~~l~~~~h~~vv~~~~~ 84 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKST-GRQVAVKKMDLRK--------------QQRRELLFNEVVIMRDYQHPNIVEMYSS 84 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCC-CCEEEEEEEeccc--------------hhHHHHHHHHHHHHHHcCCCChheEEEE
Confidence 455567999999999999987654 8899999986542 2223557889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++++||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+++
T Consensus 85 ~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l 156 (285)
T cd06648 85 YLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKL 156 (285)
T ss_pred EEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEE
Confidence 9999999999999999999999864 35889999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....|+..|+|||...+..++.++|+||||+++|+|++|+.||..... .......
T Consensus 157 ~d~g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~ 227 (285)
T cd06648 157 SDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRI 227 (285)
T ss_pred cccccchhhccCCcc--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHH
Confidence 999988765443221 1345689999999999888899999999999999999999999965322 1222222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .+.... ........+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~-~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 228 RDN-LPPKLK-------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Hhc-CCCCCc-------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 211 111100 01113346889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=298.02 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=205.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|...+.||+|+||.||+|.+... +..+++|++..... ....+.+|+..+++++|+|++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~ 80 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRAT-GKEVAIKKMRLRKQ---------------NKELIINEILIMKDCKHPNIVDY 80 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccC-CcEEEEEEEecCch---------------hHHHHHHHHHHHHHCCCCCeeEE
Confidence 456788889999999999999988754 88999999986531 34567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++++||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~ 154 (286)
T cd06614 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGS 154 (286)
T ss_pred EEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCC
Confidence 999999999999999999999999998622 47999999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||++......... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||...... ...
T Consensus 155 ~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~ 225 (286)
T cd06614 155 VKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RAL 225 (286)
T ss_pred EEECccchhhhhccchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 999999998765443221 13456788999999998888999999999999999999999999753321 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ ... .........+.+++..|++.+|.+|||+.+++.
T Consensus 226 ~~~~~~~~-~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 226 FLITTKGI-PPL-------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHhcCC-CCC-------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11111111 100 011123456888999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.05 Aligned_cols=284 Identities=19% Similarity=0.243 Sum_probs=195.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhH---HHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAAT---ELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
++|.+++.||+|+||+||++.++...+...+.|.+........ ................+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 5799999999999999999988755455555553322211110 0000000011223567889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVS-QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++++...+..|+|++++ +++|.+++.... .............++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999999999999999999 567888775421 11223345667789999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF-PFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|.. |+..... .....+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~-~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG-KPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC-CHHHHHH
Confidence 999999999998775433221 134679999999999999999999999999999999999875 4433211 1112222
Q ss_pred HHHHHHh--ccCCCc------cccccc-c--cCCCcH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVI--SSENPH------RAIDSK-L--LGNGYE------EQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~--~~~~~~------~~~d~~-l--~~~~~~------~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+.... ....+. ..++.. . .....+ .....+.+++.+|++.||.+|||+.|++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 2111110 000000 000000 0 000000 11234677888999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.36 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=203.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ......+.+|+.++++++||||++++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 68 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDT-KKMFAMKYMNKQKCVE-----------KGSVRNVLNERRILQELNHPFLVNLWYS 68 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccC-CcEEEEEEEehhhhcc-----------hhHHHHHHHHHHHHHhCCCCChHHHHHh
Confidence 477889999999999999987654 8999999997542111 2345788999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+++..++|+||+++++|.+++.. ..++++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 69 ~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred hcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEE
Confidence 9999999999999999999999965 256889999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...++...
T Consensus 142 ~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~ 213 (258)
T cd05578 142 TDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAK 213 (258)
T ss_pred eecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHH
Confidence 99999887654321 14566888999999999888999999999999999999999999764321 11222222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS--KDVR 524 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl 524 (532)
..... .......+..+.+++..||+.+|.+||+. .+++
T Consensus 214 ~~~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QETAD----------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hcccc----------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11110 01112233668899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=302.55 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=199.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
...|...+.||+|+||.||+|.+..+ |..+|+|.+....... ......+.+|+.++++++|||+++++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~-~~~valK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQS-----------NEKWQDIIKEVKFLQRIKHPNSIEYK 91 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCC-CcEEEEEEEecCCCCc-----------hHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 34588889999999999999988654 8999999987542221 22345788899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+.+..++||||++ |+|.+.+.. ...++++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.+
T Consensus 92 ~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~ 164 (317)
T cd06635 92 GCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQV 164 (317)
T ss_pred EEEeeCCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCE
Confidence 99999999999999996 588887754 2456899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+|+|||++...... ....|+..|+|||++. ++.++.++|||||||++|+|++|+.||...... .
T Consensus 165 kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~ 231 (317)
T cd06635 165 KLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------S 231 (317)
T ss_pred EEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------H
Confidence 99999998754432 3456888999999873 456889999999999999999999998653211 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
..........+. .........+.+++.+||+.+|.+||++.++++.+
T Consensus 232 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 232 ALYHIAQNESPT---------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred HHHHHHhccCCC---------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 111111111111 01122334588899999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=292.66 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=207.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...+.||.|+||.||++.+..+ +..+++|++...... ......+.+|++++++++|||++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~~~~~~~~ 67 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSD-GKLYVLKEIDLSNMS------------EKEREDALNEVKILKKLNHPNIIKYYES 67 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCC-CcEEEEEEeecccCC------------hHHHHHHHHHHHHHHhcCCCChhheEEE
Confidence 367788999999999999998764 889999999765422 2334667889999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++|+||+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|
T Consensus 68 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l 144 (258)
T cd08215 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKL 144 (258)
T ss_pred EecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEE
Confidence 99999999999999999999999864433577999999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....|++.|+|||...+..++.++|+||+|+++++|++|..||..... .......
T Consensus 145 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~ 215 (258)
T cd08215 145 GDFGISKVLSSTVDL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKI 215 (258)
T ss_pred CCccceeecccCcce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHH
Confidence 999999876554311 1345788999999999888899999999999999999999999965321 1222222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... ... ........+.+++..||+.+|++|||+.++++
T Consensus 216 ~~~~-~~~---------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 216 LKGQ-YPP---------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred hcCC-CCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2111 110 11123355888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.14 Aligned_cols=248 Identities=29% Similarity=0.372 Sum_probs=194.2
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||+||++....+ |+.+|+|.+....... ......+..|+.++++++|||++++++++...+..
T Consensus 1 lg~g~~g~vy~~~~~~~-~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 68 (277)
T cd05577 1 LGKGGFGEVCACQVKAT-GKMYACKKLDKKRLKK-----------RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDL 68 (277)
T ss_pred CCCCCceeEEEEEEcCC-CcEEEEEEEehhhhhh-----------hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeE
Confidence 69999999999987654 8999999987542111 22345677899999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
|+|+||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 69 CLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred EEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchh
Confidence 9999999999999999763 2346899999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
....... .....++..|+|||++.+..++.++|+||+|+++|+|++|+.||........... +........
T Consensus 144 ~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~-- 214 (277)
T cd05577 144 ELKGGKK---IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE----LKRRTLEMA-- 214 (277)
T ss_pred hhccCCc---cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH----HHhcccccc--
Confidence 6544221 1345678899999999888899999999999999999999999975332111111 111110000
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
..........+.+++..||+.+|.+|| ++.+++.
T Consensus 215 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 215 --------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 001112244578899999999999999 5555653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=307.18 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=198.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|....+ |..||+|.+...... ......+.+|+.++++++||||++++
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVT-GQNVAIKKLSRPFQN------------VTHAKRAYRELVLMKLVNHKNIIGLL 81 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCC-CCEEEEEecCccccC------------hhHHHHHHHHHHHHHhcCCCCCccee
Confidence 46799999999999999999988764 899999998653211 22235567899999999999999999
Q ss_pred eEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++... ...|+||||++ ++|.+.+.. .++...+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~ 151 (353)
T cd07850 82 NVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 151 (353)
T ss_pred eeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 988644 35699999995 588888753 2788899999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.++.+||+|||+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........
T Consensus 152 ~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 228 (353)
T cd07850 152 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228 (353)
T ss_pred CCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999999999987644322 1345678999999999999999999999999999999999999975432111111
Q ss_pred HH--------HHH-------HHHhccCC------CcccccccccCC----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 469 MV--------RWM-------RNVISSEN------PHRAIDSKLLGN----GYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 469 l~--------~~~-------~~~~~~~~------~~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
+. ++. ........ ....+....... ........+.+++.+|++.||++|||+.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 308 (353)
T cd07850 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308 (353)
T ss_pred HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence 10 000 00000000 001111110000 112345668899999999999999999999
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
+.
T Consensus 309 L~ 310 (353)
T cd07850 309 LQ 310 (353)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=302.51 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=194.3
Q ss_pred ceeccc--CCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 242 EIIGVG--ACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G--~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
..||+| +||+||++.+... |+.||+|++...... ....+.+.+|+.+++.++||||++++++|..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 70 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPT-GTLVTVRITDLENCT------------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTT 70 (328)
T ss_pred HHhCCcccCceeEEEEEEcCC-CcEEEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCCcceEeeeEec
Confidence 456766 9999999988654 899999998765322 2234678889999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
++..++|+||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||
T Consensus 71 ~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~ 145 (328)
T cd08226 71 GSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGL 145 (328)
T ss_pred CCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEech
Confidence 99999999999999999998763 2345889999999999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCccee-----eeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 400 GLAKLMPDGHTRIR-----ITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 400 Gla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+.+........... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||......... ...
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~---~~~ 222 (328)
T cd08226 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML---LQK 222 (328)
T ss_pred HHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH---HHH
Confidence 86543322111100 0122345679999998764 4789999999999999999999999764321111 000
Q ss_pred HHH--------------------------------HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 473 MRN--------------------------------VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 473 ~~~--------------------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
... ...........+..+...........+.+++..||+.||++|||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta 302 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH
Confidence 000 000000000111111111223456778999999999999999999
Q ss_pred HHHHH
Q 037084 521 KDVRC 525 (532)
Q Consensus 521 ~evl~ 525 (532)
.++++
T Consensus 303 ~e~l~ 307 (328)
T cd08226 303 SSLLS 307 (328)
T ss_pred HHHhh
Confidence 99974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=291.35 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=198.4
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||.|+||.||+|.+..+ +..+|+|++....... ......+.+|+.++++++||||+++++++.+++..
T Consensus 1 lg~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (262)
T cd05572 1 LGVGGFGRVELVKVKSK-NRTFALKCVKKRHIVE-----------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYI 68 (262)
T ss_pred CCCCCceEEEEEEECCC-CcEEEEEEEehhcchh-----------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCcc
Confidence 69999999999998764 8899999997543221 22346788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 69 YMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred EEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 999999999999999975 245889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
....... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +..............
T Consensus 142 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~- 212 (262)
T cd05572 142 KLKSGQK---TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILKGNGK- 212 (262)
T ss_pred ccCcccc---cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhccCCC-
Confidence 7755421 1345688999999999888899999999999999999999999975432 112222222211110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
..........+.+++..||+.+|++||+ +.++++
T Consensus 213 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 213 --------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred --------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0111112456899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=299.95 Aligned_cols=270 Identities=21% Similarity=0.243 Sum_probs=197.4
Q ss_pred cccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
...-++|...+.||+|+||.||+|....+ ++.||||.+...... ......+.+|+.++++++||||+
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~aik~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv 74 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKT-KQIVALKKVLMENEK------------EGFPITALREIKILQLLKHENVV 74 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCC-CcEEEEEEEeccCCc------------CCchhHHHHHHHHHHhCCCCCcc
Confidence 34456799999999999999999988764 899999998654211 11123456799999999999999
Q ss_pred cceeEEecCCc--------eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 037084 312 PLQAHVTRPDC--------HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383 (532)
Q Consensus 312 ~l~~~~~~~~~--------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp 383 (532)
+++++|...+. .++||||++ ++|.+.+.. ....+++...+.++.|++.||.|||+.+ ++|+||||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p 147 (310)
T cd07865 75 NLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKA 147 (310)
T ss_pred ceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 99999876543 499999995 588888764 2346899999999999999999999988 99999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcc--eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+||+++.++.+||+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...
T Consensus 148 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876443211 111345678899999987664 4788999999999999999999999754
Q ss_pred ccchhhccHHHHHHHHhccCCC---cc-----cccc-cccCCCc---------HHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENP---HR-----AIDS-KLLGNGY---------EEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~---~~-----~~d~-~l~~~~~---------~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
... .....+......... .. ..+. ....... ......+.+++..||+.||.+|||+++
T Consensus 228 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 228 TEQ----HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CHH----HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 321 111111111110000 00 0000 0000000 001235678999999999999999999
Q ss_pred HHH
Q 037084 523 VRC 525 (532)
Q Consensus 523 vl~ 525 (532)
+++
T Consensus 304 ~l~ 306 (310)
T cd07865 304 ALN 306 (310)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=296.16 Aligned_cols=259 Identities=24% Similarity=0.235 Sum_probs=194.3
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAH 316 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~ 316 (532)
|.+.+.||+|+||.||+|....+ +..||+|.++...... ......+|+..+.++. |||+++++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~-~~~~aik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~h~~i~~~~~~ 66 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKT-GKYYAIKCMKKHFKSL-------------EQVNNLREIQALRRLSPHPNILRLIEV 66 (282)
T ss_pred CceEeeccccccceEEEEEEcCC-CcEEEEEEehhccCCc-------------hhhhHHHHHHHHhhcCCCCCccceEEE
Confidence 45678999999999999988754 8999999987542111 1123346888888885 9999999999
Q ss_pred EecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 317 VTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 317 ~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+.++ +..++|+||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.+
T Consensus 67 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~ 138 (282)
T cd07831 67 LFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DIL 138 (282)
T ss_pred EecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCe
Confidence 9987 88999999996 588888864 2356899999999999999999999988 999999999999999 999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ ....++..|+|||++. +..++.++|+||+||++|||++|..||......+ ...+.
T Consensus 139 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~ 211 (282)
T cd07831 139 KLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKI 211 (282)
T ss_pred EEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHH
Confidence 99999999876543221 3356789999999764 4567889999999999999999999997643211 11222
Q ss_pred HHHhcc-----------CCCcccccccccC----CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISS-----------ENPHRAIDSKLLG----NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~-----------~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ........+.... ...+..+..+.+++..||+++|++|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111110 0000000000000 001234577999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=287.26 Aligned_cols=253 Identities=26% Similarity=0.394 Sum_probs=206.1
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|++|.||+|....+ +..|++|++...... ......+.+|+..+++++||||+++++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDT-GELMAVKSVELSGDS------------EEELEALEREIRILSSLQHPNIVRYYGSE 68 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCC-CcEEEEEEeeccccc------------hHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 66778999999999999988764 899999999776422 23457788999999999999999999999
Q ss_pred ecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 318 TRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 318 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
... +..++++||+++++|.+++... ..+++..++.++.+++.+|+|||+.+ ++|+||+|+||+++.++.++
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~ 141 (260)
T cd06606 69 RDEEKNTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVK 141 (260)
T ss_pred ecCCCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEE
Confidence 988 8899999999999999999752 27899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||.+................++..|+|||...+..++.++||||||+++|+|++|..||.... +.......
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~ 215 (260)
T cd06606 142 LADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYK 215 (260)
T ss_pred EcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHh
Confidence 999999987765542111245678899999999998889999999999999999999999997643 11111111
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... ..........+.+++.+|++.+|++||++.+++.
T Consensus 216 ~~~~~~~---------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 216 IGSSGEP---------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ccccCCC---------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1110111 1112223566889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=296.58 Aligned_cols=271 Identities=17% Similarity=0.189 Sum_probs=191.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|.+.++. +..+|+|......... .................+...+..+.|+|++.
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~---~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETI---VMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCch---hhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 467999999999999999999876431 4467777654332111 00011111111223344555677889999999
Q ss_pred ceeEEecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++.... ..+++++++ ..++.+.+.. ....++..+..++.|++.||+|||+.+ ++||||||+|||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999776543 236778877 4477776653 223567888999999999999999988 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcc-----eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
+.++.++|+|||+++.+...... .......||+.|+|||+..+..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999876432211 1113356999999999999999999999999999999999999999865321
Q ss_pred hhhcc--HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 464 TEEMN--MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 464 ~~~~~--l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
..... ..++........ . ..+..+..+.+++..|++.+|++||++.++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEGK-I-----------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHHhhhhh-h-----------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111 112222222111 0 01122456888999999999999999999998874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=296.04 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=199.3
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|.+.+.||+|+||.||+|.+... |+.+|+|.+...... ......+.+|+.++++++|||++++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~-~~~~~~K~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKT-GELVALKKIRMENEK------------EGFPITAIREIKLLQKLRHPNIVRLKEIV 67 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCC-CeEEEEEEEeccccc------------ccchHHHHHHHHHHHhccCCCeeeheeeE
Confidence 56678999999999999988754 899999999875311 12235678899999999999999999999
Q ss_pred ecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 318 TRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 318 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
... +..++|+||+++ +|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.++
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~ 140 (287)
T cd07840 68 TSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLK 140 (287)
T ss_pred ecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEE
Confidence 988 889999999964 89888864 2257899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++......... ..+...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.....
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07840 141 LADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG 219 (287)
T ss_pred EccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999876554321 1134567889999997664 4578999999999999999999999976433111111111100
Q ss_pred HHhccCC-------------CcccccccccCCCcHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSEN-------------PHRAIDSKLLGNGYEE-QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~-------------~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... ........+. ..... +...+.+++..||+.+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 220 SPTDENWPGVSKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCchhhccccccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000000000 00111 2567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.45 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=199.5
Q ss_pred cccCc-cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 234 KEDSL-ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 234 ~~~~~-~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
++.+| +....||+|+|=+||+|.+.. +|..||=-.++.... .......++|..|+.+|+.|+||||++
T Consensus 37 p~gRy~k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~----------~q~~~~leR~~~Ev~lLKsL~H~NIir 105 (632)
T KOG0584|consen 37 PTGRYLKFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDV----------TQSPEELERLYSEVHLLKSLKHPNIIR 105 (632)
T ss_pred CCCceeehhhhcccccceeeeeccccc-cchhhHHHHHhHHHh----------hcChHHHHHHHHHHHHHccCCCCceee
Confidence 34444 455789999999999998754 377776433322111 112445689999999999999999999
Q ss_pred ceeEEecCCc--eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTRPDC--HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~~~~--~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
++.+..+... .-+|+|.|..|+|..|+.++ +..+......|+.||++||.|||++. |||+|||||.+||+|+.
T Consensus 106 fy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG 180 (632)
T KOG0584|consen 106 FYDSWVDTDNKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNG 180 (632)
T ss_pred eeeheecCCCceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcC
Confidence 9998877654 67899999999999999874 34778899999999999999999984 78999999999999984
Q ss_pred -CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 391 -GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.|.|||+|.|||........ ...+|||.|||||+.. ..|.+.+||||||++++||+|+..||.... +.
T Consensus 181 ~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~ 249 (632)
T KOG0584|consen 181 NLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NP 249 (632)
T ss_pred CcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CH
Confidence 68999999999998877654 4579999999999887 689999999999999999999999996432 22
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+..+. +.++..+..+..- .+ .++.+++..|+.. .+.|||+.|++.
T Consensus 250 AQIYKK-V~SGiKP~sl~kV----~d----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 250 AQIYKK-VTSGIKPAALSKV----KD----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHHHH-HHcCCCHHHhhcc----CC----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 222222 3333333222221 11 1378899999999 999999999985
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.29 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=197.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|.++..... ......+.+|+.++++++|+|+++++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 72 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTS-GEIVALKKVRMDNER------------DGIPISSLREITLLLNLRHPNIVELK 72 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCC-CcEEEEEEEEeccCC------------CCCcchhhHHHHHHHhCCCCCCcceE
Confidence 45789999999999999999988754 899999998754321 11123456799999999999999999
Q ss_pred eEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++... +..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 73 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~ 145 (309)
T cd07845 73 EVVVGKHLDSIFLVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKG 145 (309)
T ss_pred EEEecCCCCeEEEEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence 998765 56799999995 5898888752 356899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.++|+|||++......... .+...++..|+|||.+.+ ..++.++||||+||++|+|++|++||...........+..
T Consensus 146 ~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 146 CLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred CEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999876543221 133456788999998765 4578999999999999999999999975433211111111
Q ss_pred HHHH-------HhccCCCccccc--ccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRN-------VISSENPHRAID--SKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~-------~~~~~~~~~~~d--~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... ..........+. ...... ........+.+++..|++.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 224 LLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1000 000000000000 000000 00112456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=310.52 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=207.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.+.+-|.++..||-|+||.||+|..+.+ +-..|-|++...+ ....+.|.-|+++|+.+.||+||+
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket-~~lAAaKvIetks--------------eEELEDylVEIeILa~CdHP~ivk 93 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKET-KLLAAAKVIETKS--------------EEELEDYLVEIEILAECDHPVIVK 93 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccc-hhhhhhhhhcccc--------------hhHHhhhhhhhhhhhcCCChHHHH
Confidence 3567789999999999999999987743 6677888887654 455788999999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
|++.|...+.++++.|||+||-++..+-. -+..+...++.-++++++.+|.|||++. |||||||+.|||++-+|
T Consensus 94 Ll~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldG 167 (1187)
T KOG0579|consen 94 LLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDG 167 (1187)
T ss_pred HHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecC
Confidence 99999888999999999999999998875 4567999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
.++++|||.+...... ........|||.|||||+.. ..+|+.++||||||++|.||..+.+|.....+
T Consensus 168 dirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----- 240 (1187)
T KOG0579|consen 168 DIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----- 240 (1187)
T ss_pred cEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----
Confidence 9999999987654322 22236789999999999754 55799999999999999999999999876433
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+-.+..++ |+-++-|. .-...+.+++..|+..||+.||++.++++
T Consensus 241 --MRVllKiaKSe-PPTLlqPS-------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 241 --MRVLLKIAKSE-PPTLLQPS-------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --HHHHHHHhhcC-CCcccCcc-------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11122222222 22222222 22345778888999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=296.69 Aligned_cols=245 Identities=24% Similarity=0.303 Sum_probs=186.8
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH---HHHhcCCCCCcccceeEEec
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI---ITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~H~niv~l~~~~~~ 319 (532)
.||+|+||.||++....+ |+.+|+|.+........ .....+.+|. .++...+|||++.+.+++..
T Consensus 1 ~lg~G~~g~Vy~~~~~~~-~~~~aiK~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVCMTYAFHT 68 (279)
T ss_pred CcccCCCeEEEEEEECCC-CcEEEEEEEEccccccc-----------hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec
Confidence 489999999999988754 89999999875432111 0111222333 33444579999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
++..++||||+++|+|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||++++++.++++||
T Consensus 69 ~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 69 PDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999998864 346899999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 478 (532)
|++........ ....|+..|+|||...+ ..++.++|+||+||++|+|++|..||...... ... .+.....
T Consensus 142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~-~~~~~~~ 212 (279)
T cd05633 142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKH-EIDRMTL 212 (279)
T ss_pred CcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc----CHH-HHHHHhh
Confidence 99876543321 34568999999998864 56889999999999999999999999753221 111 1111111
Q ss_pred cCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 479 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
... . .........+.+++..|++.||++|| |+.++++
T Consensus 213 ~~~------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 213 TVN------V----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCC------c----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 100 0 11122345688899999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=291.87 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=199.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|.+.+.||+|+||.||+|.+..+ |..||+|.+......... ......+.+|+.++++++||||+++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~ik~~~~~~~~~~~---------~~~~~~~~~ei~~l~~l~h~~i~~~~~ 71 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADT-GRELAVKQVPFDPDSQET---------SKEVNALECEIQLLKNLRHDRIVQYYG 71 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCC-CCEEEEEEEecCcccchh---------hHHHHHHHHHHHHHHHcCCCCcceEEE
Confidence 4688899999999999999987754 899999987543211100 234567889999999999999999999
Q ss_pred EEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++... +..++++||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~ 144 (264)
T cd06653 72 CLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGN 144 (264)
T ss_pred EEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 98764 457899999999999999864 235788999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCc-ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHT-RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||+++....... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||...... ..
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---- 217 (264)
T cd06653 145 VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AA---- 217 (264)
T ss_pred EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HH----
Confidence 99999999986543211 11113456889999999999888999999999999999999999999753221 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+......... ...+......+.+++..|++ +|..||+..+++.
T Consensus 218 ~~~~~~~~~~---------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 IFKIATQPTK---------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHHHcCCCC---------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111111 11122334568889999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=301.39 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=206.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|..-++||+||||.||-+..+.+ |+.+|.|.+...... .........+|-.+|.+++.+.||.+-
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraT-GKMYAcKkL~KKRiK-----------kr~ge~maLnEk~iL~kV~s~FiVsla 251 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRAT-GKMYACKKLDKKRIK-----------KRKGETMALNEKQILEKVSSPFIVSLA 251 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecc-hhhHHHHHHHHHHHH-----------HhhhhHHhhHHHHHHHHhccCcEEEEe
Confidence 34678889999999999999988876 999999988654322 244566778899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
-.|++++.+|+|+..|.||+|.-++.+. +...+++....-++.+|+.||+|||... ||+||+||+|||||+.|++
T Consensus 252 YAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Ghv 326 (591)
T KOG0986|consen 252 YAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHV 326 (591)
T ss_pred eeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCe
Confidence 9999999999999999999999998864 4467899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
.|+|.|||..++.+... +..+||.||||||++.++.|+...|.||+||++|||+.|+.||......... +-+.
T Consensus 327 RISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~----eEvd 399 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR----EEVD 399 (591)
T ss_pred EeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH----HHHH
Confidence 99999999998877643 5569999999999999999999999999999999999999999753321111 1122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
+...+.. .+++....+++.++....|+.||.+|..-
T Consensus 400 rr~~~~~----------~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 400 RRTLEDP----------EEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHhcch----------hhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111111 11233444556777778999999999754
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.58 Aligned_cols=263 Identities=25% Similarity=0.311 Sum_probs=197.0
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC---CCCCcccce
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI---WHRNLLPLQ 314 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~ 314 (532)
|++.+.||+|+||.||+|.++. ++..+|+|.++..... ......+.+|+.++.++ +|||+++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 67 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSE------------EGIPLSTLREIALLKQLESFEHPNIVRLL 67 (287)
T ss_pred CeEEEEecccCceEEEEEEECC-CCCEEEEEEecccccc------------chhhhhHHHHHHHHHHhhccCCCCcceEE
Confidence 5667899999999999999875 4899999999754321 11123455666666555 699999999
Q ss_pred eEEecCCc-----eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 315 AHVTRPDC-----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 315 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++...+. .+++|||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++
T Consensus 68 ~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~ 141 (287)
T cd07838 68 DVCHGPRTDRELKLTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVT 141 (287)
T ss_pred EEEeeccCCCCceeEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEc
Confidence 99988776 899999996 5899988752 2346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+++.++|+|||++......... ....++..|+|||++.+..++.++|+|||||++|+|++|.+||........ +
T Consensus 142 ~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~ 215 (287)
T cd07838 142 SDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---L 215 (287)
T ss_pred cCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---H
Confidence 9999999999999876544221 234578899999999999999999999999999999999999976433211 1
Q ss_pred HHHHHHHhccCC---C------cccccccc---cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSEN---P------HRAIDSKL---LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~---~------~~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............ + ...+.... .....+.....+.+++..||+.+|++||++.+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 216 DKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 111111100000 0 00000000 01112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.54 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=197.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|.+..... ......+..|+.++++++||||++++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~~ 69 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPT-GVKVAIKKISPFEH-------------QTFCQRTLREIKILRRFKHENIIGIL 69 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCC-CCeEEEEEeccccc-------------chhHHHHHHHHHHHHhCCCCCcCchh
Confidence 46799999999999999999988764 89999999864321 12235677899999999999999999
Q ss_pred eEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 315 AHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 315 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++... ...++++||++ ++|.+.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 70 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~ 140 (336)
T cd07849 70 DIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 140 (336)
T ss_pred heeecccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEC
Confidence 987654 35799999995 588877753 46899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcce-eeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
.++.++|+|||++.......... ......||..|+|||.+.+ ..++.++||||+||++|+|++|+.||......
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---- 216 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---- 216 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence 99999999999988764432211 1134568899999998654 56899999999999999999999999753221
Q ss_pred cHHHHHHHHhccCCCcc---ccc-------------ccc-cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 468 NMVRWMRNVISSENPHR---AID-------------SKL-LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~---~~d-------------~~l-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.....+...+....... ..+ +.. .....+.....+.+++..||+.+|++|||+.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 217 HQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111111110000 000 000 000011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=288.49 Aligned_cols=249 Identities=31% Similarity=0.441 Sum_probs=203.1
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|++|.||++.+.. ++..+++|++..... .....+.+|+..+++++|||++++++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 66 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESK--------------EKKEKIINEIQILKKCKHPNIVKYYGSY 66 (253)
T ss_pred ceeeeeeccCCceEEEEEEECC-CCcEEEEEEecccch--------------hHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 6677899999999999998875 488999999987632 2346788999999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++++||+++++|.+++... ...+++..+..++.+++.++.|||..+ ++|+||+|+||++++++.++|+
T Consensus 67 ~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~ 140 (253)
T cd05122 67 LKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLI 140 (253)
T ss_pred ecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEe
Confidence 9999999999999999999998752 256899999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... .......
T Consensus 141 d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~ 210 (253)
T cd05122 141 DFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIA 210 (253)
T ss_pred ecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHH
Confidence 9999987665432 14567889999999999888999999999999999999999999753211 1111111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ........ .......+.+++..||+.+|++|||+.++++
T Consensus 211 ~-~~~~~~~~-------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 211 T-NGPPGLRN-------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred h-cCCCCcCc-------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11111100 0111355888999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.51 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=189.8
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHH-HhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT-AGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|..... |+.||+|.+....... ......+..|..+ ....+|||++++++++...
T Consensus 2 ~~l~~g~~~~v~~a~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 69 (260)
T cd05611 2 KPISKGAFGSVYLAKKRST-GDYFAIKVLKKSDMIA-----------KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK 69 (260)
T ss_pred ccCCcCCCeeEEEEEecCC-CCeEEEEEecchhhhH-----------HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC
Confidence 5699999999999988654 8899999987542211 1112233444443 4556899999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||
T Consensus 70 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 70 DYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecc
Confidence 999999999999999999965 245889999999999999999999988 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccC
Q 037084 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480 (532)
Q Consensus 401 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~ 480 (532)
+++..... ....++..|+|||.+.+..++.++||||||+++|+|++|..||..... .. ....... .
T Consensus 143 ~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~---~~~~~~~-~ 208 (260)
T cd05611 143 LSRNGLEN------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DA---VFDNILS-R 208 (260)
T ss_pred cceecccc------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HH---HHHHHHh-c
Confidence 98764432 345688899999999888899999999999999999999999975322 11 1111111 1
Q ss_pred CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 481 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
... .. ..........+.+++..||+.+|++||++.++.+.|
T Consensus 209 ~~~--~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 209 RIN--WP----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccC--CC----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 100 00 001112345688999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.45 Aligned_cols=254 Identities=21% Similarity=0.376 Sum_probs=202.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++++.+..||.|+.|.|++++++.+ |..+|||.+...... ...+++...+.++... ..|.||+.
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~-~~iiAVK~M~rt~Nk-------------ee~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRST-GHIIAVKQMRRTGNK-------------EENKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEccc-ceEEEEEeecccCCH-------------HHHHHHHHhhhHHhhccCCCeeeee
Confidence 34567788899999999999999875 899999999877543 2345666677776665 48999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+|||..+...++.||.| ...++.++.. ...++++...-++...+.+||.||..++ +|+|||+||+|||+|+.|+
T Consensus 157 ~GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gn 230 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGN 230 (391)
T ss_pred eeEEeeCchHHHHHHHH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCC
Confidence 99999999999999999 5567777764 3556999999999999999999998764 4999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+|+||||++..+.+...+ +...|.+.|||||.+.-. .|+.++||||||++++||.||+.||..... + .
T Consensus 231 iKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-----d-F 301 (391)
T KOG0983|consen 231 IKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-----D-F 301 (391)
T ss_pred EEeecccccceeeccccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-----c-H
Confidence 999999999887776554 567899999999988644 688999999999999999999999986322 1 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.+...++++.+ .++.. ......+.+++..|++.|+.+||...++++
T Consensus 302 e~ltkvln~ePP--~L~~~------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 302 EVLTKVLNEEPP--LLPGH------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHhcCCC--CCCcc------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 223333333221 11211 113445788888999999999999999875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=294.02 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=197.5
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|.....||+|+||.||++....+ |..||+|.+.... ......+.+|+.++++++|+|++++++++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 86 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSS-GKLVAVKKMDLRK--------------QQRRELLFNEVVIMRDYQHENVVEMYNSY 86 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCC-CeEEEEEEecccc--------------hhHHHHHHHHHHHHHhcCCcchhheeeEE
Confidence 44456899999999999988754 8999999986542 22345688899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..++||||+++++|.+++.. ..+++.....++.|++.+++|||+.+ ++|+||+|+||++++++.++|+
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~ 158 (292)
T cd06657 87 LVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLS 158 (292)
T ss_pred EeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEc
Confidence 999999999999999999998753 34789999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||++......... .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||..... ......+....
T Consensus 159 dfg~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~~ 232 (292)
T cd06657 159 DFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNL 232 (292)
T ss_pred ccccceeccccccc--ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhC
Confidence 99998765443211 1345688999999999888899999999999999999999999975322 11111111111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. .. +. ........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~----~~-----~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 233 P----PK-----LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred C----cc-----cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0 00 00 01112344778899999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.22 Aligned_cols=208 Identities=25% Similarity=0.338 Sum_probs=174.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCC---cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYG---KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
..|+.+..||+|+||.||+|.-.++++ ..+|+|.++..... ........+|+.+++.++|||++.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------------tGiS~SAcREiaL~REl~h~nvi~ 91 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------------TGISMSACREIALLRELKHPNVIS 91 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------------CCcCHHHHHHHHHHHHhcCCcchh
Confidence 468889999999999999996555443 26999999876321 111245678999999999999999
Q ss_pred ceeEEec-CCceEEEEEeccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQ-GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
|..++.+ +...++++||.+. +|...++..+. ..+.++......|+.||+.|+.|||+.+ |+||||||.|||+..
T Consensus 92 Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 92 LVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMG 167 (438)
T ss_pred HHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEec
Confidence 9999887 7788999999966 88888875442 3467899999999999999999999999 999999999999987
Q ss_pred C----CcEEEeccCCcccCCCCCcce-eeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 391 G----MEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 391 ~----~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+ |.+||+|||+++.+...-.+. +....+.|.+|+|||.+.+. .||.+.|||+.||++.||+|-.+-|..
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 7 899999999999987654332 44567889999999988776 589999999999999999999888764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=286.36 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=203.6
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|++|.||++..... +..|++|.+...... ......+.+|++++++++|||++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLET-GDFVAIKQISLEKIK------------EEALKSIMQEIDLLKNLKHPNIVKYIGS 67 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCC-CcEEEEEEecccccC------------HHHHHHHHHHHHHHHhCCCCCccEEEEE
Confidence 367788999999999999987754 889999999876432 2345678999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++++||+++++|.+++.. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|
T Consensus 68 ~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l 140 (254)
T cd06627 68 IETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKL 140 (254)
T ss_pred EEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999865 256899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....++..|+|||...+..++.++|+||+|+++|+|++|+.||...... ... ...
T Consensus 141 ~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~-~~~ 211 (254)
T cd06627 141 ADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AAL-FRI 211 (254)
T ss_pred eccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHH-HHH
Confidence 999999877554321 13456889999999988888899999999999999999999999753221 111 111
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+ .........+.+++..|++.+|++|||+.+++.
T Consensus 212 ~~~~~~----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQDDHP----------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hccCCC----------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111110 011122355788999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.47 Aligned_cols=265 Identities=25% Similarity=0.338 Sum_probs=198.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|....+ |..||+|++...... ......+.+|+.++++++||||+++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~valK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~ 70 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRS-GKKVAIKKIPHAFDV------------PTLAKRTLRELKILRHFKHDNIIAIR 70 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCC-CCEEEEEEecccccc------------ccchHHHHHHHHHHHhcCCCCccCHH
Confidence 46788899999999999999988764 899999998754211 12245677899999999999999999
Q ss_pred eEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 315 AHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++.. ....++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||++++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~ 142 (334)
T cd07855 71 DILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNE 142 (334)
T ss_pred HhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcC
Confidence 98763 346799999995 689998864 345899999999999999999999988 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcc--eeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 391 GMEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.+||+|||++......... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......
T Consensus 143 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--- 219 (334)
T cd07855 143 DCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--- 219 (334)
T ss_pred CCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---
Confidence 999999999998765433211 11134578899999998765 458899999999999999999999997543211
Q ss_pred cHHHHHHHHhccCCCccccc---------------cc---ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAID---------------SK---LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d---------------~~---l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+...... .+...++ .. ......+.....+.+++..||+.+|++|||+.+++.
T Consensus 220 -~~~~~~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 220 -QLKLILSVLGS-PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred -HHHHHHHHhCC-ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01111111000 0000000 00 000011223567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=290.46 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=199.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||++.+... +..+++|.++........ ......+..|+.++++++|||+++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA-VAEERLKVLKEIPVGELN---------PNETVQANQEAQLLSKLDHPAIVKFHAS 70 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC-CCcceEEEeccccccccC---------cchHHHHHHHHHHHHhCCCCcHHHHHHH
Confidence 367788999999999999988754 556666666543211100 1123456678999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+.+.+..++|+||+++++|.+++.........+++..++.++.|++.|+.|||+.+ ++|+||+|+||++++ +.++|
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 71 FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred HhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEee
Confidence 99999999999999999999999765455567999999999999999999999988 999999999999975 56999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....|++.|+|||...+..++.++|+||||+++|+|++|..||..... .......
T Consensus 147 ~d~g~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~~~ 217 (260)
T cd08222 147 GDFGVSRLLMGSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVLRI 217 (260)
T ss_pred cccCceeecCCCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH
Confidence 999998776443221 1345678899999999888899999999999999999999999964221 1112222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+ .........+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 218 VEGPTP----------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HcCCCC----------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111 112234456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.54 Aligned_cols=266 Identities=25% Similarity=0.351 Sum_probs=198.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|.++..... ......+.+|+.++++++|||+++++
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~iK~~~~~~~~------------~~~~~~~~~e~~~~~~l~h~~i~~~~ 72 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEK------------EGFPITAIREIKILRQLNHRNIVNLK 72 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCC-CcEEEEEEEeecccc------------cCchHHHHHHHHHHHhCCCCCeeeee
Confidence 45788899999999999999998754 899999999764321 11224567899999999999999999
Q ss_pred eEEecCC----------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 037084 315 AHVTRPD----------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 315 ~~~~~~~----------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~ 384 (532)
+++.+.. ..++|+||+++ +|.+.+.. ....+++..+..++.|++.||+|||+.+ ++|+||||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~ 145 (302)
T cd07864 73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCS 145 (302)
T ss_pred heecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 9987654 78999999975 77777754 2346899999999999999999999988 999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
||++++++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||......
T Consensus 146 nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 146 NILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999999876544321 1123456788999998764 35789999999999999999999999753321
Q ss_pred hhhccHHHHHHHHhccCCCc---cc--------cccc-----ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 464 TEEMNMVRWMRNVISSENPH---RA--------IDSK-----LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~---~~--------~d~~-----l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ..-+........+. .. .+.. .........+..+.+++..||+.+|++|||+++++.
T Consensus 225 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 AQ----LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HH----HHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11111111111100 00 0000 000011123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.50 Aligned_cols=255 Identities=22% Similarity=0.397 Sum_probs=196.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
.-++|.+.+.||+|+||.||+|.++.+ |..||||.++..... .....+..|+.++.+. .||||++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~avK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~~i~~ 78 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKT-GHVMAVKQMRRTGNK-------------EENKRILMDLDVVLKSHDCPYIVK 78 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCC-CeEEEEEEEeccCCh-------------HHHHHHHHHHHHHHhccCCCchHh
Confidence 446789999999999999999998754 899999999754321 1224455677666666 5999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++|......+++|||+ +++|.+++... ...+++..+..++.+++.||+|||+ .+ ++||||+|+||+++++
T Consensus 79 ~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~ 151 (296)
T cd06618 79 CYGYFITDSDVFICMELM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDAS 151 (296)
T ss_pred hheeeecCCeEEEEeecc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCC
Confidence 999999999999999998 45788877642 3478999999999999999999997 46 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++|+|||++......... ....++..|+|||++.+.. ++.++|+||||+++|+|++|+.||......
T Consensus 152 ~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---- 224 (296)
T cd06618 152 GNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---- 224 (296)
T ss_pred CCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----
Confidence 99999999998766443221 3345788999999987654 788999999999999999999999642211
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.+..........+. . . ........+.+++.+||+.+|.+||++.++++.
T Consensus 225 --~~~~~~~~~~~~~~-~-~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 225 --FEVLTKILQEEPPS-L-P------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --HHHHHHHhcCCCCC-C-C------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111222211110 0 0 001233558899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.23 Aligned_cols=250 Identities=27% Similarity=0.358 Sum_probs=197.6
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||.||++.+..+ |+.+++|.+....... ......+.+|+.++.+++||||+++++.+..++..
T Consensus 1 lg~g~~~~vy~~~~~~~-~~~~~~k~~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 68 (265)
T cd05579 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIR-----------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNL 68 (265)
T ss_pred CCCCCceEEEEEEECCC-CCEEEEEEecchhhhh-----------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEE
Confidence 68999999999998754 8999999987653211 23456788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
++++||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.
T Consensus 69 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 69 YLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9999999999999999752 36899999999999999999999988 9999999999999999999999999988
Q ss_pred cCCCCCc------ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 404 LMPDGHT------RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 404 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
....... ........++..|+|||...+...+.++|+||||+++|++++|..||..... ........
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~ 214 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNIL 214 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHh
Confidence 6543321 0112345678899999999888899999999999999999999999975332 11111111
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
.. .... .........+.+++..||+.+|++|||+..+.+.|+
T Consensus 215 ~~-~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 NG-KIEW--------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cC-CcCC--------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11 1100 000012456889999999999999999966555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=293.68 Aligned_cols=265 Identities=26% Similarity=0.300 Sum_probs=200.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|++|.||+|.... +|+.+++|.+...... ......+.+|+.++++++||||+++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 67 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFES------------EGIPKTALREIKLLKELNHPNIIKLLDVF 67 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-CCcEEEEEEecccccc------------chhHHHHHHHHHHHHHhcCCCcchHHHhh
Confidence 4566889999999999998765 4899999998765322 12245778899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
..++..++|+||+++ +|.+++.. ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 68 ~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~ 140 (283)
T cd05118 68 RHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLA 140 (283)
T ss_pred ccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEe
Confidence 999999999999965 88888865 2257899999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH-
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN- 475 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~- 475 (532)
|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...........+...+..
T Consensus 141 df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~ 218 (283)
T cd05118 141 DFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP 218 (283)
T ss_pred eeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999887655431 11345678899999988776 7899999999999999999999999754321111111100000
Q ss_pred -------Hhc---cC--CCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 -------VIS---SE--NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 -------~~~---~~--~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .. ......+.. .....+.....+.+++..||+++|.+||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 219 DPEVWPKFTSLARNYKFSFPKKAGMP-LPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chHhcccchhhhhhhhhhhccccccC-HHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00 000000000 00112335667999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=292.30 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=201.0
Q ss_pred CccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
+|.+.+.||+|+||.||++.... .+++.||||.+....... .......+.+|+.++.++ +||||+++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~----------~~~~~~~~~~E~~~l~~~~~~~~i~~~ 70 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ----------KAKTAEHTRTERQVLEAVRRCPFLVTL 70 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh----------hhhHHHHHHHHHHHHHhccCCcchhhh
Confidence 36778899999999999998642 247899999987542111 023346788999999999 69999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.+.+..+...++||||+++|+|.+++.. ...+++.....++.|++++|.|||+.+ ++|+||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 71 HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGH 143 (288)
T ss_pred heeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCC
Confidence 9999999999999999999999999864 345889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
++|+|||+++.......... ....|+..|+|||...+.. .+.++|+||||+++|+|++|..||....... ....
T Consensus 144 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~ 219 (288)
T cd05583 144 VVLTDFGLSKEFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSE 219 (288)
T ss_pred EEEEECcccccccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHH
Confidence 99999999887654322211 2346889999999987665 7889999999999999999999996422111 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
........... ........+.+++..||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 220 ISRRILKSKPP-----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHHHHHccCCC-----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 12222211110 11112345788999999999999999988877765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.68 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=205.5
Q ss_pred cccCcccc-ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 234 KEDSLASL-EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~-~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
-+++|.+. ++||-|-.|.|-.+.++.+ |+.+|+|++.... ...+|+++--+. .|||||
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T-~ekfALKvL~Ds~-------------------KARrEVeLHw~~s~h~~iV 118 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRT-QEKFALKVLLDSP-------------------KARREVELHWMASGHPHIV 118 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccc-hhhhHHHHHhcCH-------------------HHHhHhhhhhhhcCCCceE
Confidence 45677554 6799999999999988875 9999999998762 234566654333 699999
Q ss_pred cceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 312 PLQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 312 ~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
.+++++.+ ..++++|||+|+||.|.+.+.. .+...+++..+..|+.||+.|+.|||+.+ |.||||||+|+|
T Consensus 119 ~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLL 193 (400)
T KOG0604|consen 119 SIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLL 193 (400)
T ss_pred EeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhhee
Confidence 99998864 4677899999999999999987 55677999999999999999999999999 999999999999
Q ss_pred ec---CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 037084 388 ID---DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464 (532)
Q Consensus 388 l~---~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 464 (532)
.. .|..+||+|||+|+...... ...+.+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||-....
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-- 268 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-- 268 (400)
T ss_pred eecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--
Confidence 96 45579999999999765432 23678899999999999999999999999999999999999999976433
Q ss_pred hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+...++.-+..+... +........++...+++..+|..+|++|.|+.+++.
T Consensus 269 --~aispgMk~rI~~gqy~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 269 --LAISPGMKRRIRTGQYE------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --ccCChhHHhHhhccCcc------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 33333444443333321 112335667788999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.23 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=197.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.+|+|++...... ......+.+|+.+++++ +||||+++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~h~ni~~~ 72 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRT-KEVVALKKIFDAFRN------------ATDAQRTFREIMFLQELGDHPNIVKL 72 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCC-CeEEEEEeeccccCc------------chhhhhhhHHHHHHHHhcCCCCccce
Confidence 45788899999999999999988754 889999988643211 12234567899999999 99999999
Q ss_pred eeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 314 QAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 314 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++|... ...++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~ 143 (337)
T cd07852 73 LNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSD 143 (337)
T ss_pred eeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 9998654 35799999996 599988864 26889999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcc---eeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 392 MEARISDFGLAKLMPDGHTR---IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++|+|||++......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........
T Consensus 144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999876443221 11234568999999998754 457889999999999999999999997543211111
Q ss_pred cHHHHHH-------HHhccCCCccccc------ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 468 NMVRWMR-------NVISSENPHRAID------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 468 ~l~~~~~-------~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
.+..... ...........++ ........+.....+.+++..||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1111000 0000000000000 000001111234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=288.20 Aligned_cols=242 Identities=24% Similarity=0.295 Sum_probs=187.7
Q ss_pred Ccccccee--cccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc-CCCCCcccc
Q 037084 237 SLASLEII--GVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR-IWHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~L--G~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l 313 (532)
.|.+.+.+ |+|+||.||++....+ +..+|+|.+....... . |+..... .+|||++++
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~k~~~~~~~~~-----------------~--e~~~~~~~~~h~~iv~~ 74 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPT-QKLFVQKIIKAKNFNA-----------------I--EPMVHQLMKDNPNFIKL 74 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCC-CcEEEEEEEehhhcch-----------------h--hHHHHHHhhcCCCEEEE
Confidence 44555555 9999999999987764 8899999987542111 0 1111111 269999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM- 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~- 392 (532)
++++..++..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 147 (267)
T PHA03390 75 YYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKD 147 (267)
T ss_pred EEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCC
Confidence 9999999999999999999999999975 237899999999999999999999988 99999999999999988
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.++|+|||++...... ....++..|+|||++.+..++.++|+||+|+++|+|++|+.||..... .......+
T Consensus 148 ~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~ 219 (267)
T PHA03390 148 RIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESL 219 (267)
T ss_pred eEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHH
Confidence 9999999998765433 234688999999999998999999999999999999999999974332 11222222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-SKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~ 525 (532)
.... . ... .........+.+++..||+.+|.+||+ ++++++
T Consensus 220 ~~~~-~-~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 220 LKRQ-Q-KKL----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHhh-c-ccC----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 2222 1 100 011123455888999999999999996 588874
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=303.59 Aligned_cols=268 Identities=22% Similarity=0.317 Sum_probs=198.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||+||+|....+ |..||||.+...... ......+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni~~~~ 70 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSET-NEKVAIKKIANAFDN------------RIDAKRTLREIKLLRHLDHENVIAIK 70 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCC-CCeEEEEEecccccc------------cchhHHHHHHHHHHHhcCCCCccchH
Confidence 34688899999999999999988754 899999998754211 12234567899999999999999999
Q ss_pred eEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 315 AHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 315 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++... ...++|+||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~ 142 (337)
T cd07858 71 DIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLN 142 (337)
T ss_pred HheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEc
Confidence 988654 34799999994 789888864 346899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||++......... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........
T Consensus 143 ~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 220 (337)
T cd07858 143 ANCDLKICDFGLARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220 (337)
T ss_pred CCCCEEECcCccccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence 9999999999999876543211 134567889999998765 4688999999999999999999999975322111110
Q ss_pred HHHHHHH-------HhccCCC-------cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 469 MVRWMRN-------VISSENP-------HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 469 l~~~~~~-------~~~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
+...... ....... ....+... ....+.....+.+++.+||+.+|++|||++++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 1100000 0000000 00000000 00112344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=291.27 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=197.4
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAH 316 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~ 316 (532)
|.+.+.||+|+||+||+|....+ ++.|+||.+....... ......+|+..+++++ |||+++++++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~-~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~h~~i~~~~~~ 66 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKET-GELVAIKKMKKKFYSW-------------EECMNLREVKSLRKLNEHPNIVKLKEV 66 (283)
T ss_pred CeeheeeccCCceEEEEEEECCC-CcEEEEEEehhhccch-------------hHHHHHHHHHHHHhccCCCCchhHHHH
Confidence 45678999999999999998754 8899999987542211 1123456888999998 9999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+..++..++||||+ +|+|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|
T Consensus 67 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l 140 (283)
T cd07830 67 FRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKI 140 (283)
T ss_pred hhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEE
Confidence 99999999999999 88999998752 2356899999999999999999999988 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH----
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR---- 471 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~---- 471 (532)
+|||++......... ....++..|+|||++. +..++.++|+||||+++++|++|+.||..............
T Consensus 141 ~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 217 (283)
T cd07830 141 ADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217 (283)
T ss_pred eecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCC
Confidence 999999866443221 3456788999999774 44578999999999999999999999965433211111111
Q ss_pred -----HHHHHhccCCCccccccc---ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 -----WMRNVISSENPHRAIDSK---LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 -----~~~~~~~~~~~~~~~d~~---l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
|.............+... ......+.....+.+++..||+.+|++|||+++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 111110000000000000 000111112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.26 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=202.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~ 314 (532)
++|.+.+.||+|+||.||+|....+ |..||+|++....... ......+..|..++.+++ ||||++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~~i~~~~ 68 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKET-NKEYAIKILDKRQLIK-----------EKKVKYVKIEKEVLTRLNGHPGIIKLY 68 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCC-CCEEEEEEechHhccc-----------hHHHHHHHHHHHHHHhcccCCCchhHH
Confidence 3688889999999999999988764 8999999987642211 223467888999999998 99999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 69 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 69 YTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHI 141 (280)
T ss_pred HHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCE
Confidence 999999999999999999999999975 236999999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcc------------------eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 037084 395 RISDFGLAKLMPDGHTR------------------IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 456 (532)
+++|||++......... .......++..|+|||...+..++.++|+||||++++++++|+.|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 99999998876543211 111345678899999999888899999999999999999999999
Q ss_pred CCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Q 037084 457 FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS----KDVRC 525 (532)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~ 525 (532)
|..... .... ........ .........+.+++..||+.+|.+|||+ +++++
T Consensus 222 ~~~~~~----~~~~---~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 222 FRGSNE----YLTF---QKILKLEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccH----HHHH---HHHHhcCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 975432 1111 11111100 1111224558899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.97 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=198.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|...+.||+|+||.||+|..... +..+|+|.+....... .....++.+|+.+++.++|+|++++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~ik~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~ 80 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQY 80 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCC-CcEEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCcccE
Confidence 345688889999999999999998754 8899999986532111 2234567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.+++......++|+||+. |+|.+.+.. ...++++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~ 153 (308)
T cd06634 81 RGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153 (308)
T ss_pred EEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCc
Confidence 999999999999999996 688887753 2345889999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++|+|||++...... ....++..|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 154 ~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------- 220 (308)
T cd06634 154 VKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------- 220 (308)
T ss_pred EEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------
Confidence 999999998765332 3456788999999874 356788999999999999999999998653221
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
...........+. . ........+.+++.+||+.+|.+||++.+++..
T Consensus 221 ~~~~~~~~~~~~~------~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 221 SALYHIAQNESPA------L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HHHHHHhhcCCCC------c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1111111111110 0 111234558889999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.27 Aligned_cols=271 Identities=23% Similarity=0.242 Sum_probs=195.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ ++.+|+|.+....... .....+.+|++++++++||||++++
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKT-GRVVALKKILMHNEKD------------GFPITALREIKILKKLKHPNVVPLI 73 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCC-CcEEEEEEEEeccCCC------------CcchhHHHHHHHHHhcCCCCccchh
Confidence 46799999999999999999988754 8899999986543211 1123456899999999999999999
Q ss_pred eEEecCC--------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 315 AHVTRPD--------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 315 ~~~~~~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++.... ..++|+||+. ++|.+.+.. ....+++..+..++.|+++||.|||+.+ ++|+||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~ni 146 (311)
T cd07866 74 DMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANI 146 (311)
T ss_pred hheecccccccccCceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 9875443 4599999995 477777754 2456999999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcc---------eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTR---------IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p 456 (532)
++++++.++|+|||+++........ ...+...+++.|+|||.+.+. .++.++|||||||++|+|++|++|
T Consensus 147 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~ 226 (311)
T cd07866 147 LIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226 (311)
T ss_pred EECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCC
Confidence 9999999999999999865433211 111334678889999987654 578999999999999999999999
Q ss_pred CCCcccchhhccHHHHHHHHhcc-----CCCcccc----cccccC---CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 457 FDDFFQYTEEMNMVRWMRNVISS-----ENPHRAI----DSKLLG---NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~----d~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
|...........+.......... ....... ...... .........+.+++..|++.+|.+|||+.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 97543321111111100000000 0000000 000000 00112225688999999999999999999987
Q ss_pred H
Q 037084 525 C 525 (532)
Q Consensus 525 ~ 525 (532)
.
T Consensus 307 ~ 307 (311)
T cd07866 307 E 307 (311)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.95 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=195.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|...+.||+|+||+||+|....+ |..|++|.+....... ......+.+|+.++++++|||++++++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~v~ik~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 88 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHT-NEVVAVKKMSYSGKQT-----------NEKWQDIIKEVKFLQQLKHPNTIEYKG 88 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCC-CcEEEEEEEeccccCc-----------hHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 3466677899999999999987654 8999999987543211 223456788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+....++||||++ |+|.+++.. ...++++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~k 161 (313)
T cd06633 89 CYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVK 161 (313)
T ss_pred EEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEE
Confidence 9999999999999995 688887764 2356899999999999999999999988 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
|+|||++...... ....|+..|+|||++. ...++.++|||||||++|+|++|..||..... ...
T Consensus 162 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~ 228 (313)
T cd06633 162 LADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA 228 (313)
T ss_pred EeecCCCcccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHH
Confidence 9999998643221 3456889999999874 45688999999999999999999999865322 111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.........+. .. .......+.+++..||+.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~-~~--------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 229 LYHIAQNDSPT-LQ--------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHhcCCCC-CC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111 00 1112245788999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.22 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++++-+..||.|+||+|+|..++.+ |+..|||+++.... +....++..|.+...+- +.||||++
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~s-g~~mAVKrIr~~n~-------------~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPS-GKLMAVKRIRSNNI-------------EKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCcc-CcEEEEEEeeeccc-------------hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 34577788999999999999998876 99999999987653 23345677777765554 78999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDV-SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+|.+..++..++.||.| ..||+.+.... .-....+++...-+|......||.||.... .|||||+||+|||++..|
T Consensus 129 yGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G 205 (361)
T KOG1006|consen 129 YGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHG 205 (361)
T ss_pred hhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCC
Confidence 99999999999999999 67888776542 234567899999999999999999998743 399999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+|+||||++....++-.. +.-.|...|||||.+... .|+.+|||||||++|||+.||+.||..+. ++.
T Consensus 206 ~vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svf 276 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVF 276 (361)
T ss_pred CEeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHH
Confidence 9999999999877654332 566789999999987654 48899999999999999999999997543 355
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.+.....+..+.-..+.. .-+....+.+++-.|+.+|.+.||+..++.+
T Consensus 277 eql~~Vv~gdpp~l~~~~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 EQLCQVVIGDPPILLFDKE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHcCCCCeecCccc-----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 6666666655544333322 2334456888888999999999999998865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.39 Aligned_cols=281 Identities=23% Similarity=0.244 Sum_probs=198.1
Q ss_pred cCcc-ccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 236 DSLA-SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~-~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
++|. +.+.||+|+||+||+|.+... |+.||||.+................-.......+.+|+.++++++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLT-GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCC-CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 3454 447799999999999987754 89999999876532210000000000001123577899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||++ |+|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999996 699998864 345889999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCC------------cceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 395 RISDFGLAKLMPDGH------------TRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 395 kl~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
+|+|||++....... .........++..|+|||++.+. .++.++|+|||||++|+|++|+.||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998765111 01111234568899999988764 46899999999999999999999997643
Q ss_pred cchhhccHHHHHHHHhccCCCcc-------cccc---cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHR-------AIDS---KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~-------~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+............+.. .... .............+.+++..|++.+|++|||+++++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 32111111111100000000000 0000 0000011123456889999999999999999999985
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=286.78 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=187.4
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHH---HHHHhcCCCCCcccceeEEec
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE---IITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~H~niv~l~~~~~~ 319 (532)
.||+|+||.||+|....+ |+.||+|.+........ .....+..| ...++...||||+.+.+++..
T Consensus 1 ~ig~g~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 68 (278)
T cd05606 1 IIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 68 (278)
T ss_pred CcccCCCeEEEEEEEecC-CCEEEEEEeeccccccc-----------hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence 489999999999987754 89999999876432210 001112222 334555689999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.++|+||
T Consensus 69 ~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~df 141 (278)
T cd05606 69 PDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (278)
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccC
Confidence 9999999999999999998864 346999999999999999999999988 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 478 (532)
|++........ ....|+..|+|||++.++ .++.++|+||+|+++|+|++|+.||....... .... .....
T Consensus 142 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~----~~~~-~~~~~ 212 (278)
T cd05606 142 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEI-DRMTL 212 (278)
T ss_pred cCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc----hHHH-HHHhh
Confidence 99876543321 345789999999998754 68999999999999999999999997542211 1111 11111
Q ss_pred cCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 479 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
... ..+ .......+.+++..|+..+|.+|| ++.++++
T Consensus 213 ~~~------~~~----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMA------VEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccC------CCC----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 100 011 111245688899999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=294.61 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=197.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
.+++|...+.||.|+||.||+|....+ |..||+|++...... ......+..|+.++.+++||||+++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~ 74 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFST------------PVLAKRTYRELKLLKHLRHENIISL 74 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCC-CCEEEEEEecccccc------------cchhHHHHHHHHHHHhcCCCCeeeE
Confidence 466799999999999999999987754 899999988653211 1223567789999999999999999
Q ss_pred eeEEec-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
.+++.. .+..++++||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ ++|+||+|+||++++++
T Consensus 75 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 75 SDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENC 145 (328)
T ss_pred eeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCC
Confidence 999865 45789999999 6789888853 34788888899999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.+
T Consensus 146 ~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 146 DLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred CEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999987543321 34467889999998765 5689999999999999999999999975433111111111
Q ss_pred --------HHHHHhccCCCcccccccccCC-----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 472 --------WMRNVISSENPHRAIDSKLLGN-----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 472 --------~~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
+..................... ..+.....+.+++..|++.+|++|||+.+++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111100000000000000000 011234568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=288.09 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=197.1
Q ss_pred CccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
+|++.+.||+|+||.||+|.... .+|..||+|++........ ....+.+.+|+.++.++ +|+||+.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~~i~~~ 70 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVTL 70 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----------chHHHHHHHHHHHHHhcccCCChhce
Confidence 36778899999999999998642 2488999999875421110 22346678899999999 68999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++..+...++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 71 HYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGH 143 (290)
T ss_pred eeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCC
Confidence 9999999999999999999999999975 345888999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
++|+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... ......
T Consensus 144 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~ 219 (290)
T cd05613 144 VVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE---KNSQAE 219 (290)
T ss_pred EEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc---cccHHH
Confidence 999999999876443221 11345688999999988753 467899999999999999999999964221 111222
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
..........+ ........+.+++..|++.+|++|| +..+++.
T Consensus 220 ~~~~~~~~~~~-----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 220 ISRRILKSEPP-----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHhhccCCC-----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 22222221111 1111234578899999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=299.69 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=202.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|....+ |..||+|.+...... ......+.+|+.+++.++||||+++.++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 67 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRT-GRKVAIKKISNVFDD------------LIDAKRILREIKLLRHLRHENIIGLLDI 67 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCC-CcEEEEEeecccccc------------chhhhhHHHHHHHHHhcCCcchhhhhhh
Confidence 377889999999999999988754 899999998764211 1224678889999999999999999999
Q ss_pred EecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 317 VTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 317 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+...+ ..|++|||++ ++|.+++.. ...+++..++.++.+++.||+|||+.+ ++|+||||+||+++.+
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~ 139 (330)
T cd07834 68 LRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSN 139 (330)
T ss_pred hcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 98775 7899999996 589888864 337999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+.++|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.........
T Consensus 140 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~--- 216 (330)
T cd07834 140 CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL--- 216 (330)
T ss_pred CCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---
Confidence 99999999999876554310 111345678899999999887 7899999999999999999999999764331111
Q ss_pred HHHHHHHhccCCC-----------ccccc------ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 470 VRWMRNVISSENP-----------HRAID------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 470 ~~~~~~~~~~~~~-----------~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
..+......... ...+. +.-.....+.....+.+++..||+.+|.+|||+++++..
T Consensus 217 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 217 -NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred -HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111100000 00000 000000112245668899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=283.39 Aligned_cols=246 Identities=23% Similarity=0.281 Sum_probs=200.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|..+++||+|.||.|-+++-+.+ |+.+|+|+++....-+ ......-..|-++|...+||.+..|.
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat-~k~YAiKIlkKeviia-----------kdEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKAT-GKLYAIKILKKEVIIA-----------KDEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeeccc-Cceeehhhhhhhheee-----------hHHhhhhhhHHHHHHhccCcHHHHhh
Confidence 36799999999999999999988765 9999999998764322 23345567789999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
-.|+..+++|+||||+.||.|.-+|.+ ...+++....-+...|..||.|||+.+ ||.||||.+|.|||.+|++
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCce
Confidence 999999999999999999999988864 456788877888999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++.--.... ...+.+|||.|+|||++....|+..+|.|.+||++|||+||+.||..... ..+.+.+.
T Consensus 308 KitDFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----~kLFeLIl 381 (516)
T KOG0690|consen 308 KITDFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----EKLFELIL 381 (516)
T ss_pred Eeeecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----hHHHHHHH
Confidence 9999999986433222 33688999999999999999999999999999999999999999975332 23333221
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
. ..-+ ++.....+...|+...+..||.+|..
T Consensus 382 ~--ed~k------------FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 382 M--EDLK------------FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred h--hhcc------------CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 1 0001 12222334667777889999999963
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.35 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=212.5
Q ss_pred ccccccCccccceecccCCeEEEEEEeeCCC------CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc
Q 037084 231 FLTKEDSLASLEIIGVGACGVVYKAEVPGSY------GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR 304 (532)
Q Consensus 231 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 304 (532)
+....+++.+.+.||+|.||.|++|...+.. ...||||.++.... ....+.+..|+.++..
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-------------~~~~~~~~~El~~m~~ 357 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-------------SSEKKDLMSELNVLKE 357 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-------------cHHHHHHHHHHHHHHH
Confidence 3445566677789999999999999865322 34799999987653 2345789999999999
Q ss_pred C-CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhc---CC--C-------CCCCHHHHHHHHHHHHHHHHHHHhc
Q 037084 305 I-WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS---QG--R-------RELDWLARYRIARGMASGLEYLHMY 371 (532)
Q Consensus 305 l-~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~--~-------~~l~~~~~~~i~~~ia~gl~~LH~~ 371 (532)
+ +|||++.++|+|.+.+..++|.||+..|+|.++++..+ .- . ..++....+.++.|||.|++||++.
T Consensus 358 ~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 358 LGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred hcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 9 79999999999999999999999999999999998754 00 0 2488999999999999999999998
Q ss_pred CCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccc--cccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA--GTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 372 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
. +|||||..+|||+.++..+||+|||+|+.......... .... -...|||||.+....|+.+|||||||+++||
T Consensus 438 ~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 438 P---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWE 513 (609)
T ss_pred C---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHH
Confidence 8 99999999999999999999999999997655443221 1122 3456999999999999999999999999999
Q ss_pred HHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 450 LVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 450 llt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
++| |..||..... ..++.++++.-.... .+..+..++.+++..||+.+|++||++.++++.|+
T Consensus 514 ifsLG~~PYp~~~~---~~~l~~~l~~G~r~~-------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPP---TEELLEFLKEGNRME-------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred HhhCCCCCCCCCCc---HHHHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 999 9999976221 222233333222111 12233556889999999999999999999999998
Q ss_pred h
Q 037084 529 Q 529 (532)
Q Consensus 529 ~ 529 (532)
.
T Consensus 578 ~ 578 (609)
T KOG0200|consen 578 K 578 (609)
T ss_pred H
Confidence 6
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.82 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=205.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
-++.....||.|.||.||-|....+ |.-.|+|.++..... ........+|..++..++|||+|+++|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~t-GellAvKEI~iq~~~------------~k~~~~i~eEm~vlE~lnHpNlV~YyG 1301 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDT-GELLAVKEIKIQDSD------------HKTFKLIAEEMKVLEGLNHPNLVRYYG 1301 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCc-cchhhhhhhhcCccc------------cccCcchHHHHHHHHhccCccccccCc
Confidence 3566677899999999999987764 999999999876433 234566788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
+-.+.+..+|.||||.+|+|.+.+.. +...++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|
T Consensus 1302 VEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK 1374 (1509)
T KOG4645|consen 1302 VEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIK 1374 (1509)
T ss_pred eeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEE
Confidence 99999999999999999999999965 445667777788999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCc--ceeeeccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 396 ISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 396 l~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++|||.|..+..... ........||+.|||||++.+.. ...+.||||+|||+.||+||+.||...+.
T Consensus 1375 ~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------- 1446 (1509)
T KOG4645|consen 1375 YGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------- 1446 (1509)
T ss_pred eecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------
Confidence 999999998765421 11235678999999999988754 45689999999999999999999986543
Q ss_pred HHHHHH-hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNV-ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+|.-.+ +..+..+ ..+......-.+++.+|+..||++|.++.++++
T Consensus 1447 e~aIMy~V~~gh~P---------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1447 EWAIMYHVAAGHKP---------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hhHHHhHHhccCCC---------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 222211 2222221 123335566788999999999999999988775
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=292.32 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=190.7
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
.+.+|.|+++.||++ .. +|+.||||+++..... ......+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~~~~v~~~~~--~~-~~~~~avK~~~~~~~~------------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 71 (314)
T cd08216 7 GKCFEDLMIVHLAKH--KP-TNTLVAVKKINLDSCS------------KEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71 (314)
T ss_pred hHhhcCCceEEEEEe--cC-CCCEEEEEEEeccccc------------hhHHHHHHHHHHHHHhcCCcchhhhhheeecC
Confidence 344555555555555 43 4899999999765221 23456789999999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..+++|||+++|+|.+++... ....+++.....++.|++.||.|||+.+ |+|+||||+||+++.++.++++|||
T Consensus 72 ~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~ 146 (314)
T cd08216 72 SELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLR 146 (314)
T ss_pred CeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCc
Confidence 9999999999999999999863 2345888999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCc-----ceeeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 401 LAKLMPDGHT-----RIRITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 401 la~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
.+........ ........++..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ...+-.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~ 223 (314)
T cd08216 147 YSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKV 223 (314)
T ss_pred cceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 8875532211 111134457788999998866 358899999999999999999999997543211 111110
Q ss_pred HHHh----cc-------CCCcc----cccccc----cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVI----SS-------ENPHR----AIDSKL----LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~----~~-------~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .. ..... ..++.. ...........+.+++..||+.||++|||++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 00 00000 000000 00112233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.20 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=204.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
...|.+...||+|.|+.|.+|++..+ |..||+|.+...... ......+.+|+.++..++|||||+++
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t-~~~VaiK~idkt~ln------------~~~~~k~~rev~imk~l~HPnIvkl~ 121 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILT-GTEVAIKIIDKTQLN------------PSKRQKLGREVDIMKSLNHPNIVKLF 121 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCC-CceEEEEEehhcccC------------hHHHHHHHHHHHHHHhcCCcceeeee
Confidence 45688999999999999999999876 999999999887543 22345588999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
.+......+|+||||+.+|.+++++.++. .........++.|+.++++|+|+++ |||||||++||||+.+.++
T Consensus 122 ~v~~t~~~lylV~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 122 SVIETEATLYLVMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNI 194 (596)
T ss_pred eeeeecceeEEEEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccce
Confidence 99999999999999999999999998632 2444777788999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++..+..... ..+.+|++.|.|||++.+..| ++.+|+||+|+++|-|++|..||++..- ...-
T Consensus 195 kIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~Lr 264 (596)
T KOG0586|consen 195 KIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KELR 264 (596)
T ss_pred eeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------cccc
Confidence 9999999998875433 267899999999999998876 5789999999999999999999986322 1100
Q ss_pred HHHhccCCCcccccccccCCC--cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNG--YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+ .+.+.+ +--...++.++++.++-.+|.+|++++++.+
T Consensus 265 ~r-------------vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 PR-------------VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ch-------------heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 00 011110 1112234778888899999999999998764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=289.66 Aligned_cols=266 Identities=25% Similarity=0.279 Sum_probs=200.2
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|+..+.||+|+||.||+|....+ ++.+|+|.+...... ......+..|+.++++++|||++++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~-~~~~~iK~~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 67 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKT-GEIVALKKIRLDNEE------------EGIPSTALREISLLKELKHPNIVKLLDVI 67 (282)
T ss_pred CeeehcccccCcceEEEeeecCC-CcEEEEEEecccccc------------ccccHHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 45567899999999999988764 899999999875311 22235677899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++|+||++ ++|.+++... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 68 ~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~ 140 (282)
T cd07829 68 HTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLA 140 (282)
T ss_pred hcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEe
Confidence 99999999999997 5999999752 246899999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH--
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR-- 474 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~-- 474 (532)
|||++......... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||...........+.....
T Consensus 141 d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (282)
T cd07829 141 DFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP 218 (282)
T ss_pred cCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence 99999876543221 1344567889999988776 789999999999999999999999976432111111111100
Q ss_pred -----HHhccCC-Ccccc---cccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 -----NVISSEN-PHRAI---DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 -----~~~~~~~-~~~~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....-. ....+ .........+.....+.+++..||+.+|++||++++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 00000 000000111122557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.57 Aligned_cols=263 Identities=25% Similarity=0.331 Sum_probs=196.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||+|....+ |..||||++...... ......+.+|+.++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRT-GAKVAIKKLYRPFQS------------ELFAKRAYRELRLLKHMKHENVIGL 79 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCC-CcEEEEEEecccccc------------hHHHHHHHHHHHHHHhcCCCCccce
Confidence 356799999999999999999987654 899999998653211 2234567889999999999999999
Q ss_pred eeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++.... ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nil 150 (343)
T cd07880 80 LDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLA 150 (343)
T ss_pred eeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 99987653 358999999 7899888753 35899999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+++++.++++|||++....... ....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||.........
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998654322 34567889999998876 45889999999999999999999999754321111
Q ss_pred ccHH--------HHHHHHhccCCCccc------ccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 467 MNMV--------RWMRNVISSENPHRA------IDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 467 ~~l~--------~~~~~~~~~~~~~~~------~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
..+. .+....... ..... +.+.......+.....+.+++.+|++.||++|||+.+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1110 011000000 00000 000000001112334588999999999999999999988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=294.56 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=195.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.... +|+.||+|++...... ......+.+|+.++++++||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~------------~~~~~~~~~Ei~~l~~l~h~~iv~~ 81 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQS------------IIHAKRTYRELRLLKHMKHENVIGL 81 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchh------------hHHHHHHHHHHHHHHHcCCCcccce
Confidence 56789999999999999999998765 4899999998764211 1223567789999999999999999
Q ss_pred eeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
.+++... ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl 152 (345)
T cd07877 82 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 152 (345)
T ss_pred eeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEE
Confidence 9988643 3467888887 8899888753 35899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+++++.++|+|||++....... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 153 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 153 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999988654321 34567899999998766 56889999999999999999999999653321111
Q ss_pred ccHHHHH-------HHHhccCCCcc---cccc---cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWM-------RNVISSENPHR---AIDS---KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~-------~~~~~~~~~~~---~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+.... ........... .+.. .............+.+++..|++.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 1111100 00000000000 0000 0000000012345789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=297.61 Aligned_cols=267 Identities=24% Similarity=0.318 Sum_probs=194.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|...+.||+|+||.||+|.+..+ |+.||+|.+...... ......+.+|+.++++++||||+++++
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRT-GEKVAIKKLSRPFQS------------EIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCC-CcEEEEEEecCcccc------------ccchhHHHHHHHHHHhcCCCCccchhh
Confidence 5688889999999999999987654 899999998754211 122356788999999999999999999
Q ss_pred EEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 316 HVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 316 ~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++.... ..++|+||+. .+|.++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~ 151 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151 (342)
T ss_pred eecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 987543 4589999995 47776652 35889999999999999999999988 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.++.++|+|||+++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........
T Consensus 152 ~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~ 226 (342)
T cd07879 152 EDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 226 (342)
T ss_pred CCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999987653322 34567889999998866 4688999999999999999999999975332111100
Q ss_pred HHHHH-------HHHhccCCCccccc--ccccC----CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhhh
Q 037084 469 MVRWM-------RNVISSENPHRAID--SKLLG----NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM--LSQI 530 (532)
Q Consensus 469 l~~~~-------~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l 530 (532)
+.... .............. +.... ...+.....+.+++..||+.||.+||++.+++.. ++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 00000000000000 00000 0011233457899999999999999999999843 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.32 Aligned_cols=269 Identities=23% Similarity=0.311 Sum_probs=201.8
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
+..-+.||+|+||.||+|+++.+ |+.||||.++.... ....+...+|+++|++++|||||++.++-
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnket-G~~vAvK~~~~~~~-------------~r~~e~~~~EieilkKLnh~NIVk~f~ie 80 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKET-GRLVAVKTFNKESS-------------LRPRERWCREIEILKKLNHPNIVKLFDIE 80 (732)
T ss_pred eeehhhhcCCccceeeeeccccc-ccchhHHhhhhhcc-------------cchHHHHHHHHHHHHHcCchhhhhhcccC
Confidence 45567899999999999988765 99999999987542 23356788999999999999999999887
Q ss_pred ecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-
Q 037084 318 TRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD- 390 (532)
Q Consensus 318 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~- 390 (532)
.+.. ...+|||||++|||...|..- .+...|++...+.+..++..||.|||+++ |+||||||.||++-.
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~G 156 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIG 156 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeec
Confidence 6543 558999999999999999863 34456999999999999999999999988 999999999999842
Q ss_pred -CC--cEEEeccCCcccCCCCCcceeeeccccccccccccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 391 -GM--EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 391 -~~--~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+| .-||+|||.|+...++.. .+..+||..|++||+.. ...|+..+|.|||||++|+..||..||.........
T Consensus 157 edgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~ 233 (732)
T KOG4250|consen 157 EDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN 233 (732)
T ss_pred CCCceEEeeecccccccCCCCCe---eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc
Confidence 23 479999999999888763 37889999999999988 478999999999999999999999999865442111
Q ss_pred ccHHHHHHHHhccCC--Cccccc----------ccc--cCCCcHHHHHHHHHHHHHcCCCCCCCCC--CHHHHHHHHhhh
Q 037084 467 MNMVRWMRNVISSEN--PHRAID----------SKL--LGNGYEEQMRLVLKIAYFCTSDDPEERP--SSKDVRCMLSQI 530 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~--~~~~~d----------~~l--~~~~~~~~~~~l~~l~~~cl~~~P~~RP--s~~evl~~L~~l 530 (532)
.+.++....... ...... ..+ .....+.....+-+.+-.++..+|++|. ...+....+..|
T Consensus 234 ---~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 234 ---KEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred ---chhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 111111111110 000000 011 1112334445566666677788888888 555555554443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=296.04 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=198.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||+|.+..+ +..||+|++...... ......+.+|+.++++++|||++++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~-~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 79 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKT-GRKVAIKKLSRPFQS------------AIHAKRTYRELRLLKHMDHENVIGL 79 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCC-CcEEEEEecccccch------------hhHHHHHHHHHHHHHhccCCCHHHH
Confidence 356799999999999999999988764 889999998754211 2223557789999999999999999
Q ss_pred eeEEecCCc------eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPDC------HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
.+++...+. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil 150 (343)
T cd07851 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIA 150 (343)
T ss_pred HHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeE
Confidence 988866554 89999999 7799998863 45899999999999999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+++++.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 151 l~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 151 VNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred ECCCCCEEEccccccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999998764431 34567889999998765 36789999999999999999999999754321111
Q ss_pred ccHHHH--------HHHHhccCCCccccc---ccccC---CCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRW--------MRNVISSENPHRAID---SKLLG---NGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~--------~~~~~~~~~~~~~~d---~~l~~---~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+.+. ..... .......+. ..... .........+.+++..|++.+|++|||+.++++
T Consensus 226 ~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 226 KRIMNLVGTPDEELLQKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhcCCCCHHHHhhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 111110 00000 000000000 00000 001122467889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=277.23 Aligned_cols=240 Identities=26% Similarity=0.330 Sum_probs=194.4
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|+||.||++.+.. +++.+|+|.+....... ......+..|+.++++++|||++++++.+..++..
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIK-----------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKL 68 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcc-----------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCee
Confidence 6999999999998875 48999999987653221 22456788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
+++|||+++++|.+++.. ...+++.....++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 69 YLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcce
Confidence 999999999999999975 236899999999999999999999988 9999999999999999999999999988
Q ss_pred cCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 404 LMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 404 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
....... ......++..|+|||...+...+.++|+||||+++|++++|..||..... .......... ..
T Consensus 142 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~-~~- 210 (250)
T cd05123 142 ELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKD-PL- 210 (250)
T ss_pred ecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcC-CC-
Confidence 7654321 11456788999999999888899999999999999999999999965322 1111222111 10
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
.........+.+++..||..+|++||++.+
T Consensus 211 ---------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 ---------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011111355788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=315.42 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=190.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|+.++.||+||||.||+++.+- +|..+|||++.... . ........+|+..|++|+|||+|+++.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~-s------------~~~~skI~rEVk~LArLnHpNVVRYys 544 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKA-S------------DKLYSKILREVKLLARLNHPNVVRYYS 544 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecc-cchhhhhhhccCch-H------------HHHHHHHHHHHHHHhhcCCcceeeeeh
Confidence 468899999999999999998775 59999999998874 2 344677889999999999999998765
Q ss_pred EEec----------------------------------------------------------------------------
Q 037084 316 HVTR---------------------------------------------------------------------------- 319 (532)
Q Consensus 316 ~~~~---------------------------------------------------------------------------- 319 (532)
...+
T Consensus 545 AWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~d 624 (1351)
T KOG1035|consen 545 AWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSD 624 (1351)
T ss_pred hhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccc
Confidence 1100
Q ss_pred ------------------------------------C-------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHH
Q 037084 320 ------------------------------------P-------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356 (532)
Q Consensus 320 ------------------------------------~-------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~ 356 (532)
+ ..+||=||||+..+|.+++..+.-.. .....++
T Consensus 625 edg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wr 701 (1351)
T KOG1035|consen 625 EDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWR 701 (1351)
T ss_pred ccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHH
Confidence 0 12477899999988888887522111 4567789
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCC----------------CCCcceeeeccccc
Q 037084 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP----------------DGHTRIRITTVAGT 420 (532)
Q Consensus 357 i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt 420 (532)
++.+|+.||+|+|+++ ||||||||.||+|++++.|||+|||+|+... .+......+..+||
T Consensus 702 LFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGT 778 (1351)
T KOG1035|consen 702 LFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGT 778 (1351)
T ss_pred HHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccce
Confidence 9999999999999999 9999999999999999999999999999721 01111123678999
Q ss_pred cccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHH
Q 037084 421 TGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEE 497 (532)
Q Consensus 421 ~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 497 (532)
.-|+|||++.+.. |+.|+|+||+|+|++||+. ||+...+ -..-+..+. .+..+.. + .+..+
T Consensus 779 alYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME------Ra~iL~~LR-~g~iP~~--~----~f~~~ 842 (1351)
T KOG1035|consen 779 ALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME------RASILTNLR-KGSIPEP--A----DFFDP 842 (1351)
T ss_pred eeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH------HHHHHHhcc-cCCCCCC--c----ccccc
Confidence 9999999987665 9999999999999999994 4543211 111122222 2332221 1 12223
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 498 QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 498 ~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....-.+++.+++++||++|||+.|++.
T Consensus 843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 843 EHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 3344567888999999999999999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.57 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=192.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|...+.||.|+||.||+|....+ |..||+|.+..... ...+.+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~-~~~v~iK~i~~~~~--------------~~~~~~~~Ei~~l~~l~h~~i~~~~ 68 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDC-DKRVAVKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKVY 68 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCC-CcEEEEEEEecCCC--------------chHHHHHHHHHHHHhcCCCcchhhH
Confidence 35788899999999999999988754 89999999876532 2235677899999999999999998
Q ss_pred eEEecC--------------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 315 AHVTRP--------------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 315 ~~~~~~--------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
+++... ...++|+||++ ++|.+++.. ..+++.....++.|++.||.|||+.+ ++|||
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~d 139 (342)
T cd07854 69 EVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRD 139 (342)
T ss_pred hhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 776543 35789999996 589888753 35889999999999999999999988 99999
Q ss_pred CCCCcEEec-CCCcEEEeccCCcccCCCCCcce-eeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCC
Q 037084 381 IKPANVLID-DGMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPF 457 (532)
Q Consensus 381 lkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~ 457 (532)
|||+||+++ +++.++++|||+++......... ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||
T Consensus 140 ikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf 219 (342)
T cd07854 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219 (342)
T ss_pred CCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999997 45678999999987653321111 1123457889999997654 56788999999999999999999999
Q ss_pred CCcccchhhccHHHH--------HHHHhccCCCcccccccc-----cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 458 DDFFQYTEEMNMVRW--------MRNVISSENPHRAIDSKL-----LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~--------~~~~~~~~~~~~~~d~~l-----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
..............- ...... ..+........ .....+.....+.+++..|++.||.+|||+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 220 AGAHELEQMQLILESVPVVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCCCHHHHHHHHHHhcCCCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 754321111111000 000000 00000000000 0000112335688899999999999999999997
Q ss_pred H
Q 037084 525 C 525 (532)
Q Consensus 525 ~ 525 (532)
.
T Consensus 299 ~ 299 (342)
T cd07854 299 M 299 (342)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=289.26 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=191.8
Q ss_pred CccccceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccce
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQ 314 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 314 (532)
+|.+.+.||+|+||.||++..... ++..||+|.+...... ......+.+|+.++.++ +||||++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~h~~iv~~~ 68 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK------------KILAKRALRELKLLRHFRGHKNITCLY 68 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc------------chhHHHHHHHHHHHHHhcCCCChheee
Confidence 367788999999999999987642 1678999998643211 11235677899999999 599999999
Q ss_pred eEEecC----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 315 AHVTRP----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+.+... ...+++++|+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 69 ~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~ 140 (332)
T cd07857 69 DMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNA 140 (332)
T ss_pred eeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcC
Confidence 875432 45688899984 689998853 456899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcc--eeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 391 GMEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++|+|||+++........ .......||..|+|||++.+ ..++.++|+||+|+++|+|++|.+||..........
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~ 220 (332)
T cd07857 141 DCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220 (332)
T ss_pred CCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH
Confidence 999999999999866432211 11134578999999998765 468999999999999999999999997533211000
Q ss_pred cHHH--------HHHHHhccCC--C---cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVR--------WMRNVISSEN--P---HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~--------~~~~~~~~~~--~---~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.. +......... . .............+.....+.+++.+|++.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 0000000000 0 0000000000001112356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.56 Aligned_cols=149 Identities=27% Similarity=0.405 Sum_probs=131.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+... ++.||||+++...... ......+..|+.++..++||||+++++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiKvi~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 71 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNN-SKLYAVKVVKKADMIN-----------KNMVHQVQAERDALALSKSPFIVHLYY 71 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEehhhccC-----------HHHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence 5688999999999999999988754 8999999997542211 233467888999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..|+||||+++++|.+++.. ...+++...+.++.|++.||.|||..+ |+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 72 SLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred EEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEE
Confidence 99999999999999999999999975 235788999999999999999999988 99999999999999999999
Q ss_pred EeccCCcc
Q 037084 396 ISDFGLAK 403 (532)
Q Consensus 396 l~DFGla~ 403 (532)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=290.83 Aligned_cols=247 Identities=23% Similarity=0.420 Sum_probs=200.9
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
.+.||+|.||+||-|.++++ |+.||||++..-... ......+.+|+.+|.+++||.||.|-..|+.+
T Consensus 569 devLGSGQFG~VYgg~hRkt-GrdVAvKvIdKlrFp------------~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ 635 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKT-GRDVAVKVIDKLRFP------------TKQESQLRNEVAILQNLHHPGIVNLECMFETP 635 (888)
T ss_pred HhhccCCcceeeecceeccc-CceeeeeeeecccCC------------CchHHHHHHHHHHHHhcCCCCeeEEEEeecCC
Confidence 47899999999999999986 999999999765433 22346788999999999999999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---CCcEEEe
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---GMEARIS 397 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 397 (532)
+..+.|||.+ +|+..+.+-. .....++.....-++.||+.||.|||.++ |+|+||||+||||.+ ...+|||
T Consensus 636 ervFVVMEKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 636 ERVFVVMEKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred ceEEEEehhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeec
Confidence 9999999999 6676666654 45667999888889999999999999999 999999999999964 4469999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||+|+.++..... ...+||+.|+|||++.+..|...-|+||+||++|.-++|..||.. +.++.+.+.+.
T Consensus 710 DFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE------dEdIndQIQNA- 779 (888)
T KOG4236|consen 710 DFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE------DEDINDQIQNA- 779 (888)
T ss_pred cccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC------ccchhHHhhcc-
Confidence 99999999876543 578999999999999999999999999999999999999999964 23333333221
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.+ +...+.....++++...++..-++|-|...-+.
T Consensus 780 -----aFMyPp----~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 780 -----AFMYPP----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -----ccccCC----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 111122 223344455778888888888889988776543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=273.48 Aligned_cols=220 Identities=21% Similarity=0.207 Sum_probs=176.0
Q ss_pred cCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCceEEE
Q 037084 247 GACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV 326 (532)
Q Consensus 247 G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 326 (532)
|.||.||++.+..+ |+.+|+|.+.... .+..|...+....||||+++++++...+..+++
T Consensus 4 g~~~~v~~~~~~~~-~~~~~~K~i~~~~-------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 63 (237)
T cd05576 4 GVIDKVLLVMDTRT-QQTFILKGLRKSS-------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLV 63 (237)
T ss_pred cccceEEEEEEccC-CcEEEEEeecchh-------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEE
Confidence 89999999988764 8999999997652 122344444556799999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCC
Q 037084 327 YEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406 (532)
Q Consensus 327 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~ 406 (532)
|||+++|+|.+++... ..+++.....++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 64 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 64 LQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred EecCCCCCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 9999999999998652 35899999999999999999999988 9999999999999999999999999877654
Q ss_pred CCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccc
Q 037084 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAI 486 (532)
Q Consensus 407 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 486 (532)
... ....++..|+|||...+..++.++|+||+|+++|||++|+.|+...... . . ... .+
T Consensus 137 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--------~-~~~--~~ 195 (237)
T cd05576 137 DSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--------N-THT--TL 195 (237)
T ss_pred ccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--------c-ccc--cc
Confidence 432 2345577899999998888999999999999999999999887532110 0 0 000 00
Q ss_pred cccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 487 DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 487 d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
.........+.+++.+|++.||++||++
T Consensus 196 ------~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 196 ------NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ------CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0111223457889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=249.37 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=198.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...++||+|.||+||+|+...+ ++.||+|.++.+...+ .......+|+-+|+.++|+|||++++.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t-~eivalkrvrldddde------------gvpssalreicllkelkhknivrl~dv 69 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRET-HEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCc-cceEEEEEEeccCCCC------------CCcHHHHHHHHHHHHhhhcceeehhhh
Confidence 466678999999999999988765 8999999998764331 123556789999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
...++.+.+|+||| ..+|..+... -...++......++.|+++|+.+.|+++ +.|||+||.|.|++.||.+|+
T Consensus 70 lhsdkkltlvfe~c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkl 142 (292)
T KOG0662|consen 70 LHSDKKLTLVFEFC-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKL 142 (292)
T ss_pred hccCceeEEeHHHh-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEe
Confidence 99999999999999 5688877754 3556888999999999999999999999 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~ 474 (532)
+|||+++.++-...- ....+.|.+|.||.++-+.+ |++..|+||-||++.|+.. |++.|..... ..++....+
T Consensus 143 adfglarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv---ddqlkrif~ 217 (292)
T KOG0662|consen 143 ADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFR 217 (292)
T ss_pred cccchhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH---HHHHHHHHH
Confidence 999999988665321 24567799999999887765 7889999999999999998 6666655332 122222222
Q ss_pred HH--hccC-CCc--ccccccccCCCc---------HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NV--ISSE-NPH--RAIDSKLLGNGY---------EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~--~~~~-~~~--~~~d~~l~~~~~---------~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+ ..++ ++. ..-|....+.++ +.....-.+++...+.-+|.+|.++++.++
T Consensus 218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 1111 111 111211111111 122223445666667779999999998765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=266.35 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=197.7
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 320 (532)
+.||+|+|+.|--+..-.+ |.++|||++.... .....+..+|++++.+. .|+||++|+.||+++
T Consensus 84 e~LGeGAyasVqtcv~i~t-~~EYAVKiidKq~--------------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQT-GKEYAVKIIDKQP--------------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred HHhcCccceeeeeeeeecc-chhhhhhhhhcCC--------------chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 6799999999999876654 9999999998774 33457788999999999 699999999999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc---EEEe
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME---ARIS 397 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 397 (532)
..+|||||.|.||+|..+++. +..+++....++.++|+.||.+||.+| |.|||+||+|||-.+.+. +|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999975 567899999999999999999999999 999999999999876554 8999
Q ss_pred ccCCcccCCCC--C---cceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 398 DFGLAKLMPDG--H---TRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 398 DFGla~~~~~~--~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
||.|..-.... . ......+.+|+..|||||+.. ...|+.++|.||||+|+|-||+|.+||.+.-..+-.+
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 99887643221 1 112235678999999999653 2358889999999999999999999997643322111
Q ss_pred c-------HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 N-------MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~-------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ -..-+-.-+.++... ...........+..+++...+..+|.+|.++..++.
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYe------FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYE------FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCc------CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 111111122222221 011122344556778888888899999999988765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.30 Aligned_cols=206 Identities=26% Similarity=0.348 Sum_probs=179.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.++++||+|+||.|..++++.+ ++.+|.|+++....- ......-|..|-.+|..-+.+-|++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t-~~VYAMK~lnK~eMl-----------Kr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKST-EKVYAMKILNKWEML-----------KRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeecc-ccchhHHHhhHHHHh-----------hchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 457899999999999999999999876 899999999864211 12224567888888888889999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
.-.|.+++.+|+|||||+||+|-.++.++ .++++..+.-++..+.-||.-||+.| +|||||||+|||||.+|+
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCc
Confidence 99999999999999999999999999752 26888888899999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+||+|||.|-.+..++. +.....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||..
T Consensus 214 ikLADFGsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred EeeccchhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 99999999887775543 34478899999999998753 5689999999999999999999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=269.02 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=201.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
...|....+||+|.||.||+|+..++ |+.||+|++-..... +..-....+|+.+|..++|+|++.++
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~-~kkvalkkvlmeneK------------eGfpitalreikiL~~lkHenv~nli 82 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNT-GKKVALKKVLMENEK------------EGFPITALREIKILQLLKHENVVNLI 82 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCc-cchhHHHHHHHhccc------------cCCcHHHHHHHHHHHHhcchhHHHHH
Confidence 44677788999999999999998875 888999876443211 11234456899999999999999999
Q ss_pred eEEecC--------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 315 AHVTRP--------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 315 ~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
..|... ..+|+|+++|+. +|..+|.+ ....++...+.+++.++..||.|+|... |+|||+||.|+
T Consensus 83 Eic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNv 155 (376)
T KOG0669|consen 83 EICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANV 155 (376)
T ss_pred HHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhE
Confidence 988542 347999999965 89888864 3356889999999999999999999988 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCC--cceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGH--TRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
|++.+|.+||+|||+++.+.... .....+..+.|.+|++||.+.+. .|+++.|+|.-||++.||+|+.+-++...+
T Consensus 156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte- 234 (376)
T KOG0669|consen 156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE- 234 (376)
T ss_pred EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-
Confidence 99999999999999998775432 23345677889999999987765 589999999999999999999998876332
Q ss_pred hhhccHHHHHHHHhccCC---Cccccccc---------ccCCC---cHHHHH------HHHHHHHHcCCCCCCCCCCHHH
Q 037084 464 TEEMNMVRWMRNVISSEN---PHRAIDSK---------LLGNG---YEEQMR------LVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~---~~~~~d~~---------l~~~~---~~~~~~------~l~~l~~~cl~~~P~~RPs~~e 522 (532)
......+..++.+-. .+.+..-+ +.... ..+... ..++|+..++..||++||++++
T Consensus 235 ---qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 235 ---QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred ---HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 333333443332211 11111111 11111 112222 5778889999999999999998
Q ss_pred HHH
Q 037084 523 VRC 525 (532)
Q Consensus 523 vl~ 525 (532)
++.
T Consensus 312 aln 314 (376)
T KOG0669|consen 312 ALN 314 (376)
T ss_pred hhc
Confidence 875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=275.36 Aligned_cols=246 Identities=24% Similarity=0.307 Sum_probs=194.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
..+|..+.+||+|+||.|.+|.-+++ .+.+|||+++.+..-.. ...+--..|-++|+-. +-|.++++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgt-dELyAiKiLkKDViiQd-----------DDvectm~EKrvLAL~~kppFL~ql 415 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGT-DELYAIKILKKDVIIQD-----------DDVECTMVEKRVLALPGKPPFLVQL 415 (683)
T ss_pred ecccceEEEeccCccceeeeecccCc-chhhhhhhhccceeeec-----------CcccceehhhhheecCCCCchHHHH
Confidence 35688999999999999999988765 78999999987643211 1122233455666665 56889999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
..+|+.-+++|+||||+.||+|-.+++.. ..+.+..+.-++..||-||-+||+++ |++||||.+||+||.+|+
T Consensus 416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGH 488 (683)
T KOG0696|consen 416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGH 488 (683)
T ss_pred HHHhhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCc
Confidence 99999999999999999999999888753 34666777888999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++.---+.. +..+.+|||.|+|||++..++|+.++|.|||||+||||+.|++||+..++. .+.+
T Consensus 489 iKi~DFGmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----elF~-- 560 (683)
T KOG0696|consen 489 IKIADFGMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQ-- 560 (683)
T ss_pred eEeeecccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHH--
Confidence 99999999986433322 236789999999999999999999999999999999999999999875442 2211
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
.+.. .+ -.++...+.+...+....+...|.+|..
T Consensus 561 -aI~e-hn----------vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 561 -AIME-HN----------VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -HHHH-cc----------CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1111 11 1233344566778888889999999853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=275.20 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=205.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC--CC---
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH--RN--- 309 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--~n--- 309 (532)
.+.|.+...+|+|.||.|-.+.++.+ +..||||+++.- ....+...-|+.+|.++.+ ||
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V---------------~kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNV---------------DKYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHH---------------HHHhhHHHHHHHHHHHHHhcCCCCce
Confidence 57899999999999999999987766 899999999865 4455667789999999932 33
Q ss_pred -cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 310 -LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 310 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+|.+.+||.-.++.|||+|.+ |-|+.+++.+ ++-.+++..++..++.|+++++++||+.+ ++|-||||+|||+
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILf 225 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILF 225 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEE
Confidence 788999999999999999999 7899999987 45677899999999999999999999998 9999999999998
Q ss_pred cC--------------------CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHH
Q 037084 389 DD--------------------GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448 (532)
Q Consensus 389 ~~--------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 448 (532)
.+ +..++|+|||.|+.-.... ...+.|.-|.|||++.+..++.++||||+||||+
T Consensus 226 vss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ 300 (415)
T KOG0671|consen 226 VSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV 300 (415)
T ss_pred eccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence 31 3458999999998765554 4667899999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccchhhccHHHHHHHHhccCCCccccccc-----------------------------c----cCCCc
Q 037084 449 VLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSK-----------------------------L----LGNGY 495 (532)
Q Consensus 449 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-----------------------------l----~~~~~ 495 (532)
|+.+|...|+.-.. .+ -...++..+.. .|...+... . .-...
T Consensus 301 ElytG~~LFqtHen-~E---HLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~ 375 (415)
T KOG0671|consen 301 ELYTGETLFQTHEN-LE---HLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD 375 (415)
T ss_pred EeeccceecccCCc-HH---HHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC
Confidence 99999999876332 11 11222222221 111111111 0 00112
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 496 EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 496 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+...+.+|+..++..||.+|+|+.|+++
T Consensus 376 d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 376 DLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 345567999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=277.60 Aligned_cols=265 Identities=22% Similarity=0.262 Sum_probs=202.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|-++.+||+|||+.||+|.+-. ..+.||||+-.....+.. .-.+...+...+|..+-+.|.||.||++
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~-EqRYvAvKIHqlNK~Wrd-------EKKeNYhKHAcREyrIHKeLDHpRIVKl 532 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLT-EQRYVAVKIHQLNKNWRD-------EKKENYHKHACREYRIHKELDHPRIVKL 532 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccc-hhheeeEeeehhccchhh-------HhhhhHHHHHHHHHhhhhccCcceeeee
Confidence 45789999999999999999997764 378999999766543322 1124456778899999999999999999
Q ss_pred eeEEec-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec---
Q 037084 314 QAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID--- 389 (532)
Q Consensus 314 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~--- 389 (532)
++++.- .+.+|-|+|||+|.+|+-+|.. .+.+++..+..|+.||..+|.||... ++||||-||||.||||.
T Consensus 533 YDyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 533 YDYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc
Confidence 999964 4678999999999999999975 45688999999999999999999987 57799999999999995
Q ss_pred CCCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTL----TISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
..|.+||+||||++.+.+..... -.....||.+|+|||.+--+ +++.|+||||+||++|..+.|+.||+..
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 45789999999999987654331 11356799999999976543 4688999999999999999999999863
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
- ...++.+.-.- +...... ....+....+...++.+|++..-++|...-++
T Consensus 688 q---sQQdILqeNTI-lkAtEVq--------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 688 Q---SQQDILQENTI-LKATEVQ--------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred h---hHHHHHhhhch-hcceecc--------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 2 22233321111 1110000 01122334457888999999988888776554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=286.40 Aligned_cols=240 Identities=23% Similarity=0.268 Sum_probs=194.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.....+|.|+|+.|-.+.+..+ ++..+||++..... .-.+|+.++... +||||+++
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t-~~~~~vkii~~~~~------------------~~~~e~~~~~~~~~h~niv~~ 381 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPT-DQEPAVKIISKRAD------------------DNQDEIPISLLVRDHPNIVKS 381 (612)
T ss_pred chhhccccccCCCCccceeeeecccc-ccchhheecccccc------------------ccccccchhhhhcCCCcceee
Confidence 56788888899999999999988865 88999999987632 123455454444 79999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe-cCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI-DDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll-~~~~ 392 (532)
.+.+.++...|+|||++.|+-|.+.+.. .+... ..+..|+.+++.++.|||++| +|||||||+|||+ ++.+
T Consensus 382 ~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g 453 (612)
T KOG0603|consen 382 HDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAG 453 (612)
T ss_pred cceecCCceeeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCC
Confidence 9999999999999999999988887764 12222 677789999999999999999 9999999999999 6899
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+++|+|||.++..... ....+-|..|.|||++....|++++|+||||++||+||+|+.||..-..+ .++..
T Consensus 454 ~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~- 524 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHT- 524 (612)
T ss_pred cEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHH-
Confidence 9999999999987665 14557789999999999999999999999999999999999999753321 11111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.. +.+....+....+|+.+||+.||.+||+|.++..
T Consensus 525 ---~i~~------------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 525 ---RIQM------------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---hhcC------------CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1111 1222445566889999999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=290.64 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=209.0
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.+++.|++.+.||.|.+|.||+++..+. |+..|+|++..... .-++...|..+|+.+ .|||++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~-~~~aa~kI~~~~~d---------------~deEiE~eynil~~~~~hpnv~ 79 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKT-GQLAAIKIMDPTED---------------EEEEIELEYNMLKKYSHHPNVA 79 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeec-CceeeeEeecCCcc---------------ccHHHHHHHHHHHhccCCCCcc
Confidence 3567899999999999999999988764 99999999987743 235566788888887 799999
Q ss_pred cceeEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
.++|++.. ++.++||||||.+||..|++++.. +..+.|..+..|+..++.|+.|||... ++|||||-.||
T Consensus 80 ~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~Ni 154 (953)
T KOG0587|consen 80 TFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNV 154 (953)
T ss_pred eEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceE
Confidence 99999864 478899999999999999999865 677999999999999999999999888 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
|++.++.+|++|||.+......-. +..+.+||+.|||||++... .|+..+|+||||++..||--|.+|+.++.
T Consensus 155 LLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH 232 (953)
T KOG0587|consen 155 LLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH 232 (953)
T ss_pred EEeccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence 999999999999999987655432 23678999999999987643 47789999999999999999999998766
Q ss_pred cchhhccHHHHHHHH--hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNV--ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ ++.+ +....++.+.. +..-.+++.+++..|+..|-.+||++.++++
T Consensus 233 P----------mraLF~IpRNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 233 P----------MRALFLIPRNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred h----------hhhhccCCCCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 5 1222 11222222222 2334567889999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=293.72 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=170.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCC----CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+.. + +..||+|++........ +..+ .+.+..+.+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~~e~----------------~~~e--~l~~~~~~~ 190 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGAVEI----------------WMNE--RVRRACPNS 190 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccchhHH----------------HHHH--HHHhhchhh
Confidence 45789999999999999999998864 3 68999998865421110 0000 111112222
Q ss_pred cccceeE------EecCCceEEEEEeccCCCHHHHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHH
Q 037084 310 LLPLQAH------VTRPDCHLLVYEFMKNGSLQDILHDVSQG----------------RRELDWLARYRIARGMASGLEY 367 (532)
Q Consensus 310 iv~l~~~------~~~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~gl~~ 367 (532)
+..+... +......++||||+++++|.+++...... ........+..++.|++.||.|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~y 270 (566)
T PLN03225 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDG 270 (566)
T ss_pred HHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHH
Confidence 2222111 34567889999999999999998742100 0111233456799999999999
Q ss_pred HHhcCCCCeeecCCCCCcEEecC-CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC--------------
Q 037084 368 LHMYHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-------------- 432 (532)
Q Consensus 368 LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------- 432 (532)
||+.+ |+||||||+|||++. ++.+||+|||+++......... .....+++.|+|||.+...
T Consensus 271 LH~~g---IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 271 LHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred HHHCC---EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 99988 999999999999985 6799999999998664433222 1456789999999965322
Q ss_pred --------CCCchhhHHHHHHHHHHHHhCCCCCCCcccc------hhhccHHHHHHHHhccCCCcccccccccC--CCcH
Q 037084 433 --------TISEKSDIYSFGVLLAVLVVGKFPFDDFFQY------TEEMNMVRWMRNVISSENPHRAIDSKLLG--NGYE 496 (532)
Q Consensus 433 --------~~~~~sDvwSlGvvl~elltg~~p~~~~~~~------~~~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~ 496 (532)
.++.++|||||||++|||+++..|++..... ....+...|....... .. +.+.. +...
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~d 420 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-AS-----PDLRRGFEVLD 420 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-cc-----hhhhhhhhhcc
Confidence 2345679999999999999988776532110 0011222332221111 00 00000 0000
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 497 EQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 497 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+|+..|++.||++|||+.++++
T Consensus 421 ~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 421 LDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred ccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 11123558999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=280.70 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=203.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.++..+..||-||||.|=++..++. ...+|+|+++...... ....+....|-.+|...+.|.||+|+-
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~-~~~fAlKilkK~hIVd-----------tkQqeHv~sEr~Im~~~~s~fIvrLYr 487 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQ-KATFALKILKKKHIVD-----------TKQQEHVFSERNIMMECRSDFIVRLYR 487 (732)
T ss_pred hhhhhhhhcccCccceEEEEEeccc-chHHHHHHHhHhhccc-----------hhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence 4566777899999999999988743 3358888887653222 445577889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.|.+....|++||-|-||.|...|++ +..++..+..-++..+.+|++|||+++ ||+|||||+|.+|+.+|-+|
T Consensus 488 Tfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 488 TFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceE
Confidence 99999999999999999999999975 566888888889999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|.|||+|+....+... -+.+|||.|.|||++.+...+.++|.||||+++|||++|.+||...++......+...+..
T Consensus 561 LVDFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~ 637 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK 637 (732)
T ss_pred EeehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh
Confidence 9999999998876543 4689999999999999999999999999999999999999999886653333333333322
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
.. ++........++++..+..+|.+|..
T Consensus 638 i~----------------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 638 IE----------------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh----------------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 21 12223345778888899999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=244.98 Aligned_cols=209 Identities=27% Similarity=0.409 Sum_probs=178.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.+.+++.-+..||+|++|.|-+.++..+ |+..|+|.+...-. .+...+..+|+.+..+. ..|.+|
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~s-g~imAvKri~~tvn-------------~q~q~r~L~dldi~~r~~~CPf~V 108 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQS-GTIMAVKRIRATVN-------------SQEQKRLLMDLDIIMRTVDCPFTV 108 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccC-CeEEEEeeehhhcC-------------hHHHHHHHHhhhhhccCCCCCeEE
Confidence 3456677778899999999999998875 99999999987643 22345667788877665 789999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
.++|.....+..++.||.| ..||+.+..+.-..+..+++...-+|+..+.+||.|||++- .++|||+||+|||++..
T Consensus 109 ~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~ 185 (282)
T KOG0984|consen 109 HFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYD 185 (282)
T ss_pred EeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccC
Confidence 9999999899999999999 77999999887777888999999999999999999999853 39999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL----TISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
|++|+||||++..+.++-.. +...|...|||||.+..+ .|+.+|||||||+++.||.+++.||+...
T Consensus 186 GqVKiCDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 186 GQVKICDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred CcEEEcccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99999999999887665432 446788899999976543 68999999999999999999999998644
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=277.56 Aligned_cols=219 Identities=24% Similarity=0.372 Sum_probs=187.1
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
-|..++.||-|+||.|.+++-.++ ...+|.|.++.. +++........+.|-.+|.....+-||+|+-.
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT-~~lYAmKTLrKa-----------DVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDT-RALYAMKTLRKA-----------DVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred ceEEEeeecccccceeEEEeecch-hhHHHHhhhHHH-----------HHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 477788999999999999976654 778999988754 45557778889999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
|.+.+.+|+||||++||++-.+|-+ ...+.+....-++..++.++++.|..| +|||||||+|||||.+|++||
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKL 770 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 770 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceee
Confidence 9999999999999999999999975 345778888889999999999999999 999999999999999999999
Q ss_pred eccCCcccCCC---------CCc-ce------------------------------eeeccccccccccccccccCCCCc
Q 037084 397 SDFGLAKLMPD---------GHT-RI------------------------------RITTVAGTTGYVAPEYHQTLTISE 436 (532)
Q Consensus 397 ~DFGla~~~~~---------~~~-~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 436 (532)
+|||||.-+.- +.. .. .-...+||+.|+|||++....++.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 99999974320 000 00 003467999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 437 KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 437 ~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
.+|.||.|||||||+.|++||-...+.+....+..|-.
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 99999999999999999999988777666666777643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=281.70 Aligned_cols=278 Identities=20% Similarity=0.246 Sum_probs=187.1
Q ss_pred cccCccccceecccCCeEEEEEEeeC---------------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHH
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG---------------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~---------------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 298 (532)
..++|.+.++||+|+||+||+|.+.. ..++.||||++.........-............+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 35689999999999999999997521 235689999997654321111000000111223456678
Q ss_pred HHHHhcCCCCCc-----ccceeEEec--------CCceEEEEEeccCCCHHHHHhhhcC--------------------C
Q 037084 299 IITAGRIWHRNL-----LPLQAHVTR--------PDCHLLVYEFMKNGSLQDILHDVSQ--------------------G 345 (532)
Q Consensus 299 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~ 345 (532)
+.++.+++|.|+ +.++++|.. .+..++||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 888888877654 677888753 3567999999999999999975211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeecccccccccc
Q 037084 346 RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVA 425 (532)
Q Consensus 346 ~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 425 (532)
...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567888999999999999999988 999999999999999999999999999765433211 1122345789999
Q ss_pred ccccccCC----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCcccchh-----hccHHHHHHHHh
Q 037084 426 PEYHQTLT----------------------ISEKSDIYSFGVLLAVLVVGKF-PFDDFFQYTE-----EMNMVRWMRNVI 477 (532)
Q Consensus 426 PE~~~~~~----------------------~~~~sDvwSlGvvl~elltg~~-p~~~~~~~~~-----~~~l~~~~~~~~ 477 (532)
||.+.... ...+.|+||+||++|+|++|.. |+........ ..++..|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 99875432 1234799999999999999885 7754221111 1122222211
Q ss_pred ccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHH
Q 037084 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDP---EERPSSKDVRC 525 (532)
Q Consensus 478 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~ 525 (532)
.... ++... .........+++..++..+| .+|+|+.++++
T Consensus 457 ~~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111 11111 11223457778888888765 78999999875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=257.41 Aligned_cols=240 Identities=31% Similarity=0.421 Sum_probs=193.5
Q ss_pred CCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCceEEEE
Q 037084 248 ACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVY 327 (532)
Q Consensus 248 ~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 327 (532)
+||.||+|.+.++ |..+++|++....... ....+.+|+..+++++|+|++++.+++......++++
T Consensus 1 ~~g~v~~~~~~~~-~~~~~~k~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 66 (244)
T smart00220 1 SFGKVYLARDKKT-GKLVAIKVIKKEKIKK-------------KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVM 66 (244)
T ss_pred CceEEEEEEECCC-CcEEEEEEeccccccc-------------HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEE
Confidence 6899999998753 8999999998764221 1467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCC
Q 037084 328 EFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 328 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 407 (532)
||+++++|.+++... ..+++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++++|||.+.....
T Consensus 67 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 67 EYCDGGDLFDLLKKR----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred eCCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 999999999998752 23889999999999999999999988 99999999999999999999999999987765
Q ss_pred CCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCccccc
Q 037084 408 GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAID 487 (532)
Q Consensus 408 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 487 (532)
.. ......++..|+|||...+..++.++|+||+|++++++++|..||..... ...+..+.. .......
T Consensus 140 ~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~---~~~~~~~~~---~~~~~~~--- 207 (244)
T smart00220 140 GG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ---LLELFKKIG---KPKPPFP--- 207 (244)
T ss_pred cc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHh---ccCCCCc---
Confidence 42 11456688899999999888899999999999999999999999965211 111222211 1111000
Q ss_pred ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 488 SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 488 ~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.........+.+++.+|+..+|++||++.++++
T Consensus 208 -----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 -----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred -----cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000003456888999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=254.54 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=201.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
-.+|.++++||+|+|+.|-.+++.++ .+-+|+|+++..-.+. ...+...+.|-.+..+. +||.+|.|
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t-~qiyamkvvkkel~nd-----------dedidwvqtek~vfe~asn~pflvgl 316 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKT-DQIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNNPFLVGL 316 (593)
T ss_pred cccceeeeeecCcchhhhhheehccc-ceeeehhhHHHHhcCC-----------cccchhHHhhHHHHHhccCCCeEEeh
Confidence 35799999999999999999999876 7899999987653332 12234444555555555 79999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
..+|+...++++|.||++||+|--+++. ...+++..+.-+...|.-+|.|||+.| |+.||||.+|+|+|..|+
T Consensus 317 hscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 317 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred hhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCc
Confidence 9999999999999999999999777754 456889998889999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|++|+|+++.--..... ..+.+|||.|.|||.+.+..|...+|.|++|++++||+.|+.||+-.......++..+++
T Consensus 390 ikltdygmcke~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred eeecccchhhcCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 999999999864433322 267899999999999999999999999999999999999999998654444445555555
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
-+.+-+.... .+.........+++.-+++||++|..
T Consensus 468 fqvilekqir----------iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 468 FQVILEKQIR----------IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHhhhccc----------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 5543322211 01112234556777889999999853
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=257.34 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=211.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC----CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
.++++...++-+|.||.||+|.|+..+ .+.|-||.++.... +-....+..|..++..+.|||+
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-------------~iQv~~~L~es~lly~~sH~nl 349 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-------------QIQVNLLLQESMLLYGASHPNL 349 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-------------HHHHHHHHHHHHHHhcCcCCCc
Confidence 356777888999999999999887431 24566776665431 3446788999999999999999
Q ss_pred ccceeEEecC-CceEEEEEeccCCCHHHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 311 LPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVS----QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 311 v~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
.++.+++.+. ...+.+|.++.-|+|..||.-.+ .....++..+...++.|++.|++|||..+ +||.||..+|
T Consensus 350 l~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRN 426 (563)
T KOG1024|consen 350 LSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARN 426 (563)
T ss_pred cceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhc
Confidence 9999998765 56688999999999999998322 22345677788889999999999999999 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccch
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYT 464 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~ 464 (532)
.++|+...+||+|=.+++.....+.+.-....-.+..||+||.+.+..|+..+||||||+++|||+| |+.||.+.++.+
T Consensus 427 CvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 427 CVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred ceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 9999999999999999997766555443344455778999999999999999999999999999999 999998766533
Q ss_pred hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
....+. .+.+.. .+-+++.++..++..||...|++||++++++.-|.++.
T Consensus 507 m~~ylk-------dGyRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 MEHYLK-------DGYRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHh-------ccceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 322221 111221 22345667899999999999999999999999998763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=282.07 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=188.9
Q ss_pred ccccceecccCCeE-EEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccccee
Q 037084 238 LASLEIIGVGACGV-VYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQA 315 (532)
Q Consensus 238 ~~~~~~LG~G~fG~-Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~ 315 (532)
|.-.+.+|.|+.|+ ||+|... |+.||||++-.. ......+|+..|..- .|||||++++
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~e-----------------~~~~A~rEi~lL~eSD~H~NviRyyc 570 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE---GREVAVKRLLEE-----------------FFDFAQREIQLLQESDEHPNVIRYYC 570 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC---CceehHHHHhhH-----------------hHHHHHHHHHHHHhccCCCceEEEEe
Confidence 45557799999974 7999886 889999988643 234567899999888 7999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-----
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD----- 390 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~----- 390 (532)
.-.+....||..|.| ..+|.+++...........-...+.+..|+++||+|||+.+ ||||||||.||||+.
T Consensus 571 ~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~ 646 (903)
T KOG1027|consen 571 SEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADG 646 (903)
T ss_pred eccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCc
Confidence 988899999999999 77999999752111111111334678899999999999998 999999999999975
Q ss_pred CCcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVG-KFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~ 468 (532)
...++|+|||+++....+.... ......||.||+|||++....-+.++|+||+||++|+.++| ..||++... ...+
T Consensus 647 ~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~N 724 (903)
T KOG1027|consen 647 TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQAN 724 (903)
T ss_pred ceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhh
Confidence 2468999999999887654332 23567899999999999999999999999999999999995 899987443 1122
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.. ....-..+.+ ..++ +..+|+..|++++|..||++.+|+.
T Consensus 725 Il~-------~~~~L~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 725 ILT-------GNYTLVHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hhc-------Cccceeeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 211 1111100100 1111 6889999999999999999999973
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=248.16 Aligned_cols=265 Identities=25% Similarity=0.311 Sum_probs=193.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
.+.-+.||-|+||.||.+++... |+.||+|++..--.+ ....+++.+|+.+|...+|.|+...++..
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRd-grrvalkK~pnvfq~------------L~s~krvFre~kmLcfFkHdNVLSaLDIL 121 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRS-GKRVALKKMPNVFQN------------LASCKRVFREIKMLSSFRHDNVLSLLDIL 121 (449)
T ss_pred CCCCCcccccceeEEEeccCCCC-ccchhHhhcchHHHH------------HHHHHHHHHHHHHHHhhccccHHHHHHhc
Confidence 33447899999999999998864 999999988653211 23357889999999999999999998887
Q ss_pred ecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 318 TRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 318 ~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
..+. +.|.++|.| ..+|...+- ....++-....-+..||++||.|||+.+ |+||||||.|.|++.|.
T Consensus 122 QPph~dfFqEiYV~TELm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNC 193 (449)
T KOG0664|consen 122 QPANPSFFQELYVLTELM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNC 193 (449)
T ss_pred CCCCchHHHHHHHHHHHH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCc
Confidence 6553 557888988 447777664 4567888899999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||||||+++....... ..++..+.|..|.|||.+.+. .|+...||||+||++.|++..+..|+...+...-.-+.+
T Consensus 194 vLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 194 ILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred eEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 999999999997655432 233667789999999988876 589999999999999999999988875443211111111
Q ss_pred --------HHHHHhccCCC----------cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 472 --------WMRNVISSENP----------HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 472 --------~~~~~~~~~~~----------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
-++....+.+. ...+-.++.. ....-.+...+...++.+||+.|.+..+.+..
T Consensus 273 LLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS--~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 273 LLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIAS--PDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecC--CcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11111111110 0000011111 11222345667778999999999998887654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=269.88 Aligned_cols=255 Identities=26% Similarity=0.359 Sum_probs=207.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+.++|..++.+|+|+||.|||+++..+ ++..|+|+++..... ...-.++|+.+++..+|||||.+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s-~elaavkvVkLep~d--------------d~~~iqqei~~~~dc~h~nivay 77 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRS-GELAAVKVVKLEPGD--------------DFSGIQQEIGMLRDCRHPNIVAY 77 (829)
T ss_pred CccchhheeeecCCcccchhhhccccc-CchhhheeeeccCCc--------------cccccccceeeeecCCCcChHHH
Confidence 567899999999999999999999876 999999999987532 34566789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+|.+...+.++++||||.+|+|.+..+. ..++++.++..+++...+|++|||+++ -+|||||-.||++++.|.
T Consensus 78 ~gsylr~dklwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gD 150 (829)
T KOG0576|consen 78 FGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGD 150 (829)
T ss_pred HhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCc
Confidence 9999999999999999999999999874 678999999999999999999999999 899999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeecccccccccccccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH---QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+|++|||.+..+...-. ......||+.|||||+. ..+.|...+|+|++|++..|+-.-++|--+..+. .
T Consensus 151 vklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r 222 (829)
T KOG0576|consen 151 VKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------R 222 (829)
T ss_pred eeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------H
Confidence 99999999877654322 22578899999999964 4667899999999999999999888886543331 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...-.--..-.+...-|+.-+. ..+.++++.|+..+|++|||++.++.
T Consensus 223 ~l~LmTkS~~qpp~lkDk~kws-------~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 223 ALFLMTKSGFQPPTLKDKTKWS-------EFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHhhccCCCCCcccCCccch-------HHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111222333333443322 33677888999999999999987653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=230.86 Aligned_cols=212 Identities=35% Similarity=0.538 Sum_probs=184.2
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCce
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH 323 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 323 (532)
||+|++|.||++..... |..+++|++....... ....+.+|+..++.++|++++++++++......
T Consensus 1 l~~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 66 (215)
T cd00180 1 LGEGGFGTVYLARDKKT-GKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66 (215)
T ss_pred CCcCCceEEEEEEecCC-CcEEEEEEeccccchh-------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeE
Confidence 68999999999988753 8999999998764221 246788999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-CCcEEEeccCCc
Q 037084 324 LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEARISDFGLA 402 (532)
Q Consensus 324 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla 402 (532)
++++||+++++|.+++... ...+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+
T Consensus 67 ~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~ 140 (215)
T cd00180 67 YLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLS 140 (215)
T ss_pred EEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCce
Confidence 9999999999999998752 146889999999999999999999998 999999999999999 899999999999
Q ss_pred ccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCC
Q 037084 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481 (532)
Q Consensus 403 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~ 481 (532)
........ ......+...|++||..... .++.++|+|++|++++++
T Consensus 141 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------- 187 (215)
T cd00180 141 KLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------- 187 (215)
T ss_pred EEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------
Confidence 87655431 11345678899999998887 888999999999999999
Q ss_pred CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 482 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 237788999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=257.60 Aligned_cols=205 Identities=27% Similarity=0.364 Sum_probs=176.2
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW---HRNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~ 312 (532)
.+|..++.+|+|+||.|+.|.++.. ...|+||.+.....-...+. .....-....|+.+|+.++ |+||++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWv------rDrkLGtVp~EIqIla~l~~~sH~NIlK 633 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWV------RDRKLGTVPSEIQILATLNKHSHENILK 633 (772)
T ss_pred ccceeeeeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhh------cccccCccchhHHHHHHhhhcCccchhh
Confidence 4688899999999999999999865 78999999987642221111 1222344678999999997 999999
Q ss_pred ceeEEecCCceEEEEEec-cCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPDCHLLVYEFM-KNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++|++++.+||+||.. ++-+|.+++.. .+.+++....-|++|++.|++|||+++ |||||||-+|+.++.+
T Consensus 634 lLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 634 LLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN 706 (772)
T ss_pred hhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC
Confidence 999999999999999976 56689999864 567999999999999999999999999 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
|.+||+|||.+.....+.- ...+||.+|.|||++.+.+| +..-|+|++|+++|-++....||-
T Consensus 707 g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999988776653 67899999999999999887 456899999999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=240.40 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=195.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-----C--
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-----H-- 307 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----H-- 307 (532)
..+|.+.++||.|-|++||++.+.. ..+.||+|+.+.. +...+....|+++|.+++ |
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA---------------qhYtEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA---------------QHYTEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred CceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh---------------hHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 4679999999999999999996554 4789999999865 445567788999999883 3
Q ss_pred -CCcccceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 037084 308 -RNLLPLQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382 (532)
Q Consensus 308 -~niv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 382 (532)
..||+|+++|.. +.+.|+|+|++ |.+|..++.. ..-+.++...+.+|+.||+.||.|||..+ +|||-|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlK 215 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLK 215 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCC
Confidence 358999999964 45789999999 8899999986 34455889999999999999999999875 49999999
Q ss_pred CCcEEecCC-----------------------------------------------------------------------
Q 037084 383 PANVLIDDG----------------------------------------------------------------------- 391 (532)
Q Consensus 383 p~NIll~~~----------------------------------------------------------------------- 391 (532)
|+|||+..+
T Consensus 216 PENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~ 295 (590)
T KOG1290|consen 216 PENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIE 295 (590)
T ss_pred cceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccc
Confidence 999996100
Q ss_pred --------------------------------------------------------------------------------
Q 037084 392 -------------------------------------------------------------------------------- 391 (532)
Q Consensus 392 -------------------------------------------------------------------------------- 391 (532)
T Consensus 296 ~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~ 375 (590)
T KOG1290|consen 296 EEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIA 375 (590)
T ss_pred ccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccc
Confidence
Q ss_pred ---------------CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 037084 392 ---------------MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 392 ---------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 456 (532)
-.+||+|||-|+.+.... +.-+.|..|+|||++.+..|++.+|+||++|+++||.||-..
T Consensus 376 ~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL 450 (590)
T KOG1290|consen 376 SNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL 450 (590)
T ss_pred cccccCCCCCCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence 013444454444432221 344567889999999999999999999999999999999988
Q ss_pred CCCcccch--hhcc----HHHHHH----HHhccCC-Cccccccc-----------------c--cCCCcHHHHHHHHHHH
Q 037084 457 FDDFFQYT--EEMN----MVRWMR----NVISSEN-PHRAIDSK-----------------L--LGNGYEEQMRLVLKIA 506 (532)
Q Consensus 457 ~~~~~~~~--~~~~----l~~~~~----~~~~~~~-~~~~~d~~-----------------l--~~~~~~~~~~~l~~l~ 506 (532)
|+.-.... ...+ +.+.+- .+...+. ..+.++.. + .-++..+...++.+++
T Consensus 451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL 530 (590)
T KOG1290|consen 451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL 530 (590)
T ss_pred ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence 86432211 1111 222211 1111111 11112111 0 2235678888999999
Q ss_pred HHcCCCCCCCCCCHHHHHH
Q 037084 507 YFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 507 ~~cl~~~P~~RPs~~evl~ 525 (532)
.-||+.+|++|||+.+.++
T Consensus 531 ~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 531 SPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhcCccccccHHHHhc
Confidence 9999999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=249.43 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=204.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC------
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH------ 307 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H------ 307 (532)
....|.+....|+|-|++|.+|.+... |..||||++... +...+.=..|+++|.+|+.
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r-~~~vAiKIIRnN---------------E~M~KtGl~EleiLkKL~~AD~Edk 493 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQAR-GQEVAIKIIRNN---------------EVMHKTGLKELEILKKLNDADPEDK 493 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCC-CCeeEEEEeecc---------------hHHhhhhhHHHHHHHHhhccCchhh
Confidence 356788888899999999999988765 889999999987 3344556679999999962
Q ss_pred CCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 308 RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 308 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
-+++.|+-.|...+++|||+|-+ ..+|.+.|..+.. .-.|.......++.|++-||.+|...+ |+|+||||.|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiL 568 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNIL 568 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceE
Confidence 47899999999999999999988 7799999998644 345778888999999999999999999 999999999999
Q ss_pred ecCC-CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDG-MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++++ ..+||||||.|........ +.+..+..|.|||++.+.+|+..-|+||+||+||||.||+..|.+.....
T Consensus 569 VNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-- 642 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-- 642 (752)
T ss_pred eccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH--
Confidence 9865 4689999999987766543 55666778999999999999999999999999999999999887643311
Q ss_pred ccHHHHHHH--------HhccCC---------------------------Ccccccc------cc-----cCCCcHHHHH
Q 037084 467 MNMVRWMRN--------VISSEN---------------------------PHRAIDS------KL-----LGNGYEEQMR 500 (532)
Q Consensus 467 ~~l~~~~~~--------~~~~~~---------------------------~~~~~d~------~l-----~~~~~~~~~~ 500 (532)
+..+.-. ++..+. +...+.| .+ .+...+....
T Consensus 643 --MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~ 720 (752)
T KOG0670|consen 643 --MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQ 720 (752)
T ss_pred --HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHH
Confidence 1111100 000000 0011111 11 1122344567
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 501 LVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 501 ~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
++.+|+..|+..||++|.|..+.+.
T Consensus 721 ~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 721 QLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHhccChhhcCCHHHHhc
Confidence 7899999999999999999998874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=229.84 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=192.1
Q ss_pred cccccccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 228 DIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 228 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
++...+..+.|.+.+.||+|.||.+-+++++++ .+.+++|.+..+ .....+|.+|...--.| .
T Consensus 16 el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s-~t~ivlKavp~p---------------~tt~~dF~rEfhY~~~Ls~ 79 (378)
T KOG1345|consen 16 ELKKVDLEDVYTINKQLGEGRFGKILLAEHRQS-KTRIVLKAVPRP---------------QTTQADFVREFHYSFFLSP 79 (378)
T ss_pred cccccchhhhhhHHHHhcccceeeEEeeeccCC-ceEEEeeccCcc---------------hhhHHHHHHHhccceeecc
Confidence 344456678899999999999999999999986 889999999876 44567888998877677 6
Q ss_pred CCCcccceeE-EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 307 HRNLLPLQAH-VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 307 H~niv~l~~~-~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
|.||+.-++. |+..+...+++||+|-|+|.+-+.. ..+.+....+++.|+++|+.|||+.+ +||||||.+|
T Consensus 80 H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eN 151 (378)
T KOG1345|consen 80 HQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAEN 151 (378)
T ss_pred chhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccce
Confidence 8999976654 5666777899999999999988754 34777888899999999999999999 9999999999
Q ss_pred EEec--CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 386 VLID--DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 386 Ill~--~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
||+- +.-.+|+||||+.+..+... .....+..|.+||..... ...+.+|+|.||+++|.++||++||+
T Consensus 152 iLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 152 ILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred EEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 9994 34479999999987654332 233456679999965433 24678999999999999999999998
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .......+|.... .+... --|+. .......++++...-+.++|++|-...++-+
T Consensus 227 ka~--~~d~~Y~~~~~w~--~rk~~--~~P~~----F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 227 KAS--IMDKPYWEWEQWL--KRKNP--ALPKK----FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhh--ccCchHHHHHHHh--cccCc--cCchh----hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 321 1222333333222 11111 01111 2223344667777789999999955444443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=228.82 Aligned_cols=201 Identities=31% Similarity=0.473 Sum_probs=172.6
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|++|.||++...++ +..+++|.+...... .....+.+|+..+.+++|+|++++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~-~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~ 66 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGT-GELVAVKVLKKEKTE-------------KQREEFLREIRILKKLKHPNIVKLYGVF 66 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCC-CcEEEEEeeccccch-------------HHHHHHHHHHHHHHhCCCCChhhheeee
Confidence 45668899999999999998753 789999999876422 1346788899999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
......++++||+++++|.+++.... ..+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+
T Consensus 67 ~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~ 140 (225)
T smart00221 67 EDPEPLYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLA 140 (225)
T ss_pred ecCCceEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999999997521 12789999999999999999999988 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH-QTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
|||++......... ......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 141 d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 141 DFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999877654311 11345678899999988 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=222.93 Aligned_cols=259 Identities=21% Similarity=0.286 Sum_probs=193.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
..++|++.+++|+|.++.||.|..-. +.++++||++++- ..+.+.+|+.+|..|. ||||++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~-~~eK~ViKiLKPV-----------------kkkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT-NNEKCVIKILKPV-----------------KKKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC-CCceEEEeeechH-----------------HHHHHHHHHHHHHhccCCCCeee
Confidence 46789999999999999999997554 4889999999864 2356789999999996 999999
Q ss_pred ceeEEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
|++...++. ...|++||+.+.+...+.. .++...+..++.++++||.|.|+.| |.|||+||.|+++|.
T Consensus 98 L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 98 LLDIVKDPESKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDH 167 (338)
T ss_pred hhhhhcCccccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeech
Confidence 999998764 5579999999888776653 3666777889999999999999999 999999999999995
Q ss_pred -CCcEEEeccCCcccCCCCCcceeeecccccccccccccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 391 -GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH-QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.-.++++|+|+|.+...+... ...+.+..|..||.+ ....|+.+-|+|||||++..|+..+.||-.-.. ...+
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d--N~DQ 242 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQ 242 (338)
T ss_pred hhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC--CHHH
Confidence 456999999999987655432 456677889999965 455688999999999999999999999854322 1122
Q ss_pred HHH------------HHHHHhccC--CCcccccc---cccCCC-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVR------------WMRNVISSE--NPHRAIDS---KLLGNG-----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~------------~~~~~~~~~--~~~~~~d~---~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
++. ++....-.- ....++.. ..+..+ -.-...++++++...+..|-.+|||+.|...
T Consensus 243 LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 243 LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 221 121111000 00010000 001111 1112246888888999999999999998753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=235.04 Aligned_cols=267 Identities=27% Similarity=0.331 Sum_probs=199.4
Q ss_pred cccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
++-..+|.-++.+|.|.- .|..|.+.- .+++||+|.+..+.... ...++..+|..++..++|+|++
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v-~~~~v~ikk~~~pf~n~------------~~akra~rel~l~~~v~~~nii 78 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQV-LGRPVAIKKLSRPFQNQ------------THAKRAYRELKLMKCVNHKNII 78 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhh-ccCceehhhhcCccccC------------ccchhhhhhhhhhhhhccccee
Confidence 445667888899999998 777775554 48999999987663221 1235667899999999999999
Q ss_pred cceeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 312 PLQAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 312 ~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
+++.++.-. ...|+||||| ..+|...++- .++-.....|..|++.|+.|||+.+ |+||||||+|
T Consensus 79 ~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsn 148 (369)
T KOG0665|consen 79 SLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSN 148 (369)
T ss_pred eeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 999999654 4569999999 6799988863 3566778889999999999999999 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
|++..++.+||.|||+|+..... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|..-|.+....+.
T Consensus 149 ivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 149 IVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred ceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 99999999999999999865443 234778899999999999998899999999999999999999988865332111
Q ss_pred h---------------ccHHHHHHHHhccC------CCcccccccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 037084 466 E---------------MNMVRWMRNVISSE------NPHRAIDSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSK 521 (532)
Q Consensus 466 ~---------------~~l~~~~~~~~~~~------~~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 521 (532)
. .++..-.+...... ...+.+...+... ..+-....+.+++..||..||++|.|.+
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 1 11111122221110 0111111111111 1123345678899999999999999999
Q ss_pred HHHH
Q 037084 522 DVRC 525 (532)
Q Consensus 522 evl~ 525 (532)
++++
T Consensus 306 daL~ 309 (369)
T KOG0665|consen 306 DALR 309 (369)
T ss_pred HHhc
Confidence 9875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=232.96 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=166.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.+.|..+++||+|.|++||++++... ....||+|.+..... ..+..+|+++|..+ .+.||+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----------------p~ri~~El~~L~~~gG~~ni~ 98 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----------------PSRILNELEMLYRLGGSDNII 98 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----------------chHHHHHHHHHHHhccchhhh
Confidence 45688899999999999999988752 367999999977532 25578899999999 689999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-C
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-D 390 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-~ 390 (532)
++.+++..++..++|+||+++.+-.+++.. ++...+..+++.++.||.|+|..| ||||||||+|+|.+ .
T Consensus 99 ~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 99 KLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRR 168 (418)
T ss_pred cchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccc
Confidence 999999999999999999999999999865 678888999999999999999999 99999999999997 4
Q ss_pred CCcEEEeccCCcccCCC--------C-----C-----------------------------cceeeeccccccccccccc
Q 037084 391 GMEARISDFGLAKLMPD--------G-----H-----------------------------TRIRITTVAGTTGYVAPEY 428 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~--------~-----~-----------------------------~~~~~~~~~gt~~y~aPE~ 428 (532)
.+.-.|.|||+|..... . . .........||+||.|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 56789999999982100 0 0 0001134669999999997
Q ss_pred ccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 429 HQT-LTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 429 ~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+.. +.-+++.||||.|++++-+++++.||-.
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred HhhccCcCCccceeeccceeehhhcccccccc
Confidence 654 4578899999999999999999999954
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=267.64 Aligned_cols=196 Identities=16% Similarity=0.188 Sum_probs=140.5
Q ss_pred cCCC-CCcccceeEE-------ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 304 RIWH-RNLLPLQAHV-------TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPC 375 (532)
Q Consensus 304 ~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ 375 (532)
+++| +||+.++++| .+....+.++||+ +++|.+++.. ....+++..+..++.||++||.|||+.+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3446 6888888888 3334677889988 6799999974 2456999999999999999999999998
Q ss_pred eeecCCCCCcEEecCC-------------------CcEEEeccCCcccCCCCCc--------------ceeeeccccccc
Q 037084 376 IIHRDIKPANVLIDDG-------------------MEARISDFGLAKLMPDGHT--------------RIRITTVAGTTG 422 (532)
Q Consensus 376 ivH~Dlkp~NIll~~~-------------------~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~ 422 (532)
|+||||||+||||+.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666654211000 000122468999
Q ss_pred cccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHH
Q 037084 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLV 502 (532)
Q Consensus 423 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 502 (532)
|+|||++.+..++.++|||||||++|||++|.+|+..... .+........ .+. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~~~---------~~~-----~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHRVL---------PPQ-----ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHhhc---------Chh-----hhhcCHHH
Confidence 9999999999999999999999999999999988753111 1111111100 000 01112235
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHH
Q 037084 503 LKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 503 ~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+++.+||+++|.+|||+.++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 67788999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=204.88 Aligned_cols=167 Identities=20% Similarity=0.239 Sum_probs=126.7
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcce
Q 037084 333 GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412 (532)
Q Consensus 333 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 412 (532)
|||.+++.. .+..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||+++.....
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 789999975 2456999999999999999999999875 999999999999999 9998865442
Q ss_pred eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccC
Q 037084 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLG 492 (532)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 492 (532)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+..... ...+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~-~~~~~~-------~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMP-ADDPRD-------R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhc-cCCccc-------c
Confidence 236889999999999999999999999999999999999999653221 111111111111 110000 0
Q ss_pred CCcHHHHH--HHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 493 NGYEEQMR--LVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 493 ~~~~~~~~--~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........ .+.+++..||+.+|++|||+.++++.+..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 01122222 589999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=218.13 Aligned_cols=172 Identities=17% Similarity=0.140 Sum_probs=131.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+...++..+|||++......... ......|.+|+++|.+++|+|++..+
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---------~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---------PLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc---------HHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 467999999999999999999887655888999987532110000 22345689999999999999998533
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI-KPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-kp~NIll~~~~~ 393 (532)
.. .+..|+|||||+|++|... . ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.
T Consensus 88 ~~---~~~~~LVmE~~~G~~L~~~-~---~~~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 88 LA---TGKDGLVRGWTEGVPLHLA-R---PHG-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred EE---cCCcEEEEEccCCCCHHHh-C---ccc-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCC
Confidence 22 2467999999999999632 1 111 1357889999999999998 999999 999999999999
Q ss_pred EEEeccCCcccCCCCCccee------eeccccccccccccccccC
Q 037084 394 ARISDFGLAKLMPDGHTRIR------ITTVAGTTGYVAPEYHQTL 432 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 432 (532)
++|+|||+|+.+........ .+...+++.|+|||++...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999998765432211 2456788899999987643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-24 Score=212.88 Aligned_cols=261 Identities=23% Similarity=0.277 Sum_probs=192.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC----CCccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH----RNLLP 312 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~ 312 (532)
.|.+.+.||+|+||.||++.........+|+|......... ...+..|..++..+.+ +++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------------~~~l~~E~~vl~~l~~~~~~~~~~~ 84 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------------PSVLKIEIQVLKKLEKKNGPSHFPK 84 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------------CccchhHHHHHHHHhhhcCCCCCCE
Confidence 79999999999999999998765423579999887642111 1146667777777762 57888
Q ss_pred ceeEE-ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHV-TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++... ..+...++||+.+ |.||.++..... ...++..+..+|+.|++.+|.+||+.| ++||||||.|+++...
T Consensus 85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQS 158 (322)
T ss_pred EEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCC
Confidence 88888 4777889999998 999999886533 567999999999999999999999999 9999999999999854
Q ss_pred -----CcEEEeccCCcccCC--CCCc----cee--eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 392 -----MEARISDFGLAKLMP--DGHT----RIR--ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 392 -----~~~kl~DFGla~~~~--~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
..+.+.|||+++.+. .... ... .....||..|+++....+...+.+.|+||++.++.+++.|..||.
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 468999999999332 2211 111 134559999999999999999999999999999999999999997
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...................... .....+ ..+.++...+-..+...+|....+...|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 239 ALEMTDLKSKFEKDPRKLLTDR----------FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred cccccchHHHHHHHhhhhcccc----------ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 5433222221211111111110 111122 3344555556668999999999998887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=204.02 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=197.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
++.++.+|.+...|..|+|+|. |..+++|+++..... .+..+.|..|.-.|+-..||||..++|.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t------------~risrdfneefp~lrifshpnilpvlga 255 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVT------------ARISRDFNEEFPALRIFSHPNILPVLGA 255 (448)
T ss_pred hhhhhhhhccCCCccccccccc---Ccchhhhhhhhhhcc------------hhhcchhhhhCcceeeecCCchhhhhhh
Confidence 4556678899999999999997 667888888754322 3445789999999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
|..+..+.++..|||.|||...|++ +.....+-.+..+++.++++|++|||+.. +.|.---|.+..+++|++...+|
T Consensus 256 cnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 256 CNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred ccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhe
Confidence 9999999999999999999999997 55566788899999999999999999975 33444578999999999988777
Q ss_pred e--ccCCcccCCCCCcceeeeccccccccccccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 397 S--DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS---EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 397 ~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+ |--++. +. ......+.||+||.++..+.+ .++|+|||++++||+.|...||.+..+-+..+.+.
T Consensus 333 smad~kfsf---qe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia- 402 (448)
T KOG0195|consen 333 SMADTKFSF---QE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA- 402 (448)
T ss_pred ecccceeee---ec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-
Confidence 4 322111 11 234557899999998876543 57899999999999999999998866543333221
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+ ..+....++.....+.+++.-|++.||.+||.+..++-.||+++
T Consensus 403 -----l----------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 -----L----------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----h----------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 11222334444556888888899999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-22 Score=198.08 Aligned_cols=264 Identities=29% Similarity=0.405 Sum_probs=197.7
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC-CcccceeE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR-NLLPLQAH 316 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~~~ 316 (532)
|...+.||.|+||.||++... ..+++|.+........ .....+.+|+.+++.+.|+ |++.+...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 66 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKS-----------KEVERFLREIQILASLNHPPNIVKLYDF 66 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec----cEEEEEeechhhccch-----------hHHHHHHHHHHHHHHccCCcceeeEEEE
Confidence 566788999999999999865 6899999987643221 2356788999999999988 79999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-cEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-EAR 395 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 395 (532)
+......+++++|+.++++.+++...... ..+.......+..+++.++.|+|+.+ ++|||+||+||+++..+ .++
T Consensus 67 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~ 142 (384)
T COG0515 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVK 142 (384)
T ss_pred EecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEE
Confidence 97777789999999999999777642111 36888999999999999999999999 99999999999999988 799
Q ss_pred EeccCCcccCCCCCcce----eeecccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 396 ISDFGLAKLMPDGHTRI----RITTVAGTTGYVAPEYHQT---LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
++|||+++......... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...........
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~ 222 (384)
T COG0515 143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222 (384)
T ss_pred EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHH
Confidence 99999998665443221 2367789999999999987 5788999999999999999999999765332100111
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+...... ........ .........+.+++..|+..+|..|.+..+...
T Consensus 223 ~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 223 TLKIILELPTP-SLASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHHHHHhcCCc-ccccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 22222111111 00000000 000222356778888999999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=188.03 Aligned_cols=261 Identities=24% Similarity=0.299 Sum_probs=194.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-CCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH-RNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~ 312 (532)
....|.++++||+|+||.+|.|..-. +|..||||.-+..... ..+..|..+.+.|+| ..|..
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a~h----------------pqL~yEskvY~iL~~g~GiP~ 75 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKAKH----------------PQLLYESKVYRILQGGVGIPH 75 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc-CCceEEEEeecccCCC----------------cchhHHHHHHHHhccCCCCch
Confidence 45679999999999999999998775 4999999998765422 345667888888876 67888
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC--
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-- 390 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-- 390 (532)
+.-|..+.....+|||.. |.||.++..- ....++..+.+-.+-|+..-++|+|..+ ++||||||+|+|..-
T Consensus 76 i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgr 148 (341)
T KOG1163|consen 76 IRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGR 148 (341)
T ss_pred hhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeecccc
Confidence 888889999999999999 8999999874 2456888999999999999999999999 999999999999963
Q ss_pred -CCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 037084 391 -GMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464 (532)
Q Consensus 391 -~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 464 (532)
...+.++|||+|+.+.+..+.. ......||..|.+-....+..-+...|+-|+|.++.++..|..||++.....
T Consensus 149 h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 149 HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 4468999999999875543221 2256779999999888887788899999999999999999999999866544
Q ss_pred hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
..+......+.... .+. ..+.. ..+.++.-.+..|-..--++-|...-+.+.+.
T Consensus 229 k~QKyEkI~EkK~s--~~i----e~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 229 KKQKYEKISEKKMS--TPI----EVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHHHHHHHhhcC--CCH----HHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 33322221111110 000 01111 12233444555676666777777666655543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-23 Score=221.06 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=189.0
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCC---CChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQ---PPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
...+.+|.|++|.|+.+.... ..+..+.|.... +.... ......+..|..+-..+.|||++..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~-----------~~~~~~i~sE~~i~~~l~h~~~~e~l~ 388 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESE-----------RKYNYNITSEFCIGSSLSHPNIIETLD 388 (601)
T ss_pred CccceeeecccCceEEEEecC-CCccchhhhhhcccCCcccH-----------HHHhhhhhhheeecccccCCchhhhHH
Confidence 456789999999777775542 244444444331 11110 112222777888889999999988888
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
.+.+....+-+||||++ +|..++.. ...+....+..++.|+..|+.|+|+.| +.|||+||+|+++..+|.+|
T Consensus 389 ~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lk 460 (601)
T KOG0590|consen 389 IVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILK 460 (601)
T ss_pred HHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceE
Confidence 77777666666999999 99999975 245777888899999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcc--eeeeccccccccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 396 ISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTLTISEK-SDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 396 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
|+|||.+..+...... ......+|+..|+|||.+.+..|.+. .||||.|+++..|.+|+.||..........
T Consensus 461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----- 535 (601)
T KOG0590|consen 461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----- 535 (601)
T ss_pred EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----
Confidence 9999999887654432 23356789999999999999998764 799999999999999999997543311110
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .....-...-........+.....++.++++++|.+|.|++++++
T Consensus 536 -~~~~---~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 536 -KTNN---YSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -hhhc---cccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 000000000001123455677888999999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=186.56 Aligned_cols=203 Identities=25% Similarity=0.334 Sum_probs=169.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 314 (532)
-.|.+.++||+|.||..+.|+.-- ++++||||.-...+.. -++..|.+..+.| ..++|...+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~-nne~VAIKfEPrkS~A----------------PQLrdEYr~YKlL~g~~GIP~vY 90 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLY-NNEPVAIKFEPRKSEA----------------PQLRDEYRTYKLLGGTEGIPQVY 90 (449)
T ss_pred ccceeccccccCcceeeecccccc-cCceEEEEeccccCCc----------------chHHHHHHHHHHHcCCCCCCcee
Confidence 368999999999999999997543 4899999986554322 2344566666666 468999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC----
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---- 390 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~---- 390 (532)
-|..++..-.||+|.+ |-||+|+..- .+..++..+...++.|+..-++|+|+++ +|.|||||+|+||..
T Consensus 91 YFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k 163 (449)
T KOG1165|consen 91 YFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTK 163 (449)
T ss_pred eeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCC
Confidence 8888888889999999 8999998763 4567999999999999999999999999 999999999999964
Q ss_pred -CCcEEEeccCCcccCCCCCccee-----eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 391 -GMEARISDFGLAKLMPDGHTRIR-----ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 391 -~~~~kl~DFGla~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
...+.++|||+|+.+.+..+... .....||.+||+-....+..-+...|+-|+|=|+.+.|.|..||+....
T Consensus 164 ~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 164 DANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 34589999999999876544321 2456799999999999999999999999999999999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=187.87 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=154.5
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC---------
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH--------- 307 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--------- 307 (532)
.+...+.||.|+++.||.+++..+ |+++|||++....... ....+.+.+|......+.+
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t-~~~~avkvf~~~~~~~-----------~~~~~~~~~e~l~~~~~~~~~~p~~a~~ 80 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVET-GEEFAVKVFLLPADAS-----------ANEYEQLKEEQLAITLFPGVKNPKEAYR 80 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEEEESSTTH-----------TTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred EEEEccccccCCceEEEEEEEccC-CceEEEEEEecccccc-----------hHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence 356678999999999999999875 9999999987665222 2335566666655555432
Q ss_pred --CCccccee--------EEecC---C-----ceEEEEEeccCCCHHHHHhh---hcCCCCCCCHHHHHHHHHHHHHHHH
Q 037084 308 --RNLLPLQA--------HVTRP---D-----CHLLVYEFMKNGSLQDILHD---VSQGRRELDWLARYRIARGMASGLE 366 (532)
Q Consensus 308 --~niv~l~~--------~~~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~gl~ 366 (532)
.-++++-- ++... + ..+++|+-+ -++|.+++.- .......+....++.+..|+.+.++
T Consensus 81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA 159 (288)
T PF14531_consen 81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVA 159 (288)
T ss_dssp HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHH
Confidence 11121111 11111 1 236778877 6688887543 2233344666777888899999999
Q ss_pred HHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc--------CCCCchh
Q 037084 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT--------LTISEKS 438 (532)
Q Consensus 367 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~s 438 (532)
+||+.| ++|+||+|+|++++.+|.++|+||+.....+... .....+..|.|||.... -.++.+.
T Consensus 160 ~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~ 231 (288)
T PF14531_consen 160 NLHSYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFAT 231 (288)
T ss_dssp HHHHTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred HHhhcc---eEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeecc
Confidence 999999 9999999999999999999999998766543321 12445678999996643 2578899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCC
Q 037084 439 DIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEER 517 (532)
Q Consensus 439 DvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 517 (532)
|.|++|+++|.|+||..||+......... | . -..+.+.++.+..|+..+++.||.+|
T Consensus 232 DaW~LG~~ly~lWC~~lPf~~~~~~~~~~----~-----------------~-f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 232 DAWQLGITLYSLWCGRLPFGLSSPEADPE----W-----------------D-FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHSS-STCCCGGGSTSG----G-----------------G-GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CHHHHHHHHHHHHHccCCCCCCCcccccc----c-----------------c-chhcCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999999999998643311110 0 1 11233667789999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=183.78 Aligned_cols=180 Identities=13% Similarity=0.146 Sum_probs=134.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...++||.|+||.||++.. ++..+|||.++........... .......+.+|+..+.+++||+|..+
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~-----~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLK-----SFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHH-----hhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 357899999999999999999744 2668999999865433211110 00012347899999999999999999
Q ss_pred eeEEecC--------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 314 QAHVTRP--------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 314 ~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
..++... +..+|+|||++|.+|.++.. ++. ....+++.++..+|..+ ++|||+||+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~N 165 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGN 165 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHH
Confidence 8886533 35789999999999988742 222 24568999999999999 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 451 (532)
|+++++| ++++|||........... ..++....+..++|+||||+++..+.
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988 999999988765332211 01344445667999999999886554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=180.02 Aligned_cols=155 Identities=16% Similarity=0.123 Sum_probs=111.7
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHH---H----HHHH-----HHHHHHHHHHHHHHHHHhcCCCC
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATEL---L----NVRR-----VLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~---~----~~~~-----~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
.+.||+|+||.||+|... +|++||||+++......... . ..+. ............|+..+.++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 468999999999999886 59999999998653211100 0 0000 00000112345699999999888
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEE
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYL-HMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dlkp~NIl 387 (532)
++.....+.. ...++||||++++++...... ...++......++.|++.+|.|+ |+.+ |+||||||+||+
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 7754443322 234899999998877655322 24688899999999999999999 6888 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCC
Q 037084 388 IDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~ 407 (532)
++ ++.++|+|||+|.....
T Consensus 151 i~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred EE-CCcEEEEEccccccCCC
Confidence 98 47899999999975533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=174.33 Aligned_cols=155 Identities=15% Similarity=0.138 Sum_probs=113.8
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHH----HH--------HHHHHHHHHHHHHHHHHhcCCCC
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV----RR--------VLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
.+.||+|+||.||+|.+. +|+.||||+++............ .. -........+..|...+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 468999999999999876 59999999998763211000000 00 00011123456899999999999
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEE
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVL 387 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIl 387 (532)
++.....+... ..++||||++|+++...... ...++......++.+++.++.++|+ .+ ++||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 88655544433 24899999988865443221 2346778889999999999999999 88 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCC
Q 037084 388 IDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~ 407 (532)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 78999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.4e-22 Score=212.11 Aligned_cols=252 Identities=23% Similarity=0.236 Sum_probs=179.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
++...+.||++.|=.|.+|+++ .|. |+||++-.....-. .....+-..|++ ...++|||.+++.-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~s----------L~~~~qrL~~ik-~~l~~~pn~lPfqk~ 89 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTIS----------LRPFKQRLEEIK-FALMKAPNCLPFQKV 89 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCC----------chHHHHHHHHHH-HHhhcCCcccchHHH
Confidence 5677789999999999999887 354 99999865432110 111122223333 455689999999888
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
-......|||=+|..+ +|.|.+. .++-+.......|+.|++.||...|..+ |+|+|||.+|||++.-+-+.|
T Consensus 90 ~~t~kAAylvRqyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 90 LVTDKAAYLVRQYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHhhHHHHHHHHHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhh
Confidence 8888888999999944 8999884 5677888888999999999999999999 999999999999999999999
Q ss_pred eccCCcccCC--CCC---cceeeeccccccccccccccccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037084 397 SDFGLAKLMP--DGH---TRIRITTVAGTTGYVAPEYHQTL-----------TISEKSDIYSFGVLLAVLVV-GKFPFDD 459 (532)
Q Consensus 397 ~DFGla~~~~--~~~---~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvvl~ellt-g~~p~~~ 459 (532)
+||..-+... .+. ...-..+...-.+|.|||.+... ..+++.||||+||++.||++ |++||.-
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 9998766432 111 11112344445689999976431 15788999999999999999 7888852
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
. ++..+ ...+ ..++...-+.. +-..+.+++..|++.||++|.++++.++.-
T Consensus 242 S-------QL~aY----r~~~----~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 242 S-------QLLAY----RSGN----ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred H-------HHHhH----hccC----ccCHHHHHHhC--cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1 11111 1110 00110000000 001378899999999999999999998763
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=170.65 Aligned_cols=190 Identities=14% Similarity=0.069 Sum_probs=143.1
Q ss_pred ccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeEEe
Q 037084 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAHVT 318 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 318 (532)
....|++|+||+||.+.. ++.+++.+.+........ .-....|.+|+++|++|. |+++++++++
T Consensus 6 ~~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~----------~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-- 70 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLR----------GVAWWLARREALALRQLDGLPRTPRLLHW-- 70 (218)
T ss_pred cceeecCCCcceEEEeec---CCceeeecccccchhhhh----------hHHHHHHHHHHHHHHhcCCCCCCCEEEEE--
Confidence 457899999999997744 478999888887653321 111236889999999995 5889999887
Q ss_pred cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEecCCCcEEEe
Q 037084 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI-KPANVLIDDGMEARIS 397 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~ 397 (532)
+..+++|||++|.+|...+.. . ...++.+++.+|.++|+.+ |+|||| ||+|||++.++.++|+
T Consensus 71 --~~~~lvmeyI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LI 134 (218)
T PRK12274 71 --DGRHLDRSYLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVI 134 (218)
T ss_pred --cCEEEEEeeecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEE
Confidence 446999999999998654321 1 1346788999999999999 999999 7999999999999999
Q ss_pred ccCCcccCCCCCcc----e-------eeeccccccccccccccccC-CCC-chhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 398 DFGLAKLMPDGHTR----I-------RITTVAGTTGYVAPEYHQTL-TIS-EKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 398 DFGla~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
|||++......... . ......+++.|++|+...-. ..+ ...+.++-|+-+|.++|++.|+-..
T Consensus 135 DFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 135 DFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 99999865543310 0 00123368888888854432 233 5679999999999999999887543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=190.17 Aligned_cols=218 Identities=24% Similarity=0.365 Sum_probs=164.9
Q ss_pred HhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 037084 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381 (532)
Q Consensus 302 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 381 (532)
|+.+.|.|+.+++|.+..+...+.|.+||.-|+|.|.+.. ....++|.....++++++.||+|||... -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 3568899999999999999999999999999999999975 4567999999999999999999999753 2399999
Q ss_pred CCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCC-------CCchhhHHHHHHHHHHHHhCC
Q 037084 382 KPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-------ISEKSDIYSFGVLLAVLVVGK 454 (532)
Q Consensus 382 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvvl~elltg~ 454 (532)
+++|.++|....+|++|||+.................-..-|.|||.+.... .+.+.|+||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999988765311111111222345699999887642 466799999999999999999
Q ss_pred CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 455 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.||+..........+...+.. .+ ...+.|.+.... +....+..++..||..+|.+||+++.+-..++.+.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999875443333334443333 11 111222221111 33346888999999999999999999998887653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.7e-19 Score=193.27 Aligned_cols=195 Identities=23% Similarity=0.296 Sum_probs=157.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW---HRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv 311 (532)
.+.|.+.+.||+|+||+||+|... +|+.||+|+-+.+..++-.+ -.+++.||+ -+.|.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~--~~~~~alK~e~P~~~WEfYI-----------------~~q~~~RLk~~~~~~~~ 757 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHS--NGKLVALKVEKPPNPWEFYI-----------------CLQVMERLKPQMLPSIM 757 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecC--CCcEEEEEeecCCCceeeee-----------------hHHHHHhhchhhhcchH
Confidence 356888899999999999999887 49999999998876553221 111222333 23444
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec--
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-- 389 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-- 389 (532)
.+...+.-.+..+||+||.+-|+|.++++ ..+..+|...+.+..|++..+++||..+ |||+||||+|+||.
T Consensus 758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 758 HISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRRE 830 (974)
T ss_pred HHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecc
Confidence 45555555677899999999999999996 4667899999999999999999999999 99999999999993
Q ss_pred -----CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 037084 390 -----DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF 455 (532)
Q Consensus 390 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 455 (532)
++..++|+|||.+--+.--..........+|-.+-.+|...+.+++...|.|.++.+++.||.|+.
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 344589999999876543333344577889999999999999999999999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=163.73 Aligned_cols=136 Identities=15% Similarity=0.153 Sum_probs=104.2
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-----CCCCcccc
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-----WHRNLLPL 313 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l 313 (532)
...+.||+|+||.||. ++. ++.. +||++..... ...+.+.+|+.+++.+ .||||+++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~~--------------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~ 66 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRGD--------------GGDKEIRRELKYYAHLSRRLIDWSGIPRY 66 (210)
T ss_pred CCcceecCCCceEEEE--CCC-CcCe-EEEEEecccc--------------chHHHHHHHHHHHHHhhccCCCCccccee
Confidence 3457899999999995 553 3545 6998876431 1235688999999999 57999999
Q ss_pred eeEEecCC---ceE-EEEEe--ccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcE
Q 037084 314 QAHVTRPD---CHL-LVYEF--MKNGSLQDILHDVSQGRRELDWLARYRIARGMASGL-EYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 314 ~~~~~~~~---~~~-lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+|++.++. ..+ +|+|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+.+ |+||||||+||
T Consensus 67 yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NI 136 (210)
T PRK10345 67 YGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNI 136 (210)
T ss_pred eEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHE
Confidence 99998873 333 78999 567999999964 125544 35577888777 9999999 99999999999
Q ss_pred EecC----CCcEEEeccCCc
Q 037084 387 LIDD----GMEARISDFGLA 402 (532)
Q Consensus 387 ll~~----~~~~kl~DFGla 402 (532)
|++. ++.++|+||+.+
T Consensus 137 Ll~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 137 LCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEeccCCCCCcEEEEECCCC
Confidence 9974 347999995544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-18 Score=163.01 Aligned_cols=142 Identities=21% Similarity=0.313 Sum_probs=117.1
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
+.||+|++|.||+|.+. |..+++|............. .......+.+|+.++..++|+|++....++...+
T Consensus 2 ~~l~~G~~~~vy~~~~~---~~~~~vK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 72 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL---GIKAVIKWRIPKRYRHPELD------ERIRRERTRREARIMSRARKAGVNVPAVYFVDPE 72 (211)
T ss_pred cccccCceEEEEEEeeC---CCceEEEEeCCcCCcChHHH------HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC
Confidence 57999999999999874 77899998765433221111 0223456889999999999999988888887778
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..+++|||++|++|.+++... .+ .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||+
T Consensus 73 ~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 73 NFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred CCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCc
Confidence 889999999999999998641 12 77889999999999999998 99999999999999 78899999999
Q ss_pred ccc
Q 037084 402 AKL 404 (532)
Q Consensus 402 a~~ 404 (532)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-20 Score=188.49 Aligned_cols=229 Identities=25% Similarity=0.319 Sum_probs=176.5
Q ss_pred eecccCCeEEEEEEee--CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeEEec
Q 037084 243 IIGVGACGVVYKAEVP--GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAHVTR 319 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 319 (532)
.+|+|+||.|+++.-- ...|..+|.|+++....... .......|..++...+ ||.+|.+.-.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~------------~~~~t~~er~il~~~~~~~f~v~lhyafqt 68 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR------------DRTHTKQERIILAFVHNTPFLVKLHYAFQT 68 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccc------------cccccccHHHHHhhccCCCceeeeeeeecc
Confidence 3799999999976421 11267889998877543321 1124556777788886 9999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
+...+++.+|..||.|...+.. ...+.......+...++-+++++|+.+ ++|||+|++||+++.+|++++.||
T Consensus 69 ~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdf 141 (612)
T KOG0603|consen 69 DGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDF 141 (612)
T ss_pred ccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCc
Confidence 9999999999999999888854 344666666677888899999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhcc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~ 479 (532)
|+++..-... ..+||..|||||++. .....+|.||||++++||+||..||.. +.+..+...
T Consensus 142 glske~v~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~ 202 (612)
T KOG0603|consen 142 GLSKEAVKEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKA 202 (612)
T ss_pred hhhhHhHhhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhh
Confidence 9998765543 228999999999998 467789999999999999999999975 112222211
Q ss_pred CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 480 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
. ...+.+....+.+++..++..+|.+|.-.
T Consensus 203 ~-----------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 E-----------LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred c-----------cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 12234445556777777888888888655
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=168.84 Aligned_cols=196 Identities=19% Similarity=0.245 Sum_probs=136.0
Q ss_pred CCCCcccceeEEec---------------------------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHH
Q 037084 306 WHRNLLPLQAHVTR---------------------------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358 (532)
Q Consensus 306 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 358 (532)
+|||||++.+.|.+ +..+|+||.-. ..+|..++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 69999998887642 34568888877 4589998863 345666777799
Q ss_pred HHHHHHHHHHHhcCCCCeeecCCCCCcEEec--CCC--cEEEeccCCcccCCCCCcce----eeeccccccccccccccc
Q 037084 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLID--DGM--EARISDFGLAKLMPDGHTRI----RITTVAGTTGYVAPEYHQ 430 (532)
Q Consensus 359 ~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~ 430 (532)
.|+++|+.|||.++ |.|||+|++|||+. +++ .+.|+|||.+--.....-.. ..-...|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999983 333 47899999875433211111 112345788899999877
Q ss_pred cCCC------CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHH
Q 037084 431 TLTI------SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLK 504 (532)
Q Consensus 431 ~~~~------~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 504 (532)
..+- -.|+|.|+.|.+.||++....||... .+...+...+-+ ... +.-++.++-.+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r--Gem~L~~r~Yqe-----~qL---------Palp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR--GEMLLDTRTYQE-----SQL---------PALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc--chheechhhhhh-----hhC---------CCCcccCChHHHH
Confidence 5432 35899999999999999999999652 112222211111 111 1112233344778
Q ss_pred HHHHcCCCCCCCCCCHHHHHHH
Q 037084 505 IAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 505 l~~~cl~~~P~~RPs~~evl~~ 526 (532)
++...++.||++||+..-....
T Consensus 489 lV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHhcCCccccCCccHHHhH
Confidence 8888999999999997654443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=159.63 Aligned_cols=139 Identities=21% Similarity=0.321 Sum_probs=111.0
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCc
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC 322 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 322 (532)
.||+|+||.||+|.+. |..+++|..........+.. ......++.+|+.++..++|+++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~---~~~~viK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL---GLKAVIKERVPKSYRHPELD------ERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN 71 (199)
T ss_pred CCCCCceEEEEEeecC---CccEEEEEecCCcCcCchHH------HHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC
Confidence 4899999999999864 78899999665432111110 02234678899999999999887766666667777
Q ss_pred eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCc
Q 037084 323 HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402 (532)
Q Consensus 323 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 402 (532)
.++||||++|++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++
T Consensus 72 ~~lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 72 KTIVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred CEEEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCC
Confidence 89999999999999987541 10 78999999999999988 99999999999999 789999999998
Q ss_pred ccC
Q 037084 403 KLM 405 (532)
Q Consensus 403 ~~~ 405 (532)
...
T Consensus 137 ~~~ 139 (199)
T TIGR03724 137 KYS 139 (199)
T ss_pred cCC
Confidence 753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=179.51 Aligned_cols=144 Identities=21% Similarity=0.254 Sum_probs=113.6
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...+.||+|+||+||+|.+. +..+++|+........... .......++.+|+.++..++|+|++....+
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~---~~~~v~k~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL---GRDAVIKERVPKGYRHPEL------DERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccCccceeccCCcEEEEEEeec---CccceeEEEecccccchhH------HHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 3456789999999999999876 4445555433221111100 012234678899999999999999988888
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+......++||||+++++|.+++. ....++.+++.+|.|||+.+ ++||||||+||++ +++.++|
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 888788899999999999999885 24578999999999999988 9999999999999 6778999
Q ss_pred eccCCcccC
Q 037084 397 SDFGLAKLM 405 (532)
Q Consensus 397 ~DFGla~~~ 405 (532)
+|||+++..
T Consensus 469 iDFGla~~~ 477 (535)
T PRK09605 469 IDFGLGKYS 477 (535)
T ss_pred EeCcccccC
Confidence 999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=158.65 Aligned_cols=160 Identities=16% Similarity=0.085 Sum_probs=112.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHH----H-----H-HHHHHHHHHHHHHHHHHhcCC
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV----R-----R-VLINRKMRQIKSEIITAGRIW 306 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~----~-----~-~~~~~~~~~~~~E~~~l~~l~ 306 (532)
.|.+.+.||+|+||.||+|.++..+|+.||+|+++............ . . .........+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36777899999999999998333359999999997653211000000 0 0 000111234678999999997
Q ss_pred CCC--cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 037084 307 HRN--LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 307 H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~ 384 (532)
+.+ +..++++ ...++||||+++++|...... ...+.......++.|++.++.+||+.+ .++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 643 3333432 235899999999888765422 234555666789999999999999765 3999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCC
Q 037084 385 NVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~ 407 (532)
||+++ ++.++|+|||.+.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=154.91 Aligned_cols=151 Identities=19% Similarity=0.142 Sum_probs=110.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHH--------HHHHHHHHHHHHHHHhcCCCCC
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL--------INRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~H~n 309 (532)
|...+.||+|+||.||++... +|+.||||++..+...........+.. .......+..|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 666789999999999999875 599999999876542211111100000 0112234678899999998874
Q ss_pred --cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 310 --LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 310 --iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++..++ ....++||||++|++|.+.... .....++.+++.++.++|+.+ ++|+||||+||+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil 157 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL 157 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence 334433 2456899999999999765421 234568899999999999988 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCC
Q 037084 388 IDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~ 407 (532)
+++++.++|+|||++.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-18 Score=172.79 Aligned_cols=124 Identities=30% Similarity=0.471 Sum_probs=109.1
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
.+|+.|++|.-.+|.+|+.+. ......++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999753 344567888999999999999999 66 99999999999999999999999999
Q ss_pred cccCCCCC----cceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 402 AKLMPDGH----TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 402 a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
........ .....+...||..||+||.+.+..|+.++|+||||++++|+++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 88776554 2223467889999999999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-17 Score=177.37 Aligned_cols=212 Identities=25% Similarity=0.309 Sum_probs=143.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
-..+|..++.|-.|+||.||.++++.+ .+++|.|+-+..- -..+ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~t-rqrfa~kiNkq~l-------------------ilRn---ilt~a~npfvv-- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKET-RQRFAMKINKQNL-------------------ILRN---ILTFAGNPFVV-- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeecccc-ccchhhcccccch-------------------hhhc---cccccCCccee--
Confidence 356799999999999999999998864 6788884322210 0000 11122222222
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
|+-...+.. -++++... +.+++|||+.+ |+|||+||+|.+++.-|+
T Consensus 136 -------------------gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGh 181 (1205)
T KOG0606|consen 136 -------------------GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGH 181 (1205)
T ss_pred -------------------chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeeccc
Confidence 344444432 22333322 66899999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCC-------------cceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 394 ARISDFGLAKLMPDGH-------------TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+|++|||+++...... ........+||+.|.|||++..+.|...+|.|++|+++||.+-|+.||...
T Consensus 182 iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 182 IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 9999999988532110 011124568999999999999999999999999999999999999999864
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
.+.+ .+..++... ..+.+.......++.+++...++.+|..|--
T Consensus 262 tpee-------lfg~visd~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 262 TPEE-------LFGQVISDD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred CHHH-------HHhhhhhhh--------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 3311 111111110 0111223333455788888899999999853
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=138.48 Aligned_cols=135 Identities=20% Similarity=0.231 Sum_probs=112.8
Q ss_pred ccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC--CCcccceeEE
Q 037084 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH--RNLLPLQAHV 317 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~ 317 (532)
+.+.||+|.++.||++... +..+++|....... ...+..|+..+..++| .+++++++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~ 62 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK----------------GADREREVAILQLLARKGLPVPKVLASG 62 (155)
T ss_pred cceecccccccceEEEEec---CCeEEEEecCCCCc----------------hhHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 3578999999999999875 47899999876531 2457788888988876 5888999998
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++++||++++++..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.
T Consensus 63 ~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~ 131 (155)
T cd05120 63 ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGII 131 (155)
T ss_pred CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEE
Confidence 888889999999988777543 445667789999999999998755569999999999999998999999
Q ss_pred ccCCccc
Q 037084 398 DFGLAKL 404 (532)
Q Consensus 398 DFGla~~ 404 (532)
|||.+..
T Consensus 132 Df~~~~~ 138 (155)
T cd05120 132 DWEYAGY 138 (155)
T ss_pred ecccccC
Confidence 9999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-15 Score=140.42 Aligned_cols=151 Identities=20% Similarity=0.151 Sum_probs=99.1
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHH--HHH--------HHHHHHHHHHHHHHHhcCCCCC-
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVR--RVL--------INRKMRQIKSEIITAGRIWHRN- 309 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~--~~~--------~~~~~~~~~~E~~~l~~l~H~n- 309 (532)
.+.||+|+||.||+|.+. +|+.||||+++............. ... ..........|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 467999999999999876 589999999876532211110000 000 0000111234555666664443
Q ss_pred -cccceeEEecCCceEEEEEeccCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcE
Q 037084 310 -LLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANV 386 (532)
Q Consensus 310 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NI 386 (532)
+.+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|+ .+ ++|+||||+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 3333332 24589999999854322 121100 01 4567889999999999998 77 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCC
Q 037084 387 LIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~ 407 (532)
+++ ++.++++|||.+.....
T Consensus 147 li~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEE-CCcEEEEECcccccccC
Confidence 999 88999999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.7e-15 Score=144.14 Aligned_cols=149 Identities=14% Similarity=0.182 Sum_probs=108.7
Q ss_pred cceec-ccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc--ccceeEE
Q 037084 241 LEIIG-VGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL--LPLQAHV 317 (532)
Q Consensus 241 ~~~LG-~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~ 317 (532)
...|| .||.|+||.+... +..++||.+........- ..............+.+|+.++.+++|+++ +..+++.
T Consensus 36 ~~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv-~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKL-SKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred CceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhh-hhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 45788 8999999999765 778999998654321110 000000001234668899999999999885 5677765
Q ss_pred ecCCc----eEEEEEeccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 318 TRPDC----HLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 318 ~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
..... .++|+||++| .+|.+++.. .+++.. .+.+++.++.+||+.| |+|+||||.|||++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDG 179 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCC
Confidence 43322 2599999997 699988853 234443 3568999999999999 99999999999999989
Q ss_pred cEEEeccCCcccC
Q 037084 393 EARISDFGLAKLM 405 (532)
Q Consensus 393 ~~kl~DFGla~~~ 405 (532)
.++|+|||.+...
T Consensus 180 ~v~LIDfg~~~~~ 192 (239)
T PRK01723 180 KFWLIDFDRGELR 192 (239)
T ss_pred CEEEEECCCcccC
Confidence 9999999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.2e-17 Score=176.16 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=191.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l 313 (532)
...|...+.||+|+|+.|-...........+|+|.+...... .........|..+-..+. |+|++.+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~------------~~~~~~i~~e~~~~~~~s~h~n~~~~ 86 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS------------EDSSEHIDTETDIQKKLSKHSNTVHM 86 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc------------cchhhhcCcccccccccccccccccc
Confidence 445778888999999999998765544567888887766411 111233444566666665 9999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH-MYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++....++..++..+|..++++.+.+.. ......+....-.+..|+..++.|+| ..+ +.|+|+||+|.+++.++
T Consensus 87 ~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 87 IEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESG 161 (601)
T ss_pred CCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCC
Confidence 9999999999999999999999988831 12213344455667999999999999 777 99999999999999999
Q ss_pred -cEEEeccCCcccCCC-CCcceeeecccc-ccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 393 -EARISDFGLAKLMPD-GHTRIRITTVAG-TTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 393 -~~kl~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.++++|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+...... ...
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~--~~~ 239 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK--DGR 239 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc--ccc
Confidence 999999999998877 444444466778 9999999988874 4567899999999999999999999764431 122
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
...|..... . .... ..........++...++..+|..|.+.+++.
T Consensus 240 ~~~~~~~~~---~----~~~~----~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 240 YSSWKSNKG---R----FTQL----PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ceeeccccc---c----cccC----ccccCChhhhhcccccccCCchhcccccccc
Confidence 222222110 0 0000 1112223366777788889999999988764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-13 Score=143.10 Aligned_cols=155 Identities=18% Similarity=0.221 Sum_probs=104.1
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHH--HH----------------------HHHHHHHHHH--HHHH
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATE--LL----------------------NVRRVLINRK--MRQI 295 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~--~~----------------------~~~~~~~~~~--~~~~ 295 (532)
+.||+|++|.||+|+++ +|+.||||+.+......-. .. ...+...... .-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 67999999999999987 6999999999765322110 00 0000111111 1246
Q ss_pred HHHHHHHhcCC-----CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 037084 296 KSEIITAGRIW-----HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS-GLEYLH 369 (532)
Q Consensus 296 ~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH 369 (532)
.+|+..+.+++ ++++.-..-+....+..+|||||++|++|.++...... ..+ +.+++..++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHH
Confidence 67777766663 34433222222233457999999999999988753111 122 3456666665 467889
Q ss_pred hcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCC
Q 037084 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 370 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 407 (532)
..| ++|+|++|.||++++++.++++|||++.....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 888 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.3e-14 Score=136.33 Aligned_cols=202 Identities=21% Similarity=0.300 Sum_probs=142.7
Q ss_pred HhcCCCCCcccceeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 037084 302 AGRIWHRNLLPLQAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376 (532)
Q Consensus 302 l~~l~H~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 376 (532)
|-++-|.|||++..|..+. .+..++.|||..|+|..+|++.......+......+++.||..||.|||+. .++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 4456799999999988653 456899999999999999999887788888899999999999999999997 5779
Q ss_pred eecCCCCCcEEecCCCcEEEeccCCcccCC--CCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 037084 377 IHRDIKPANVLIDDGMEARISDFGLAKLMP--DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454 (532)
Q Consensus 377 vH~Dlkp~NIll~~~~~~kl~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 454 (532)
+|+++..+.|++..+|-+|++----..... ............+-++|.+||+-.....+..+|||+||...++|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999999985321111000 000000112344678999999888778888999999999999998877
Q ss_pred CC-CCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 455 FP-FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 455 ~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.- -...........+.. ........+ =..++..|++..|..||+|++++.
T Consensus 280 iq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence 43 221111111111100 000111111 123556799999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.3e-12 Score=138.10 Aligned_cols=158 Identities=14% Similarity=0.171 Sum_probs=94.9
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhh--HHHHHH-------------------HHHHHHHHH---
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAA--TELLNV-------------------RRVLINRKM--- 292 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~-------------------~~~~~~~~~--- 292 (532)
.|.. +.||+|++|.||+|+++.+ |+.||||++++.-... .++... ..+. ....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~-G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v-~e~~~~l 197 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDN-GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV-AEFEKTL 197 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCC-CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH-HHHHHHH
Confidence 4555 7899999999999999843 9999999998763211 000000 0000 0111
Q ss_pred ---HHHHHHHHHHhcCC----CCCcccceeEEec-CCceEEEEEeccCCCHHHHH--hhhcCCCCCCCHHHHHHHHHHHH
Q 037084 293 ---RQIKSEIITAGRIW----HRNLLPLQAHVTR-PDCHLLVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRIARGMA 362 (532)
Q Consensus 293 ---~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~ia 362 (532)
-+|.+|+.-+.+++ +.+.+.+=.++.+ ....+|||||++|+++.+.- .........+.......+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~----- 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF----- 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH-----
Confidence 23455555554442 3333322222222 34568999999999998753 211001111222222222
Q ss_pred HHHHHHHhcCCCCeeecCCCCCcEEecCCC----cEEEeccCCcccCCC
Q 037084 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGM----EARISDFGLAKLMPD 407 (532)
Q Consensus 363 ~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFGla~~~~~ 407 (532)
+..++..| ++|+|++|.||+++.++ .+++.|||++...+.
T Consensus 273 --~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 --FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23344566 99999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-12 Score=117.51 Aligned_cols=131 Identities=19% Similarity=0.209 Sum_probs=96.0
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc-ceeEEec
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP-LQAHVTR 319 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~ 319 (532)
++.|+.|.++.||+++.. |..+++|....... ....+..|+..+..+.+.++++ ++.+.
T Consensus 3 ~~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~~~P~~~~~~-- 62 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE---------------LLINRENEAENSKLAAEAGIGPKLYYFD-- 62 (170)
T ss_pred eeecCCcccCceEEEEEC---CeEEEEEeCCCCcc---------------cccCHHHHHHHHHHHHHhCCCCceEEEe--
Confidence 467899999999999864 77899999865421 1123567888888886655543 44443
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEecCCCcEEEe
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH--RPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
....++||||++|.++.+.. . ....++.+++++++.||+.+ ...++|+|++|.||+++ ++.++++
T Consensus 63 ~~~~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~li 129 (170)
T cd05151 63 PETGVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLI 129 (170)
T ss_pred CCCCeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence 23458999999998875430 0 11235678999999999876 23469999999999999 6689999
Q ss_pred ccCCccc
Q 037084 398 DFGLAKL 404 (532)
Q Consensus 398 DFGla~~ 404 (532)
|||.+..
T Consensus 130 Df~~a~~ 136 (170)
T cd05151 130 DWEYAGM 136 (170)
T ss_pred ecccccC
Confidence 9998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.7e-11 Score=109.00 Aligned_cols=139 Identities=22% Similarity=0.330 Sum_probs=108.4
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPD 321 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 321 (532)
..+++|+-+.+|.+.+. |.++++|.-.......+++.. .-...+-.+|++++++++--.+....-+..+++
T Consensus 2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~------klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDE------KLRRERTRREARILAKAREAGVPVPIVYDVDPD 72 (204)
T ss_pred chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHH------HHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 35889999999999875 656777765443322222211 223567789999999998778877778888888
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
...|+|||++|..|.+.+... ...++..+-.-+.-||..+ |+|+||+++||++.+.+ +.++||||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGL 137 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGL 137 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCc
Confidence 889999999999999898752 2456777777888899998 99999999999998765 99999999
Q ss_pred ccc
Q 037084 402 AKL 404 (532)
Q Consensus 402 a~~ 404 (532)
+..
T Consensus 138 g~~ 140 (204)
T COG3642 138 GEF 140 (204)
T ss_pred ccc
Confidence 874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.2e-11 Score=107.72 Aligned_cols=151 Identities=21% Similarity=0.232 Sum_probs=112.9
Q ss_pred ccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
.+..|-||+-+.|+++.+. |+.+.||.-.......+.+. ..-...+..+|++.|.+++--.|.-..-++.+
T Consensus 11 ~l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD------~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D 81 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALD------QKLTRKRTKQEARLLAKCRALGIPAPRLIFID 81 (229)
T ss_pred cceeeeccceeeEeeeccC---CceeEEeecccccccchHHH------HHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe
Confidence 4678999999999999886 88888886544332222111 13335778899999999877777766677777
Q ss_pred CCceEEEEEeccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc---EE
Q 037084 320 PDCHLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME---AR 395 (532)
Q Consensus 320 ~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~k 395 (532)
.....|+|||++| .++.+++..... .+........++..+-+.+.-||..+ ++|+||..+||+|..++. +.
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence 7788899999966 488888876332 22222333678888999999999998 999999999999975553 58
Q ss_pred EeccCCccc
Q 037084 396 ISDFGLAKL 404 (532)
Q Consensus 396 l~DFGla~~ 404 (532)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.7e-12 Score=133.82 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=178.4
Q ss_pred cCccccceecc--cCCeEEEEEEe--eCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCc
Q 037084 236 DSLASLEIIGV--GACGVVYKAEV--PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNL 310 (532)
Q Consensus 236 ~~~~~~~~LG~--G~fG~Vy~~~~--~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ni 310 (532)
..+.....+|. |.+|.||.+.. .. ++..+|+|.-+...... ....+=.+|+..-..+ .|+|.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~s~p------------~~~~~k~~~~~s~~~i~~~~~~ 180 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPFSPP------------LDSKRKLREFLSHHKIDSHENP 180 (524)
T ss_pred hhcccccccccCCCCCceeecccCCccc-CCcccccccccCCCCCc------------cccccccchhhcccccCccccc
Confidence 34666788999 99999999987 54 37889999844332110 1112223455555556 58999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcE
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMAS----GLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++........+..++-+|+| +.+|..+.+. ....++....+.+..+..+ |+.++|+.+ ++|-|+||.||
T Consensus 181 v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i 253 (524)
T KOG0601|consen 181 VRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANI 253 (524)
T ss_pred cccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhhe
Confidence 99888889999999999999 6788888774 2344666777888888888 999999988 99999999999
Q ss_pred EecCC-CcEEEeccCCcccCCCCCccee---eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 387 LIDDG-MEARISDFGLAKLMPDGHTRIR---ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 387 ll~~~-~~~kl~DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
+...+ ...+++|||+...+........ .....|...|++||...+ .++..+|+|++|.++.+-.+|..+......
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 99998 8899999999998876542211 122357778999998865 788999999999999999988766543110
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. .|.. .... . +..+++......+...+..+++.+|..|++...+..
T Consensus 333 ----~---~W~~--~r~~-----~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 ----S---SWSQ--LRQG-----Y---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----C---Cccc--cccc-----c---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 0110 0000 0 011122222233445778899999999999887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.31 E-value=3e-11 Score=111.26 Aligned_cols=153 Identities=17% Similarity=0.091 Sum_probs=101.8
Q ss_pred ceecccCCeEEEEEEeeCC-----CCcEEEEEEcCCCChhhHHHHHHH----HH--------HHHHHHHHHHHHHHHHhc
Q 037084 242 EIIGVGACGVVYKAEVPGS-----YGKMIAIKKIDQPPMAATELLNVR----RV--------LINRKMRQIKSEIITAGR 304 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~~E~~~l~~ 304 (532)
..||.|--+.||.|...+. .+..+|||+.+.....-.....+. +. ..........+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 5799999999999975421 247999999875432111111000 00 001112234489999999
Q ss_pred CCC--CCcccceeEEecCCceEEEEEeccCCCHHH-HHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecC
Q 037084 305 IWH--RNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYRIARGMASGLEYL-HMYHRPCIIHRD 380 (532)
Q Consensus 305 l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~D 380 (532)
+.. -+++.++++ ...++||||+.++.+.. .+.+ ..++......+..+++.+|..| |..+ ++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 854 355566654 56689999997654422 2221 2244455667789999999998 7888 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~ 407 (532)
|+|.||++++ +.+.|+|||.+.....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999974 6799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.6e-10 Score=120.49 Aligned_cols=165 Identities=15% Similarity=0.166 Sum_probs=123.8
Q ss_pred CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecCCceEEEEEeccCCCHHHHHh
Q 037084 261 YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340 (532)
Q Consensus 261 ~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 340 (532)
++.+|.|...+.... .......+-++-|+.++||||++++....+.+..|||+|-+ ..|..++.
T Consensus 36 ~~~~vsVF~~~~~~~--------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk 99 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLK 99 (690)
T ss_pred cCCceEEEEEeCCCc--------------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHH
Confidence 588898888877642 11233456677789999999999999999999999999987 36777776
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccc
Q 037084 341 DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420 (532)
Q Consensus 341 ~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt 420 (532)
. +........+.||+.||.+||..+. ++|++|..+.|+++..|+.||++|-++.......... ....--
T Consensus 100 ~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~ 168 (690)
T KOG1243|consen 100 E-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLI 168 (690)
T ss_pred H-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhh
Confidence 5 2244556678999999999986442 9999999999999999999999998876544332111 112223
Q ss_pred cccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 037084 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454 (532)
Q Consensus 421 ~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 454 (532)
..|..|+.+.... -..|.|.|||+++|++.|.
T Consensus 169 ~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 169 ESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 3466777554332 3469999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-10 Score=108.29 Aligned_cols=143 Identities=22% Similarity=0.276 Sum_probs=107.2
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC--CcccceeEEec
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR--NLLPLQAHVTR 319 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~ 319 (532)
+.||.|.++.||+++.. +|..+++|........ .....+..|+.++..+.+. ++.+++.+...
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~-------------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~ 68 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALL-------------PSAHDVAREYRVLRALAGTGVPVPKVLALCED 68 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccC-------------cccccHHHHHHHHHHhhCCCCCCCCEEEECCC
Confidence 67899999999999875 3689999998664211 0124577888889888663 45677777766
Q ss_pred CC---ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 037084 320 PD---CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH------------------------ 372 (532)
Q Consensus 320 ~~---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------ 372 (532)
.. ..++||||++|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 69 ~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (223)
T cd05154 69 PSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWR 143 (223)
T ss_pred CCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHH
Confidence 43 66899999999888765421 24666677778888888888888521
Q ss_pred -----------------------------CCCeeecCCCCCcEEecC--CCcEEEeccCCccc
Q 037084 373 -----------------------------RPCIIHRDIKPANVLIDD--GMEARISDFGLAKL 404 (532)
Q Consensus 373 -----------------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~ 404 (532)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 144 RQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.2e-11 Score=123.01 Aligned_cols=250 Identities=18% Similarity=0.162 Sum_probs=172.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
...+|..+..||.|.|+.|+....+..++..+++|.+......... ...-..|+.+...+ .|.+++.
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~------------di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS------------DIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh------------hhcchhhhhHhhHhhcccccCC
Confidence 3457899999999999999998755456789999998776433211 11223344444444 5788887
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC-
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG- 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~- 391 (532)
+..........|+=-|||+++++..... ....++...++++..+++.++.++|+.. ++|+|+||+||++..+
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccch
Confidence 7666666677789999999998877762 2234666778889999999999999888 9999999999999886
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccc--cccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYV--APEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+..+++|||....+.... ....++.+++ +|.......+..+.|++|||..+.+.++|..--....+
T Consensus 404 ~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------- 471 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------- 471 (524)
T ss_pred hhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------
Confidence 788999999876422221 2233344555 45555566788899999999999999988753322111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
|.. +..+... .. +....++..+...+..+++..||.+.++....+
T Consensus 472 --~~~--i~~~~~p---------~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 472 --SLT--IRSGDTP---------NL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --cee--eeccccc---------CC-CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 110 1111111 00 111144666777789999999999988776544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-08 Score=100.54 Aligned_cols=266 Identities=16% Similarity=0.174 Sum_probs=160.1
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEE
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHV 317 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 317 (532)
...+.||+|+-+.+|-.-- -.-.+-|+...+...... ..+..|... .||-+-.=+.|=
T Consensus 14 ~~gr~LgqGgea~ly~l~e----~~d~VAKIYh~Pppa~~a-----------------qk~a~la~~p~~p~~~~rvaWP 72 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE----VRDQVAKIYHAPPPAAQA-----------------QKVAELAATPDAPLLNYRVAWP 72 (637)
T ss_pred CCCccccCCccceeeecch----hhchhheeecCCCchHHH-----------------HHHHHhccCCCCcchhhhhccc
Confidence 4457899999999996421 122345777665433210 112223333 455433212221
Q ss_pred ------ecC-CceEEEEEeccCCC-HHHHHhh--hcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 318 ------TRP-DCHLLVYEFMKNGS-LQDILHD--VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 318 ------~~~-~~~~lV~E~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
-+. ...-++|..+++.. ..+++.. .++.-...+|...++.+..++.+.+.||..| .+-+|++++|+|
T Consensus 73 qa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~l 149 (637)
T COG4248 73 QATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFL 149 (637)
T ss_pred HHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCcccee
Confidence 111 22557777776642 3333331 1234566799999999999999999999998 899999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCcc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVG-KFPFDDFF 461 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~ 461 (532)
+++++.+.+.|=..-.....+. .....+|...|.+||... +-.-+..+|.|.+|+++++++.| +.||....
T Consensus 150 Vsd~~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 150 VSDDSKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eecCceEEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 9999999998754433332221 125678999999999655 22346789999999999999986 99997654
Q ss_pred cchhhccHHH-HHHHH--hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHHhhhh
Q 037084 462 QYTEEMNMVR-WMRNV--ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDD--PEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 462 ~~~~~~~l~~-~~~~~--~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~L~~l~ 531 (532)
.....-.-.+ -+... ....+......+.-..-.....+..+..+..+|+... +.-|||++.++..|..++
T Consensus 227 ~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 227 LISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred ccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 3222111111 00000 0000000000010001112223344666666787643 678999999999887765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.1e-09 Score=100.49 Aligned_cols=149 Identities=16% Similarity=0.131 Sum_probs=102.1
Q ss_pred ecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHH-HHHHHHHHHHHHHHHhcCCCCCcc--cceeEEec-
Q 037084 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL-INRKMRQIKSEIITAGRIWHRNLL--PLQAHVTR- 319 (532)
Q Consensus 244 LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~H~niv--~l~~~~~~- 319 (532)
+-......|++..+. |+.+.||......... .. +... .......+.+|...+.++...+|. .++++...
T Consensus 30 v~~~~~rrvvr~~~~---g~~~~vKr~~~~~~~~--~~--k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~ 102 (268)
T PRK15123 30 FRELEGRRTLRFELA---GKSYFLKWHRGTGWGE--IF--KNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERG 102 (268)
T ss_pred EecCCCceEEEEEEC---CEEEEEEEecCCcHHH--Hh--hhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEec
Confidence 333333446677664 7899999875543211 00 0000 001112477889988888655554 44556543
Q ss_pred ----CCceEEEEEeccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC----
Q 037084 320 ----PDCHLLVYEFMKNG-SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---- 390 (532)
Q Consensus 320 ----~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~---- 390 (532)
....++|+|++++. +|.+++.... ..+.+......++.+++..+..||..| ++|+|++++|||++.
T Consensus 103 ~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 103 SNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred CCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 23468999999886 8999986421 234556677789999999999999999 999999999999975
Q ss_pred ---CCcEEEeccCCccc
Q 037084 391 ---GMEARISDFGLAKL 404 (532)
Q Consensus 391 ---~~~~kl~DFGla~~ 404 (532)
++.+.++||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 46789999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.8e-11 Score=127.46 Aligned_cols=255 Identities=22% Similarity=0.208 Sum_probs=165.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+.+.+.+.+-+|.+|.++.+.-..+ |...+.|.......-. ....+....+-.++-..+||-++.
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~s-gh~~~~~v~~~ap~i~-----------~~~~~s~r~~s~~~i~p~~P~v~~ 868 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGS-GHTRPSKVHGLAPKIR-----------TNDYESIRSKSNILITPRSPAVVR 868 (1205)
T ss_pred CCCccceecccccCCCCcccccCCcccc-ccccchhhhccchhhc-----------cccccccCCccCccccCCCCceec
Confidence 3456788888899999999998865543 5555555544332110 001111111211221223455555
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
..-.+......+|+++|..+++|...|+... ..+..........+....+|||... +.|+|++|.|++...++
T Consensus 869 ~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 869 SFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred ccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccC
Confidence 4444455677899999999999999998632 2333333344556677899999876 89999999999999999
Q ss_pred cEEEeccCCcccCCCC--------C-------------c----c----eeeeccccccccccccccccCCCCchhhHHHH
Q 037084 393 EARISDFGLAKLMPDG--------H-------------T----R----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~--------~-------------~----~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 443 (532)
+.+++|||.......- . . . .......||+.|.+||...+......+|.|++
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 9999999844432100 0 0 0 01134568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 037084 444 GVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521 (532)
Q Consensus 444 Gvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 521 (532)
|++++|.++|.+||......... +++....-+ +............+++...+..+|.+|-.+.
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~f-------~ni~~~~~~--------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQIF-------ENILNRDIP--------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhhh-------hccccCCCC--------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999865442111 111111111 1222333344466677778888888887654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.6e-09 Score=96.42 Aligned_cols=140 Identities=21% Similarity=0.206 Sum_probs=83.9
Q ss_pred EEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHH------------HHHHHHHHHHHHHHHHHHHhcCCCC--CcccceeE
Q 037084 251 VVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV------------RRVLINRKMRQIKSEIITAGRIWHR--NLLPLQAH 316 (532)
Q Consensus 251 ~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~ 316 (532)
.||.|... +|..+|||+.+............ .............+|.+.|.++..- +++.++.+
T Consensus 1 ~Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 48999765 58899999987643221110000 0011122346778899999999876 45556544
Q ss_pred EecCCceEEEEEecc--CCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 317 VTRPDCHLLVYEFMK--NGSLQDILHDVSQGRRELDWLARYRIARGMASGLEY-LHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~-LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
. ..+|||||++ |..+..+... . ++......++.+++..+.. +|..+ ++|+||.+.||+++++ .
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~-~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDV-D-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHC-G-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred e----CCEEEEEecCCCccchhhHHhc-c-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 2 4579999998 5555443322 1 1122334567777775555 57777 9999999999999988 8
Q ss_pred EEEeccCCcccCC
Q 037084 394 ARISDFGLAKLMP 406 (532)
Q Consensus 394 ~kl~DFGla~~~~ 406 (532)
+.++|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.7e-08 Score=100.13 Aligned_cols=171 Identities=18% Similarity=0.254 Sum_probs=127.8
Q ss_pred CCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec----CCce
Q 037084 248 ACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR----PDCH 323 (532)
Q Consensus 248 ~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 323 (532)
.-.+.|++..+- +|..|++|+++....... ..-..-++.++++.|+|+|++..++.. ...+
T Consensus 288 ~~~Ttyk~~s~~-DG~~YvLkRlhg~r~~~~--------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Sl 352 (655)
T KOG3741|consen 288 FSITTYKATSNV-DGNAYVLKRLHGDRDQST--------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSL 352 (655)
T ss_pred ccceeEeeeecc-CCceeeeeeeccccccCc--------------ccchHHHHHHHHhccCceeehhhhhhhhccCcceE
Confidence 456889996654 699999999954422111 011223567888999999999988863 3567
Q ss_pred EEEEEeccC-CCHHHHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 324 LLVYEFMKN-GSLQDILHDVSQG-----------RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 324 ~lV~E~~~~-gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++||+|.|+ ++|.+........ +...++...|.++.|+..||.++|+.| +.-+-|.|.+|+++.+
T Consensus 353 vlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~ 429 (655)
T KOG3741|consen 353 VLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGK 429 (655)
T ss_pred EEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCc
Confidence 899999986 5788876543222 244678899999999999999999999 8889999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF 455 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 455 (532)
.+++|+..|+......+.. |-+ .--.+-|.=-||.+++.|.||..
T Consensus 430 ~RIriS~C~i~Dvl~~d~~----------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 430 MRIRISGCGIMDVLQEDPT----------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ceEEEecccceeeecCCCC----------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 9999998888766544431 000 11235699999999999999964
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.9e-08 Score=93.80 Aligned_cols=150 Identities=21% Similarity=0.206 Sum_probs=104.9
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHH--------HHHHHHHHHHHHHHHhcCCCC--
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL--------INRKMRQIKSEIITAGRIWHR-- 308 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~H~-- 308 (532)
.+..+||-|--|.||.|... .|.++|||.=+....+.......+... ..-......+|.+.|.+|...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 44578999999999999877 589999998776655444433332221 112234567889999998655
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
.+...+++ +..++||||++|-.|...- ++......++..|+.-+..+-..| +||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 66666655 5568999999886664332 122233345555555555555667 9999999999999
Q ss_pred cCCCcEEEeccCCcccCC
Q 037084 389 DDGMEARISDFGLAKLMP 406 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~ 406 (532)
+++|.+.++||-.+....
T Consensus 236 ~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 236 TEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred ecCCCEEEEeCcccccCC
Confidence 999999999997665433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.6e-07 Score=84.51 Aligned_cols=143 Identities=14% Similarity=0.063 Sum_probs=103.1
Q ss_pred cccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC--cccceeEEe-cC-
Q 037084 245 GVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN--LLPLQAHVT-RP- 320 (532)
Q Consensus 245 G~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~-~~- 320 (532)
|.||.+.|++.... |..+-+|.-...-...... ......|.+|...|.++...+ +.+.. ++. ..
T Consensus 27 ~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~--------P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~ 94 (216)
T PRK09902 27 RRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRY--------PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKI 94 (216)
T ss_pred CCCCcceEEEEEeC---CcEEEEEeccCcccccccC--------CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeecc
Confidence 67999999998775 5689999876321111000 113467889999999885433 44444 332 11
Q ss_pred ---CceEEEEEeccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc--E
Q 037084 321 ---DCHLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME--A 394 (532)
Q Consensus 321 ---~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~ 394 (532)
-.-+||+|-++| -+|.+++.. ....+.+...+..+..+++..+.-||+.+ +.|+|+.+.||+++.++. +
T Consensus 95 ~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v 169 (216)
T PRK09902 95 EGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEA 169 (216)
T ss_pred CCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeE
Confidence 234799997753 589999864 22335677778899999999999999999 999999999999986667 9
Q ss_pred EEeccCCccc
Q 037084 395 RISDFGLAKL 404 (532)
Q Consensus 395 kl~DFGla~~ 404 (532)
+++||--++.
T Consensus 170 ~lIDlEk~r~ 179 (216)
T PRK09902 170 GFLDLEKSRR 179 (216)
T ss_pred EEEEhhccch
Confidence 9999976553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.61 E-value=7e-07 Score=83.93 Aligned_cols=106 Identities=24% Similarity=0.289 Sum_probs=83.0
Q ss_pred HHHHHHHHHHhcCCCCCc--ccceeEEecCC----ceEEEEEeccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 037084 293 RQIKSEIITAGRIWHRNL--LPLQAHVTRPD----CHLLVYEFMKNG-SLQDILHDVSQGRRELDWLARYRIARGMASGL 365 (532)
Q Consensus 293 ~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl 365 (532)
....+|...+.++....| +..+++..... ..++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 456778887777755443 45666665532 348999999884 8999987521 255666788999999999
Q ss_pred HHHHhcCCCCeeecCCCCCcEEecCCC---cEEEeccCCcccC
Q 037084 366 EYLHMYHRPCIIHRDIKPANVLIDDGM---EARISDFGLAKLM 405 (532)
Q Consensus 366 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFGla~~~ 405 (532)
+-||..| ++|+|++|.|||++.++ .+.++||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.9e-07 Score=94.24 Aligned_cols=155 Identities=19% Similarity=0.206 Sum_probs=97.6
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhh------------------------HHHHHHHHHHHHHH--HHHH
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAA------------------------TELLNVRRVLINRK--MRQI 295 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~------------------------~~~~~~~~~~~~~~--~~~~ 295 (532)
+.|+.++-|.||+|+++ +|+.||||+.+++-... .......+...... .-++
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 67999999999999998 59999999997753211 00011111111111 1235
Q ss_pred HHHHHHHhcCC-----CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHH
Q 037084 296 KSEIITAGRIW-----HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASG-LEYLH 369 (532)
Q Consensus 296 ~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g-l~~LH 369 (532)
.+|..-+.+++ .|++.-..-|.+-.+...|+|||++|..+.+...-.. ..++. ..++..++++ +..+-
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHHHHHHHHHHHH
Confidence 56666655552 3444332223333356689999999999988853211 22332 2333333332 33333
Q ss_pred hcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCC
Q 037084 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 370 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~ 407 (532)
..| +.|.|..|.||+++.+|.+.+.|||+......
T Consensus 283 ~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 355 99999999999999999999999999887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.9e-08 Score=104.35 Aligned_cols=150 Identities=18% Similarity=0.227 Sum_probs=98.4
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcc-eee------eccccccccccccccccC
Q 037084 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR-IRI------TTVAGTTGYVAPEYHQTL 432 (532)
Q Consensus 360 ~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~------~~~~gt~~y~aPE~~~~~ 432 (532)
+++.|+.|+|.. ..+||++|.|++|.++.++..||+.|+.+......... ... -.......|.|||++.+.
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344899999974 45999999999999999999999999987755432110 000 111234579999999998
Q ss_pred CCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCC
Q 037084 433 TISEKSDIYSFGVLLAVLVVG-KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTS 511 (532)
Q Consensus 433 ~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~ 511 (532)
..+.++|+||+|+++|.+..| +.-+..... ...... ..... + .-......+.+.++.+=+...+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~---~~~~~---------~-~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSF---SRNLL---------N-AGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC-cchhhh---hhccc---------c-cccccccccCcHHHHHHHHHHhc
Confidence 999999999999999999854 444432211 111100 00000 0 00111223445556666677899
Q ss_pred CCCCCCCCHHHHHH
Q 037084 512 DDPEERPSSKDVRC 525 (532)
Q Consensus 512 ~~P~~RPs~~evl~ 525 (532)
.++..||++..+..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.1e-06 Score=80.62 Aligned_cols=139 Identities=15% Similarity=0.142 Sum_probs=84.3
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC--cccceeEEe
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN--LLPLQAHVT 318 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~ 318 (532)
..+||+|..+.||+. .|..+++|........ ....+|.++++.+..-+ +.+.++++.
T Consensus 6 ~~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~~~----------------~~i~~E~~~l~~l~~~glpvP~~~~~~~ 64 (226)
T TIGR02172 6 WTQTGEGGNGESYTH-----KTGKWMLKLYNPGFDK----------------ETIKREFDASRKVFSLGIPTPHPFDLVE 64 (226)
T ss_pred heeecCCCCcceeEe-----cCCCEEEEeCCCCCCH----------------HHHHHHHHHHHHHHHcCCCCCceEEEEe
Confidence 367999999999984 2556788988754311 23467888888876443 356777777
Q ss_pred cCCceEEEEEeccCCC-HHHH---------------------HhhhcCCCCCCCHHHHH-HHHHH----------HHH-H
Q 037084 319 RPDCHLLVYEFMKNGS-LQDI---------------------LHDVSQGRRELDWLARY-RIARG----------MAS-G 364 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gs-L~~~---------------------l~~~~~~~~~l~~~~~~-~i~~~----------ia~-g 364 (532)
..+...+|||+++|.+ +... +|...... .+..... ++..+ +.. .
T Consensus 65 ~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l 142 (226)
T TIGR02172 65 DGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKA 142 (226)
T ss_pred cCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence 7778889999998863 2111 11110011 1111110 01000 011 1
Q ss_pred HHHHHhc-CCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 365 LEYLHMY-HRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 365 l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
..+|... ..+.++|+|+.|.||++++++ +.|+||+.+.
T Consensus 143 ~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 143 RAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2222221 234579999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1e-05 Score=75.22 Aligned_cols=150 Identities=15% Similarity=0.187 Sum_probs=91.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
...+|...+.+-......|.+-..+ |..+.+|..+.......... ..................+....--....+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~---~~kyIlK~pr~~~~r~er~~--~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID---GKKYILKEPREENRRPERRF--KSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC---CcEEEEeccchhhhhHHHHH--HHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 3456777788888887888877654 88999998876532211100 001111112222222222222222223333
Q ss_pred eeEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+..... ....+++|||++|..|.+... ++. .+...+.+.+.-||+.| +.|+|..|+|+++
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv 168 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV 168 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence 333322 234568999999988876642 222 24456777899999999 9999999999999
Q ss_pred cCCCcEEEeccCCccc
Q 037084 389 DDGMEARISDFGLAKL 404 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~ 404 (532)
++++ +++.||+..+.
T Consensus 169 ~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 169 SNNG-IRIIDTQGKRM 183 (229)
T ss_pred ECCc-EEEEECccccc
Confidence 9665 99999986553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.9e-05 Score=74.31 Aligned_cols=151 Identities=19% Similarity=0.171 Sum_probs=93.5
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHH----------HHHHHHHHHHHHHHHHHHhcCC--CCC
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVR----------RVLINRKMRQIKSEIITAGRIW--HRN 309 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~E~~~l~~l~--H~n 309 (532)
..|.+|-.+.||+|.-. ++..+|||+++...........+. .-...........|..-|.++. +-.
T Consensus 54 g~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 54 GCISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eeecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 46889999999999754 488999999977543322211100 0000111233455666676663 333
Q ss_pred cccceeEEecCCceEEEEEeccCCC-HHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEE
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGS-LQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVL 387 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIl 387 (532)
+.+.+++.. ..|||||+.... -.-.|.+ .++.......+..++.+.+.-|-. .+ +||+||..-|||
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL 199 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNIL 199 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheE
Confidence 444444433 369999995431 1111111 112222455667777777777766 55 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCC
Q 037084 388 IDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~ 407 (532)
+. ++.+.|+|||.|....+
T Consensus 200 ~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 200 VH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred EE-CCeEEEEECccccccCC
Confidence 99 77899999998876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.4e-05 Score=77.28 Aligned_cols=141 Identities=14% Similarity=0.114 Sum_probs=83.1
Q ss_pred eecccCC-eEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeEEecC
Q 037084 243 IIGVGAC-GVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAHVTRP 320 (532)
Q Consensus 243 ~LG~G~f-G~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 320 (532)
.|-.|.. ..||+.... +..+.||+..... ...+.+|+.++..+. +--+.+++++....
T Consensus 5 ~~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~-----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 64 (244)
T cd05150 5 RVTEGQSGATVYRLDGK---NPGLYLKIAPSGP-----------------TYELEREAERLRWLAGKLPVPEVIDYGSDD 64 (244)
T ss_pred ecCCCCCcCeEEEEcCC---CCcEEEEecCCCc-----------------ccchHHHHHHHHHHHhcCCCCeEEEEEecC
Confidence 3455555 889998643 4688899886542 123445777776663 33455677777766
Q ss_pred CceEEEEEeccCCCHHHHH-------------------hhhcCCCCCCCHH--HHHHHHH--------------------
Q 037084 321 DCHLLVYEFMKNGSLQDIL-------------------HDVSQGRRELDWL--ARYRIAR-------------------- 359 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l-------------------~~~~~~~~~l~~~--~~~~i~~-------------------- 359 (532)
+..++|||+++|.+|.... |.......++... .......
T Consensus 65 ~~~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (244)
T cd05150 65 GRAWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGW 144 (244)
T ss_pred CccEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCC
Confidence 6789999999998776442 1110101111100 0000000
Q ss_pred HHHHHHHHHHh----cCCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 360 GMASGLEYLHM----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 360 ~ia~gl~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
.+......|-. ...+.++|+|+.|.||++++++.+.|+||+.+.
T Consensus 145 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 145 SAEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CHHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 01111222211 123459999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.1e-05 Score=74.89 Aligned_cols=144 Identities=20% Similarity=0.257 Sum_probs=81.4
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC--CcccceeEEe
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR--NLLPLQAHVT 318 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 318 (532)
++.|+.|..+.||+.... +..+++|..... .....+..|..++..+... .+..++.++.
T Consensus 2 i~~l~~G~~n~~~~v~~~---~~~~vlK~~~~~----------------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~ 62 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD---DGRYVLKFYRPP----------------DAAERLRREAAVLRQLAEHGIPVPRVLAFDT 62 (239)
T ss_dssp EEEEEESSSSEEEEEEET---TSEEEEEEESSH----------------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEE
T ss_pred CccCCCCCeeeEEEEEEC---CcEEEEEEeCCC----------------CCHHHHHHHHHHHHHHHhcCCCCceEEeecc
Confidence 467999999999999765 359999997654 1224455677777776433 3456666543
Q ss_pred cC---CceEEEEEeccCCCHHH----------------HH---hhhcCCCCCCCHHHH---------HHH----------
Q 037084 319 RP---DCHLLVYEFMKNGSLQD----------------IL---HDVSQGRRELDWLAR---------YRI---------- 357 (532)
Q Consensus 319 ~~---~~~~lV~E~~~~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i---------- 357 (532)
.. ...+++|++++|.++.. .+ +..........+... ...
T Consensus 63 ~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (239)
T PF01636_consen 63 SDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELF 142 (239)
T ss_dssp ETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCH
T ss_pred cccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhh
Confidence 32 34689999999988877 11 111111111111110 000
Q ss_pred --HHHHHH-HHHHHHh----cCCCCeeecCCCCCcEEec-CCCcEEEeccCCcc
Q 037084 358 --ARGMAS-GLEYLHM----YHRPCIIHRDIKPANVLID-DGMEARISDFGLAK 403 (532)
Q Consensus 358 --~~~ia~-gl~~LH~----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~ 403 (532)
...+.. .+..++. .....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 143 DDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 011222 2333332 2345599999999999999 66666899998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.3e-05 Score=82.57 Aligned_cols=154 Identities=18% Similarity=0.196 Sum_probs=91.9
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhh--HHHHHHH-------------------HHHHHHH--HHHHHHH
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAA--TELLNVR-------------------RVLINRK--MRQIKSE 298 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~--~~~~~~~-------------------~~~~~~~--~~~~~~E 298 (532)
+.||.-+.|.||+|+++ +|+.||||+.++.-... .++...+ +.+.+.. .-+|.+|
T Consensus 167 ~piaaASlaQVhrA~L~--~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK--NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEec--CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 67999999999999999 59999999998753222 1111110 0010111 1124444
Q ss_pred HHHHh----cCCCCC------cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HH
Q 037084 299 IITAG----RIWHRN------LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGL-EY 367 (532)
Q Consensus 299 ~~~l~----~l~H~n------iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl-~~ 367 (532)
++-.. .+.|-+ |.+++-.+. ....|+||||+|..+.|.-.-. ...++.. .++..+.++. .-
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~---~~gi~~~---~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAID---KRGISPH---DILNKLVEAYLEQ 316 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHH---HcCCCHH---HHHHHHHHHHHHH
Confidence 44333 334544 333322222 4567999999998777763321 1224433 3444444432 22
Q ss_pred HHhcCCCCeeecCCCCCcEEecC----CCcEEEeccCCcccCCCC
Q 037084 368 LHMYHRPCIIHRDIKPANVLIDD----GMEARISDFGLAKLMPDG 408 (532)
Q Consensus 368 LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFGla~~~~~~ 408 (532)
+-..| ++|+|-.|.||++.. ++.+.+-|||+.......
T Consensus 317 If~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 317 IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 22334 999999999999983 678999999998866543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.3e-05 Score=73.70 Aligned_cols=139 Identities=22% Similarity=0.324 Sum_probs=94.3
Q ss_pred cCccccceecccCC-eEEEEEEeeCCCCcEEEEEEcCCCChhhHH-----HHHH--HHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 236 DSLASLEIIGVGAC-GVVYKAEVPGSYGKMIAIKKIDQPPMAATE-----LLNV--RRVLINRKMRQIKSEIITAGRIWH 307 (532)
Q Consensus 236 ~~~~~~~~LG~G~f-G~Vy~~~~~~~~g~~vavK~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~E~~~l~~l~H 307 (532)
.+++.++.||.|.- |.||++... |..+|+|.+..-...... +... ...........|..|.+..++|+.
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 67899999999999 999999886 889999994331111110 0000 000011235689999999998853
Q ss_pred ---CCc--ccceeEEecC------------------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 037084 308 ---RNL--LPLQAHVTRP------------------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASG 364 (532)
Q Consensus 308 ---~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~g 364 (532)
.++ |+.+||..=. ....||.||++... .+... -+.++.+-
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~d 176 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRD 176 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHH
Confidence 455 8888887211 12368888886543 12222 24556667
Q ss_pred HHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCc
Q 037084 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402 (532)
Q Consensus 365 l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla 402 (532)
+..+|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 177 l~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 78899888 999999999987 5689999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.04 E-value=1.9e-05 Score=72.86 Aligned_cols=104 Identities=20% Similarity=0.196 Sum_probs=81.6
Q ss_pred HHHHHHhcCCC-CCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 297 SEIITAGRIWH-RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPC 375 (532)
Q Consensus 297 ~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ 375 (532)
.|..++..+++ +++++++|+|-. ++|.||.+.+++....... ..-...+|..|.+|+.++++.+.+|+......
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47777888876 689999999943 6799999877664321000 01124689999999999999999999865555
Q ss_pred eeecCCCCCcEEecCCCcEEEeccCCcccC
Q 037084 376 IIHRDIKPANVLIDDGMEARISDFGLAKLM 405 (532)
Q Consensus 376 ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 405 (532)
+.-+|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=9.2e-07 Score=92.31 Aligned_cols=190 Identities=19% Similarity=0.132 Sum_probs=136.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC-cccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN-LLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l 313 (532)
+.-+....-.++|+++.+||.+-.. .+...++.+... ....-++++|.+++||| .+..
T Consensus 241 ~kws~~fh~fvK~altknpKkRpta--eklL~h~fvs~~-------------------l~~rl~~eLLdK~n~P~~~v~~ 299 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTA--EKLLQHPFVSQT-------------------LSRRLAIELLDKVNNPNPVVRY 299 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCCh--hhheeceeeccc-------------------hhhHHHHHHHHHccCCCCcccc
Confidence 3334555668999999999986542 233445555443 22345788999999999 7777
Q ss_pred eeEEecCCceEEEEEeccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNG-SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++-++.+....++++++.++ +-..... ...-.+...+...++..-+++++++|+.. -+|+| ||+..+ +
T Consensus 300 ~~d~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~ 368 (829)
T KOG0576|consen 300 LEDYDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-E 368 (829)
T ss_pred cccCCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-c
Confidence 77777778889999999776 2222111 11122333444556666778899999865 58998 777665 5
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
..+.+||+....+.... ......+|+.++|||+.....+...-|+|+.|.-..++--|-+|-..
T Consensus 369 ~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 369 EVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 79999999988776654 22567899999999999999999999999999877777777776543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=9.6e-05 Score=65.91 Aligned_cols=132 Identities=17% Similarity=0.165 Sum_probs=92.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc-ce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP-LQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~ 314 (532)
......+.||+|++|.||++.+. |..+|+|+-+.++. ...+..|+++|..++-.++.+ ++
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds~----------------r~~l~kEakiLeil~g~~~~p~vy 82 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR---GGEVALKVRRRDSP----------------RRNLEKEAKILEILAGEGVTPEVY 82 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc---CceEEEEEecCCcc----------------hhhHHHHHHHHHHhhhcCCCceEE
Confidence 34566788999999999999997 67999999887642 356888999999888777654 44
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK-PANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk-p~NIll~~~~~ 393 (532)
.|-.+ ++.|||+.|-+|.++-.. .+-.+ ...+++.---|...| |-|+.|. |...++-+++.
T Consensus 83 ~yg~~----~i~me~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~ 144 (201)
T COG2112 83 FYGED----FIRMEYIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRD 144 (201)
T ss_pred Eechh----hhhhhhhcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCc
Confidence 44332 355999988888777542 12222 233444444456666 8999887 44444444458
Q ss_pred EEEeccCCccc
Q 037084 394 ARISDFGLAKL 404 (532)
Q Consensus 394 ~kl~DFGla~~ 404 (532)
+.|+||..|+.
T Consensus 145 ~~iIDFd~At~ 155 (201)
T COG2112 145 VYIIDFDSATF 155 (201)
T ss_pred EEEEEccchhh
Confidence 99999998874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.8e-05 Score=71.21 Aligned_cols=31 Identities=35% Similarity=0.676 Sum_probs=26.0
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
.+.++|+|+.|.||+++++...-|.||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3458999999999999877656799999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.4e-05 Score=90.05 Aligned_cols=126 Identities=13% Similarity=0.076 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHHHHHHHHhhhchHHHHHHHHHHHHHHHHHHHhhhhhccCChHHHhHHHHHHHHHhhHHHHHHHhhhHHH
Q 037084 27 SIEAIIQNLESDWLQKFAGEAHIQADLMGWINMLVKISEVVDDAVEKQMTNPHVKLWLGELQNLACDVEYLFDEFQTEAF 106 (532)
Q Consensus 27 ~~~~~~~kl~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~dae~~~~~~~~~~~wl~~l~~~~yd~ed~~d~~~~~~~ 106 (532)
.+++.++|+.+++-+++....|+++.+.+|+++|..++.+|.||+.++.+...++.|...+++++|++||+++.|..+..
T Consensus 4 ~~s~~~~~~~~~l~~~~~~~~~~~~~i~~Lk~~L~~l~~~l~d~~a~~~~~~~~~~~~e~~~~~~~~~e~~~~~~~v~~~ 83 (889)
T KOG4658|consen 4 CVSFGVEKLDQLLNRESECLDGKDNYILELKENLKALQSALEDLDAKRDDLERRVNWEEDVGDLVYLAEDIIWLFLVEEI 83 (889)
T ss_pred EEEEehhhHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34456778888999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hcccccCcc------cccccccccchHhhhHHHHHHHHHHhHhccccccccc
Q 037084 107 RSKLLPLDY------DYSTDDEFDSLAKTKVMEIHTRLQGIASQIDSLELTG 152 (532)
Q Consensus 107 ~~~~~~~~~------~~~~~~~f~~~~~~~i~ei~~~L~~i~~~~~~~~l~~ 152 (532)
+.+....-. +..+...|.+.....+..+..++-.+..+...++...
T Consensus 84 ~~~~~~~l~~~~~~~~~~c~~~~~~~~~~~~~~~~~rv~~~l~~ve~l~~~~ 135 (889)
T KOG4658|consen 84 ERKANDLLSTRSVERQRLCLCGFCSKNVSDSYKYGKRVSKVLREVESLGSKG 135 (889)
T ss_pred HHHHhHHhhhhHHHHHHHhhhhhHhHhhhhhHhHHHHHHHHHHHHHHhcccc
Confidence 775443211 1222224666666666666666666666555555433
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00014 Score=82.61 Aligned_cols=81 Identities=12% Similarity=0.175 Sum_probs=56.2
Q ss_pred cceecccCCeEEEEEEeeCCC-CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCc--ccceeE
Q 037084 241 LEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNL--LPLQAH 316 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~ 316 (532)
++.++.|.+..+|+....... ...+++|+....... .....+.+|..+++.+. |+++ .+++.+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-------------~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~ 109 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-------------QSAHAVEREYQVLRALGEHTDVPVPKVYCL 109 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-------------ccHHHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 467899999999998765321 146788876543211 11235678999999885 6665 677888
Q ss_pred EecC---CceEEEEEeccCCC
Q 037084 317 VTRP---DCHLLVYEFMKNGS 334 (532)
Q Consensus 317 ~~~~---~~~~lV~E~~~~gs 334 (532)
|.+. +..|+||||++|..
T Consensus 110 ~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 110 CTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred ecCCCcCCCceEEEEecCCcc
Confidence 8764 46789999998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00034 Score=64.84 Aligned_cols=142 Identities=19% Similarity=0.227 Sum_probs=91.6
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHH--HHHHHHHHHHHHHHHHHHHHHHHhcCC------CCCccc
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATE--LLNVRRVLINRKMRQIKSEIITAGRIW------HRNLLP 312 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~ 312 (532)
...||+|+.=.||. ++ +.....||+.......... -.............++.+|+.....+. +..|.+
T Consensus 6 ~~~i~~G~~R~cy~--HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CcccccCCCceEEE--CC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 46799999999997 44 3566889998876500000 000011111122445555665555554 788999
Q ss_pred ceeEEecCCceEEEEEeccC------CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 313 LQAHVTRPDCHLLVYEFMKN------GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++|+.+++.-.-+|+|.+.+ -+|.+++.+ ..++. .. ...+-+-..||-..+ |+.+|++|.||
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~---~~~L~~f~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-EL---RQALDEFKRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HH---HHHHHHHHHHHHHcC---CeecCCCcccE
Confidence 99999999888999998754 367788753 23444 22 333334456777777 99999999999
Q ss_pred EecCCC----cEEEec
Q 037084 387 LIDDGM----EARISD 398 (532)
Q Consensus 387 ll~~~~----~~kl~D 398 (532)
++..+. .+.|+|
T Consensus 150 v~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEecCCCceEEEEEe
Confidence 996332 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00036 Score=69.44 Aligned_cols=78 Identities=10% Similarity=0.022 Sum_probs=55.4
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC---CCccccee
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH---RNLLPLQA 315 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~ 315 (532)
...+.||.|..+.||+.... +..+.+|..+... ....|..|...|+.+.- -.+.++++
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~---~~~~~~k~~~~~~----------------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~ 77 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS---QGNPMPLMARSFS----------------TPGVAQQEAWKLSMLARSGTVRMPTVYG 77 (297)
T ss_pred heeeecCCccceeEEEEEcC---CCCEEEEEecccc----------------cchHHHHHHHHHHHHccCCCCCcCcEEE
Confidence 34578999999999998643 3357777754311 11467788888888843 35677888
Q ss_pred EEec---CCceEEEEEeccCCCH
Q 037084 316 HVTR---PDCHLLVYEFMKNGSL 335 (532)
Q Consensus 316 ~~~~---~~~~~lV~E~~~~gsL 335 (532)
+|.. .+..+||||+++++++
T Consensus 78 ~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 78 VMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred EeccCCcCCCeEEEEeccCCEec
Confidence 8754 3668999999998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0004 Score=66.54 Aligned_cols=76 Identities=14% Similarity=0.169 Sum_probs=46.7
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc-cceeEEec
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL-PLQAHVTR 319 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~ 319 (532)
++.|..|-...+|+....+.++..+++|+....... .....+|+.++..+...+++ ++++.+.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---------------~~d~~~E~~~~~~l~~~gl~P~v~~~~~- 66 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---------------IIDRERELRIHKLLSKHGLAPKLYATFQ- 66 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---------------eecHHHHHHHHHHHHhCCCCCeEEEEeC-
Confidence 356888888999998654211568889977643211 11223577777777544443 3444332
Q ss_pred CCceEEEEEeccCCCH
Q 037084 320 PDCHLLVYEFMKNGSL 335 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL 335 (532)
..++|||++|.++
T Consensus 67 ---~~~l~e~i~G~~l 79 (235)
T cd05157 67 ---NGLIYEFIPGRTL 79 (235)
T ss_pred ---CcEEEEeeCCCcC
Confidence 2489999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0004 Score=77.86 Aligned_cols=198 Identities=19% Similarity=0.181 Sum_probs=139.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeEEecCCce----EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 037084 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH----LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEY 367 (532)
Q Consensus 292 ~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~ 367 (532)
+.....|...+..+.|+|++.+++|..+.... .+..++|..-++.+.+.. -..++..+...+..+..+|+.|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHH
Confidence 44555677888899999999999998765322 355678888888888864 4567888888899999999999
Q ss_pred HHhcCCCCeeecCCCCC---cEEecCCCcEEEe--ccCCcccCCCCCcceeeeccccccccccccccccCCCCch--hhH
Q 037084 368 LHMYHRPCIIHRDIKPA---NVLIDDGMEARIS--DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK--SDI 440 (532)
Q Consensus 368 LH~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDv 440 (532)
+|+.. ..|.-+..+ +-..+..+.+.++ ||+.++...+.... .....+..|.+||......++.+ .|+
T Consensus 302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHH
Confidence 99986 666666655 5555667777777 99988876654322 23344566888887777665544 799
Q ss_pred HHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 441 YSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 441 wSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
|.+|.....+..|..+-..... . ..++.. ... ....+....|+..++++|++.
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~------~----~~~l~~--------------~~~---~~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAV------P----VSLLDV--------------LST---SELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccc------h----hhhhcc--------------ccc---hhhhhhhhhhcchhhhhccch
Confidence 9999999999888765332111 0 000100 000 035566778999999999999
Q ss_pred HHHHHH
Q 037084 521 KDVRCM 526 (532)
Q Consensus 521 ~evl~~ 526 (532)
.+++..
T Consensus 429 ~~ll~~ 434 (1351)
T KOG1035|consen 429 LELLTH 434 (1351)
T ss_pred hhhhhc
Confidence 988764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0012 Score=64.30 Aligned_cols=140 Identities=14% Similarity=0.058 Sum_probs=78.5
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc-cceeEEecCC
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL-PLQAHVTRPD 321 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~ 321 (532)
.+..|-.+.+|+... +|..+++|........ ......+|..+++.+....++ ++++.+.
T Consensus 3 ~~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~--------------~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--- 62 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH---PGISFVWRPQSPVCKA--------------LGVDRQREYQILQALSALGLAPKPILVNE--- 62 (256)
T ss_pred cCCCcCcCCeEEEEe---CCccEEEeeCCccccc--------------ccCcHHHHHHHHHHHHhcCCCCceEEEeC---
Confidence 456688889998863 3778889976543210 001245677777777544343 3444432
Q ss_pred ceEEEEEeccCCCHHH--------------H---HhhhcCCCCCCCHHHH-HHHHHHH---------HHHHHHHHhc---
Q 037084 322 CHLLVYEFMKNGSLQD--------------I---LHDVSQGRRELDWLAR-YRIARGM---------ASGLEYLHMY--- 371 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~--------------~---l~~~~~~~~~l~~~~~-~~i~~~i---------a~gl~~LH~~--- 371 (532)
.++|+||++|..+.. . +|.......+++.... .....++ ...+..+-..
T Consensus 63 -~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 141 (256)
T TIGR02721 63 -HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEP 141 (256)
T ss_pred -CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCC
Confidence 368999999866532 1 2221111222222211 1111111 1112222211
Q ss_pred --CCCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 372 --HRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 372 --~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
....++|+|+.|.||++++++ +.++||..+..
T Consensus 142 ~~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 142 APLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CCCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 123589999999999999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.30 E-value=6.2e-05 Score=85.83 Aligned_cols=165 Identities=13% Similarity=0.027 Sum_probs=119.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeEEe--cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037084 292 MRQIKSEIITAGRIWHRNLLPLQAHVT--RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH 369 (532)
Q Consensus 292 ~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH 369 (532)
.+....|...++...|+++.....-.. +..+.+.+++|+.+|.+.+.+-+......+++.........+......-.|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 445556666677788998876544432 234568999999999999999864444445544444433333344444444
Q ss_pred hc--CCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHH
Q 037084 370 MY--HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447 (532)
Q Consensus 370 ~~--~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 447 (532)
+. .....+|+++|+-|.++..+.+++++++|+.+........ .....+++-|+.|+....-.++.++|+|..|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 43 2345899999999999999999999999999843322211 2566788899999999999999999999999999
Q ss_pred HHHHhCCCCCC
Q 037084 448 AVLVVGKFPFD 458 (532)
Q Consensus 448 ~elltg~~p~~ 458 (532)
|+...|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99988887774
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0054 Score=61.39 Aligned_cols=32 Identities=34% Similarity=0.438 Sum_probs=27.6
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
+..++|+|+.+.||++++++...|.||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 34699999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0062 Score=62.68 Aligned_cols=82 Identities=13% Similarity=0.053 Sum_probs=50.3
Q ss_pred ceecccCCeEEEEEEeeCCCC-cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-C--CCcccceeEE
Q 037084 242 EIIGVGACGVVYKAEVPGSYG-KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-H--RNLLPLQAHV 317 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~ 317 (532)
+.||.|.+..||++... +| +.++||.-........+. -.....++..|.+.|..+. + .++++++.+
T Consensus 32 ~elggGn~N~VyrV~~~--~g~~svIVKqa~p~~r~~g~~-------wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 32 REIGDGNLNLVFRVSDT--EGGKSVIVKQALPYVRVVGES-------WPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eEcCCCceEEEEEEEeC--CCCeEEEEEecCccccccccc-------ccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 57999999999999876 35 589999854221100000 0011245556667776652 2 345666666
Q ss_pred ecCCceEEEEEeccCCC
Q 037084 318 TRPDCHLLVYEFMKNGS 334 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gs 334 (532)
+.+..++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 3355789999998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0091 Score=59.31 Aligned_cols=144 Identities=19% Similarity=0.172 Sum_probs=82.3
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC--cccceeE--
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN--LLPLQAH-- 316 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-- 316 (532)
.+.|..|....+|+.... +..+++|+..... ......|+.++..+.+.+ +.+++..
T Consensus 19 i~~i~~G~~n~~y~v~~~---~~~~vLr~~~~~~-----------------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~ 78 (296)
T cd05153 19 FEGISAGIENTNYFVTTD---SGRYVLTLFEKVS-----------------AEELPFFLALLDHLAERGLPVPRPIADRD 78 (296)
T ss_pred eecccCccccceEEEEeC---CCcEEEEEcCCCC-----------------hHhccHHHHHHHHHHHCCCCCCccccCCC
Confidence 467888888999998643 4578999876421 122334555555553322 3333331
Q ss_pred ----EecCCceEEEEEeccCCCHHH--------------HHhhhcCC-------CCCCCHHHHH----------HHHHHH
Q 037084 317 ----VTRPDCHLLVYEFMKNGSLQD--------------ILHDVSQG-------RRELDWLARY----------RIARGM 361 (532)
Q Consensus 317 ----~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~-------~~~l~~~~~~----------~i~~~i 361 (532)
....+..++|++|++|.++.. .+|..... .....|.... .....+
T Consensus 79 g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 79 GEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred CcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 223456689999999866432 11211110 0111222211 011122
Q ss_pred HHHHHHHHh----cCCCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 362 ASGLEYLHM----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 362 a~gl~~LH~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
...+.++.. .....++|+|+.|.||++++++.+.|.||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 334445443 1234599999999999999987778999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.013 Score=58.89 Aligned_cols=31 Identities=29% Similarity=0.311 Sum_probs=26.4
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
.+++|+|+.|.||+++++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4599999999999999765568999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.00065 Score=66.35 Aligned_cols=151 Identities=18% Similarity=0.155 Sum_probs=97.9
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHH--------HHHHHHHHHHHHHhcCCCC-
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLIN--------RKMRQIKSEIITAGRIWHR- 308 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~H~- 308 (532)
+...++||-|--+.+|.+.+. .|.+.++|.-+....+...+.+.++.... -..-...+|...|+.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 567889999999999999776 58999999877665554444333322111 1122345566667666321
Q ss_pred -CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 309 -NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 309 -niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
-++..+++ ++.++|||++.+-.|...-+ ..+..++ ...+..-+--|-..| +||+|+.-=||+
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~~l---y~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPPTL---YDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeee-------cCChHHH---HHHHHHHHHHHHHcC---ceecccchheeE
Confidence 23333333 56789999998877755432 1222332 233333344455566 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCC
Q 037084 388 IDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~ 407 (532)
+++++.++++||--+....+
T Consensus 235 v~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred EecCCCEEEeechHhhccCC
Confidence 99999999999976654443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0055 Score=61.10 Aligned_cols=31 Identities=23% Similarity=0.365 Sum_probs=27.3
Q ss_pred CCCeeecCCCCCcEEecCC----CcEEEeccCCcc
Q 037084 373 RPCIIHRDIKPANVLIDDG----MEARISDFGLAK 403 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~ 403 (532)
...++|+|+.|.||+++++ +.+.++||..|.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4569999999999999985 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.011 Score=58.22 Aligned_cols=31 Identities=29% Similarity=0.636 Sum_probs=25.5
Q ss_pred CCeeecCCCCCcEEecCCCc-EEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGME-ARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~-~kl~DFGla~~ 404 (532)
+.++|+|+.|.||++++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0089 Score=58.95 Aligned_cols=75 Identities=17% Similarity=0.175 Sum_probs=47.1
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCccccee
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW---HRNLLPLQA 315 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~ 315 (532)
...+.++-|....+|+.. ++++.+.||.-.... ...|..|..-|+.|. --.+++.++
T Consensus 20 ~~~~~v~GG~i~~a~~~~---~~~~~~FvK~~~~~~-----------------~~~f~~Ea~gL~~L~~~~~~~vP~vi~ 79 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD---TDGGSYFVKVNSESG-----------------RDMFEGEAEGLKALAEANPIRVPKVIA 79 (288)
T ss_dssp -EEEEE--SSSSEEEEEE---TTS-EEEEEEEEGGG-----------------CCHHHHHHHHHHHHCHTTTSBS--EEE
T ss_pred eeeEecCCCChhheEEEE---CCCccEEEEecChhh-----------------HHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 445678999999999986 248899999877321 135667777777773 345678899
Q ss_pred EEecCCceEEEEEeccCC
Q 037084 316 HVTRPDCHLLVYEFMKNG 333 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~g 333 (532)
+....+..+||+||++.+
T Consensus 80 ~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 80 WGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEE-SSCCEEEEE-----
T ss_pred EEeecCCceEEEEeecCC
Confidence 888877889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.042 Score=54.70 Aligned_cols=33 Identities=36% Similarity=0.690 Sum_probs=29.3
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccC
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLM 405 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 405 (532)
.++++|+|+.+.|++++.++-+-|.||+++..-
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 357999999999999999888999999998753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.058 Score=53.89 Aligned_cols=29 Identities=28% Similarity=0.421 Sum_probs=25.2
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
.+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 678999998765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.051 Score=54.42 Aligned_cols=153 Identities=18% Similarity=0.131 Sum_probs=96.3
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhh----H------HH------HHHHHHHHHHHHHHHHHHHHHH
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAA----T------EL------LNVRRVLINRKMRQIKSEIITA 302 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~----~------~~------~~~~~~~~~~~~~~~~~E~~~l 302 (532)
.+-.+|..|--+.||.|.-. +|..+|||+++.+-... . .+ .+.+ .........|++-|
T Consensus 147 ~inGCiSTGKEANVYHat~~--dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPR----KMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE--DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPR----KMVKTWAEKEMRNL 220 (520)
T ss_pred ecccccccCccceeEeeecC--CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcH----HHHHHHHHHHHHHH
Confidence 34467899999999999755 79999999986432100 0 00 0000 11123345677777
Q ss_pred hcCCCCCcccceeEEecCCceEEEEEeccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 037084 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNG-SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381 (532)
Q Consensus 303 ~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 381 (532)
.+++...|...--+.. ....|||+|+... --.-.|. ...++...+..+-.+++.-+.-|.+.+ .+||.||
T Consensus 221 kRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADL 291 (520)
T KOG2270|consen 221 KRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADL 291 (520)
T ss_pred HHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccch
Confidence 7777666553333332 2346999999421 1111222 234566666677777777777776654 3999999
Q ss_pred CCCcEEecCCCcEEEeccCCcccCCC
Q 037084 382 KPANVLIDDGMEARISDFGLAKLMPD 407 (532)
Q Consensus 382 kp~NIll~~~~~~kl~DFGla~~~~~ 407 (532)
.--|+|+.+ |.+.|+|.+.+....+
T Consensus 292 SEfN~Lyhd-G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 292 SEFNLLYHD-GKLYIIDVSQSVEHDH 316 (520)
T ss_pred hhhhheEEC-CEEEEEEccccccCCC
Confidence 999999865 5799999987765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.056 Score=54.99 Aligned_cols=144 Identities=16% Similarity=0.189 Sum_probs=80.8
Q ss_pred ceecccCCeEEEEEEeeCC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc-cceeEE
Q 037084 242 EIIGVGACGVVYKAEVPGS---YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL-PLQAHV 317 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~ 317 (532)
+.|-.|-.-.+|+..+.+. .+..|++|+....... .-.-.+|..++..+...++. ++++.+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~---------------~idR~~E~~~~~~l~~~gl~P~~~~~~ 106 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL---------------FFDRDDEIRTFECMSRHGQGPRLLGRF 106 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe---------------eechHHHHHHHHHHHHcCCCCceEEEE
Confidence 4555578889999875421 2368999988664211 11124577777777544443 455655
Q ss_pred ecCCceEEEEEeccCCCHHHH-----------------HhhhcCC-CC-CCCHHHHHHHHHHH-----------------
Q 037084 318 TRPDCHLLVYEFMKNGSLQDI-----------------LHDVSQG-RR-ELDWLARYRIARGM----------------- 361 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~-----------------l~~~~~~-~~-~l~~~~~~~i~~~i----------------- 361 (532)
.. + .|++|+++.+|... +|..... .. ...|....++..++
T Consensus 107 ~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l 182 (344)
T PLN02236 107 PN-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSL 182 (344)
T ss_pred CC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHH
Confidence 33 2 58999987666421 2221111 11 11222222222111
Q ss_pred HHHHHHH----Hh-cCCCCeeecCCCCCcEEecC-CCcEEEeccCCccc
Q 037084 362 ASGLEYL----HM-YHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKL 404 (532)
Q Consensus 362 a~gl~~L----H~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~ 404 (532)
...+..| .. .....++|+|+++.||++++ ++.+.++||..+..
T Consensus 183 ~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 183 EDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1112222 21 22345999999999999986 46799999988764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.11 Score=52.05 Aligned_cols=32 Identities=19% Similarity=0.366 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
..+++|+|+.+.|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34699999999999999998999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.054 Score=54.76 Aligned_cols=145 Identities=13% Similarity=0.169 Sum_probs=79.8
Q ss_pred ceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc-cceeEEe
Q 037084 242 EIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL-PLQAHVT 318 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~ 318 (532)
+.|..|=...+|+....+.+ +..|++|+...... ..-.-.+|..++..+..-++- ++++++.
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---------------~~IdR~~E~~il~~l~~~gl~P~~l~~~~ 84 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---------------YVIDRERELQAIKYLSAAGFGAKLLGVFG 84 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---------------eEechHHHHHHHHHHHhcCCCCceeEEeC
Confidence 44555777888988655321 23788998765421 111224577777777555553 4565553
Q ss_pred cCCceEEEEEeccCCCHHH--------------H---HhhhcCC-CC-CCCHHHHHHHHHHH------------------
Q 037084 319 RPDCHLLVYEFMKNGSLQD--------------I---LHDVSQG-RR-ELDWLARYRIARGM------------------ 361 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gsL~~--------------~---l~~~~~~-~~-~l~~~~~~~i~~~i------------------ 361 (532)
.+ +|.+|+++.+|.. . +|..... .. +-.|....++..++
T Consensus 85 -~G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~ 160 (330)
T PLN02421 85 -NG---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETIS 160 (330)
T ss_pred -Cc---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccC
Confidence 22 5899997765522 1 1211101 11 11233322222221
Q ss_pred ----HHHHHHHH----h-cCCCCeeecCCCCCcEEecC-CCcEEEeccCCcccC
Q 037084 362 ----ASGLEYLH----M-YHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKLM 405 (532)
Q Consensus 362 ----a~gl~~LH----~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFGla~~~ 405 (532)
..-+..+. . ..+...+|+|+.|.||++++ ++.++++||..|..-
T Consensus 161 ~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 161 FEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11111111 1 11235899999999999974 578999999987653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.16 Score=50.98 Aligned_cols=28 Identities=46% Similarity=0.722 Sum_probs=25.5
Q ss_pred eeecCCCCCcEEecCCCc-EEEeccCCcc
Q 037084 376 IIHRDIKPANVLIDDGME-ARISDFGLAK 403 (532)
Q Consensus 376 ivH~Dlkp~NIll~~~~~-~kl~DFGla~ 403 (532)
+||+|+.|.||+++.+.. +.+.|||-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998885 8899999775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.17 Score=52.17 Aligned_cols=79 Identities=11% Similarity=0.041 Sum_probs=47.6
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHH-HHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCcccceeE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATE-LLNVRRVLINRKMRQIKSEIITAGRIW---HRNLLPLQAH 316 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~ 316 (532)
.+.||-|....||+.... +..++||.-......... + .....+-..|...|..+. ..++++++.+
T Consensus 37 ~~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~w--------pl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ 105 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESW--------PMTKERAYFEATALREHGRLCPDHVPEVYHF 105 (418)
T ss_pred EEEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccc--------cCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence 467899999999998753 457999986632110000 0 001122223345554442 3467778888
Q ss_pred EecCCceEEEEEeccC
Q 037084 317 VTRPDCHLLVYEFMKN 332 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~ 332 (532)
+. +..+++|||+++
T Consensus 106 de--d~~vlvME~L~~ 119 (418)
T PLN02756 106 DR--TMALIGMRYLEP 119 (418)
T ss_pred CC--CCCEEEEeecCC
Confidence 87 446789999976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.42 E-value=0.25 Score=49.88 Aligned_cols=29 Identities=24% Similarity=0.387 Sum_probs=24.2
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
..++|+|+.+.||+++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3489999999999995 3 578999998763
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.027 Score=58.60 Aligned_cols=44 Identities=23% Similarity=0.232 Sum_probs=35.1
Q ss_pred HHHHHHhcCCCCCcccceeEEecC-CceEEEEEeccCCCHHHHHhh
Q 037084 297 SEIITAGRIWHRNLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHD 341 (532)
Q Consensus 297 ~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~ 341 (532)
-...+++.+.|+|+...+.+.... .+..+|+|++ +.||.+.+..
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 345678889999999988887643 4577899999 8899999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.058 Score=53.94 Aligned_cols=73 Identities=19% Similarity=0.131 Sum_probs=56.3
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
...|++|++. |+++.- .+...|.+...|+.+.+..+.-+... -+.-|||+.-.|||++ +|++.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 3456777765 555522 23356888889999988887777763 3589999999999999 9999999999
Q ss_pred CcccC
Q 037084 401 LAKLM 405 (532)
Q Consensus 401 la~~~ 405 (532)
+++.-
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99953
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.021 Score=53.69 Aligned_cols=31 Identities=32% Similarity=0.582 Sum_probs=21.7
Q ss_pred CCeeecCCCCCcEEe-cCCCcEEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLI-DDGMEARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll-~~~~~~kl~DFGla~~ 404 (532)
..++|+|+.|.||++ +.++.++++||-.|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.29 Score=46.01 Aligned_cols=75 Identities=15% Similarity=0.143 Sum_probs=52.7
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC---CCcccceeEEe
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH---RNLLPLQAHVT 318 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~ 318 (532)
+.+--|.--..|...+. ..++-||+-.. .....|..|+.-|..+.- -++.+.+.+-.
T Consensus 22 ~~v~gG~inea~~v~dg---~~~~FvK~n~~-----------------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~ 81 (286)
T COG3001 22 EEVSGGDINEAWRLRDG---TDPFFVKCNQR-----------------EQLSMFTAEADGLELLARSNTITVPKVIAVGA 81 (286)
T ss_pred cccCCccccceeEeecC---CcceEEEecch-----------------hhHHHHHHHHHHHHHHHhcCCccccceEEecC
Confidence 44555555666666432 56888997542 334677788877776644 45677888888
Q ss_pred cCCceEEEEEeccCCCHH
Q 037084 319 RPDCHLLVYEFMKNGSLQ 336 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gsL~ 336 (532)
+.+..|+|+||++-+.+.
T Consensus 82 ~~~~sylVle~L~~~~~d 99 (286)
T COG3001 82 SRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCCeeEEEEeeccCCCCC
Confidence 899999999999987665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.2 Score=50.68 Aligned_cols=31 Identities=13% Similarity=0.322 Sum_probs=25.7
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcccC
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLM 405 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~ 405 (532)
..++|+|+.|.||++++++ ++++||..+..-
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G 222 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYG 222 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccccC
Confidence 3589999999999998764 889999877653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF05659 RPW8: Arabidopsis broad-spectrum mildew resistance protein RPW8; InterPro: IPR008808 This entry represents the RPW8 domain found in several broad-spectrum mildew resistance proteins from Arabidopsis thaliana and other dicots | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.52 Score=41.34 Aligned_cols=84 Identities=8% Similarity=0.018 Sum_probs=64.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhchHHHHHHHHHHHHHHHHHHHhhhhhc-cCChHHHhHHHHHHHHHhhH
Q 037084 16 EETTSHYFHSESIEAIIQNLESDWLQKFAGEAHIQADLMGWINMLVKISEVVDDAVEKQ-MTNPHVKLWLGELQNLACDV 94 (532)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~kl~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~dae~~~-~~~~~~~~wl~~l~~~~yd~ 94 (532)
+|++++|++.++++.++ ..+.........++.-+++|..++.+|.-++.+-+.-+ .-|..-+.=+++|++..-++
T Consensus 3 ~eL~~gaalG~~~~eLl----k~v~~~~~k~~~fk~~l~~L~sTl~~i~P~i~eI~~~~~eld~~~~ee~e~L~~~L~~g 78 (147)
T PF05659_consen 3 AELVGGAALGAVFGELL----KAVIDASKKSLSFKSILKRLESTLESIIPIIKEIDKLNVELDRPRQEEIERLKELLEKG 78 (147)
T ss_pred HHHHHHHHHHHHHHHHH----HHHHHHHHHHHhhhhHHHHHHHHHHHhhhHHHHHHHHhhhcCCchhHHHHHHHHHHHHH
Confidence 45555555555555555 57778888888999999999999999999998776642 22333478899999999999
Q ss_pred HHHHHHhhh
Q 037084 95 EYLFDEFQT 103 (532)
Q Consensus 95 ed~~d~~~~ 103 (532)
+++++.|.-
T Consensus 79 ~~LV~k~sk 87 (147)
T PF05659_consen 79 KELVEKCSK 87 (147)
T ss_pred HHHHHHhcc
Confidence 999999854
|
Plant disease resistance (R) genes control the recognition of specific pathogens and activate subsequent defence responses. The R protein-mediated defences typically involve a rapid, localized necrosis, or hypersensitive response (HR), at the site of infection, and the localised formation of antimicrobial chemicals and proteins that restrict growth of the pathogen. The A. thaliana locus Resistance to Powdery Mildew 8 (RPW8) contains two naturally polymorphic, dominant R genes: RPW8.1 and RPW8.2, which individually control resistance to a broad range of powdery mildew pathogens. They induce localised, salicylic acid-dependent defences similar to those induced by R genes that control specific resistance. Apparently, broad-spectrum resistance mediated by RPW8 uses the same mechanisms as specific resistance [, ]. RPW8.1 and RPW8.2 share similarity with an ~150 amino acid module forming the N terminus of a group of disease resistance proteins, which have a nucleotide-binding site (NBS) and leucine-rich repeats (LRRs) [, ]. The RPW8 domain sequences contain a predicted N-terminal transmembrane (TM) region or possibly a signal peptide, and a coiled-coil (CC) motif []. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.83 Score=53.34 Aligned_cols=31 Identities=32% Similarity=0.454 Sum_probs=26.1
Q ss_pred CCeeecCCCCCcEEecCCC--cEE-EeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGM--EAR-ISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~--~~k-l~DFGla~~ 404 (532)
..+||+|+.+.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999875 555 999998764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.3 Score=49.77 Aligned_cols=61 Identities=20% Similarity=0.187 Sum_probs=42.8
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEecC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH-MYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~Dlkp~NIll~~ 390 (532)
...|+=+|++|-++..++.. ...++....+++.--+.++-.+- -.+ .+|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEEe
Confidence 34678889999999999864 22344556666666666654433 334 999999999999953
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.41 Score=49.37 Aligned_cols=76 Identities=13% Similarity=0.137 Sum_probs=45.2
Q ss_pred ceecccCCeEEEEEEeeCCCCc-----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc-ccee
Q 037084 242 EIIGVGACGVVYKAEVPGSYGK-----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL-PLQA 315 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~-----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~ 315 (532)
+.|..|-...+|++......+. .|.++...... ...-.-.+|..+++.+...++- ++++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~---------------~l~IdR~~E~~i~~~Ls~~glgP~l~~ 120 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN---------------SLVIDNDLQYNIAKLLGDNNFGPKIIG 120 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC---------------ceEeccHHHHHHHHHHHhCCCCCeEEE
Confidence 4566688889999876532222 24444432221 1111234678888888665554 4566
Q ss_pred EEecCCceEEEEEeccCCCHH
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQ 336 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~ 336 (532)
.+.. .+++||++|.+|.
T Consensus 121 ~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 121 RFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred ecCC----EEEEEEeccccCC
Confidence 5542 5999999987664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 532 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-23 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-11 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-11 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-07 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 2e-91
Identities = 102/286 (35%), Positives = 154/286 (53%), Gaps = 17/286 (5%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
I+G G G VYK + G ++A+K++ + E Q ++E+
Sbjct: 37 ILGRGGFGKVYKGRLAD--GTLVAVKRLKEERTQGGE-------------LQFQTEVEMI 81
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
HRNLL L+ P LLVY +M NGS+ L + + + LDW R RIA G A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
GL YLH + P IIHRD+K AN+L+D+ EA + DFGLAKLM T + T V GT G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIG 200
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE-MNMVRWMRNVISSEN 481
++APEY T SEK+D++ +GV+L L+ G+ FD ++ + ++ W++ ++ +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
+D L GN +E++ ++++A CT P ERP +V ML
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-79
Identities = 92/290 (31%), Positives = 135/290 (46%), Gaps = 25/290 (8%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G G GVVYK V +A+KK+ TE L +Q EI
Sbjct: 38 KMGEGGFGVVYKGYVNN---TTVAVKKLAAMVDITTEELK----------QQFDQEIKVM 84
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
+ H NL+ L + D LVY +M NGSL D L G L W R +IA+G A
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAA 143
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
+G+ +LH IHRDIK AN+L+D+ A+ISDFGLA+ + + + GTT
Sbjct: 144 NGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTA 200
Query: 423 YVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+APE L I+ KSDIYSFGV+L ++ G D ++ E ++ + E
Sbjct: 201 YMAPEA---LRGEITPKSDIYSFGVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDEE 254
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
K + + + + +A C + +RP K V+ +L ++
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 4e-79
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 22/286 (7%)
Query: 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+IG G G VYK + G +A+K+ + ++EI T
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVALKRRTPESSQGI--------------EEFETEIETL 89
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
H +L+ L + +L+Y++M+NG+L+ L+ + W R I G A
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG-HTRIRITTVAGTT 421
GL YLH IIHRD+K N+L+D+ +I+DFG++K + T + T V GT
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL-STVVKGTL 205
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSEN 481
GY+ PEY ++EKSD+YSFGV+L ++ + E +N+ W ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ-SLPREMVNLAEWAVESHNNGQ 264
Query: 482 PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
+ +D L E +R A C + E+RPS DV L
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 7e-63
Identities = 78/322 (24%), Positives = 118/322 (36%), Gaps = 50/322 (15%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
L LE+ G G V+KA++ Y +A+K P N V M+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLNEY---VAVKIF--PIQDKQSWQNEYEVYSLPGMK- 76
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCH----LLVYEFMKNGSLQDILHDVSQGRRELD 350
H N+L R L+ F + GSL D L +
Sbjct: 77 ------------HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVS 119
Query: 351 WLARYRIARGMASGLEYLHM-------YHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
W IA MA GL YLH H+P I HRDIK NVL+ + + A I+DFGLA
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEY-----HQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
G + GT Y+APE + + D+Y+ G++L L D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
Query: 459 D--------FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCT 510
F + + + M+ V+ + + + M ++ + C
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKH---AGMAMLCETIEECW 296
Query: 511 SDDPEERPSSKDVRCMLSQIKH 532
D E R S+ V ++Q++
Sbjct: 297 DHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 79/293 (26%), Positives = 136/293 (46%), Gaps = 43/293 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
E IG G+ G V++ + G +A+K + + A + R V I +++R
Sbjct: 43 EKIGAGSFGTVHR----AEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR------ 92
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
H N++ VT+P +V E++ GSL +LH S R +LD R +A
Sbjct: 93 -------HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAY 144
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+A G+ YLH P I+HR++K N+L+D ++ DFGL++L T + + AG
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAG 201
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW--MRNVI 477
T ++APE + +EKSD+YSFGV+L L + P+ + + + V + R I
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEI 260
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
Q+ +++ C +++P +RPS + +L +
Sbjct: 261 PRNLN--------------PQVAAIIEG---CWTNEPWKRPSFATIMDLLRPL 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-53
Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 49/300 (16%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
+ E++G GA GVV K + K +AIK+I+ +
Sbjct: 8 KEIEVEEVVGRGAFGVVCK----AKWRAKDVAIKQIESESE----------------RKA 47
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
E+ R+ H N++ L P C LV E+ + GSL ++LH ++
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AEPLPYYTAAHA 104
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME-ARISDFGLAKLMPDGHTRIR 413
+ G+ YLH +IHRD+KP N+L+ G +I DFG A +
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----H 159
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV--R 471
+T G+ ++APE + SEK D++S+G++L ++ + PFD+ +
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
R + P + + ++ C S DP +RPS +++ +++ +
Sbjct: 220 GTRPPLIKNLP--------------KPIESLMTR---CWSKDPSQRPSMEEIVKIMTHLM 262
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 71/307 (23%), Positives = 140/307 (45%), Gaps = 46/307 (14%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
++ + + IG G G+V+K + ++AIK + + K +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKD-KSVVAIKSLILGDSEG-------ETEMIEKFQ 68
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ + E+ + H N++ L + P +V EF+ G L L D + W
Sbjct: 69 EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---KAHPIKWSV 123
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME-----ARISDFGLAKLMPDG 408
+ R+ +A G+EY+ P I+HRD++ N+ + E A+++DFGL++
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
Query: 409 HTRIRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF-FQYTE 465
++ + G ++APE + + +EK+D YSF ++L ++ G+ PFD++ + +
Sbjct: 183 -----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 466 EMNMVRW--MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+NM+R +R I + P ++R V+++ C S DP++RP +
Sbjct: 238 FINMIREEGLRPTIPEDCP--------------PRLRNVIEL---CWSGDPKKRPHFSYI 280
Query: 524 RCMLSQI 530
LS++
Sbjct: 281 VKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-51
Identities = 74/313 (23%), Positives = 121/313 (38%), Gaps = 66/313 (21%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
L EIIG+G G VY+ + G +A+K P + +
Sbjct: 7 AELTLEEIIGIGGFGKVYR----AFWIGDEVAVKAARHDPDEDIS----------QTIEN 52
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
++ E + H N++ L+ + LV EF + G L +L + +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDIL 107
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR--------ISDFGLAKLMP 406
A +A G+ YLH IIHRD+K +N+LI +E I+DFGLA+
Sbjct: 108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
+ AG ++APE + S+ SD++S+GVLL L+ G+ PF
Sbjct: 168 RTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG------- 216
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVL---------KIAYFCTSDDPEER 517
++ + V ++ L + K+ C + DP R
Sbjct: 217 IDGLAVAYGVA------------------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
Query: 518 PSSKDVRCMLSQI 530
PS ++ L+ I
Sbjct: 259 PSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 9e-51
Identities = 68/304 (22%), Positives = 108/304 (35%), Gaps = 52/304 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
L L + G ++K G + G I +K + + RK R
Sbjct: 10 KQLNFLTKLNENHSGELWK----GRWQGNDIVVKVLKVRDWST------------RKSRD 53
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLL--VYEFMKNGSLQDILHDVSQGRRELDWL 352
E H N+LP+ P + +M GSL ++LH+ +D
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQS 111
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+ A MA G+ +LH P I + +V+ID+ M ARIS +
Sbjct: 112 QAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----- 165
Query: 413 RITTVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
+VAPE T +D++SF VLL LV + PF D E
Sbjct: 166 --PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD-LSNMEIGMK 222
Query: 470 VRW--MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
V +R I + ++KI C ++DP +RP + +L
Sbjct: 223 VALEGLRPTIPPGIS--------------PHVSKLMKI---CMNEDPAKRPKFDMIVPIL 265
Query: 528 SQIK 531
+++
Sbjct: 266 EKMQ 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-49
Identities = 67/320 (20%), Positives = 119/320 (37%), Gaps = 58/320 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
++ IG G G V+ G + G+ +A+K ++EI
Sbjct: 42 VKQIGKGRYGEVWM----GKWRGEKVAVKVFFTT---------------EEASWFRETEI 82
Query: 300 ITAGRIWHRNLLPLQAHVTRPDC----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
+ H N+L A + L+ ++ +NGSL D L LD +
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSML 137
Query: 356 RIARGMASGLEYLHM-----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
++A SGL +LH +P I HRD+K N+L+ I+D GLA
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 411 RIRI--TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLL----------AVLVV 452
+ I T GT Y+ PE +D+YSFG++L ++
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
Query: 453 GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSD 512
+ P+ D MR ++ + + ++ + QM ++ C +
Sbjct: 258 YQLPYHD---LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE---CWAH 311
Query: 513 DPEERPSSKDVRCMLSQIKH 532
+P R ++ V+ L+++
Sbjct: 312 NPASRLTALRVKKTLAKMSE 331
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-49
Identities = 74/332 (22%), Positives = 120/332 (36%), Gaps = 61/332 (18%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
D+L LE+IG G G VYK GS + +A+K +N + + M
Sbjct: 13 DNLKLLELIGRGRYGAVYK----GSLDERPVAVKVFSFANRQ--NFINEKNIYRVPLME- 65
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCH-----LLVYEFMKNGSLQDILHDVSQGRREL 349
H N+ R LLV E+ NGSL L
Sbjct: 66 ------------HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTS 108
Query: 350 DWLARYRIARGMASGLEYLHM------YHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
DW++ R+A + GL YLH +++P I HRD+ NVL+ + ISDFGL+
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168
Query: 404 LM------PDGHTRIRITTVAGTTGYVAPEY-------HQTLTISEKSDIYSFGVLL--- 447
+ G + GT Y+APE + ++ D+Y+ G++
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
Query: 448 AVLVVGKFPFDD-------FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMR 500
+ FP + F M+ ++S E N +R
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKEN--SLAVR 286
Query: 501 LVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+ + C D E R +++ ++++
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-48
Identities = 67/315 (21%), Positives = 120/315 (38%), Gaps = 52/315 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
LE +G G G V++ GS+ G+ +A+K + +R
Sbjct: 13 LECVGKGRYGEVWR----GSWQGENVAVKIF--SSRDEKSWFRETELYNTVMLR------ 60
Query: 300 ITAGRIWHRNLLPLQAHVTRPDC----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H N+L A L+ + + GSL D L LD ++
Sbjct: 61 -------HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCL 108
Query: 356 RIARGMASGLEYLHM-----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
RI +ASGL +LH+ +P I HRD+K N+L+ + I+D GLA +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 411 RIRI--TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
++ + GT Y+APE ++ DI++FG++L +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 463 YT---EEMN----MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPE 515
Y ++ MR V+ + I ++ + + ++K C +P
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE---CWYQNPS 285
Query: 516 ERPSSKDVRCMLSQI 530
R ++ ++ L++I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 68/317 (21%), Positives = 117/317 (36%), Gaps = 66/317 (20%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
L E++G G G K + G+++ +K++ + R
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRET-GEVMVMKELIRFD--------------EETQRTF 54
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
E+ + H N+L + + + E++K G+L+ I+ + W R
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRV 111
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG------- 408
A+ +ASG+ YLH + IIHRD+ N L+ + ++DFGLA+LM D
Sbjct: 112 SFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 409 -----HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463
R + TV G ++APE + EK D++SFG++L ++ D+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL-- 226
Query: 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDP 514
R + G + I C DP
Sbjct: 227 ---------PRTMD-------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDP 264
Query: 515 EERPSSKDVRCMLSQIK 531
E+RPS + L ++
Sbjct: 265 EKRPSFVKLEHWLETLR 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-47
Identities = 69/299 (23%), Positives = 126/299 (42%), Gaps = 40/299 (13%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQ 294
+ + IG G+ G VYK G + +A+K ++ +L + V + RK R
Sbjct: 24 GQITVGQRIGSGSFGTVYK----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR- 78
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H N+L + T P +V ++ + SL LH + +
Sbjct: 79 ------------HVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHA---SETKFEMKKL 122
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
IAR A G++YLH IIHRD+K N+ + + +I DFGLA +
Sbjct: 123 IDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179
Query: 415 TTVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
++G+ ++APE + S +SD+Y+FG++L L+ G+ P+ + + + MV
Sbjct: 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV- 238
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ D + + ++M+ ++ C +ERPS + + ++
Sbjct: 239 --------GRGSLSPDLSKVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 69/310 (22%), Positives = 121/310 (39%), Gaps = 55/310 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQ 294
+ L E+IG G G VY G + +AI+ ID +L +R V+ R+ R
Sbjct: 33 EQLEIGELIGKGRFGQVYH----GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR- 87
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H N++ P ++ K +L ++ D + LD
Sbjct: 88 ------------HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKT 132
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR- 413
+IA+ + G+ YL H I+H+D+K NV D+G I+DFGL + R
Sbjct: 133 RQIAQEIVKGMGYL---HAKGILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRRE 188
Query: 414 --ITTVAGTTGYVAPEYHQTLTI---------SEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
+ G ++APE + L+ S+ SD+++ G + L ++PF
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QP 247
Query: 463 YTEEMNMVRW-MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
+ + M+ +S + I ++L C + + EERP+
Sbjct: 248 AEAIIWQMGTGMKPNLSQIGMGKEI------------SDILLF----CWAFEQEERPTFT 291
Query: 522 DVRCMLSQIK 531
+ ML ++
Sbjct: 292 KLMDMLEKLP 301
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 67/317 (21%), Positives = 116/317 (36%), Gaps = 52/317 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSY-GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
E IG G G V++ G + G+ +A+K + +R
Sbjct: 47 QESIGKGRFGEVWR----GKWRGEEVAVKIF--SSREERSWFREAEIYQTVMLR------ 94
Query: 300 ITAGRIWHRNLLPLQAHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H N+L A + + LV ++ ++GSL D L+ R +
Sbjct: 95 -------HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMI 142
Query: 356 RIARGMASGLEYLHM-----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
++A ASGL +LHM +P I HRD+K N+L+ I+D GLA
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 411 RIRI--TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD--- 459
I I GT Y+APE + +++DIY+ G++ +
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 460 ----FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPE 515
++ V MR V+ + I ++ M +++ C +
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE---CWYANGA 319
Query: 516 ERPSSKDVRCMLSQIKH 532
R ++ ++ LSQ+
Sbjct: 320 ARLTALRIKKTLSQLSQ 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 20/226 (8%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQ---PPMAATELLNVRRVLINRKMRQIKSEII 300
+ G + E K A+KK ++ N ++ I K K+E+
Sbjct: 39 LNQGKFNKIILCE---KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH-----DVSQGRRELDWLARY 355
I + L + +T D ++YE+M+N S+ D + + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
I + + + Y+H I HRD+KP+N+L+D ++SDFG ++ M D +I
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIK 208
Query: 416 TVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT ++ PE +++ K DI+S G+ L V+ PF
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+G G ++ + ++ A K + + +L+ R ++ EI
Sbjct: 49 LGKGGFAKCFEISDADT-KEVFAGKIVP------------KSLLLKPHQREKMSMEISIH 95
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGM 361
+ H++++ D +V E + SL ++ + E ARY R +
Sbjct: 96 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTE--PEARY-YLRQI 150
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA-KLMPDGHTRIRITTVAGT 420
G +YLH +IHRD+K N+ +++ +E +I DFGLA K+ DG R + GT
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGT 204
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y+APE S + D++S G ++ L+VGK PF+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 7e-37
Identities = 59/223 (26%), Positives = 108/223 (48%), Gaps = 34/223 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+G G+ VY+AE + G +AIK ID ++ + M ++++E+
Sbjct: 19 LGKGSFAGVYRAESIHT-GLEVAIKMID------------KKAMYKAGMVQRVQNEVKIH 65
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
++ H ++L L + + LV E NG + L ++ + + AR+ + +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFM-HQII 122
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA-KLMPDGHTRIRITTVAGTT 421
+G+ YLH + I+HRD+ +N+L+ M +I+DFGLA +L + T+ GT
Sbjct: 123 TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTP 176
Query: 422 GYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y++PE H +SD++S G + L++G+ PFD
Sbjct: 177 NYISPEIATRSAH-----GLESDVWSLGCMFYTLLIGRPPFDT 214
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 9e-37
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+G G ++ + ++ A K + + +L+ R ++ EI
Sbjct: 23 LGKGGFAKCFEISDADT-KEVFAGKIVP------------KSLLLKPHQREKMSMEISIH 69
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
+ H++++ D +V E + SL ++ + ARY R +
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KRRKALTEP-EARY-YLRQIV 125
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA-KLMPDGHTRIRITTVAGTT 421
G +YLH +IHRD+K N+ +++ +E +I DFGLA K+ DG R + GT
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVLCGTP 179
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y+APE S + D++S G ++ L+VGK PF+
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 65/287 (22%), Positives = 110/287 (38%), Gaps = 45/287 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
IG G+ VYK + +A ++ + +E ++ K E
Sbjct: 32 IEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLTKSER------------QRFKEEAEM 78
Query: 302 AGRIWHRNL---LPLQAHVTRPDCHLLVY-EFMKNGSLQDILHDVSQGRRELDWLARYRI 357
+ H N+ + +++ E M +G+L+ L + +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSW 134
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLID--DGMEARISDFGLAKLMPDGHTRIRIT 415
R + GL++LH P IIHRD+K N+ I G +I D GLA L +
Sbjct: 135 CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLKRASFAK---- 188
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
V GT ++APE ++ E D+Y+FG+ + + ++P Y+E N + R
Sbjct: 189 AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRR 241
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
V S P + D E ++ C + +ER S KD
Sbjct: 242 VTSGVKP-ASFDKVA----IPEVKEIIEG----CIRQNKDERYSIKD 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 38/244 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG G V++ ++ AIK ++ N+ + ++EI
Sbjct: 33 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVN------------LEEADNQTLDSYRNEIA 78
Query: 301 TAGRIWHRNL--LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD-WLARYRI 357
++ + + L + +V E N L L ++ +D W +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKS-Y 132
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ M + +H + I+H D+KPAN LI DGM ++ DFG+A M T + +
Sbjct: 133 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 418 AGTTGYVAPE-----------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
GT Y+ PE IS KSD++S G +L + GK PF +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 467 MNMV 470
++ +
Sbjct: 249 LHAI 252
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 56/244 (22%), Positives = 97/244 (39%), Gaps = 38/244 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG G V++ ++ AIK ++ N+ + ++EI
Sbjct: 14 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVN------------LEEADNQTLDSYRNEIA 59
Query: 301 TAGRIWHRNL--LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD-WLARYRI 357
++ + + L + +V E N L L ++ +D W +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKS-Y 113
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ M + +H + I+H D+KPAN LI DGM ++ DFG+A M T + +
Sbjct: 114 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 418 AGTTGYVAPE-----------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
GT Y+ PE IS KSD++S G +L + GK PF +
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 467 MNMV 470
++ +
Sbjct: 230 LHAI 233
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 55/244 (22%), Positives = 96/244 (39%), Gaps = 38/244 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG G V++ ++ AIK ++ N+ + ++EI
Sbjct: 61 LKQIGSGGSSKVFQVL--NEKKQIYAIKYVN------------LEEADNQTLDSYRNEIA 106
Query: 301 TAGRIWHRNL--LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD-WLARYRI 357
++ + + L + +V E N L L ++ +D W +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKS-Y 160
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ M + +H + I+H D+KPAN LI DGM ++ DFG+A M T + +
Sbjct: 161 WKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 418 AGTTGYVAPE-----------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
G Y+ PE IS KSD++S G +L + GK PF +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 467 MNMV 470
++ +
Sbjct: 277 LHAI 280
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 35/301 (11%), Positives = 73/301 (24%), Gaps = 37/301 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLN--VRRVLINRKMR------ 293
E + VG VV+ + A+K + L ++
Sbjct: 68 EPLRVGDRSVVFLVRDVER-LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 294 -------QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMK--NGSLQDILHDVSQ 344
+ S+ + L +LL+ L L V
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
R + LA + + + L ++H P N+ I + D
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 405 MPDGHTRIRITTVAGTTGYVAPEY--HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
+ R + Y E+ T T + + + G+ + + PF
Sbjct: 244 VGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298
Query: 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + ++ + L+ + + D R +
Sbjct: 299 GIKGS-----WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR----FLNFDRRRRLLPLE 349
Query: 523 V 523
Sbjct: 350 A 350
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-34
Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 44/299 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ ++G GA G V KA + AIKKI + +L+ +L + + +
Sbjct: 11 IAVLGQGAFGQVVKAR-NALDSRYYAIKKIRHTEEKLSTILSEVMLL-----ASLNHQYV 64
Query: 301 TA--GRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
R + L + E+ +NG+L D++H +R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRL 121
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI--- 414
R + L Y+H IIHRD+KP N+ ID+ +I DFGLAK + +++
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 415 ---------TTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464
T+ GT YVA E T +EK D+YS G++ ++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTG----- 231
Query: 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
M V ++ + S N + + +++ DP +RP ++ +
Sbjct: 232 --MERVNILKKLRSVSIE---FPPDFDDNKMKVEKKIIRL----LIDHDPNKRPGARTL 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 32/247 (12%), Positives = 80/247 (32%), Gaps = 39/247 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV--RRVLINRKMRQIKSEI 299
++G +A + G+ + + + VL R +R IK++
Sbjct: 79 TVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 137
Query: 300 ITAGRI------------WHRNLLPLQAHVTRPDCH--LLVYEFMK--NGSLQDILHDVS 343
+ + ++ ++ +Y M+ + ++L S
Sbjct: 138 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 197
Query: 344 QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ L AR ++ + L LH Y ++H ++P ++++D ++ F
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 404 LMPDGHTRIRITTVAGTTGYVAPEY-----------HQTLTISEKSDIYSFGVLLAVLVV 452
DG + + G+ PE + ++ D ++ G+++ +
Sbjct: 255 --RDGAR----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 453 GKFPFDD 459
P
Sbjct: 309 ADLPITK 315
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 66/292 (22%), Positives = 119/292 (40%), Gaps = 46/292 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
L IG G+ G K GK++ K++D M E + V + R+++
Sbjct: 11 LYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMTEAEKQMLVSEVNLLRELK------ 63
Query: 300 ITAGRIWHRNLLPLQAH-VTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELD----WLA 353
H N++ + R + L +V E+ + G L ++ ++ R+ LD
Sbjct: 64 -------HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL-- 114
Query: 354 RYRIARGMASGLEYLHMYHRPC--IIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
R+ + L+ H ++HRD+KPANV +D ++ DFGLA+++ H
Sbjct: 115 --RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDT 170
Query: 412 IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
T GT Y++PE ++ +EKSDI+S G LL L PF F +
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKE 223
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ + + Y +++ ++ + RPS +++
Sbjct: 224 LAGKIREGKFRR-------IPYRYSDELNEIITR---MLNLKDYHRPSVEEI 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-34
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM-RQIKSEIITA 302
+G G G VY A S ++A+K + + L + Q++ E+
Sbjct: 17 LGKGKFGNVYLAREKQS-KFILALKVLF------------KAQLEKAGVEHQLRREVEIQ 63
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
+ H N+L L + L+ E+ G++ L + + + +A
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFD-EQRTA-TYITELA 119
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
+ L Y H +IHRDIKP N+L+ E +I+DFG + P R T + GT
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLD 172
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y+ PE + EK D++S GVL +VGK PF+
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-33
Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 25/217 (11%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM-RQIKSEIITA 302
+G G G VY A + ++A+K + + L + Q++ EI
Sbjct: 22 LGKGKFGNVYLAREKQN-KFIMALKVLF------------KSQLEKEGVEHQLRREIEIQ 68
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
+ H N+L + + L+ EF G L L GR + + + +A
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFD-EQRSA-TFMEELA 124
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
L Y H +IHRDIKP N+L+ E +I+DFG + P R T+ GT
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLD 177
Query: 423 YVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y+ PE + T EK D++ GVL +VG PFD
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 59/287 (20%), Positives = 113/287 (39%), Gaps = 45/287 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG G+ G + G+ IK+I+ M++ E + + E+
Sbjct: 29 LQKIGEGSFGKAILVKSTED-GRQYVIKEINISRMSSKER------------EESRREVA 75
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RE---LDWLARYR 356
+ H N++ + +V ++ + G L ++ +E LDW +
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ-- 133
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+ L+++H I+HRDIK N+ + ++ DFG+A+++ T
Sbjct: 134 ----ICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARA 184
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT Y++PE + + KSDI++ G +L L K F+ +M + +
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-------SMKNLVLKI 237
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
IS P + Y +R ++ +P +RPS +
Sbjct: 238 ISGSFPP-------VSLHYSYDLRSLVSQ---LFKRNPRDRPSVNSI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 61/306 (19%), Positives = 108/306 (35%), Gaps = 47/306 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ +G G V E G A+K+I E + + E
Sbjct: 34 IQKLGEGGFSYVDLVEGLHD-GHFYALKRILCHEQQDRE--------------EAQREAD 78
Query: 301 TAGRIWHRNLLPLQAHVTRPDCH----LLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
H N+L L A+ R L+ F K G+L + + + L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM---PDGHTRIR 413
+ G+ GLE +H HRD+KP N+L+ D + + D G +G +
Sbjct: 139 LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 414 IT----TVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
T Y APE I E++D++S G +L ++ G+ P+D FQ +
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526
+ + + ++P + + +L + DP +RP +
Sbjct: 256 VALAV-QNQLSIPQSPR-----------HSSALWQLLN---SMMTVDPHQRPHIPLLLSQ 300
Query: 527 LSQIKH 532
L ++
Sbjct: 301 LEALQP 306
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 73/306 (23%), Positives = 125/306 (40%), Gaps = 64/306 (20%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL---INR 290
K D L + +G GA GVV K S G+++A+K+I AT ++ L ++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIR-----ATVNSQEQKRLLMDLDI 58
Query: 291 KMRQIKSEIITA--------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
MR + G +W + E M + SL V
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVW------------------ICMELM-DTSLDKFYKQV 99
Query: 343 SQGRREL--DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
+ + D L + IA + LE+LH +IHRD+KP+NVLI+ + ++ DFG
Sbjct: 100 IDKGQTIPEDILGK--IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG 155
Query: 401 LAKLMPDGHTRIRITTVAGTTGYVAPE----YHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
++ + D + AG Y+APE S KSDI+S G+ + L + +FP
Sbjct: 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 457 FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE 516
+D + +++ V+ +P +L + + + C + +E
Sbjct: 213 YDSWGTPFQQLKQ------VVEEPSP------QLPADKFSAEFVDFTSQ---CLKKNSKE 257
Query: 517 RPSSKD 522
RP+ +
Sbjct: 258 RPTYPE 263
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 33/245 (13%), Positives = 70/245 (28%), Gaps = 28/245 (11%)
Query: 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV--RRVLINRKMRQI 295
L ++G +A + G+ + + + VL R +R I
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 296 KSEIITAGRI----------------WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL 339
K++ + R L + L + ++L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 340 HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
S + L AR ++ + L LH Y ++H ++P ++++D ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 400 GLAKLMPDGHTRIRITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGK 454
I A H ++ D ++ G+ + +
Sbjct: 256 EHLVRDGAS-AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 455 FPFDD 459
P D
Sbjct: 315 LPNTD 319
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKID------------QPPMAATELLNVRRVLINRK 291
IG G+ GVV A A+K + +PP T +
Sbjct: 21 IGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRP-DCHL-LVYEFMKNGSLQDILHDVSQGRREL 349
+ Q+ EI ++ H N++ L + P + HL +V+E + G + ++ +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSE 136
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
D AR + + G+EYLH Y + IIHRDIKP+N+L+ + +I+DFG++
Sbjct: 137 D-QAR-FYFQDLIKGIEYLH-YQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 410 TRIRITTVAGTTGYVAPEYHQTLTISE--------KSDIYSFGVLLAVLVVGKFPFDD 459
+ GT ++APE ++SE D+++ GV L V G+ PF D
Sbjct: 192 ALLS--NTVGTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 64/305 (20%), Positives = 114/305 (37%), Gaps = 59/305 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ +G G GVV++A+ AIK+I P ++ E+
Sbjct: 10 IQCLGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNR-------------ELAREKVMREVK 55
Query: 301 TAGRIWHRN-----------LLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRE 348
++ H + + P +L + + + +L+D ++ E
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEE 114
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM--- 405
+ I +A +E+LH ++HRD+KP+N+ ++ DFGL M
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 406 -------PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
R T GT Y++PE + S K DI+S G++L L+ PF
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228
Query: 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP 518
+M VR + +V + + P L Y + +V S P ERP
Sbjct: 229 T------QMERVRTLTDVRNLKFP------PLFTQKYPCEYVMVQD----MLSPSPMERP 272
Query: 519 SSKDV 523
+ ++
Sbjct: 273 EAINI 277
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 41/288 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKID-QPPMAATELLNVRRVLINRKMRQIKSEI 299
+ IG G VY+A G +A+KK+ M A EI
Sbjct: 37 EKKIGRGQFSEVYRAACLLD-GVPVALKKVQIFDLMDAKAR------------ADCIKEI 83
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD----WLARY 355
++ H N++ A + +V E G L ++ + +R + W
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW---- 139
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + S LE++H ++HRDIKPANV I ++ D GL +
Sbjct: 140 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAH 194
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
++ GT Y++PE + KSDI+S G LL + + PF Y ++MN+ +
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYSLCKK 249
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ + P L + Y E++R ++ + C + DPE+RP V
Sbjct: 250 IEQCDYP------PLPSDHYSEELRQLVNM---CINPDPEKRPDVTYV 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 69/320 (21%), Positives = 115/320 (35%), Gaps = 60/320 (18%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K+D + +G G GVV+K S G ++A K I +
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLI---HLEIKP----------AIRN 76
Query: 294 QIKSEIITAGRIWHRNLLP-----LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
QI E+ ++ H P A + + + E M GSL +L GR
Sbjct: 77 QIIREL----QVLHECNSPYIVGFYGAFYSDGEISI-CMEHMDGGSLDQVLKKA--GRIP 129
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
L + ++ + GL YL H+ I+HRD+KP+N+L++ E ++ DFG++ + D
Sbjct: 130 EQILGK--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF--DDFFQYTEE 466
+ GT Y++PE Q S +SDI+S G+ L + VG++P D +
Sbjct: 186 MAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYF------------------ 508
+ P + ++ +
Sbjct: 242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 301
Query: 509 ------CTSDDPEERPSSKD 522
C +P ER K
Sbjct: 302 QDFVNKCLIKNPAERADLKQ 321
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 58/316 (18%), Positives = 109/316 (34%), Gaps = 46/316 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+I+G GA V++ + G + AIK + + R + E
Sbjct: 15 DILGQGATANVFRGRHKKT-GDLFAIKVFN-------------NISFLRPVDVQMREFEV 60
Query: 302 AGRIWHRNLLPLQAHVTRPDCHL--LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
++ H+N++ L A L+ EF GSL +L + S + + R
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLR 119
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR----ISDFGLAKLMPDGHTRIRIT 415
+ G+ +L I+HR+IKP N++ G + + ++DFG A+ + D
Sbjct: 120 DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FV 173
Query: 416 TVAGTTGYVAPEYHQTLTI--------SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
++ GT Y+ P+ ++ + D++S GV G PF F
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSD-----------DPEE 516
++ + S ++ + M + ++ D E+
Sbjct: 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
Query: 517 RPSSKDVRCMLSQIKH 532
S I H
Sbjct: 294 CWGFDQFFAETSDILH 309
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 62/321 (19%), Positives = 113/321 (35%), Gaps = 56/321 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+I+G GA V++ + G + AIK + + R + E
Sbjct: 15 DILGQGATANVFRGRHKKT-GDLFAIKVFN-------------NISFLRPVDVQMREFEV 60
Query: 302 AGRIWHRNLLPLQAHVTRPDCHL--LVYEFMKNGSLQDIL--HDVSQGRRELDWLARYRI 357
++ H+N++ L A L+ EF GSL +L + G E + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE--FL-IV 117
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR----ISDFGLAKLMPDGHTRIR 413
R + G+ +L I+HR+IKP N++ G + + ++DFG A+ + D
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--- 171
Query: 414 ITTVAGTTGYVAPEYHQTLTI--------SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465
++ GT Y+ P+ ++ + D++S GV G PF F
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNG---YEEQMRLVLKIAYFCTSD---------- 512
+ M +I+ + + NG + M + ++
Sbjct: 232 NKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE 288
Query: 513 -DPEERPSSKDVRCMLSQIKH 532
D E+ S I H
Sbjct: 289 ADQEKCWGFDQFFAETSDILH 309
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 72/309 (23%), Positives = 122/309 (39%), Gaps = 63/309 (20%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-I 300
+I+G G+ G V G+ +A+K++ EI +
Sbjct: 21 KILGYGSSGTVVFQGS--FQGRPVAVKRMLI-----------------DFCDIALMEIKL 61
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL---HDVSQGRRELDWLARYRI 357
H N++ T + E N +LQD++ + + + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLID-------------DGMEARISDFGLAKL 404
R +ASG+ +LH IIHRD+KP N+L+ + + ISDFGL K
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 405 MPDGHT--RIRITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLL-AVLVVGK 454
+ G + R + +GT+G+ APE ++ DI+S G + +L GK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDP 514
PF D +Y+ E N+ +R + S + D L+ E L+ + DP
Sbjct: 238 HPFGD--KYSRESNI---IRGIFSLDEMKCLHDRSLI----AEATDLISQ----MIDHDP 284
Query: 515 EERPSSKDV 523
+RP++ V
Sbjct: 285 LKRPTAMKV 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 62/242 (25%), Positives = 97/242 (40%), Gaps = 34/242 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E +G G G V + + G+ +AIK+ + L + + EI
Sbjct: 19 KERLGTGGFGYVLRWIHQDT-GEQVAIKQCR-------------QELSPKNRERWCLEIQ 64
Query: 301 TAGRIWHRNLLPL------QAHVTRPDCHLLVYEFMKNGSLQDIL--HDVSQGRRELDWL 352
++ H N++ + D LL E+ + G L+ L + G +E
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-- 122
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR---ISDFGLAKLMPDGH 409
R + ++S L YLH IIHRD+KP N+++ G + I D G AK + G
Sbjct: 123 IR-TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
T GT Y+APE + + D +SFG L + G PF +Q +
Sbjct: 179 L---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 470 VR 471
VR
Sbjct: 236 VR 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 67/309 (21%), Positives = 115/309 (37%), Gaps = 60/309 (19%)
Query: 231 FLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL--I 288
+ + L L IG GA G V K S G+++A+K+I + + +++L +
Sbjct: 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRIR----STVDEKEQKQLLMDL 71
Query: 289 NRKMRQIKSEIITA--------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340
+ MR I G W + E M + S
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCW------------------ICMELM-STSFDKFYK 112
Query: 341 DV---SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397
V + L + I L +L + IIHRDIKP+N+L+D ++
Sbjct: 113 YVYSVLDDVIPEEILGK--ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLC 168
Query: 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPE----YHQTLTISEKSDIYSFGVLLAVLVVG 453
DFG++ + D + T AG Y+APE +SD++S G+ L L G
Sbjct: 169 DFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
Query: 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDD 513
+FP+ + ++ + V+ + P S + + + C + D
Sbjct: 226 RFPYPKW------NSVFDQLTQVVKGDPP---QLSNSEEREFSPSFINFVNL---CLTKD 273
Query: 514 PEERPSSKD 522
+RP K+
Sbjct: 274 ESKRPKYKE 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 66/293 (22%), Positives = 112/293 (38%), Gaps = 52/293 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-I 300
+++G GA G + + + +A+K+I E+ +
Sbjct: 30 DVLGHGAEGTIVYRGM--FDNRDVAVKRILP-----------------ECFSFADREVQL 70
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ + E +LQ+ + L+ + +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLE---PITLLQQ 126
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI-----DDGMEARISDFGLAK-LMPDGHTRIRI 414
SGL +LH + I+HRD+KP N+LI ++A ISDFGL K L H+ R
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 415 TTVAGTTGYVAPEY---HQTLTISEKSDIYSFGVLLA-VLVVGKFPFDDFFQYTEEMNMV 470
+ V GT G++APE + DI+S G + V+ G PF + N++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK--SLQRQANIL 241
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ +P + D L+ K + DP++RPS+K V
Sbjct: 242 L-GACSLDCLHPEKHED--------VIARELIEK----MIAMDPQKRPSAKHV 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 65/337 (19%), Positives = 110/337 (32%), Gaps = 78/337 (23%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM------RQ 294
++ +G G GVV++A+ AIK+I P +R V K+ R
Sbjct: 11 IQCMGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLL----------------------------- 325
+ + T W + + D L
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 326 ---------VYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
+ + +L+D + + + I +A +E+LH +
Sbjct: 130 SSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGL 185
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKLM----------PDGHTRIRITTVAGTTGYVAP 426
+HRD+KP+N+ ++ DFGL M T GT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 427 EYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAI 486
E S K DI+S G++L L+ M VR + +V + + P
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQ---------MERVRIITDVRNLKFP---- 292
Query: 487 DSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
L Y ++ +V S P ERP + D+
Sbjct: 293 --LLFTQKYPQEHMMVQD----MLSPSPTERPEATDI 323
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+ +G GACG V A + K +AI+ I + A +++EI
Sbjct: 141 KTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSARE------ADPALNVETEIEI 193
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIAR 359
++ H ++ ++ D ++ V E M+ G L D + V R +E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CK-LYFY 246
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
M ++YLH IIHRD+KP NVL+ ++ +I+DFG +K++ + + T
Sbjct: 247 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRT 300
Query: 417 VAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT Y+APE T + D +S GV+L + + G PF +
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+ +G GACG V A + K +AIK I + A +++EI
Sbjct: 16 KTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSARE------ADPALNVETEIEI 68
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIAR 359
++ H ++ ++ D ++ V E M+ G L D + V R +E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLKEAT--CK-LYFY 121
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
M ++YLH IIHRD+KP NVL+ ++ +I+DFG +K++ + + T
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRT 175
Query: 417 VAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT Y+APE T + D +S GV+L + + G PF +
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 51/242 (21%), Positives = 89/242 (36%), Gaps = 42/242 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ G VY+A+ GS G+ A+K++ K R I E+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGS-GREYALKRLLSNEE--------------EKNRAIIQEVC 77
Query: 301 TAGRI-WHRNLLPLQAH-------VTRPDCHLLVYEFMKNGSLQDILHDVSQGRR--ELD 350
++ H N++ + L+ + G L + L +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
L +I ++++H +P IIHRD+K N+L+ + ++ DFG A +
Sbjct: 138 VL---KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPD 193
Query: 411 RIRIT----------TVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
T T Y PE + I EK DI++ G +L +L + PF
Sbjct: 194 YSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
Query: 458 DD 459
+D
Sbjct: 254 ED 255
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G V A + G+ +AIK ID + L ++++ E+
Sbjct: 23 IGKGNFAKVKLARHILT-GREVAIKIID------------KTQLNPTSLQKLFREVRIMK 69
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGMA 362
+ H N++ L + L+ E+ G + D L V+ GR +E + AR R +
Sbjct: 70 ILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKE--AR-SKFRQIV 124
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
S ++Y H + I+HRD+K N+L+D M +I+DFG + G + G
Sbjct: 125 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPP 178
Query: 423 YVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y APE Y + D++S GV+L LV G PFD
Sbjct: 179 YAAPELFQGKKYD-----GPEVDVWSLGVILYTLVSGSLPFDG 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 54/287 (18%), Positives = 94/287 (32%), Gaps = 50/287 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
L +G G+ G V+K G++ A+K+ P + V + K+ Q
Sbjct: 62 LSRLGHGSYGEVFKVRSKED-GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ----- 115
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE---LDWLARYR 356
H + L+ L E SLQ E +L
Sbjct: 116 -------HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD-- 165
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
L +LH ++H D+KPAN+ + ++ DFGL +
Sbjct: 166 ----TLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG---EV 215
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
G Y+APE Q + +D++S G+ + + E +R +
Sbjct: 216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH----GGEGWQQLR--QGY 268
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ E G ++R VL DP+ R +++ +
Sbjct: 269 LPPEFT----------AGLSSELRSVLV---MMLEPDPKLRATAEAL 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 25/226 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-I 300
EI+G G VV + + K A+K ID + V+ + E+ I
Sbjct: 23 EILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQEL-----REATLKEVDI 76
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIAR 359
H N++ L+ LV++ MK G L D L + E + R +I R
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE--TR-KIMR 131
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ + LH + I+HRD+KP N+L+DD M +++DFG + + G ++ V G
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCG 185
Query: 420 TTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T Y+APE ++ D++S GV++ L+ G PF
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-29
Identities = 60/289 (20%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E+IG G G V+KA+ GK IK++ A R V + ++ I
Sbjct: 16 IELIGSGGFGQVFKAKHRID-GKTYVIKRVKYNNEKA-----EREVKA---LAKLDHVNI 66
Query: 301 TA------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
G + + ++ C + EF G+L+ + + +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+ G++Y+H +I+RD+KP+N+ + D + +I DFGL + + R
Sbjct: 127 L--FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
T GT Y++PE + ++ D+Y+ G++LA L+ F+ ++ +R
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT---AFETSKFFTDLR--D 233
Query: 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+IS ++++ + +L+ S PE+RP++ ++
Sbjct: 234 GIISD--------------IFDKKEKTLLQK---LLSKKPEDRPNTSEI 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G GA G V A + + +A+K +D IK EI
Sbjct: 15 LGEGAYGEVQLAVNRVT-EEAVAVKIVD-------------MKRAVDCPENIKKEICINK 60
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGMA 362
+ H N++ H + L E+ G L D + E D A+ R +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPD--AQ-RFFHQLM 115
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
+G+ YLH I HRDIKP N+L+D+ +ISDFGLA + + + + GT
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 423 YVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
YVAPE +H +E D++S G++L ++ G+ P+D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 57/308 (18%), Positives = 115/308 (37%), Gaps = 63/308 (20%)
Query: 231 FLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVL--- 287
+ + + L +L +G G CG V+K + G +IA+K++ + + +
Sbjct: 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQMR-----RSGNKEENKRILMD 73
Query: 288 INRKMRQIKSEIITA--------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL 339
++ ++ I ++ + E M + +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTDVF------------------IAMELM-GTCAEKLK 114
Query: 340 HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
+ E L + + + L YL H +IHRD+KP+N+L+D+ + ++ DF
Sbjct: 115 KRMQGPIPE-RILGK--MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDF 169
Query: 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGK 454
G++ + D + AG Y+APE ++ ++D++S G+ L L G+
Sbjct: 170 GISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDP 514
FP+ + E + + E P G+ + +K C + D
Sbjct: 227 FPYKNCKTDFEVLTK-------VLQEEPPLLPGHM----GFSGDFQSFVKD---CLTKDH 272
Query: 515 EERPSSKD 522
+RP
Sbjct: 273 RKRPKYNK 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/285 (20%), Positives = 99/285 (34%), Gaps = 46/285 (16%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+G G+ G V++ + + G A+KK+ E++
Sbjct: 64 PRVGRGSFGEVHRMKDKQT-GFQCAVKKVRLE-------------------VFRVEELVA 103
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ ++PL V + E ++ GSL ++ Q + A Y
Sbjct: 104 CAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALY-YLGQA 159
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPD---GHTRIRITTV 417
GLEYLH I+H D+K NVL+ DG A + DFG A + G + + +
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
GT ++APE K DI+S ++ ++ G P+ +
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ-------YFRGPLCLKIA 269
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
S P R I ++ +P R S+ +
Sbjct: 270 SEPPPIREIPPSC-----APLTAQAIQE---GLRKEPVHRASAME 306
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 62/223 (27%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G GA G V A + + +A+K +D IK EI
Sbjct: 15 LGEGAYGEVQLAVNRVT-EEAVAVKIVD-------------MKRAVDCPENIKKEICINK 60
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGMA 362
+ H N++ H + L E+ G L D + E D A+ R +
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPD--AQ-RFFHQLM 115
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTG 422
+G+ YLH I HRDIKP N+L+D+ +ISDFGLA + + + + GT
Sbjct: 116 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 423 YVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
YVAPE +H +E D++S G++L ++ G+ P+D
Sbjct: 173 YVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQ 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 37/224 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+GVG G V E + G +A+K ++ R+ + + + +IK EI
Sbjct: 19 LGVGTFGKVKIGEHQLT-GHKVAVKILN------------RQKIRSLDVVGKIKREIQNL 65
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGM 361
H +++ L ++ P +V E++ G L D + GR E++ AR R+ + +
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CKHGRVEEME--AR-RLFQQI 120
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
S ++Y H R ++HRD+KP NVL+D M A+I+DFGL+ +M DG + T G+
Sbjct: 121 LSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSP 174
Query: 422 GYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y APE Y + DI+S GV+L L+ G PFDD
Sbjct: 175 NYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCGTLPFDD 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 51/231 (22%), Positives = 82/231 (35%), Gaps = 37/231 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI- 299
++G G G V+ +AIK I + V E+
Sbjct: 36 GPLLGKGGFGTVFAGHRLTD-RLQVAIKVIPRN--------RVLGWSPLSDSVTCPLEVA 86
Query: 300 ---ITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGS-LQDILHDVSQGRRELDWLARY 355
H ++ L + +LV E L D + +G +R
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEG-PSR- 142
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-EARISDFGLAKLMPDGHTRIRI 414
+ + +++ H ++HRDIK N+LID A++ DFG L+ D
Sbjct: 143 CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----Y 195
Query: 415 TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T GT Y PE YH + + ++S G+LL +V G PF+
Sbjct: 196 TDFDGTRVYSPPEWISRHQYH-----ALPATVWSLGILLYDMVCGDIPFER 241
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 36/233 (15%), Positives = 72/233 (30%), Gaps = 33/233 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
++G GA VY+A + +K N I ++ +
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--------NPWEFYIGTQLMERL 121
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV-SQGRRELDWLARY 355
+ + + + +LV E G+L + ++ + + +
Sbjct: 122 KPSM------QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA-----------RISDFGLAKL 404
A M +E +H IIH DIKP N ++ +G + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 405 MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
M T T+G+ E + + D + + ++ G +
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI-I 300
++IG G VV + + G A+K ++ + + + E I
Sbjct: 100 DVIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSP------EQLEEVREATRRETHI 152
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIAR 359
H +++ L LV++ M+ G L D L + E + R I R
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKE--TR-SIMR 207
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ + +LH + I+HRD+KP N+L+DD M+ R+SDFG + + G ++ + G
Sbjct: 208 SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCG 261
Query: 420 TTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T GY+APE ++ D+++ GV+L L+ G PF
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 51/235 (21%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
+G G+ G V + + A+K + + +L + +K EI
Sbjct: 13 LGEGSYGKVKEVLDSET-LCRRAVKILKK-----KKLRRIPNGE-----ANVKKEIQLLR 61
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDI---LHDVSQGRREL-DWLARYRI-- 357
R+ H+N++ L + + N Q + + G +E+ D + R
Sbjct: 62 RLRHKNVIQL-------------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 358 --ARG----MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
A G + GLEYLH I+H+DIKP N+L+ G +IS G+A+ +
Sbjct: 109 CQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 412 IRITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T G+ + PE + K DI+S GV L + G +PF+
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFS-----GFKVDIWSAGVTLYNITTGLYPFEG 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 35/229 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++G G G VY +AIK +++ + ++ E++
Sbjct: 48 GPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKD--------RISDWGELPNGTRVPMEVV 98
Query: 301 TAGRIWHR--NLLPLQAHVTRPDCHLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRI 357
++ ++ L RPD +L+ E + L D + +G + + LAR
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEE-LAR-SF 154
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIRITT 416
+ + + H ++HRDIK N+LID + E ++ DFG L+ D T
Sbjct: 155 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTD 207
Query: 417 VAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT Y PE YH + ++S G+LL +V G PF+
Sbjct: 208 FDGTRVYSPPEWIRYHRYH-----GRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 74/364 (20%), Positives = 130/364 (35%), Gaps = 78/364 (21%)
Query: 189 VSEAKGYCGVKALVSA-LRGRGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVG 247
E +G+ + L+ L + + + R + K ++ + L E IG G
Sbjct: 69 RLEGEGFPSIPLLIDHLLSTQQPLTKKSGVVLHRAVPKD---KWVLNHEDLVLGEQIGRG 125
Query: 248 ACGVVYKAEVPGSYGKMIAIK--KIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI 305
G V+ + +A+K + PP + L R+ ++Q
Sbjct: 126 NFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARI-----LKQYS--------- 170
Query: 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGL 365
H N++ L T+ +V E ++ G L L ++ A+G+
Sbjct: 171 -HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGM 226
Query: 366 EYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYV- 424
EYL IHRD+ N L+ + +ISDFG+++ DG + +G V
Sbjct: 227 EYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG-----VYAASGGLRQVP 278
Query: 425 ----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRN--VI 477
APE S +SD++SFG+LL +G P+ + + N
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN-------------LSNQQTR 325
Query: 478 SSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSSKDVRCMLS 528
+ + G RL V ++ C + +P +RPS + L
Sbjct: 326 -----------EFVEKGG----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
Query: 529 QIKH 532
I+
Sbjct: 371 SIRK 374
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 29/227 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ +G GA G V+ A K + +K I + E + + + K+ ++ EI
Sbjct: 29 MSPLGSGAFGFVWTAVDKEK-NKEVVVKFIKK------EKVLEDCWIEDPKLGKVTLEIA 81
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGS-LQDILHDVSQGRRELDWLARYRIAR 359
R+ H N++ + LV E +G L + R + LA I R
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHPRLDEP-LAS-YIFR 137
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ S + YL + IIHRDIK N++I + ++ DFG A + G T G
Sbjct: 138 QLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCG 191
Query: 420 TTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
T Y APE Y + +++S GV L LV + PF +
Sbjct: 192 TIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVFEENPFCEL 233
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 60/320 (18%), Positives = 110/320 (34%), Gaps = 61/320 (19%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE---VPGSYGKMIAIK--KIDQPPMAATELLNVRRVLI 288
++ L + +G G G V + G+ +A+K K + +L
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK------- 71
Query: 289 NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH--LLVYEFMKNGSLQDILHDVSQGR 346
EI ++H N++ + T + L+ EF+ +GSL++ L +
Sbjct: 72 --------KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NK 120
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+++ + + A + G++YL +HRD+ NVL++ + +I DFGL K +
Sbjct: 121 NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
Query: 407 DGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
APE SD++SFGV L +L
Sbjct: 178 TDKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 461 FQYTEEMNMVRW-MRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCT 510
+ + + M R + L G RL V ++ C
Sbjct: 234 ALFLKMIGPTHGQMTV-------TRLV--NTLKEGK----RLPCPPNCPDEVYQLMRKCW 280
Query: 511 SDDPEERPSSKDVRCMLSQI 530
P R S +++ +
Sbjct: 281 EFQPSNRTSFQNLIEGFEAL 300
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 51/294 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI- 299
+E++G G G VYK + G++ AIK +D + + +IK EI
Sbjct: 29 VELVGNGTYGQVYKGRHVKT-GQLAAIKVMD---------------VTGDEEEEIKQEIN 72
Query: 300 ITAGRIWHRNLLP-----LQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ HRN+ ++ + D L LV EF GS+ D++ + + +W+A
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
I R + GL +LH + +IHRDIK NVL+ + E ++ DFG++ + T R
Sbjct: 133 Y--ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGR 185
Query: 414 ITTVAGTTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468
T GT ++APE + KSD++S G+ + G P D M+
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------MH 238
Query: 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+R + +I +L + ++ + ++ C + +RP+++
Sbjct: 239 PMRALF-LIPRNPA-----PRLKSKKWSKKFQSFIES---CLVKNHSQRPATEQ 283
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
E +G GA VV + + G A K I+ ++A + + R I R+++
Sbjct: 12 EELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARI---CRKLQ---- 63
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIAR 359
H N++ L + H LV++ + G L + + V++ E D A +
Sbjct: 64 ------HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--AS-HCIQ 112
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ + Y H I+HR++KP N+L+ G +++DFGLA + D
Sbjct: 113 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHG 166
Query: 417 VAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
AGT GY++PE Y S+ DI++ GV+L +L+VG PF D
Sbjct: 167 FAGTPGYLSPEVLKKDPY------SKPVDIWACGVILYILLVGYPPFWD 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 68/307 (22%), Positives = 112/307 (36%), Gaps = 62/307 (20%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ +G G G VY+ +A+K + + M E L
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEEFL-------------- 264
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
E I H NL+ L TR ++ EFM G+L D L R+E+ +
Sbjct: 265 -KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLL 321
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+A ++S +EYL + IHR++ N L+ + +++DFGL++LM
Sbjct: 322 YMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMR 474
+ APE S KSD+++FGVLL + G P+ +
Sbjct: 379 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------------ID 424
Query: 475 N--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSSKDV 523
V +LL Y R+ V ++ C +P +RPS ++
Sbjct: 425 LSQVY-----------ELLEKDY----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 524 RCMLSQI 530
+
Sbjct: 470 HQAFETM 476
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 85/357 (23%), Positives = 133/357 (37%), Gaps = 78/357 (21%)
Query: 197 GVKALVSALRGRGGGRYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAE 256
G + L + Y P P R + + +IIG G G V
Sbjct: 10 GRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGR 69
Query: 257 --VPGSYGKMIAIK--KIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312
VPG +AIK K + L SE G+ H N++
Sbjct: 70 LRVPGQRDVPVAIKALKAGYTERQRRDFL---------------SEASIMGQFDHPNIIR 114
Query: 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH 372
L+ VTR ++V E+M+NGSL L + + + RG+ +G+ YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG-----TTGYVAPE 427
+HRD+ NVL+D + ++SDFGL++++ D TT T APE
Sbjct: 172 ---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APE 224
Query: 428 --YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRN--VISSENP 482
+T + SD++SFGV++ VL G+ P+ + M N VI
Sbjct: 225 AIAFRTFSS--ASDVWSFGVVMWEVLAYGERPYWN-------------MTNRDVI----- 264
Query: 483 HRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ GY RL + ++ C D +RP + +L +
Sbjct: 265 ------SSVEEGY----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 37/224 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+GVG G V + + G +A+K ++ R+ + + + +I+ EI
Sbjct: 24 LGVGTFGKVKVGKHELT-GHKVAVKILN------------RQKIRSLDVVGKIRREIQNL 70
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGM 361
H +++ L ++ P +V E++ G L D + GR E + +R R+ + +
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKE--SR-RLFQQI 125
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
SG++Y H R ++HRD+KP NVL+D M A+I+DFGL+ +M DG + T G+
Sbjct: 126 LSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSP 179
Query: 422 GYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y APE Y + DI+S GV+L L+ G PFDD
Sbjct: 180 NYAAPEVISGRLYA-----GPEVDIWSSGVILYALLCGTLPFDD 218
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 66/321 (20%), Positives = 113/321 (35%), Gaps = 77/321 (23%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAE--VPGSYGKM-IAIK--KIDQPPMAATELLNVRRV 286
+ KE ++++G GA G VYK G K+ +AIK + P A E+L
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--DEA 68
Query: 287 LINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
+ M + + ++ L L+ + M G L D + + +
Sbjct: 69 YV---MASVD----------NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR---EHK 111
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+ +A G+ YL ++HRD+ NVL+ +I+DFGLAKL+
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 407 DGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
G V A E + +SD++S+GV + ++ G P+D
Sbjct: 169 AEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG- 222
Query: 461 FQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFC 509
+ + +L G RL V I C
Sbjct: 223 ------------IPASEIS-----------SILEKGE----RLPQPPICTIDVYMIMRKC 255
Query: 510 TSDDPEERPSSKDVRCMLSQI 530
D + RP +++ S++
Sbjct: 256 WMIDADSRPKFRELIIEFSKM 276
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 20/218 (9%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ +G G VY AE +AIK P E ++R + E+
Sbjct: 16 VDKLGGGGMSTVYLAE-DTILNIKVAIK-AIFIPPREKEET-LKR---------FEREVH 63
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ ++ H+N++ + DC+ LV E+++ +L + + L
Sbjct: 64 NSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQ 119
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ G+++ H I+HRDIKP N+LID +I DFG+AK + + + V GT
Sbjct: 120 ILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
Y +PE + E +DIYS G++L ++VG+ PF+
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 53/223 (23%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
EI+G G V+ A + +A+K + + +A R + E
Sbjct: 17 GEILGFGGMSEVHLAR-DLRDHRDVAVK-VLRADLARDPSF-YLR---------FRREAQ 64
Query: 301 TAGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
A + H ++ + +A +V E++ +L+DI+H +
Sbjct: 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIE 120
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT- 415
+ L + H IIHRD+KPAN++I ++ DFG+A+ + D + T
Sbjct: 121 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
V GT Y++PE + ++ +SD+YS G +L ++ G+ PF
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 68/319 (21%), Positives = 121/319 (37%), Gaps = 59/319 (18%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE---VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINR 290
+E L L+ +G G G V + + G+++A+KK+
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-------------- 53
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH--LLVYEFMKNGSLQDILHDVSQGRRE 348
+R + EI + H N++ + L+ E++ GSL+D L +
Sbjct: 54 HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKER 110
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
+D + + + G+EYL IHRD+ N+L+++ +I DFGL K++P
Sbjct: 111 IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167
Query: 409 HTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQ 462
+ G APE S SD++SFGV+L + + +
Sbjct: 168 KEFFK----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223
Query: 463 YTEEMNMVRW--MRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTS 511
+ + + M I+ LL N RL + I C +
Sbjct: 224 FMRMIGNDKQGQMIV-------FHLIE--LLKNNG----RLPRPDGCPDEIYMIMTECWN 270
Query: 512 DDPEERPSSKDVRCMLSQI 530
++ +RPS +D+ + QI
Sbjct: 271 NNVNQRPSFRDLALRVDQI 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 59/312 (18%), Positives = 105/312 (33%), Gaps = 79/312 (25%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE IG G G V+K G + AIK+ +P + + N R E+
Sbjct: 16 LEKIGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALR------------EV- 61
Query: 301 TAGRIWHRNLLPLQAH--VTR------PDCHLLVY-EFMKNGSLQDILHDVSQGRRELDW 351
L H V R D H+L+ E+ GSL D + + +
Sbjct: 62 -------YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-------------------DGM 392
+ + GL Y+H ++H DIKP+N+ I + +
Sbjct: 115 AELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLV 451
+I D G + G + ++A E + T K+DI++ + +
Sbjct: 172 MFKIGDLGHVTRISSPQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
Query: 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTS 511
+ + ++ + +R + I ++ +LK+
Sbjct: 226 GAEPLPRNG----DQWHEIR--------QGRLPRIPQV-----LSQEFTELLKV---MIH 265
Query: 512 DDPEERPSSKDV 523
DPE RPS+ +
Sbjct: 266 PDPERRPSAMAL 277
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 76/322 (23%), Positives = 119/322 (36%), Gaps = 67/322 (20%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE---VPGSYGKMIAIK--KIDQPPMAATELLNVRRVLI 288
+ L + +G G G V G+M+A+K K D P +
Sbjct: 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK------- 81
Query: 289 NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC--HLLVYEFMKNGSLQDILHDVSQGR 346
EI ++H +++ + LV E++ GSL+D L S G
Sbjct: 82 --------QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL 133
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+L A +I GM YLH H IHRD+ NVL+D+ +I DFGLAK +P
Sbjct: 134 AQLLLFA-QQICEGM----AYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185
Query: 407 DGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
+GH G APE + SD++SFGV L +L
Sbjct: 186 EGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241
Query: 461 FQYTEEMNMVRW-MRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYF 508
++ E + + + M + +LL G RL V +
Sbjct: 242 TKFLELIGIAQGQMTVLRLT-----------ELLERGE----RLPRPDKCPAEVYHLMKN 286
Query: 509 CTSDDPEERPSSKDVRCMLSQI 530
C + RP+ +++ +L +
Sbjct: 287 CWETEASFRPTFENLIPILKTV 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
++G G+ G V K + + + A+K I+ + N+ I E+
Sbjct: 28 CMLGKGSFGEVLKCKDRIT-QQEYAVKVIN------------KASAKNKDTSTILREVEL 74
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIAR 359
++ H N++ L + +V E G L D I + + R E D A RI +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHD--AA-RIIK 128
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ SG+ Y+H ++ I+HRD+KP N+L+ + + +I DFGL+ ++
Sbjct: 129 QVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKD 182
Query: 417 VAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT Y+APE Y EK D++S GV+L +L+ G PF
Sbjct: 183 RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYG 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E++G GA V+ + + GK+ A+K I + +++EI
Sbjct: 15 EVLGSGAFSEVFLVKQRLT-GKLFALKCIK------------KSPAFRDSS--LENEIAV 59
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIAR 359
+I H N++ L+ + LV + + G L D I + +G E D A + +
Sbjct: 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEKD--AS-LVIQ 113
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ S ++YLH I+HRD+KP N+L ++ + I+DFGL+K+ +G ++T
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMST 166
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT GYVAPE S+ D +S GV+ +L+ G PF +
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 68/319 (21%), Positives = 120/319 (37%), Gaps = 59/319 (18%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE---VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINR 290
+E L L+ +G G G V + + G+++A+KK+
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH------------- 85
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH--LLVYEFMKNGSLQDILHDVSQGRRE 348
+R + EI + H N++ + L+ E++ GSL+D L +
Sbjct: 86 -LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKER 141
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
+D + + + G+EYL IHRD+ N+L+++ +I DFGL K++P
Sbjct: 142 IDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
Query: 409 HTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQ 462
G APE S SD++SFGV+L + + +
Sbjct: 199 KE----YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254
Query: 463 YTEEMNMVRW--MRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTS 511
+ + + M I +LL N RL + I C +
Sbjct: 255 FMRMIGNDKQGQMIV-------FHLI--ELLKNNG----RLPRPDGCPDEIYMIMTECWN 301
Query: 512 DDPEERPSSKDVRCMLSQI 530
++ +RPS +D+ + QI
Sbjct: 302 NNVNQRPSFRDLALRVDQI 320
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 70/286 (24%), Positives = 113/286 (39%), Gaps = 43/286 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
++G G G+VY S IAIK+I +R + + EI
Sbjct: 28 VVLGKGTYGIVYAG-RDLSNQVRIAIKEIP--------------ERDSRYSQPLHEEIAL 72
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ H+N++ + + E + GSL +L ++ + + +
Sbjct: 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQI 131
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLID--DGMEARISDFGLAKLMPDGHTRIRITTVAG 419
GL+YLH I+HRDIK NVLI+ G+ +ISDFG +K + + T G
Sbjct: 132 LEGLKYLH---DNQIVHRDIKGDNVLINTYSGV-LKISDFGTSKRLAGINPCTE--TFTG 185
Query: 420 TTGYVAPE--YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN-MVRWMRNV 476
T Y+APE + +DI+S G + + GK P F++ E M +
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP---FYELGEPQAAMFK----- 237
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ H I + E +LK C DP++R + D
Sbjct: 238 VGMFKVHPEIPESMS----AEAKAFILK----CFEPDPDKRACAND 275
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 65/260 (25%), Positives = 94/260 (36%), Gaps = 55/260 (21%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
IG G+ GVV A + + AIK +++ + + + +IK+E+
Sbjct: 32 GAIGQGSYGVVRVAIENQT-RAIRAIKIMNKNKIRQIN---------PKDVERIKTEVRL 81
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD------------------------ 337
++ H N+ L LV E G L D
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 338 ------ILHDVSQGRRELDWLARY------RIARGMASGLEYLHMYHRPCIIHRDIKPAN 385
+ S I R + S L YLH I HRDIKP N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPEN 198
Query: 386 VLI--DDGMEARISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPE--YHQTLTISEKSD 439
L + E ++ DFGL+K + +TT AGT +VAPE + K D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 440 IYSFGVLLAVLVVGKFPFDD 459
+S GVLL +L++G PF
Sbjct: 259 AWSAGVLLHLLLMGAVPFPG 278
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 70/312 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+SL +G G G V+ G+ +AIK + M+ L
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL-------------- 310
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
E ++ H L+ L A V+ + +V E+M GSL D L + + L
Sbjct: 311 -QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLV 366
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+A +ASG+ Y+ + +HRD++ AN+L+ + + +++DFGLA+L+ D R
Sbjct: 367 DMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 416 T---VAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVR 471
+ T APE + KSD++SFG+LL + G+ P+
Sbjct: 424 AKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------------ 467
Query: 472 WMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSS 520
M N V+ + GY R+ + + C +PEERP+
Sbjct: 468 -MVNREVL-----------DQVERGY----RMPCPPECPESLHDLMCQCWRKEPEERPTF 511
Query: 521 KDVRCMLSQIKH 532
+ ++ L
Sbjct: 512 EYLQAFLEDYFT 523
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 61/351 (17%), Positives = 113/351 (32%), Gaps = 68/351 (19%)
Query: 181 KALVSALMVSEAKGYCGV-KALVSALRGRGGGRYRGPAICARPIFKKRDIAFLTKEDSLA 239
+AL++ +V E+K +C V G G C + L D +A
Sbjct: 22 EALMTNPVVPESKRFCWNCGRPVGRSDSETKGASEG--WCPYCGSPYSFLPQLNPGDIVA 79
Query: 240 S----LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
I G G +Y A G+ + +K + A
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMA---------- 128
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHL-----LVYEFMKNGSLQDILHDVSQGRRELD 350
E + H +++ + V D H +V E++ SL+ ++L
Sbjct: 129 --ERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLP 180
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
+ L YLH +++ D+KP N+++ + + ++ D G +
Sbjct: 181 VAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSF 234
Query: 411 RIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469
+ GT G+ APE T + +DIY+ G LA L + +
Sbjct: 235 ----GYLYGTPGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPTRNG--------RY 280
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
V + + + RL+ + DP +R ++
Sbjct: 281 VDGLPEDDPVLKTYDSYG------------RLLRR----AIDPDPRQRFTT 315
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 77/336 (22%), Positives = 133/336 (39%), Gaps = 70/336 (20%)
Query: 212 RYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKID 271
+ P + ++P A+ +SL + +G G G V+ A +A+K +
Sbjct: 164 KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKH--TKVAVKTMK 221
Query: 272 QPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMK 331
M+ L +E + H L+ L A VT+ + ++ EFM
Sbjct: 222 PGSMSVEAFL---------------AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 265
Query: 332 NGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391
GSL D L S + + +A G+ ++ + IHRD++ AN+L+
Sbjct: 266 KGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320
Query: 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYV---APEYHQTLTISEKSDIYSFGVLL- 447
+ +I+DFGLA+++ D T G + APE + + KSD++SFG+LL
Sbjct: 321 LVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLM 376
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---- 501
++ G+ P+ M N VI + L GY R+
Sbjct: 377 EIVTYGRIPYPG-------------MSNPEVI-----------RALERGY----RMPRPE 408
Query: 502 -----VLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+ I C + PEERP+ + ++ +L
Sbjct: 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 40/229 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+G GA G V+ E S G IK I+ + M QI++EI
Sbjct: 28 RKLGSGAFGDVHLVEERSS-GLERVIKTIN-------------KDRSQVPMEQIEAEIEV 73
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRR--ELDWLARYRIA 358
+ H N++ + +V E + G L + I+ ++G+ E +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY--VA-ELM 130
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRIT 415
+ M + L Y H H ++H+D+KP N+L +I DFGLA+L T
Sbjct: 131 KQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HST 184
Query: 416 TVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
AGT Y+APE + K DI+S GV++ L+ G PF
Sbjct: 185 NAAGTALYMAPEVFKRDV------TFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 38/224 (16%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR-QIKSEIITA 302
+G G+ G V A + + +A+K I R++L M +++ EI
Sbjct: 17 LGEGSFGKVKLATHYKT-QQKVALKFIS------------RQLLKKSDMHMRVEREISYL 63
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGM 361
+ H +++ L +T P ++V E+ G L D + V + R E + R R + +
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI--VEKKRMTEDE--GR-RFFQQI 117
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
+EY H R I+HRD+KP N+L+DD + +I+DFGL+ +M DG+ + T G+
Sbjct: 118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171
Query: 422 GYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y APE Y + D++S G++L V++VG+ PFDD
Sbjct: 172 NYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLPFDD 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 73/310 (23%), Positives = 124/310 (40%), Gaps = 70/310 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+SL +G G G V+ G+ +AIK + M+ L
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL-------------- 227
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
E ++ H L+ L A V+ + +V E+M GSL D L + + L
Sbjct: 228 -QEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLV 283
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+A +ASG+ Y+ + +HRD++ AN+L+ + + +++DFGLA+L+ D R
Sbjct: 284 DMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 416 T---VAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVR 471
+ T APE + KSD++SFG+LL + G+ P+
Sbjct: 341 AKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG------------ 384
Query: 472 WMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSS 520
M N V+ + GY R+ + + C +PEERP+
Sbjct: 385 -MVNREVL-----------DQVERGY----RMPCPPECPESLHDLMCQCWRKEPEERPTF 428
Query: 521 KDVRCMLSQI 530
+ ++ L
Sbjct: 429 EYLQAFLEDY 438
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 44/223 (19%), Positives = 92/223 (41%), Gaps = 27/223 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
+ +G G VV + + G+ A K + + + + + + KS
Sbjct: 35 KELGRGKFAVVRQCISKST-GQEYAAKFLKKRRRGQDCRAEILHEIAV---LELAKS--- 87
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYRIAR 359
++ L +L+ E+ G + L ++++ E D R+ +
Sbjct: 88 ------CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND--VI-RLIK 138
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ G+ YLH + I+H D+KP N+L+ + +I DFG+++ + +
Sbjct: 139 QILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELRE 192
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT Y+APE I+ +D+++ G++ +L+ PF
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+G GA G V + AIK I + + + I + +I +EI
Sbjct: 42 RKLGSGAYGEVLLCKEKNG-HSEKAIKVIKKSQFDKGRYSDDNK-NIEKFHEEIYNEISL 99
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
+ H N++ L LV EF + G L + + +++ + E D A I +
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECD--AA-NIMKQ 154
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ SG+ YLH ++ I+HRDIKP N+L+ + + +I DFGL+ + ++
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 418 AGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT Y+APE Y +EK D++S GV++ +L+ G PF
Sbjct: 209 LGTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYPPFGG 249
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 61/227 (26%), Positives = 88/227 (38%), Gaps = 41/227 (18%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
IG G+ G V A G+ A KKI + + + K EI
Sbjct: 15 NTIGRGSWGEVKIAVQKGT-RIRRAAKKIP------------KYFVEDVDR--FKQEIEI 59
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
+ H N++ L LV E G L + + V + RE D A RI +
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV--VHKRVFRESD--AA-RIMKD 114
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ S + Y H + + HRD+KP N L ++ DFGLA G + T
Sbjct: 115 VLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTK 168
Query: 418 AGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT YV+P+ Y + D +S GV++ VL+ G PF
Sbjct: 169 VGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 73/317 (23%), Positives = 120/317 (37%), Gaps = 82/317 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ +G G G VY+ +A+K + + M E L V M++I
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVEEFLKEAAV-----MKEI 66
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
K H NL+ L TR ++ EFM G+L D L R+E+ +
Sbjct: 67 K----------HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLL 114
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR---- 411
+A ++S +EYL + IHRD+ N L+ + +++DFGL++LM
Sbjct: 115 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
Query: 412 ----IRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYT 464
I+ T APE + +I KSD+++FGVLL + G P+
Sbjct: 172 AKFPIKWT---------APESLAYNKFSI--KSDVWAFGVLLWEIATYGMSPYP------ 214
Query: 465 EEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDD 513
+ V +LL Y R+ V ++ C +
Sbjct: 215 -------GIDLSQVY-----------ELLEKDY----RMERPEGCPEKVYELMRACWQWN 252
Query: 514 PEERPSSKDVRCMLSQI 530
P +RPS ++ +
Sbjct: 253 PSDRPSFAEIHQAFETM 269
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 65/245 (26%), Positives = 103/245 (42%), Gaps = 45/245 (18%)
Query: 244 IGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG 303
IG G GV + +++A+K I+ R I+ ++ EII
Sbjct: 28 IGSGNFGVARLMRDKLT-KELVAVKYIE------------RGAAIDEN---VQREIINHR 71
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARGMA 362
+ H N++ + + P ++ E+ G L + + + GR E + AR + +
Sbjct: 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI--CNAGRFSEDE--AR-FFFQQLL 126
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR--ISDFGLAKLMPDGHTRIRITTVAGT 420
SG+ Y H I HRD+K N L+D R I DFG +K + + GT
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGT 180
Query: 421 TGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
Y+APE Y + +D++S GV L V++VG +PF+D EE R
Sbjct: 181 PAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFED----PEEPRDYRKTI 231
Query: 475 NVISS 479
I S
Sbjct: 232 QRILS 236
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE---VPGSYGKMIAIKKI-DQPPMAATELLNVRRVLIN 289
+E L + +G G G V + + G ++A+K++ P +
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQ-------- 72
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCH--LLVYEFMKNGSLQDILHDVSQGRR 347
EI + ++ + P LV E++ +G L+D L R
Sbjct: 73 -------REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRA 122
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407
LD + + G+EYL +HRD+ N+L++ +I+DFGLAKL+P
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
Query: 408 GHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
V G APE + +SD++SFGV+L +
Sbjct: 180 DKD----YYVVREPGQSPIFWYAPESLSDNIFSR--QSDVWSFGVVLYELFTYCDKSCSP 233
Query: 460 FFQYTEEMNMVR-WMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFC 509
++ M R R + +LL G RL V ++ C
Sbjct: 234 SAEFLRMMGCERDVPAL-------SRLL--ELLEEGQ----RLPAPPACPAEVHELMKLC 280
Query: 510 TSDDPEERPSSKDVRCMLSQI 530
+ P++RPS + L +
Sbjct: 281 WAPSPQDRPSFSALGPQLDML 301
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
E +G GA VV + + G A K I+ ++A + + R I R+++
Sbjct: 35 EELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLSARDFQKLEREARI---CRKLQ---- 86
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIAR 359
H N++ L + H LV++ + G L + + V++ E D A +
Sbjct: 87 ------HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD--AS-HCIQ 135
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ + Y H I+HR++KP N+L+ G +++DFGLA + D
Sbjct: 136 QILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHG 189
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
AGT GY++PE + S+ DI++ GV+L +L+VG PF D
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 37/292 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E+IG GA VV A + +AIK+I+ M ++ EI
Sbjct: 20 QEVIGSGATAVVQAAYCAPK-KEKVAIKRINLEK-------------CQTSMDELLKEIQ 65
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-HDVSQGRRELDWLARYRIA- 358
+ H N++ D LV + + GS+ DI+ H V++G + L IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 359 --RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI-- 414
R + GLEYLH IHRD+K N+L+ + +I+DFG++ + G R
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 415 -TTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472
T GT ++APE Q K+DI+SFG+ L G P+ ++
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-------YPPMKV 235
Query: 473 MRNVISSENP--HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + ++ P + K + Y + R ++ + C DPE+RP++ +
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL---CLQKDPEKRPTAAE 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 24/224 (10%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E+IG G VV + + G+ A+K +D ++ L+ + K E
Sbjct: 30 EVIGKGPFSVVRRCINRET-GQQFAVKIVDVAKFTSSPGLSTEDL---------KREASI 79
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRR--ELDWLARYRIA 358
+ H +++ L + +V+EFM L I+ G E A
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV--AS-HYM 136
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRIT 415
R + L Y H + IIHRD+KP VL+ ++ ++ FG+A + +
Sbjct: 137 RQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAG 191
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT ++APE + + D++ GV+L +L+ G PF
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 70/314 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLNVRRVLINRK 291
+++ +++G G G V + K I AIK K+ + L
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL---------- 94
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
E G+ H N++ L+ VT+ ++V E+M+NGSL L + +
Sbjct: 95 -----GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+ + RG+ASG++YL +HRD+ N+LI+ + ++SDFGL +++ D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 412 IRITTVAGTTGYV---APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEM 467
T G + +PE + SD++S+G++L V+ G+ P+ +
Sbjct: 204 AYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE-------- 253
Query: 468 NMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEE 516
M N VI K + GY RL + ++ C D
Sbjct: 254 -----MSNQDVI-----------KAVDEGY----RLPPPMDCPAALYQLMLDCWQKDRNN 293
Query: 517 RPSSKDVRCMLSQI 530
RP + + +L ++
Sbjct: 294 RPKFEQIVSILDKL 307
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 70/315 (22%), Positives = 116/315 (36%), Gaps = 80/315 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
L ++ IG G G+V+ +AIK I + M+ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEEDFI-------------- 51
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
E ++ H L+ L LV EFM++G L D L R
Sbjct: 52 -EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLL 107
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + G+ YL +IHRD+ N L+ + ++SDFG+ + + D T
Sbjct: 108 GMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----T 160
Query: 416 TVAGT------TGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
+ GT +PE + KSD++SFGVL+ V GK P+++
Sbjct: 161 SSTGTKFPVKWA---SPEVFSFSRYSS--KSDVWSFGVLMWEVFSEGKIPYEN------- 208
Query: 467 MNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPE 515
N V+ + + G+ RL V +I C + PE
Sbjct: 209 ------RSNSEVV-----------EDISTGF----RLYKPRLASTHVYQIMNHCWRERPE 247
Query: 516 ERPSSKDVRCMLSQI 530
+RP+ + L++I
Sbjct: 248 DRPAFSRLLRQLAEI 262
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 41/282 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE IG G+ G V+K + K++AIK ID ++ I+ EI
Sbjct: 27 LEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEE-------------AEDEIEDIQQEIT 72
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ + + ++ E++ GS D+L G + +A I R
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIAT--ILRE 127
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL+YLH IHRDIK ANVL+ + E +++DFG+A + D T+I+ T GT
Sbjct: 128 ILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGT 182
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
++APE + K+DI+S G+ L G+ P + ++ ++ + +I
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-------LHPMKVLF-LIPKN 234
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
NP L Y + ++ ++ C + +P RP++K+
Sbjct: 235 NPPT------LEGNYSKPLKEFVEA---CLNKEPSFRPTAKE 267
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/297 (23%), Positives = 128/297 (43%), Gaps = 58/297 (19%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
+ E IG GA G VY A + G+ +AI++++ EL+ + +L+ MR+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQPKKELI-INEILV---MRE 73
Query: 295 IKSEIITA--------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
K+ I +W +V E++ GSL D++ +
Sbjct: 74 NKNPNIVNYLDSYLVGDELW------------------VVMEYLAGGSLTDVVT---ETC 112
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLM 405
+ +A + R LE+LH +IHRDIK N+L+ +++DFG A++
Sbjct: 113 MDEGQIAA--VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 406 PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465
P+ R +T+ GT ++APE K DI+S G++ ++ G+ P+ +
Sbjct: 168 PEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN------ 218
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
N +R + +I++ + + L + + + C D E+R S+K+
Sbjct: 219 -ENPLRALY-LIATNGTPELQNPEKLSAIFRDFLNR-------CLEMDVEKRGSAKE 266
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 63/326 (19%), Positives = 118/326 (36%), Gaps = 77/326 (23%)
Query: 227 RDIAFLTKEDSLASLEIIGVGACGVVYKAE--VPGSYGKM-IAIK--KIDQPPMAATELL 281
+ +A + KE L L+++G G G V+K G K+ + IK + + +
Sbjct: 4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT 63
Query: 282 NVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD 341
++ G + H +++ L LV +++ GSL D +
Sbjct: 64 ---------------DHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR- 106
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
Q R L +A G+ YL + ++HR++ NVL+ + +++DFG+
Sbjct: 107 --QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV 161
Query: 402 AKLMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKF 455
A L+P + + A E + +SD++S+GV + ++ G
Sbjct: 162 ADLLPPDD-----KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 456 PFDDFFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLK 504
P+ +R V LL G RL V
Sbjct: 217 PYAG-------------LRLAEVP-----------DLLEKGE----RLAQPQICTIDVYM 248
Query: 505 IAYFCTSDDPEERPSSKDVRCMLSQI 530
+ C D RP+ K++ +++
Sbjct: 249 VMVKCWMIDENIRPTFKELANEFTRM 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 63/318 (19%), Positives = 110/318 (34%), Gaps = 75/318 (23%)
Query: 234 KEDSLASLEI-IGVGACGVVYKAEVPGSYGKM-IAIK--KIDQPPMAATELLNVRRVLIN 289
K D+L +I +G G G V + ++ +AIK K E++
Sbjct: 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-------- 58
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
E ++ + ++ L + +LV E G L L R E+
Sbjct: 59 -------REAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV---GKREEI 107
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+ ++ G++YL + +HRD+ NVL+ + A+ISDFGL+K +
Sbjct: 108 PVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 410 TRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQY 463
+ A + G APE S +SD++S+GV + L G+ P+
Sbjct: 165 S----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK---- 216
Query: 464 TEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSD 512
M+ V+ + G R+ + + C
Sbjct: 217 ---------MKGPEVM-----------AFIEQGK----RMECPPECPPELYALMSDCWIY 252
Query: 513 DPEERPSSKDVRCMLSQI 530
E+RP V +
Sbjct: 253 KWEDRPDFLTVEQRMRAC 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E +G G +V K + G A K I + A+ R +I+ E+
Sbjct: 18 EELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVCRE--------EIEREVSI 68
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
++ H N++ L +L+ E + G L D L + E + A +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--AT-SFIKQ 123
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI----DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ G+ YLH I H D+KP N+++ ++ DFGLA + DG
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT +VAPE + ++D++S GV+ +L+ G PF
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 20/218 (9%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++G G G VY+AE +++A+K + +++ + R M++ E
Sbjct: 39 RRLVGRGGMGDVYEAEDT-VRERIVALKLMS-ETLSSDPVFRTR-------MQR---EAR 86
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
TAGR+ +++P+ + + L +L QG L I R
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR--QGP--LAPPRAVAIVRQ 142
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ S L+ H HRD+KP N+L+ A + DFG+A ++ GT
Sbjct: 143 IGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGT 198
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
Y+APE + ++DIY+ +L + G P+
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+ +G GA G V + AIK I + + ++ E+
Sbjct: 43 KKLGSGAYGEVLLCRDKVT-HVERAIKIIR------------KTSVSTSSNSKLLEEVAV 89
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
+ H N++ L + LV E K G L D + + + + E+D A I +
Sbjct: 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHRMKFNEVD--AA-VIIKQ 144
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ SG+ YLH ++ I+HRD+KP N+L+ + +I DFGL+ + + ++
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKER 198
Query: 418 AGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT Y+APE Y EK D++S GV+L +L+ G PF
Sbjct: 199 LGTAYYIAPEVLRKKY------DEKCDVWSIGVILFILLAGYPPFGG 239
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 60/227 (26%), Positives = 102/227 (44%), Gaps = 39/227 (17%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
++G G+ G V K + + + A+K I+ + N+ I E+
Sbjct: 28 CMLGKGSFGEVLKCKDRIT-QQEYAVKVIN------------KASAKNKDTSTILREVEL 74
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
++ H N++ L + +V E G L D + + + R E D A RI +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHD--AA-RIIKQ 129
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ SG+ Y+H ++ I+HRD+KP N+L+ + + +I DFGL+ ++
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDR 183
Query: 418 AGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT Y+APE Y EK D++S GV+L +L+ G PF
Sbjct: 184 IGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYG 224
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E +G G +V K G+ GK A K I + ++++ R +I+ E+
Sbjct: 11 EELGSGQFAIVRKCRQKGT-GKEYAAKFIKKRRLSSSRRGVSRE--------EIEREVNI 61
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
I H N++ L +L+ E + G L D L + E + A + +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDE--AT-QFLKQ 116
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI----DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ G+ YLH I H D+KP N+++ ++ DFG+A + G+
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKN 170
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT +VAPE + ++D++S GV+ +L+ G PF
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 52/288 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE +G G+ G VYKA + G+++AIK++ + +++I EI
Sbjct: 34 LEKLGEGSYGSVYKAIHKET-GQIVAIKQVP----------------VESDLQEIIKEIS 76
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
+ ++ V + +V E+ GS+ DI+ ++ E D +A
Sbjct: 77 IMQQCDSPHV------VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE-DEIAT 129
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
I + GLEYLH IHRDIK N+L++ A+++DFG+A + D T +
Sbjct: 130 --ILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--TMAKR 182
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
TV GT ++APE Q + + +DI+S G+ + GK P+ D ++ +R +
Sbjct: 183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-------IHPMRAIF 235
Query: 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+I + P +L + + + ++ C PE+R ++
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQ-------CLVKSPEQRATATQ 275
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 58/297 (19%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
L S IG G+ G+V A S G+ +A+K +D ELL V+I MR
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHS-GRQVAVKMMDLRKQQRRELL-FNEVVI---MRD 98
Query: 295 IKSEIITA--------GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
+ + +W ++ EF++ G+L DI VSQ R
Sbjct: 99 YQHFNVVEMYKSYLVGEELW------------------VLMEFLQGGALTDI---VSQVR 137
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLM 405
+ +A + + L YLH +IHRDIK ++L+ ++SDFG A++
Sbjct: 138 LNEEQIAT--VCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192
Query: 406 PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465
+ ++ GT ++APE + + DI+S G+++ +V G+ P+
Sbjct: 193 K---DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS------ 243
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ V+ M+ + P + +S + + + DP+ER ++++
Sbjct: 244 -DSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLER-------MLVRDPQERATAQE 291
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 74/344 (21%), Positives = 139/344 (40%), Gaps = 81/344 (23%)
Query: 212 RYRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKM---IAIK 268
Y A+ + P + ++IG G G VYK + S GK +AIK
Sbjct: 20 LYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK 79
Query: 269 --KIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV 326
K + L + M Q H N++ L+ +++ +++
Sbjct: 80 TLKAGYTEKQRVDFLGEAGI-----MGQFS----------HHNIIRLEGVISKYKPMMII 124
Query: 327 YEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386
E+M+NG+L L + E L + RG+A+G++YL + +HRD+ N+
Sbjct: 125 TEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNI 178
Query: 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT------TGYVAPE--YHQTLTISEKS 438
L++ + ++SDFGL++++ D T+ G T APE ++ T S
Sbjct: 179 LVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWT---APEAISYRKFTS--AS 231
Query: 439 DIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGY 495
D++SFG+++ V+ G+ P+ + + N V+ K + +G+
Sbjct: 232 DVWSFGIVMWEVMTYGERPYWE-------------LSNHEVM-----------KAINDGF 267
Query: 496 EEQMRL---------VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
RL + ++ C + RP D+ +L ++
Sbjct: 268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 70/315 (22%), Positives = 119/315 (37%), Gaps = 80/315 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
L L+ +G G GVV + G Y +AIK I + M+ E + +V M +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIKEGSMSEDEFIEEAKV-----MMNL 76
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H L+ L T+ ++ E+M NG L + L + R
Sbjct: 77 S----------HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLL 123
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + + +EYL +HRD+ N L++D ++SDFGL++ + D T
Sbjct: 124 EMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY----T 176
Query: 416 TVAGT------TGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
+ G+ + PE + + KSDI++FGVL+ + +GK P++
Sbjct: 177 SSVGSKFPVRWS---PPEVLMYSKFSS--KSDIWAFGVLMWEIYSLGKMPYER------- 224
Query: 467 MNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPE 515
N + + G RL V I Y C + +
Sbjct: 225 ------FTNSETA-----------EHIAQGL----RLYRPHLASEKVYTIMYSCWHEKAD 263
Query: 516 ERPSSKDVRCMLSQI 530
ERP+ K + + +
Sbjct: 264 ERPTFKILLSNILDV 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E +G G +V K + G A K I + A+ R +I+ E+
Sbjct: 18 EELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRRGVSRE--------EIEREVSI 68
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
++ H N++ L +L+ E + G L D L + E + A +
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEE--AT-SFIKQ 123
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI----DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ G+ YLH I H D+KP N+++ ++ DFGLA + DG
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKN 177
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT +VAPE + ++D++S GV+ +L+ G PF
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 66/321 (20%), Positives = 113/321 (35%), Gaps = 77/321 (23%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAE--VPGSYGKM-IAIK--KIDQPPMAATELLNVRRV 286
+ KE ++++G GA G VYK G K+ +AIK + P A E+L
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--DEA 68
Query: 287 LINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR 346
+ M + + ++ L L+ + M G L D + + +
Sbjct: 69 YV---MASVD----------NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVR---EHK 111
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+ +A G+ YL ++HRD+ NVL+ +I+DFGLAKL+
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 407 DGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDF 460
G V A E + +SD++S+GV + ++ G P+D
Sbjct: 169 AEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG- 222
Query: 461 FQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFC 509
+ + +L G RL V I C
Sbjct: 223 ------------IPASEIS-----------SILEKGE----RLPQPPICTIDVYMIMVKC 255
Query: 510 TSDDPEERPSSKDVRCMLSQI 530
D + RP +++ S++
Sbjct: 256 WMIDADSRPKFRELIIEFSKM 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 66/258 (25%), Positives = 105/258 (40%), Gaps = 42/258 (16%)
Query: 215 GPAICARPIFKKRDIAFLTKEDSLASL----EIIGVGACGVVYKAEVPGSYGKMIAIKKI 270
GP + + + ++G G+ G V + + G+ A+K I
Sbjct: 1 GPGSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVI 59
Query: 271 DQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFM 330
+ R+V + E+ ++ H N++ L LV E
Sbjct: 60 SK-----------RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 331 KNGSLQDILHDVSQGR-RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI- 388
G L D + +S+ R E+D A RI R + SG+ Y+H I+HRD+KP N+L+
Sbjct: 109 TGGELFDEI--ISRKRFSEVD--AA-RIIRQVLSGITYMHKNK---IVHRDLKPENLLLE 160
Query: 389 --DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE-----YHQTLTISEKSDIY 441
RI DFGL+ ++ GT Y+APE Y EK D++
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHGTY------DEKCDVW 211
Query: 442 SFGVLLAVLVVGKFPFDD 459
S GV+L +L+ G PF+
Sbjct: 212 STGVILYILLSGCPPFNG 229
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 65/316 (20%), Positives = 124/316 (39%), Gaps = 80/316 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
+ + L+ +G G GVV + G Y +A+K I + M+ E + M ++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQEAQT-----MMKL 60
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H L+ ++ +V E++ NG L + L + L+
Sbjct: 61 S----------HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR---SHGKGLEPSQLL 107
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + G+ +L + IHRD+ N L+D + ++SDFG+ + + D
Sbjct: 108 EMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----V 160
Query: 416 TVAGT------TGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEE 466
+ GT + APE ++ + KSD+++FG+L+ V +GK P+D
Sbjct: 161 SSVGTKFPVKWS---APEVFHYFKYSS--KSDVWAFGILMWEVFSLGKMPYDL------- 208
Query: 467 MNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPE 515
N V+ + G+ RL + +I Y C + PE
Sbjct: 209 ------YTNSEVV-----------LKVSQGH----RLYRPHLASDTIYQIMYSCWHELPE 247
Query: 516 ERPSSKDVRCMLSQIK 531
+RP+ + + + ++
Sbjct: 248 KRPTFQQLLSSIEPLR 263
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 28/221 (12%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
E +G GA GVV++ + G A K + P + E VR+ + M ++
Sbjct: 163 EELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKE--TVRKEIQT---MSVLR---- 212
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H L+ L + +++YEFM G L + + D E + A R
Sbjct: 213 ------HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--AV-EYMRQ 263
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI--SDFGLAKLMPDGHTRIRITTVA 418
+ GL ++H + +H D+KP N++ + DFGL + +
Sbjct: 264 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTT 317
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
GT + APE + + +D++S GVL +L+ G PF
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 9e-24
Identities = 63/325 (19%), Positives = 114/325 (35%), Gaps = 74/325 (22%)
Query: 226 KRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKM-IAIK--KIDQPPMAATELLN 282
K FL +++ L + +G G G V + ++ +AIK K E++
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
++ M Q+ + ++ L + +LV E G L L
Sbjct: 386 EAQI-----MHQLD----------NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV-- 427
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
R E+ + ++ G++YL + +HR++ NVL+ + A+ISDFGL+
Sbjct: 428 -GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLS 483
Query: 403 KLMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFP 456
K + + A + G APE S +SD++S+GV + L G+ P
Sbjct: 484 KALGADDS----YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
Query: 457 FDDFFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKI 505
+ M+ V+ + G R+ + +
Sbjct: 540 YKK-------------MKGPEVM-----------AFIEQGK----RMECPPECPPELYAL 571
Query: 506 AYFCTSDDPEERPSSKDVRCMLSQI 530
C E+RP V +
Sbjct: 572 MSDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 7/201 (3%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+ ++ +++ A ++L R ++ K+ + E R+ H + L
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 100
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
+ + KNG L + + + R+ A + S LEYLH IIH
Sbjct: 101 DDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAE-IVSALEYLHGKG---IIH 153
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RD+KP N+L+++ M +I+DFG AK++ + R + GT YV+PE + + S
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 213
Query: 439 DIYSFGVLLAVLVVGKFPFDD 459
D+++ G ++ LV G PF
Sbjct: 214 DLWALGCIIYQLVAGLPPFRA 234
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 38/233 (16%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
+++G GA V + + A+K I++ P V R V + + Q +
Sbjct: 19 DVLGEGAHARVQTCINLIT-SQEYAVKIIEKQPGHIRS--RVFREVEM---LYQCQG--- 69
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIAR 359
HRN+L L D LV+E M+ GS+ H + EL+ A + +
Sbjct: 70 ------HRNVLELIEFFEEEDRFYLVFEKMRGGSILS--HIHKRRHFNELE--AS-VVVQ 118
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRI-- 414
+AS L++LH I HRD+KP N+L + +I DF L + I
Sbjct: 119 DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 415 ---TTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T G+ Y+APE + ++ D++S GV+L +L+ G PF
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 77/316 (24%), Positives = 114/316 (36%), Gaps = 64/316 (20%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLNVRRVLINRK 291
E L LE +G G+ GVV + E GK + A+K + ++ E
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-----------A 64
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
M E+ + HRNL+ L V P +V E GSL D L + +
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLR---KHQGHFLL 120
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
R A +A G+ YL IHRD+ N+L+ +I DFGL + +P
Sbjct: 121 GTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD- 176
Query: 412 IRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTE 465
V V APE +T T S SD + FGV L + G+ P+
Sbjct: 177 ---HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------ 227
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEE 516
+ I K+ G RL + + C + PE+
Sbjct: 228 -------LNG--------SQILHKIDKEGE----RLPRPEDCPQDIYNVMVQCWAHKPED 268
Query: 517 RPSSKDVRCMLSQIKH 532
RP+ +R L + +
Sbjct: 269 RPTFVALRDFLLEAQP 284
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+ +G G+ + K S + A+K I + A T+ + + ++ +
Sbjct: 17 KPLGEGSFSICRKCVHKKS-NQAFAVKIISKRMEANTQ----KEITA---LKLCEG---- 64
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
H N++ L LV E + G L + + E + A I R
Sbjct: 65 -----HPNIVKLHEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETE--AS-YIMRK 114
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ S + ++H ++HRD+KP N+L +D +E +I DFG A+L P + + T
Sbjct: 115 LVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTP 169
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T Y APE E D++S GV+L ++ G+ PF
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-23
Identities = 80/317 (25%), Positives = 137/317 (43%), Gaps = 84/317 (26%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
++L +E +G G G V+ G +A+K + Q M+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFL-------------- 56
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
+E ++ H+ L+ L A VT+ + ++ E+M+NGSL D L + +L
Sbjct: 57 -AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLL 112
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD------GH 409
+A +A G+ ++ + IHRD++ AN+L+ D + +I+DFGLA+L+ D
Sbjct: 113 DMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
Query: 410 TR--IRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYT 464
+ I+ T APE + T TI KSD++SFG+LL ++ G+ P+
Sbjct: 170 AKFPIKWT---------APEAINYGTFTI--KSDVWSFGILLTEIVTHGRIPYPG----- 213
Query: 465 EEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDD 513
M N VI + L GY R+ + ++ C +
Sbjct: 214 --------MTNPEVI-----------QNLERGY----RMVRPDNCPEELYQLMRLCWKER 250
Query: 514 PEERPSSKDVRCMLSQI 530
PE+RP+ +R +L
Sbjct: 251 PEDRPTFDYLRSVLEDF 267
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 26/220 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E +G GA GVV++ + G++ K I+ +++ +K+EI
Sbjct: 57 EELGSGAFGVVHRCVEKAT-GRVFVAKFIN------------TPYPLDKYT--VKNEISI 101
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
++ H L+ L +L+ EF+ G L D + E + R
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VI-NYMRQA 158
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLI--DDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
GL+++H + I+H DIKP N++ +I DFGLA + +
Sbjct: 159 CEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTA 212
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
T + APE + +D+++ GVL VL+ G PF
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 28/226 (12%)
Query: 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQI 295
+++ EI+G G G V+K E + G +A K I M E V+ + + M Q+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETAT-GLKLAAKIIKTRGMKDKE--EVKNEISV---MNQL 143
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H NL+ L + +LV E++ G L D + D S ELD
Sbjct: 144 D----------HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TI- 190
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLI--DDGMEARISDFGLAKLMPDGHTRIR 413
+ + G+ ++H + I+H D+KP N+L D + +I DFGLA+ +
Sbjct: 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT ++APE +S +D++S GV+ +L+ G PF
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+G GA +VY+ + G+ K A+K + + + +++EI
Sbjct: 59 SELGRGATSIVYRCKQKGT-QKPYALKVLKK----------------TVDKKIVRTEIGV 101
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIAR 359
R+ H N++ L+ P LV E + G L D I V +G E D A +
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSERD--AA-DAVK 155
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ + YLH I+HRD+KP N+L +I+DFGL+K++ + T
Sbjct: 156 QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKT 209
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
V GT GY APE + + D++S G++ +L+ G PF D
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 71/325 (21%), Positives = 112/325 (34%), Gaps = 72/325 (22%)
Query: 227 RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLN 282
+D+ + S +IG G GVVY E I AIK L
Sbjct: 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR 71
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLL-VYEFMKNGSLQDILHD 341
+ MR + H N+L L + P+ + +M +G L +
Sbjct: 72 EGLL-----MRGLN----------HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+R +A G+EYL +HRD+ N ++D+ +++DFGL
Sbjct: 117 ---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGL 170
Query: 402 AKLMPDGHTRIRITTVAGTTG------YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGK 454
A+ + D +V + A E QT + KSD++SFGVLL +L G
Sbjct: 171 ARDILDRE----YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKI 505
P Y ++ L G RL + ++
Sbjct: 227 PP------YRHIDP-----FDLT-----------HFLAQGR----RLPQPEYCPDSLYQV 260
Query: 506 AYFCTSDDPEERPSSKDVRCMLSQI 530
C DP RP+ + + + QI
Sbjct: 261 MQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 73/314 (23%), Positives = 115/314 (36%), Gaps = 78/314 (24%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
L L+ IG G G V + G +A+K I + A L
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI-KNDATAQAFL-------------- 234
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
+E ++ H NL+ L + L +V E+M GSL D L S+GR L
Sbjct: 235 -AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCL 291
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+ + + +EYL + +HRD+ NVL+ + A++SDFGL K ++
Sbjct: 292 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348
Query: 415 ----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNM 469
T APE + S KSD++SFG+LL + G+ P+
Sbjct: 349 PVKWT---------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR---------- 389
Query: 470 VRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERP 518
+ V+ + GY ++ V + C D RP
Sbjct: 390 ---IPLKDVV-----------PRVEKGY----KMDAPDGCPPAVYDVMKNCWHLDAATRP 431
Query: 519 SSKDVRCMLSQIKH 532
+ +R L I+
Sbjct: 432 TFLQLREQLEHIRT 445
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 31/224 (13%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
E +G GA VV + + G+ A I+ ++A + + R I R +K
Sbjct: 17 EELGKGAFSVVRRCVKVLA-GQEYAAMIINTKKLSARDHQKLEREARI---CRLLK---- 68
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR-RELDWLARYRIA 358
H N++ L ++ H L+++ + G L + I V++ E D A
Sbjct: 69 ------HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VAREYYSEAD--AS-HCI 116
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + + + H ++HR++KP N+L+ G +++DFGLA +
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWF 171
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
AGT GY++PE + + D+++ GV+L +L+VG PF D
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G+G G V + + G+ A+K + P A E V + +
Sbjct: 35 QVLGLGVNGKVLECFHRRT-GQKCALKLLYDSPKARQE------VDHHWQASG------- 80
Query: 302 AGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYR 356
+++ + + C L++ E M+ G L I Q E + A
Sbjct: 81 -----GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE--AA-E 132
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIR 413
I R + + +++LH ++ I HRD+KP N+L + +++DFG AK
Sbjct: 133 IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----A 185
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ T T YVAPE + D++S GV++ +L+ G PF
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-23
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 27/229 (11%)
Query: 241 LEIIGVGAC--GVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298
L +IG G V A + G+ + +++I+ + A N + ++ E
Sbjct: 30 LTVIGKGFEDLMTVNLARYKPT-GEYVTVRRIN---LEACS---------NEMVTFLQGE 76
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ + H N++P +A + +V FM GS +D++ +A I
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY--IL 134
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR----- 413
+G+ L+Y+H +HR +K +++LI + +S M R R
Sbjct: 135 QGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 414 ITTVAGTTGYVAPE-YHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDF 460
+++PE Q L KSDIYS G+ L G PF D
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 56/223 (25%), Positives = 91/223 (40%), Gaps = 25/223 (11%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E +G G VV K + G A K I + ++ R I+ E+
Sbjct: 17 EELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGVSRE--------DIEREVSI 67
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGR-RELDWLARYRIARG 360
I H N++ L +L+ E + G L D L + E + A +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEE--AT-EFLKQ 122
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI----DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ +G+ YLH I H D+KP N+++ +I DFGLA + G+
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKN 176
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ GT +VAPE + ++D++S GV+ +L+ G PF
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 8e-23
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--------DQPPMAATELLNVRRVLINRKM 292
++G G G V +V + GKM A KK+ MA E +++L
Sbjct: 189 YRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIKKRKGEAMALNE----KQILEKVN- 242
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
R ++ L D LV M G L+ ++ + Q
Sbjct: 243 --------------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR- 287
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
A + A + GLE LH I++RD+KP N+L+DD RISD GLA +P+G T
Sbjct: 288 AVFYAAE-ICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 341
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
I GT GY+APE + + D ++ G LL ++ G+ PF
Sbjct: 342 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-22
Identities = 73/325 (22%), Positives = 119/325 (36%), Gaps = 72/325 (22%)
Query: 227 RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLN 282
+ + + E+IG G G VY + + GK I A+K ++ L
Sbjct: 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL- 74
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC-HLLVYEFMKNGSLQDILHD 341
+E I H N+L L R + L+V +MK+G L++ + +
Sbjct: 75 --------------TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+A G++YL +HRD+ N ++D+ +++DFGL
Sbjct: 121 ---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 402 AKLMPDGHTRIRITTVAGTTG------YVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGK 454
A+ M D +V TG ++A E QT + KSD++SFGVLL ++ G
Sbjct: 175 ARDMYDKEY----YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230
Query: 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKI 505
P+ D N L G RL + ++
Sbjct: 231 PPYPDV--------------------NTFDIT--VYLLQGR----RLLQPEYCPDPLYEV 264
Query: 506 AYFCTSDDPEERPSSKDVRCMLSQI 530
C E RPS ++ +S I
Sbjct: 265 MLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 68/324 (20%), Positives = 117/324 (36%), Gaps = 70/324 (21%)
Query: 227 RDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLN 282
+ + + E+IG G G VY + + GK I A+K ++ L
Sbjct: 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 139
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC-HLLVYEFMKNGSLQDILHD 341
+ M+ H N+L L R + L+V +MK+G L++ + +
Sbjct: 140 EGII-----MKDFS----------HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 184
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+A G+++L +HRD+ N ++D+ +++DFGL
Sbjct: 185 ---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGL 238
Query: 402 AKLMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKF 455
A+ M + + + T + A E QT + KSD++SFGVLL ++ G
Sbjct: 239 ARDM---YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295
Query: 456 PFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIA 506
P+ D N L G RL + ++
Sbjct: 296 PYPDV--------------------NTFDIT--VYLLQGR----RLLQPEYCPDPLYEVM 329
Query: 507 YFCTSDDPEERPSSKDVRCMLSQI 530
C E RPS ++ +S I
Sbjct: 330 LKCWHPKAEMRPSFSELVSRISAI 353
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 76/316 (24%), Positives = 117/316 (37%), Gaps = 82/316 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQI 295
L L+ IG G G V + G +A+K I + A L V M Q+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY---RGNKVAVKCI-KNDATAQAFLAEASV-----MTQL 71
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
+ H NL+ L + L +V E+M GSL D L S+GR L
Sbjct: 72 R----------HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCL 119
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+ + + +EYL + +HRD+ NVL+ + A++SDFGL K ++
Sbjct: 120 LKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176
Query: 415 ----TTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEM 467
T APE + + KSD++SFG+LL + G+ P+
Sbjct: 177 PVKWT---------APEALREKKFST--KSDVWSFGILLWEIYSFGRVPYPR-------- 217
Query: 468 NMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEE 516
+ V+ + GY ++ V ++ C D
Sbjct: 218 -----IPLKDVV-----------PRVEKGY----KMDAPDGCPPAVYEVMKNCWHLDAAM 257
Query: 517 RPSSKDVRCMLSQIKH 532
RPS +R L IK
Sbjct: 258 RPSFLQLREQLEHIKT 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 33/223 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEII 300
E +G G G+V++ S K K + + T+ + V++ + I + +
Sbjct: 11 EDLGRGEFGIVHRCVETSS-KKTYMAKFV---KVKGTDQVLVKKEISI---LNIAR---- 59
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRR--ELDWLARYRIA 358
HRN+L L + ++++EF+ + + + + E +
Sbjct: 60 ------HRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNERE--IV-SYV 108
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLI--DDGMEARISDFGLAKLMPDGHTRIRITT 416
+ L++LH ++ I H DI+P N++ +I +FG A+ + G
Sbjct: 109 HQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRL 162
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ Y APE HQ +S +D++S G L+ VL+ G PF
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 61/308 (19%), Positives = 103/308 (33%), Gaps = 74/308 (24%)
Query: 243 IIGVGACGVVYKAEVPGSYGKM-IAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+G G G V K +A+K + ++ +E
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL------------KDELLAEANV 71
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
++ + ++ + + +LV E + G L L Q R + + +
Sbjct: 72 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQV 126
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTT 421
+ G++YL + +HRD+ NVL+ A+ISDFGL+K + A T
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN----YYKAQTH 179
Query: 422 GYV-----APE--YHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWM 473
G APE + + KSD++SFGVL+ G+ P+ M
Sbjct: 180 GKWPVKWYAPECINYYKFSS--KSDVWSFGVLMWEAFSYGQKPYRG-------------M 224
Query: 474 RN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDPEERPSSKD 522
+ V +L G R+ + + C + D E RP
Sbjct: 225 KGSEVT-----------AMLEKGE----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 269
Query: 523 VRCMLSQI 530
V L
Sbjct: 270 VELRLRNY 277
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 47/289 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ +G GA G VYKA+ + G + A K I+ ++ EI
Sbjct: 24 VGELGDGAFGKVYKAKNKET-GALAAAKVIE--------------TKSEEELEDYIVEIE 68
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H ++ L ++ EF G++ I+ ++ +G E + + R
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQV--VCRQ 125
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL-AKLMPDGHTRIRITTVAG 419
M L +LH IIHRD+K NVL+ + R++DFG+ AK + T + + G
Sbjct: 126 MLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---KTLQKRDSFIG 179
Query: 420 TTGYVAPEYHQTLTISE-----KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
T ++APE T+ + K+DI+S G+ L + + P + +N +R +
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE-------LNPMRVLL 232
Query: 475 NVISSENPHRAIDSKLL-GNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ S+ P LL + + + R LKI +PE RPS+
Sbjct: 233 KIAKSDPP------TLLTPSKWSVEFRDFLKI---ALDKNPETRPSAAQ 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 65/240 (27%), Positives = 94/240 (39%), Gaps = 51/240 (21%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
E IGVG+ V + + A+K ID+ T + I + Q
Sbjct: 28 EDIGVGSYSVCKRCIHKAT-NMEFAVKIIDKSKRDPT-----EEIEILLRYGQ------- 74
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGR---RELDWLARYRI 357
H N++ L+ +V E MK G L D I + Q RE A +
Sbjct: 75 -----HPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LRQKFFSERE----AS-AV 121
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLI----DDGMEARISDFGLAKLMPDGHTRIR 413
+ +EYLH ++HRD+KP+N+L + RI DFG AK + +
Sbjct: 122 LFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--L 176
Query: 414 ITTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
+ T T +VAPE Y DI+S GVLL ++ G PF + T E
Sbjct: 177 LMTPCYTANFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 64/322 (19%), Positives = 111/322 (34%), Gaps = 85/322 (26%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLNVRRVLIN 289
+ + I+G G G VY+ G+ I A+K K D + ++ +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVI--- 66
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
M+ + H +++ L + P ++ E G L L + +
Sbjct: 67 --MKNLD----------HPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLE---RNKNS 109
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD- 407
L L + + + YL + +HRDI N+L+ ++ DFGL++ + D
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
Query: 408 -----GHTR--IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
TR I+ +PE + SD++ F V + +L GK PF
Sbjct: 167 DYYKASVTRLPIKWM---------SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
Query: 460 FFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYF 508
+ N VI +L G RL + +
Sbjct: 218 -------------LENKDVI-----------GVLEKGD----RLPKPDLCPPVLYTLMTR 249
Query: 509 CTSDDPEERPSSKDVRCMLSQI 530
C DP +RP ++ C LS +
Sbjct: 250 CWDYDPSDRPRFTELVCSLSDV 271
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 68/318 (21%), Positives = 110/318 (34%), Gaps = 77/318 (24%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLNVRRVLIN 289
+ + + IG G G V++ + AIK K + L
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALT--- 69
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
MRQ H +++ L +T ++ E G L+ L + L
Sbjct: 70 --MRQFD----------HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKYSL 113
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
D + A +++ L YL +HRDI NVL+ ++ DFGL++ M D
Sbjct: 114 DLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 169
Query: 410 TRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQY 463
T + G + APE + SD++ FGV + +L+ G PF
Sbjct: 170 -----TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG---- 220
Query: 464 TEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSD 512
++N VI + NG RL + + C +
Sbjct: 221 ---------VKNNDVI-----------GRIENGE----RLPMPPNCPPTLYSLMTKCWAY 256
Query: 513 DPEERPSSKDVRCMLSQI 530
DP RP +++ LS I
Sbjct: 257 DPSRRPRFTELKAQLSTI 274
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 4e-22
Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--------DQPPMAATELLNVRRVLINRKM 292
IIG G G VY + GKM A+K + +A E R +L
Sbjct: 194 HRIIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQGETLALNE----RIML----- 243
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
+++ G ++ + PD + + M G D+ + +SQ +
Sbjct: 244 -----SLVSTGD--CPFIVCMSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEAD 293
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
R+ A + GLE++H +++RD+KPAN+L+D+ RISD GLA
Sbjct: 294 MRFYAAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH- 348
Query: 413 RITTVAGTTGYVAPEYHQTLTISEKS-DIYSFGVLLAVLVVGKFPFDD 459
GT GY+APE Q + S D +S G +L L+ G PF
Sbjct: 349 ---ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-22
Identities = 56/325 (17%), Positives = 120/325 (36%), Gaps = 85/325 (26%)
Query: 234 KEDSLASLEIIGVGACGVVYKAE--VPGSYGKM----IAIKKIDQPPMAATELLNVRRVL 287
+ + L E +G G ++K G YG++ + +K +D+ +E
Sbjct: 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-FEAAS 64
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRR 347
+ M ++ H++L+ D ++LV EF+K GSL L +
Sbjct: 65 M---MSKLS----------HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKN 108
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID--------DGMEARISDF 399
++ L + +A+ +A+ + +L +IH ++ N+L+ + ++SD
Sbjct: 109 CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 400 GLAKLM-PDGHTRIRITTVAGTTGYVAPE---YHQTLTISEKSDIYSFGVLL-AVLVVGK 454
G++ + P + RI +V PE + L + +D +SFG L + G
Sbjct: 166 GISITVLPKDILQERIP-------WVPPECIENPKNLNL--ATDKWSFGTTLWEICSGGD 216
Query: 455 FPFDDFFQYTEEMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL-------VLKI 505
P + + + + + + +L + +
Sbjct: 217 KPLSA-------------LDSQRKL-----------QFYEDRH----QLPAPKAAELANL 248
Query: 506 AYFCTSDDPEERPSSKDVRCMLSQI 530
C +P+ RPS + + L+ +
Sbjct: 249 INNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 39/239 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--------DQPPMAATELLNVRRVLINRKM 292
++G G G V+ ++ + GK+ A KK+ A E +++L
Sbjct: 190 FRVLGRGGFGEVFACQMKAT-GKLYACKKLNKKRLKKRKGYQGAMVE----KKIL----- 239
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELD- 350
++ R ++ L L LV M G ++ +++V +
Sbjct: 240 ----------AKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
A + A+ + SGLE+LH + II+RD+KP NVL+DD RISD GLA + G T
Sbjct: 289 PRAIFYTAQ-IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF--DDFFQYTEEM 467
+ + AGT G++APE D ++ GV L ++ + PF +E+
Sbjct: 345 KTK--GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 64/320 (20%), Positives = 113/320 (35%), Gaps = 72/320 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLN-VRRVLINRKM 292
+ L +I+G G G V + + G + A+K + + E+ + M
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC---M 90
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCH-----LLVYEFMKNGSLQDIL--HDVSQG 345
+ H N++ L +++ FMK G L L + G
Sbjct: 91 KDFS----------HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 346 RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM 405
+ + + +A G+EYL + +HRD+ N ++ D M ++DFGL+K +
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 406 PDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDD 459
G G + A E + KSD+++FGV + + G P
Sbjct: 198 YSGD-----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--- 249
Query: 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCT 510
Y N + L +G+ RL + +I Y C
Sbjct: 250 ---YPGVQN-----HEMY-----------DYLLHGH----RLKQPEDCLDELYEIMYSCW 286
Query: 511 SDDPEERPSSKDVRCMLSQI 530
DP +RP+ +R L ++
Sbjct: 287 RTDPLDRPTFSVLRLQLEKL 306
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 68/316 (21%), Positives = 109/316 (34%), Gaps = 77/316 (24%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIK--KIDQPPMAATELLNVRRVLINRK 291
+ + IG G G V++ + AIK K + L
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT----- 444
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDW 351
MRQ H +++ L +T ++ E G L+ L + LD
Sbjct: 445 MRQFD----------HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQ---VRKFSLDL 490
Query: 352 LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
+ A +++ L YL +HRDI NVL+ ++ DFGL++ M D
Sbjct: 491 ASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--- 544
Query: 412 IRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTE 465
T + G + APE + SD++ FGV + +L+ G PF
Sbjct: 545 ---TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG------ 595
Query: 466 EMNMVRWMRN--VISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFCTSDDP 514
++N VI + NG RL + + C + DP
Sbjct: 596 -------VKNNDVI-----------GRIENGE----RLPMPPNCPPTLYSLMTKCWAYDP 633
Query: 515 EERPSSKDVRCMLSQI 530
RP +++ LS I
Sbjct: 634 SRRPRFTELKAQLSTI 649
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 44/285 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G+ G VY A + +++AIKK+ + E K + I E+
Sbjct: 59 LREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNE-----------KWQDIIKEVR 106
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H N + + R LV E+ GS D+L + +E +A + G
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE-VEIAA--VTHG 162
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
GL YLH ++ +IHRD+K N+L+ + ++ DFG A +M + GT
Sbjct: 163 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGT 213
Query: 421 TGYVAPE---YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
++APE K D++S G+ L K P + MN + + ++
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIA 266
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+E+P L + E R + C P++RP+S+
Sbjct: 267 QNESP------ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEV 302
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 48/232 (20%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G+G G V + + + A+K + P A E V ++ + Q
Sbjct: 68 QVLGLGINGKVLQIFNKRT-QEKFALKMLQDCPKARRE------VELHWRASQ------- 113
Query: 302 AGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYR 356
+++ + + C L+V E + G L I Q E + A
Sbjct: 114 -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--AS-E 165
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIR 413
I + + ++YLH + I HRD+KP N+L +++DFG AK +
Sbjct: 166 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 219
Query: 414 ITTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+TT T YVAPE Y + D++S GV++ +L+ G PF
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKY------DKSCDMWSLGVIMYILLCGYPPFYS 265
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 63/332 (18%), Positives = 118/332 (35%), Gaps = 86/332 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
+ L+ + +G GA G V +A G +A+K K L++ +V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV--- 79
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL---------- 339
+ + + H N++ L T L++ E+ G L + L
Sbjct: 80 --LSYLGN---------HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 340 ----HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395
+ LD + +A G+ +L + IHRD+ N+L+ G +
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLLA 448
I DFGLA+ + + V + APE ++ T +SD++S+G+ L
Sbjct: 186 ICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTF--ESDVWSYGIFLW 238
Query: 449 VLV-VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL------ 501
L +G P+ ++ M++ G+ R+
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYKMIK---------------------EGF----RMLSPEHA 273
Query: 502 ---VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ I C DP +RP+ K + ++ +
Sbjct: 274 PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 66/321 (20%), Positives = 116/321 (36%), Gaps = 73/321 (22%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLN-VRRVLINRKM 292
++G G G V +A++ G + A+K + +A++++ +R M
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC---M 79
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPD------CHLLVYEFMKNGSLQDIL--HDVSQ 344
++ H ++ L R +++ FMK+G L L + +
Sbjct: 80 KEFD----------HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 345 GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404
L R +A G+EYL + IHRD+ N ++ + M ++DFGL++
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 405 MPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFD 458
+ G G + A E + SD+++FGV + ++ G+ P
Sbjct: 187 IYSGD-----YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-- 239
Query: 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------VLKIAYFC 509
Y N + L G RL V + Y C
Sbjct: 240 ----YAGIEN-----AEIY-----------NYLIGGN----RLKQPPECMEEVYDLMYQC 275
Query: 510 TSDDPEERPSSKDVRCMLSQI 530
S DP++RPS +R L I
Sbjct: 276 WSADPKQRPSFTCLRMELENI 296
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 53/234 (22%), Positives = 86/234 (36%), Gaps = 49/234 (20%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKM-IAIK--KIDQPPMAATELLNVRRVLINRKM 292
+ + ++IG G G V KA + +M AIK K + V +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV-----L 79
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
++ H N++ L L E+ +G+L D L + +
Sbjct: 80 CKLGH---------HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 353 ARY------------RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
A +A G++YL IHRD+ N+L+ + A+I+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 187
Query: 401 LAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL 447
L+ R + V T G + A E + T SD++S+GVLL
Sbjct: 188 LS--------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTT--NSDVWSYGVLL 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 68/331 (20%), Positives = 116/331 (35%), Gaps = 85/331 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
D L + +G GA G V +A+ G +A+K K L++ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI--- 83
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV-YEFMKNGSLQDIL--------- 339
+ I H N++ L T+P L+V EF K G+L L
Sbjct: 84 --LIHIGH---------HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132
Query: 340 ---HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396
+ L + +A G+E+L IHRD+ N+L+ + +I
Sbjct: 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKI 189
Query: 397 SDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL-A 448
DFGLA+ + V + APE + + TI +SD++SFGVLL
Sbjct: 190 CDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTI--QSDVWSFGVLLWE 242
Query: 449 VLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL------- 501
+ +G P+ E ++ G R+
Sbjct: 243 IFSLGASPYPGVKIDEEFCRRLK---------------------EGT----RMRAPDYTT 277
Query: 502 --VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ + C +P +RP+ ++ L +
Sbjct: 278 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 70/332 (21%), Positives = 121/332 (36%), Gaps = 87/332 (26%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK------MIAIK--KIDQPPMAATELLNVRRVL 287
D L + +G G G V AE G +A+K K D ++L++ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM- 139
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-------- 339
M+ I H+N++ L T+ ++ E+ G+L++ L
Sbjct: 140 ----MKMIGK---------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 340 ----HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395
++ + +A G+EYL IHRD+ NVL+ + +
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMK 243
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL- 447
I+DFGLA+ + + T G + APE + + T +SD++SFGVL+
Sbjct: 244 IADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLMW 296
Query: 448 AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL------ 501
+ +G P Y + KLL G+ R+
Sbjct: 297 EIFTLGGSP------YPGIPV-----EELF-----------KLLKEGH----RMDKPANC 330
Query: 502 ---VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ + C P +RP+ K + L +I
Sbjct: 331 TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 56/239 (23%), Positives = 96/239 (40%), Gaps = 51/239 (21%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK------MIAIK--KIDQPPMAATELLNVRRVL 287
D L + +G GA G V AE G +A+K K D ++L++ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM- 93
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-------- 339
M+ I H+N++ L T+ ++ E+ G+L++ L
Sbjct: 94 ----MKMIGK---------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 340 ----HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395
++ + +A G+EYL IHRD+ NVL+ + +
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMK 197
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL 447
I+DFGLA+ + + T G + APE + + T +SD++SFGVL+
Sbjct: 198 IADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTH--QSDVWSFGVLM 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 51/229 (22%), Positives = 82/229 (35%), Gaps = 40/229 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
++ + +G GA G VY+ +V G +A+K + L +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI--- 86
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD---VSQGR 346
+ + H+N++ + ++ E M G L+ L +
Sbjct: 87 --ISKFN----------HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQP 134
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR---ISDFGLAK 403
L L +AR +A G +YL H IHRDI N L+ R I DFG+A+
Sbjct: 135 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
Query: 404 LMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL 447
+ G + PE + K+D +SFGVLL
Sbjct: 192 DIYRAS-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 46/229 (20%), Positives = 85/229 (37%), Gaps = 40/229 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
+ + +G G+ G+VY+ G +AIK E L
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-------- 76
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
+E +++ L V++ L++ E M G L+ L +
Sbjct: 77 -------NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 350 DWLAR------YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
LA ++A +A G+ YL+ +HRD+ N ++ + +I DFG+ +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 404 LMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL 447
+ + G G + +PE + + SD++SFGV+L
Sbjct: 187 DIYETD-----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 33/214 (15%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV- 317
GS+GK+ ++K D M A + +N ++ + ++R + E ++ H
Sbjct: 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE---------LQIMQGLEHPF 76
Query: 318 ---------TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYL 368
D + V + + G D+ + + Q + + I + L+YL
Sbjct: 77 LVNLWYSFQDEEDMFM-VVDLLLGG---DLRYHLQQNVHFKEETVKLFICE-LVMALDYL 131
Query: 369 HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE- 427
IIHRD+KP N+L+D+ I+DF +A ++P ITT+AGT Y+APE
Sbjct: 132 QNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEM 185
Query: 428 -YHQTLTISEKS-DIYSFGVLLAVLVVGKFPFDD 459
+ + D +S GV L+ G+ P+
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 55/241 (22%), Positives = 95/241 (39%), Gaps = 58/241 (24%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
++ +E +G G VYK + G +AIK K E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-------- 60
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL---------- 339
E + R+ H N++ L VT+ +++ + +G L + L
Sbjct: 61 -------HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVG 113
Query: 340 --HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397
D + L+ + +A+G+EYL +H ++H+D+ NVL+ D + +IS
Sbjct: 114 STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKIS 170
Query: 398 DFGLAKLMPD-------GHTR--IRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVL 446
D GL + + G++ IR APE + +I SDI+S+GV+
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWM---------APEAIMYGKFSI--DSDIWSYGVV 219
Query: 447 L 447
L
Sbjct: 220 L 220
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 65/328 (19%), Positives = 113/328 (34%), Gaps = 84/328 (25%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKI-DQPPMAATELLNVRRVLINR 290
+ +G GA G V+ AE + ++A+K + + A +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ--------- 91
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL----------- 339
E + H++++ T L+V+E+M++G L L
Sbjct: 92 ------REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA 145
Query: 340 HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
L +A +A+G+ YL H +HRD+ N L+ G+ +I DF
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDF 202
Query: 400 GLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL-AVLV 451
G+++ + G + PE ++ T +SD++SFGV+L +
Sbjct: 203 GMSRDIYSTD-----YYRVGGRTMLPIRWMPPESILYRKFTT--ESDVWSFGVVLWEIFT 255
Query: 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL---------V 502
GK P + + N I + G L V
Sbjct: 256 YGKQP------WYQLSN-----TEAI-----------DCITQGR----ELERPRACPPEV 289
Query: 503 LKIAYFCTSDDPEERPSSKDVRCMLSQI 530
I C +P++R S KDV L +
Sbjct: 290 YAIMRGCWQREPQQRHSIKDVHARLQAL 317
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 51/229 (22%), Positives = 83/229 (36%), Gaps = 40/229 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
++ + +G GA G VY+ +V G +A+K + L +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI--- 127
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
+ + H+N++ + ++ E M G L+ L + +
Sbjct: 128 --ISKFN----------HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 350 DWLARYR---IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR---ISDFGLAK 403
LA +AR +A G +YL H IHRDI N L+ R I DFG+A+
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
Query: 404 LMPDGHTRIRITTVAGTTGYV-----APEYHQTLTISEKSDIYSFGVLL 447
+ G + PE + K+D +SFGVLL
Sbjct: 233 DIYRAG-----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 54/237 (22%), Positives = 97/237 (40%), Gaps = 51/237 (21%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
++L + +G GA G V +A G + +A+K K L++ ++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI--- 102
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
M + H N++ L T L++ E+ G L + L S+
Sbjct: 103 --MSHLGQ---------HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 350 DWLARY----------RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399
A + +A G+ +L + IHRD+ NVL+ +G A+I DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDF 208
Query: 400 GLAKLM-------PDGHTRIRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL 447
GLA+ + G+ R+ + ++APE + T+ +SD++S+G+LL
Sbjct: 209 GLARDIMNDSNYIVKGNARLPVK-------WMAPESIFDCVYTV--QSDVWSYGILL 256
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 57/240 (23%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAA-TELLNVRRVLINR 290
+ +G GA G V+ AE ++A+K + P +AA +
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ--------- 65
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL----------- 339
E + H +++ D ++V+E+MK+G L L
Sbjct: 66 ------REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 340 -HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISD 398
Q + EL IA +ASG+ YL H +HRD+ N L+ + +I D
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGD 176
Query: 399 FGLAKLMPD-------GHTR--IRITTVAGTTGYVAPE--YHQTLTISEKSDIYSFGVLL 447
FG+++ + GHT IR PE ++ T +SD++SFGV+L
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWM---------PPESIMYRKFTT--ESDVWSFGVIL 225
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 66/247 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ G G G V + + G +AIKK+ Q P NR+++ ++
Sbjct: 28 ERMAGQGTFGTVQLGKEKST-GMSVAIKKVIQDPRFR-----------NRELQIMQD--- 72
Query: 301 TAGRIWHRNLLPLQAHVTRP-------DCHL-LVYEFMKNGSLQDILHDVSQGRRELDW- 351
+ H N++ LQ D +L +V E++ +L + + +
Sbjct: 73 -LAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPI 129
Query: 352 ---LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-EARISDFGLAKLMPD 407
+ +++ R + LH+ + HRDIKP NVL+++ ++ DFG AK +
Sbjct: 130 LIKVFLFQLIRSIG----CLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 408 GHTRIRITTVAGTTGYV------APE-------YHQTLTISEKSDIYSFGVLLAVLVVGK 454
Y+ APE Y T + DI+S G + A +++G+
Sbjct: 185 SEP---------NVAYICSRYYRAPELIFGNQHY--TTAV----DIWSVGCIFAEMMLGE 229
Query: 455 --FPFDD 459
F D+
Sbjct: 230 PIFRGDN 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 51/239 (21%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK------MIAIK--KIDQPPMAATELLNVRRVL 287
D L + +G GA G V AE G +A+K K D ++L++ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM- 127
Query: 288 INRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL-------- 339
M+ I H+N++ L T+ ++ E+ G+L++ L
Sbjct: 128 ----MKMIGK---------HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 174
Query: 340 ----HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395
+ +L A +A G+EYL IHRD+ NVL+ + +
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMK 231
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSFGVLL 447
I+DFGLA+ + T G + APE + + T +SD++SFGVLL
Sbjct: 232 IADFGLARDIHHID-----YYKKTTNGRLPVKWMAPEALFDRIYTH--QSDVWSFGVLL 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 69/337 (20%), Positives = 118/337 (35%), Gaps = 91/337 (27%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
++L +++G GA G V A G +A+K K L++ ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM--- 101
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL----HDVSQG 345
M Q+ S H N++ L T L++E+ G L + L S+
Sbjct: 102 --MTQLGS---------HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 346 RRELDWLARY---------------RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390
E + R A +A G+E+L +HRD+ NVL+
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTH 207
Query: 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYSF 443
G +I DFGLA+ + V + APE + TI KSD++S+
Sbjct: 208 GKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTI--KSDVWSY 260
Query: 444 GVLLAVLV-VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL- 501
G+LL + +G P+ +++ NG+ ++
Sbjct: 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQ---------------------NGF----KMD 295
Query: 502 --------VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ I C + D +RPS ++ L
Sbjct: 296 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 64/243 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++IG G+ GVVY+A++ S G+++AIKK+ Q K R+++ I+
Sbjct: 59 TKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQDKR--------------FKNRELQ--IM 101
Query: 301 TAGRIWHRNLLPLQAHVTRP-----DCHL-LVYEFMKNGSLQDILHDVSQGRRELDW--- 351
++ H N++ L+ + +L LV +++ ++ + S+ ++ L
Sbjct: 102 R--KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 352 -LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGH 409
L Y++ R +A Y+H I HRDIKP N+L+D D ++ DFG AK + G
Sbjct: 159 KLYMYQLFRSLA----YIHS-FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 410 TRIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
Y+ APE T +I D++S G +LA L++G+ FP
Sbjct: 212 P---------NVSYICSRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQPIFP 258
Query: 457 FDD 459
D
Sbjct: 259 GDS 261
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 48/257 (18%), Positives = 94/257 (36%), Gaps = 60/257 (23%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAA---------------TELLNVRR 285
+ +G G+ G+V + S GK A+KK+ Q P +L++
Sbjct: 12 GKTLGTGSFGIVCEVFDIES-GKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70
Query: 286 VLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL-----LVYEFMKNGSLQDILH 340
+ + + + N + + ++ E++ + +L +L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129
Query: 341 DVSQGRRELDW----LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEAR 395
+ R + + Y++ R + ++H I HRDIKP N+L++ +
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVG----FIHSLG---ICHRDIKPQNLLVNSKDNTLK 182
Query: 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFG 444
+ DFG AK + + Y+ APE T +I D++S G
Sbjct: 183 LCDFGSAKKLIPSEP---------SVAYICSRFYRAPELMLGATEYTPSI----DLWSIG 229
Query: 445 VLLAVLVVGK--FPFDD 459
+ L++GK F +
Sbjct: 230 CVFGELILGKPLFSGET 246
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 70/338 (20%), Positives = 126/338 (37%), Gaps = 94/338 (27%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK--KIDQPPMAATELLNVRRVLIN 289
+L + +G G G V KA G+ +A+K K + P +LL
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-------- 74
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDIL---------- 339
SE ++ H +++ L ++ LL+ E+ K GSL+ L
Sbjct: 75 -------SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGY 127
Query: 340 ----------HDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389
R L A ++ G++YL ++HRD+ N+L+
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVA 184
Query: 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYV-----APE--YHQTLTISEKSDIYS 442
+G + +ISDFGL++ + + + V + G + A E + T +SD++S
Sbjct: 185 EGRKMKISDFGLSRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTT--QSDVWS 237
Query: 443 FGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRL 501
FGVLL ++ +G P Y + LL G+ R+
Sbjct: 238 FGVLLWEIVTLGGNP------YPGIPP-----ERLF-----------NLLKTGH----RM 271
Query: 502 ---------VLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ ++ C +P++RP D+ L ++
Sbjct: 272 ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 62/240 (25%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
L+ IG GA G+V A + +AIKK+ +P A R +++ + +
Sbjct: 67 LKPIGSGAQGIVCAA-YDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVN---- 119
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELD 350
H+N++ L +V P L LV E M L V Q + +
Sbjct: 120 ---------HKNIISLL-NVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHE 164
Query: 351 WLA--RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
++ Y++ G +++LH IIHRD+KP+N+++ +I DFGLA+
Sbjct: 165 RMSYLLYQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 409 HTRIRITTVAGTTGYV------APEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDF 460
T YV APE + E DI+S G ++ +V K FP D+
Sbjct: 218 FM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 67/252 (26%)
Query: 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKM 292
+E + + ++IG G+ GVV++A++ +AIKK+ Q + R + I R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKL--VESDEVAIKKVLQD--KRFKN---RELQIMRIV 89
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQG 345
+ H N++ L+ + LV E++ ++ ++
Sbjct: 90 K-------------HPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKL 134
Query: 346 RRELDW----LARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFG 400
++ + L Y++ R +A Y+H I HRDIKP N+L+D ++ DFG
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLA----YIHS-IG--ICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 401 LAKLMPDGHTRIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFGVLLAV 449
AK++ G Y+ APE + T I DI+S G ++A
Sbjct: 188 SAKILIAGEP---------NVSYICSRYYRAPELIFGATNYTTNI----DIWSTGCVMAE 234
Query: 450 LVVGK--FPFDD 459
L+ G+ FP +
Sbjct: 235 LMQGQPLFPGES 246
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 33/219 (15%), Positives = 70/219 (31%), Gaps = 50/219 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L G ++A + + + +A+ +D + ++ ++ L S +
Sbjct: 36 LIFHGGVPPLQFWQA-LDTALDRQVALTFVDPQGVLPDDV--LQETL---------SRTL 83
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
RI + + V L+V E+++ GSLQ++ + R +
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQS 137
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+A+ + H R + P+ V +S G L
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDVVL--------------AY 172
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
+ + + DI G L L+V ++P +
Sbjct: 173 PATMPDA-------NPQDDIRGIGASLYALLVNRWPLPE 204
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 49/211 (23%), Positives = 87/211 (41%), Gaps = 20/211 (9%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IITAGRIWHRNLLPLQAH 316
G++ ++ +K + A +++N +L ++ + E ++ G R + L
Sbjct: 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD--RRWITQLHFA 129
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
+ LV E+ G L + G R +AR+ +A + ++ +H
Sbjct: 130 FQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLAE-IVMAIDSVHRLG---Y 183
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS 435
+HRDIKP N+L+D R++DFG L DG R GT Y++PE Q +
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV--RSLVAVGTPDYLSPEILQAVGGG 241
Query: 436 EKSDIY-------SFGVLLAVLVVGKFPFDD 459
+ Y + GV + G+ PF
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
G++GK+I +K+ A ++L ++ ++ +E H L L+
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
D V E+ G ++ +S+ R + AR+ A + S L+YLH +++
Sbjct: 219 THDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKN--VVY 272
Query: 379 RDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK 437
RD+K N+++D +I+DFGL K + DG T + T GT Y+APE +
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRA 329
Query: 438 SDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
D + GV++ ++ G+ PF + Q E++
Sbjct: 330 VDWWGLGVVMYEMMCGRLPFYN--QDHEKL 357
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-17
Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 49/235 (20%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
+ IG GA G V+KA + G+ +A+K++ + P++ +R V + R +
Sbjct: 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST-----IREVAVLRHLET 70
Query: 295 IKSEIITAGRIWHRNLLPLQ--AHVTRPDCHL---LVYEFMKNGSLQDILHDVSQGRREL 349
+ H N++ L V+R D LV+E + L L V +
Sbjct: 71 FE----------HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+ + + GL++LH HR ++HRD+KP N+L+ + +++DFGLA++
Sbjct: 120 ETIKDM--MFQLLRGLDFLHS-HR--VVHRDLKPQNILVTSSGQIKLADFGLARIY---S 171
Query: 410 TRIRITTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
++ +T+V T Y APE Y + D++S G + A + K F
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKPLFR 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 60/240 (25%), Positives = 99/240 (41%), Gaps = 58/240 (24%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
L+ IG GA G+V A + +AIKK+ +P A R +++ + +
Sbjct: 30 LKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVN---- 82
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELD 350
H+N++ L +V P L +V E M + L V Q + +
Sbjct: 83 ---------HKNIIGLL-NVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELDHE 127
Query: 351 WLA--RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
++ Y++ G +++LH IIHRD+KP+N+++ +I DFGLA+
Sbjct: 128 RMSYLLYQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 409 HTRIRITTVAGTTGYV------APEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDF 460
T YV APE + E DI+S G ++ ++ G FP D
Sbjct: 181 FM---------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 57/272 (20%), Positives = 99/272 (36%), Gaps = 70/272 (25%)
Query: 213 YRGPAICARPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIK 268
Y+ + P + +++ + IG GA G V++A PG M+A+K
Sbjct: 28 YQRMPLLLNPKLLSLEY----PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK 83
Query: 269 --KIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLV 326
K + + E + N++ L L+
Sbjct: 84 MLKEEASADMQADFQ---------------REAALMAEFDNPNIVKLLGVCAVGKPMCLL 128
Query: 327 YEFMKNGSLQDIL--------------------HDVSQGRRELDWLARYRIARGMASGLE 366
+E+M G L + L S G L + IAR +A+G+
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188
Query: 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-------PDGHTR--IRITTV 417
YL +HRD+ N L+ + M +I+DFGL++ + DG+ IR
Sbjct: 189 YLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWM-- 243
Query: 418 AGTTGYVAPE--YHQTLTISEKSDIYSFGVLL 447
PE ++ T +SD++++GV+L
Sbjct: 244 -------PPESIFYNRYTT--ESDVWAYGVVL 266
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 51/237 (21%), Positives = 92/237 (38%), Gaps = 66/237 (27%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ +G G V++A + + + +K + P+ ++ R + I +R
Sbjct: 41 VRKLGRGKYSEVFEAINITN-NEKVVVKILK--PVKKKKIK--REIKILENLRG------ 89
Query: 301 TAGRIWHRNLLPLQAHVTRPDCH---LLVYEFMKNGSLQDILHDVSQGRRELDWLAR--- 354
N++ L + + LV+E + N + + ++ D+ R
Sbjct: 90 ------GPNIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DYDIRFYM 136
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIR 413
Y I + L+Y H I+HRD+KP NV+ID + + R+ D+GLA+ G
Sbjct: 137 YEILKA----LDYCHS-MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 187
Query: 414 ITTVAGTTGYV------APE-------YHQTLTISEKSDIYSFGVLLAVLVVGKFPF 457
V PE Y +L D++S G +LA ++ K PF
Sbjct: 188 -------NVRVASRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 50/236 (21%)
Query: 244 IGVGACGVVYKA-EVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G G G VYKA G K A+K+I+ ++ + R + + R+++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS---ACREIALLRELK--------- 76
Query: 303 GRIWHRNLLPLQ-AHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ LQ ++ D + L++++ + D+ H + R ++ RG
Sbjct: 77 ----HPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRG 128
Query: 361 MA--------SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR----ISDFGLAKLM-PD 407
M G+ YLH + ++HRD+KPAN+L+ R I+D G A+L
Sbjct: 129 MVKSLLYQILDGIHYLHA-NW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 408 GHTRIRITTVAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
+ V T Y APE H T I DI++ G + A L+ + F
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSEPIFH 237
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-16
Identities = 49/208 (23%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IITAGRIWHRNLLPLQAH 316
G++G++ +K + + A ++LN +L + + E ++ G + + L
Sbjct: 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD--SKWITTLHYA 142
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
+ LV ++ G L +L + R + AR+ +A M ++ +H H
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-ARFYLAE-MVIAIDSVHQLH---Y 196
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+HRDIKP N+L+D R++DFG + + T ++ + GT Y++PE Q + +
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGK 255
Query: 437 KS-----DIYSFGVLLAVLVVGKFPFDD 459
D +S GV + ++ G+ PF
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYA 283
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 39/230 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATE----LLNVRRVLINRKMRQIK 296
+++IG GA G V + K+ A+K + + M R ++
Sbjct: 74 VKVIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----- 127
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
++ L +V E+M G D+++ +S W AR+
Sbjct: 128 ----------SPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKW-ARFY 173
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
A + L+ +H IHRD+KP N+L+D +++DFG M +R T
Sbjct: 174 TAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDT 228
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIY-------SFGVLLAVLVVGKFPFDD 459
GT Y++PE L Y S GV L ++VG PF
Sbjct: 229 AVGTPDYISPE---VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318
GS+G+++ +K + A ++L+ ++V+ +++ +E + L+ L+
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378
+V E++ G + L + R + AR+ A+ + EYLH +I+
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQ-IVLTFEYLHSLD---LIY 164
Query: 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS 438
RD+KP N+LID +++DFG AK + R T+ GT +APE I K
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPE-----IILSKG 214
Query: 439 -----DIYSFGVLLAVLVVGKFPFDD 459
D ++ GVL+ + G PF
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 45/167 (26%), Positives = 74/167 (44%), Gaps = 30/167 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI----DQPPMAATELLNVRRVLINRKMRQIK 296
+ IG G+ GVV+K + G+++AIKK D P + L R + + ++++
Sbjct: 8 IGKIGEGSYGVVFKCRNRDT-GQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK--- 60
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H NL+ L V R L LV+E+ +LH++ + +R +
Sbjct: 61 ----------HPNLVNLL-EVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVK 105
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
I + + H H IHRD+KP N+LI ++ DFG A
Sbjct: 106 SITWQTLQAVNFCHK-HN--CIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 36/170 (21%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQ-------PPMAATELLNVRRVLINRKMR 293
L ++G G+ G+V K + G+++AIKK + +A E+ + ++
Sbjct: 30 LGLVGEGSYGMVMKCRNKDT-GRIVAIKKFLESDDDKMVKKIAMREI---------KLLK 79
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWL 352
Q++ H NL+ L V + LV+EF+ IL D+ LD+
Sbjct: 80 QLR----------HENLVNLL-EVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQ 124
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ + +G+ + H H IIHRDIKP N+L+ ++ DFG A
Sbjct: 125 VVQKYLFQIINGIGFCHS-HN--IIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 59/246 (23%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKID--QPPMAATELLNVRRVLINRKMRQIKSE 298
++G GA GVV A + G+++AIKKI+ P+ A L R + I + +
Sbjct: 16 KSLLGEGAYGVVCSATHKPT-GEIVAIKKIEPFDKPLFALRTL--REIKILKHFK----- 67
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
H N++ + ++ RPD ++ E M+ D LH V + D
Sbjct: 68 --------HENIITIF-NIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLSDDH 113
Query: 353 AR---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+ Y+ R ++ LH + +IHRD+KP+N+LI+ + ++ DFGLA+++ +
Sbjct: 114 IQYFIYQTLRA----VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 410 TRIRITTVAGT--TGYV------APE-----YHQTLTISEKSDIYSFGVLLAVLVVGK-- 454
T + +V APE + + D++S G +LA L + +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRRPI 222
Query: 455 FPFDDF 460
FP D+
Sbjct: 223 FPGRDY 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 51/239 (21%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G G G+V+ A K +AIKKI T+ +V+ L R+IK II
Sbjct: 16 LKPLGCGGNGLVFSAVDNDC-DKRVAIKKI-----VLTDPQSVKHAL-----REIK--II 62
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDI----------LHDVSQGRRELD 350
R+ H N++ + + P L + L + L +V + L+
Sbjct: 63 R--RLDHDNIVKVF-EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119
Query: 351 WLAR---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMP 406
AR Y++ RG L+Y+H + ++HRD+KPAN+ I+ + + +I DFGLA++M
Sbjct: 120 EHARLFMYQLLRG----LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 407 DGHTRIRITT--VAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
++ + + T Y +P + T I D+++ G + A ++ GK F
Sbjct: 173 PHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKTLFA 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 53/238 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI---------DQPPMAATELLNVRRVLINRK 291
+ IGVGA G VYKA P S G +A+K + P++ VR V + R+
Sbjct: 14 VAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGGGGGGGLPIST-----VREVALLRR 67
Query: 292 MRQIKSEIITAGRIWHRNLLPLQ--AHVTRPDCHL---LVYEFMKNGSLQDILHDVSQGR 346
+ + H N++ L +R D + LV+E + L+ L
Sbjct: 68 LEAFE----------HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG 116
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+ + R GL++LH + I+HRD+KP N+L+ G +++DFGLA++
Sbjct: 117 LPAETIKDL--MRQFLRGLDFLHA-NC--IVHRDLKPENILVTSGGTVKLADFGLARIY- 170
Query: 407 DGHTRIRITTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
++ +T V T Y APE Y + D++S G + A + K F
Sbjct: 171 --SYQMALTPVVVTLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRKPLFC 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 68/246 (27%), Positives = 102/246 (41%), Gaps = 70/246 (28%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
L+ +G GA G V A + G +AIKK+ +P + A R + + + MR
Sbjct: 30 LQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMR---- 82
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELD 350
H N++ L V PD L LV FM D L + + + +
Sbjct: 83 ---------HENVIGLL-DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGE 127
Query: 351 WLAR---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPD 407
+ Y++ +G L Y+H IIHRD+KP N+ +++ E +I DFGLA+
Sbjct: 128 DRIQFLVYQMLKG----LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
Query: 408 GHTRIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFGVLLAVLVVGK-- 454
TGYV APE T T+ DI+S G ++A ++ GK
Sbjct: 181 EM-----------TGYVVTRWYRAPEVILNWMRYTQTV----DIWSVGCIMAEMITGKTL 225
Query: 455 FPFDDF 460
F D
Sbjct: 226 FKGSDH 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 66/243 (27%), Positives = 105/243 (43%), Gaps = 64/243 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
L +G GA G V A + G +A+KK+ +P + A R + + + M+
Sbjct: 34 LSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMK---- 86
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELD 350
H N++ L V P L LV M D L+++ + ++ D
Sbjct: 87 ---------HENVIGLL-DVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLTD 131
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
++ + + GL+Y+H IIHRD+KP+N+ +++ E +I DFGLA+
Sbjct: 132 DHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------- 180
Query: 411 RIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FPF 457
T TGYV APE H T+ DI+S G ++A L+ G+ FP
Sbjct: 181 ----HTADEMTGYVATRWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGRTLFPG 232
Query: 458 DDF 460
D
Sbjct: 233 TDH 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 69/245 (28%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
+G GA G V A S G+ +AIKK+ +P + A R +L+ + M+
Sbjct: 29 PTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQ---- 81
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL-------LVYEFMKNGSLQDILHDVSQGRRELD 350
H N++ L V P L LV FM+ D L + + +
Sbjct: 82 ---------HENVIGLL-DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEE 126
Query: 351 WLA--RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG 408
+ Y++ +G L+Y+H ++HRD+KP N+ +++ E +I DFGLA+
Sbjct: 127 KIQYLVYQMLKG----LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR----- 174
Query: 409 HTRIRITTVAGTTGYV------APE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--F 455
A TGYV APE H T+ DI+S G ++A ++ GK F
Sbjct: 175 ------HADAEMTGYVVTRWYRAPEVILSWMHYNQTV----DIWSVGCIMAEMLTGKTLF 224
Query: 456 PFDDF 460
D+
Sbjct: 225 KGKDY 229
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 31/169 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
+E IG G GVVYKA + G+++A+KKI + P A +R + + +++
Sbjct: 8 VEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTA-----IREISLLKELN- 60
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H N++ L + + LV+EF+ + L+ + + L +
Sbjct: 61 ------------HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKS 107
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
Y + GL + H HR ++HRD+KP N+LI+ +++DFGLA+
Sbjct: 108 Y--LFQLLQGLAFCHS-HR--VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 37/171 (21%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-----DQPPMAATELLNVRRVLINRKMRQI 295
L+ +G G VYK + + ++A+K+I + P A +R V + + ++
Sbjct: 7 LDKLGEGTYATVYKGKSKLT-DNLVALKEIRLEHEEGAPCTA-----IREVSLLKDLK-- 58
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H N++ L + LV+E++ L+ L D + +
Sbjct: 59 -----------HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI------INMH 100
Query: 356 RIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + GL Y H + ++HRD+KP N+LI++ E +++DFGLA+
Sbjct: 101 NVKLFLFQLLRGLAYCHR-QK--VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 39/192 (20%)
Query: 221 RPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPP 274
+ ++ F + LE +G G GVVYKA+ S G+++A+K+I + P
Sbjct: 6 HHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK--DSQGRIVALKRIRLDAEDEGIP 63
Query: 275 MAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGS 334
A +R + + +++ H N++ L + C LV+EFM+
Sbjct: 64 STA-----IREISLLKELH-------------HPNIVSLIDVIHSERCLTLVFEFMEK-D 104
Query: 335 LQDILHDVSQGRRELDWLARYRIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLIDDG 391
L+ +L + G L +I + G+ + H HR I+HRD+KP N+LI+
Sbjct: 105 LKKVLDENKTG------LQDSQIKIYLYQLLRGVAHCHQ-HR--ILHRDLKPQNLLINSD 155
Query: 392 MEARISDFGLAK 403
+++DFGLA+
Sbjct: 156 GALKLADFGLAR 167
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE--IITAGRIWHRNLLPLQAH 316
G++GK+I +++ A ++L ++ ++ +E ++ R H L L+
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR--HPFLTALKYA 73
Query: 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
D V E+ G ++ +S+ R + AR+ A + S LEYLH +
Sbjct: 74 FQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAE-IVSALEYLHSRD---V 126
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTIS 435
++RDIK N+++D +I+DFGL K + DG T + T GT Y+APE +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE-----VLE 178
Query: 436 EKS-----DIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
+ D + GV++ ++ G+ PF + Q E +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERL 213
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 54/236 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKID--QPPMAATELLNVRRVLINRKMRQIKSE 298
L IG GA G+V A + +AIKKI + L R + I + R
Sbjct: 32 LSYIGEGAYGMVCSAYDNLN-KVRVAIKKISPFEHQTYCQRTL--REIKILLRFR----- 83
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELDWL 352
H N++ + + R +V + M+ D L+ + + + +
Sbjct: 84 --------HENIIGIN-DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDH 129
Query: 353 AR---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
Y+I RG L+Y+H + ++HRD+KP+N+L++ + +I DFGLA++ H
Sbjct: 130 ICYFLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 410 TRIRITT--VAGTTGYVAPE-----YHQTLTISEKSDIYSFGVLLAVLVVGK--FP 456
T VA T Y APE T +I DI+S G +LA ++ + FP
Sbjct: 183 DHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNRPIFP 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 71/253 (28%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQP---PMAATELLNVRRVLINRKMRQIKS 297
++ +G GA G+V+K+ + G+++A+KKI A R ++I ++
Sbjct: 14 VKKLGKGAYGIVWKSIDRRT-GEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSG--- 67
Query: 298 EIITAGRIWHRNLLPLQAHVTRPDCHL---LVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H N++ L +V R D LV+++M+ D LH V + +
Sbjct: 68 ---------HENIVNLL-NVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVHKQ 112
Query: 355 ---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR 411
Y++ + ++YLH ++HRD+KP+N+L++ +++DFGL++ +
Sbjct: 113 YVVYQLIK----VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 412 IRITTVAGT-------------TGYV------APE-------YHQTLTISEKSDIYSFGV 445
++ T YV APE Y T I D++S G
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGI----DMWSLGC 219
Query: 446 LLAVLVVGK--FP 456
+L ++ GK FP
Sbjct: 220 ILGEILCGKPIFP 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 56/251 (22%), Positives = 91/251 (36%), Gaps = 65/251 (25%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR-VLINRKMRQIKSEI 299
I G+ G V S G +AIK++ + + L R +R+I+ +
Sbjct: 27 QRFISSGSYGAVCAGV--DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR--L 82
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELDWLA 353
+ H N+L L+ + LV E M+ D L V +R + ++
Sbjct: 83 LNHFH--HPNILGLR-DIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIV--IS 132
Query: 354 R-------YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
Y I G L LH ++HRD+ P N+L+ D + I DF LA+
Sbjct: 133 PQHIQYFMYHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185
Query: 407 DGHTRIRITTVAGTTGYV------APE-------YHQTLTISEKSDIYSFGVLLAVLVVG 453
T YV APE + + + D++S G ++A +
Sbjct: 186 ADAN---------KTHYVTHRWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNR 230
Query: 454 K--FPFDDFFQ 462
K F F+
Sbjct: 231 KALFRGSTFYN 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK++ ++ + A ++L V+ + + E + A L L +
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
D V E++ G D+++ + Q R + A + A +A GL +L II
Sbjct: 412 QTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---II 464
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K NV++D +I+DFG+ K + DG T T GT Y+APE +
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGK 521
Query: 437 KSDIYSFGVLLAVLVVGKFPFDD 459
D ++FGVLL ++ G+ PF+
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEG 544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 40/169 (23%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-----DQPPMAATELLNVRRVLINRKMRQI 295
LE +G G VYK + G +A+K++ + P A +R + + ++++
Sbjct: 10 LEKLGNGTYATVYKGLNKTT-GVYVALKEVKLDSEEGTPSTA-----IREISLMKELK-- 61
Query: 296 KSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H N++ L + + LV+EFM + L+ + + G
Sbjct: 62 -----------HENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNL 109
Query: 356 --RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ GL + H ++ I+HRD+KP N+LI+ + ++ DFGLA
Sbjct: 110 VKYFQWQLLQGLAFCHE-NK--ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 39/172 (22%), Positives = 77/172 (44%), Gaps = 38/172 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
LE IG G G V+KA+ + +++A+K++ + P +A +R + + ++++
Sbjct: 7 LEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDDEGVPSSA-----LREICLLKELK- 59
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H+N++ L + LV+EF L+ + L
Sbjct: 60 ------------HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD------LDP 100
Query: 355 YRIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + GL + H ++HRD+KP N+LI+ E ++++FGLA+
Sbjct: 101 EIVKSFLFQLLKGLGFCHS-RN--VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK+ + A + L VL++ + E + + H L +
Sbjct: 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
+ V E++ G D+++ + + A + A + GL++LH I+
Sbjct: 88 QTKENLFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAE-IILGLQFLHSKG---IV 140
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K N+L+D +I+DFG+ K M T GT Y+APE +
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEILLGQKYNH 197
Query: 437 KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
D +SFGVLL +++G+ PF Q EE+
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHG--QDEEEL 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 67/246 (27%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI--DQ-----PPMAATELLNVRRVLINRKMR 293
L IG G G V+KA + G+ +A+KK+ + P A +R + I + ++
Sbjct: 22 LAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKEGFPITA------LREIKILQLLK 74
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHL--------LVYEFMKNGSLQDILHD---- 341
H N++ L LV++F + HD
Sbjct: 75 -------------HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGL 113
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+S + R+ + + +GL Y+H ++ I+HRD+K ANVLI +++DFGL
Sbjct: 114 LSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NK--ILHRDMKAANVLITRDGVLKLADFGL 170
Query: 402 AKLM--PDGHTRIRITTVAGTTGYVAPE-------YHQTLTISEKSDIYSFGVLLAVLVV 452
A+ R T T Y PE Y D++ G ++A +
Sbjct: 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWT 224
Query: 453 GK--FP 456
Sbjct: 225 RSPIMQ 230
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK++ + + + A ++L +L + + +E I + H L L
Sbjct: 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
PD V EF+ G D++ + + RR + AR+ A + S L +LH II
Sbjct: 94 QTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-IISALMFLHDKG---II 146
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K NVL+D +++DFG+ K + +G T T GT Y+APE + E
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT---ATFCGTPDYIAPE-----ILQE 198
Query: 437 KS-----DIYSFGVLLAVLVVGKFPFDD 459
D ++ GVLL ++ G PF+
Sbjct: 199 MLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK++ + + A ++L + +L ++ + I SE + + H L+ L
Sbjct: 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 318 TRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCI 376
D L V +++ G ++ + + + R L+ AR+ A +AS L YLH + I
Sbjct: 109 QTAD-KLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAE-IASALGYLHSLN---I 160
Query: 377 IHRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTIS 435
++RD+KP N+L+D ++DFGL K + T +T GT Y+APE +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-----VLH 212
Query: 436 EKS-----DIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467
++ D + G +L ++ G PF + T EM
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEM 247
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 9e-14
Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 18/104 (17%)
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ LEYLH II+RD+KP N+L+D +I+DFG AK +PD T+ GT
Sbjct: 115 VCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166
Query: 421 TGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGKFPFDD 459
Y+APE +S K D +SFG+L+ ++ G PF D
Sbjct: 167 PDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 39/142 (27%), Positives = 70/142 (49%), Gaps = 23/142 (16%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
L+ +F++ G L + + ++ +A +A L++LH II+RD+KP
Sbjct: 103 LILDFLRGGDL--FTRLSKEVMFTEED-VKFYLAE-LALALDHLHSLG---IIYRDLKPE 155
Query: 385 NVLID-DGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS---- 438
N+L+D +G +++DFGL+K + + GT Y+APE ++ +
Sbjct: 156 NILLDEEG-HIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPE-----VVNRRGHTQS 206
Query: 439 -DIYSFGVLLAVLVVGKFPFDD 459
D +SFGVL+ ++ G PF
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQG 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 19/106 (17%)
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKL-MPDGHTRIRITTVA 418
++ L +LH II+RD+KP N++++ G +++DFGL K + DG T
Sbjct: 130 ISMALGHLHQKG---IIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTV---THTFC 182
Query: 419 GTTGYVAPEYHQTLTISEKS-----DIYSFGVLLAVLVVGKFPFDD 459
GT Y+APE + D +S G L+ ++ G PF
Sbjct: 183 GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GSY K++ ++ + A +++ V + + +++E + H L+ L +
Sbjct: 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
V E++ G D++ + + R+ + AR+ A ++ L YLH II
Sbjct: 80 QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---II 132
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K NVL+D +++D+G+ K + G T +T GT Y+APE +
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-----ILRG 184
Query: 437 KS-----DIYSFGVLLAVLVVGKFPFD 458
+ D ++ GVL+ ++ G+ PFD
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFD 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GS+GK++ ++ + A ++L V+ + + E + A L L +
Sbjct: 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
D V E++ G D+++ + Q R + A + A +A GL +L II
Sbjct: 91 QTMDRLYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAE-IAIGLFFLQSKG---II 143
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K NV++D +I+DFG+ K + DG T T GT Y+APE +
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIAYQPYGK 200
Query: 437 KSDIYSFGVLLAVLVVGKFPFDD 459
D ++FGVLL ++ G+ PF+
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 43/176 (24%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-----DQ-----PPMAATELLNVRRVLINR 290
L+ +G G VYKA + +++AIKKI + A +R + + +
Sbjct: 15 LDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAKDGINRTA------LREIKLLQ 67
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
++ H N++ L LV++FM+ L+ I+ D S
Sbjct: 68 ELS-------------HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLV----- 108
Query: 351 WLARYRIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
L I M GLEYLH H I+HRD+KP N+L+D+ +++DFGLAK
Sbjct: 109 -LTPSHIKAYMLMTLQGLEYLHQ-HW--ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 69.8 bits (172), Expect = 2e-13
Identities = 49/172 (28%), Positives = 79/172 (45%), Gaps = 39/172 (22%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
LE IG G GVVYKA+ +YG+ A+KKI + P +R + I ++++
Sbjct: 7 LEKIGEGTYGVVYKAQ--NNYGETFALKKIRLEKEDEGIPSTT-----IREISILKELK- 58
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
H N++ L + +LV+E + L+ +L G L
Sbjct: 59 ------------HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG------LES 99
Query: 355 YRIARGMA---SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ +G+ Y H R ++HRD+KP N+LI+ E +I+DFGLA+
Sbjct: 100 VTAKSFLLQLLNGIAYCHD-RR--VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 259 GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE-IITAGRIWHRNLLPLQAHV 317
GSY K++ ++ + A ++ V + + +++E + H L+ L +
Sbjct: 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122
Query: 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCII 377
V E++ G D++ + + R+ + AR+ A ++ L YLH II
Sbjct: 123 QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG---II 175
Query: 378 HRDIKPANVLIDDGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISE 436
+RD+K NVL+D +++D+G+ K + G T +T GT Y+APE +
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-----ILRG 227
Query: 437 KS-----DIYSFGVLLAVLVVGKFPFD 458
+ D ++ GVL+ ++ G+ PFD
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFD 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 36/172 (20%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+IG G+ G V +A +++AIKKI + +L++ +R+L R+I I+
Sbjct: 58 RHLIGTGSYGHVCEAYDKLE-KRVVAIKKILRV---FEDLIDCKRIL-----REIA--IL 106
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRREL-DWLA 353
R+ H +++ + + P +V E D + + L +
Sbjct: 107 N--RLNHDHVVKVL-DIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLTELHI 158
Query: 354 R---YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ Y + G ++Y+H I+HRD+KPAN L++ ++ DFGLA
Sbjct: 159 KTLLYNLLVG----VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 67/250 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+IG G+ G VY A + K +AIKK+++ +L++ +R+L R+I I+
Sbjct: 31 KHLIGRGSYGYVYLAYDKNT-EKNVAIKKVNRM---FEDLIDCKRIL-----REIT--IL 79
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL------LVYEFMKNGSLQDILHDVSQGRRELD---- 350
+ ++ L + PD L +V E D L + + L
Sbjct: 80 NRLK--SDYIIRLY-DLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHI 131
Query: 351 -WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
+ Y + G ++H IIHRD+KPAN L++ ++ DFGLA+ +
Sbjct: 132 KTIL-YNLLLG----ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183
Query: 410 TRIRITTVAGT--------------TGYV------APE-----YHQTLTISEKSDIYSFG 444
+ + T +V APE + T +I DI+S G
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTG 239
Query: 445 VLLAVLVVGK 454
+ A L+
Sbjct: 240 CIFAELLNML 249
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 325 LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384
L+ +++ G L H + R + + + LE+LH II+RDIK
Sbjct: 136 LILDYINGGEL--FTHLSQRERFTEHE-VQIYVGE-IVLALEHLHKLG---IIYRDIKLE 188
Query: 385 NVLID-DGMEARISDFGLAKL-MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKS---- 438
N+L+D +G ++DFGL+K + D R GT Y+AP+ + +
Sbjct: 189 NILLDSNG-HVVLTDFGLSKEFVADETERAY--DFCGTIEYMAPD---IVRGGDSGHDKA 242
Query: 439 -DIYSFGVLLAVLVVGKFPF--DDFFQYTEEM 467
D +S GVL+ L+ G PF D E+
Sbjct: 243 VDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 47/226 (20%), Positives = 84/226 (37%), Gaps = 57/226 (25%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G+G G V + + + A+K + P A E V ++ + Q
Sbjct: 24 QVLGLGINGKVLQIFNKRT-QEKFALKMLQDCPKARRE------VELHWRASQ------- 69
Query: 302 AGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQD-ILHDVSQGRRELDWLARYR 356
+++ + + C L+V E + G L I Q E + A
Sbjct: 70 -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--AS-E 121
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIR 413
I + + ++YLH + I HRD+KP N+L +++DFG AK
Sbjct: 122 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE----- 173
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459
Y + D++S GV++ +L+ G PF
Sbjct: 174 --------KY-----------DKSCDMWSLGVIMYILLCGYPPFYS 200
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-12
Identities = 39/174 (22%), Positives = 73/174 (41%), Gaps = 38/174 (21%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI------DQPPMAATELLNVRRVLINRKMRQ 294
+ +G G G VYKA + + +AIK+I + P A +R V + ++++
Sbjct: 39 ITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEEEGVPGTA-----IREVSLLKELQ- 91
Query: 295 IKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
HRN++ L++ + L++E+ + D L ++
Sbjct: 92 ------------HRNIIELKSVIHHNHRLHLIFEYAE----ND-LKKYMDKNPDVSMRVI 134
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR-----ISDFGLAK 403
+ +G+ + H R +HRD+KP N+L+ + I DFGLA+
Sbjct: 135 KSFLYQLINGVNFCHS-RR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 56/271 (20%), Positives = 93/271 (34%), Gaps = 66/271 (24%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYG----KMIAIK----------------------- 268
D L + +G GA G V +A+ G + +A+K
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 269 ---------------KIDQPPMAATE----------LLNVRRVLINRKMRQIKSEIITAG 303
K P M E L + R + K + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 304 RIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR-------YR 356
L + F++ SL D+ + + D+L ++
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+A+GM E+L R CI HRD+ N+L+ + +I DFGLA+ + +R
Sbjct: 202 VAKGM----EFLA--SRKCI-HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 254
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447
++APE + +SD++SFGVLL
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 285
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 24/130 (18%), Positives = 52/130 (40%), Gaps = 12/130 (9%)
Query: 334 SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393
SLQ L + L + ++A + LE+LH +H ++ N+ +D +
Sbjct: 143 SLQSALDV--SPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQ 197
Query: 394 ARI--SDFGLAKLMPDGHTRIRI-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL 446
+++ + +G A + + G +++ + H+ S +SD+ S G
Sbjct: 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYC 257
Query: 447 LAVLVVGKFP 456
+ + G P
Sbjct: 258 MLKWLYGFLP 267
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/312 (20%), Positives = 109/312 (34%), Gaps = 64/312 (20%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-DQPPM---AATELLNVRRVL--INRKMRQ 294
L++IG G+ G V KA + +A+K + ++ AA E+ R+L + ++ +
Sbjct: 102 LKVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEEI----RILEHLRKQDKD 156
Query: 295 IKSEIITAGR-IWHRNLLPLQAHVTRPDC---HLL---VYEFMKNGSLQDILHDVSQGRR 347
+I RN H+ C LL +YE +K Q + +
Sbjct: 157 NTMNVIHMLENFTFRN------HI----CMTFELLSMNLYELIKKNKFQGFSLPLVR--- 203
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA--RISDFGLAKLM 405
+ A + L+ LH + IIH D+KP N+L+ + ++ DFG +
Sbjct: 204 --------KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC-- 250
Query: 406 PDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465
+ R+ T + Y APE D++S G +LA L+ G +
Sbjct: 251 ---YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP----LLPGED 303
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNG-----YEEQMRLVLKIAYFCTSDDPEERPSS 520
E + + M ++ KLL + SD
Sbjct: 304 EGDQLACMIELLG------MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGG 357
Query: 521 KDVRCMLSQIKH 532
+ R L
Sbjct: 358 RSRRGKLRGPPE 369
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 34/126 (26%), Positives = 55/126 (43%), Gaps = 15/126 (11%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA------RISDFGLAKLMPDGH 409
+I++ + GL+Y+H IIH DIKP NVL++ +I+D G A
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CW 187
Query: 410 TRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK--FPFDDFFQYTEEM 467
T T Y +PE +DI+S L+ L+ G F D+ YT++
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 468 NMVRWM 473
+ + +
Sbjct: 248 DHIAQI 253
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 27/111 (24%), Positives = 47/111 (42%), Gaps = 13/111 (11%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR-----ISDFGLAKLMPDGHT 410
A+ M + ++ +H +++RDIKP N LI + DFG+ K D T
Sbjct: 110 MAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166
Query: 411 RIRI-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
+ I ++GT Y++ H S + D+ + G + + G P
Sbjct: 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 22/108 (20%), Positives = 44/108 (40%), Gaps = 10/108 (9%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI--SDFGLAKLMPDGHTRIR 413
+++ + LEY+H + +H DIK +N+L++ ++ D+GLA
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 414 I-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
GT + + + H + S + D+ G + + G P
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 25/108 (23%), Positives = 47/108 (43%), Gaps = 10/108 (9%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI--SDFGLAKLMPDGHTRIR 413
++ M LEY+H +H DIK AN+L+ ++ +D+GL+ +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 414 I-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
GT + + + H+ + +S +SD+ G + + GK P
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 8e-09
Identities = 84/625 (13%), Positives = 180/625 (28%), Gaps = 193/625 (30%)
Query: 17 ETTSHYFHSESI-----EAIIQNLE----SDWLQKFAGEA---HI--------QADLMGW 56
ET H + + I +A + N + D + + HI + W
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 57 INMLVKISEVVDDAVEKQMTNPHVKLWLGELQNLACDVEYLFDEFQTEAFRSKLLPLDYD 116
+L K E+V VE + L + ++L +TE + ++ Y
Sbjct: 70 T-LLSKQEEMVQKFVE---------------EVLRINYKFLMSPIKTEQRQPSMMTRMYI 113
Query: 117 YSTDDEF---DSLAKTKV--MEIHTRLQGIASQIDS---LELTGISG-GKS-------RN 160
D + AK V ++ + +L+ ++ + + G+ G GK+ +
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 161 --VRKRLST----ISLVGEAKEYGGVKALVSALMVSEAKGYCGVKALVSALRGR-GGGRY 213
V+ ++ ++ + V ++ L+ + S ++ R +
Sbjct: 174 YKVQCKMDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 214 RGPAICARPIFKK-----RDI-------AF--------LTKE----DSLASL---EIIGV 246
+ ++ ++ AF T+ D L++ I
Sbjct: 233 ELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD 292
Query: 247 GACGVVYKAEVPGSYGKMIAIKKIDQPPMAAT----------ELL--------NVRRVLI 288
+ EV K + + D P T E + N + V
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352
Query: 289 NRKMRQIKSEIITAGRIWHRNLLP--LQAH-----VTRPDCHL------LVYEFMKNGSL 335
++ I+S + L P + V P H+ L++ + +
Sbjct: 353 DKLTTIIESSL--------NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 336 QDILHDVSQGRRELDWLARYR-IARGMASGLEYLHMYHRPCIIHRDIKPA--NVLIDDGM 392
+++ L +Y + + + + + + + A ++D
Sbjct: 405 MVVVNK----------LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYN 454
Query: 393 EARISDF-GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV 451
+ D L D + + ++ +H L E + +
Sbjct: 455 IPKTFDSDDLIPPYLDQY----FYS------HIG--HH--LKNIEHPERMTL-------- 492
Query: 452 VGKFP--FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKI--AY 507
F F DF R++ I R + +G LK Y
Sbjct: 493 ---FRMVFLDF----------RFLEQKI------RHDSTAWNASGSILNTLQQLKFYKPY 533
Query: 508 FCTSDDPEERPSSKDVRCMLSQIKH 532
C +D ER +++ I
Sbjct: 534 ICDNDPKYER--------LVNAILD 550
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 32/111 (28%), Positives = 49/111 (44%), Gaps = 13/111 (11%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR-----ISDFGLAKLMPDGHT 410
IA + S +EY+H + +I+RD+KP N LI I DF LAK D T
Sbjct: 109 MIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 411 RIRI-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
+ I ++ GT Y++ H S + D+ + G + + G P
Sbjct: 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 11/109 (10%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA---RISDFGLAKLMPDGHTRI 412
+A M S +EY+H + IHRD+KP N L+ G + I DFGLAK D T
Sbjct: 109 LLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 413 RI-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
I + GT Y + H + S + D+ S G +L +G P
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 35/109 (32%), Positives = 49/109 (44%), Gaps = 11/109 (10%)
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR---ISDFGLAKLMPDGHTRI 412
+A M + +E++H +HRDIKP N L+ G A I DFGLAK D T
Sbjct: 107 MLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
Query: 413 RI-----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456
I + GT Y + H + S + D+ S G +L + G P
Sbjct: 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 53/245 (21%), Positives = 102/245 (41%), Gaps = 45/245 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-DQPPMAATELLNVRRVL--INRKMRQIKS 297
+IG G+ G V KA + +AIK I ++ + VR +L +N+ ++K
Sbjct: 59 DSLIGKGSFGQVVKAYDRVE-QEWVAIKIIKNKKAFLNQAQIEVR-LLELMNKHDTEMKY 116
Query: 298 EIITAGRI-WHRNLLPLQAHVTRPDC---HLL---VYEFMKNGSLQDILHDVSQGRRELD 350
I+ R RN H+ C +L +Y+ ++N + + + ++++
Sbjct: 117 YIVHLKRHFMFRN------HL----CLVFEMLSYNLYDLLRNTNFRGVSLNLTR------ 160
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA--RISDFGLAKLMPDG 408
+ A+ M + L +L IIH D+KP N+L+ + + +I DFG +
Sbjct: 161 -----KFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----C 209
Query: 409 HTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468
RI + Y +PE + D++S G +L + G+ F E++
Sbjct: 210 QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP----LFSGANEVD 265
Query: 469 MVRWM 473
+ +
Sbjct: 266 QMNKI 270
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 4e-08
Identities = 31/203 (15%), Positives = 53/203 (26%), Gaps = 45/203 (22%)
Query: 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
+ L E IG G G V++ +AIK I + +L+N + +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD---HTPVAIKII---AIEGPDLVNGSH---QKTFEE 69
Query: 295 IKSEIITAGRIWHRNLLPLQAHV-------------TRPDCHLLVYEFM--KNGSLQDIL 339
I EII + + + + P L ++ GS D
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 340 HDVSQ-------------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380
+ I + + L HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 381 IKPANVLIDDGMEARISDFGLAK 403
+ NVL+ ++ K
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 36/186 (19%), Positives = 63/186 (33%), Gaps = 60/186 (32%)
Query: 323 HL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381
H+ +V+E + + L + + L + + I + + GL+YLH R IIH DI
Sbjct: 119 HICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDI 173
Query: 382 KPANVLI-------------------------------------------------DDGM 392
KP N+L+ + +
Sbjct: 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233
Query: 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452
+ +I+D G A + T I T Y + E + +DI+S + L
Sbjct: 234 KVKIADLGNACWVHKHFTED-IQTRQ----YRSLEVLIGSGYNTPADIWSTACMAFELAT 288
Query: 453 GKFPFD 458
G + F+
Sbjct: 289 GDYLFE 294
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 51/271 (18%), Positives = 88/271 (32%), Gaps = 73/271 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-DQPPM---AATELLNVRRVL--INRKMRQ 294
+ +G G G V + +A+K I + A E+ VL I K ++
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI----NVLKKIKEKDKE 79
Query: 295 IKSEIITAGRIW--HRNLLPLQAHVTRPDC---HLL---VYEFMKNGSLQDILHDVSQGR 346
K + W H+ C LL +EF+K + Q +
Sbjct: 80 NKFLCVLMSD-WFNFHG------HM----CIAFELLGKNTFEFLKENNFQPYPLPHVR-- 126
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
+A + L +LH + H D+KP N+L + + + +
Sbjct: 127 ---------HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 407 -DGHTRIRI-------------TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVL 446
+T IR+ TT+ T Y PE + ++ D++S G +
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCI 228
Query: 447 LAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
L G FQ E + M ++
Sbjct: 229 LFEYYRGFT----LFQTHENREHLVMMEKIL 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 47/271 (17%), Positives = 92/271 (33%), Gaps = 73/271 (26%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKI-DQPPM---AATELLNVRRVL--INRKMRQ 294
++ +G GA G V + + G+ +A+K + + A +E+ +VL +N
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI----QVLEHLNTTDPN 74
Query: 295 IKSEIITAGRIW--HRNLLPLQAHVTRPDC---HLL---VYEFMKNGSLQDILHDVSQGR 346
+ W H H+ C LL Y+F+K D +
Sbjct: 75 STFRCVQMLE-WFEHHG------HI----CIVFELLGLSTYDFIKENGFLPFRLDHIR-- 121
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
++A + + +LH + H D+KP N+L + + +
Sbjct: 122 ---------KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 407 D-GHTRIRI-------------TTVAGTTGYVAPE------YHQTLTISEKSDIYSFGVL 446
+ I++ +T+ T Y APE + S+ D++S G +
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCI 223
Query: 447 LAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
L +G F + + M ++
Sbjct: 224 LIEYYLGFT----VFPTHDSKEHLAMMERIL 250
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 34/178 (19%), Positives = 57/178 (32%), Gaps = 50/178 (28%)
Query: 326 VYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385
+YE + + + + + L YL + H D+KP N
Sbjct: 122 LYEIITRNNYNGFHIEDIK-----------LYCIEILKALNYLRKMS---LTHTDLKPEN 167
Query: 386 VLIDDGMEARISDFGLAKLMPD-------GHTRIRI-------------TTVAGTTGYVA 425
+L+DD + T I++ ++ T Y A
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRA 227
Query: 426 PE------YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
PE + SD++SFG +LA L G F+ E M + M ++I
Sbjct: 228 PEVILNLGW------DVSSDMWSFGCVLAELYTGSL----LFRTHEHMEHLAMMESII 275
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 11/75 (14%), Positives = 21/75 (28%), Gaps = 4/75 (5%)
Query: 332 NGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH----MYHRPCIIHRDIKPANVL 387
L ++ G + R + + +H + H D N++
Sbjct: 147 VFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLI 206
Query: 388 IDDGMEARISDFGLA 402
D+G D G
Sbjct: 207 FDEGKLIGCIDVGRV 221
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 3qfl_A | 115 | MLA10; coiled-coil, (CC) domain, NLRS, nucleotide- | 99.84 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.63 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.39 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.38 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=443.99 Aligned_cols=265 Identities=24% Similarity=0.414 Sum_probs=208.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+++.+.+.||+|+||+||+|+++ ..||||+++..... ....+.|.+|+.++++++|||||+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~------------~~~~~~f~~E~~il~~l~HpNIV~ 96 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPT------------PEQFQAFRNEVAVLRKTRHVNILL 96 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCC------------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCC------------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 35678889999999999999999875 35999999765432 334578999999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++|+|.+ +..+||||||+||+|.++++. ....++|..+..|+.|++.||+|||+.+ ||||||||+||||++++
T Consensus 97 l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~ 169 (307)
T 3omv_A 97 FMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGL 169 (307)
T ss_dssp EEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTE
T ss_pred EEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCC
Confidence 9999875 568999999999999999975 3456999999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT---LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.+||+|||+|+...........+...||+.|||||++.+ +.|+.++|||||||++|||+||+.||......
T Consensus 170 ~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------ 243 (307)
T 3omv_A 170 TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------ 243 (307)
T ss_dssp EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------
T ss_pred cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------
Confidence 999999999997765433333356789999999999864 46899999999999999999999999754321
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
..+......+... +. .......++..+.+|+..||+.||++|||+.+|++.|+.|++
T Consensus 244 -~~~~~~~~~~~~~----p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 244 -DQIIFMVGRGYAS----PD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -HHHHHHHHTTCCC----CC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -HHHHHHHhcCCCC----CC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111122221111 00 011223345668899999999999999999999999998874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-57 Score=445.44 Aligned_cols=264 Identities=21% Similarity=0.341 Sum_probs=215.8
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||+||+|++.+ .+|..||||+++... ....++|.+|+.++++++|||
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------------~~~~~~f~~E~~il~~l~Hpn 76 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------------DNARKDFHREAELLTNLQHEH 76 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--------------HHHHHHHHHHHHHHTTCCCTT
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--------------hHHHHHHHHHHHHHHhCCCCC
Confidence 35678899999999999999998753 247889999998653 334567999999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhc---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS---------QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
||+++|+|.+++..+||||||++|+|.++++... .....++|..+..|+.|+++||+|||+.+ |+|||
T Consensus 77 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRD 153 (299)
T 4asz_A 77 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRD 153 (299)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCc
Confidence 9999999999999999999999999999998632 23457999999999999999999999988 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDD 459 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~ 459 (532)
|||+||||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus 154 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 154 LATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999987655433322244579999999999999999999999999999999999 9999976
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
... ..+.. .......+. .+..++..+.+|+..||+.||++|||+++|++.|+++.
T Consensus 234 ~~~----~~~~~---~i~~~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 234 LSN----NEVIE---CITQGRVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp SCH----HHHHH---HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCH----HHHHH---HHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 432 12222 222222111 11223456889999999999999999999999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=450.96 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=215.6
Q ss_pred ccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..++++.+.||+|+||+||+|.+.+ .+++.||||+++..... ...++|.+|+.++++++||||
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-------------~~~~~f~~E~~il~~l~HpNI 91 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-------------PLREEFRHEAMLRARLQHPNV 91 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------------CHHHHHHHHHHHHHCCCTTB
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-------------HHHHHHHHHHHHHHhCCCCCC
Confidence 3467788999999999999999742 24689999999765321 224679999999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 378 (532)
|+++|+|.+++..+||||||++|||.++|+.... ....++|..+.+|+.|+|+||+|||+.+ |||
T Consensus 92 V~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiH 168 (308)
T 4gt4_A 92 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVH 168 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCC
Confidence 9999999999999999999999999999975321 1346999999999999999999999998 999
Q ss_pred cCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 037084 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPF 457 (532)
Q Consensus 379 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~ 457 (532)
|||||+||||++++.+||+|||+|+...........+...||+.|||||++.++.++.++|||||||++|||+| |+.||
T Consensus 169 RDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf 248 (308)
T 4gt4_A 169 KDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 248 (308)
T ss_dssp SCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987654433323356789999999999999999999999999999999998 89999
Q ss_pred CCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 458 DDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
..... ..+... ......+. .+..++..+.+|+..||+.||++|||+.+|++.|+.+.|
T Consensus 249 ~~~~~----~~~~~~---i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 249 CGYSN----QDVVEM---IRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp TTCCH----HHHHHH---HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred CCCCH----HHHHHH---HHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 76432 222222 22222111 122344568899999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=446.23 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=209.0
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||+||+|++++ .++..||||+++... ....++|.+|+.++++++|||
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------------~~~~~~f~~E~~il~~l~Hpn 104 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------------ESARQDFQREAELLTMLQHQH 104 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--------------HHHHHHHHHHHHHHTTCCCTT
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--------------HHHHHHHHHHHHHHHhCCCCC
Confidence 34678888999999999999998753 247899999998653 334568999999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-----------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 378 (532)
||+++|+|.+++..|||||||++|+|.++++.... ...+++|..++.|+.|++.||+|||+.+ |||
T Consensus 105 IV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiH 181 (329)
T 4aoj_A 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVH 181 (329)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred CCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eec
Confidence 99999999999999999999999999999986432 2356999999999999999999999988 999
Q ss_pred cCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 037084 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPF 457 (532)
Q Consensus 379 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~ 457 (532)
|||||+||||++++.+||+|||+++...........+...||+.|||||++.+..++.++|||||||++|||+| |+.||
T Consensus 182 RDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf 261 (329)
T 4aoj_A 182 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261 (329)
T ss_dssp SCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCC
Confidence 99999999999999999999999997755443333356789999999999999999999999999999999999 99999
Q ss_pred CCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 458 DDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... ..+.. .......+. .+..++..+.+|+..||+.||++|||+.+|++.|+.+.
T Consensus 262 ~~~~~----~~~~~---~i~~g~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 262 YQLSN----TEAID---CITQGRELE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp CSSCH----HHHHH---HHHHTCCCC----------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCH----HHHHH---HHHcCCCCC----------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 76432 12222 222221111 11223456889999999999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-55 Score=438.00 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=207.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
..-++|.+++.||+|+||+||+|++..+ |+.||||+++..... ....+.|.+|+.++++++|||||+
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTED-GRQYVIKEINISRMS------------SKEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTT-CCEEEEEEEECTTSC------------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCC-CCEEEEEEEehHHCC------------HHHHHHHHHHHHHHHHCCCCCCCc
Confidence 3456899999999999999999988764 999999999765433 233567899999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+++..|||||||+||+|.+++.. .....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.+|
T Consensus 88 ~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 162 (350)
T 4b9d_A 88 YRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDG 162 (350)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTC
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCC
Confidence 99999999999999999999999999976 34456899999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+|+........ .+..+||+.|||||++.+..|+.++|||||||++|||+||+.||..... .+.
T Consensus 163 ~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~ 233 (350)
T 4b9d_A 163 TVQLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNL 233 (350)
T ss_dssp CEEECSTTEESCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHH
T ss_pred CEEEcccccceeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHH
Confidence 9999999999876543211 2456899999999999999999999999999999999999999975322 222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+........+. . ....+..+.+|+..||+.||++|||+.|+++
T Consensus 234 ~~~i~~~~~~~------~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 234 VLKIISGSFPP------V----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHTCCCC------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCC------C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33333322211 1 1122345888999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=417.95 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=200.0
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEe
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 318 (532)
.+.+.||+|+||+||+|.+..+ +..||+|++...... ......|.+|+.++++++|||||+++++|.
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 95 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCC-CeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 5667899999999999998765 899999999754322 233567999999999999999999999986
Q ss_pred c----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-CCCc
Q 037084 319 R----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGME 393 (532)
Q Consensus 319 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 393 (532)
. ++..|||||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||||+||||+ .++.
T Consensus 96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~ 170 (290)
T 3fpq_A 96 STVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp EEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSC
T ss_pred eccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCC
Confidence 5 3457999999999999999976 346899999999999999999999875 4599999999999998 4899
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+|+....... ...+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... .....
T Consensus 171 vKl~DFGla~~~~~~~~----~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~------~~~~~ 239 (290)
T 3fpq_A 171 VKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIY 239 (290)
T ss_dssp EEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHH
T ss_pred EEEEeCcCCEeCCCCcc----CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------HHHHH
Confidence 99999999986544322 56789999999998865 699999999999999999999999964322 11222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... +.....++. .. +.++.+|+..||+.||++|||+.++++
T Consensus 240 ~~i~~-~~~~~~~~~----~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 240 RRVTS-GVKPASFDK----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHTT-TCCCGGGGG----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHc-CCCCCCCCc----cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222 221111111 11 234788999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=431.75 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=208.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|+..+.||+|+||+||+|++..+ |+.||||++...... ..+.+.+|+.+|++++|||||+++
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~t-g~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~ 137 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSS-GKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY 137 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEGGGCS--------------SGGGGHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCC-CCEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35689999999999999999998765 999999999654221 124578899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|||||||+||+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+||||+.+|++
T Consensus 138 ~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 138 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp EEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCE
Confidence 999999999999999999999999975 35899999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+........ .+..+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ..+ +.
T Consensus 210 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~---~~ 280 (346)
T 4fih_A 210 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKA---MK 280 (346)
T ss_dssp EECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH---HH
T ss_pred EEecCcCceecCCCCCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH---HH
Confidence 99999999987654332 2567899999999999999999999999999999999999999975332 111 22
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+. . .........+.+|+..||+.||++|||+.|+++
T Consensus 281 ~i~~~~~~~-~-------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 281 MIRDNLPPR-L-------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSSCCC-C-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCC-C-------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222211111 0 111223456889999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=429.68 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=206.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.+.++||+|+||+||+|++..+ |+.||||+++.... +.+|+.++++++|||||++
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~-g~~vAiK~i~~~~~-------------------~~~E~~il~~l~HpnIV~l 115 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQT-GFQCAVKKVRLEVF-------------------RVEELVACAGLSSPRIVPL 115 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEETTTC-------------------CTHHHHTTTTCCCTTBCCE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCC-CCEEEEEEECHHHh-------------------HHHHHHHHHhCCCCCCCcE
Confidence 345688889999999999999998765 99999999976521 2369999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM- 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~- 392 (532)
++++.+++..|||||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+||||+.+|
T Consensus 116 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~ 188 (336)
T 4g3f_A 116 YGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGS 188 (336)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCC
Confidence 9999999999999999999999999976 346999999999999999999999998 99999999999999887
Q ss_pred cEEEeccCCcccCCCCCcc---eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTR---IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
++||+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....... +
T Consensus 189 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~ 264 (336)
T 4g3f_A 189 RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----L 264 (336)
T ss_dssp CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----C
T ss_pred EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----H
Confidence 6999999999987543221 11234679999999999999999999999999999999999999997643321 1
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.. .......+.. ...+..+..+.+++..||+.||++|||+.|+++.|...
T Consensus 265 ~~---~i~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 265 CL---KIASEPPPIR--------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HH---HHHHSCCGGG--------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHcCCCCch--------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 1111111111 11122345588899999999999999999999887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-54 Score=432.80 Aligned_cols=266 Identities=24% Similarity=0.316 Sum_probs=216.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH- 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H- 307 (532)
.+.++|.+.+.||+|+||+||+|.+.+. .++.||||.++.... ....+.|.+|+.+|.+++|
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-------------~~~~~~~~~E~~il~~l~hh 127 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHH 127 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------------hHHHHHHHHHHHHHHHcCCC
Confidence 4567899999999999999999998753 236899999987542 2234679999999999965
Q ss_pred CCcccceeEEecC-CceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 308 RNLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 308 ~niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||+++|+|.++ +..+||||||++|+|.++|+.... ....+++..+..++.|+|+||+|||+.+
T Consensus 128 pnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~-- 205 (353)
T 4ase_A 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-- 205 (353)
T ss_dssp TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--
Confidence 8999999999765 568999999999999999986332 1356899999999999999999999998
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
||||||||+|||+++++.+||+|||+|+...........+...||+.|||||++.+..|+.++|||||||++|||+| |
T Consensus 206 -iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 206 -CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 99999999999999999999999999998766554444456789999999999999999999999999999999998 9
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+.||...... ..+...+ .....+. .+...+..+.+++..||+.||++|||+.++++.|+++
T Consensus 285 ~~Pf~~~~~~---~~~~~~i---~~g~~~~----------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 285 ASPYPGVKID---EEFCRRL---KEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSSTTCCCS---HHHHHHH---HHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCHH---HHHHHHH---HcCCCCC----------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 9999764321 1111111 1111111 1112234588899999999999999999999999876
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=427.26 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=210.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||+||+|++..+ |+.||||++...... .......+.+|+.++++++|||||+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~-~~~~AiK~i~k~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~ 98 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELAT-SREYAIKILEKRHII-----------KENKVPYVTRERDVMSRLDHPFFVKLY 98 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCC-CCEEEEEEEEHHHCC-----------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45799999999999999999998765 999999999753211 122356789999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|||||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++++
T Consensus 99 ~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~v 171 (311)
T 4aw0_A 99 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI 171 (311)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCE
Confidence 999999999999999999999999975 346999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+.+............+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+...
T Consensus 172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~ 244 (311)
T 4aw0_A 172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------GLIFA 244 (311)
T ss_dssp EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 99999999987654433333677999999999999999999999999999999999999999975332 11222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
...... +. + +.....++.+|+..||+.||++|||++|++
T Consensus 245 ~i~~~~-~~------~----p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 245 KIIKLE-YD------F----PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHTC-CC------C----CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHcCC-CC------C----CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 222221 10 1 111234578899999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=424.66 Aligned_cols=268 Identities=25% Similarity=0.333 Sum_probs=203.3
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||+||+|+++ |+.||||+++... .....+..|+..+.+++|||||+++++
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~---g~~VAvK~l~~~~---------------~~~~~~e~Ei~~~~~l~HpNIv~l~g~ 65 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE---------------ERSWFREAEIYQTVMLRHENILGFIAA 65 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET---TEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccc---------------hhhHHHHHHHHHHhcCCCCCCCcEEEE
Confidence 4777899999999999999885 8899999997542 111234467777889999999999999
Q ss_pred EecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEE
Q 037084 317 VTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-----HRPCIIHRDIKPANVL 387 (532)
Q Consensus 317 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dlkp~NIl 387 (532)
|.+++ ..|||||||++|||.++++. ..++|..+.+++.|++.||+|||+. +.++|+||||||+|||
T Consensus 66 ~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NIL 140 (303)
T 3hmm_A 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEE
T ss_pred EEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEE
Confidence 98764 57999999999999999975 3589999999999999999999986 2345999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcce--eeeccccccccccccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTL------TISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
|+.++++||+|||+|+......... .....+||++|||||++.+. .++.++|||||||++|||+||++||..
T Consensus 141 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 9999999999999998765443221 12356899999999998754 467899999999999999999888754
Q ss_pred cccchh-------hccHHHHHHHHhccCCCcccccccccCC-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 460 FFQYTE-------EMNMVRWMRNVISSENPHRAIDSKLLGN-GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 460 ~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...... .......+........ +++.+... ...+.+..+.+|+..||+.||++|||+.+|++.|++|.
T Consensus 221 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccccchhcccccchHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 321110 0011122222222111 11111111 12356678999999999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=410.24 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=192.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||+|+||+||+|.+..+ |+.||||+++...... ......+.+|+.++++++|||||++++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~-~~~vAiK~i~~~~~~~-----------~~~~~~~~~Ei~il~~l~HpnIv~~~~ 80 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTT-GQKVALKIINKKVLAK-----------SDMQGRIEREISYLRLLRHPHIIKLYD 80 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTT-CCEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEeHHHcCC-----------HHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 5799999999999999999988764 9999999997653221 222467899999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+||||| +|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++++|
T Consensus 81 ~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 81 VIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp EEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEE
T ss_pred EEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEE
Confidence 999999999999999 7899999975 356999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+|+....... ....+||+.|+|||++.+..+ +.++||||+||++|+|+||+.||..... .....
T Consensus 153 l~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~~~~ 222 (275)
T 3hyh_A 153 IADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PVLFK 222 (275)
T ss_dssp ECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HHHHH
Confidence 999999987654332 246789999999999998876 5799999999999999999999975322 12222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... +. + +...+..+.+++..||+.||++|||++|+++
T Consensus 223 ~i~~~~-~~------~----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 223 NISNGV-YT------L----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHTC-CC------C----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHcCC-CC------C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222221 11 0 1112345788999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=430.55 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=208.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|+..+.||+|+||.||+|.+..+ |+.||||++...... ..+.+.+|+.+|++++|||||+++
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~t-g~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~ 214 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSS-GKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMY 214 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEESTTCS--------------SGGGHHHHHHHHHHCCCTTBCCEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCC-CCEEEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCCCceE
Confidence 45799999999999999999998765 999999999765322 124578899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++.+|||||||+||+|.+++.. ..+++..+..++.|++.||+|||+++ ||||||||+||||+.+|.+
T Consensus 215 ~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 215 NSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence 999999999999999999999999964 34899999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+.+...... .+..+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..+ +.
T Consensus 287 Kl~DFGla~~~~~~~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~---~~ 357 (423)
T 4fie_A 287 KLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKA---MK 357 (423)
T ss_dssp EECCCTTCEECCSSCCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH---HH
T ss_pred EEecCccceECCCCCcc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH---HH
Confidence 99999999987654332 2567899999999999999999999999999999999999999975332 112 22
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+. . .........+.+|+..||+.||++|||+.|+++
T Consensus 358 ~i~~~~~~~-~-------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 358 MIRDNLPPR-L-------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSCCCC-C-------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHcCCCCC-C-------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 222211111 0 011122345888999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=416.28 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=195.8
Q ss_pred ccCccccceecccCCeEEEEEEee--CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVP--GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|++++.||+|+||+||+|+.. +.+++.||||+++....... ....+.+|+.++++++|||||+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~ 90 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------------DRVRTKMERDILVEVNHPFIVK 90 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE------------ECC------CCCCCCCCTTEEC
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH------------HHHHHHHHHHHHHHCCCCCCCe
Confidence 357999999999999999999874 22478999999976432211 1235778999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+|
T Consensus 91 l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g 163 (304)
T 3ubd_A 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEG 163 (304)
T ss_dssp EEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTS
T ss_pred EEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCC
Confidence 99999999999999999999999999976 346999999999999999999999999 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++||+|||+|+........ ....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .+.
T Consensus 164 ~vKl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~ 234 (304)
T 3ubd_A 164 HIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KET 234 (304)
T ss_dssp CEEEESSEEEEC-----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHH
T ss_pred CEEecccccceeccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHH
Confidence 9999999999876443322 2567899999999999999999999999999999999999999976432 122
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
+....... +. .+...+..+.+++..||+.||++|||+
T Consensus 235 ~~~i~~~~-~~----------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 235 MTMILKAK-LG----------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHHHHHCC-CC----------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHHHHcCC-CC----------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 22222221 11 011123458889999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=401.60 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=190.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|++++.||+|+||+||+|++..+ |+.||||+++.... ....+.+.+|+.++++++|||||+++++
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~-------------~~~~~~~~~E~~il~~l~HpnIV~~~~~ 71 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNR-------------ELAREKVMREVKALAKLEHPGIVRYFNA 71 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTT-CCEEEEEEEEECSS-------------HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hCEEeeEEecCCCeEEEEEEECCC-CCEEEEEEEeccCC-------------HHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 588999999999999999988764 89999999975532 2234678899999999999999999999
Q ss_pred EecCC------------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 037084 317 VTRPD------------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 317 ~~~~~------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~ 384 (532)
+.+.+ ..|+|||||++|+|.+++.... .....++..++.++.|+++||+|||+++ |+||||||+
T Consensus 72 ~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~ 147 (299)
T 4g31_A 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPS 147 (299)
T ss_dssp EEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred EEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHH
Confidence 87544 3689999999999999997532 2234577788899999999999999998 999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcc----------eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTR----------IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 454 (532)
|||++.++.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 148 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp GEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred HeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 999999999999999999987543221 11245679999999999999999999999999999999996
Q ss_pred CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 455 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
||..... ....+..... ...+. ..+.....+.+++..||+.||++|||+.++++
T Consensus 226 -Pf~~~~~------~~~~~~~~~~-~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 -PFSTQME------RVRTLTDVRN-LKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -CCSSHHH------HHHHHHHHHT-TCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccH------HHHHHHHHhc-CCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7754211 1111111111 11110 11223344678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=402.69 Aligned_cols=265 Identities=24% Similarity=0.342 Sum_probs=203.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+++.||+|+||+||+|.+..+ |+.||||+++..... ......+.+|+.+|++++|||||+++
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t-~~~vAiK~i~~~~~~------------~~~~~~~~~Ei~il~~l~HpnIv~l~ 119 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDV------------VTNAKRTLRELKILKHFKHDNIIAIK 119 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEETTTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCeEEEEEEecccCeEEEEEEECCC-CCEEEEEEECccccc------------hHHHHHHHHHHHHHHhcCCCCcceEe
Confidence 46799999999999999999988765 999999999765332 22346788999999999999999999
Q ss_pred eEEec------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTR------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++.. .+..|||||||+ |+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 120 ~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~ 191 (398)
T 4b99_A 120 DILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLV 191 (398)
T ss_dssp EECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred eeeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCcccccc
Confidence 99764 367899999995 689999964 457999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCc--ceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 389 DDGMEARISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
+.++.+||+|||+|+.+..... ....+..+||+.|+|||++.+. .++.++||||+||++|||++|++||......
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-- 269 (398)
T 4b99_A 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-- 269 (398)
T ss_dssp CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--
T ss_pred CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--
Confidence 9999999999999987644321 1223567899999999998775 5699999999999999999999999764321
Q ss_pred hccHHHHHHHHhccCCCcccccc--------------cccCC----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDS--------------KLLGN----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~--------------~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+.......... .... ..... ..+.....+.+|+..||+.||++|||+.|+++
T Consensus 270 --~~l~~I~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 270 --HQLQLIMMVLGTPSPA-VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp --HHHHHHHHHHCCCCGG-GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHHHhcCCCChH-HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1122121111111100 0000 00000 01112346889999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=381.85 Aligned_cols=279 Identities=29% Similarity=0.465 Sum_probs=239.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|...+.||+|+||.||+|.+. +|..||||++..... .....+.+|+.++++++||||++
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~ 99 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESS--------------QGIEEFETEIETLSFCRHPHLVS 99 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCS--------------SHHHHHHHHHHGGGSCCCTTBCC
T ss_pred HHHhccCccceeecCCCeeEEEEEEC--CCCEEEEEEecccCh--------------HHHHHHHHHHHHHHhCCCCCEee
Confidence 45678999999999999999999865 589999999876532 23457889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~ 176 (321)
T 2qkw_B 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF 176 (321)
T ss_dssp EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence 999999999999999999999999999764444557999999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ........|
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~-~~~~~~~~~ 255 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP-REMVNLAEW 255 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS-SSCCCHHHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc-HHHHHHHHH
Confidence 9999999999875543322222456789999999999999999999999999999999999999976544 334456677
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.......+.....+++.+.....+..+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 66666666677777777777778889999999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=386.75 Aligned_cols=199 Identities=25% Similarity=0.393 Sum_probs=169.7
Q ss_pred ccCccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.+.|++.+.||+|+||+||+|+++. .+++.||||.+..... ..++.+|+.+|..+ +||||+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------------~~~~~~E~~~l~~~~~h~nIv 83 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------------PIRIAAELQCLTVAGGQDNVM 83 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------------HHHHHHHHHHHHHTCSBTTBC
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------------HHHHHHHHHHHHHhcCCCCCc
Confidence 4679999999999999999998752 2478999999876531 13467899999998 699999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.+.+..|+|||||++|+|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 84 ~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 84 GVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRR 153 (361)
T ss_dssp CCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred eEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCC
Confidence 99999999999999999999999999984 3889999999999999999999999 9999999999999876
Q ss_pred -CcEEEeccCCcccCCCCCcc--------------------------eeeeccccccccccccccccC-CCCchhhHHHH
Q 037084 392 -MEARISDFGLAKLMPDGHTR--------------------------IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSF 443 (532)
Q Consensus 392 -~~~kl~DFGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSl 443 (532)
+.+||+|||+|+........ ...+..+||++|+|||++.+. .++.++||||+
T Consensus 154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 79999999999865432210 112456799999999998775 58999999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 037084 444 GVLLAVLVVGKFPFDD 459 (532)
Q Consensus 444 Gvvl~elltg~~p~~~ 459 (532)
||++|||++|+.||..
T Consensus 234 G~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 234 GVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHHHTCSSSSC
T ss_pred HHHHHHHHHCCCCCCC
Confidence 9999999999999954
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=380.75 Aligned_cols=282 Identities=36% Similarity=0.612 Sum_probs=240.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.++++++||||++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQ-------------GGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC------------------CCCHHHHHHHGGGTCCCTTBCC
T ss_pred HHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCc-------------hHHHHHHHHHHHHHhccCCCccc
Confidence 35678999999999999999999765 5899999999865321 11235889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++..++..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+.++++||||||+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 99999999999999999999999999987655566799999999999999999999999323399999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc-chhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ-YTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~-~~~~~~l~~ 471 (532)
.+||+|||+++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .........
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999999998776543332 2456699999999999999999999999999999999999999964321 123455677
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
|+.............+..+........+..+.+++..||+.||.+|||+.++++.|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 88777777777788888887888899999999999999999999999999999999753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=408.11 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=209.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.++.+ |+.||+|++.... ......+.+|+.+|+.++|||||++++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~t-g~~~AiK~i~~~~--------------~~~~~~~~~Ei~il~~l~hpnIv~l~~ 221 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPH--------------ESDKETVRKEIQTMSVLRHPTLVNLHD 221 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCS--------------HHHHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCC-CCEEEEEEEeccc--------------hhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 6799999999999999999998765 9999999997764 223456789999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC--Cc
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG--ME 393 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~--~~ 393 (532)
++.+.+..|||||||+||+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.+ +.
T Consensus 222 ~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~ 295 (573)
T 3uto_A 222 AFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 295 (573)
T ss_dssp EEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCC
T ss_pred EEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCC
Confidence 99999999999999999999999864 3456999999999999999999999999 9999999999999854 89
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+|+.+..... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... . +.+
T Consensus 296 vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~----~---~~~ 365 (573)
T 3uto_A 296 LKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND----D---ETL 365 (573)
T ss_dssp EEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H---HHH
T ss_pred EEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----H---HHH
Confidence 99999999998765432 2567899999999999999999999999999999999999999976432 1 122
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... +..... ......+.+|+..||+.||.+|||+.|+++
T Consensus 366 ~~i~~~~~~---~~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 366 RNVKSCDWN---MDDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHTTCCC---CCSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCC---CCcccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222221110 111111 122345788999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=406.70 Aligned_cols=255 Identities=23% Similarity=0.296 Sum_probs=202.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|.+.+.||+|+||.||+|+...+ |+.||||++.......... .........++.+++.++|||||+++
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~t-g~~~AiK~i~K~~i~~~~~--------~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQG--------ETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHHTTC--------HHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCC-CCEEEEEEEeHHHcchhhh--------HHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 35799999999999999999998765 9999999996532111000 11122334557788889999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++.+|||||||+||+|.+++.. ...+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|++
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~v 331 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHV 331 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCE
Confidence 999999999999999999999999976 346999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+|+....... ...+||+.|||||++.+ ..|+.++|+||+||++|||++|++||..... .+.....
T Consensus 332 KL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~----~~~~~i~ 403 (689)
T 3v5w_A 332 RISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEID 403 (689)
T ss_dssp EECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC----CCHHHHH
T ss_pred EecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHH
Confidence 9999999987765432 46789999999999864 5799999999999999999999999975322 1122222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVR 524 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl 524 (532)
....... +. .+......+.+|+..||+.||.+|++ ++++.
T Consensus 404 ~~i~~~~-~~----------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 404 RMTLTMA-VE----------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HHHHHCC-CC----------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred HhhcCCC-CC----------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 2222211 10 11122345889999999999999998 56654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=361.57 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=213.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |..||+|.+.... ......|.+|+.++++++||||+++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~~va~K~~~~~~--------------~~~~~~~~~E~~~l~~l~hp~iv~~ 72 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRET-GEVMVMKELIRFD--------------EETQRTFLKEVKVMRCLEHPNVLKF 72 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTT-CCEEEEEEESCCC--------------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCC-CcEEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCcCcccE
Confidence 356799999999999999999988764 8999999986643 3345778999999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+++..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~ 146 (310)
T 3s95_A 73 IGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKN 146 (310)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSC
T ss_pred EEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCC
Confidence 9999999999999999999999999975 2456999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcce------------eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 394 ARISDFGLAKLMPDGHTRI------------RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 9999999998765433211 0125679999999999999999999999999999999999999997644
Q ss_pred cchhh--ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 462 QYTEE--MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 462 ~~~~~--~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... ............ +..+..+.+++..||+.||++|||+.++++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 227 PRTMDFGLNVRGFLDRYCP-----------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp CBCTTSSBCHHHHHHHTCC-----------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhhhccccccCC-----------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 32211 122222221111 111223888999999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=374.50 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=215.5
Q ss_pred cccCccccceecccCCeEEEEEEeeC------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
..++|.+.+.||+|+||.||+|.+.+ .++..||||+++.... ......+.+|+.+++++ +
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~ 145 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-------------EKDLSDLVSEMEMMKMIGK 145 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB-------------HHHHHHHHHHHHHHHHSCC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC-------------HHHHHHHHHHHHHHHHhcC
Confidence 45679999999999999999998742 2356899999986532 23456789999999999 8
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||++++++|...+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 146 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 223 (370)
T 2psq_A 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-- 223 (370)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999999999986432 1245899999999999999999999998
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 224 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 224 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999987655433222244567889999999999999999999999999999999 9
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||..... ..+...+. ....+ .........+.+++..||+.+|++|||+.++++.|+++.
T Consensus 303 ~~p~~~~~~----~~~~~~~~---~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 303 GSPYPGIPV----EELFKLLK---EGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp CCSSTTCCG----GGHHHHHH---TTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCH----HHHHHHHh---cCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999976432 22222111 11111 111223345888999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=373.14 Aligned_cols=269 Identities=26% Similarity=0.343 Sum_probs=211.1
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~ 82 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD---------------KQSWQNEYEVYSLPGMKHENILQ 82 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCC
T ss_pred cchhhchhhheecccCceEEEEEEEC---CCEEEEEEeecCc---------------hHHHHHHHHHHHHhcCCCCCchh
Confidence 35578999999999999999999875 7899999997542 22244566999999999999999
Q ss_pred ceeEEecCCc----eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeee
Q 037084 313 LQAHVTRPDC----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY----------HRPCIIH 378 (532)
Q Consensus 313 l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~----------~~~~ivH 378 (532)
+++++..... .++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH 154 (322)
T 3soc_A 83 FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISH 154 (322)
T ss_dssp EEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EEC
T ss_pred hcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEe
Confidence 9999987543 6999999999999999975 3489999999999999999999988 7 999
Q ss_pred cCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----CCCchhhHHHHHHHHHHHHhC
Q 037084 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-----TISEKSDIYSFGVLLAVLVVG 453 (532)
Q Consensus 379 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg 453 (532)
|||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 155 ~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 155 RDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 999999999999999999999999876654433333456899999999998863 566789999999999999999
Q ss_pred CCCCCCcccchh---------hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 454 KFPFDDFFQYTE---------EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 454 ~~p~~~~~~~~~---------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
+.||........ ......+........ ....+.... .....+..+.+++..||+.||++|||+.+++
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell 310 (322)
T 3soc_A 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVG 310 (322)
T ss_dssp BTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCcchhccchhhhhccCCchhhhhhhhhccc-CCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999976432110 011122222222111 111111110 1224566799999999999999999999999
Q ss_pred HHHhhhh
Q 037084 525 CMLSQIK 531 (532)
Q Consensus 525 ~~L~~l~ 531 (532)
+.|++|+
T Consensus 311 ~~L~~l~ 317 (322)
T 3soc_A 311 ERITQMQ 317 (322)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999886
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=362.19 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=204.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+. |..||||++...... ......+.+|+.++++++||||+++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~ 99 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFH------------AERVNEFLREVAIMKRLRHPNIVLF 99 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEECCCCCS------------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC---CCcEEEEEecCCCCC------------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 4568999999999999999999874 889999999876433 2334678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++++||||||+||+++.++.
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp EEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCC
T ss_pred EEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCc
Confidence 999999999999999999999999997521 1234899999999999999999999875 34999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+
T Consensus 178 ~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~ 251 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAV 251 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHH
T ss_pred EEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH
Confidence 99999999986544322 12456799999999999999999999999999999999999999976432 1111111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.. ..... .........+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus 252 ~~---~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 252 GF---KCKRL---------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp HH---SCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hh---cCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 11110 011122345888999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=379.64 Aligned_cols=262 Identities=23% Similarity=0.303 Sum_probs=213.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+..+ |+.||||.++.... ......|.+|+.++++++||||++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~ 176 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRAD-NTLVAVKSCRETLP-------------PDLKAKFLQEARILKQYSHPNIVR 176 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTT-CCEEEEEECCTTSC-------------HHHHTTTTHHHHHHTTCCCTTBCC
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecC-CeEEEEEEccccCC-------------HHHHHHHHHHHHHHHhCCCCCEEE
Confidence 4567899999999999999999998754 89999999976532 223457889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 177 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~ 250 (377)
T 3cbl_A 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKN 250 (377)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEEEecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCC
Confidence 999999999999999999999999999752 345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||..... .....
T Consensus 251 ~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~ 326 (377)
T 3cbl_A 251 VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTRE 326 (377)
T ss_dssp CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHH
T ss_pred cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 999999999987554322211123345788999999999999999999999999999998 9999976432 11112
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.+. ....+. .+...+..+.+++..||+.||++|||+.++++.|++++
T Consensus 327 ~~~---~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 327 FVE---KGGRLP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp HHH---TTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---cCCCCC----------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 111 111111 11122345888999999999999999999999999886
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=359.53 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=207.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++...... ....+.+|+.++++++||||+++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~--------------~~~~~~~E~~~l~~l~hp~iv~~ 82 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNY 82 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTT-CCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCC-CcEEEEEEeeccccc--------------HHHHHHHHHHHHhcCCCCCCCeE
Confidence 346799999999999999999987654 899999998654321 12457889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~ 154 (297)
T 3fxz_A 83 LDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154 (297)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred eEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 25899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...
T Consensus 155 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~ 225 (297)
T 3fxz_A 155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RAL 225 (297)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH
T ss_pred EEEeeCCCceecCCcccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 999999999876554332 24568999999999999999999999999999999999999999754321 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........+.. .........+.+++..||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 226 YLIATNGTPEL--------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHCSCCC--------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCCC--------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11111111110 011223455888999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=361.78 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=206.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||++++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~l~ 80 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLN------------PTSLQKLFREVRIMKILNHPNIVKLF 80 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEhhcCC------------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45799999999999999999988654 999999999754322 23346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 81 EVIETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCE
Confidence 9999999999999999999999999752 45899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS-EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++........ .....||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ....
T Consensus 154 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~ 223 (328)
T 3fe3_A 154 KIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELR 223 (328)
T ss_dssp EECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred EEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 9999999987654432 2567899999999999888775 789999999999999999999976432 1222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... +......+.+++..||+.||.+|||++++++
T Consensus 224 ~~i~~~~~~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 224 ERVLRGKYRI-----------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHHHCCCCC-----------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHHHhCCCCC-----------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222211100 0112345788999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=365.18 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=210.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+..+ .+..||||+++.... ......|.+|+.++++++||||+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv 113 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-------------ERQRRDFLSEASIMGQFDHPNII 113 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC-------------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC-------------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 456799999999999999999998643 244699999986532 23346789999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 187 (325)
T 3kul_A 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSN 187 (325)
T ss_dssp CEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred cEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCC
Confidence 999999999999999999999999999964 3456999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... ..+
T Consensus 188 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~ 263 (325)
T 3kul_A 188 LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDV 263 (325)
T ss_dssp CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHH
T ss_pred CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHH
Confidence 99999999999987554322 12234456788999999999999999999999999999999 9999976432 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........... .....+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 264 ---~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 264 ---ISSVEEGYRLP----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ---HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCC----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12222111111 11123356888999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=352.68 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=212.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||++
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~ 69 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQ 69 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCC
T ss_pred eChhhceeeheecCCCccEEEEEEec--CCCeEEEEEecccccC---------------HHHHHHHHHHHHhCCCCCEee
Confidence 34567999999999999999999886 4788999999876432 245789999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~ 143 (269)
T 4hcu_A 70 LYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQ 143 (269)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGG
T ss_pred EEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCC
Confidence 99999999999999999999999999974 3456899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... . .
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~----~---~ 215 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----S---E 215 (269)
T ss_dssp CEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H---H
T ss_pred CEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH----H---H
Confidence 9999999999876543221 1134567788999999999999999999999999999999 9999976332 1 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
............ . .......+.+++..||+.+|++|||+.++++.|+++.
T Consensus 216 ~~~~~~~~~~~~---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 216 VVEDISTGFRLY---K-------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHTTCCCC---C-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCccCC---C-------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 122222111110 0 1112345888999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=353.31 Aligned_cols=272 Identities=33% Similarity=0.515 Sum_probs=217.7
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
|...+.||+|+||.||+|.+. ++.||||++........ ......+.+|+.++++++||||+++++++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 99 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITT----------EELKQQFDQEIKVMAKCQHENLVELLGFS 99 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESS---SCEEEEEEECCCTTSCT----------TTHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCccccCCCeEEEEEEEC---CceEEEEEEecccCcch----------HHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 334489999999999999864 78999999875421110 22346788999999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
...+..++||||+++++|.+++.... ...++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~ 175 (307)
T 2nru_A 100 SDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKIS 175 (307)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEe
Confidence 99999999999999999999997532 3456999999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHh
Q 037084 398 DFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477 (532)
Q Consensus 398 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~ 477 (532)
|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|..||........ +..+.....
T Consensus 176 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~ 251 (307)
T 2nru_A 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL---LLDIKEEIE 251 (307)
T ss_dssp CCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB---TTHHHHHHH
T ss_pred ecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH---HHHHHHHhh
Confidence 9999987665433333345679999999998865 589999999999999999999999986443222 222222222
Q ss_pred ccCC-CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 478 SSEN-PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 478 ~~~~-~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.... ....+++. ........+..+.+++..||+.+|.+|||+.++++.|++++
T Consensus 252 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 252 DEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 2111 22222322 23456777888999999999999999999999999999885
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=357.08 Aligned_cols=264 Identities=25% Similarity=0.389 Sum_probs=209.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ......+.+|+.++++++||||++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~~ 77 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTIL-NIKVAIKAIFIPPREK-----------EETLKRFEREVHNSSQLSHQNIVSMI 77 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT-CSEEEEEEEECCSSCC-----------HHHHHHHHHHHHHHTTCCBTTBCCEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCC-CCeEEEEEeccCcccc-----------HHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 46799999999999999999987754 8999999986543322 33457789999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EeeeeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999752 46899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ....
T Consensus 151 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~ 222 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAI 222 (294)
T ss_dssp EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHH
T ss_pred EEEeCCCccccccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHH
Confidence 999999998765443221 24567999999999999999999999999999999999999999764321 1111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-SSKDVRCMLSQIK 531 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~ 531 (532)
.......+.. ... .....+..+.+++..|++.||.+|| ++.++.+.|+.+.
T Consensus 223 ~~~~~~~~~~--~~~----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 223 KHIQDSVPNV--TTD----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHSSCCCCH--HHH----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHhhccCCCc--chh----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1111111110 001 1112345688899999999999998 9999999998763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=370.56 Aligned_cols=262 Identities=22% Similarity=0.379 Sum_probs=200.7
Q ss_pred cccCccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|++.. .++..||||+++.... ......|.+|+.++++++||||+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv 109 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-------------EKQRRDFLGEASIMGQFDHPNII 109 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC-------------HHHHHHHHHHHHHHTTCCCTTBC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC-------------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 45689999999999999999998762 2367899999976532 23356799999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.+.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 183 (373)
T 2qol_A 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSN 183 (373)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred eEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCC
Confidence 999999999999999999999999999974 3456999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~----~~~ 259 (373)
T 2qol_A 184 LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN----QDV 259 (373)
T ss_dssp CCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH----HHH
T ss_pred CCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHH
Confidence 999999999998775442211 1123345778999999999999999999999999999998 9999975432 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.. ........ ......+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 260 ~~---~i~~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 260 IK---AVDEGYRL----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp HH---HHHTTEEC----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHHcCCCC----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 11 11111110 111223456889999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=363.78 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=213.4
Q ss_pred ccccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
...++|.+.+.||+|+||.||+|.+. ..+++.||||+++.... ......+.+|+.++.++ +|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h 85 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHH 85 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC-------------HHHHHHHHHHHHHHHhhcCC
Confidence 45678999999999999999999853 23468999999986532 22346789999999999 88
Q ss_pred CCcccceeEEecCCc-eEEEEEeccCCCHHHHHhhhcCC-----------------------------------------
Q 037084 308 RNLLPLQAHVTRPDC-HLLVYEFMKNGSLQDILHDVSQG----------------------------------------- 345 (532)
Q Consensus 308 ~niv~l~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~~----------------------------------------- 345 (532)
|||+++++++.+.+. .++|||||++|+|.+++......
T Consensus 86 pniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (359)
T 3vhe_A 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASS 165 (359)
T ss_dssp TTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------
T ss_pred cceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccc
Confidence 999999999987654 89999999999999999864221
Q ss_pred ---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 346 ---------------------RRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 346 ---------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 242 (359)
T 3vhe_A 166 GFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242 (359)
T ss_dssp ------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred ccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceee
Confidence 122899999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCc
Q 037084 405 MPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPH 483 (532)
Q Consensus 405 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~ 483 (532)
..............||+.|+|||++.+..++.++|||||||++|||++ |..||....... .+...+. ......
T Consensus 243 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~---~~~~~~ 316 (359)
T 3vhe_A 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCRRLK---EGTRMR 316 (359)
T ss_dssp TTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHHHHH---HTCCCC
T ss_pred ecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHHHHH---cCCCCC
Confidence 755544334456778999999999999999999999999999999998 999997643211 1111111 111110
Q ss_pred ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 484 RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 484 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........+.+++..||+.||.+|||+.++++.|+++.
T Consensus 317 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 317 ----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 01112345888999999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=350.48 Aligned_cols=258 Identities=22% Similarity=0.369 Sum_probs=212.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. ++..||+|++...... ...+.+|+.++.+++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~~ 68 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGSMS---------------EDEFFQEAQTMMKLSHPKLVKF 68 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTTBC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCCCc---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4567999999999999999999876 4778999999865422 2457889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 142 (268)
T 3sxs_A 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLC 142 (268)
T ss_dssp EEEECSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCC
T ss_pred EEEEccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCC
Confidence 99999999999999999999999999763 345899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..
T Consensus 143 ~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~ 214 (268)
T 3sxs_A 143 VKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EV 214 (268)
T ss_dssp EEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HH
T ss_pred EEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HH
Confidence 9999999998776543322 244556788999999999899999999999999999999 99999754321 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
........... .+ ...+..+.+++..||+.+|++|||+.++++.|+.+++
T Consensus 215 ~~~~~~~~~~~---~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 215 VLKVSQGHRLY---RP-------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHTTCCCC---CC-------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHcCCCCC---CC-------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11111111110 01 1112458889999999999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=365.49 Aligned_cols=266 Identities=23% Similarity=0.330 Sum_probs=215.1
Q ss_pred ccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
...++|.+.+.||+|+||.||+|.+.+ .+++.||||+++.... ......+.+|+.++++++||
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp 110 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-------------ADMQADFQREAALMAEFDNP 110 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-------------HHHHHHHHHHHHHHHTCCCT
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCC
Confidence 356789999999999999999999874 2358999999986532 23346789999999999999
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG--------------------RRELDWLARYRIARGMASGLEYL 368 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~L 368 (532)
||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|++.||.||
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 190 (343)
T 1luf_A 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190 (343)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999864221 25799999999999999999999
Q ss_pred HhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHH
Q 037084 369 HMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA 448 (532)
Q Consensus 369 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 448 (532)
|+.+ ++||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|
T Consensus 191 H~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 267 (343)
T 1luf_A 191 SERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267 (343)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHH
Confidence 9998 9999999999999999999999999998664433222224567899999999999999999999999999999
Q ss_pred HHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Q 037084 449 VLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527 (532)
Q Consensus 449 ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L 527 (532)
+|++ |..||..... . +....... +.... .....+..+.+++..||+.||++|||+.++++.|
T Consensus 268 el~t~g~~p~~~~~~----~---~~~~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 268 EIFSYGLQPYYGMAH----E---EVIYYVRD-GNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp HHHTTTCCTTTTSCH----H---HHHHHHHT-TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCcCCCCCh----H---HHHHHHhC-CCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9999 9999975332 1 11222222 11110 1112234588899999999999999999999999
Q ss_pred hhhh
Q 037084 528 SQIK 531 (532)
Q Consensus 528 ~~l~ 531 (532)
+++.
T Consensus 331 ~~~~ 334 (343)
T 1luf_A 331 QRMC 334 (343)
T ss_dssp HHTT
T ss_pred HHHH
Confidence 9875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=358.39 Aligned_cols=265 Identities=22% Similarity=0.364 Sum_probs=215.7
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+.. .++..||||++..... ......+.+|+.++++++|||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~ 87 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-------------PSELRDLLSEFNVLKQVNHPH 87 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC-------------HHHHHHHHHHHHHHTTCCCTT
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC-------------HHHHHHHHHHHHHHhhCCCCc
Confidence 45789999999999999999998742 2358999999976532 233467889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--------------------GRRELDWLARYRIARGMASGLEYLH 369 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~gl~~LH 369 (532)
|+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999986432 1235899999999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 370 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
+.+ ++||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+
T Consensus 168 ~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 244 (314)
T 2ivs_A 168 EMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244 (314)
T ss_dssp HTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHH
Confidence 998 99999999999999999999999999987765543333345567889999999999899999999999999999
Q ss_pred HHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 450 LVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 450 llt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
|++ |..||..... ..+...+. .+... ......+..+.+++..||+.||++|||+.++++.|+
T Consensus 245 l~t~g~~p~~~~~~----~~~~~~~~----~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 245 IVTLGGNPYPGIPP----ERLFNLLK----TGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp HHTTSCCSSTTCCG----GGHHHHHH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH----HHHHHHhh----cCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999 9999976433 12222211 11110 111123355889999999999999999999999999
Q ss_pred hhh
Q 037084 529 QIK 531 (532)
Q Consensus 529 ~l~ 531 (532)
++-
T Consensus 308 ~~~ 310 (314)
T 2ivs_A 308 KMM 310 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=353.76 Aligned_cols=268 Identities=23% Similarity=0.344 Sum_probs=207.8
Q ss_pred ccCccccceecccCCeEEEEEEe---eCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEV---PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~---~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.++|++.+.||+|+||+||+|++ ...+|+.||||++.... ......+.+|+.++++++||||+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv 74 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------------EEHLRDFEREIEILKSLQHDNIV 74 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--------------HHHHHHHHHHHHHHHhCCCCCEe
Confidence 46799999999999999999985 23358899999998663 33456788999999999999999
Q ss_pred cceeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 312 PLQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 312 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++++++... ...++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 75 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~ 148 (295)
T 3ugc_A 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE 148 (295)
T ss_dssp CEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred eEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEc
Confidence 999999654 5689999999999999999762 345899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch----
Q 037084 390 DGMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT---- 464 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---- 464 (532)
.++.+||+|||+++......... ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+.......
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~ 228 (295)
T 3ugc_A 149 NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228 (295)
T ss_dssp ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHH
T ss_pred CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhh
Confidence 99999999999998775543221 1234557788999999999999999999999999999999999987532210
Q ss_pred ----hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 ----EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 ----~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.................. .......+..+.+++..||+.||++|||+.++++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 229 GNDKQGQMIVFHLIELLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccccchhHHHHHHHHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000011111111111111 0112233456888999999999999999999999999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=363.89 Aligned_cols=266 Identities=24% Similarity=0.307 Sum_probs=216.6
Q ss_pred ccccCccccceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI- 305 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 305 (532)
...++|.+.+.||+|+||+||+|.+.+. .+..||||++..... ......+.+|+.+++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~ 132 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-------------EKDLSDLISEMEMMKMIG 132 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC-------------HHHHHHHHHHHHHHHHhc
Confidence 3457899999999999999999987532 246899999986532 23456788999999999
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHR 373 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 373 (532)
+||||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 133 ~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 211 (382)
T 3tt0_A 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 211 (382)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 999999999999999999999999999999999986432 1246999999999999999999999998
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV- 452 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt- 452 (532)
|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 212 --ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~ 289 (382)
T 3tt0_A 212 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 289 (382)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999987765433333345667899999999999999999999999999999999
Q ss_pred CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 453 GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 453 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
|..||..... ..+. .......... ........+.+++..||+.+|++|||+.++++.|+++.
T Consensus 290 g~~p~~~~~~----~~~~---~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 290 GGSPYPGVPV----EELF---KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp SCCSSTTCCH----HHHH---HHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCH----HHHH---HHHHcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999975332 1122 2222211111 11122345888999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=364.15 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=204.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||+||+|.+..+ |+ +||+|.+..... ......|.+|+.++++++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ 78 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC--------------------CHHHHHHHHHHHHHCCBTT
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCC-CceEEEEEEEeecccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 456799999999999999999987654 44 468888865421 223467899999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|++++++|...+ .++|+||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 79 iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~ 151 (327)
T 3poz_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 151 (327)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred EeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEEC
Confidence 999999998754 7899999999999999975 2456999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 152 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~ 227 (327)
T 3poz_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH----HH
Confidence 999999999999987765443333345567889999999999999999999999999999999 9999976433 12
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+...+.. ..... ........+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus 228 ~~~~~~~---~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 228 ISSILEK---GERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHT---TCCCC----------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHc---CCCCC----------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 2222211 11110 11223345888999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=359.22 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=207.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |..+|+|.+.... .....+.+|+.+++.++||||++++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~---------------~~~~~~~~E~~~l~~l~hpnIv~~~ 67 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVKG---------------TDQVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCCT---------------HHHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCC-CcEEEEEEEecCc---------------ccHHHHHHHHHHHHhCCCCCCCeEe
Confidence 45799999999999999999988764 8999999998653 2235678999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC--CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--GM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--~~ 392 (532)
+++.+.+..++|||||++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++
T Consensus 68 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~ 141 (321)
T 1tki_A 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCC
T ss_pred EEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCC
Confidence 999999999999999999999999964 3456999999999999999999999998 999999999999987 78
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ..
T Consensus 142 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~---~~ 211 (321)
T 1tki_A 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN----Q---QI 211 (321)
T ss_dssp CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH----H---HH
T ss_pred CEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH----H---HH
Confidence 999999999988765432 2456799999999999998899999999999999999999999975332 1 12
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ++.... +..+..+.+++..||+.||.+|||+.++++
T Consensus 212 ~~~i~~~~~~---~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 212 IENIMNAEYT---FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCC---CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCC---CChhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2222221111 011111 122345889999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.27 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=214.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ +..||||.++.... ....|.+|+.++++++||||+++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l 281 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQL 281 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGG-TEEEEEEECCSSSS---------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCC-CeEEEEEEecCccc---------------chHHHHHHHHHHHhcCCCCEeeE
Confidence 456799999999999999999998854 88999999986532 23568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++|...+..++|||||++|+|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 282 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~ 356 (495)
T 1opk_A 282 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHL 356 (495)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCc
Confidence 9999999999999999999999999986 34456899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+...
T Consensus 357 ~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~----~~~~~~ 431 (495)
T 1opk_A 357 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYEL 431 (495)
T ss_dssp EEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHH
T ss_pred EEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 999999999876543321 1134456789999999999999999999999999999999 9999976432 122222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+.. .... ......+..+.+++..||+.||++|||+.++++.|+.+-
T Consensus 432 ~~~---~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 432 LEK---DYRM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHT---TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHc---CCCC----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 211 1111 111223456888999999999999999999999998863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=351.29 Aligned_cols=273 Identities=22% Similarity=0.296 Sum_probs=215.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++...... .....+.+|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~ 72 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKL 72 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCC-CcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCcceE
Confidence 346799999999999999999998764 899999999754321 123567789999999999999999
Q ss_pred eeEEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---
Q 037084 314 QAHVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI--- 388 (532)
Q Consensus 314 ~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll--- 388 (532)
++++...+ ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 148 (319)
T 4euu_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148 (319)
T ss_dssp EEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEEC
T ss_pred EEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEecc
Confidence 99998765 7799999999999999998632 2234899999999999999999999998 9999999999999
Q ss_pred -cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 389 -DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ--------TLTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 389 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+.++.+||+|||+++........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 149 ~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 149 EDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp TTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 88889999999999877654332 4567999999999876 56789999999999999999999999975
Q ss_pred cccchhhccHHHHHHHHhccCC---Cccc---------ccc--cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 460 FFQYTEEMNMVRWMRNVISSEN---PHRA---------IDS--KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~---~~~~---------~d~--~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.........+ +........ .... +.. .............+.+++..||+.||++|||+.++++
T Consensus 226 ~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 226 FEGPRRNKEV---MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp TTCGGGCHHH---HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCccchhHHH---HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 4332222222 222222111 1000 000 1112345677888999999999999999999999999
Q ss_pred HHhhh
Q 037084 526 MLSQI 530 (532)
Q Consensus 526 ~L~~l 530 (532)
...+-
T Consensus 303 h~~d~ 307 (319)
T 4euu_A 303 ETSDI 307 (319)
T ss_dssp HHHHH
T ss_pred ccHHH
Confidence 87654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=367.42 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=211.7
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||+||+|.+.+ .++..||||++..... ......+.+|+.++++++|||
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpn 135 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-------------EQDELDFLMEALIISKFNHQN 135 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC-------------HHHHHHHHHHHHHHHHCCCTT
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC-------------hhhHHHHHHHHHHHHhCCCCC
Confidence 35679999999999999999998642 2467899999975432 233456889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
|+++++++...+..++|||||++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI 212 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 212 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhE
Confidence 99999999999999999999999999999987542 2346899999999999999999999998 99999999999
Q ss_pred EecCCC---cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 387 LIDDGM---EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 387 ll~~~~---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
|++.++ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~ 292 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999555 599999999985432222112245678999999999999999999999999999999998 9999976332
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+ .........+. .....+..+.+++..||+.+|.+|||+.++++.|+.+.
T Consensus 293 ----~~~---~~~i~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 293 ----QEV---LEFVTSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----HHH---HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHH---HHHHHcCCCCC----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112 22222221111 11122345888999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=375.46 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=211.3
Q ss_pred cccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
....++|.+.+.||+|+||.||+|.++ .+..||||+++.... ..+.|.+|+.++++++||||+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~iv 246 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLV 246 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTSB---------------CHHHHHHHHHHHTTCCCTTBC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCCc---------------cHHHHHHHHHHHhhCCCCCEe
Confidence 345678999999999999999999886 478899999987532 135788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++. .+..++|||||++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.+
T Consensus 247 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320 (454)
T ss_dssp CEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTT
T ss_pred eEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCC
Confidence 9999987 56789999999999999999752 2245889999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 321 ~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~----~~~~ 395 (454)
T 1qcf_A 321 LVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVI 395 (454)
T ss_dssp CCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----HHHH
T ss_pred CcEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 999999999998765432111 133456788999999999999999999999999999999 9999976432 1122
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+. ...... .....+..+.+++..||+.||++|||++++++.|+++.
T Consensus 396 ~~i~---~~~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 396 RALE---RGYRMP----------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp HHHH---HTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HHHH---cCCCCC----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 2221 111111 11123456889999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=355.36 Aligned_cols=267 Identities=21% Similarity=0.303 Sum_probs=216.2
Q ss_pred ccccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
...++|.+.+.||+|+||.||+|.+. ..++..||||++..... ......+.+|+.++.++ +|
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h 86 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------------LTEREALMSELKVLSYLGNH 86 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-------------HHHHHHHHHHHHHHhhcccC
Confidence 35678999999999999999999863 33478999999986532 22346788999999999 99
Q ss_pred CCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037084 308 RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--------------GRRELDWLARYRIARGMASGLEYLHMYHR 373 (532)
Q Consensus 308 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 373 (532)
|||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 165 (313)
T 1t46_A 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN- 165 (313)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 9999999999999999999999999999999986321 1235899999999999999999999998
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV- 452 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt- 452 (532)
++||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 166 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 243 (313)
T 1t46_A 166 --CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (313)
T ss_dssp --CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999988766544333345667889999999999999999999999999999999
Q ss_pred CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 453 GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 453 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
|..||....... .....+..... . ......+..+.+++..||+.||.+|||+.++++.|+++.
T Consensus 244 g~~p~~~~~~~~---~~~~~~~~~~~---~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 244 GSSPYPGMPVDS---KFYKMIKEGFR---M----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp TCCSSTTCCSSH---HHHHHHHHTCC---C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcccchh---HHHHHhccCCC---C----------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 999997643211 11111111110 0 011122345888999999999999999999999998763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=358.49 Aligned_cols=267 Identities=23% Similarity=0.354 Sum_probs=196.9
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCC--cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
...++|.+.+.||+|+||.||+|.+...++ ..||||+++..... ......+.+|+.++++++||||
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i 87 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA------------SSDIEEFLREAACMKEFDHPHV 87 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC------------HHHHHHHHHHHHHHHHCCCCce
Confidence 356789999999999999999998875422 38999999765322 2235678999999999999999
Q ss_pred ccceeEEecCCce------EEEEEeccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 037084 311 LPLQAHVTRPDCH------LLVYEFMKNGSLQDILHDVSQ--GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382 (532)
Q Consensus 311 v~l~~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 382 (532)
+++++++...+.. ++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dik 164 (323)
T 3qup_A 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLA 164 (323)
T ss_dssp CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCC
Confidence 9999999887655 999999999999999976432 2336899999999999999999999998 9999999
Q ss_pred CCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Q 037084 383 PANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFF 461 (532)
Q Consensus 383 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~ 461 (532)
|+||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~ 244 (323)
T 3qup_A 165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE 244 (323)
T ss_dssp GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence 9999999999999999999987655433322245567889999999999999999999999999999999 999997643
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. ..+.. ......... .....+..+.+++..||+.||++|||+.++++.|+++-
T Consensus 245 ~----~~~~~---~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 245 N----AEIYN---YLIGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp G----GGHHH---HHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h----HHHHH---HHhcCCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3 11211 111111111 11223346889999999999999999999999999874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=353.50 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=215.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ....+.+|+.++++++||||+++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~ 74 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQL 74 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGG-TEEEEEEEECSCST---------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceeEEeecCCCCceeEEEeEecCC-CEEEEEEecCcCHH---------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 466799999999999999999998864 88999999987532 24568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 149 (288)
T 3kfa_A 75 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL 149 (288)
T ss_dssp EEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGC
T ss_pred EEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCC
Confidence 9999999999999999999999999976 34566999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
++|+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..+...
T Consensus 150 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~----~~~~~~ 224 (288)
T 3kfa_A 150 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYEL 224 (288)
T ss_dssp EEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG----GGHHHH
T ss_pred EEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence 999999999877654322 2245567889999999999999999999999999999999 9999976432 222222
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+.... .. ......+..+.+++..|++.||.+|||+.++++.|+++.
T Consensus 225 ~~~~~---~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 225 LEKDY---RM----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp HHTTC---CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccC---CC----------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 21111 10 111122355889999999999999999999999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.20 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=208.0
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+. |+.||||+++... ....|.+|+.++++++||||++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~ 250 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQ 250 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT----------------TSHHHHHHHHHHHTCCCTTBCC
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch----------------HHHHHHHHHHHHHhccCCCEEE
Confidence 34578999999999999999999875 7899999998653 1256889999999999999999
Q ss_pred ceeEEecCC-ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++++.+.+ ..++|||||++|+|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.+
T Consensus 251 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 325 (450)
T 1k9a_A 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSED 325 (450)
T ss_dssp EEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCC
Confidence 999987765 789999999999999999863 3345799999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++...... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..... ..+.
T Consensus 326 ~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~~ 396 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVV 396 (450)
T ss_dssp SCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TTHH
T ss_pred CCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 999999999998543322 23467889999999999999999999999999999998 9999976433 1222
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+ .....+ ..+..++..+.+++..||+.||.+|||+.++++.|++++
T Consensus 397 ~~i---~~~~~~----------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 397 PRV---EKGYKM----------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHH---HTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---HcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 211 111111 111223456888999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.14 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=212.8
Q ss_pred cccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
....++|.+.+.||+|+||.||+|.+.+ .++..||||++..... ......+.+|+.++.++ +
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~ 107 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------------SSEREALMSELKMMTQLGS 107 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-------------HHHHHHHHHHHHHHHhhcC
Confidence 3456789999999999999999999732 2367899999985421 22346788999999999 9
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHH
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG-------------------RRELDWLARYRIARGMASGLEY 367 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~gl~~ 367 (532)
||||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|
T Consensus 108 hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 187 (344)
T 1rjb_A 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187 (344)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999763211 1348999999999999999999
Q ss_pred HHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHH
Q 037084 368 LHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447 (532)
Q Consensus 368 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 447 (532)
||+.+ |+||||||+||+++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++
T Consensus 188 LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 264 (344)
T 1rjb_A 188 LEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264 (344)
T ss_dssp HHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHH
Confidence 99998 999999999999999999999999999876554433333456778999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 448 AVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 448 ~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
|+|+| |..||....... .....+ ..+... ......+..+.+++..||+.||.+|||+.++++.
T Consensus 265 ~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 265 WEIFSLGVNPYPGIPVDA---NFYKLI----QNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp HHHTTTSCCSSTTCCCSH---HHHHHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCcccCCcHH---HHHHHH----hcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99998 999997643211 111111 111100 0111223558889999999999999999999999
Q ss_pred Hhhhh
Q 037084 527 LSQIK 531 (532)
Q Consensus 527 L~~l~ 531 (532)
|+.+.
T Consensus 329 l~~~~ 333 (344)
T 1rjb_A 329 LGCQL 333 (344)
T ss_dssp HHHHC
T ss_pred HHHHH
Confidence 98763
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.07 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=205.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|+...+ |+.||+|+++..... .......+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~l~ 71 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEeHHHhh-----------hhhHHHHHHHHHHHHHhCCCCcCcceE
Confidence 35799999999999999999988754 899999999643110 022346688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|++
T Consensus 72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 72 YAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCE
Confidence 999999999999999999999999975 346899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... . ....
T Consensus 145 kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~---~~~~ 215 (337)
T 1o6l_A 145 KITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E---RLFE 215 (337)
T ss_dssp EECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H---HHHH
T ss_pred EEeeccchhhcccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH----H---HHHH
Confidence 99999999864433221 2567899999999999999999999999999999999999999975322 1 1112
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
...... .. .+......+.+++..||+.||++|| +++++++
T Consensus 216 ~i~~~~-~~----------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 LILMEE-IR----------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCC-CC----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHcCC-CC----------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 222111 10 0111234588899999999999999 8888864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=361.35 Aligned_cols=280 Identities=17% Similarity=0.197 Sum_probs=212.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+..+ .++.||||++...... .......+.......+..|+..++.++|||
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP---LFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH---HHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh---HHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 456899999999999999999988743 2578999999776432 222222222233455777888999999999
Q ss_pred cccceeEEecC----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 310 LLPLQAHVTRP----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 310 iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
|+++++++... ...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N 182 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN 182 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence 99999999765 4479999999 9999999975 3456999999999999999999999998 9999999999
Q ss_pred EEec--CCCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 386 VLID--DGMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 386 Ill~--~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
||++ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 88999999999998765432111 1134559999999999999999999999999999999999999998
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...... ........... ......+++.+... ..+..+.+++..||+.+|.+||++.++++.|+++
T Consensus 263 ~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKDP---KYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTCH---HHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccCH---HHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 532211 11111111111 11122222221111 1234578889999999999999999999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.03 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=203.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++...... ......+.+|+.++++++||||++++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 85 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAED------------EGIPSTAIREISLLKELHHPNIVSLI 85 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------------------CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEeccccc------------chhhHHHHHHHHHHHHcCCCCEeeee
Confidence 467999999999999999999875 4899999999765321 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..++..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~ 158 (311)
T 3niz_A 86 DVIHSERCLTLVFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGAL 158 (311)
T ss_dssp EEECCSSCEEEEEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred eEEccCCEEEEEEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCE
Confidence 99999999999999996 588888864 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... .....+
T Consensus 159 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i 232 (311)
T 3niz_A 159 KLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPKI 232 (311)
T ss_dssp EECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHHH
T ss_pred EEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHHH
Confidence 99999999876543322 245678999999998876 56899999999999999999999999764332 222222
Q ss_pred HHHhccCCCccc----------------ccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRA----------------IDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~----------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........+... ++........+.....+.+++..||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222111110 0000000001122346789999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=367.77 Aligned_cols=255 Identities=21% Similarity=0.332 Sum_probs=206.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.+|+|++...... ......+.+|+.++++++||||++++
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~-~~~~a~K~i~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~l~ 76 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLA-GQEYAAMIINTKKLS------------ARDHQKLEREARICRLLKHPNIVRLH 76 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTT-TEEEEEEEEESCSCH------------HHHHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCC-CcEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCcCCCeEE
Confidence 45799999999999999999987764 999999999876433 23346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec---CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID---DG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~---~~ 391 (532)
+++.+.+..++|||||++|+|.+.+.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+
T Consensus 77 ~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 77 DSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp EEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTT
T ss_pred EEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCC
Confidence 999999999999999999999999975 356999999999999999999999998 99999999999998 56
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||+||++|+|++|.+||..... ..+.
T Consensus 150 ~~vkL~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~----~~~~- 222 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ----HRLY- 222 (444)
T ss_dssp CCEEECCCSSCBCCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHH-
T ss_pred CcEEEccCceeEEecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH----HHHH-
Confidence 78999999999876554322 1456899999999999999999999999999999999999999975332 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ . +... .....+..+.+++..||+.||++|||+.++++
T Consensus 223 --~~i~~~~~-~--~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 223 --QQIKAGAY-D--FPSP----EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp --HHHHHTCC-C--CCTT----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHhCCC-C--CCcc----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 12111111 0 0000 11122345888999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=345.90 Aligned_cols=258 Identities=28% Similarity=0.379 Sum_probs=197.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+. |..||||++........ ....+.+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDI----------SQTIENVRQEAKLFAMLKHPNIIALR 72 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET---TEEEEEEEC--------------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccH----------HHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 467999999999999999999875 88999999976532210 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC----
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---- 390 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~---- 390 (532)
+++..++..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+++||||||+||+++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 73 GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp EEECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EEEecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 999999999999999999999999853 46899999999999999999999987666899999999999986
Q ss_pred ----CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 391 ----GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 391 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++.+||+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 220 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--- 220 (271)
T ss_dssp SCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---
T ss_pred ccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 77899999999986654332 3457899999999999999999999999999999999999999764321
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
............. ......+..+.+++..||+.||.+|||+.++++.|++|
T Consensus 221 ----~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ----AVAYGVAMNKLAL---------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHHHhhhcCCCCC---------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111111111110 11122335588999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=353.09 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=208.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||+||+|.+. ++..||+|++...... ...+.+|+.++.+++||||++
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~ 83 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQ 83 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTSBC---------------HHHHHHHHHHHHTCCCTTBCC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCCCC---------------HHHHHHHHHHHhcCCCCCEee
Confidence 34678999999999999999999877 4788999999876432 245788999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~ 157 (283)
T 3gen_A 84 LYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQG 157 (283)
T ss_dssp EEEEECSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTS
T ss_pred EEEEEecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCC
Confidence 999999999999999999999999999752 346999999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|+|++ |+.||...... .
T Consensus 158 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------~ 229 (283)
T 3gen_A 158 VVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------E 229 (283)
T ss_dssp CEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H
T ss_pred CEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------H
Confidence 9999999999876543221 1134556788999999999999999999999999999998 99999764331 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
............ ........+.+++..||+.+|.+|||+.++++.|+++.
T Consensus 230 ~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 230 TAEHIAQGLRLY----------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccCCC----------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 111111111110 01111245888999999999999999999999998874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.65 Aligned_cols=260 Identities=22% Similarity=0.303 Sum_probs=199.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+... .+..||+|.+..... ......+.+|+.++++++||||+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv 79 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHIV 79 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC-------------HHHHHHHHHHHHHHHhCCCCccc
Confidence 456899999999999999999988642 256799999876432 23346788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++. .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 80 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 152 (281)
T 1mp8_A 80 KLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 152 (281)
T ss_dssp CEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCC
Confidence 9999985 4678999999999999999975 2346899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~----~~~~ 227 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVI 227 (281)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGHH
T ss_pred CCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH----HHHH
Confidence 99999999999876544322 1134557889999999999999999999999999999997 9999976433 1222
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+ ....... ..+..+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 228 ~~i---~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 228 GRI---ENGERLP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH---HcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 221 1111110 11223355888999999999999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=361.29 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=208.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.+.+.||+|+||.||+|.+..+ |..||+|++.......... ......+.+|+.++.+++||||+++
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~~avK~i~~~~~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~l 80 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRR--------GVCREEIEREVSILRQVLHPNIITL 80 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEBCSSTTCSS--------SBCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCC-CCEEEEEEEEccccccccc--------hhHHHHHHHHHHHHHhCCCcCCCcE
Confidence 356799999999999999999988764 8999999997653221100 0013568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC-
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM- 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~- 392 (532)
++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~ 153 (361)
T 2yab_A 81 HDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNI 153 (361)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTS
T ss_pred EEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCC
Confidence 9999999999999999999999999964 456999999999999999999999998 99999999999998877
Q ss_pred ---cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 ---EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||..... .
T Consensus 154 ~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~----~-- 224 (361)
T 2yab_A 154 PIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK----Q-- 224 (361)
T ss_dssp SSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH----H--
T ss_pred CccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH----H--
Confidence 799999999987765432 2456799999999999999999999999999999999999999975332 1
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+......... . .+++.... .....+.+++..||+.||++|||+.++++
T Consensus 225 -~~~~~i~~~~-~--~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 -ETLANITAVS-Y--DFDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -HHHHHHHTTC-C--CCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHhcC-C--CCCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1122221111 0 01111111 12345888999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=344.11 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=208.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|++. |..||||++...... ......|.+|+.++++++||||+++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 72 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWS------------TRKSRDFNEECPRLRIFSHPNVLPV 72 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCC------------HHHHHHHHHHGGGGCCCSCTTEECE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccC------------HHHHHHHHHHHHHHHhcCCCchhhe
Confidence 3467999999999999999999885 889999999875432 2334678999999999999999999
Q ss_pred eeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 314 QAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 314 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++... +..++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ ++++||||||+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~ 149 (271)
T 3kmu_A 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDED 149 (271)
T ss_dssp EEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTT
T ss_pred EEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCC
Confidence 9999887 788999999999999999975 33346899999999999999999999864 449999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCc---hhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISE---KSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.++|+|||++..... ....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||......
T Consensus 150 ~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----- 217 (271)
T 3kmu_A 150 MTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM----- 217 (271)
T ss_dssp SCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----
T ss_pred cceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----
Confidence 9999999988754322 3457899999999988765544 899999999999999999999754321
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
............. ......+..+.+++..||+.||++|||++++++.|+++++
T Consensus 218 --~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 --EIGMKVALEGLRP---------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --HHHHHHHHSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111222111111 1111223458889999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=359.42 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=206.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |..||+|++...... ......+.+|+.++++++||||++++
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~~~ 94 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLS------------ARDFQKLEREARICRKLQHPNIVRLH 94 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEETTTCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCC-CCEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45799999999999999999988754 899999999765432 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~ 167 (362)
T 2bdw_A 95 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG 167 (362)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTT
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCC
Confidence 999999999999999999999999864 456899999999999999999999998 99999999999998654
Q ss_pred -cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 -EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..+
T Consensus 168 ~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~----~~~-- 238 (362)
T 2bdw_A 168 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRL-- 238 (362)
T ss_dssp CCEEECCCTTCBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--
T ss_pred CCEEEeecCcceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHH--
Confidence 5999999999877644321 456899999999999999999999999999999999999999975332 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........... .. .........+.+++..||+.||++|||+.++++
T Consensus 239 -~~~i~~~~~~~---~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 239 -YAQIKAGAYDY---PS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -HHHHHHTCCCC---CT----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHHhCCCCC---Cc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111111100 00 011123355889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=357.11 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=204.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||++..... ......+.+|+.+++.++||||++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnIv~~~ 71 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRA-------------VDCPENIKKEICINKMLNHENVVKFY 71 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCC-CcEEEEEEEEcccc-------------cchHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35799999999999999999988764 89999999976532 11235678999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~ 144 (323)
T 3tki_A 72 GHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNL 144 (323)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCE
Confidence 999999999999999999999999864 456999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... ......|.
T Consensus 145 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~ 222 (323)
T 3tki_A 145 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWK 222 (323)
T ss_dssp EECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHH
T ss_pred EEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh
Confidence 9999999987644332222346789999999999987775 77899999999999999999999754321 11111111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ..... .........+.+++..||+.||++|||+.++++
T Consensus 223 ~----~~~~~---------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 223 E----KKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp T----TCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c----ccccC---------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 11100 001122345788999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.54 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=196.0
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||+||++....+ |+.||||++...... ...+.+|+.++++++||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~ 80 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLT-KELVAVKYIERGAAI---------------DENVQREIINHRSLRHPNIVR 80 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTT-CCEEEEEEEESSTTS---------------CHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCC-CcEEEEEEEecCccc---------------cHHHHHHHHHHHhCCCCCCCc
Confidence 3467899999999999999999988764 899999999765322 245778999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++..++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~ 153 (361)
T 3uc3_A 81 FKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSP 153 (361)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSS
T ss_pred EEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC
Confidence 99999999999999999999999999975 245899999999999999999999998 99999999999998776
Q ss_pred c--EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 393 E--ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEK-SDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
. +||+|||+++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ...
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~ 227 (361)
T 3uc3_A 154 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDY 227 (361)
T ss_dssp SCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCH
T ss_pred CceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHH
Confidence 5 99999999975433222 145679999999999988888766 89999999999999999999764331 222
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.......... . ........+.+++..||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~---~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 228 RKTIQRILSVKYSI---P------DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHHHHHHTTCCCC---C------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCCCC---C------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 22233322211100 0 00012245788999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.21 Aligned_cols=247 Identities=25% Similarity=0.314 Sum_probs=198.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|++..+ |+.||||+++..... .......+.+|..++..+ +||||+++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~AvK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~~hp~Iv~l 89 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKET-GDLYAVKVLKKDVIL-----------QDDDVECTMTEKRILSLARNHPFLTQL 89 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HHTTHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCC-CCEEEEEEEEHHHhc-----------chhHHHHHHHHHHHHHhccCCCceeeE
Confidence 46799999999999999999988764 899999999753211 122356678899999988 79999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++
T Consensus 90 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence 9999999999999999999999999976 245899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++........ ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...... +..
T Consensus 163 ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~~ 233 (353)
T 3txo_A 163 CKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-------DLF 233 (353)
T ss_dssp EEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH
T ss_pred EEEccccceeecccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 999999999864433221 25678999999999999989999999999999999999999999764321 112
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
......... ........+.+++..||+.||.+||++
T Consensus 234 ~~i~~~~~~-----------~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 234 EAILNDEVV-----------YPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp HHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred HHHHcCCCC-----------CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 222221110 011123457889999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=350.65 Aligned_cols=249 Identities=23% Similarity=0.353 Sum_probs=204.2
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
.|...+.||+|+||.||+|.+..+ |+.||||++...... ....+.+|+.++++++||||++++++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~-g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~~~~~ 110 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHS-GRQVAVKMMDLRKQQ--------------RRELLFNEVVIMRDYQHFNVVEMYKS 110 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEETTTCC--------------SHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCC-CcEEEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 366677999999999999988754 899999999765321 23567899999999999999999999
Q ss_pred EecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEE
Q 037084 317 VTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 396 (532)
+...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 111 ~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 111 YLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred EEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEE
Confidence 9999999999999999999999863 35899999999999999999999998 999999999999999999999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... . ......
T Consensus 183 ~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~---~~~~~~ 253 (321)
T 2c30_A 183 SDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----V---QAMKRL 253 (321)
T ss_dssp CCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----H---HHHHHH
T ss_pred eeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H---HHHHHH
Confidence 999999876554322 1456899999999999999999999999999999999999999975322 1 111222
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+. . .........+.+++..||+.||++|||+.++++
T Consensus 254 ~~~~~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 RDSPPPK-L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSSCCC-C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCC-c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2111111 0 011122345888999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=347.81 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=201.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR--IWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~ 312 (532)
.++|.+.+.||+|+||+||+|.+. |+.||||++.... ...+..|.+++.. ++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~niv~ 66 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ---GENVAVKIFSSRD-----------------EKSWFRETELYNTVMLRHENILG 66 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET---TEEEEEEEECGGG-----------------HHHHHHHHHHHHHTCCCCTTBCC
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC---CEEEEEEEecccc-----------------chhhHHHHHHHHHhhccCcCeee
Confidence 467999999999999999999874 8899999987542 1233445555544 89999999
Q ss_pred ceeEEecC----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecC
Q 037084 313 LQAHVTRP----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH--------MYHRPCIIHRD 380 (532)
Q Consensus 313 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~D 380 (532)
+++++... ...++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ ++|||
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~D 138 (301)
T 3q4u_A 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRD 138 (301)
T ss_dssp EEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSC
T ss_pred EEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCC
Confidence 99987543 457999999999999999953 46999999999999999999999 767 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcce--eeeccccccccccccccccC------CCCchhhHHHHHHHHHHHHh
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTL------TISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~ellt 452 (532)
|||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 139 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t 218 (301)
T 3q4u_A 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218 (301)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999998765443221 11345799999999998876 45579999999999999999
Q ss_pred C----------CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 453 G----------KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 453 g----------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
| ..||........ .... +............+.. .......+..+.+++..||+.||++|||+.+
T Consensus 219 g~~~~~~~~~~~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 292 (301)
T 3q4u_A 219 RMVSNGIVEDYKPPFYDVVPNDP--SFED-MRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALR 292 (301)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSC--CHHH-HHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hhcCccccccccccccccCCCCc--chhh-hhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHH
Confidence 9 788865432111 1111 2222211111111111 1123356778999999999999999999999
Q ss_pred HHHHHhhh
Q 037084 523 VRCMLSQI 530 (532)
Q Consensus 523 vl~~L~~l 530 (532)
+++.|++|
T Consensus 293 i~~~L~~i 300 (301)
T 3q4u_A 293 IKKTLTKI 300 (301)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhcc
Confidence 99999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=346.36 Aligned_cols=263 Identities=23% Similarity=0.385 Sum_probs=198.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+. ..||+|+++..... ......|.+|+.++++++||||+++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPT------------PQQLQAFKNEVGVLRKTRHVNILLF 85 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCC------------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCC------------HHHHHHHHHHHHHHHhCCCCcEEEE
Confidence 4678999999999999999999754 35999999866433 3345678999999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++. .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 86 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~ 158 (289)
T 3og7_A 86 MGYST-APQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNT 158 (289)
T ss_dssp EEEEC-SSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred Eeecc-CCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCC
Confidence 99764 4668999999999999999964 3456999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+||+|||++................||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... ..+.
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~ 235 (289)
T 3og7_A 159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQII 235 (289)
T ss_dssp EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHH
T ss_pred EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHH
Confidence 9999999998765433333335567999999999886 667889999999999999999999999764331 1122
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+.. +...... .......+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 236 ~~~~~----~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 236 EMVGR----GSLSPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHH----TSCCCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHhcc----cccCcch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 22211 1111100 1111223456889999999999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=373.38 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=205.2
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.++ .+..||||+++..... .+.|.+|+.++++++||||++
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hp~iv~ 243 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQ 243 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cChhHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCCCC---------------HHHHHHHHHHHHhCCCCCEee
Confidence 45678999999999999999999987 3578999999875321 256889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+ +..++|||||++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 244 ~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~ 317 (452)
T 1fmk_A 244 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL 317 (452)
T ss_dssp EEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCC
Confidence 9999976 6789999999999999999752 2345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+
T Consensus 318 ~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~~-- 390 (452)
T 1fmk_A 318 VCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REV-- 390 (452)
T ss_dssp CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH--
T ss_pred CEEECCCccceecCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH----HHH--
Confidence 99999999998765432211 134457889999999999999999999999999999999 9999975432 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.........+. .....+..+.+++..||+.||++|||++++++.|+++-
T Consensus 391 -~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 391 -LDQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -HHHHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -HHHHHcCCCCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 12222111111 11223456889999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=341.25 Aligned_cols=264 Identities=24% Similarity=0.433 Sum_probs=207.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ ++.||+|++.......... .......+.+|+.++++++||||+++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKD-KSVVAIKSLILGDSEGETE-------MIEKFQEFQREVFIMSNLNHPNIVKL 88 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTT-CCEEEEEECCCCTTTCCHH-------HHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred hhccceehhccccCCceeEEEEEEcCC-ceEEEEEEeeccccccchh-------HHHHHHHHHHHHHHHHhCCCCCchhh
Confidence 456899999999999999999988754 8999999997654322110 01112678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.. ++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++++||||||+||+++.++.
T Consensus 89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 89 YGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp EEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCT
T ss_pred heeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCC
Confidence 99997654 799999999999998864 3457999999999999999999999875 34999999999999988776
Q ss_pred -----EEEeccCCcccCCCCCcceeeecccccccccccccc--ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 394 -----ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH--QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 394 -----~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+||+|||+++..... .....||+.|+|||++ ....++.++|||||||++|+|++|+.||......
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--- 234 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--- 234 (287)
T ss_dssp TCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---
T ss_pred CCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---
Confidence 999999999854432 2457899999999998 4456789999999999999999999999754321
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
-.............. ......+..+.+++..||+.||.+|||+.++++.|++|
T Consensus 235 --~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 --KIKFINMIREEGLRP---------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHHHHHHHHHSCCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --HHHHHHHHhccCCCC---------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111122222111111 11122335688999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=347.00 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=204.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|....+ |..||||++....... ......+.+|+.++++++||||++++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~ 98 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLD-GVPVALKKVQIFDLMD-----------AKARADCIKEIDLLKQLNHPNVIKYY 98 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTT-CCEEEEEEECTTSSCC-----------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCC-CceEEEEeeehhhccC-----------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45799999999999999999987654 8999999997643221 23456788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCE
Confidence 9999999999999999999999999865555677999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .......
T Consensus 176 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~ 248 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK 248 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHH
T ss_pred EEEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHH
Confidence 99999999876543221 1345789999999999999999999999999999999999999964321 2222222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.......+. . . .......+.+++..||+.||++|||+.++++.|++++
T Consensus 249 ~~~~~~~~~-~-----~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 249 KIEQCDYPP-L-----P---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHTTCSCC-C-----C---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcccCCC-C-----c---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 222211111 0 0 0112345888999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=354.95 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=205.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||+||+|.+..+ |. +||+|.+...... .....+.+|+.++++++|||
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~kv~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~ 76 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPE-GESIKIPVCIKVIEDKSGR-------------QSFQAVTDHMLAIGSLDHAH 76 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCT-TCSCCEEEEEEEECCTTSC-------------SCBCSCCHHHHHHHTCCCTT
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCC-CceEEEEEEEEeccccccH-------------HHHHHHHHHHHHHhcCCCCC
Confidence 456799999999999999999998754 54 3888888654211 11245678999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|+++++++.. +..++||||+++|+|.+++.. .+..+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 77 iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~ 149 (325)
T 3kex_A 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLK 149 (325)
T ss_dssp BCCEEEEECB-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEES
T ss_pred cCeEEEEEcC-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEEC
Confidence 9999999974 668999999999999999974 2456889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|+|++ |+.||..... ..
T Consensus 150 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~ 225 (325)
T 3kex_A 150 SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL----AE 225 (325)
T ss_dssp SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT----TH
T ss_pred CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH----HH
Confidence 999999999999998765544333356678889999999999999999999999999999999 9999986432 12
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+...+.. ...... .......+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 226 ~~~~~~~---~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 226 VPDLLEK---GERLAQ----------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHHHHHT---TCBCCC----------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHc---CCCCCC----------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2222211 111100 0011223778999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=350.81 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=213.3
Q ss_pred cccCccccceecccCCeEEEEEEeeC------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-C
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-W 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 306 (532)
..++|.+.+.||+|+||.||+|.+.+ .++..||||++..... ......+.+|+.+++++ +
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~ 99 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-------------EKDLSDLVSEMEMMKMIGK 99 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC-------------HHHHHHHHHHHHHHHHHCC
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc-------------HHHHHHHHHHHHHHHHhhc
Confidence 45789999999999999999998742 2467899999986532 23356788999999999 9
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG------------RRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
||||+++++++...+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 100 hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 177 (334)
T 2pvf_A 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-- 177 (334)
T ss_dssp CTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 999999999999999999999999999999999864321 235899999999999999999999998
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
++||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 178 -ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 256 (334)
T 2pvf_A 178 -CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256 (334)
T ss_dssp -EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred -eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987765443333345567889999999998899999999999999999999 9
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||..... ..+...+ ....... ........+.+++..||+.+|.+|||+.++++.|+++.
T Consensus 257 ~~p~~~~~~----~~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 257 GSPYPGIPV----EELFKLL---KEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp CCSSTTCCH----HHHHHHH---HHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCcCCH----HHHHHHH---hcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999975322 1122211 1111110 11122345888999999999999999999999998863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.15 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=207.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||+||+|.+..+ |+.||||++......... ......+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~ 92 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRET-GQQFAVKIVDVAKFTSSP---------GLSTEDLKREASICHMLKHPHIVELL 92 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHTSS---------SCCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCC-CCEEEEEEEEhhhccccc---------cchHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45799999999999999999988764 899999998643110000 01235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc-
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME- 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~- 393 (532)
+++.+.+..|+|||||++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~ 169 (351)
T 3c0i_A 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENS 169 (351)
T ss_dssp EEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTT
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCC
Confidence 9999999999999999999999988765445567899999999999999999999998 999999999999987655
Q ss_pred --EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 394 --ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .+
T Consensus 170 ~~vkl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~-- 240 (351)
T 3c0i_A 170 APVKLGGFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RL-- 240 (351)
T ss_dssp CCEEECCCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HH--
T ss_pred CcEEEecCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HH--
Confidence 999999999877654322 2456899999999999999999999999999999999999999975321 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ..+.... .....+.+++..||+.||++|||+.++++
T Consensus 241 -~~~i~~~~~~---~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 -FEGIIKGKYK---MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -HHHHHHTCCC---CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHcCCCC---CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111110 0111111 12346889999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=361.58 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=201.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|++..+ ++.||+|+++...... ......+..|..++.++ +||||+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~-~~~~AvK~~~k~~~~~-----------~~~~~~~~~E~~il~~~~~hp~Iv~l 118 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKT-DRIYAMRVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGL 118 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEGGGTC---------------CCHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEhhhccC-----------HHHHHHHHHHHHHHHhcCCCCCcCee
Confidence 46799999999999999999998764 8999999997543221 22335577888998887 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++
T Consensus 119 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 119 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCC
Confidence 9999999999999999999999999975 246899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh-hccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE-EMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-~~~l~~~ 472 (532)
+||+|||+++........ ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .......
T Consensus 192 ikL~DFGla~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~ 269 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 269 (396)
T ss_dssp EEECCCTTCBCCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred EEEeecceeeecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence 999999999864332221 2567899999999999999999999999999999999999999964322111 1111122
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
+........+. .+......+.+++..||+.||++||++
T Consensus 270 ~~~~i~~~~~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 270 LFQVILEKQIR----------IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHCCCC----------CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHhccccC----------CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 22222111111 111223458889999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=346.27 Aligned_cols=265 Identities=20% Similarity=0.250 Sum_probs=203.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 68 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEESSCSS------------TTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCC-CceEEEEeeeccCCc------------CCcchHHHHHHHHHhcCCCCCEeeEEe
Confidence 4688999999999999999988764 899999999765422 223456788999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 69 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~k 141 (292)
T 3o0g_A 69 VLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred EEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999965 66666653 2456999999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++........ .....||+.|+|||++.+.. ++.++||||+||++|+|++|..|+..... .......+.
T Consensus 142 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~---~~~~~~~i~ 216 (292)
T 3o0g_A 142 LANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHH
T ss_pred EeecccceecCCcccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC---HHHHHHHHH
Confidence 9999999876543322 24567899999999987765 79999999999999999998888643221 111112222
Q ss_pred HHhccCCCccc--cc-------------ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRA--ID-------------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~--~d-------------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........... .. ........+.....+.+++..||+.||++|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 21111110000 00 00011112234456889999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.02 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=199.8
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|.+. +|+.||+|++....... .....+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSNIVKLYD 67 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGG------------CCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcC--CCCEEEEEEEecccccc------------ccchhHHHHHHHHHhcCCCCEeeeee
Confidence 46889999999999999999874 58999999997654221 12356778999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 140 (288)
T 1ob3_A 68 VIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK 140 (288)
T ss_dssp EEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred EEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999999999965 99999874 2356899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ +.. +.
T Consensus 141 l~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~-~~ 214 (288)
T 1ob3_A 141 IADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IF 214 (288)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HH
T ss_pred EeECccccccCccccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HH
Confidence 9999999876543221 2456789999999988764 589999999999999999999999976432111 111 11
Q ss_pred HHhccCCCc--------ccccccc-------cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPH--------RAIDSKL-------LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~--------~~~d~~l-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... ..+++.. ...........+.+++..||+.||++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111000 0000000 00111223456789999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=355.19 Aligned_cols=267 Identities=22% Similarity=0.316 Sum_probs=214.4
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCC----CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
...++|.+.+.||+|+||.||+|.+.... +..||+|.+..... ......+.+|+.+++++ +|
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h 109 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-------------ADEKEALMSELKIMSHLGQH 109 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-------------hHHHHHHHHHHHHHHhhcCC
Confidence 35678999999999999999999886531 24899999986542 22346788999999999 89
Q ss_pred CCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 037084 308 RNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ----------GRRELDWLARYRIARGMASGLEYLHMYHRPCII 377 (532)
Q Consensus 308 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~iv 377 (532)
|||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++
T Consensus 110 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iv 186 (333)
T 2i1m_A 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CI 186 (333)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred CCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cc
Confidence 9999999999999999999999999999999976321 1346899999999999999999999998 99
Q ss_pred ecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 037084 378 HRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFP 456 (532)
Q Consensus 378 H~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p 456 (532)
||||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 187 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 266 (333)
T 2i1m_A 187 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266 (333)
T ss_dssp CSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred cCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999987654433333345667889999999999999999999999999999999 9999
Q ss_pred CCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 457 FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
|....... .....+....... .....+..+.+++..||+.||.+|||+.++++.|+++.
T Consensus 267 ~~~~~~~~---~~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 267 YPGILVNS---KFYKLVKDGYQMA-------------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp STTCCSSH---HHHHHHHHTCCCC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcccchhH---HHHHHHhcCCCCC-------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 97643211 1111111111100 01112345888999999999999999999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.56 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=207.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||.||+|.+..+ |+.||+|++..... .....+.+|+.++++++||||++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~--------------~~~~~~~~E~~il~~l~hpnIv~~~ 114 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYP--------------LDKYTVKNEISIMNQLHHPKLINLH 114 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCC-CCEEEEEEecccch--------------hhHHHHHHHHHHHHhCCCcCCCeEE
Confidence 46799999999999999999988764 89999999987642 2235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC--CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--GM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--~~ 392 (532)
+++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++
T Consensus 115 ~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~ 188 (387)
T 1kob_A 115 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKAS 188 (387)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCC
T ss_pred EEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCC
Confidence 999999999999999999999999864 3446899999999999999999999998 999999999999974 57
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... . ..
T Consensus 189 ~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~---~~ 258 (387)
T 1kob_A 189 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----L---ET 258 (387)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----H---HH
T ss_pred ceEEEecccceecCCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----H---HH
Confidence 7999999999877554322 455799999999999999999999999999999999999999976332 1 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+......... ++.. ........+.+++..||+.||++|||+.++++
T Consensus 259 ~~~i~~~~~~---~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 259 LQNVKRCDWE---FDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHCCCC---CCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCC---CCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1222111110 1111 11223345889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.23 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=206.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||.||+|.+..+ |..||+|++.......... ......+.+|+.++++++||||++++
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~hp~iv~~~ 80 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRR--------GVSREDIEREVSILKEIQHPNVITLH 80 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTT-CCEEEEEEEEBCCSTTCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCC-CcEEEEEEEEccccccccc--------hhhHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45689999999999999999988754 8999999997653221000 01135688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~ 153 (326)
T 2y0a_A 81 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP 153 (326)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSS
T ss_pred EEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCC
Confidence 999999999999999999999999964 456999999999999999999999998 99999999999999887
Q ss_pred --cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 --EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 --~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 154 ~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~- 225 (326)
T 2y0a_A 154 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ET- 225 (326)
T ss_dssp SCCEEECCCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HH-
T ss_pred CCCEEEEECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HH-
Confidence 7999999999877544321 4567999999999999999999999999999999999999999753221 11
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... +..... ......+.+++..||+.||++|||+.++++
T Consensus 226 --~~~~~~~~~~---~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 226 --LANVSAVNYE---FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --HHHHHHTCCC---CCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHHHHhcCCC---cCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100 000111 112345788999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=342.68 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=211.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~~ 68 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQL 68 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTBC---------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhheeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCCC---------------HHHHHHHHHHHHhCCCCCEeeE
Confidence 4567999999999999999999886 4789999999876422 2467889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~ 142 (267)
T 3t9t_A 69 YGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQV 142 (267)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGC
T ss_pred EEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCC
Confidence 9999999999999999999999999975 2356899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~ 472 (532)
+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 143 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~ 214 (267)
T 3t9t_A 143 IKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEV 214 (267)
T ss_dssp EEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHH
T ss_pred EEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHH
Confidence 999999999876543211 1134567889999999998899999999999999999999 8999975332 111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........... ........+.+++..||+.+|++|||+.++++.|+++.
T Consensus 215 ~~~i~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 215 VEDISTGFRLY----------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCcCC----------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22222111110 01112345888999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=349.46 Aligned_cols=267 Identities=22% Similarity=0.360 Sum_probs=202.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
...++|.+.+.||+|+||.||+|.+... ++..||+|.++..... ......+.+|+.++++++||||
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i 98 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS------------QREIEEFLSEAACMKDFSHPNV 98 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC------------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc------------hhHHHHHHHHHHHHhcCCCCCe
Confidence 3567899999999999999999987653 2458999999765332 2335678899999999999999
Q ss_pred ccceeEEecCCc-----eEEEEEeccCCCHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 037084 311 LPLQAHVTRPDC-----HLLVYEFMKNGSLQDILHDVS--QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKP 383 (532)
Q Consensus 311 v~l~~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp 383 (532)
+++++++...+. .++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 99 v~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp 175 (313)
T 3brb_A 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAA 175 (313)
T ss_dssp CCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSG
T ss_pred eeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCc
Confidence 999999987653 499999999999999996432 23467999999999999999999999998 99999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
+||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 176 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 255 (313)
T 3brb_A 176 RNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN 255 (313)
T ss_dssp GGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred ceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 999999999999999999987655432222245567889999999999999999999999999999999 8999976433
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+... ......+. .....+..+.+++..||+.||.+|||+.++++.|+++.
T Consensus 256 ----~~~~~~---~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 256 ----HEMYDY---LLHGHRLK----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp ----GGHHHH---HHTTCCCC----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHH---HHcCCCCC----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 122221 11111111 11223345889999999999999999999999999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=356.05 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=203.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.+++.++||||++++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~l~ 75 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKT-QQKVALKFISRQLLKK-----------SDMHMRVEREISYLKLLRHPHIIKLY 75 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEehHHccc-----------hhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35799999999999999999998754 8999999986431110 11235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++..++..++||||+ +|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 76 ~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~ 147 (336)
T 3h4j_B 76 DVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNV 147 (336)
T ss_dssp EEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCE
T ss_pred EEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCE
Confidence 9999999999999999 7899999875 246899999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+
T Consensus 148 kl~DFG~s~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---- 220 (336)
T 3h4j_B 148 KIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---- 220 (336)
T ss_dssp EECCSSCTBTTTTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----
T ss_pred EEEEeccceeccCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----
Confidence 99999999876554322 45679999999999988776 78999999999999999999999763321110000
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... ...+...+..+.+++..||+.||.+|||+.++++
T Consensus 221 ----~~~~----------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 ----NSCV----------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----CSSC----------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----HcCC----------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 0111123345788999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=351.38 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=204.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|+...+ |+.||+|+++..... .......+.+|..+++.++||||++++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~Iv~~~ 72 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIVV-----------RLKQVEHTNDERLMLSIVTHPFIIRMW 72 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCBTTBCCEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------hhhHHHHHHHHHHHHhhCCCCCCceEe
Confidence 35799999999999999999988754 899999998643111 012346678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+|.+
T Consensus 73 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCE
Confidence 999999999999999999999999975 346899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++...... ....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .....
T Consensus 146 kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~ 213 (318)
T 1fot_A 146 KITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYE 213 (318)
T ss_dssp EECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHH
T ss_pred EEeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence 999999998765432 456899999999999999999999999999999999999999975332 11122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
....... . ........+.+++..|++.||++|| +++++++
T Consensus 214 ~i~~~~~-~----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 214 KILNAEL-R----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHCCC-C----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHhCCC-C----------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2222111 0 0111234588899999999999999 8888763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=351.55 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=209.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|....+ |+.||||++..... ...+.+|+.+++++ +||||+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~~~ 70 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYT-NEYVAIKLEPMKSR----------------APQLHLEYRFYKQLGSGDGIPQV 70 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTT-TEEEEEEEEETTCS----------------SCCHHHHHHHHHHHCSCTTSCCE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCC-CcEEEEEEeccccc----------------hHHHHHHHHHHHHhhCCCCCCEE
Confidence 46799999999999999999987654 89999999875432 13577899999999 99999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~ 143 (330)
T 2izr_A 71 YYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143 (330)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGG
T ss_pred EEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCC
Confidence 99999999999999999 99999999752 457999999999999999999999998 999999999999999887
Q ss_pred -----EEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 394 -----ARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 394 -----~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 144 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~ 223 (330)
T 2izr_A 144 KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223 (330)
T ss_dssp TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence 9999999998765433211 114567999999999999999999999999999999999999999864331
Q ss_pred hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
............... . +. ...... .+ .+.+++..||+.+|.+||++.++++.|+++.
T Consensus 224 ~~~~~~~~i~~~~~~-~-~~-----~~~~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 224 TLKERYQKIGDTKRA-T-PI-----EVLCEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp SHHHHHHHHHHHHHH-S-CH-----HHHTTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHhhhcc-C-CH-----HHHhcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 111111111111110 0 00 000111 12 6888999999999999999999999998763
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=357.33 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=204.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|++....... ......+.+|+.++.+++||||++++
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~-~~~~AiK~~~~~~~~~-----------~~~~~~~~~E~~il~~l~hp~Iv~l~ 81 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDT-KKMYAMKYMNKQKCVE-----------RNEVRNVFKELQIMQGLEHPFLVNLW 81 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEehhhccc-----------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 46799999999999999999988764 8999999986432110 22346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~v 154 (384)
T 4fr4_A 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHV 154 (384)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCE
Confidence 999999999999999999999999974 456999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT---LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .....
T Consensus 155 kL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~ 227 (384)
T 4fr4_A 155 HITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS----TSSKE 227 (384)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT----SCHHH
T ss_pred EEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC----ccHHH
Confidence 9999999987754432 256789999999999874 4589999999999999999999999975322 11112
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-SKDVR 524 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl 524 (532)
.......... .........+.+++..||+.||.+||+ ++++.
T Consensus 228 ~~~~~~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 228 IVHTFETTVV-----------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHHHHHCCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred HHHHHhhccc-----------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 2222111110 011122345889999999999999998 66655
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=345.41 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=210.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+.. +|+.||||++..... ...+.+|+..+.++ +|+|++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~ 71 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNV 71 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCE
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCCc----------------cHHHHHHHHHHHHHhcCCCCCeE
Confidence 4679999999999999999998765 489999999875432 13467789999999 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++......++||||+ +++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~ 144 (298)
T 1csn_A 72 YYFGQEGLHNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNS 144 (298)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSS
T ss_pred EeecCCCceeEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCC
Confidence 99999999999999999 99999999752 346999999999999999999999988 999999999999987776
Q ss_pred -----EEEeccCCcccCCCCCcc-----eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 394 -----ARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 394 -----~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 999999999876554321 1124567999999999999999999999999999999999999999864332
Q ss_pred hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.....+........ ..... .+ ....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~-~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 225 TNKQKYERIGEKKQ-STPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHHHHHHHHHHHH-HSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ccHHHHHHHHhhcc-CccHH-----HH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 22111111111111 01100 00 0112345889999999999999999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=360.21 Aligned_cols=276 Identities=21% Similarity=0.282 Sum_probs=207.8
Q ss_pred cccccCccccceeccc--CCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 232 LTKEDSLASLEIIGVG--ACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G--~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
....++|.+.+.||+| +||.||+|.+..+ |+.||||++...... ......+.+|+.++++++|||
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~n 87 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPT-GEYVTVRRINLEACS------------NEMVTFLQGELHVSKLFNHPN 87 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTT-CCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHHHCCCTT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCC-CCEEEEEEecccccC------------hHHHHHHHHHHHHHHhCCCCC
Confidence 3456789999999999 9999999998764 899999999764322 234567889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|+++++++...+..++|||||++|+|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~ 162 (389)
T 3gni_B 88 IVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILIS 162 (389)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CCcEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence 99999999999999999999999999999976 33356999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcc-----eeeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 390 DGMEARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999998754322110 11134578999999999987 5799999999999999999999999976433
Q ss_pred chhhccHHHH-HHHHhcc-CCCc-----------------cccc---------ccccCCCcHHHHHHHHHHHHHcCCCCC
Q 037084 463 YTEEMNMVRW-MRNVISS-ENPH-----------------RAID---------SKLLGNGYEEQMRLVLKIAYFCTSDDP 514 (532)
Q Consensus 463 ~~~~~~l~~~-~~~~~~~-~~~~-----------------~~~d---------~~l~~~~~~~~~~~l~~l~~~cl~~~P 514 (532)
.......... ....... ..+. ..+. ..............+.+|+..||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 322 (389)
T 3gni_B 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322 (389)
T ss_dssp TTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCT
T ss_pred HHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCc
Confidence 2111110000 0000000 0000 0000 000001122334568899999999999
Q ss_pred CCCCCHHHHHH
Q 037084 515 EERPSSKDVRC 525 (532)
Q Consensus 515 ~~RPs~~evl~ 525 (532)
++|||+.++++
T Consensus 323 ~~Rpta~ell~ 333 (389)
T 3gni_B 323 DARPSASTLLN 333 (389)
T ss_dssp TTSCCHHHHTT
T ss_pred ccCCCHHHHhc
Confidence 99999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=354.15 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=201.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+..+ |+ +||+|.+...... .....+.+|+.++++++|||
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~kv~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~ 78 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPH 78 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCT-TCSCCEEEEEEEECCCSSC-------------CCHHHHHHHHHHHTTCCBTT
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCC-CceEEEEEEEEeeccccCH-------------HHHHHHHHHHHHHHhCCCCC
Confidence 457899999999999999999998654 44 4688887654321 12357889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
|+++++++.... .++|++|+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 79 iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~ 151 (327)
T 3lzb_A 79 VCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 151 (327)
T ss_dssp BCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred eeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEc
Confidence 999999998754 7899999999999999975 2456899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |..||..... ..
T Consensus 152 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~ 227 (327)
T 3lzb_A 152 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 227 (327)
T ss_dssp ETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG
T ss_pred CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH----HH
Confidence 999999999999987755443333345567889999999999999999999999999999999 9999976433 12
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+...+.. ..... ........+.+++..||+.||.+|||+.++++.|+++.
T Consensus 228 ~~~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 228 ISSILEK---GERLP----------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHT---TCCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHc---CCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2222211 11111 11122345888999999999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=367.38 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=206.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.++||+|+||+||+|++..+ |+.||+|+++..... .......+.+|..++..++||||+++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~-~~~vAvK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNA-DKVFAMKILNKWEML-----------KRAETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEHHHHH-----------HTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCC-CcEEEEEEEEHHHhh-----------hHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 457899999999999999999998864 899999998643110 01122348889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++|.+.+..|+|||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~ 213 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence 9999999999999999999999999975 2456999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+||+|||+++........ .....+||++|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 214 vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~ 292 (437)
T 4aw2_A 214 IRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292 (437)
T ss_dssp EEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred EEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHh
Confidence 999999999876554332 224568999999999987 56789999999999999999999999976433222222
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 525 (532)
+..+.... ..+. ........+.+++..|+..+|++ ||+++++++
T Consensus 293 i~~~~~~~---~~p~----------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKERF---QFPT----------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHHHC---CCCS----------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccccc---cCCc----------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 22111111 0000 00112345788999999888888 999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.46 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=202.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|++..+ |+.||+|++....... ......+.+|..++.++ +||||+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~aiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~~~~hp~iv~l 75 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKT-DRIYAMKVVKKELVND-----------DEDIDWVQTEKHVFEQASNHPFLVGL 75 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEGGGSCS-----------HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCC-CCEEEEEEEEhHHhcc-----------hHHHHHHHHHHHHHHhcCCCCccCeE
Confidence 35799999999999999999998764 8999999997543221 23346678899999988 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++
T Consensus 76 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 76 HSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 245899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh-hccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE-EMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-~~~l~~~ 472 (532)
+||+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|||++|+.||........ .......
T Consensus 149 ~kL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 226 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226 (345)
T ss_dssp EEECCGGGCBCSCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred EEEEeccccccccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence 999999999864333221 2567899999999999999999999999999999999999999964321110 0011111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
+.......... .+......+.+++..||+.||++||++
T Consensus 227 ~~~~i~~~~~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQIR----------IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCCCC----------CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCCCC----------CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 22211111111 111223458889999999999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=355.42 Aligned_cols=249 Identities=21% Similarity=0.272 Sum_probs=205.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|++..+ |+.||+|++...... .......+.+|+.++.+++||||++++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~ 107 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVV-----------KLKQIEHTLNEKRILQAVNFPFLVKLE 107 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCC-CCEEEEEEEEhHHhc-----------cHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 45799999999999999999988764 899999998643211 022346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 180 (350)
T 1rdq_E 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCE
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCE
Confidence 9999999999999999999999999762 35899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++...... ....||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .....
T Consensus 181 kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~ 248 (350)
T 1rdq_E 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYE 248 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHH
T ss_pred EEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHH
Confidence 999999998765432 456799999999999999999999999999999999999999975332 11222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
..... ... .+......+.+++..||+.||.+||+ ++++++
T Consensus 249 ~i~~~-~~~----------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 249 KIVSG-KVR----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHHC-CCC----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHcC-CCC----------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 22221 110 01112345888999999999999998 777754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=347.96 Aligned_cols=268 Identities=22% Similarity=0.295 Sum_probs=200.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|.+..+ |+.||+|++...... ......+.+|+.++++++||||+++++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 69 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDT-GQIVAIKKFLESEDD------------PVIKKIALREIRMLKQLKHPNLVNLLE 69 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECCCCC-------------HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCC-CcEEEEEEeeccccc------------hHHHHHHHHHHHHHHhCCCCCccchhh
Confidence 4688999999999999999988764 899999998765432 233467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 70 ~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 142 (311)
T 4agu_A 70 VFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIK 142 (311)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred eeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEE
Confidence 99999999999999999999998864 356899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH-
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM- 473 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~- 473 (532)
|+|||++.......... ....||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||...........+....
T Consensus 143 l~Dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 220 (311)
T 4agu_A 143 LCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLG 220 (311)
T ss_dssp ECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCchhccCccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhc
Confidence 99999998765443221 45678999999998876 568999999999999999999999997643321111111100
Q ss_pred ------HHHhccCC-Cc--ccccccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 ------RNVISSEN-PH--RAIDSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ------~~~~~~~~-~~--~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ .. ..-++..... ..+.....+.+++..||+.||++|||++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 00 0000000000 01223455889999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=353.03 Aligned_cols=265 Identities=18% Similarity=0.321 Sum_probs=213.7
Q ss_pred ccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
...++|.+.+.||+|+||.||+|.+.+ .++..||||.+..... ......+.+|+.++++++||
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ 88 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-------------MRERIEFLNEASVMKEFNCH 88 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-------------HHHHHHHHHHHHHGGGCCCT
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC-------------HHHHHHHHHHHHHHHhcCCC
Confidence 356789999999999999999998762 2367899999986532 22345688999999999999
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 382 (532)
||+++++++...+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++|||||
T Consensus 89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dik 165 (322)
T 1p4o_A 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLA 165 (322)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCS
T ss_pred CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCc
Confidence 999999999999999999999999999999975321 1246799999999999999999999998 9999999
Q ss_pred CCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcc
Q 037084 383 PANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFF 461 (532)
Q Consensus 383 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~ 461 (532)
|+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999999999999999999986644332222234567889999999999999999999999999999999 899997543
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
. . ............. .....+..+.+++..||+.||.+|||+.++++.|+++
T Consensus 246 ~----~---~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 N----E---QVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp H----H---HHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred H----H---HHHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 2 1 1122222211110 1112334588899999999999999999999999876
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=350.22 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=192.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|+++..... .....+.+|+.++++++||||++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~ 69 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTT-GVYVALKEVKLDSEE-------------GTPSTAIREISLMKELKHENIVRLY 69 (317)
T ss_dssp ---------------CEEEEEECSSS-CCEEEEEEEECCSTT-------------CSCHHHHHHHHHHTTCCBTTBCCEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCC-CcEEEEEEeeccccc-------------ccHHHHHHHHHHHHhcCCCCcceEE
Confidence 45789999999999999999987754 899999999765321 1124577899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++..++..++||||++ |+|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 70 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~ 145 (317)
T 2pmi_A 70 DVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRG 145 (317)
T ss_dssp EEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred EEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCC
Confidence 99999999999999997 699999876432 2345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 146 ~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~ 219 (317)
T 2pmi_A 146 QLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE----EQLK 219 (317)
T ss_dssp CEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH
T ss_pred CEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHH
Confidence 9999999999876543221 145678999999999876 46899999999999999999999999764331 1112
Q ss_pred HHHHHhccCCCc---c-----cccccc------------cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPH---R-----AIDSKL------------LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~---~-----~~d~~l------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.......... . ...+.. ...........+.+++..||+.||++|||+.++++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 121111110000 0 000000 00001112346889999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=344.08 Aligned_cols=252 Identities=19% Similarity=0.285 Sum_probs=203.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCC-------cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYG-------KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 306 (532)
..++|.+.+.||+|+||+||+|.+..+ + ..||+|++..... .....+.+|+.++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~ 70 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREV-GDYGQLHETEVLLKVLDKAHR--------------NYSESFFEAASMMSKLS 70 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEE-CGGGCEEEEEEEEEEECGGGG--------------GGHHHHHHHHHHHHTSC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecc-cccccccchhhhhhhcccccH--------------HHHHHHHHHHHHHHhCC
Confidence 356799999999999999999988754 3 5799999965431 22357889999999999
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
||||+++++++..++..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 71 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NI 144 (289)
T 4fvq_A 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNI 144 (289)
T ss_dssp CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceE
Confidence 99999999999999999999999999999999975 2345899999999999999999999998 99999999999
Q ss_pred EecCCCc--------EEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCC-CC
Q 037084 387 LIDDGME--------ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGK-FP 456 (532)
Q Consensus 387 ll~~~~~--------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~-~p 456 (532)
+++.++. +||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|. +|
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9998887 999999998755332 34568899999999887 67899999999999999999955 55
Q ss_pred CCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 457 FDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 457 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+..... .... ............. ...+.+++..||+.||++|||+.++++.|+++-
T Consensus 219 ~~~~~~----~~~~---~~~~~~~~~~~~~------------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 219 LSALDS----QRKL---QFYEDRHQLPAPK------------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTTSCH----HHHH---HHHHTTCCCCCCS------------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ccccch----HHHH---HHhhccCCCCCCC------------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 543211 1111 1111111111111 123788999999999999999999999999874
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.30 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=209.1
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+. ++..||||.+...... ...+.+|+.++++++||||++
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~~i~~ 72 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLVR 72 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCccc---------------HHHHHHHHHHHHhCCCcCcce
Confidence 45678999999999999999999876 4778999999765322 256888999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.. +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 73 ~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~ 146 (279)
T 1qpc_A 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTL 146 (279)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTS
T ss_pred EEEEEcC-CCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCC
Confidence 9999874 5689999999999999999642 2236899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... . +
T Consensus 147 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~---~ 218 (279)
T 1qpc_A 147 SCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----P---E 218 (279)
T ss_dssp CEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----H---H
T ss_pred CEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH----H---H
Confidence 9999999999877554322 1134557889999999998899999999999999999999 9999975332 1 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
............ .....+..+.+++..|++.+|++|||+.++++.|+++.
T Consensus 219 ~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 219 VIQNLERGYRMV----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp HHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccCCC----------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 122222111110 11122346888999999999999999999999998863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=356.89 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=203.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
..++|.+.+.||+|+||.||+|+++.+ |+.||+|+++..... .......+..|..++..+ +||||++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vaiK~~~~~~~~-----------~~~~~~~~~~E~~il~~~~~hp~iv~ 82 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVL-----------MDDDVECTMVEKRVLSLAWEHPFLTH 82 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHHTTCTTBCC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEhHHhh-----------hhhhHHHHHHHHHHHHhcCCCCCCCc
Confidence 346799999999999999999998764 899999999753210 012245677888888877 9999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 83 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g 155 (345)
T 1xjd_A 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 155 (345)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCC
Confidence 99999999999999999999999999975 245899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++||+|||+++........ ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ..+
T Consensus 156 ~vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~--- 226 (345)
T 1xjd_A 156 HIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----EEL--- 226 (345)
T ss_dssp CEEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---
T ss_pred CEEEeEChhhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH----HHH---
Confidence 9999999999865433222 2567899999999999999999999999999999999999999975332 111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK-DVR 524 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 524 (532)
....... .+. ........+.+++..||+.||++||++. ++.
T Consensus 227 ~~~i~~~-~~~----------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 227 FHSIRMD-NPF----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHC-CCC----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHhC-CCC----------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1222111 110 0111234588899999999999999997 553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.18 Aligned_cols=250 Identities=25% Similarity=0.342 Sum_probs=199.1
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEE
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHV 317 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 317 (532)
+...+.||+|+||.||+|.+..+ |..||+|+++.... .....+.+|+.++++++||||+++++++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~-g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 155 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETAT-GLKLAAKIIKTRGM--------------KDKEEVKNEISVMNQLDHANLIQLYDAF 155 (373)
T ss_dssp EEEEEECC-----CEEEEEETTT-CCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCC-CcEEEEEEEccccc--------------ccHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34467899999999999988754 89999999987642 2346788999999999999999999999
Q ss_pred ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe--cCCCcEE
Q 037084 318 TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI--DDGMEAR 395 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~k 395 (532)
...+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 156 ~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~k 229 (373)
T 2x4f_A 156 ESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIK 229 (373)
T ss_dssp ECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEE
Confidence 999999999999999999999875 2356899999999999999999999998 9999999999999 6778999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..
T Consensus 230 l~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~ 299 (373)
T 2x4f_A 230 IIDFGLARRYKPREKL---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNN 299 (373)
T ss_dssp ECCCSSCEECCTTCBC---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHH
T ss_pred EEeCCCceecCCcccc---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHH
Confidence 9999999877554322 4557999999999999999999999999999999999999999754321 11222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... +.... .......+.+++..||+.||.+|||+.++++
T Consensus 300 i~~~~~~---~~~~~----~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 300 ILACRWD---LEDEE----FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHTCCC---SCSGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhccCC---CChhh----hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2221111 00111 1122345889999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=346.45 Aligned_cols=267 Identities=24% Similarity=0.327 Sum_probs=213.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH 307 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H 307 (532)
...++|.+.+.||+|+||.||+|.+.+ .+++.||||++..... ......+.+|+.++.++ +|
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~h 90 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHH 90 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHCCC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-------------cHHHHHHHHHHHHHHhcccC
Confidence 356789999999999999999998642 3478999999986532 22346788999999999 79
Q ss_pred CCcccceeEEecCC-ceEEEEEeccCCCHHHHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 308 RNLLPLQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQG------------RRELDWLARYRIARGMASGLEYLHMYHRP 374 (532)
Q Consensus 308 ~niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~ 374 (532)
|||+++++++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 91 p~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-- 168 (316)
T 2xir_A 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-- 168 (316)
T ss_dssp TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred CCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999998765 489999999999999999863221 223889999999999999999999998
Q ss_pred CeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-C
Q 037084 375 CIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-G 453 (532)
Q Consensus 375 ~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g 453 (532)
++||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 169 -i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 247 (316)
T 2xir_A 169 -CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247 (316)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987765544433356678999999999999999999999999999999998 9
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..||....... .+.. ......... ........+.+++..||+.||.+|||+.++++.|+++.
T Consensus 248 ~~p~~~~~~~~---~~~~---~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 248 ASPYPGVKIDE---EFCR---RLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSSTTCCCSH---HHHH---HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccchhH---HHHH---HhccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 99997543211 1111 111111110 01112345888999999999999999999999998864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=344.10 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=198.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHH------------HHHHHHHHHHHHHHHHHHHHH
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELL------------NVRRVLINRKMRQIKSEIITA 302 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~E~~~l 302 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++........... ...........+.+.+|+.++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEND-NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTT-TEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCC-CcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45799999999999999999987754 89999999976532111000 000000112246789999999
Q ss_pred hcCCCCCcccceeEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 037084 303 GRIWHRNLLPLQAHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRD 380 (532)
Q Consensus 303 ~~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 380 (532)
++++||||+++++++.. .+..++||||+++++|.+++. ...+++..+..++.|++.||.|||+.+ ++|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 99999999999999987 567899999999999987643 356999999999999999999999998 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCC
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPF 457 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~ 457 (532)
|||+||+++.++.+||+|||+++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999876554322 24568999999999988765 478899999999999999999999
Q ss_pred CCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 458 DDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... ..+....... ..... ..+.....+.+++..||+.||++|||+.++++
T Consensus 241 ~~~~~-------~~~~~~~~~~-~~~~~--------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERI-------MCLHSKIKSQ-ALEFP--------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSH-------HHHHHHHHHC-CCCCC--------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccH-------HHHHHHHhcc-cCCCC--------CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 75322 1111211111 11000 00112345888999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=352.64 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=182.0
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeEEec
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAHVTR 319 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 319 (532)
.+.||+|+||.||+|.+..+ |+.||||++.... ...+.+|+.++..+. ||||+++++++.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~-----------------~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKS-NQAFAVKIISKRM-----------------EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp SCCSEEETTEEEEEEEETTT-CCEEEEEEEEGGG-----------------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCccccCCCeEEEEEEECCC-CCEEEEEEEChhh-----------------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 37899999999999988764 8999999996431 245668999999996 9999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC---cEEE
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM---EARI 396 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 396 (532)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEE
T ss_pred CCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEE
Confidence 9999999999999999999976 356999999999999999999999998 99999999999998765 8999
Q ss_pred eccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHH
Q 037084 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476 (532)
Q Consensus 397 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~ 476 (532)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............+.....
T Consensus 151 ~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i 228 (325)
T 3kn6_A 151 IDFGFARLKPPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228 (325)
T ss_dssp CCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH
T ss_pred eccccceecCCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH
Confidence 999999876544322 245678999999999999999999999999999999999999998644322222333333333
Q ss_pred hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 477 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .. +.. .........+.+++..||+.||.+|||++++++
T Consensus 229 ~~~~-~~--~~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 229 KKGD-FS--FEG----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TTTC-CC--CCS----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HcCC-CC--CCc----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2221 11 000 011223456889999999999999999998863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.09 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=198.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+. ++.||||.+.... ....|.+|+.++++++||||++++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~hp~iv~~~ 67 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESES----------------ERKAFIVELRQLSRVNHPNIVKLY 67 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET---TEEEEEEECSSTT----------------HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC---CeeEEEEEecChh----------------HHHHHHHHHHHHhcCCCCCcCeEE
Confidence 457899999999999999999875 7899999997542 235788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc-
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME- 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~- 393 (532)
+++.+ ..++||||+++|+|.+++... .....+++..++.++.|+++||.|||+.+..+++||||||+||+++.++.
T Consensus 68 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~ 144 (307)
T 2eva_A 68 GACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144 (307)
T ss_dssp EBCTT--TTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTE
T ss_pred EEEcC--CcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCE
Confidence 98874 579999999999999999752 12235788999999999999999999943334999999999999998886
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 145 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~ 214 (307)
T 2eva_A 145 LKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIM 214 (307)
T ss_dssp EEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHH
T ss_pred EEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHH
Confidence 7999999997654322 3456899999999999999999999999999999999999999753221 11111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........+. .....+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 215 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 215 WAVHNGTRPP----------LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHTTCCCC----------CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHhcCCCCC----------cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1222111111 11122345888999999999999999999999998875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.79 Aligned_cols=268 Identities=21% Similarity=0.301 Sum_probs=209.8
Q ss_pred ccCccccceecccCCeEEEEEEe---eCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEV---PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~---~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
...|++.+.||+|+||.||+|++ ...+|+.||||++..... ......+.+|+.++++++||||+
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~ 86 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------------GNHIADLKKEIEILRNLYHENIV 86 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------------CCHHHHHHHHHHHHTCCCTTBC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-------------chhHHHHHHHHHHHHhCCCCCee
Confidence 35689999999999999999985 223589999999986531 12246788999999999999999
Q ss_pred cceeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 312 PLQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 312 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++++++... +..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 87 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~ 160 (302)
T 4e5w_A 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVE 160 (302)
T ss_dssp CEEEEEEC---CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred eeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEc
Confidence 999999876 6689999999999999999652 345899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc-----
Q 037084 390 DGMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY----- 463 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~----- 463 (532)
.++.+||+|||++......... .......||..|+|||.+.+..++.++||||+|+++|+|++|..|+......
T Consensus 161 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 240 (302)
T 4e5w_A 161 SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240 (302)
T ss_dssp ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH
T ss_pred CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc
Confidence 9999999999999887654332 1224566888999999999999999999999999999999999987543210
Q ss_pred ---hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 464 ---TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 464 ---~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
................... ......+..+.+++..||+.||.+|||+.++++.|+++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRL----------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHhccCCC----------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0111111111211111111 111223456889999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=354.81 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=212.7
Q ss_pred cccCccccceecccCCeEEEEEEe---eCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEV---PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~---~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..++|.+.+.||+|+||.||+|++ ...++..||||++.... ....+.+.+|+.++++++||||
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~i 86 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------------PDQQRDFQREIQILKALHSDFI 86 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------------HHHHHHHHHHHHHHHhcCCCce
Confidence 456899999999999999999985 23358899999998764 2334678899999999999999
Q ss_pred ccceeEEe--cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 311 LPLQAHVT--RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 311 v~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++++. +.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~ 160 (327)
T 3lxl_A 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILV 160 (327)
T ss_dssp CCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred eEEEEEEecCCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEE
Confidence 99999987 446689999999999999999753 235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh--
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE-- 465 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~-- 465 (532)
+.++.+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 240 (327)
T 3lxl_A 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240 (327)
T ss_dssp EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence 999999999999999776543321 22345688889999999999999999999999999999999999875332100
Q ss_pred -----hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 466 -----EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 466 -----~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.......+......+. ........+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 241 MGCERDVPALSRLLELLEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp CC----CCHHHHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred cccccccccHHHHHHHhhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001111111111111 11112233456889999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=349.77 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=177.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-----CC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-----HR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----H~ 308 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++... ......+..|+.+++.++ ||
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDN-KKYYAVKVVRNI---------------KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECSC---------------HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCC-CeEEEEEEeccc---------------hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 357899999999999999999988754 899999999864 233456677889998886 99
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
||+++++++...+..++||||+ +++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 170 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILL 170 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEE
Confidence 9999999999999999999999 9999999986 33346899999999999999999999998 9999999999999
Q ss_pred cC-------------------------CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHH
Q 037084 389 DD-------------------------GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSF 443 (532)
Q Consensus 389 ~~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 443 (532)
+. ++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 245 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSF 245 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHH
Confidence 75 7889999999998755432 45678999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcc
Q 037084 444 GVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 444 Gvvl~elltg~~p~~~~~ 461 (532)
||++|+|++|+.||....
T Consensus 246 G~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 246 GCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHCCCCCCCCc
Confidence 999999999999997643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=338.04 Aligned_cols=260 Identities=19% Similarity=0.304 Sum_probs=206.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+.... +..||+|.+..... ......+.+|+.++++++||||+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~ 76 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-------------LDNKEKFMSEAVIMKNLDHPHIV 76 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC-------------HHHHHHHHHHHHHHHHHCCTTBC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC-------------chHHHHHHHHHHHHHhCCCCCcc
Confidence 4567999999999999999999876432 34699999986532 22346788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.+ +..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 77 ~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 149 (281)
T 3cc6_A 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASP 149 (281)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEET
T ss_pred eEEEEEcC-CCCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCC
Confidence 99999875 4568999999999999999752 345899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....
T Consensus 150 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~----~~~~ 224 (281)
T 3cc6_A 150 ECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN----KDVI 224 (281)
T ss_dssp TEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG----GGHH
T ss_pred CcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh----HHHH
Confidence 99999999999876554321 1244567889999999998999999999999999999998 9999975332 1222
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+.. ..... .....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 225 ~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 225 GVLEK---GDRLP----------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp HHHHH---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhc---CCCCC----------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 22211 11111 01112345888999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=349.13 Aligned_cols=247 Identities=19% Similarity=0.258 Sum_probs=194.4
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 314 (532)
++|++.++||+|+||+||+|.+..+ |+.||||++....... .....+..|+..+.++ +||||++++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~------------~~~~~~~~e~~~~~~~~~h~~iv~l~ 123 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKED-GRLYAVKRSMSPFRGP------------KDRARKLAEVGSHEKVGQHPCCVRLE 123 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTT-SCEEEEEEESSSCCSH------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hheeeeheeccCCCeEEEEEEECCC-CeEEEEEEecccccCh------------HHHHHHHHHHHHHHHhcCCCcEEEEE
Confidence 5799999999999999999988754 8999999987653321 1223444555555555 999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
++|.+.+..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 124 QAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCE
T ss_pred EEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCE
Confidence 9999999999999999 77999998763 356999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||++........ .....||++|+|||++.+ .++.++|||||||++|||++|..|+..... | .
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~-~ 262 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W-Q 262 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H-H
T ss_pred EEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H-H
Confidence 9999999987654432 145679999999998876 799999999999999999999776643211 1 1
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .+... +... ......+.+++..||+.||++|||+.++++
T Consensus 263 ~~~-~~~~~----~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 QLR-QGYLP----PEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHT-TTCCC----HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHh-ccCCC----cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 11111 1111 112355889999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=351.44 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=199.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|++..+ |+.||||++..... ....+.+.+|+.++++++||||+++++
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~~~~ 71 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNR-------------ELAREKVMREVKALAKLEHPGIVRYFN 71 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTT-CCEEEEEEEECCST-------------TTHHHHHHHHHHHHTSCCCTTBCCEEE
T ss_pred hcCceeeEecCCCCeEEEEEEEcCC-CcEEEEEEeecCCc-------------hhHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4688999999999999999998754 89999999976532 123467889999999999999999999
Q ss_pred EEecCCc---------------------------------------------------------eEEEEEeccCCCHHHH
Q 037084 316 HVTRPDC---------------------------------------------------------HLLVYEFMKNGSLQDI 338 (532)
Q Consensus 316 ~~~~~~~---------------------------------------------------------~~lV~E~~~~gsL~~~ 338 (532)
++.+.+. .++|||||++++|.++
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 151 (332)
T 3qd2_B 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW 151 (332)
T ss_dssp EEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHH
T ss_pred EEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHH
Confidence 9866442 7999999999999999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcc-------
Q 037084 339 LHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTR------- 411 (532)
Q Consensus 339 l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~------- 411 (532)
+.... .....++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 152 ~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~ 227 (332)
T 3qd2_B 152 MNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227 (332)
T ss_dssp HHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------
T ss_pred Hhccc-CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccc
Confidence 98632 3345677788999999999999999998 999999999999999999999999999887654221
Q ss_pred ---eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccc
Q 037084 412 ---IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDS 488 (532)
Q Consensus 412 ---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 488 (532)
.......||+.|+|||++.+..++.++|||||||++|+|++|..|+... .. ....... ....
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~---~~~~~~~-~~~~----- 292 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VR---IITDVRN-LKFP----- 292 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HH---HHHHHHT-TCCC-----
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HH---HHHHhhc-cCCC-----
Confidence 1124457999999999999999999999999999999999998775321 11 1111111 1111
Q ss_pred cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 489 KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 489 ~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.........+.+++..||+.||++|||+.++++
T Consensus 293 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 ----LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ----HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ----cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 112233456788999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=339.33 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=206.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |..||+|++...... ......+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINTKKLS------------ARDFQKLEREARICRKLQHPNIVRLH 71 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCC-CceEEEEEeecccCC------------HHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 46799999999999999999988764 899999999765322 23346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc-
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME- 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~- 393 (532)
+++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 72 ~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~ 144 (284)
T 3kk8_A 72 DSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKG 144 (284)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTT
T ss_pred EEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCC
Confidence 999999999999999999999999875 346899999999999999999999998 999999999999986665
Q ss_pred --EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 394 --ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+||+|||++......... ....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ....
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~- 216 (284)
T 3kk8_A 145 AAVKLADFGLAIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ----HRLY- 216 (284)
T ss_dssp CCEEECCCTTCEECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH-
T ss_pred CcEEEeeceeeEEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch----hHHH-
Confidence 999999999876554322 456799999999999999999999999999999999999999975332 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... .. .........+.+++..||+.||++|||+.++++
T Consensus 217 --~~~~~~~~~~---~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 217 --AQIKAGAYDY---PS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --HHHHHTCCCC---CT----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHhccccC---Cc----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111111100 00 001122345888999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=342.60 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=209.5
Q ss_pred cccCccccc-eecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLE-IIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~-~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+ .||+|+||.||+|.+.. .++..||||+++.... ......+.+|+.++++++||||+
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~ 73 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------------KADTEEMMREAQIMHQLDNPYIV 73 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc-------------hhHHHHHHHHHHHHHhCCCCCEe
Confidence 455677766 99999999999998642 2477899999987532 23456788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++ ..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 74 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~ 146 (287)
T 1u59_A 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNR 146 (287)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEET
T ss_pred EEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCC
Confidence 999999 45678999999999999999964 3456999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..... ..+
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~ 222 (287)
T 1u59_A 147 HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEV 222 (287)
T ss_dssp TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHH
T ss_pred CCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----HHH
Confidence 999999999998775443221 1134456899999999998899999999999999999998 9999976432 112
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.. .......+ ......+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 223 ~~---~i~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 223 MA---FIEQGKRM----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp HH---HHHTTCCC----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHhcCCcC----------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 22 11111111 111223456888999999999999999999999998763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=363.77 Aligned_cols=257 Identities=20% Similarity=0.270 Sum_probs=205.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|++..+ |+.||+|+++..... .......+.+|+.+++.++||||+++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~-~~~~AiK~~~k~~~~-----------~~~~~~~~~~E~~il~~l~hp~Iv~l 134 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMI-----------KRSDSAFFWEERDIMAFANSPWVVQL 134 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTCCCSTHHHHHHHHHHCCCTTBCCE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCC-CcEEEEEEEehhhhh-----------hhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 456899999999999999999998764 899999998642110 01113457889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..|+|||||+||+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++
T Consensus 135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence 9999999999999999999999999975 24889999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+||+|||+++........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+
T Consensus 207 ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 285 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285 (410)
T ss_dssp EEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence 999999999876554321 224678999999999988765 789999999999999999999999764332111111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEE--RPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~ 525 (532)
..+.... ..+. .......+.+++..||+.+|.+ ||+++++++
T Consensus 286 ~~~~~~~---~~p~-----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 286 MNHKNSL---TFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HTHHHHC---CCCT-----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred Hhccccc---cCCC-----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111110 0000 0112345888999999999988 999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=349.05 Aligned_cols=262 Identities=22% Similarity=0.400 Sum_probs=204.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCC---CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSY---GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
..++|...+.||+|+||.||+|.+..++ +..||||.+..... ......+.+|+.++++++||||
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i 108 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------------EKQRVDFLGEAGIMGQFSHHNI 108 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCCCC
Confidence 4567888999999999999999887542 24699999986532 2234578899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++...+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 109 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~ 182 (333)
T 1mqb_A 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNS 182 (333)
T ss_dssp CCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred CcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECC
Confidence 9999999999999999999999999999975 2456899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~- 257 (333)
T 1mqb_A 183 NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----H- 257 (333)
T ss_dssp TCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----H-
T ss_pred CCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----H-
Confidence 999999999999876543221 11123456789999999999999999999999999999999 9999975332 1
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+..........+. .....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 258 --~~~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 258 --EVMKAINDGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --HHHHHHHTTCCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHCCCcCC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122222211111 11123345888999999999999999999999998763
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.39 Aligned_cols=247 Identities=22% Similarity=0.278 Sum_probs=201.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|+...+ |+.||+|+++..... .......+..|..++..+ +||||+++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~AiK~~~~~~~~-----------~~~~~~~~~~E~~~l~~~~~hp~iv~l 86 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVI-----------QDDDVECTMVEKRVLALPGKPPFLTQL 86 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTE-EEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEHHHhh-----------cchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence 46799999999999999999998754 889999998753211 012346678899999988 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|+
T Consensus 87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ 159 (353)
T 2i0e_A 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH 159 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCc
Confidence 99999999999999999999999999752 45899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++........ ....+||+.|+|||++.+..++.++|+|||||++|||++|+.||..... . +..
T Consensus 160 vkL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~----~---~~~ 230 (353)
T 2i0e_A 160 IKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----D---ELF 230 (353)
T ss_dssp EEECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH----H---HHH
T ss_pred EEEEeCCcccccccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH----H---HHH
Confidence 999999999864332221 2567899999999999999999999999999999999999999975332 1 122
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
....... +. .+......+.+++..||+.||.+||+.
T Consensus 231 ~~i~~~~-~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 231 QSIMEHN-VA----------YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp HHHHHCC-CC----------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred HHHHhCC-CC----------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 2222211 10 111223458889999999999999964
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.40 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=209.1
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|....+ |+.||||++.... ......+.+|+.++++++||||++
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv~ 90 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHD-GHFYALKRILCHE--------------QQDREEAQREADMHRLFNHPNILR 90 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTT-CCEEEEEEEEESS--------------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCC-CcEEEEEEEecCC--------------HHHHHHHHHHHHHHhhcCCCCeee
Confidence 3457899999999999999999988654 8999999986543 234567889999999999999999
Q ss_pred ceeEEe----cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVT----RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++. .....++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~ 167 (317)
T 2buj_A 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILL 167 (317)
T ss_dssp CCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 999997 335779999999999999999876556678999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcce-------eeeccccccccccccccccCC---CCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRI-------RITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
+.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.
T Consensus 168 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 999999999999987654321100 012345799999999987654 6899999999999999999999996
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.... ........... .... .........+.+++..||+.||.+|||+.++++.|+.++
T Consensus 248 ~~~~--~~~~~~~~~~~---~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 248 MVFQ--KGDSVALAVQN---QLSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHH--TTSCHHHHHHC---C--C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhhc--ccchhhHHhhc---cCCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 4221 11111111111 0000 001122345889999999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=348.12 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=198.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC---CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI---WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~H~niv 311 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||++......... ......+.+|+.+++++ +||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~h~niv 77 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHS-GHFVALKSVRVPNGGGGG---------GGLPISTVREVALLRRLEAFEHPNVV 77 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTT-CCEEEEEEEEEECCCTTS---------SCCCHHHHHHHHHHHHHHHHCCTTBC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEecccccccc---------cccchhHHHHHHHHHHHhhcCCCCeE
Confidence 56799999999999999999987654 899999998643211000 00012344556655555 599999
Q ss_pred cceeEEecCC-----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTRPD-----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++++.... ..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Ni 151 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTE
T ss_pred EeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 9999998765 4799999995 699999976 33345999999999999999999999999 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+++.++.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 226 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-- 226 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 9999999999999999876543322 45789999999999999999999999999999999999999997643321
Q ss_pred ccHHHHHHHHhccCC----Ccc------cccccc---cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSEN----PHR------AIDSKL---LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~----~~~------~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+........ +.. .+.+.. .....++....+.+++..||+.||++|||+.++++
T Consensus 227 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 227 --QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp --HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111111111110 000 000000 00001123456889999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.67 Aligned_cols=274 Identities=22% Similarity=0.288 Sum_probs=215.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.+.+.||+|+||+||+|.+..+ |+.||||++...... .....+.+|+.++++++||||+++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~ 72 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKT-GDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKL 72 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCC-CcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCCCeE
Confidence 356799999999999999999998764 899999999754221 123567789999999999999999
Q ss_pred eeEEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---
Q 037084 314 QAHVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI--- 388 (532)
Q Consensus 314 ~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll--- 388 (532)
++++...+ ..++|||||++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 148 (396)
T 4eut_A 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148 (396)
T ss_dssp EEEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEEC
T ss_pred EEeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeec
Confidence 99998765 67999999999999999975322 234899999999999999999999998 9999999999999
Q ss_pred -cCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 389 -DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT--------LTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 389 -~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+.++.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 149 ~~~~~~~kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 149 EDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp TTSCEEEEECCGGGCEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCceeEEEecCCCceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 78888999999999876554322 45679999999998865 5678899999999999999999999975
Q ss_pred cccchhhccHHHHHHHHhccCCCccc------------ccc--cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRA------------IDS--KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~------------~d~--~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... .+.+............ +.. .............+.+++..||+.||++|||+.++++
T Consensus 226 ~~~~~~~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 226 FEGPRRN---KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TTCTTTC---HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccch---HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 4332222 2222222222111000 000 1112234677888999999999999999999999999
Q ss_pred HHhhhh
Q 037084 526 MLSQIK 531 (532)
Q Consensus 526 ~L~~l~ 531 (532)
.++++-
T Consensus 303 ~l~~il 308 (396)
T 4eut_A 303 ETSDIL 308 (396)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=351.85 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=191.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.+.+.||+|+||.||+|.+..+ ++.||||++.... ..+.+.+|+.++++++||||+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~ 113 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGT-QKPYALKVLKKTV----------------DKKIVRTEIGVLLRLSHPNIIKL 113 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEC--------------------------CHHHHHCCCTTBCCE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCC-CcEEEEEEeccch----------------hHHHHHHHHHHHHhCCCCCCcce
Confidence 356799999999999999999998764 8899999997642 12457789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--- 390 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--- 390 (532)
++++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~ 186 (349)
T 2w4o_A 114 KEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAP 186 (349)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSST
T ss_pred eeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCC
Confidence 9999999999999999999999999964 356899999999999999999999998 999999999999975
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .
T Consensus 187 ~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~--- 257 (349)
T 2w4o_A 187 DAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD---Q--- 257 (349)
T ss_dssp TCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH---H---
T ss_pred CCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc---H---
Confidence 88999999999987654322 14567999999999999999999999999999999999999999753321 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............ .. ..........+.+++..||+.||++|||+.++++
T Consensus 258 ~~~~~i~~~~~~---~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 258 FMFRRILNCEYY---FI----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHHHTTCCC---CC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCCCc---cC----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111222221110 00 0111223456889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=353.70 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=197.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC--CCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH--RNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv 311 (532)
..+.|.+.+.||+|+||.||+|... +++.||||++...... ......+.+|+.++.+++| |||+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~iv 72 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD------------NQTLDSYRNEIAYLNKLQQHSDKII 72 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCC------------HHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccc------------hHHHHHHHHHHHHHHhhhhcCCceE
Confidence 3567999999999999999999875 5899999999765432 3345678999999999976 9999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++...+..++|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ +
T Consensus 73 ~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~ 143 (343)
T 3dbq_A 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-D 143 (343)
T ss_dssp CEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-T
T ss_pred EEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-C
Confidence 999999999999999995 58899999975 356899999999999999999999998 99999999999997 5
Q ss_pred CcEEEeccCCcccCCCCCcceeeecccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----------LTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 144 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 7899999999987765443322346689999999999865 67899999999999999999999999753
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ....+.......... .........+.+++..||+.||.+|||+.++++
T Consensus 224 ~~------~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 224 IN------QISKLHAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CS------HHHHHHHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hh------HHHHHHHHhcCCccc---------CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 22 111122222111110 111111245788999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.86 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=202.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ +..||+|++....... ......+.+|+.++++++||||+++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSHLRHPNILRL 74 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHH-----------HTCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccC-CcEEEEEEEeccccch-----------hhHHHHHHHHHHHHHcCCCCCCcch
Confidence 346799999999999999999988764 8899999986432110 1224678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~ 147 (279)
T 3fdn_A 75 YGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 147 (279)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSC
T ss_pred hheEecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCC
Confidence 99999999999999999999999999753 45899999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
++|+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... .. .
T Consensus 148 ~~l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~---~ 216 (279)
T 3fdn_A 148 LKIADFGWSVHAPSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ET---Y 216 (279)
T ss_dssp EEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HH---H
T ss_pred EEEEeccccccCCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH----HH---H
Confidence 99999999865544322 4567899999999999999999999999999999999999999753321 11 1
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ .........+.+++..||+.||++|||++++++
T Consensus 217 ~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 217 KRISRVEF-----------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHTCC-----------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCC-----------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111110 011112345788999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=341.48 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=205.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
.+|.+.+.||+|+||.||+|.+..+ |+.||+|.+.... ..+.+|+.++++++||||+++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~~~ 71 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRID-GKTYVIKRVKYNN------------------EKAEREVKALAKLDHVNIVHYNG 71 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTT-CCEEEEEEEECCS------------------GGGHHHHHHHHHCCCTTBCCEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCC-CeEEEEEEecccc------------------HHHHHHHHHHHhCCCCCEEEEee
Confidence 5688999999999999999988754 8999999998653 24567999999999999999999
Q ss_pred EEec----------------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 316 HVTR----------------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 316 ~~~~----------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++.. ....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~ 146 (284)
T 2a19_B 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINR 146 (284)
T ss_dssp EEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred eEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 8864 34579999999999999999763 2356899999999999999999999998 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
||||+||+++.++.+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..|+..
T Consensus 147 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred cCCHHHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999999999999999999877654322 456799999999999999999999999999999999999998743
Q ss_pred cccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhhC
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~ 532 (532)
.. ....... ....... ....+.+++..||+.||.+|||+.++++.|+.+++
T Consensus 224 ~~---------~~~~~~~-~~~~~~~------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 224 TS---------KFFTDLR-DGIISDI------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HH---------HHHHHHH-TTCCCTT------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HH---------HHHHHhh-ccccccc------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11 1111111 1111111 12347789999999999999999999999998763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=350.15 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=198.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.++.+++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hp~iv~~~ 78 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRD-HRDVAVKVLRADLARD-----------PSFYLRFRREAQNAAALNHPAIVAVY 78 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECTTTTTS-----------HHHHHHHHHHHTTCCCCCCTTBCCEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCC-CceEEEEEeCccccCC-----------HHHHHHHHHHHHHHHcCCCCCcceEE
Confidence 46799999999999999999988654 8999999998754322 23456788999999999999999999
Q ss_pred eEEecCCce----EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 315 AHVTRPDCH----LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++...... |+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~ 151 (311)
T 3ork_A 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 151 (311)
T ss_dssp EEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred EeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcC
Confidence 998776544 999999999999999975 246899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------ 225 (311)
T 3ork_A 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------ 225 (311)
T ss_dssp TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------
T ss_pred CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------
Confidence 999999999999876543222 1223467899999999999999999999999999999999999999764321
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR-CMLS 528 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl-~~L~ 528 (532)
............... .. ....+..+.+++..||+.||.+||+..+++ ..|.
T Consensus 226 -~~~~~~~~~~~~~~~---~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 226 -SVAYQHVREDPIPPS---AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp -HHHHHHHHCCCCCHH---HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCcc---cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 111122221111100 00 011234588899999999999999766554 4443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=343.13 Aligned_cols=252 Identities=28% Similarity=0.385 Sum_probs=200.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.++++++||||+++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~~iv~~ 79 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQL 79 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred ChhhceEEeEEecCCCceEEEEEEc---CCEEEEEEecchh----------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 4567999999999999999999875 8899999998653 23568899999999999999999
Q ss_pred eeEEecC-CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++++.+. +..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 154 (278)
T 1byg_A 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 154 (278)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred EEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCC
Confidence 9997654 5789999999999999999763 2234789999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..+..
T Consensus 155 ~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~----~~~~~ 225 (278)
T 1byg_A 155 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 225 (278)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHH
T ss_pred cEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 99999999988654432 33467889999999999999999999999999999998 9999976432 11211
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.......+ ......+..+.+++..||+.||++|||+.++++.|++++
T Consensus 226 ---~~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 226 ---RVEKGYKM----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ---HHTTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHhcCCCC----------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11111110 111223345888999999999999999999999999886
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.08 Aligned_cols=251 Identities=26% Similarity=0.392 Sum_probs=203.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|...+.||+|+||+||+|.... +|+.||||++....... ......+.+|+.++++++||||+++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~ 119 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQY 119 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCH-----------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccc-----------hHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 34568899999999999999998765 48999999997653221 2335678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 120 ~~~~~~~~~~~lv~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 192 (348)
T 1u5q_A 120 RGCYLREHTAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 192 (348)
T ss_dssp EEEEEETTEEEEEEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTE
T ss_pred EEEEEECCeEEEEEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence 999999999999999996 6888888642 356899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+||+|||+++..... ....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .
T Consensus 193 ~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~ 259 (348)
T 1u5q_A 193 VKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M 259 (348)
T ss_dssp EEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------H
T ss_pred EEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------H
Confidence 999999999876432 3467999999999874 56789999999999999999999999975332 1
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+........+. ... ......+.+++..||+.||++|||++++++
T Consensus 260 ~~~~~~~~~~~~~------~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 260 SALYHIAQNESPA------LQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHHSCCCC------CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCCCC------CCC---CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1222222222111 001 112345788999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=350.66 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=208.1
Q ss_pred ccccceecccCCeEEEEEEeeC---CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 238 LASLEIIGVGACGVVYKAEVPG---SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
|.+.+.||+|+||+||++.+.. .+|+.||||++..... ......+.+|+.++++++||||++++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG-------------PQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC-------------hHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 4899999999999999887532 2478999999986532 23356788999999999999999999
Q ss_pred eEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 315 AHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 315 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++... ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~ 171 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDR 171 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCC
Confidence 999874 567999999999999999965 24899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch-------
Q 037084 393 EARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT------- 464 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~------- 464 (532)
.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 99999999999876543321 1244568889999999999899999999999999999999999997532210
Q ss_pred -hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 -EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 -~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
....... +......... .......+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 252 ~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 252 QGQMTVLR-LTELLERGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp CHHHHHHH-HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHH-HHHHHhcccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0001111 1111111111 1112233456889999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.29 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=192.1
Q ss_pred ccCcccc-ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHh-cCCCCCccc
Q 037084 235 EDSLASL-EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG-RIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~ 312 (532)
.++|.+. +.||+|+||+||+|.+..+ |+.||||++... ..+.+|+.++. ..+||||++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~-~~~vAiK~~~~~-------------------~~~~~E~~~~~~~~~hp~iv~ 119 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRT-QEKFALKMLQDC-------------------PKARREVELHWRASQCPHIVR 119 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECS-------------------HHHHHHHHHHHHHTTSTTBCC
T ss_pred cccceeccceeeeccCeEEEEEEECCC-CCEEEEEEeCcc-------------------hhHHHHHHHHHHhcCCCCcce
Confidence 3456665 6899999999999988754 899999999753 23456777764 458999999
Q ss_pred ceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++.. .+..|+|||||++|+|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 120 l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill 194 (400)
T 1nxk_A 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 194 (400)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEE
Confidence 9999875 5678999999999999999975 23456999999999999999999999998 9999999999999
Q ss_pred cC---CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 389 DD---GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 389 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
+. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 195 ~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 195 TSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp SSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred ecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 97 78999999999987654322 2567889999999999999999999999999999999999999976443222
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+.. +... +. ..........+.+++..||+.||++|||+.++++
T Consensus 272 ~~~~~~~i~~----~~~~--~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 272 SPGMKTRIRM----GQYE--FP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCSHHHHHHH----TCCC--CC----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHc----Cccc--CC----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222222211 1100 00 0011123455889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.46 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=204.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|+++.+ |+.||+|+++..... .......+.+|..++..++||||+++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~-~~~vAiK~l~k~~~~-----------~~~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDML-----------KRGEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHH-----------HHGGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEeHHHhh-----------hHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 456899999999999999999988754 899999999643111 12223568889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..|+|||||++|+|.+++... +..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++
T Consensus 127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence 99999999999999999999999999753 246899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-------TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+||+|||+++........ .....+||+.|+|||++. +..++.++|+|||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999877554322 224568999999999987 457899999999999999999999999764332211
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEER---PSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~ 525 (532)
..+..+-... ... ......+..+.+++..||. +|.+| |+++++++
T Consensus 280 ~~i~~~~~~~----~~p---------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYKEHL----SLP---------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHHHHC----CCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcccCc----CCC---------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 2222111110 000 0011223458889999999 99998 58888764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.14 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=204.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...|.+.+.||+|+||+||+|.+...+ +..+|+|.+..... ......+.+|+.++++++||||++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~ 90 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVLS 90 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS-------------HHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC-------------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 346888999999999999999875432 23689999876432 233567889999999999999999
Q ss_pred ceeEEe-cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVT-RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++++. ..+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 91 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~ 164 (298)
T 3f66_A 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEK 164 (298)
T ss_dssp CCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred eeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCC
Confidence 999865 45678999999999999999974 3456899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcc--eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 392 MEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
+.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||..... ..
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~ 240 (298)
T 3f66_A 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD 240 (298)
T ss_dssp CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TT
T ss_pred CCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HH
Confidence 99999999999876543221 12245567889999999999999999999999999999999 5666654322 11
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... ....... .....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 241 ~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 241 ITVYL---LQGRRLL----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp HHHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH---hcCCCCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 21111 1111110 01112345888999999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=366.28 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=197.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|....+ |+.||||++....... ......+.+|+.++++++||||++++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~l~ 214 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKAT-GRYYAMKILKKEVIVA-----------KDEVAHTLTENRVLQNSRHPFLTALK 214 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEHHHHC------------------------CCCCCSCTTSCCEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCC-CCEEEEEEEEhhhhhh-----------hHHHHHHHHHHHHHHhCCCCeEeeEE
Confidence 46799999999999999999988764 8999999987431110 23346678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++...+..++|||||++|+|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 215 YSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp EEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSC
T ss_pred EEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCC
Confidence 999999999999999999999999975 3468999999999999999999998 77 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...
T Consensus 288 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~---~~~ 358 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----E---KLF 358 (446)
T ss_dssp EEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H---HHH
T ss_pred EEEccCCCceeccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH----H---HHH
Confidence 999999999865443222 2567899999999999999999999999999999999999999975332 1 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
......... .+......+.+++..||+.||.+|| |++++++
T Consensus 359 ~~i~~~~~~-----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 359 ELILMEEIR-----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp HHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHhCCCC-----------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 222211110 0111234588899999999999999 9999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=342.95 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=206.0
Q ss_pred cccCccccc-eecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLE-IIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~-~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+ .||+|+||.||+|.+.. .++..||||+++..... ......+.+|+.++++++||||+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~ 81 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIV 81 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBC
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC------------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 346788887 99999999999996542 23689999999765321 22356789999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++ ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 82 ~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 82 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQ 153 (291)
T ss_dssp CEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred EEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCC
Confidence 999999 56778999999999999999975 345899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..+
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~ 229 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV 229 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHH
Confidence 999999999998775543321 1133456789999999998889999999999999999999 9999976432 111
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
... ......+ ......+..+.+++..||+.||++|||+.++++.|+++
T Consensus 230 ~~~---~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 230 TAM---LEKGERM----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHH---HHTTCCC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---HHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 1111111 11122345688999999999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.75 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=201.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|.+.+.||+|+||.||+|.+..+ |+.||+|++....... ......+.+|+.++.+++||||++++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~~ 100 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVR-ERIVALKLMSETLSSD-----------PVFRTRMQREARTAGRLQEPHVVPIH 100 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTT-TEEEEEEECGGGGGGS-----------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCC-CeEEEEEecCcccccC-----------HHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 46799999999999999999988754 8999999997653221 23356788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EEEEETTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred EEEeeCCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCE
Confidence 9999999999999999999999999752 46899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... . .+.
T Consensus 174 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~----~~~ 244 (309)
T 2h34_A 174 YLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----S----VMG 244 (309)
T ss_dssp EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----H----HHH
T ss_pred EEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----H----HHH
Confidence 99999999876543221 12456789999999999999999999999999999999999999975322 1 111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-SSKDVRCMLSQI 530 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l 530 (532)
.......+.. ....+..+..+.+++..||+.||++|| |++++++.|+++
T Consensus 245 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 245 AHINQAIPRP-------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp HHHHSCCCCG-------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred HHhccCCCCc-------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 2221111110 001112234588899999999999999 999999999875
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.71 Aligned_cols=262 Identities=24% Similarity=0.341 Sum_probs=207.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|.+...... ......+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 71 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMT------------EAEKQMLVSEVNLLRELKHPNIVRYY 71 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEECTTCC------------HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCC-CcEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhcCCCCCCeEE
Confidence 45799999999999999999988754 899999999765432 23356788999999999999999999
Q ss_pred eEEe--cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEecC
Q 037084 315 AHVT--RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH--RPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlkp~NIll~~ 390 (532)
+++. ..+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~ 151 (279)
T 2w5a_A 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 151 (279)
T ss_dssp EEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS
T ss_pred EEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC
Confidence 9884 357789999999999999999875555567999999999999999999999876 245999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++.+||+|||+++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..+.
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~ 225 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KELA 225 (279)
T ss_dssp SSCEEECCCCHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred CCCEEEecCchheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----HHHH
Confidence 9999999999998765443211 345789999999999999999999999999999999999999976432 1111
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
. .... +.... .....+..+.+++..||+.||++|||+.++++.+.
T Consensus 226 ~---~i~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 G---KIRE-GKFRR---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp H---HHHH-TCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred H---HHhh-ccccc---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1 1111 11110 11122345888999999999999999999997654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.00 Aligned_cols=254 Identities=20% Similarity=0.268 Sum_probs=195.1
Q ss_pred ccCccccceecccCCeEEEEEEee--CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVP--GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|... ..+|+.||+|+++....... ......+.+|+.++++++||||++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~ 85 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----------AKDTAHTKAERNILEEVKHPFIVD 85 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------HHHHHHHCCCTTBCC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHHhCCCCCccc
Confidence 467999999999999999999874 13589999999986532110 223456788999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 86 LIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQG 158 (327)
T ss_dssp EEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTS
T ss_pred eeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCC
Confidence 99999999999999999999999999975 245889999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~ 229 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-------KT 229 (327)
T ss_dssp CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HH
T ss_pred cEEEEeCCcccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-------HH
Confidence 9999999999865433221 14567999999999999999999999999999999999999999753321 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
........ . ...+.....+.+++..||+.||.+|| ++.++++
T Consensus 230 ~~~i~~~~-~----------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 230 IDKILKCK-L----------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHHHTC-C----------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHHhCC-C----------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 12222111 0 01111234588899999999999999 6677764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.67 Aligned_cols=259 Identities=24% Similarity=0.333 Sum_probs=205.3
Q ss_pred CccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.|...+.||+|+||+||+|.+..+ ++..||+|.+..... ....+.+.+|+.++++++||||++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 88 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-------------MQQVEAFLREGLLMRGLNHPNVLALI 88 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS-------------HHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc-------------HHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 466779999999999999987543 234799999976432 23456788999999999999999999
Q ss_pred eEEecCCce-EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCH-LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~-~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++.+.+.. ++|+||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~ 162 (298)
T 3pls_A 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFT 162 (298)
T ss_dssp EEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCC
T ss_pred EEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 999876655 999999999999999974 3456899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCc--ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP-FDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p-~~~~~~~~~~~~l~ 470 (532)
+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |..... ..+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~ 238 (298)
T 3pls_A 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLT 238 (298)
T ss_dssp EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHH
T ss_pred EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHH
Confidence 99999999986644321 1112455678999999999999999999999999999999995555 443221 2222
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+.. ..... .....+..+.+++..||+.||.+|||+.++++.|+++.
T Consensus 239 ~~~~~---~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 239 HFLAQ---GRRLP----------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp HHHHT---TCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhc---CCCCC----------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22221 11110 01112345888999999999999999999999999874
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.84 Aligned_cols=266 Identities=24% Similarity=0.364 Sum_probs=199.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR--IWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|.+. |+.||||++..... ..+..|.+++.. ++||||++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~-----------------~~~~~e~~~~~~~~~~h~~i~~ 95 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTEE-----------------ASWFRETEIYQTVLMRHENILG 95 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGGH-----------------HHHHHHHHHHTSTTCCCTTBCC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEecccc-----------------chhhhHHHHHHHHhhcCCCeee
Confidence 467999999999999999999875 88999999864421 223334444444 59999999
Q ss_pred ceeEEecC----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCC
Q 037084 313 LQAHVTRP----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH-----RPCIIHRDIKP 383 (532)
Q Consensus 313 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlkp 383 (532)
+++++... ...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. .++++||||||
T Consensus 96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred EEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 99999887 678999999999999999975 35899999999999999999999871 11299999999
Q ss_pred CcEEecCCCcEEEeccCCcccCCCCCcce--eeeccccccccccccccccCCCCch------hhHHHHHHHHHHHHhC--
Q 037084 384 ANVLIDDGMEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTLTISEK------SDIYSFGVLLAVLVVG-- 453 (532)
Q Consensus 384 ~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg-- 453 (532)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+...+.. +|||||||++|||++|
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999999999998765433221 1135679999999999988766654 9999999999999999
Q ss_pred --------CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 454 --------KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 454 --------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..||........ .. ...............+... ......+..+.+++..||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDP--SY-EDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSC--CH-HHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccccccccHhhhcCCCC--ch-hhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 566654322111 11 1111111111111111110 012367788999999999999999999999999
Q ss_pred HHhhhh
Q 037084 526 MLSQIK 531 (532)
Q Consensus 526 ~L~~l~ 531 (532)
.|+++.
T Consensus 325 ~L~~l~ 330 (337)
T 3mdy_A 325 TLAKMS 330 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=338.92 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=200.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||.||+|....+ |..+|+|++...... .....+.+|+.++++++||||++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~ 86 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSS-GLERVIKTINKDRSQ-------------VPMEQIEAEIEVLKSLDHPNIIKIF 86 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEGGGCC-------------SCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhheeecceeccCCCeEEEEEEEccC-CceEEEEEeeccccc-------------hhHHHHHHHHHHHHhCCCchHHhHH
Confidence 46799999999999999999988754 899999998754311 1235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---cCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~~~ 391 (532)
+++...+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||++ +.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~ 163 (285)
T 3is5_A 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPH 163 (285)
T ss_dssp EEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTT
T ss_pred HheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCC
Confidence 9999999999999999999999999765444567999999999999999999999998 9999999999999 456
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||++......... ....||+.|+|||.+. ..++.++||||||+++|+|++|+.||..... ....
T Consensus 164 ~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~----~~~~- 234 (285)
T 3is5_A 164 SPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL----EEVQ- 234 (285)
T ss_dssp CCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH-
T ss_pred CCEEEEeeecceecCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH----HHHH-
Confidence 78999999999876543321 4567999999999886 4689999999999999999999999976432 1111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... +...... . .....+.+++..||+.||++|||+.++++
T Consensus 235 --~~~~~~~-~~~~~~~---~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 235 --QKATYKE-PNYAVEC---R----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --HHHHHCC-CCCCC-----C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --hhhccCC-ccccccc---C----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1100000 0 12245778999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.07 Aligned_cols=260 Identities=25% Similarity=0.352 Sum_probs=197.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCC--cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..|.+.+.||+|+||+||+|.+...++ ..||||.++.... ......|.+|+.++++++||||+++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~il~~l~hpnIv~~ 155 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVLSL 155 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC-------------SHHHHHHHHHHTTSTTCCCTTBCCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC-------------HHHHHHHHHHHHHHHhCCCCCcceE
Confidence 346778999999999999998864333 4689999875432 2235678999999999999999999
Q ss_pred eeEEec-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++|.. .+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 229 (373)
T 3c1x_A 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 229 (373)
T ss_dssp CEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred EEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCC
Confidence 998754 4678999999999999999974 3456889999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcc--eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 393 EARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
.+||+|||+++........ .......+|+.|+|||.+.+..++.++|||||||++|||++ |.+||..... ..+
T Consensus 230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~~~ 305 (373)
T 3c1x_A 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDI 305 (373)
T ss_dssp CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----SCH
T ss_pred CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----HHH
Confidence 9999999999876443211 11234567889999999999999999999999999999999 7788875432 222
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...+ .....+. .....+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 306 ~~~~---~~~~~~~----------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 306 TVYL---LQGRRLL----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp HHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2221 1111110 01122345888999999999999999999999998763
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=355.15 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=195.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHH-HhcCCCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT-AGRIWHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~H~niv~ 312 (532)
..++|.+.+.||+|+||.||+|++..+ +..||+|+++...... ......+..|..+ ++.++||||++
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~~AiK~~~~~~~~~-----------~~~~~~~~~e~~~ll~~~~hp~Iv~ 103 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAE-EVFYAVKVLQKKAILK-----------KKEEKHIMSERNVLLKNVKHPFLVG 103 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTT-CCEEEEEEEEGGGBC------------------------CCBCCCCCTTBCC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCC-CCEEEEEEEEHHHhhh-----------hHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 346799999999999999999998764 8999999997643221 1223456667776 57789999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|
T Consensus 104 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g 176 (373)
T 2r5t_A 104 LHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQG 176 (373)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCC
Confidence 99999999999999999999999999975 245889999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
++||+|||+++........ ....+||+.|+|||++.+..++.++|+|||||++|||++|..||...... +.
T Consensus 177 ~ikL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-------~~ 247 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------EM 247 (373)
T ss_dssp CEEECCCCBCGGGBCCCCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH-------HH
T ss_pred CEEEeeCccccccccCCCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH-------HH
Confidence 9999999999864332221 25678999999999999999999999999999999999999999754321 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
........ .. ..+.....+.+++..||+.||++||++.+.+
T Consensus 248 ~~~i~~~~-~~----------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 248 YDNILNKP-LQ----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HHHHHHSC-CC----------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred HHHHHhcc-cC----------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 22222211 10 0111234588899999999999999986433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=349.46 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=206.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcE--EEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKM--IAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.++|.+.+.||+|+||.||+|.+..+ |.. +|+|.+..... ......+.+|+.++.++ +||||+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~v~iK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~hp~iv 89 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNII 89 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBC
T ss_pred HHHccceeeeecCCCceEEEEEEccC-Ccccceeeeeeccccc-------------hHHHHHHHHHHHHHHhccCCCchh
Confidence 46799999999999999999998754 664 49999875421 22346788999999999 999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS------------QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++++++...+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 166 (327)
T 1fvr_A 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHR 166 (327)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred hhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 99999999999999999999999999997632 22357999999999999999999999998 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFD 458 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~ 458 (532)
||||+||+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.
T Consensus 167 dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~ 243 (327)
T 1fvr_A 167 DLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243 (327)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999987543221 1134567889999999998889999999999999999998 999997
Q ss_pred CcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 459 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.... ............+ .........+.+++..||+.+|.+|||+.++++.|+++.
T Consensus 244 ~~~~-------~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 244 GMTC-------AELYEKLPQGYRL----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp TCCH-------HHHHHHGGGTCCC----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcH-------HHHHHHhhcCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 5432 1122222211111 011122345889999999999999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=354.24 Aligned_cols=265 Identities=21% Similarity=0.320 Sum_probs=191.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++.++. ||||+++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~------------~~~~~~~~~E~~~l~~l~~h~niv~l 74 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRT-GEVVAVKKIFDAFQN------------STDAQRTFREIMILTELSGHENIVNL 74 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTT-CCEEEEEEECC--CC------------HHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCC-CCEEEEEEecccccC------------hHHHHHHHHHHHHHHhccCCCCCCee
Confidence 35799999999999999999988764 899999998654222 233466778999999997 9999999
Q ss_pred eeEEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 314 QAHVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 314 ~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++...+ ..|+|||||+ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~ 145 (388)
T 3oz6_A 75 LNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145 (388)
T ss_dssp EEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred eeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCC
Confidence 99997554 6899999996 699999875 36889999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCC-------------------cceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHH
Q 037084 392 MEARISDFGLAKLMPDGH-------------------TRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell 451 (532)
+.+||+|||+++...... .....+..+||++|+|||++.+ ..++.++||||+||++|||+
T Consensus 146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 999999999998654311 0111245689999999998876 67899999999999999999
Q ss_pred hCCCCCCCcccchhhccHHHHHHHHhccCCCccc--cc------------------ccccCCCcH-------------HH
Q 037084 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRA--ID------------------SKLLGNGYE-------------EQ 498 (532)
Q Consensus 452 tg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d------------------~~l~~~~~~-------------~~ 498 (532)
+|++||...........+ ............ +. ........+ ..
T Consensus 226 ~g~~pf~~~~~~~~~~~i----~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 226 CGKPIFPGSSTMNQLERI----IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HSSCSCCCSSHHHHHHHH----HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred hCCCCCCCCCHHHHHHHH----HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 999999764331111111 111110000000 00 000000001 22
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 499 MRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 499 ~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.+|+..||+.||++|||++++++
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 346889999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=349.29 Aligned_cols=271 Identities=22% Similarity=0.340 Sum_probs=203.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~ 88 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDT-GRIVAIKKFLESDDD------------KMVKKIAMREIKLLKQLRHENLVN 88 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTT-CCEEEEEEEESCSSC------------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCC-CceEEEEEEecCCCc------------hHHHHHHHHHHHHHhhCCCCCEee
Confidence 3456899999999999999999988764 899999998665432 223456789999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~ 161 (331)
T 4aaa_A 89 LLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSG 161 (331)
T ss_dssp EEEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred EEEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCC
Confidence 99999999999999999999999888653 345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 162 VVKLCDFGFARTLAAPGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp CEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cEEEEeCCCceeecCCccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 9999999999876543322 1456789999999998775 789999999999999999999999976433211111111
Q ss_pred H-------HHHHhc-cCCCcccccccccCC-----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 W-------MRNVIS-SENPHRAIDSKLLGN-----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~-------~~~~~~-~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ...... .........+..... ..+.....+.+++..||+.||++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000 000000001111111 11223566899999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=337.37 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=205.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++..... ...+.+|+.++..++|+|++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~ 69 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPT 69 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEEC-------------------CCCHHHHHHHHHHHTTSTTCCC
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCC-CceEEEEeeccccc----------------chHHHHHHHHHHHhcCCCCCCe
Confidence 356799999999999999999987654 89999998765421 2357789999999999887776
Q ss_pred eeEE-ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---c
Q 037084 314 QAHV-TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---D 389 (532)
Q Consensus 314 ~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~ 389 (532)
+.++ ...+..++||||+ +++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++ +
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~ 142 (296)
T 4hgt_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGG
T ss_pred eeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccC
Confidence 6666 5667789999999 9999999974 2346999999999999999999999998 9999999999999 7
Q ss_pred CCCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 037084 390 DGMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 464 (532)
.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 143 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 88999999999998765543211 1235679999999999999999999999999999999999999998654422
Q ss_pred hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
....+........... .. ... ...+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~--~~----~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 223 KRQKYERISEKKMSTP--IE----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSSHHHHHHHHHHHSC--HH----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccccch--hh----hhh----ccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 2222222222111110 00 000 111345889999999999999999999999998864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=367.78 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=207.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|...+.||+|+||.||+|++..+ |+.||+|++....... ......+.+|+.++++++||||++++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~t-g~~vAiK~l~k~~~~~-----------~~~~~~~~~E~~iL~~l~hp~Iv~l~ 251 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKAT-GKLYACKKLNKKRLKK-----------RKGYQGAMVEKKILAKVHSRFIVSLA 251 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCC-CcEEEEEEEEhHHhhh-----------hHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 45789999999999999999998764 9999999986432110 12246788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..|+||||++||+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|++
T Consensus 252 ~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~v 328 (543)
T 3c4z_A 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNV 328 (543)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCE
Confidence 9999999999999999999999999865444567999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++........ .....||+.|+|||++.+..++.++|+|||||++|||++|+.||....... .......
T Consensus 329 kL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~ 403 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQ 403 (543)
T ss_dssp EECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHH
T ss_pred EEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHH
Confidence 99999999876554322 134689999999999999999999999999999999999999997643211 1122222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
....... ..+......+.+++..||+.||++||++
T Consensus 404 ~i~~~~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 404 RVLEQAV-----------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HHHHCCC-----------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred HHhhccc-----------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 2222111 0111223458889999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.68 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=197.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--CCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--HRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~ 312 (532)
...|.+.+.||+|+||.||+|.+. .|+.||||++...... ......+.+|+.++.+++ ||||++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~------------~~~~~~~~~Ei~~l~~l~~~~~~iv~ 120 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD------------NQTLDSYRNEIAYLNKLQQHSDKIIR 120 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCC------------HHHHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEeccccc------------HHHHHHHHHHHHHHHHcccCCCeEEE
Confidence 456999999999999999999875 4889999999765332 334567899999999996 599999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++
T Consensus 121 ~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~ 191 (390)
T 2zmd_A 121 LYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DG 191 (390)
T ss_dssp EEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SS
T ss_pred EEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CC
Confidence 9999999999999999 558899999976 346889999999999999999999998 99999999999996 57
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----------LTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 899999999987755433222346689999999998865 468999999999999999999999997532
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. ....+........... ........+.+++..||+.||++|||+.++++
T Consensus 272 ~------~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 272 N------QISKLHAIIDPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp C------HHHHHHHHHCTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H------HHHHHHHHhCccccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 2 1112222222111100 00111345788999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=348.32 Aligned_cols=280 Identities=16% Similarity=0.178 Sum_probs=205.8
Q ss_pred cccCccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+.. .++..+|||++....... ..............+.+|+..+..++||||+
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~---~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL---FSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHH---HHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcch---HHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 34679999999999999999999864 137899999998764321 1112222222345688899999999999999
Q ss_pred cceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 312 PLQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 312 ~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 183 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL 183 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence 99999988 67889999999 99999999752 37999999999999999999999998 999999999999
Q ss_pred ecCCC--cEEEeccCCcccCCCCCcc-----eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 388 IDDGM--EARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 388 l~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99877 9999999999876432211 1113457999999999999999999999999999999999999999642
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.... ......... .....+.. +..... ....+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 264 ~~~~--~~~~~~~~~-~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 264 LKDP--VAVQTAKTN-LLDELPQS-VLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TTCH--HHHHHHHHH-HHHTTTHH-HHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccc--HHHHHHHHh-hcccccHH-HHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 2211 111111111 11111110 000000 0022345888999999999999999999999998753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=369.07 Aligned_cols=257 Identities=27% Similarity=0.385 Sum_probs=207.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|++...... .......+.+|+.++.+++||||++++
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~t-g~~vAvK~l~k~~~~-----------~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 250 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRAT-GKMYACKKLEKKRIK-----------KRKGEAMALNEKQILEKVNSRFVVSLA 250 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEhHhhh-----------hhHHHHHHHHHHHHHHHcCCCCEeeEE
Confidence 45789999999999999999988764 999999999643211 012245688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+.+..|+||||++||+|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|++
T Consensus 251 ~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 251 YAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCe
Confidence 999999999999999999999999975 23445999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+.
T Consensus 326 KL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~ 402 (576)
T 2acx_A 326 RISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402 (576)
T ss_dssp EECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH
T ss_pred EEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh
Confidence 9999999987765432 2456899999999999999999999999999999999999999986432111111222111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
. ... .........+.+++..||+.||.+|| +++++++
T Consensus 403 ---~-~~~----------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 ---E-VPE----------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---H-CCC----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---c-ccc----------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1 110 01112234588899999999999999 6777764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=345.62 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=206.7
Q ss_pred cccCccccceecccCCeEEEEEEee----CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVP----GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+. ..++..||||.+..... ......+.+|+.++++++|||
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~ 94 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-------------EQDELDFLMEALIISKFNHQN 94 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC-------------HHHHHHHHHHHHHHHHCCCTT
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc-------------hhhHHHHHHHHHHHhhCCCCC
Confidence 4568999999999999999999853 22477999999975432 233457889999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
|+++++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NI 171 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNC 171 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHE
Confidence 99999999999999999999999999999986432 1245899999999999999999999998 99999999999
Q ss_pred EecC---CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 387 LIDD---GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 387 ll~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
+++. +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 9984 44699999999986543332222245678999999999999999999999999999999998 9999975322
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..+.. .......+. .....+..+.+++..||+.||.+|||+.++++.|+.+.
T Consensus 252 ----~~~~~---~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 252 ----QEVLE---FVTSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----HHHHH---HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHH---HHhcCCCCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11222 222111110 11122345888999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=360.14 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=206.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.+++.++||||++++
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~-g~~vAvK~i~~~~~~~-----------~~~~~~~~~Ei~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRS-----------LDVVGKIRREIQNLKLFRHPHIIKLY 82 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEEhhhccC-----------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45799999999999999999988764 8999999997532110 12245788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~v 155 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNA 155 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCe
Confidence 999999999999999999999999964 456999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||++......... ....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||..... ....
T Consensus 156 kL~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~ 225 (476)
T 2y94_A 156 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLF 225 (476)
T ss_dssp EECCCSSCEECCTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHH
T ss_pred EEEeccchhhccccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHH
Confidence 99999999877654321 45689999999999988765 6899999999999999999999976332 1122
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ... ........+.+++..||+.||.+|||+.++++
T Consensus 226 ~~i~~~-~~~----------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 KKICDG-IFY----------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HHHHTT-CCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcC-CcC----------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 222221 110 00112235788999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.34 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=184.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.++++++||||++++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~ 77 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHT-GLEVAIKMIDKKAMYK-----------AGMVQRVQNEVKIHCQLKHPSILELY 77 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHTTBCCTTBCCEE
T ss_pred cccceeeeeecCCCceEEEEEEEccC-CceEEEEEeehhhhhh-----------hhHHHHHHHHHHHHHhCCCCCeEeEE
Confidence 35689999999999999999987654 8999999986431110 12246788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 78 NYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp EEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCE
T ss_pred EEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCE
Confidence 999999999999999999999999974 3457899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... . ..
T Consensus 152 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~---~~ 222 (278)
T 3cok_A 152 KIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----T---LN 222 (278)
T ss_dssp EECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------
T ss_pred EEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----H---HH
Confidence 99999999876543221 134678999999999999899999999999999999999999997533210 0 01
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... +.. ........+.+++..||+.||++|||++++++
T Consensus 223 ~~~~~-------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 223 KVVLA-------DYE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCSS-------CCC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhhc-------ccC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11000 000 11122345788999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=337.99 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=192.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||+|++...... ......+..+...++.++||||+++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~~~~~~~~~~h~~iv~~ 71 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPS-GQIMAVKRIRATVNS------------QEQKRLLMDLDISMRTVDCPFTVTF 71 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEC---CH------------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCC-CeEEEEEEeecccCc------------HHHHHHHHHHHHHHHhCCCCeEEEE
Confidence 456899999999999999999988654 899999999765322 1223445556666888999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++++..++..++||||++ |+|.+++.........+++..++.++.|++.||.|||+. + ++||||||+||+++.++
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~ 147 (290)
T 3fme_A 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALG 147 (290)
T ss_dssp EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTC
T ss_pred eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCC
Confidence 999999999999999996 599998876555567899999999999999999999997 8 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH----QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.+||+|||+++........ ....||+.|+|||++ .+..++.++||||+|+++|+|++|+.||..... ..
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~-- 220 (290)
T 3fme_A 148 QVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PF-- 220 (290)
T ss_dssp CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HH--
T ss_pred CEEEeecCCcccccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hH--
Confidence 9999999999876554322 345799999999995 566789999999999999999999999975322 11
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+........+... ....+..+.+++..||+.||++|||+.++++
T Consensus 221 --~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 221 --QQLKQVVEEPSPQLP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --HHHHHHHHSCCCCCC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHHHHHhccCCCCcc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111122222111110 1112345888999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.09 Aligned_cols=266 Identities=27% Similarity=0.308 Sum_probs=202.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+..+ +..||+|++........ .......+.+|+.++++++||||++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQT-RAIRAIKIMNKNKIRQI---------NPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHHC------------CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhhheeecceeeecCCeEEEEEEECCC-CceEEEeehhhhhhccc---------CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3457899999999999999999988754 89999999864321100 0233567899999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCC------------------------------------CCCCCHHHHHH
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG------------------------------------RRELDWLARYR 356 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~ 356 (532)
+++++.+.+..++|||||++|+|.+++...... ...+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 999999999999999999999999998531111 22346777889
Q ss_pred HHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--cEEEeccCCcccCCCCCc--ceeeecccccccccccccccc-
Q 037084 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM--EARISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPEYHQT- 431 (532)
Q Consensus 357 i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~- 431 (532)
++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+
T Consensus 173 i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 173 IMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 9999999999999998 99999999999998776 899999999986533211 112246679999999999865
Q ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcC
Q 037084 432 -LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCT 510 (532)
Q Consensus 432 -~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl 510 (532)
..++.++|||||||++|+|++|+.||...... +............ .. .........+.+++..||
T Consensus 250 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~---~~----~~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCF---EN----PNYNVLSPLARDLLSNLL 315 (345)
T ss_dssp SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCT---TS----GGGGGSCHHHHHHHHHHS
T ss_pred CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhccccc---CC----cccccCCHHHHHHHHHHc
Confidence 67899999999999999999999999764321 1112222211110 00 011122345888999999
Q ss_pred CCCCCCCCCHHHHHH
Q 037084 511 SDDPEERPSSKDVRC 525 (532)
Q Consensus 511 ~~~P~~RPs~~evl~ 525 (532)
+.||.+|||+.++++
T Consensus 316 ~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 316 NRNVDERFDAMRALQ 330 (345)
T ss_dssp CSCTTTSCCHHHHHH
T ss_pred CCChhHCCCHHHHhc
Confidence 999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=372.45 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=210.0
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+. .+..||||+++..... .+.|.+|+.++++++||||++
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~hpniv~ 326 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQ 326 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cchhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCCCC---------------HHHHHHHHHHHHhCCCCCEee
Confidence 45678999999999999999999987 3578999999875321 256889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+ +..++|||||++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 327 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~ 400 (535)
T 2h8h_A 327 LYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENL 400 (535)
T ss_dssp EEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCC
Confidence 9999976 6789999999999999999752 2345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+
T Consensus 401 ~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~----~~~-- 473 (535)
T 2h8h_A 401 VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----REV-- 473 (535)
T ss_dssp CEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH----HHH--
T ss_pred cEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHH--
Confidence 9999999999876543211 1133456789999999999999999999999999999999 9999975432 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........... ....++..+.+++..||+.||++|||+++|++.|+++-
T Consensus 474 -~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 474 -LDQVERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 12222111110 11223456888999999999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.88 Aligned_cols=266 Identities=25% Similarity=0.306 Sum_probs=198.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++...... ......+.+|+.+++.++||||+++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vAiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~l 126 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIISL 126 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTT-TEEEEEEEEESGGGS------------HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCC-CCEEEEEEECccccC------------hHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 457899999999999999999988764 899999999764221 2335678899999999999999999
Q ss_pred eeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++...+ ..|+|||||++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 127 ~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIl 196 (464)
T 3ttj_A 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 196 (464)
T ss_dssp SEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred EEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEE
Confidence 99997653 56999999965 57666642 3889999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++.+||+|||+++....... .+...||++|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 197 l~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 197 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp ECTTSCEEECCCCCC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EeCCCCEEEEEEEeeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987654322 256789999999999999999999999999999999999999997643311111
Q ss_pred cHHHH---------------HHHHhccCCC------cccccccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 468 NMVRW---------------MRNVISSENP------HRAIDSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 468 ~l~~~---------------~~~~~~~~~~------~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
.+... .......... ...+...+... ........+.+|+..||+.||++|||++|+
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 11110 0111110000 00000000000 011235678999999999999999999998
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
++
T Consensus 354 L~ 355 (464)
T 3ttj_A 354 LQ 355 (464)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=343.40 Aligned_cols=268 Identities=23% Similarity=0.353 Sum_probs=210.5
Q ss_pred ccCccccceecccCCeEEEEEEee---CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVP---GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~---~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.++|.+.+.||+|+||.||+|.+. ..+|+.||||++.... ......+.+|+.++++++||||+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv 105 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------------EEHLRDFEREIEILKSLQHDNIV 105 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------------SHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------------HHHHHHHHHHHHHHHhCCCCCee
Confidence 457899999999999999999852 3358999999998753 22346788999999999999999
Q ss_pred cceeEEecCC--ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 312 PLQAHVTRPD--CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 312 ~l~~~~~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++++++...+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 179 (326)
T 2w1i_A 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVE 179 (326)
T ss_dssp CEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEE
T ss_pred eEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEc
Confidence 9999987654 78999999999999999975 2346899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCccee-eeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch----
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIR-ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT---- 464 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~---- 464 (532)
.++.+||+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+.......
T Consensus 180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~ 259 (326)
T 2w1i_A 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259 (326)
T ss_dssp ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence 999999999999988765433211 133457788999999998889999999999999999999999986432100
Q ss_pred ----hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 ----EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 ----~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
........+.......... ......+..+.+++..||+.||++|||+.++++.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0000111111111111110 111223456888999999999999999999999999886
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=348.00 Aligned_cols=265 Identities=20% Similarity=0.256 Sum_probs=195.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||+++..... ......+.+|+.++++++||||+++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~ 98 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVT-NETVAIKRIRLEHEE------------EGVPGTAIREVSLLKELQHRNIIEL 98 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTT-TEEEEEEECCCCC--------------------CHHHHHHGGGCCCTTBCCE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCC-CceEEEEEEcccccc------------cccchhHHHHHHHHHHcCCCCcceE
Confidence 456799999999999999999987764 899999999765422 2234567889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe-----
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI----- 388 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll----- 388 (532)
++++...+..++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 99 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 99 KSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC---
T ss_pred EEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCC
Confidence 999999999999999996 599999975 345899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++.+||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--- 245 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--- 245 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---
T ss_pred CccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---
Confidence 45556999999999876543222 2456789999999998775 48999999999999999999999997643311
Q ss_pred cHHHHHHHHhccCCC---cccc--------cccccCCCcH-----HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENP---HRAI--------DSKLLGNGYE-----EQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~---~~~~--------d~~l~~~~~~-----~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+...... ...... .... .+........ .....+.+++..||+.||++|||+.++++
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 246 QLFKIFEV-LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHHH-HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11111111 110000 0000 0000000001 12356889999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=347.42 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=197.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++||||++++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~---------------~~~~~e~~~~~~~~~~h~~i~~~~ 73 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFSFANR---------------QNFINEKNIYRVPLMEHDNIARFI 73 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET---TEEEEEEEEEGGGH---------------HHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC---CeEEEEEEeeccch---------------hhHHHHHHHHHHHhccCcchhhhe
Confidence 467999999999999999999774 88999999975421 111122344445668999999999
Q ss_pred eEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecC
Q 037084 315 AHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY---------HRPCIIHRD 380 (532)
Q Consensus 315 ~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~---------~~~~ivH~D 380 (532)
+++.. ....++||||+++|+|.+++.. ...++..++.++.|++.||.|||+. + |+|||
T Consensus 74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~D 145 (336)
T 3g2f_A 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRD 145 (336)
T ss_dssp EEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSS
T ss_pred ecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecc
Confidence 86542 2356899999999999999975 2358899999999999999999998 6 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCc------ceeeecccccccccccccccc-------CCCCchhhHHHHHHHH
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHT------RIRITTVAGTTGYVAPEYHQT-------LTISEKSDIYSFGVLL 447 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl 447 (532)
|||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++
T Consensus 146 ikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il 225 (336)
T 3g2f_A 146 LNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225 (336)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHH
T ss_pred cccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHH
Confidence 999999999999999999999987654321 111235579999999999886 4567899999999999
Q ss_pred HHHHhCCCCCCCcccchhhcc----------HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCC
Q 037084 448 AVLVVGKFPFDDFFQYTEEMN----------MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEER 517 (532)
Q Consensus 448 ~elltg~~p~~~~~~~~~~~~----------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R 517 (532)
|||++|..|+........... .................+.... ......+..+.+++..||+.||++|
T Consensus 226 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEAR 303 (336)
T ss_dssp HHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhC
Confidence 999999777643222111100 0111111111111111111111 1223466779999999999999999
Q ss_pred CCHHHHHHHHhhhh
Q 037084 518 PSSKDVRCMLSQIK 531 (532)
Q Consensus 518 Ps~~evl~~L~~l~ 531 (532)
||+.++++.|+++.
T Consensus 304 ps~~e~l~~L~~ll 317 (336)
T 3g2f_A 304 LTAQXAEERMAELM 317 (336)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHH
Confidence 99999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.61 Aligned_cols=264 Identities=24% Similarity=0.313 Sum_probs=208.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+.. +|+.||||++...... ..+.+|+.+++.++|+|++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~----------------~~~~~e~~~l~~l~~~~~i~~ 69 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKTKH----------------PQLHIESKIYKMMQGGVGIPT 69 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCSSC----------------CHHHHHHHHHHHHTTSTTCCC
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCcch----------------hHHHHHHHHHHHhhcCCCCCc
Confidence 35689999999999999999998765 4899999998765321 357789999999999887776
Q ss_pred eeEE-ecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---c
Q 037084 314 QAHV-TRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---D 389 (532)
Q Consensus 314 ~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~ 389 (532)
+.++ ...+..++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||++ +
T Consensus 70 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 142 (296)
T 3uzp_A 70 IRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGG
T ss_pred cccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCC
Confidence 6665 5667789999999 9999999974 2346999999999999999999999998 9999999999999 4
Q ss_pred CCCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 037084 390 DGMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 464 (532)
.++.+||+|||+++......... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.......
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 88899999999998765543211 1245679999999999999999999999999999999999999998654322
Q ss_pred hhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 465 EEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
....+........... .. .+. ...+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~--~~----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 223 KRQKYERISEKKMSTP--IE----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSSHHHHHHHHHHHSC--HH----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hhhhhhhhcccccCCc--hH----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 2222222222111110 00 000 112345888999999999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.21 Aligned_cols=249 Identities=20% Similarity=0.271 Sum_probs=200.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||+|++....... .....+.+|+..+.++ +||||+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~~~~l~~h~~iv~~ 76 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGS------------VDEQNALREVYAHAVLGQHSHVVRY 76 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCCTTS------------HHHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCC-CceEEEEEeccccccc------------HHHHHHHHHHHHHHHhCCCCCeeee
Confidence 45789999999999999999988754 8999999998653321 2235677899999999 99999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC--
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG-- 391 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~-- 391 (532)
++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCC
Confidence 99999999999999999999999999875444467899999999999999999999998 9999999999999844
Q ss_pred -----------------CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhC
Q 037084 392 -----------------MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVG 453 (532)
Q Consensus 392 -----------------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg 453 (532)
..+||+|||++...... ....||+.|+|||.+.+. .++.++|||||||++|+|++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 227 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred CcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence 47999999999876543 234689999999998776 566899999999999999999
Q ss_pred CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 454 KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 454 ~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+|+..... ...... +... .+ .......+.+++..||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~----------~~~~~~-~~~~-----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 228 EPLPRNGDQ----------WHEIRQ-GRLP-----RI----PQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCCSSSHH----------HHHHHT-TCCC-----CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCcchhH----------HHHHHc-CCCC-----CC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 987753211 111111 1111 01 1112345888999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=349.44 Aligned_cols=252 Identities=26% Similarity=0.317 Sum_probs=200.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++..... .+.+|+.++.++ +||||+++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~avK~~~~~~~------------------~~~~E~~~l~~~~~hp~iv~~ 81 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKAT-NMEFAVKIIDKSKR------------------DPTEEIEILLRYGQHPNIITL 81 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTTC------------------CCHHHHHHHHHHTTSTTBCCE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCC-CCEEEEEEEEcccC------------------ChHHHHHHHHHhcCCCCcCeE
Confidence 45799999999999999999988764 89999999976532 233577777777 79999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC--
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG-- 391 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~-- 391 (532)
++++.+.+..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++.++
T Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~ 154 (342)
T 2qr7_A 82 KDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESG 154 (342)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSC
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCC
Confidence 9999999999999999999999999974 346899999999999999999999998 9999999999998533
Q ss_pred --CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 --MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 --~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~ 228 (342)
T 2qr7_A 155 NPESIRICDFGFAKQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD----DTP 228 (342)
T ss_dssp SGGGEEECCCTTCEECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT----SCH
T ss_pred CcCeEEEEECCCcccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc----CCH
Confidence 35999999999876544322 1456889999999999888899999999999999999999999975321 112
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+........ ... +...........+.+++..||+.||++|||+.++++
T Consensus 229 ~~~~~~i~~~-~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 229 EEILARIGSG-KFS------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHC-CCC------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccC-Ccc------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2222222221 111 011111223456888999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.85 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=198.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|...+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~l 89 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQS------------ELFAKRAYRELRLLKHMRHENVIGL 89 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTT-CCEEEEEECSSTTSS------------HHHHHHHHHHHHHHHHCCBTTBCCC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCC-CCEEEEEEeCccccC------------HHHHHHHHHHHHHHHhCCCcCCCCc
Confidence 457899999999999999999988754 899999999654322 2334678899999999999999999
Q ss_pred eeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++...+ ..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 160 (367)
T 1cm8_A 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLA 160 (367)
T ss_dssp SEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred eeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEE
Confidence 99998763 459999999 8899999975 35899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++.++.+||+|||+++...... +...||++|+|||++.+ ..++.++||||+||++|||++|+.||........
T Consensus 161 l~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~- 234 (367)
T 1cm8_A 161 VNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ- 234 (367)
T ss_dssp ECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-
T ss_pred EcCCCCEEEEeeeccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999998765432 45678999999998877 6799999999999999999999999976432111
Q ss_pred ccHHHHHHHHhccCCCccc------------------ccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRA------------------IDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~------------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+...... .+... ..........+.....+.+++..||+.||++|||+.++++
T Consensus 235 ---l~~i~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 235 ---LKEIMKVTGT-PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp ---HHHHHHHHCC-CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHhcCC-CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1111111100 00000 0000001111223456889999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=344.72 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=207.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||.||+|.+..+ |..||+|++.......... ......+.+|+.++++++||||++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~ 81 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKST-GLEYAAKFIKKRQSRASRR--------GVSREEIEREVSILRQVLHHNVITLH 81 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEBCSSSSCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCC-CeEEEEEEEeccccccccc--------chhHHHHHHHHHHHHhCCCCCcceEE
Confidence 45799999999999999999988754 8999999997653221000 01135688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 82 DVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSS
T ss_pred EEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCC
Confidence 999999999999999999999999964 356899999999999999999999998 99999999999999888
Q ss_pred --cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 --EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 --~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------- 224 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------- 224 (321)
T ss_dssp SCCEEECCCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------
T ss_pred cCCEEEccCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------
Confidence 7999999999877654322 4567999999999999999999999999999999999999999753221
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.......... ..++.... .....+.+++..||+.||++|||+.++++
T Consensus 225 ~~~~~i~~~~~---~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 225 ETLANITSVSY---DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTTCC---CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccc---ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111111110 01111111 12345888999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=336.98 Aligned_cols=251 Identities=24% Similarity=0.278 Sum_probs=203.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ +..+|+|.+...... ....+.+|+.++++++||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~a~k~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~~ 72 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGT-RIRRAAKKIPKYFVE--------------DVDRFKQEIEIMKSLDHPNIIRLY 72 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCC-CcEEEEEeehhhccc--------------hHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45689999999999999999988764 889999998754221 135688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---cCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~~~ 391 (532)
+++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 145 (277)
T 3f3z_A 73 ETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPD 145 (277)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTT
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCC
Confidence 999999999999999999999999875 345899999999999999999999998 9999999999999 788
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.++|+|||++......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... +
T Consensus 146 ~~~~l~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~ 214 (277)
T 3f3z_A 146 SPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------E 214 (277)
T ss_dssp CCEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------H
T ss_pred CcEEEEecccceeccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------H
Confidence 99999999999876554322 45679999999998876 4899999999999999999999999764321 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............ ..... ......+.+++..||+.||.+|||+.++++
T Consensus 215 ~~~~~~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 215 VMLKIREGTFTF---PEKDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHCCCCC---CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHhCCCCC---Cchhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111100 00000 012345888999999999999999999875
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=349.61 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=197.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|.+..+ |+.||+|++..... ......+.+|+.++++++||||+++++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~~ 67 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLT-DNLVALKEIRLEHE-------------EGAPCTAIREVSLLKDLKHANIVTLHD 67 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECC-------------------CCCCCCCHHHHSCCCCTTBCCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCC-CcEEEEEEEecccc-------------cccchhHHHHHHHHHhcCCCCCCeeee
Confidence 4688999999999999999988754 89999999976531 111224567999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 68 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~k 140 (324)
T 3mtl_A 68 IIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140 (324)
T ss_dssp EEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEE
Confidence 9999999999999996 699999875 2456899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+++........ .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ......+.
T Consensus 141 l~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~i~ 214 (324)
T 3mtl_A 141 LADFGLARAKSIPTKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV----EEQLHFIF 214 (324)
T ss_dssp ECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred EccCcccccccCCccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 9999999865543222 245678999999998876 5689999999999999999999999976433 12222222
Q ss_pred HHhccCCCc---ccccc---------cccCC----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPH---RAIDS---------KLLGN----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~---~~~d~---------~l~~~----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... ..... ..... ..+.....+.+++..||+.||++|||++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 215 RILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 222211110 00000 00000 01122356789999999999999999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=331.42 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=201.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
...|.+.+.||+|+||+||+|.+..+ +..||+|.+...... ......+.+|+.++++++||||++++
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~va~k~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~ 91 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFY 91 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCC-ceEEEEEEecchhhC------------HHHHHHHHHHHHHHHhCCCCCeeeee
Confidence 34578889999999999999988764 889999998754322 23356788999999999999999999
Q ss_pred eEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-
Q 037084 315 AHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID- 389 (532)
Q Consensus 315 ~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~- 389 (532)
+++.. ....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++
T Consensus 92 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~ 166 (290)
T 1t4h_A 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITG 166 (290)
T ss_dssp EEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESS
T ss_pred eeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEEC
Confidence 99865 3557999999999999999975 245899999999999999999999875 3599999999999998
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.++.+||+|||++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... .
T Consensus 167 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~ 235 (290)
T 1t4h_A 167 PTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------A 235 (290)
T ss_dssp TTSCEEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------H
T ss_pred CCCCEEEeeCCCccccccccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc------H
Confidence 789999999999976554432 45679999999998874 699999999999999999999999975322 1
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............+ ..++. . ....+.+++..||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~-~~~~~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 236 AQIYRRVTSGVKP-ASFDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHTTTCCC-GGGGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCCc-cccCC----C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1222222221111 11111 1 1235888999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=347.97 Aligned_cols=268 Identities=24% Similarity=0.280 Sum_probs=199.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++......... ......+.+|+.++++++||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAK---------DGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSC-CSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCC-CcEEEEEEEecCCcchhh---------hhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 46799999999999999999988754 899999999764322110 11234678999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCE
Confidence 999999999999999975 89888864 3456888899999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... .+....
T Consensus 152 kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~ 226 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIF 226 (346)
T ss_dssp EECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEEecccceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence 99999999876543322 2456789999999998654 58999999999999999999999997643211 111111
Q ss_pred HHHhccCCCccc---------ccccccCCC-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRA---------IDSKLLGNG-----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~---------~d~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. .......... +........ .......+.+++..||+.||++|||+.++++
T Consensus 227 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 227 E-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp H-HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred H-HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1 1111100000 000000000 0223456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=345.16 Aligned_cols=255 Identities=15% Similarity=0.112 Sum_probs=203.8
Q ss_pred cccCccccceecccCCeEEEEEEe----eCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEV----PGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--- 306 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~----~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--- 306 (532)
..++|.+.+.||+|+||+||+|.+ ...+++.||||++..... ..+..|+.++.+++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----------------WEFYIGTQLMERLKPSM 125 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH-----------------HHHHHHHHHHHHSCGGG
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh-----------------hHHHHHHHHHHHhhhhh
Confidence 467899999999999999999952 122488999999986531 34566677777665
Q ss_pred CCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 307 HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-GRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 307 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
|+||+.+++++...+..++|||||++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~N 202 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHH
Confidence 99999999999999999999999999999999986433 3567999999999999999999999988 9999999999
Q ss_pred EEecC-----------CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC
Q 037084 386 VLIDD-----------GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK 454 (532)
Q Consensus 386 Ill~~-----------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 454 (532)
||++. ++.+||+|||+++...........+...||++|+|||++.+..++.++|||||||++|||++|+
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99998 8999999999997654333333346678999999999999999999999999999999999999
Q ss_pred CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhhh
Q 037084 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEER-PSSKDVRCMLSQI 530 (532)
Q Consensus 455 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~l 530 (532)
.||....... . .....+..... ...+.+++..|++.+|.+| |++.++.+.|+++
T Consensus 283 ~pf~~~~~~~--~-----------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 283 YMKVKNEGGE--C-----------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp CCCEEEETTE--E-----------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CccccCCCCc--e-----------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 9996432210 0 00011111111 3346678888999999999 6788888887764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=372.08 Aligned_cols=259 Identities=20% Similarity=0.262 Sum_probs=203.5
Q ss_pred ccCccccc-eecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLE-IIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~-~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.+++.+.+ .||+|+||.||+|.+... ++..||||+++..... .....|.+|+.++++++||||++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~E~~il~~l~hpniv~ 400 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVR 400 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-------------TTHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-------------HHHHHHHHHHHHHHhCCCCCEee
Confidence 34455555 799999999999988642 3568999999865321 22467889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++++|.. +..++|||||++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 401 l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~ 473 (613)
T 2ozo_A 401 LIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRH 473 (613)
T ss_dssp EEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETT
T ss_pred EEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCC
Confidence 9999986 568999999999999999974 3456999999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 393 EARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.
T Consensus 474 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~ 549 (613)
T 2ozo_A 474 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVM 549 (613)
T ss_dssp EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHH
T ss_pred cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHH
Confidence 99999999998765433211 1123445789999999999999999999999999999998 99999864331 122
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.. ......+ .....++..+.+++..||+.+|++|||+.++++.|+.+
T Consensus 550 ~~---i~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 550 AF---IEQGKRM----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HH---HHTTCCC----------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HH---HHcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22 1111111 11122345688999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.33 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=203.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++............ ......+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEK-NKEVVVKFIKKEKVLEDCWIE------DPKLGKVTLEIAILSRVEHANIIKVL 95 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTT-TEEEEEEEEESTTSCTTSEEE------ETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred ccceEEEeEEEecCCEEEEEEEECCC-CcEEEEEEEehhhcccccccc------hHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45799999999999999999987764 899999999765321100000 01123567899999999999999999
Q ss_pred eEEecCCceEEEEEeccCC-CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNG-SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++.+.+..++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence 9999999999999999777 99999974 346999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
+||+|||+++........ ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........
T Consensus 169 ~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------- 238 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE------- 238 (335)
T ss_dssp EEECCCTTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------
T ss_pred EEEeecccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------
Confidence 999999999877654332 45679999999999988876 7899999999999999999999975322000
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ......+.+++..||+.||++|||+.++++
T Consensus 239 -----~~~~~~------------~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 239 -----AAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -----TCCCCS------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hccCCC------------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 012345888999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.84 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=204.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |..||+|++..... ......+.+|+.++++++||||++++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~va~K~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEECCCC-------------HHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCC-CcEEEEEEeccccC-------------HHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 46799999999999999999988764 89999999986532 23346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCCc
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++..++..++||||+++++|.+++... ..+++..+..++.+++.||.|||+. + |+||||||+||+++.++.
T Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~ 170 (360)
T 3eqc_A 98 GAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGE 170 (360)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCC
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCC
Confidence 9999999999999999999999999762 3589999999999999999999985 7 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc-----
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN----- 468 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~----- 468 (532)
+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 171 ~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 246 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246 (360)
T ss_dssp EEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred EEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 9999999987543221 1456789999999999999999999999999999999999999976432111000
Q ss_pred ------------------------------HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC
Q 037084 469 ------------------------------MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP 518 (532)
Q Consensus 469 ------------------------------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP 518 (532)
..+..........+ ..........+.+++..||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---------KLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCCC---------CCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC---------CCCcccccHHHHHHHHHHhhcChhhCC
Confidence 00011111110000 000111234588999999999999999
Q ss_pred CHHHHHH
Q 037084 519 SSKDVRC 525 (532)
Q Consensus 519 s~~evl~ 525 (532)
|++++++
T Consensus 318 t~~ell~ 324 (360)
T 3eqc_A 318 DLKQLMV 324 (360)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=334.05 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=204.2
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+..+ |+.||||++...... .....+.+|+.++++++||||+++++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 72 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFYG 72 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEEGGGCT-------------THHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCC-CcEEEEEEeeeccch-------------hhhHHHHHHHHHHHhcCCCCceeeee
Confidence 5688999999999999999988754 899999998654221 12356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+|
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 145 (276)
T 2yex_A 73 HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145 (276)
T ss_dssp EEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEE
Confidence 99999999999999999999998853 456899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||++................||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... ......|..
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~ 223 (276)
T 2yex_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKE 223 (276)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHT
T ss_pred EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhh
Confidence 999999987643322222245678999999999987765 77899999999999999999999764321 111112211
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... .........+.+++..||+.||++|||+.++++
T Consensus 224 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 224 ----KKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccccc---------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 11100 001122345788999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.19 Aligned_cols=265 Identities=15% Similarity=0.190 Sum_probs=206.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCC-------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGS-------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH 307 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H 307 (532)
.++|.+.+.||+|+||.||+|.+..+ +++.||||++... ..+.+|+.++++++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------------STHHHHHHHHHHHCC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------------chHHHHHHHHHHhcc
Confidence 46899999999999999999998753 3789999999764 246788999999999
Q ss_pred CCccc---------------ceeEEec-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 037084 308 RNLLP---------------LQAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY 371 (532)
Q Consensus 308 ~niv~---------------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~ 371 (532)
|||++ +++++.. .+..++||||+ +++|.+++... ....+++..++.++.|++.||.|||+.
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~ 178 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN 178 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99887 6777776 67889999999 99999999862 246799999999999999999999999
Q ss_pred CCCCeeecCCCCCcEEecCCC--cEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHH
Q 037084 372 HRPCIIHRDIKPANVLIDDGM--EARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFG 444 (532)
Q Consensus 372 ~~~~ivH~Dlkp~NIll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 444 (532)
+ |+||||||+||+++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||
T Consensus 179 ~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 179 E---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp T---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred C---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 8 99999999999999998 89999999998765432111 11345799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 445 VLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 445 vvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
|++|+|++|+.||..... ....+.......... +....+.... ....+..+.+++..||+.||++|||+++++
T Consensus 256 ~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLP--NTEDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp HHHHHHHHSCCTTGGGTT--CHHHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHHhCCCCcccCCc--CHHHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 999999999999986432 112222222222211 1111111100 011234588899999999999999999999
Q ss_pred HHHhhhh
Q 037084 525 CMLSQIK 531 (532)
Q Consensus 525 ~~L~~l~ 531 (532)
+.|+++.
T Consensus 329 ~~L~~~~ 335 (352)
T 2jii_A 329 NNLEALL 335 (352)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.84 Aligned_cols=265 Identities=26% Similarity=0.354 Sum_probs=202.6
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
...++|.+.+.||+|+||+||+|.+...++. .||||+++...... ......+.+|+.++++++||||
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i 83 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----------PEAMDDFIREVNAMHSLDHRNL 83 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTB
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-----------HHHHHHHHHHHHHHHhCCCCCc
Confidence 3457899999999999999999987654444 69999987643211 2345678899999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++..++ .++|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 84 ~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~ 156 (291)
T 1u46_A 84 IRLYGVVLTPP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLAT 156 (291)
T ss_dssp CCEEEEECSSS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEE
T ss_pred ccEEEEEccCC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcC
Confidence 99999998765 88999999999999999753 346899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
++.+||+|||++.......... ......+|..|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------ 230 (291)
T 1u46_A 157 RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------ 230 (291)
T ss_dssp TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------
T ss_pred CCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------
Confidence 9999999999998776543321 1234567889999999998889999999999999999999 9999975432
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.............. ......+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 231 -~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 231 -SQILHKIDKEGERL---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -HHHHHHHHTSCCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -HHHHHHHHccCCCC---------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11222222211111 011123456889999999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=357.17 Aligned_cols=199 Identities=26% Similarity=0.344 Sum_probs=157.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+++
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~i~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~l 117 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLE-KRVVAIKKILRVFED------------LIDCKRILREIAILNRLNHDHVVKV 117 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC---CEEEEEEECSTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCC-CcEEEEEEechhhcC------------HHHHHHHHHHHHHHHhCCCCCCCce
Confidence 356899999999999999999988764 899999999754322 2334678899999999999999999
Q ss_pred eeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++... +..|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 118 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl 189 (458)
T 3rp9_A 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLV 189 (458)
T ss_dssp EEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEE
T ss_pred EEEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEE
Confidence 9999443 5689999998 6799999864 456999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcc-------------------------eeeecccccccccccccc-ccCCCCchhhHHH
Q 037084 389 DDGMEARISDFGLAKLMPDGHTR-------------------------IRITTVAGTTGYVAPEYH-QTLTISEKSDIYS 442 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwS 442 (532)
+.++.+||+|||+++........ ...+..+||++|+|||++ .+..++.++||||
T Consensus 190 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwS 269 (458)
T 3rp9_A 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269 (458)
T ss_dssp CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHH
Confidence 99999999999999876432110 122456789999999975 5667999999999
Q ss_pred HHHHHHHHHhC
Q 037084 443 FGVLLAVLVVG 453 (532)
Q Consensus 443 lGvvl~elltg 453 (532)
|||++|||++|
T Consensus 270 lG~il~elltg 280 (458)
T 3rp9_A 270 IGCIFAELLNM 280 (458)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHHh
Confidence 99999999993
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=337.54 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=203.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||+|++..... .....+.+|+.++++++||||++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPA--------------FRDSSLENEIAVLKKIKHENIVTLE 72 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEECC--------------------HHHHHHHHHHHCCCTTBCCEE
T ss_pred hccceeeeeccCCCCceEEEEEECCC-CCEEEEEEEecccc--------------cchHHHHHHHHHHHhCCCCCeeehh
Confidence 45789999999999999999988754 89999999986531 1235678899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---cCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~~~ 391 (532)
+++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++ +.+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~ 145 (304)
T 2jam_A 73 DIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEEN 145 (304)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTT
T ss_pred hhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCC
Confidence 999999999999999999999999875 245899999999999999999999998 9999999999999 788
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ..+
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~-- 215 (304)
T 2jam_A 146 SKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE----SKL-- 215 (304)
T ss_dssp CCEEBCSCSTTCCCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH--
T ss_pred CCEEEccCCcceecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHH--
Confidence 9999999999976543321 345789999999999999999999999999999999999999975322 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... +.. ......+..+.+++..||+.||++|||+.++++
T Consensus 216 -~~~i~~~~~~---~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 216 -FEKIKEGYYE---FES----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -HHHHHHCCCC---CCT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -HHHHHcCCCC---CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111110 001 111223355889999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=349.29 Aligned_cols=206 Identities=26% Similarity=0.320 Sum_probs=171.2
Q ss_pred cccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 232 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
+...++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vAiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~nIv 88 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNT-EKNVAIKKVNRMFED------------LIDCKRILREITILNRLKSDYII 88 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECSTTTS------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCC-CcEEEEEEeCchhcC------------hHHHHHHHHHHHHHHHcCCCCcc
Confidence 34567899999999999999999988764 899999999764322 23346788999999999999999
Q ss_pred cceeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++++... +..|+||||++ |+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 89 ~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NI 160 (432)
T 3n9x_A 89 RLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANC 160 (432)
T ss_dssp CEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred eEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHe
Confidence 999999776 57899999995 699999964 456999999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcc--------------------eeeecccccccccccccc-ccCCCCchhhHHHHHH
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTR--------------------IRITTVAGTTGYVAPEYH-QTLTISEKSDIYSFGV 445 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGv 445 (532)
|++.++.+||+|||+++........ ...+..+||++|+|||++ ....++.++||||+||
T Consensus 161 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~ 240 (432)
T 3n9x_A 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240 (432)
T ss_dssp EECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred EECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHH
Confidence 9999999999999999976543211 122567899999999985 5667999999999999
Q ss_pred HHHHHHhCCCCCC
Q 037084 446 LLAVLVVGKFPFD 458 (532)
Q Consensus 446 vl~elltg~~p~~ 458 (532)
++|||++|..||.
T Consensus 241 il~ell~g~~p~~ 253 (432)
T 3n9x_A 241 IFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHTTCTTTC
T ss_pred HHHHHHhcccccc
Confidence 9999998655553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=334.00 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=207.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ ++.||+|++....... ......+.+|+.++++++||||+++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 80 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADT-KEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 80 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCC-CceEEEEEechhhccC-----------HHHHHHHHHHHHHHHhCCCCCEeee
Confidence 346799999999999999999988764 8899999986542211 2334678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 153 (294)
T 2rku_A 81 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 153 (294)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCC
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCC
Confidence 9999999999999999999999999875 346899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +..
T Consensus 154 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~ 224 (294)
T 2rku_A 154 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETY 224 (294)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHH
T ss_pred EEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHH
Confidence 999999999876543322 14567899999999999989999999999999999999999999763321 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ... + .......+.+++..||+.||++|||+.++++
T Consensus 225 ~~~~~~-~~~------~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 225 LRIKKN-EYS------I----PKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHTT-CCC------C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhhc-cCC------C----ccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 110 0 1112245788999999999999999999876
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=336.56 Aligned_cols=250 Identities=26% Similarity=0.307 Sum_probs=205.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ +..||+|++....... ......+.+|+.++++++||||++++
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQN-KFIMALKVLFKSQLEK-----------EGVEHQLRREIEIQSHLRHPNILRMY 80 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCC-CcEEEEEEEcccccch-----------HHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence 35799999999999999999988754 8899999986431110 11235788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCE
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCE
Confidence 9999999999999999999999999762 35899999999999999999999988 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|..||...... ....
T Consensus 154 kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~ 222 (284)
T 2vgo_A 154 KIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------ETHR 222 (284)
T ss_dssp EECCCTTCEECSSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHH
T ss_pred EEecccccccCccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------HHHH
Confidence 9999999876544322 4567899999999999999999999999999999999999999754321 1111
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... .. . ........+.+++..|++.||.+|||+.++++
T Consensus 223 ~~~~~-~~------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 223 RIVNV-DL------K----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHTT-CC------C----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhcc-cc------C----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 12111 11 0 11112345788999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.65 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=188.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
...+|.+.+.||+|+||.||+|.+..+ |+.||||++.... ......+.+|+.++.++. ||||++
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~~h~~iv~ 90 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGS-GREYALKRLLSNE--------------EEKNRAIIQEVCFMKKLSGHPNIVQ 90 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTT-CCEEEEEEEEESS--------------HHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred cCceEEEEEEEccCCceEEEEEEECCC-CcEEEEEEecCCc--------------hHHHHHHHHHHHHHHHhccCCChhh
Confidence 456799999999999999999998764 8999999986543 233467889999999995 999999
Q ss_pred ceeEEe--------cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 037084 313 LQAHVT--------RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 313 l~~~~~--------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~ 384 (532)
+++++. .....++|+||+ +|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++++||||||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~ 167 (337)
T 3ll6_A 91 FCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVE 167 (337)
T ss_dssp EEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGG
T ss_pred ccccccccccccccCCceEEEEEEec-CCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcc
Confidence 999994 334579999999 579999987543 2456999999999999999999999864 34999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcce----------eeecccccccccccccc---ccCCCCchhhHHHHHHHHHHHH
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTRI----------RITTVAGTTGYVAPEYH---QTLTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~ell 451 (532)
||+++.++.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|+
T Consensus 168 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~ 247 (337)
T 3ll6_A 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247 (337)
T ss_dssp GCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred cEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence 9999999999999999998765432211 11245689999999988 5667899999999999999999
Q ss_pred hCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 452 tg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+|+.||..... .. ........ ... ......+.+++..||+.||.+|||+.++++.|+++.
T Consensus 248 ~g~~p~~~~~~----~~---~~~~~~~~-~~~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 248 FRQHPFEDGAK----LR---IVNGKYSI-PPH------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp HSSCCC-------------------CCC-CTT------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCcchhH----HH---hhcCcccC-Ccc------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999975322 11 11110000 000 011123778999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=335.63 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=207.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+.|...+.||+|+||.||+|.+..+ |+.||||++...... .....+.+|+.++++++||||++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~ 84 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRT-QKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTK 84 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEETTTCS-------------TTHHHHHHHHHHHHHCCCTTBCC
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCC-CcEEEEEEecccccH-------------HHHHHHHHHHHHHHhCCCCCEeE
Confidence 3556799999999999999999987654 899999999765321 12466889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 156 (303)
T 3a7i_A 85 YYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHG 156 (303)
T ss_dssp EEEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTS
T ss_pred EEEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCC
Confidence 99999999999999999999999999863 46899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......
T Consensus 157 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~ 230 (303)
T 3a7i_A 157 EVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVLFL 230 (303)
T ss_dssp CEEECCCTTCEECBTTBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHH
T ss_pred CEEEeecccceecCccccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHHHH
Confidence 9999999999876544322 2456789999999999999999999999999999999999999975432 111111
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~ 526 (532)
+ .. .... .+.. .....+.+++..||+.||++|||+.++++.
T Consensus 231 ~---~~-~~~~-----~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 231 I---PK-NNPP-----TLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp H---HH-SCCC-----CCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred h---hc-CCCC-----CCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 11 1111 1111 123458889999999999999999999863
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=341.55 Aligned_cols=263 Identities=25% Similarity=0.337 Sum_probs=206.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc--CCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR--IWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~ 312 (532)
.++|.+.+.||+|+||.||+|.+. |+.||||++.... ...+.+|.+++.. ++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~l~h~ni~~ 100 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSRE-----------------ERSWFREAEIYQTVMLRHENILG 100 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEECGGG-----------------HHHHHHHHHHHHHSCCCCTTBCC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc---CccEEEEEeCchh-----------------HHHHHHHHHHHHHhhcCCCcEEE
Confidence 467999999999999999999874 8899999996431 1345677777776 79999999
Q ss_pred ceeEEecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecC
Q 037084 313 LQAHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH--------MYHRPCIIHRD 380 (532)
Q Consensus 313 l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~D 380 (532)
+++++...+ ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ ++|||
T Consensus 101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~D 172 (342)
T 1b6c_B 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRD 172 (342)
T ss_dssp EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSC
T ss_pred EEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCC
Confidence 999998876 78999999999999999975 35899999999999999999999 667 99999
Q ss_pred CCCCcEEecCCCcEEEeccCCcccCCCCCcce--eeeccccccccccccccccCC------CCchhhHHHHHHHHHHHHh
Q 037084 381 IKPANVLIDDGMEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTLT------ISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 381 lkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~ellt 452 (532)
|||+||+++.++.+||+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|||++
T Consensus 173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999999999999999999998765443221 124567999999999987752 3478999999999999999
Q ss_pred C----------CCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 453 G----------KFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 453 g----------~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
| ..||...... ......+........ ....+.... ...+.+..+.+++..||+.||++|||+.+
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~ 326 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPS--DPSVEEMRKVVCEQK-LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALR 326 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCS--SCCHHHHHHHHTTSC-CCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccCcCCcccccccCccccCcC--cccHHHHHHHHHHHH-hCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence 9 7788653321 112222222222211 111111100 12356778999999999999999999999
Q ss_pred HHHHHhhhh
Q 037084 523 VRCMLSQIK 531 (532)
Q Consensus 523 vl~~L~~l~ 531 (532)
+++.|+++.
T Consensus 327 i~~~L~~i~ 335 (342)
T 1b6c_B 327 IKKTLSQLS 335 (342)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.06 Aligned_cols=200 Identities=23% Similarity=0.279 Sum_probs=173.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC------CCC
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI------WHR 308 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~H~ 308 (532)
..+|.+.+.||+|+||+||+|.+..+ ++.||||++... ......+.+|+.++..+ +|+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~-~~~vAvK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~ 159 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKV-HQHVALKMVRNE---------------KRFHRQAAEEIRILEHLRKQDKDNTM 159 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTT-TEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHTTCTTSCS
T ss_pred cCcEEEEEEcccCccEEEEEEEECCC-CcEEEEEEECCc---------------cchHHHHHHHHHHHHHHhhccccCCc
Confidence 45799999999999999999988764 899999999865 22334566677776665 678
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
||+.+++++...+..++||||+. ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl 233 (429)
T 3kvw_A 160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILL 233 (429)
T ss_dssp CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEE
T ss_pred CEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 99999999999999999999995 799999986 33345899999999999999999999998 9999999999999
Q ss_pred cCCCc--EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 389 DDGME--ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 389 ~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
+.++. +||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|++||....
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99887 9999999997654432 45689999999999999999999999999999999999999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.54 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=193.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ ++.||||++........... .......+.+|+.++++++||||++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAR------EADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEEGGGGTTC--------------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCC-CcEEEEEEEEechhcccccc------cchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 46799999999999999999988764 89999999875432110000 012234588999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++.. +..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~ 278 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSS
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCc
Confidence 99865 557999999999999988854 456999999999999999999999998 99999999999997544
Q ss_pred -cEEEeccCCcccCCCCCcceeeecccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 393 -EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT---LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 393 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ...
T Consensus 279 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~ 352 (419)
T 3i6u_A 279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT---QVS 352 (419)
T ss_dssp CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS---SCC
T ss_pred ceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc---hHH
Confidence 599999999987754432 245689999999998853 5688899999999999999999999975322 112
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+...+. .+... ..+... ......+.+++..||+.||++|||+.++++
T Consensus 353 ~~~~i~----~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 353 LKDQIT----SGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHHH----TTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHh----cCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222111 11110 001111 112356889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=358.66 Aligned_cols=248 Identities=14% Similarity=0.174 Sum_probs=192.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH---HHHhcCCCCCc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI---ITAGRIWHRNL 310 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~H~ni 310 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ....+.+.+|+ ..+++++||||
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~l~hpni 138 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPP-----------SNAIKQMKEEVLRLRLLRGIKNQKQ 138 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CC-CCEEEEEEEEECC-CC-----------TTHHHHHHHHHHGGGGSTTCCSHHH
T ss_pred CCceEEEcceeecCCCEEEEEEEECCC-CcEEEEEEEeeccccc-----------hHHHHHHHHHHHHHHhccccCCHHH
Confidence 456799999999999999999988654 8999999997432111 22346788899 56666789999
Q ss_pred ccce-------eEEecCCc-----------------eEEEEEeccCCCHHHHHhhhcC---CCCCCCHHHHHHHHHHHHH
Q 037084 311 LPLQ-------AHVTRPDC-----------------HLLVYEFMKNGSLQDILHDVSQ---GRRELDWLARYRIARGMAS 363 (532)
Q Consensus 311 v~l~-------~~~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~ 363 (532)
++++ +++..++. .|+||||+ +|+|.+++..... ....+++..++.++.|++.
T Consensus 139 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~ 217 (377)
T 3byv_A 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217 (377)
T ss_dssp HHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHH
Confidence 9998 66665543 78999999 7899999986321 1234557888999999999
Q ss_pred HHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-----------
Q 037084 364 GLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL----------- 432 (532)
Q Consensus 364 gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------- 432 (532)
||+|||+.+ |+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 218 aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~ 288 (377)
T 3byv_A 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRT 288 (377)
T ss_dssp HHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred HHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccc
Confidence 999999998 99999999999999999999999999986433 1245677 999999999887
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCC
Q 037084 433 TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSD 512 (532)
Q Consensus 433 ~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~ 512 (532)
.++.++|||||||++|||++|+.||.......... .... .....+..+.+++..||+.
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~------~~~~~~~~~~~li~~~L~~ 346 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE----------------WIFR------SCKNIPQPVRALLEGFLRY 346 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC------CCSG----------------GGGS------SCCCCCHHHHHHHHHHTCS
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCcccccccchh----------------hhhh------hccCCCHHHHHHHHHHcCC
Confidence 89999999999999999999999997533211000 0000 0011234588899999999
Q ss_pred CCCCCCCHHHHHH
Q 037084 513 DPEERPSSKDVRC 525 (532)
Q Consensus 513 ~P~~RPs~~evl~ 525 (532)
||++|||+.++++
T Consensus 347 dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 347 PKEDRLLPLQAME 359 (377)
T ss_dssp SGGGCCCHHHHHT
T ss_pred CchhCCCHHHHhh
Confidence 9999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=352.28 Aligned_cols=264 Identities=20% Similarity=0.250 Sum_probs=200.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++..... ...+|+.+++.++||||+++
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~-~~~vAiK~~~~~~~------------------~~~~E~~il~~l~hpnIv~l 65 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIES-GKRFALKKVLQDPR------------------YKNRELDIMKVLDHVNIIKL 65 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTT-CCEEEEEEEECCTT------------------SCCHHHHHHTTCCCTTBCCE
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCC-CCEEEEEEEecCcc------------------hHHHHHHHHHHcCCCCccch
Confidence 456799999999999999999988764 89999999876531 22368999999999999999
Q ss_pred eeEEecC--------------------------------------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHH
Q 037084 314 QAHVTRP--------------------------------------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355 (532)
Q Consensus 314 ~~~~~~~--------------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~ 355 (532)
++++... ...++||||++ |+|.+.+.........+++..+.
T Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~ 144 (383)
T 3eb0_A 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLIS 144 (383)
T ss_dssp EEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHH
T ss_pred hheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHH
Confidence 9998543 33789999997 59988887655556789999999
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-C
Q 037084 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-T 433 (532)
Q Consensus 356 ~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~ 433 (532)
.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||+++........ ....||+.|+|||++.+. .
T Consensus 145 ~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 145 IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATE 218 (383)
T ss_dssp HHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCC
Confidence 99999999999999998 99999999999998 6889999999999876544322 456789999999988765 4
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH--------HHHHhccCCCcccccccccCC-----CcHHHHH
Q 037084 434 ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW--------MRNVISSENPHRAIDSKLLGN-----GYEEQMR 500 (532)
Q Consensus 434 ~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~--------~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~ 500 (532)
++.++||||+||++|+|++|+.||...........+... +.... .......-+..... .....+.
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN--PHYTEVRFPTLKAKDWRKILPEGTPS 296 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC--TTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhC--cccccccCCccCcccHHhhCCCCCCH
Confidence 899999999999999999999999864332111111110 00000 00000000000000 1122345
Q ss_pred HHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 501 LVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 501 ~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.+++..||+.||++|||+.++++
T Consensus 297 ~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 297 LAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCCCHHHHhc
Confidence 6889999999999999999999974
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.13 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=205.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+..+ |+.||+|++.......... ......+.+|+.++++++||||+++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 75 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGT-GKEYAAKFIKKRRLSSSRR--------GVSREEIEREVNILREIRHPNIITLHD 75 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEBCSSTTCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCC-CCeeehHHhhhcccccccc--------chHHHHHHHHHHHHHhCCCCCeeehhh
Confidence 4688999999999999999988764 8999999987653221100 011356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC---
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM--- 392 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 392 (532)
++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 76 IFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSS
T ss_pred eecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCC
Confidence 99999999999999999999999975 346899999999999999999999998 99999999999998877
Q ss_pred -cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 -EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 149 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~ 218 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-------E 218 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H
T ss_pred CceEEEecccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------H
Confidence 8999999999876543321 4557899999999999999999999999999999999999999764321 1
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC--MLSQI 530 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~l 530 (532)
........ ... ...... ...+..+.+++..||+.||++|||+.++++ .++.+
T Consensus 219 ~~~~~~~~-~~~--~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 219 TLTNISAV-NYD--FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHTT-CCC--CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHhHhc-ccC--Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 11111111 100 011111 112345888999999999999999999987 44443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=340.13 Aligned_cols=253 Identities=21% Similarity=0.342 Sum_probs=207.1
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||++.+..+ ++.||+|++....... ......+.+|+.++++++||||+++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADT-KEVFAGKIVPKSLLLK-----------PHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGCCS-----------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEechhhhcC-----------HHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 346799999999999999999988764 8899999986542211 2345678899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 179 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLE 179 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCC
Confidence 9999999999999999999999999875 246899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +..
T Consensus 180 ~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~ 250 (335)
T 2owb_A 180 VKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-------ETY 250 (335)
T ss_dssp EEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHH
T ss_pred EEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-------HHH
Confidence 999999999876543322 14567999999999999999999999999999999999999999753221 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... + .......+.+++..||+.||++|||+.++++
T Consensus 251 ~~~~~~~~~-------~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 251 LRIKKNEYS-------I----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHTCCC-------C----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHhcCCCC-------C----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111100 0 0112234788999999999999999999875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=347.73 Aligned_cols=264 Identities=18% Similarity=0.203 Sum_probs=205.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--------
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-------- 306 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------- 306 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||++... ......+.+|+.++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~ 99 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQG-KKFVAMKVVKSA---------------EHYTETALDEIRLLKSVRNSDPNDPN 99 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHHSCTTCGG
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCC-CeEEEEEEEecC---------------CcchHHHHHHHHHHHHHhhcCCCCCC
Confidence 46799999999999999999987754 899999999865 233466788999998885
Q ss_pred CCCcccceeEEe----cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCC
Q 037084 307 HRNLLPLQAHVT----RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDI 381 (532)
Q Consensus 307 H~niv~l~~~~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dl 381 (532)
||||+++++++. .....++||||+ +++|.+++.. .....+++..+..++.|++.||.|||+. + |+||||
T Consensus 100 ~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDi 173 (397)
T 1wak_A 100 REMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDI 173 (397)
T ss_dssp GGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCC
T ss_pred cceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 788999999997 556789999999 6777777765 3345699999999999999999999998 8 999999
Q ss_pred CCCcEEecCCC-------------------------------------------------cEEEeccCCcccCCCCCcce
Q 037084 382 KPANVLIDDGM-------------------------------------------------EARISDFGLAKLMPDGHTRI 412 (532)
Q Consensus 382 kp~NIll~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~ 412 (532)
||+|||++.++ .+||+|||+++......
T Consensus 174 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~--- 250 (397)
T 1wak_A 174 KPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--- 250 (397)
T ss_dssp SGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---
T ss_pred CHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---
Confidence 99999999776 79999999998765432
Q ss_pred eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh--hccHHHHHHHHhccCC---------
Q 037084 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE--EMNMVRWMRNVISSEN--------- 481 (532)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~--~~~l~~~~~~~~~~~~--------- 481 (532)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......+........
T Consensus 251 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 328 (397)
T 1wak_A 251 --TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328 (397)
T ss_dssp --CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTT
T ss_pred --ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccc
Confidence 456789999999999999999999999999999999999999975433211 1111111111111100
Q ss_pred Cccccccc-------------------ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 482 PHRAIDSK-------------------LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 482 ~~~~~d~~-------------------l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+... -...........+.+|+..||+.||++|||+.++++
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000 001234667788999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.08 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=199.2
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
+.|.+.+.||+|+||+||+|.+..+ +..||+|++...... ......+.+|+.++++++||||+++++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~~ 103 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVT-HVERAIKIIRKTSVS------------TSSNSKLLEEVAVLKLLDHPNIMKLYD 103 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTT-CCEEEEEEEEC-----------------CTTHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCC-CcEEEEEEEeccccC------------chHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4699999999999999999988764 899999999765321 112356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC---C
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG---M 392 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 392 (532)
++...+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +
T Consensus 104 ~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 104 FFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCC
Confidence 99999999999999999999999875 245899999999999999999999998 9999999999999764 4
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|..||..... .. .
T Consensus 177 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~---~ 245 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD----QE---I 245 (494)
T ss_dssp CEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH---H
T ss_pred cEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HH---H
Confidence 599999999987755432 24567999999999886 4699999999999999999999999976432 11 1
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ++...+ ...+..+.+++..||+.+|.+|||+.++++
T Consensus 246 ~~~i~~~~~~---~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 246 LRKVEKGKYT---FDSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHTCCC---CCSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCC---CCchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2222211111 011111 122345888999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.91 Aligned_cols=266 Identities=20% Similarity=0.293 Sum_probs=207.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC-----
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN----- 309 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n----- 309 (532)
.++|.+.+.||+|+||.||+|.+...+|+.||||+++.. ......+.+|+.++..++|+|
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~~~~ 77 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------------DRYCEAARSEIQVLEHLNTTDPNSTF 77 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------------HHHHHHHHHHHHHHHHHHHHCTTCTT
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------------CchhHHHHHHHHHHHHhhhcCCCCce
Confidence 457999999999999999999885556899999999765 233456778888888887654
Q ss_pred -cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 310 -LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 310 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++++++...+..++||||+ +++|.+++.. ....++++..+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~ 151 (339)
T 1z57_A 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILF 151 (339)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred eeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 999999999999999999999 8999999976 33456899999999999999999999998 9999999999999
Q ss_pred cC-------------------CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 389 DD-------------------GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 389 ~~-------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
+. ++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 226 (339)
T 1z57_A 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226 (339)
T ss_dssp SCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred eccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence 87 6689999999998754432 45678999999999999999999999999999999
Q ss_pred HHhCCCCCCCcccchhhccHHHHHHHHhccCCCccc---------cc---------------------c-cccCCCcHHH
Q 037084 450 LVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRA---------ID---------------------S-KLLGNGYEEQ 498 (532)
Q Consensus 450 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------~d---------------------~-~l~~~~~~~~ 498 (532)
|++|+.||....... ....+...... .+... +. + .-........
T Consensus 227 l~~g~~pf~~~~~~~----~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (339)
T 1z57_A 227 YYLGFTVFPTHDSKE----HLAMMERILGP-LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE 301 (339)
T ss_dssp HHHSSCSCCCSCHHH----HHHHHHHHHCS-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHhCCCCCCCCChHH----HHHHHHHHhCC-CCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhh
Confidence 999999997643311 11111111110 00000 00 0 0001122345
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHHH--Hhhhh
Q 037084 499 MRLVLKIAYFCTSDDPEERPSSKDVRCM--LSQIK 531 (532)
Q Consensus 499 ~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~ 531 (532)
...+.+++..||+.||.+|||+.++++. +++++
T Consensus 302 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 6779999999999999999999999843 44443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=340.24 Aligned_cols=265 Identities=27% Similarity=0.430 Sum_probs=188.2
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+..+ |+.||||++..... ......+.+|+.++++++||||++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~ 77 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPK-KEKVAIKRINLEKC-------------QTSMDELLKEIQAMSQCHHPNIVS 77 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC-----CEEEEECCC-----------------------------CCCCCCCTTBCC
T ss_pred cchhhhhhhheeccccceEEEEEEECCC-CcEEEEEEEEhhhc-------------chhHHHHHHHHHHHhhcCCCCEee
Confidence 3457899999999999999999987654 88999999876421 123467889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVS----QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++...+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~ 154 (303)
T 2vwi_A 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILL 154 (303)
T ss_dssp EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEE
Confidence 9999999999999999999999999997532 12456899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcc---eeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccch
Q 037084 389 DDGMEARISDFGLAKLMPDGHTR---IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYT 464 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~ 464 (532)
+.++.+||+|||++......... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......
T Consensus 155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 99999999999998876543211 11134578999999998876 568999999999999999999999997643311
Q ss_pred hhccHHHHHHHHhccCCC---cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 465 EEMNMVRWMRNVISSENP---HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 465 ~~~~l~~~~~~~~~~~~~---~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ........+ ....++.... .....+.+++..||+.||.+|||+.++++
T Consensus 235 ----~~---~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 235 ----VL---MLTLQNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp ----HH---HHHHTSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ----HH---HHHhccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 111111111 0111111111 22345788999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.89 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=202.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||++...... ......+.+|+.++++++||||++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~~ 87 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVINKASAK------------NKDTSTILREVELLKKLDHPNIMKLF 87 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTT-CCEEEEEEEEHHHHB------------CSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCC-CCEEEEEEEeccccc------------chHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 45799999999999999999988754 899999998643111 11235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec---CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID---DG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~---~~ 391 (532)
+++...+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 160 (486)
T 3mwu_A 88 EILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD 160 (486)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTT
T ss_pred EEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCC
Confidence 999999999999999999999999875 246899999999999999999999998 99999999999995 45
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ..+
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~-- 230 (486)
T 3mwu_A 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YDI-- 230 (486)
T ss_dssp CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH--
T ss_pred CCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH--
Confidence 6799999999987655432 245689999999999876 599999999999999999999999976432 111
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.......... +.. .....+..+.+++..||+.||.+|||+.++++
T Consensus 231 -~~~i~~~~~~~---~~~----~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 231 -LKRVETGKYAF---DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -HHHHHHTCCCS---CSG----GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHHHHhCCCCC---CCc----ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22222111110 000 01122345889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.11 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=196.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.++++++||||++++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~ 77 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLT-GHKVAVKILNRQKIRS-----------LDVVGKIKREIQNLKLFRHPHIIKLY 77 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCC-CceEEEEEeccccccc-----------hhHHHHHHHHHHHHhcCCCCCEeEEE
Confidence 45799999999999999999988754 8999999986432110 12246788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 78 QVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCE
T ss_pred EEEecCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCE
Confidence 9999999999999999999999999752 35899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+|+|||++......... ....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ..+ .
T Consensus 151 ~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~---~ 220 (276)
T 2h6d_A 151 KIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTL---F 220 (276)
T ss_dssp EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---H
T ss_pred EEeecccccccCCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHH---H
Confidence 99999999876554321 35578999999999988765 6899999999999999999999975322 111 1
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... +... ........+.+++..||+.||++|||+.++++
T Consensus 221 ~~~~~-~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 221 KKIRG-GVFY----------IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp HHHHH-CCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhhc-Cccc----------CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 11111 1110 01112345788999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=335.00 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=200.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..+.|.+.+.||+|+||.||+|.+..+ |+.||+|.+..... ...+.+|+.++.+++||||+++
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~ 89 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKET-GQIVAIKQVPVESD----------------LQEIIKEISIMQQCDSPHVVKY 89 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTT-CCEEEEEEEETTSC----------------CHHHHHHHHHHHTCCCTTBCCE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCC-CCEEEEEecCchHH----------------HHHHHHHHHHHHhCCCCCCccE
Confidence 456799999999999999999988754 89999999976531 2457889999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 163 (314)
T 3com_A 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGH 163 (314)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred EEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCC
Confidence 9999999999999999999999999974 2356899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ...
T Consensus 164 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~ 234 (314)
T 3com_A 164 AKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAI 234 (314)
T ss_dssp EEECCCTTCEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHH
T ss_pred EEEeecccchhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHH
Confidence 999999999876543221 14567899999999999999999999999999999999999999754321 111
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... ..... ........+.+++..||+.||.+|||+.++++
T Consensus 235 ~~~~~~~-~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 235 FMIPTNP-PPTFR-------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHSC-CCCCS-------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhcCC-CcccC-------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111 11100 01112345888999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=373.33 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=199.2
Q ss_pred ceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
+.||+|+||.||+|.+... .++.||||+++..... ......+.+|+.++.+++||||++++++|..
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 441 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIVRMIGICEA- 441 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC------------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4799999999999976432 3689999999764322 1224678999999999999999999999975
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence 568999999999999999975 346899999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhc
Q 037084 401 LAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVIS 478 (532)
Q Consensus 401 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 478 (532)
+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.. ....
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~~~~---~i~~ 587 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTA---MLEK 587 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHH---HHHT
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH---HHHc
Confidence 99877554321 11234457889999999999999999999999999999998 9999976433 11111 1111
Q ss_pred cCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 479 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...+ ......+..+.+++..||+.||++|||+.++++.|+++
T Consensus 588 ~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 588 GERM----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 11122345688999999999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.33 Aligned_cols=254 Identities=25% Similarity=0.341 Sum_probs=199.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.....||+|+||.||+|.+..+ +..||||.+..... .....+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 86 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSN-QVRIAIKEIPERDS--------------RYSQPLHEEIALHKHLKHKNIVQYLG 86 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTT-CCEEEEEEEECCCC-----------------HHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCC-CeEEEEEEccCCch--------------HHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 3455567899999999999988754 89999999976532 22356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-CCcE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEA 394 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~ 394 (532)
++...+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 162 (295)
T 2clq_A 87 SFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVL 162 (295)
T ss_dssp EEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCE
T ss_pred EEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCE
Confidence 999999999999999999999999763 23345778999999999999999999998 999999999999987 8999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
||+|||++......... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..
T Consensus 163 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~ 235 (295)
T 2clq_A 163 KISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AM 235 (295)
T ss_dssp EECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HH
T ss_pred EEeecccccccCCCCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HH
Confidence 99999999876543221 14567899999999987654 88999999999999999999999975322111 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... + .........+.+++..||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 236 FKVGMFKVH------P----EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHCCC------C----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred Hhhcccccc------c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111100 0 111223345888999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=339.87 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=205.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++.......... ........+.+|+.++.++ +||||+++
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~-g~~vavK~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPE------QLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEETTSSCCCHH------HHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhcccceEEecCCCEEEEEEEECCC-CcEEEEEEEEccccccCHH------HHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 35689999999999999999988654 8999999987653211000 0123356788999999999 89999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999975 346899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeecccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT------LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .
T Consensus 239 ikl~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~ 311 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----I 311 (365)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred EEEEecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----H
Confidence 999999999877654322 45689999999998863 3588999999999999999999999975322 1
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.. ........... ...... .....+.+++..||+.||++|||+.++++
T Consensus 312 ~~---~~~i~~~~~~~---~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LM---LRMIMEGQYQF---SSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH---HHHHHHTCCCC---CHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH---HHHHHhCCCCC---CCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111111100 000001 12345888999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.26 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=200.2
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...+.|.+.+.||+|+||.||+|.+..+ |..||+|++.... ......+.+|+.++++++||||++
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~~aiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~ 80 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKET-GALAAAKVIETKS--------------EEELEDYIVEIEILATCDHPYIVK 80 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTT-CCEEEEEEEC------------------CCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccceeecceeccCCCeEEEEEEEcCC-CcEEEEEEecCCC--------------HHHHHHHHHHHHHHhcCCCCCEee
Confidence 3567899999999999999999998754 8999999987653 122467889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++...+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 154 (302)
T 2j7t_A 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEG 154 (302)
T ss_dssp EEEEEECC-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTS
T ss_pred eeeeeeeCCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCC
Confidence 999999999999999999999999998752 345899999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccc-----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH-----QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
.+||+|||++........ ......||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 155 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---- 228 (302)
T 2j7t_A 155 DIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---- 228 (302)
T ss_dssp CEEECCCHHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred CEEEEECCCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----
Confidence 999999998764321111 11345789999999987 4667899999999999999999999999764321
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...........+.. .. ....+..+.+++..||+.||++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~-~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 229 ---RVLLKIAKSDPPTL-LT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHHSCCCCC-SS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHhccCCccc-CC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11222222221111 11 1122345888999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=332.59 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=200.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+..+ +..||+|++........ ......+.+|+.++++++||||+++++
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSET-LCRRAVKILKKKKLRRI----------PNGEANVKKEIQLLRRLRHKNVIQLVD 73 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTT-CCEEEEEEECHHHHHHS----------TTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCC-CcEEEEEEecccccccc----------chhHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 5799999999999999999987654 89999999975421100 123467889999999999999999999
Q ss_pred EEe--cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 316 HVT--RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 316 ~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++. +.+..++||||++++ |.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~ 147 (305)
T 2wtk_C 74 VLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGT 147 (305)
T ss_dssp EEECC---CEEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEcCCCCeEEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCc
Confidence 984 456789999999776 8787765 23457999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT--ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+||+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..
T Consensus 148 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~ 220 (305)
T 2wtk_C 148 LKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YK 220 (305)
T ss_dssp EEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH
T ss_pred EEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HH
Confidence 9999999998775443333335667999999999987654 37899999999999999999999975322 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........ ... + .......+.+++..||+.||++|||+.++++
T Consensus 221 ~~~~i~~~-~~~------~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 221 LFENIGKG-SYA------I----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHHHC-CCC------C----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHhcC-CCC------C----CCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11221111 110 0 1112345788999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.78 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=202.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ +..||+|++.............. .......+.+.+|+.++++++||||++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNG-HSEKAIKVIKKSQFDKGRYSDDN-KNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTT-CCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCC-CcEEEEEEEEhhhcccccccccc-hhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 46799999999999999999988764 89999999976542211100000 00012346788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++.+.+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999975 345899999999999999999999998 99999999999998776
Q ss_pred -cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 393 -EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
.+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|..||..... ..
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~--- 254 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND----QD--- 254 (504)
T ss_dssp SSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH---
T ss_pred ccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH----HH---
Confidence 6999999999877654322 45679999999999874 699999999999999999999999976432 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+....... .. ++...+. ..+..+.+++..||+.||.+|||+.++++
T Consensus 255 ~~~~i~~~~-~~--~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 IIKKVEKGK-YY--FDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHCC-CC--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHcCC-CC--CCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 122222111 10 0101111 12345889999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=334.52 Aligned_cols=262 Identities=24% Similarity=0.307 Sum_probs=196.6
Q ss_pred ccCcccc-ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 235 EDSLASL-EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
.+.|.+. +.||+|+||.||+|.+..+ |+.||||++...... ....+.+|+.++.++ +||||++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~~~~h~~i~~ 75 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLIT-SQEYAVKIIEKQPGH--------------IRSRVFREVEMLYQCQGHRNVLE 75 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSS-CCEEEEEEEECCSSC--------------CHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ceeEEecCceecCCceEEEEEEEEcCC-CcEEEEEEEeeCcch--------------hHHHHHHHHHHHHHhcCCCCeee
Confidence 3467774 7899999999999987654 899999999765321 235678899999885 7999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~ 148 (316)
T 2ac3_A 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPN 148 (316)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSS
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCC
Confidence 999999999999999999999999999762 46899999999999999999999998 99999999999999877
Q ss_pred c---EEEeccCCcccCCCCCc-----ceeeecccccccccccccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 393 E---ARISDFGLAKLMPDGHT-----RIRITTVAGTTGYVAPEYHQT-----LTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 393 ~---~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
. +||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 6 99999999986543211 111134569999999999875 5688999999999999999999999976
Q ss_pred cccchhhcc--------HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 460 FFQYTEEMN--------MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 460 ~~~~~~~~~--------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... .......... +... +..... ......+.+++..||+.||++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQE-GKYE--FPDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHH-CCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccccccccchhHHHHHHHHHhc-cCcc--cCchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 432111000 0111111111 1110 000000 112345889999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.13 Aligned_cols=261 Identities=19% Similarity=0.283 Sum_probs=202.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||++.... ...+.+|+.++++++ ||||++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~i~~ 95 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIIT 95 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECSCC-----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCC-CcEEEEEEecccc-----------------hHHHHHHHHHHHHcCCCCCEEE
Confidence 457899999999999999999987654 8999999998543 245788999999997 999999
Q ss_pred ceeEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++.. ....++||||+++++|.+++.. +++..+..++.|++.||.|||+.+ ++||||||+|||++.
T Consensus 96 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH 165 (330)
T ss_dssp EEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred eeeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcC
Confidence 9999987 5678999999999999999853 888999999999999999999998 999999999999997
Q ss_pred CC-cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh-c
Q 037084 391 GM-EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE-M 467 (532)
Q Consensus 391 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-~ 467 (532)
++ .+||+|||+++........ ....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 76 8999999999876544322 45678999999999877 67899999999999999999999999543221110 0
Q ss_pred ---------cHHHHHHHHhcc----------CCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 ---------NMVRWMRNVISS----------ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ---------~l~~~~~~~~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+..++...... ......................+.+++..||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 243 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111110000 0000000111111112224566899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.32 Aligned_cols=257 Identities=11% Similarity=0.036 Sum_probs=184.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHH---HHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI---ITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~H~niv 311 (532)
...|...+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+ ..|+. +||||+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~~~~l~~-~hp~iv 127 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVER-LEDFALKVFTMGAENS-----------RSELERLHEATFAAARLLG-ESPEEA 127 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEECCSTTH-----------HHHHHHHHHHHHHHHHHHC-------
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCC-CceeEEEEEEeccccc-----------ccHHHHHHHHHHHHHHhcc-cChhhh
Confidence 34588999999999999999988764 8999999998865322 23345667774 45555 799977
Q ss_pred cce-------eEEecCC-----------------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHH------HHHHHHH
Q 037084 312 PLQ-------AHVTRPD-----------------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR------YRIARGM 361 (532)
Q Consensus 312 ~l~-------~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i 361 (532)
+++ +++...+ ..++|||||+ |+|.+++.... ..+++..+ ..++.|+
T Consensus 128 ~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi 203 (371)
T 3q60_A 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQL 203 (371)
T ss_dssp ----CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHH
T ss_pred hhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHH
Confidence 744 4554332 3799999998 89999998632 23455555 7788999
Q ss_pred HHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc--CCCCchhh
Q 037084 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT--LTISEKSD 439 (532)
Q Consensus 362 a~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sD 439 (532)
+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|
T Consensus 204 ~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 204 IRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred HHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCcccc
Confidence 99999999998 9999999999999999999999999998664321 25567799999999987 67999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC
Q 037084 440 IYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519 (532)
Q Consensus 440 vwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs 519 (532)
||||||++|||++|+.||.......... ......................+..+.+++..||+.||++|||
T Consensus 276 iwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 276 AWQLGLSIYRVWCLFLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp HHHHHHHHHHHHHSSCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCcCcccccc---------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC
Confidence 9999999999999999998653211000 0000000000001111111233456889999999999999999
Q ss_pred HHHHHH
Q 037084 520 SKDVRC 525 (532)
Q Consensus 520 ~~evl~ 525 (532)
+.++++
T Consensus 347 ~~e~l~ 352 (371)
T 3q60_A 347 PLEAME 352 (371)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.09 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=205.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+.++++++||||++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~avK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~~ 92 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQ-----------KTDKESLLREVQLLKQLDHPNIMKLY 92 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEETTTCCB-----------SSCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCC-CCEEEEEEEEhhhccc-----------chHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45799999999999999999988764 8999999986543211 11235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---cCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DDG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~~~ 391 (532)
+++...+..++|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 93 EFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred EEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCC
Confidence 999999999999999999999999964 356899999999999999999999998 9999999999999 567
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||+++........ ....||+.|+|||++.+ .++.++||||+||++|+|++|++||..... ..+.
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~- 236 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE----YDIL- 236 (484)
T ss_dssp CCEEECCTTHHHHBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH-
T ss_pred CcEEEEeeeeeEEccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH----HHHH-
Confidence 89999999999876554322 45679999999999876 699999999999999999999999976432 1122
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ... .....+..+.+++..||+.+|.+|||+.++++
T Consensus 237 --~~i~~~~~~~---~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 237 --KKVEKGKYTF---ELP----QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp --HHHHHCCCCC---CSG----GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHcCCCCC---CCc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2222111110 000 11123455889999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=354.48 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=197.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|...+.||+|+||.||+|.+..+ |+.||||++.... ..+.+|+.++++++||||++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~-~~~vaiK~~~~~~------------------~~~~~E~~il~~l~hpniv~l~ 113 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQDK------------------RFKNRELQIMRKLDHCNIVRLR 113 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEECCT------------------TSCCHHHHHHHTCCCTTBCCEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCC-CcEEEEEEecccc------------------hhHHHHHHHHHHcCCCCcccee
Confidence 34689999999999999999998764 8999999987642 1233689999999999999999
Q ss_pred eEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++... ...++||||+++ +|.+.+.........+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl 189 (420)
T 1j1b_A 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLL 189 (420)
T ss_dssp EEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEE
T ss_pred eEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEE
Confidence 998542 235799999965 777777654445677999999999999999999999988 9999999999999
Q ss_pred cCC-CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 389 DDG-MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 389 ~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+.+ +.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 190 ~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-- 264 (420)
T 1j1b_A 190 DPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-- 264 (420)
T ss_dssp ETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred eCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 954 67899999999876544322 456789999999998764 78999999999999999999999997643211
Q ss_pred ccHHHHHHHHh---------ccCCCcccccccccCC-----CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVI---------SSENPHRAIDSKLLGN-----GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~---------~~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+...+...- ..........+.+... +.+.....+.+|+..||+.||.+|||+.++++
T Consensus 265 -~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 265 -QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp -HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1222111100 0000000000111010 11123456889999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.59 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=199.9
Q ss_pred cCcccc-ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 236 DSLASL-EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 236 ~~~~~~-~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
+.|.+. +.||+|+||.||+|.+..+ |+.||+|++....... .....+.+|+.++.++ +||||+++
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKST-GQEYAAKFLKKRRRGQ------------DCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEESEETTE------------ECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCC-CCEEEEEEEehhhcch------------HHHHHHHHHHHHHHhccCCCCEEEE
Confidence 446665 8899999999999988754 8999999997643221 1135678899999999 56999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--- 390 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--- 390 (532)
++++...+..++||||+++|+|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC
Confidence 9999999999999999999999999864 33467999999999999999999999998 999999999999997
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++.+||+|||+++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~ 242 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETY 242 (327)
T ss_dssp BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH
T ss_pred CCcEEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHH
Confidence 789999999999876544321 4567999999999999999999999999999999999999999764321 111
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+... ..... ..........+.+++..||+.||.+|||++++++
T Consensus 243 ~~i~~~--~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 243 LNISQV--NVDYS--------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHT--CCCCC--------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhc--ccccC--------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111 00100 1111223455888999999999999999999875
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.70 Aligned_cols=266 Identities=23% Similarity=0.290 Sum_probs=194.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.+++.++||||+++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpniv~~ 89 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAIL-ERNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIIGL 89 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEECTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCC-CceEEEEEeccccCC------------hHHHHHHHHHHHHHHhcCCCCccce
Confidence 346899999999999999999987654 899999999764322 2334678899999999999999999
Q ss_pred eeEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++...+ ..++||||++ |+|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 90 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl 159 (371)
T 2xrw_A 90 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159 (371)
T ss_dssp EEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred EEeeccccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEE
Confidence 99997765 6799999996 578888752 4889999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
++.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 160 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp ECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EcCCCCEEEEEeecccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999987654321 245679999999999999999999999999999999999999997643211100
Q ss_pred cHH---------------HHHHHHhccCCC------cccccccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 037084 468 NMV---------------RWMRNVISSENP------HRAIDSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523 (532)
Q Consensus 468 ~l~---------------~~~~~~~~~~~~------~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~ev 523 (532)
.+. ..+......... ...+.....+. ........+.+++..||+.||++|||++++
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 000 000000000000 00000000011 112346679999999999999999999999
Q ss_pred HH
Q 037084 524 RC 525 (532)
Q Consensus 524 l~ 525 (532)
++
T Consensus 317 l~ 318 (371)
T 2xrw_A 317 LQ 318 (371)
T ss_dssp HH
T ss_pred hC
Confidence 86
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=341.83 Aligned_cols=267 Identities=23% Similarity=0.272 Sum_probs=202.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... .....+.+|+.++++++||||++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 82 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVNLI 82 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTT-CCEEEEEECCCSSCSS------------SSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceeEEEEEecCCCcEEEEEEECCC-CCEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCcccHh
Confidence 45799999999999999999988754 8999999986653221 1124567899999999999999999
Q ss_pred eEEecC--------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 315 AHVTRP--------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 315 ~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++... +..++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NI 155 (351)
T 3mi9_A 83 EICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 155 (351)
T ss_dssp EEEEEC--------CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred heeeccccccccCCceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHE
Confidence 999873 46899999996 488887764 3356999999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCc--ceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHT--RIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
+++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 156 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~- 234 (351)
T 3mi9_A 156 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE- 234 (351)
T ss_dssp EECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred EEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 999999999999999987653221 122245678999999998876 4589999999999999999999999986433
Q ss_pred hhhccHHHHHHHHhccCCCcc--ccc-ccc---------cCCCcHHH------HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 464 TEEMNMVRWMRNVISSENPHR--AID-SKL---------LGNGYEEQ------MRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~--~~d-~~l---------~~~~~~~~------~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......+........+.. ..+ ... ........ ...+.+++..||+.||++|||+.++++
T Consensus 235 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 235 ---QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp ---HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 122222222221111100 000 000 00001111 235889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=336.57 Aligned_cols=254 Identities=27% Similarity=0.383 Sum_probs=196.5
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
...++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ...+.+|+.++.++ +||||+
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~h~~i~ 84 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKT-GQLAAIKVMDVTGDE---------------EEEIKQEINMLKKYSHHRNIA 84 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCSST---------------THHHHHHHHHHHHHCCSTTBC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCC-CCeEEEEEEecCccc---------------HHHHHHHHHHHHhccCCCCee
Confidence 3567899999999999999999988654 899999999765322 24677899999998 899999
Q ss_pred cceeEEec------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 312 PLQAHVTR------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 312 ~l~~~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
++++++.. .+..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~N 159 (326)
T 2x7f_A 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQN 159 (326)
T ss_dssp CEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred eeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHH
Confidence 99999977 46789999999999999999863 3456899999999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
|+++.++.+||+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|++|..||...
T Consensus 160 Il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 160 VLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp EEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EEEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999876543221 14567899999999987 567899999999999999999999999754
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... .. .........+ ... . ......+.+++..||+.||.+|||+.++++
T Consensus 238 ~~~----~~---~~~~~~~~~~-~~~-----~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 238 HPM----RA---LFLIPRNPAP-RLK-----S---KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CHH----HH---HHHHHHSCCC-CCS-----C---SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cHH----HH---HHHhhcCccc-cCC-----c---cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 321 11 1111111111 110 1 112345888999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=329.53 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=207.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++.......... .........+.+|+.+++++. ||||+++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSA-----EEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTCSTTCCH-----HHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhccceeeeecCCCceEEEEEEEcCc-CceEEEEEEecccccccCH-----HHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 46799999999999999999988764 8999999997653211000 001233567889999999995 9999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~ 162 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN 162 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCc
Confidence 9999999999999999999999999975 346899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ------TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+||+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||..... .
T Consensus 163 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~ 235 (298)
T 1phk_A 163 IKLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----M 235 (298)
T ss_dssp EEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H
T ss_pred EEEecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH----H
Confidence 999999999876544321 4567899999999875 45688999999999999999999999975322 1
Q ss_pred cHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............. . .......+..+.+++..||+.||.+|||+.++++
T Consensus 236 ---~~~~~~~~~~~~~---~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 236 ---LMLRMIMSGNYQF---G----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---HHHHHHHHTCCCC---C----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHhcCCccc---C----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111221111100 0 0111223456889999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=336.45 Aligned_cols=265 Identities=22% Similarity=0.305 Sum_probs=202.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ +..||||++..... ......+.+|+.++.+++||||+++
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~ 90 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLN-KVRVAIKKISPFEH-------------QTYCQRTLREIKILLRFRHENIIGI 90 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCTTC-------------HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCC-CeEEEEEEeccccC-------------cHHHHHHHHHHHHHHhcCCCCCccc
Confidence 456899999999999999999987754 89999999975432 2334678899999999999999999
Q ss_pred eeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++... ...++|+||++ |+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 91 ~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~ 161 (364)
T 3qyz_A 91 NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLL 161 (364)
T ss_dssp CEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred eeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEE
Confidence 9999765 36799999996 699999864 35899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcce-eeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 241 (364)
T 3qyz_A 162 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241 (364)
T ss_dssp CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH
T ss_pred CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence 999999999999998765432211 1245689999999998654 45899999999999999999999999764332211
Q ss_pred ccHHHHHHHHhccCCCccc--------------c-ccc--ccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRA--------------I-DSK--LLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~--------------~-d~~--l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+ ............ . ... ......+.....+.+++..||+.||++|||+.++++
T Consensus 242 ~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 242 NHI----LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHH----HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH----HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 111111000000 0 000 000001122345889999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=344.84 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=185.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~hpnIv~~ 93 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQS------------IIHAKRTYRELRLLKHMKHENVIGL 93 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTT-TEEEEEEECSSTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCC-CCEEEEEEeCccccC------------HHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 457899999999999999999987754 899999999764322 2334678899999999999999999
Q ss_pred eeEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++... ...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIl 164 (367)
T 2fst_X 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLA 164 (367)
T ss_dssp SEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred EEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEE
Confidence 9999754 5679999999 7899998863 46899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++.++.+||+|||+++..... .+...||++|+|||++.+ ..++.++||||+||++|+|++|+.||......
T Consensus 165 l~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 236 (367)
T 2fst_X 165 VNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--- 236 (367)
T ss_dssp ECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---
T ss_pred ECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 999999999999999875433 145689999999999876 67899999999999999999999999764331
Q ss_pred ccHHHHHHHHhccCCCccccc--------------ccccCCC----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAID--------------SKLLGNG----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d--------------~~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+........ ...+. +...... .+.....+.+|+..||+.||++|||+.++++
T Consensus 237 -~~l~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 237 -DQLKLILRLVGTPG-AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp -HHHHHHHHHHCSCC-HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHhCCCC-HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11111111111100 00000 0000000 0112345889999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.13 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=202.9
Q ss_pred ccCccccceecccCCeEEEEEEeeC--CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPG--SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv 311 (532)
.++|.+.+.||+|+||.||+|+... .+|+.||||+++....... ......+.+|+.++.++ +||||+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~~h~~iv 122 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLV 122 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh----------hhHHHHHHHHHHHHHHccCCCcee
Confidence 3679999999999999999998742 2489999999875321100 01124466788999999 699999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 123 TLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSN 195 (355)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred EEEEEEeeCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 9999999999999999999999999999752 45899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ..
T Consensus 196 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~ 271 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQ 271 (355)
T ss_dssp SCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CH
T ss_pred CcEEEeeCCCCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hH
Confidence 999999999998765432221 2456799999999998863 47899999999999999999999997533211 22
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRCM 526 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~ 526 (532)
............. ........+.+++..||+.||++|| |+.++++.
T Consensus 272 ~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 272 AEISRRILKSEPP-----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHhccCCC-----------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 2222222221111 1122234578899999999999999 89998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=368.95 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=203.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||+++..... .......+..|..++..+ +||||+.+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~-~~~vAvK~l~~~~~~-----------~~~~~~~~~~E~~~l~~~~~~~~i~~l 407 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVI-----------QDDDVECTMVEKRVLALPGKPPFLTQL 407 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSS-CCEEEEEEEEHHHHH-----------HTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCC-CcEEEEEEEeccccc-----------cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 46799999999999999999998864 899999998743111 022345678899999988 79999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.+++
T Consensus 408 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp EEECBCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSC
T ss_pred EEEEEeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCc
Confidence 99999999999999999999999999862 45899999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..
T Consensus 481 ikL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~ 551 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELF 551 (674)
T ss_dssp EEECCCTTCEECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred EEEeecceeeccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHH
Confidence 999999999865433222 2567899999999999999999999999999999999999999976432 1222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~ 520 (532)
....... .. ++......+.+|+..||+.||++||++
T Consensus 552 ~~i~~~~-~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 552 QSIMEHN-VA----------YPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HHHHSSC-CC----------CCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HHHHhCC-CC----------CCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 2222211 10 111233458889999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.16 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=198.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++........... .......+.+|+.++++++||||++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 81 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIKIISKRKFAIGSAR------EADPALNVETEIEILKKLNHPCIIKIK 81 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCCEE
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCC-CcEEEEEEeehhhhhhcccc------cchhhhhHHHHHHHHHhCCCCCCceEe
Confidence 45789999999999999999988764 89999999976532110000 012235688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc-
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME- 393 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~- 393 (532)
+++...+ .++||||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 82 ~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 153 (322)
T 2ycf_A 82 NFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 153 (322)
T ss_dssp EEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred eEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence 9997655 8999999999999999864 456899999999999999999999998 999999999999987665
Q ss_pred --EEEeccCCcccCCCCCcceeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 394 --ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 394 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+||+|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|..||...... ..
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~ 227 (322)
T 2ycf_A 154 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---VS 227 (322)
T ss_dssp CCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---SC
T ss_pred CeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---HH
Confidence 99999999987654322 13467899999999863 567899999999999999999999999753321 12
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+...+.. +... ..+... ......+.+++..||+.||++|||+.++++
T Consensus 228 ~~~~~~~----~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 LKDQITS----GKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHH----TCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHh----Cccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 2222211 1110 001111 112356889999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=340.50 Aligned_cols=269 Identities=21% Similarity=0.258 Sum_probs=191.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |..||||++...... ...+.+++..++.++||||+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~---------------~~~~~~~~~~l~~l~h~niv~~ 84 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKST-GMSVAIKKVIQDPRF---------------RNRELQIMQDLAVLHHPNIVQL 84 (360)
T ss_dssp HHTTEEEC----------CEEEEETTT-CCEEEEEEEECCTTC---------------CCHHHHHHHHHHHHCCTTBCCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEecCccc---------------cHHHHHHHHHHHhcCCCCcccH
Confidence 356899999999999999999988764 899999998665321 1345567778888999999999
Q ss_pred eeEEecCCc-------eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCC
Q 037084 314 QAHVTRPDC-------HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH--MYHRPCIIHRDIKPA 384 (532)
Q Consensus 314 ~~~~~~~~~-------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--~~~~~~ivH~Dlkp~ 384 (532)
++++...+. .++||||+++ +|.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~ 160 (360)
T 3e3p_A 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPH 160 (360)
T ss_dssp EEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGG
T ss_pred HHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHH
Confidence 999976443 7899999965 666666554455677899999999999999999999 777 999999999
Q ss_pred cEEecC-CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 385 NVLIDD-GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 385 NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
|||++. ++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999996 899999999999877654332 456789999999988654 489999999999999999999999986433
Q ss_pred chhhccHHH--------HHHHHhccCCCcccccc------cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVR--------WMRNVISSENPHRAIDS------KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~--------~~~~~~~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......+.. +..............+. .............+.+++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 221111111 11111000000000000 0011112224567899999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.76 Aligned_cols=202 Identities=24% Similarity=0.300 Sum_probs=171.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CC-----
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HR----- 308 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~----- 308 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||+++.. ......+..|+.++..++ |+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~~~~ 116 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVE-QEWVAIKIIKNK---------------KAFLNQAQIEVRLLELMNKHDTEMKY 116 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECSS---------------HHHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCC-CcEEEEEEEecc---------------HHHHHHHHHHHHHHHHHHhcccccce
Confidence 46899999999999999999988754 899999999865 223455667888887774 45
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++.+++++...+..++||||++ |+|.+++... ....+++..+..++.|++.||.|||+. ..+|+||||||+|||+
T Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 117 YIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL 192 (382)
T ss_dssp GBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred eEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence 49999999999999999999995 6999999862 335689999999999999999999952 1239999999999999
Q ss_pred c--CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 389 D--DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 389 ~--~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
+ .++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4 57889999999998765432 45688999999999999999999999999999999999999998643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=361.66 Aligned_cols=260 Identities=22% Similarity=0.306 Sum_probs=206.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCC--CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS--YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+... .+..||||.+..... ....+.|.+|+.++++++||||+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv 454 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHIV 454 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC-------------HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC-------------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 346788899999999999999988643 256899999876432 23346788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++.+ +..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 455 ~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~ 527 (656)
T 2j0j_A 455 KLIGVITE-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSN 527 (656)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred eEEEEEec-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCC
Confidence 99999854 668999999999999999975 2346899999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..+.
T Consensus 528 ~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~----~~~~ 602 (656)
T 2j0j_A 528 DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDVI 602 (656)
T ss_dssp TEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHH
T ss_pred CCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH----HHHH
Confidence 99999999999877554322 1234567889999999999999999999999999999997 9999976432 1122
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. .......+. ..+..+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 603 ~---~i~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 603 G---RIENGERLP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp H---HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHcCCCCC----------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 222211111 11123356888999999999999999999999998873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=337.49 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=200.8
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC---CCCCc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI---WHRNL 310 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~H~ni 310 (532)
..++|.+.+.||+|+||.||+|.+...+|+.||+|++........ ....+.+|+.+++.+ +||||
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~~i 76 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNV 76 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTB
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc------------CCchhhHHHHHHHhhhccCCCCe
Confidence 457899999999999999999998544589999999865322110 012344556555555 89999
Q ss_pred ccceeEEe-----cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 311 LPLQAHVT-----RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 311 v~l~~~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
+++++++. .....++||||++ |+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~N 150 (326)
T 1blx_A 77 VRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 150 (326)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHH
Confidence 99999997 5567899999996 6999999763 3445899999999999999999999998 9999999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
|+++.++.+||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 226 (326)
T 1blx_A 151 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD- 226 (326)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred eEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 9999999999999999987654321 245678999999999999999999999999999999999999997643311
Q ss_pred hccHHHHHHHHhccC----CCc------ccccc---cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSE----NPH------RAIDS---KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~----~~~------~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+....... .+. ..+.. .............+.+++..||+.||++|||+.++++
T Consensus 227 ---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 227 ---QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp ---HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111111100 000 00000 0001111223456888999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.66 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=201.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--------
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-------- 306 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------- 306 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||++... ......+.+|+.++.+++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~---------------~~~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGD---------------KVYTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCC-CcEEEEEEecCC---------------ccchhhhhHHHHHHHHhhcccccchh
Confidence 46799999999999999999987654 899999999865 223356778888888876
Q ss_pred ---CCCcccceeEEecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeee
Q 037084 307 ---HRNLLPLQAHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIH 378 (532)
Q Consensus 307 ---H~niv~l~~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH 378 (532)
||||+++++++...+ ..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+. + |+|
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH 155 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIH 155 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EEC
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEe
Confidence 899999999998654 789999999 99999999863 344589999999999999999999997 8 999
Q ss_pred cCCCCCcEEec------CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh
Q 037084 379 RDIKPANVLID------DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV 452 (532)
Q Consensus 379 ~Dlkp~NIll~------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 452 (532)
|||||+|||++ ..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 230 (373)
T 1q8y_A 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230 (373)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999994 44589999999998765432 45678999999999999999999999999999999999
Q ss_pred CCCCCCCcccchhh--ccHHHHHHHHhccCC------------------Ccccccc----------cccCCCcHHHHHHH
Q 037084 453 GKFPFDDFFQYTEE--MNMVRWMRNVISSEN------------------PHRAIDS----------KLLGNGYEEQMRLV 502 (532)
Q Consensus 453 g~~p~~~~~~~~~~--~~l~~~~~~~~~~~~------------------~~~~~d~----------~l~~~~~~~~~~~l 502 (532)
|+.||......... .....-+........ ....+.. .-...........+
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (373)
T 1q8y_A 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310 (373)
T ss_dssp SSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHH
T ss_pred CCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHH
Confidence 99999754321111 011111111111000 0000000 00112346778889
Q ss_pred HHHHHHcCCCCCCCCCCHHHHHH
Q 037084 503 LKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 503 ~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+++..||+.||++|||+.++++
T Consensus 311 ~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 311 SDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHHHhccCccccCCHHHHhh
Confidence 99999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=347.92 Aligned_cols=262 Identities=21% Similarity=0.298 Sum_probs=207.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-CCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH-RNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l 313 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ..+..|+.++..++| +++..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~~~~----------------~~~~~E~~il~~L~~~~~i~~i 68 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH----------------PQLLYESKIYRILQGGTGIPNV 68 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTT-CCEEEEEEEETTCSS----------------CCHHHHHHHHHHTTTSTTCCCE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCC-CcEEEEEEecccccc----------------HHHHHHHHHHHHhcCCCCCCeE
Confidence 46799999999999999999987654 899999988765321 346789999999987 555566
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe---cC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI---DD 390 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll---~~ 390 (532)
..++...+..++||||+ +++|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||||+|||+ +.
T Consensus 69 ~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~ 141 (483)
T 3sv0_A 69 RWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141 (483)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGG
T ss_pred EEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCC
Confidence 66777788889999999 9999999975 2346999999999999999999999998 9999999999999 68
Q ss_pred CCcEEEeccCCcccCCCCCcce-----eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 391 GMEARISDFGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 8999999999998765543211 11366799999999999999999999999999999999999999987543222
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...+.......... ... .+.. ..+..+.+++..||+.+|++||++.+|++.|+++
T Consensus 222 ~~~~~~i~~~~~~~-~~~-----~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 222 KQKYEKISEKKVAT-SIE-----ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHHHHHHHHS-CHH-----HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhhccccc-cHH-----HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22222221111110 000 0001 1234688999999999999999999999999876
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=333.34 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=203.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC-----
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN----- 309 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n----- 309 (532)
.++|.+.+.||+|+||.||+|.+..+++..||+|+++.. ......+.+|+.++++++|+|
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------------~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---------------GKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---------------HHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---------------ccchhHHHHHHHHHHHHhhcCCCCce
Confidence 467999999999999999999887654579999999865 233456778888888887766
Q ss_pred -cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 310 -LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 310 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++.+.+++...+..++||||+ +++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll 156 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILF 156 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence 889999999999999999999 7788888765 33356999999999999999999999998 9999999999999
Q ss_pred -------------------cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 389 -------------------DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 389 -------------------~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 231 (355)
T 2eu9_A 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231 (355)
T ss_dssp SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred ecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence 567899999999998654432 45679999999999999999999999999999999
Q ss_pred HHhCCCCCCCcccchhhccHHHHHHHHhccCCCccc----------ccc---------------------cccCCCcHHH
Q 037084 450 LVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRA----------IDS---------------------KLLGNGYEEQ 498 (532)
Q Consensus 450 lltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~----------~d~---------------------~l~~~~~~~~ 498 (532)
|++|+.||...... .....+...... .+... ... ..........
T Consensus 232 l~~g~~pf~~~~~~----~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (355)
T 2eu9_A 232 YYRGFTLFQTHENR----EHLVMMEKILGP-IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLE 306 (355)
T ss_dssp HHHSSCSCCCSSHH----HHHHHHHHHHCC-CCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred HHhCCCCCCCCCHH----HHHHHHHHHcCC-CcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchh
Confidence 99999999764321 111111111110 00000 000 0000112334
Q ss_pred HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 499 MRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 499 ~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+.+++..||+.||++|||+.++++
T Consensus 307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 307 HVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 567899999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=347.26 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=194.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
..+|.+.+.||+|+||+||+|.+.. +..+|+|++..... ...+|+.+++.++||||++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~--~~~~aikk~~~~~~------------------~~~~E~~il~~l~h~niv~l~ 98 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE--SDEVAIKKVLQDKR------------------FKNRELQIMRIVKHPNVVDLK 98 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT--TEEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC--CCeEEEEEEecCcc------------------hHHHHHHHHHhCCCCCcceEE
Confidence 4579999999999999999998863 45588888865421 123689999999999999999
Q ss_pred eEEecCCc------eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRPDC------HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++...+. .++||||+++ ++.+.+.........+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill 174 (394)
T 4e7w_A 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLL 174 (394)
T ss_dssp EEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred EEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEE
Confidence 99965443 7899999976 444444433334567999999999999999999999998 9999999999999
Q ss_pred c-CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 389 D-DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 389 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++||||+||++|||++|+.||.........
T Consensus 175 ~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l 251 (394)
T 4e7w_A 175 DPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251 (394)
T ss_dssp ETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9 7999999999999876544322 456789999999988665 5899999999999999999999999864332111
Q ss_pred ccHHHHH--------HHH---hccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWM--------RNV---ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~--------~~~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+.... ... .........-...+...........+.+++..||+.||.+|||+.++++
T Consensus 252 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111110 000 0000000000000000011123456889999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=335.84 Aligned_cols=259 Identities=24% Similarity=0.312 Sum_probs=198.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||+++
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~ 106 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQS------------EIFAKRAYRELLLLKHMQHENVIGL 106 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCC-CCEEEEEEecccccc------------hhHHHHHHHHHHHHHhcCCCCchhh
Confidence 457899999999999999999988764 999999999865322 2335678899999999999999999
Q ss_pred eeEEecCCce------EEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 037084 314 QAHVTRPDCH------LLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVL 387 (532)
Q Consensus 314 ~~~~~~~~~~------~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIl 387 (532)
++++...+.. ++||||++ ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 107 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl 176 (371)
T 4exu_A 107 LDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLA 176 (371)
T ss_dssp SEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred hhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeE
Confidence 9999887665 99999996 68888773 24899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 177 l~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 251 (371)
T 4exu_A 177 VNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 251 (371)
T ss_dssp ECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ECCCCCEEEEecCcccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999998654332 45678999999998877 67899999999999999999999999764321111
Q ss_pred ccHHHHHHHHhccCCCcccc---------------cccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAI---------------DSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~---------------d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..+.. ..... ..... ....... ..+.....+.+++..||+.||++|||+.++++
T Consensus 252 ~~i~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 252 TQILK----VTGVP-GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHH----HHCCC-CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHH----HhCCC-cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 11111 00000 00000 0000000 01122456889999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=328.26 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=193.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++... ......+.+|+.++++++||||++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~---------------~~~~~~~~~E~~~l~~l~h~~i~~~~ 68 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALD-SRYYAIKKIRHT---------------EEKLSTILSEVMLLASLNHQYVVRYY 68 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEEE---------------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccchhhheeccCCcEEEEEEEEcCC-CeEEEEEEEecc---------------HHHHHHHHHHHHHHHhcCchHHHHHH
Confidence 35688999999999999999987654 899999999653 33456788999999999999999999
Q ss_pred eEEec-------------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 037084 315 AHVTR-------------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDI 381 (532)
Q Consensus 315 ~~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 381 (532)
+++.+ .+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 142 (303)
T 1zy4_A 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDL 142 (303)
T ss_dssp EEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccC
Confidence 98865 3567999999999999999975 2356788999999999999999999998 999999
Q ss_pred CCCcEEecCCCcEEEeccCCcccCCCCCc------------ceeeeccccccccccccccccC-CCCchhhHHHHHHHHH
Q 037084 382 KPANVLIDDGMEARISDFGLAKLMPDGHT------------RIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLA 448 (532)
Q Consensus 382 kp~NIll~~~~~~kl~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~ 448 (532)
||+||+++.++.+||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|
T Consensus 143 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 222 (303)
T 1zy4_A 143 KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222 (303)
T ss_dssp CGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHH
T ss_pred CHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHH
Confidence 99999999999999999999987653211 1112456789999999998764 6899999999999999
Q ss_pred HHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 449 VLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 449 elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+|++ ||.... ... ......... .. ..........+..+.+++..||+.||.+|||+.++++
T Consensus 223 ~l~~---p~~~~~---~~~---~~~~~~~~~-~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 223 EMIY---PFSTGM---ERV---NILKKLRSV-SI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHS---CCSSHH---HHH---HHHHHHHST-TC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHh---ccCCch---hHH---HHHHhcccc-cc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 9998 554311 111 112222111 10 0111222334456788999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=336.46 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=200.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. ..+|+|+++...... .....+.+|+.++++++||||+++
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~avk~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNE------------DQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES----SSEEEEECCCCSCCC------------CCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc----CeEEEEEeecCCCCH------------HHHHHHHHHHHHHhcCCCCCEeEE
Confidence 4578999999999999999999875 249999997653221 112457789999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++ ++.
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---C
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCC
Confidence 9999999999999999999999999964 3456899999999999999999999998 99999999999998 679
Q ss_pred EEEeccCCcccCCCCCc---ceeeecccccccccccccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 394 ARISDFGLAKLMPDGHT---RIRITTVAGTTGYVAPEYHQT---------LTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999876532211 111234568999999998864 457899999999999999999999997643
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.. ...........+. .... ..+..+.+++..||+.||++|||+.++++.|+++.
T Consensus 248 ~~-------~~~~~~~~~~~~~-~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 248 AE-------AIIWQMGTGMKPN-LSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HH-------HHHHHHHTTCCCC-CCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HH-------HHHHHhccCCCCC-CCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 21 1112222111111 1100 11234888999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=331.62 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=181.3
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHH-HHhcCCCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII-TAGRIWHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~ 312 (532)
..++|...+.||+|+||.||+|.+..+ |+.||||++...... .....+..|+. +++.++||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~h~niv~ 85 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPS-GQIMAVKRIRSTVDE-------------KEQKQLLMDLDVVMRSSDCPYIVQ 85 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTT-TEEEEEEEEECCCCH-------------HHHHHHHHHHHHHHSSCCCTTBCC
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCC-CCEEEEEEeecccCc-------------hHHHHHHHHHHHHHHcCCCCcEee
Confidence 457899999999999999999988754 899999999765321 12234445555 778889999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVS-QGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++...+..++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+. + ++||||||+||+++.
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~ 161 (327)
T 3aln_A 86 FYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDR 161 (327)
T ss_dssp EEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEET
T ss_pred eeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcC
Confidence 99999999999999999964 8888876422 2356789999999999999999999998 8 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeecccccccccccccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH----QTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
++.+||+|||+++........ ....||+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 235 (327)
T 3aln_A 162 SGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--- 235 (327)
T ss_dssp TTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred CCCEEEccCCCceeccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH---
Confidence 999999999999876543221 345799999999998 4667899999999999999999999999753221
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.+..... +... .+...........+.+++..||+.||++|||+.++++
T Consensus 236 ---~~~~~~~~~-~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 236 ---FDQLTQVVK-GDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -------CCCCC-SCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HHHHHHHhc-CCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111111 1111 1111111223446888999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=343.27 Aligned_cols=273 Identities=21% Similarity=0.239 Sum_probs=195.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+. +|..||||++............. ........+.+|+.++++++||||+++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNIL---SDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGG---GSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred hccceEEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhh---hhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 4578999999999999999999875 48999999986533211000000 002334778999999999999999999
Q ss_pred eeEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++.. ....++||||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999954 335799999996 688888874 3457999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999985544322 145678999999998876 678999999999999999999999997643322111
Q ss_pred cHHHHHHHHhccCCCc------------------ccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSENPH------------------RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~~~------------------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+.. ........ ............+.....+.+++..||+.||.+|||+.++++
T Consensus 245 ~i~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 KIVE----VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHH----HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH----HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111 11000000 000000000011122345889999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.22 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=195.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--CCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--HRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+. +|+.||||++...... ......+.+|+.++.+++ ||||+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEAD------------NQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCC------------HHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEecccccc------------ccchHHHHHHHHHHHhccccCCceE
Confidence 4567999999999999999999875 4889999999765332 234567889999999997 59999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
++++++...+..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~- 162 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD- 162 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-
Confidence 99999999999999999 558899999975 346899999999999999999999998 999999999999975
Q ss_pred CcEEEeccCCcccCCCCCcceeeecccccccccccccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-----------LTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
+.+||+|||+++...............||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 8999999999987755433222245679999999999875 46888999999999999999999999753
Q ss_pred ccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 461 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... ...+.......... .........+.+++..||+.||++|||+.++++
T Consensus 243 ~~~------~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 243 INQ------ISKLHAIIDPNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CSH------HHHHHHHHCTTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH------HHHHHHHHhccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 321 11122222211110 001111345888999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=333.70 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=200.6
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++..... ......+.+|+.++++++||||+++
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~ 74 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPT-GEIVAIKKIEPFDK-------------PLFALRTLREIKILKHFKHENIITI 74 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCCSS-------------HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCC-CcEEEEEeeccccc-------------chHHHHHHHHHHHHHhCcCCCcCCe
Confidence 356899999999999999999988754 89999999975432 2234567899999999999999999
Q ss_pred eeEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 314 QAHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 314 ~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++++... ...++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 75 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 75 FNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLI 145 (353)
T ss_dssp EEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 9998764 67899999996 699999875 35899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcce--------eeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRI--------RITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
+.++.+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998765432111 1134578999999998654 6789999999999999999999999976
Q ss_pred cccchhhccHHHHHHHHhccCCCcc---ccc---------------ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 037084 460 FFQYTEEMNMVRWMRNVISSENPHR---AID---------------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521 (532)
Q Consensus 460 ~~~~~~~~~l~~~~~~~~~~~~~~~---~~d---------------~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~ 521 (532)
.... .....+........... .+. ........+.....+.+++..||+.||++|||+.
T Consensus 226 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 226 RDYR----HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SSHH----HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCcH----HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 4321 11111111111100000 000 0000000112345688999999999999999999
Q ss_pred HHHH
Q 037084 522 DVRC 525 (532)
Q Consensus 522 evl~ 525 (532)
++++
T Consensus 302 ell~ 305 (353)
T 2b9h_A 302 EALE 305 (353)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.60 Aligned_cols=270 Identities=22% Similarity=0.258 Sum_probs=183.2
Q ss_pred cCccc-cceecccCCeEEEEEEeeC-CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 236 DSLAS-LEIIGVGACGVVYKAEVPG-SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 236 ~~~~~-~~~LG~G~fG~Vy~~~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+.|.+ .++||+|+||+||+|.+.. .++..||||++...... ..+.+|+.++++++||||+++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~E~~~l~~l~hpniv~~ 83 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------------MSACREIALLRELKHPNVISL 83 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------------HHHHHHHHHHHHCCCTTBCCC
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------------HHHHHHHHHHHhcCCCCeeeE
Confidence 34555 4589999999999998753 24789999999765322 356789999999999999999
Q ss_pred eeEEec--CCceEEEEEeccCCCHHHHHhhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 314 QAHVTR--PDCHLLVYEFMKNGSLQDILHDVS-----QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 314 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
++++.. ....++||||++ |+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NI 159 (405)
T 3rgf_A 84 QKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANI 159 (405)
T ss_dssp CEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHe
Confidence 999954 678899999995 58888876432 12235899999999999999999999998 99999999999
Q ss_pred Ee----cCCCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 387 LI----DDGMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 387 ll----~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
|+ +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 160 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 160 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp EECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99 77889999999999876543211 122456899999999998874 5899999999999999999999999754
Q ss_pred ccchh-----hccHHHHHHHHhccCCCcccccc---------------cccCCC-cH--------HHHHHHHHHHHHcCC
Q 037084 461 FQYTE-----EMNMVRWMRNVISSENPHRAIDS---------------KLLGNG-YE--------EQMRLVLKIAYFCTS 511 (532)
Q Consensus 461 ~~~~~-----~~~l~~~~~~~~~~~~~~~~~d~---------------~l~~~~-~~--------~~~~~l~~l~~~cl~ 511 (532)
..... .......+............-+. ...... .. .....+.+|+..||+
T Consensus 240 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~ 319 (405)
T 3rgf_A 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 319 (405)
T ss_dssp C------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSC
T ss_pred cccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHcc
Confidence 32100 01111111111111110000000 000000 00 013457899999999
Q ss_pred CCCCCCCCHHHHHH
Q 037084 512 DDPEERPSSKDVRC 525 (532)
Q Consensus 512 ~~P~~RPs~~evl~ 525 (532)
.||.+|||++++++
T Consensus 320 ~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 320 MDPIKRITSEQAMQ 333 (405)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=332.33 Aligned_cols=258 Identities=24% Similarity=0.307 Sum_probs=197.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+.+|+.++++++||||++++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 89 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRS-GEKVAIKKLSRPFQS------------EIFAKRAYRELLLLKHMQHENVIGLL 89 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEESSTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCC-CCEEEEEEecccccc------------hHHHHHHHHHHHHHHhcCCCCcccHh
Confidence 46799999999999999999988764 999999999765322 23346788999999999999999999
Q ss_pred eEEecCCc------eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRPDC------HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++...+. .++||||++ ++|.+++. ..+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 90 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~ 159 (353)
T 3coi_A 90 DVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAV 159 (353)
T ss_dssp EEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEE
T ss_pred heEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeE
Confidence 99987654 499999996 68877763 24899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-- 232 (353)
T 3coi_A 160 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-- 232 (353)
T ss_dssp CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--
T ss_pred CCCCcEEEeecccccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 999999999999998654321 45678999999998876 6789999999999999999999999976432111
Q ss_pred cHHHHHHHHhccCC------------------CcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWMRNVISSEN------------------PHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~~~~~~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...+........ ....... ......+.....+.+++..||+.||++|||+.++++
T Consensus 233 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 233 --LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRK-DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp --HHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSC-CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred --HHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCc-cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111000000 0000000 001112234556889999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=333.85 Aligned_cols=272 Identities=23% Similarity=0.339 Sum_probs=204.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHH---HHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELL---NVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.++|.+.+.||+|+||.||+|.+ +|+.||||++........... .............+.+|+.++++++||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 46899999999999999999987 489999999864311100000 000000000126788999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHH------HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDI------LHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDIKPA 384 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlkp~ 384 (532)
++++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ .+ ++||||||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999999999999999999999999998 432 225679999999999999999999998 88 999999999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISE-KSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
||+++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|+|++|..||.....
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999876543 22567899999999999887 5666 99999999999999999999975432
Q ss_pred chhhccHHHHHHHHhccCCCccccc-----ccc----cCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAID-----SKL----LGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d-----~~l----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. . +....... .......+ ... ...........+.+++..||+.||.+|||+.++++
T Consensus 258 ~---~---~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 L---V---ELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S---H---HHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H---H---HHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 1 11222211 11110000 000 00001233456889999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=331.26 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=173.3
Q ss_pred cccCccccc-eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 234 KEDSLASLE-IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~-~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
..++|.+.+ .||+|+||.||+|.+..+ |+.||||++.... ....+ ....+..++||||++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~-~~~vavK~~~~~~---------------~~~~e---~~~~~~~~~h~~i~~ 86 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRT-GQKCALKLLYDSP---------------KARQE---VDHHWQASGGPHIVC 86 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEESSH---------------HHHHH---HHHHHHHTTSTTBCC
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCC-CCEEEEEEecCcH---------------HHHHH---HHHHHHhcCCCChHH
Confidence 456788854 699999999999988764 8999999997642 11111 222355679999999
Q ss_pred ceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++.. ....++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll 161 (336)
T 3fhr_A 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLY 161 (336)
T ss_dssp EEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred HHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999976 4457999999999999999986 33457999999999999999999999998 9999999999999
Q ss_pred cC---CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 389 DD---GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 389 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
+. ++.+||+|||+++....... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 162 ~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 162 TSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp SCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred EecCCCceEEEeccccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 86 45599999999986654322 456789999999999988999999999999999999999999975433111
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+.. .... ............+.+++..||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~----~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 238 SPGMKRRIRL----GQYG------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----------------C------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHhhhc----cccc------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111100 0000 000111223455888999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.98 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=193.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||+|++.... ......+.+|+.++++++||||+++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~iv~~ 73 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDC-DKRVAIKKIVLTD--------------PQSVKHALREIKIIRRLDHDNIVKV 73 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTT-TEEEEEEEEECCS--------------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCC-CeEEEEEEEecCC--------------hHHHHHHHHHHHHHHhcCCCCeeEE
Confidence 356799999999999999999988754 8999999997653 2335678899999999999999999
Q ss_pred eeEEe--------------cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 037084 314 QAHVT--------------RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHR 379 (532)
Q Consensus 314 ~~~~~--------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~ 379 (532)
++++. +.+..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ ++||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 144 (320)
T 2i6l_A 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144 (320)
T ss_dssp EEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCC
T ss_pred EEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 99874 3467799999996 699999853 45899999999999999999999998 9999
Q ss_pred CCCCCcEEec-CCCcEEEeccCCcccCCCCCc-ceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCC
Q 037084 380 DIKPANVLID-DGMEARISDFGLAKLMPDGHT-RIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 380 Dlkp~NIll~-~~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p 456 (532)
||||+||+++ +++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 567999999999987643221 111244567999999998765 6789999999999999999999999
Q ss_pred CCCcccchhhccHHHH--------HHHHhccCCCccccccccc-C-----CCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 457 FDDFFQYTEEMNMVRW--------MRNVISSENPHRAIDSKLL-G-----NGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 457 ~~~~~~~~~~~~l~~~--------~~~~~~~~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
|...........+... ...... .....+..... . ...+.....+.+++..||+.||++|||+.+
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 225 FAGAHELEQMQLILESIPVVHEEDRQELLS--VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp SCCSSHHHHHHHHHHHSCCCCHHHHHHHHT--TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhhhhhhh--cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 9764331111111100 000000 00000000000 0 001123456889999999999999999999
Q ss_pred HHH
Q 037084 523 VRC 525 (532)
Q Consensus 523 vl~ 525 (532)
+++
T Consensus 303 ll~ 305 (320)
T 2i6l_A 303 ALS 305 (320)
T ss_dssp HHT
T ss_pred HhC
Confidence 976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=322.16 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=202.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++...... ......+.+|+.++++++||||++++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~valK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~ 87 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVINKASAK------------NKDTSTILREVELLKKLDHPNIMKLF 87 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGBS------------SSCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCC-CcEEEEEEecccccc------------hHHHHHHHHHHHHHHhccCCCccEEE
Confidence 45799999999999999999988754 899999998654221 11235688899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC---
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG--- 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~--- 391 (532)
+++...+..++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 88 EILEDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD 160 (287)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTT
T ss_pred EEEeCCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCc
Confidence 9999999999999999999999998752 35899999999999999999999998 9999999999999764
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||++......... ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||..... ..
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~--- 229 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE----YD--- 229 (287)
T ss_dssp CCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH---
T ss_pred ccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH----HH---
Confidence 46999999999876544321 34568999999998876 589999999999999999999999976432 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............ +.... ...+..+.+++..||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~---~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 230 ILKRVETGKYAF---DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHCCCCC---CSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCC---Cchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 122222111110 00001 122345888999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=321.84 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=183.9
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
...++|.+.+.||+|+||.||+|.+..+ |+.||||++...... ......+..+..+++.++||||++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vavK~~~~~~~~------------~~~~~~~~~~~~~~~~~~h~~i~~ 88 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKT-GHVIAVKQMRRSGNK------------EENKRILMDLDVVLKSHDCPYIVQ 88 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTT-CCEEEEEEEETTSCH------------HHHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhhccccccceeeecCCeeEEEEEEecC-CeEEEEEEecccccc------------hHHHHHHHHHHHHHHhcCCCceee
Confidence 3456899999999999999999988754 899999999765432 122334455556788889999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++++...+..++||||+ ++.+..+... ....+++..+..++.|++.||.|||+. + ++|+||||+||+++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~ 161 (318)
T 2dyl_A 89 CFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDER 161 (318)
T ss_dssp EEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTT
T ss_pred EEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCC
Confidence 999999999999999999 5666665543 235689999999999999999999985 8 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+.+||+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||.....
T Consensus 162 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 234 (318)
T 2dyl_A 162 GQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT---- 234 (318)
T ss_dssp SCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----
T ss_pred CCEEEEECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----
Confidence 99999999999866543321 4567899999999984 55688999999999999999999999975322
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....+........+.... .......+.+++..||+.||.+|||+.++++
T Consensus 235 --~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 235 --DFEVLTKVLQEEPPLLPG--------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --HHHHHHHHHHSCCCCCCS--------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cHHHHHHHhccCCCCCCc--------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111222222222111000 0112345888999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.29 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=192.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC----CCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI----WHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~H~n 309 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++.......... ......+.+|+.++.++ +|||
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~~h~~ 99 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTD-RLQVAIKVIPRNRVLGWSP--------LSDSVTCPLEVALLWKVGAGGGHPG 99 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTT-CCEEEEEECCSTTTC----------------CCCCHHHHHHHHHHSSCCCSS
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccC-CeEEEEEEEeccccccccc--------chhhHHHHHHHHHHHhhcccCCCCC
Confidence 356799999999999999999987654 8999999997654321100 11234566788888888 8999
Q ss_pred cccceeEEecCCceEEEEEe-ccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 310 LLPLQAHVTRPDCHLLVYEF-MKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
|+++++++...+..++|+|| +++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEE
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEE
Confidence 99999999999999999999 789999999976 245899999999999999999999998 9999999999999
Q ss_pred c-CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 389 D-DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTIS-EKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 389 ~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
+ .++.+||+|||++........ ....||..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 9 889999999999987765432 456799999999998877664 489999999999999999999975211
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ ... .. .........+.+++..||+.||++|||+.++++
T Consensus 245 --~-------~~~-~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --I-------LEA-EL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --H-------HHT-CC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --H-------hhh-cc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 00 011112345788999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=335.12 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=186.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~ 314 (532)
+.|...+.||+|+||+||.+... +|+.||||++.... ...+.+|+.++.++ +||||++++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~~-----------------~~~~~~E~~~l~~l~~HpnIv~~~ 75 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDF-----------------CDIALMEIKLLTESDDHPNVIRYY 75 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEES--SSSEEEEEEEEGGG-----------------HHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred heeeccCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHHH-----------------HHHHHHHHHHHHhccCCCCcCeEE
Confidence 44566788999999999866433 48999999986531 13466899999876 899999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE---LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++.+.+..++|||||+ |+|.+++......... .++..++.++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 76 ~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~ 151 (434)
T 2rio_A 76 CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTS 151 (434)
T ss_dssp EEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECC
T ss_pred EEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecC
Confidence 99999999999999995 6999999763222111 133345789999999999999998 9999999999999754
Q ss_pred -------------CcEEEeccCCcccCCCCCcce--eeecccccccccccccccc-------CCCCchhhHHHHHHHHHH
Q 037084 392 -------------MEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQT-------LTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 392 -------------~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~e 449 (532)
+.+||+|||+++......... ......||++|+|||++.+ ..++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e 231 (434)
T 2rio_A 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231 (434)
T ss_dssp HHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred cccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence 489999999999876543211 1235679999999999875 578999999999999999
Q ss_pred HHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 450 LVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 450 llt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
|++ |+.||...... . ...+.... ... .............+.+++..||+.||.+|||+.++++
T Consensus 232 llt~g~~Pf~~~~~~--~---~~i~~~~~---~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 232 ILSKGKHPFGDKYSR--E---SNIIRGIF---SLD-----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTTSCCTTCSTTTH--H---HHHHHTCC---CCC-----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCCCchhh--H---HHHhcCCC---Ccc-----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 999 99999754321 1 11111111 100 0111123456778999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=325.71 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=199.0
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--CCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--HRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv 311 (532)
..++|.+.+.||+|+||.||+|.+..+ |+.||||++.......... ......+.+|+.++++++ ||||+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGE--------LPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTT-TEEEEEEEEEGGGCCCEEE--------CTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCC-CcEEEEEEEecccchhhhh--------hhhhhHHHHHHHHHHhhccCCCCce
Confidence 356799999999999999999987654 8999999986542111000 001134667889999996 59999
Q ss_pred cceeEEecCCceEEEEEeccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-
Q 037084 312 PLQAHVTRPDCHLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID- 389 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~- 389 (532)
++++++..++..++|+||+.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 999999999999999999976 899999975 346899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+++.+||+|||+++....... ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------ 254 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 254 (320)
T ss_dssp TTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred CCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------
Confidence 789999999999987764332 45679999999999887766 6789999999999999999999975211
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
....... + .......+.+++..||+.||++|||+.++++
T Consensus 255 -------~~~~~~~---~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -------IIRGQVF---F--------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------HHHCCCC---C--------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------hhccccc---c--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001000 0 0112345888999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.61 Aligned_cols=260 Identities=25% Similarity=0.316 Sum_probs=199.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|.+..+ |..||||++..... ......+.+|+.++++++||||+++++
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~t-g~~VAVKvi~~~~~-------------~~~~~~~~~Ei~iL~~L~HpnIV~l~~ 79 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDT-GEQVAIKQCRQELS-------------PKNRERWCLEIQIMKKLNHPNVVSARE 79 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTT-TCCEEECCCCSCCC-------------HHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCC-CcEEEEEEecccCC-------------HHHHHHHHHHHHHHHhCCCCCCCceee
Confidence 5799999999999999999987654 89999999976532 233567889999999999999999999
Q ss_pred EEec------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 316 HVTR------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 316 ~~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
++.. .+..++|||||++|+|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+||+++
T Consensus 80 v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~ 155 (676)
T 3qa8_A 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQ 155 (676)
T ss_dssp CCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEE
T ss_pred eecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEee
Confidence 8765 677899999999999999997532 2346888999999999999999999998 99999999999999
Q ss_pred CCCc---EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 390 DGME---ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 390 ~~~~---~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
.++. +||+|||++......... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 156 ~~g~~~~vKL~DFG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--- 229 (676)
T 3qa8_A 156 PGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--- 229 (676)
T ss_dssp CCSSSCEEEECSCCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---
T ss_pred cCCCceeEEEccccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---
Confidence 7765 999999999877554322 4568999999999999999999999999999999999999999753211
Q ss_pred ccHHHHHHHHhccCCC--------ccc--ccc--cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 037084 467 MNMVRWMRNVISSENP--------HRA--IDS--KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~--------~~~--~d~--~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e 522 (532)
..|.......... ... +.. ..........+..+.+++..||+.||++|||+.+
T Consensus 230 ---~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 230 ---VQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ---HHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred ---hhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 1111100000000 000 000 0111234456778999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.92 Aligned_cols=242 Identities=19% Similarity=0.250 Sum_probs=195.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+...+|+.||||++..... ......+.+|+.++++++||||++++
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 145 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD-------------AEAQAMAMAERQFLAEVVHPSIVQIF 145 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC-------------HHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC-------------HHHHHHHHHHHHHHHhcCCCCcCeEe
Confidence 46899999999999999999998754589999999875432 22346788999999999999999999
Q ss_pred eEEecCCc-----eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 315 AHVTRPDC-----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 315 ~~~~~~~~-----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++...+. .|+||||++|++|.+++.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 146 ~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~ 216 (681)
T 2pzi_A 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLT 216 (681)
T ss_dssp EEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred eeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEe
Confidence 99988766 6999999999999987642 6899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
.+ .+||+|||+++..... ....||++|+|||++.+. ++.++|||||||++|+|++|.+||........
T Consensus 217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---- 284 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---- 284 (681)
T ss_dssp SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----
T ss_pred CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----
Confidence 85 8999999999876543 356799999999998765 48999999999999999999998864321000
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-SKDVRCMLSQI 530 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~~l 530 (532)
+ ...........+.+++..||+.||++||+ ++++...|..+
T Consensus 285 ------------~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ------------P--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ------------C--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ------------c--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 00011123356889999999999999995 66666666543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.59 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=185.4
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
...+|...+.||+|+||+||..... +|+.||||++..... ..+.+|+.+++++ +||||++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~-----------------~~~~~E~~~l~~l~~HpnIv~ 82 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF-----------------SFADREVQLLRESDEHPNVIR 82 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE-----------------EECHHHHHHHHHSCCCTTBCC
T ss_pred ccEEEecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH-----------------HHHHHHHHHHHhccCCCCcCe
Confidence 4456899999999999996543333 489999999976432 2245789999999 8999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC--
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-- 390 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~-- 390 (532)
+++++.+.+..|+|||||+ |+|.+++... ...+.+.....++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 83 l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~ 155 (432)
T 3p23_A 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPN 155 (432)
T ss_dssp EEEEEEETTEEEEEEECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCB
T ss_pred EEEEEecCCEEEEEEECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCC
Confidence 9999999999999999995 6999999752 223444456789999999999999998 999999999999953
Q ss_pred ---CCcEEEeccCCcccCCCCCcc-eeeeccccccccccccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCccc
Q 037084 391 ---GMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQ---TLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQ 462 (532)
Q Consensus 391 ---~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~ 462 (532)
...+||+|||+++........ .......||++|+|||++. +..++.++|||||||++|||++ |..||.....
T Consensus 156 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 335889999999877543211 1224567999999999987 4567889999999999999999 9999965322
Q ss_pred chhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 463 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
. . .......... .... ........+.+++..||+.||.+|||+.++++
T Consensus 236 ~-----~---~~~~~~~~~~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 R-----Q---ANILLGACSL-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp H-----H---HHHHTTCCCC-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H-----H---HHHHhccCCc-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1 1 1111111111 1111 11233455788999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.40 Aligned_cols=235 Identities=15% Similarity=0.136 Sum_probs=184.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||.||+|.+..+ |+.||||++....... ......+.+|+..+.+++||||++++
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTAL-DRQVALTFVDPQGVLP-----------DDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTT-TEEEEEEESCTTCCSC-----------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCC-CceEEEEEECcccccC-----------HHHHHHHHHHHHHHhcCCCCCcceee
Confidence 36799999999999999999988754 8999999998764332 23456788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++...+..|+||||++|++|.+++.. . .......+++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCE
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCE
Confidence 999999999999999999999999953 1 345567889999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+++| |++ .++.++|||||||++|+|++|+.||..............
T Consensus 169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~--- 216 (286)
T 3uqc_A 169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER--- 216 (286)
T ss_dssp EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB---
T ss_pred EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH---
Confidence 998543 333 368899999999999999999999986433110000000
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
... +.+. .+. ......+..+.+++..||+.||++| |+.++++.|+++.
T Consensus 217 -~~~-~~~~---~~~---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 217 -DTA-GQPI---EPA---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp -CTT-SCBC---CHH---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred -Hhc-cCCC---Chh---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 000 0000 000 0011233458899999999999999 9999999998864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=305.06 Aligned_cols=228 Identities=20% Similarity=0.299 Sum_probs=177.7
Q ss_pred ccCcccc-ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHH-hcCCCCCccc
Q 037084 235 EDSLASL-EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA-GRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~-~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~ 312 (532)
.++|.+. +.||+|+||.||+|.+..+ |+.||+|++... ..+.+|+.++ +.++||||++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~-------------------~~~~~e~~~~~~~~~h~~i~~ 75 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRT-QEKFALKMLQDC-------------------PKARREVELHWRASQCPHIVR 75 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECS-------------------HHHHHHHHHHHHHTTSTTBCC
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCC-CcEEEEEEeccc-------------------HHHHHHHHHHHHhccCCCchh
Confidence 3467776 7899999999999988654 899999999754 2345677777 5569999999
Q ss_pred ceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++.. .+..++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 150 (299)
T 3m2w_A 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 150 (299)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred HHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 9999976 6778999999999999999986 33456999999999999999999999998 9999999999999
Q ss_pred cC---CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 389 DD---GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 389 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
+. ++.+||+|||++.... +..++.++|||||||++|+|++|+.||........
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 151 TSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp SSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 98 7889999999986432 23467899999999999999999999975332110
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCc----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGY----EEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
... ....+.... .... ......+.+++..||+.||++|||+.++++
T Consensus 207 ~~~-------------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 SPG-------------MKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CC-------------SCCSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHH-------------HHHHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000 000000000 0001 123456889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.24 Aligned_cols=247 Identities=15% Similarity=0.149 Sum_probs=184.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-CCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH-RNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l 313 (532)
...|...+.||+|+||+||+|.+..+ |+.||||++....... ....+.|.+|+.+++.++| +|....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~-g~~vAvK~~~~~~~~~-----------~~~~~~~~~E~~~~~~l~~~~~~~~~ 144 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQET-GESFEVHVPYFTERPP-----------SNAIKQMKEEVLRLRLLRGIKNQKQA 144 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEECCSCC---------------CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEecCC-CCceEEEEEecCCCcc-----------HHHHHHHHHHHHHHHhhccCCCHHHH
Confidence 44578889999999999999998764 8999999998543221 2224678899999999987 322111
Q ss_pred e---------------------eEEec-----CCceEEEEEeccCCCHHHHHhhh---cCCCCCCCHHHHHHHHHHHHHH
Q 037084 314 Q---------------------AHVTR-----PDCHLLVYEFMKNGSLQDILHDV---SQGRRELDWLARYRIARGMASG 364 (532)
Q Consensus 314 ~---------------------~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~ia~g 364 (532)
. .++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a 223 (413)
T 3dzo_A 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 223 (413)
T ss_dssp HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence 1 11111 12456777766 78999998532 2345568899999999999999
Q ss_pred HHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeecccccccccccccc----------ccCCC
Q 037084 365 LEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYH----------QTLTI 434 (532)
Q Consensus 365 l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~ 434 (532)
|+|||+.+ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..+
T Consensus 224 L~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~ 294 (413)
T 3dzo_A 224 LASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLM 294 (413)
T ss_dssp HHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred HHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCC
Confidence 99999998 999999999999999999999999998865433 245677 999999998 56668
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCC
Q 037084 435 SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDP 514 (532)
Q Consensus 435 ~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P 514 (532)
+.++|||||||++|||++|+.||.......... ..+.. .. ..+..+.+++..||+.||
T Consensus 295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~----------------~~~~~--~~----~~~~~~~~li~~~l~~dP 352 (413)
T 3dzo_A 295 TFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE----------------WIFRS--CK----NIPQPVRALLEGFLRYPK 352 (413)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG----------------GGGSS--CC----CCCHHHHHHHHHHTCSSG
T ss_pred CchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH----------------HHHhh--cc----cCCHHHHHHHHHHccCCh
Confidence 899999999999999999999997643211100 00000 00 122558899999999999
Q ss_pred CCCCCHHHHHH
Q 037084 515 EERPSSKDVRC 525 (532)
Q Consensus 515 ~~RPs~~evl~ 525 (532)
++|||+.++++
T Consensus 353 ~~Rpt~~~~l~ 363 (413)
T 3dzo_A 353 EDRLLPLQAME 363 (413)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCcCHHHHHh
Confidence 99999887754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=312.69 Aligned_cols=250 Identities=17% Similarity=0.160 Sum_probs=182.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--------
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-------- 306 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-------- 306 (532)
.++|.+.+.||+|+||+||+|++. |+.||||++.........-. .......+.+|+.++++++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~vAvK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD---HTPVAIKIIAIEGPDLVNGS------HQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET---TEEEEEEEEEESCSSCBTTB------CCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccchheeeecccCceEEEEEEeC---CceEEEEEEecCCccccccc------cchhHHHHHHHHHHHHHHHHhhccccc
Confidence 467999999999999999999873 89999999976532100000 0111245677777777775
Q ss_pred -CCCcccceeE-----------------Eec-------------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHH
Q 037084 307 -HRNLLPLQAH-----------------VTR-------------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355 (532)
Q Consensus 307 -H~niv~l~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~ 355 (532)
||||+++.+. +.+ .+..|+|||||++|++.+.+.+ ..+++..+.
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~ 164 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAK 164 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHH
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHH
Confidence 6666665554 333 6789999999999977666632 458999999
Q ss_pred HHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEecCCC--------------------cEEEeccCCcccCCCCCcceee
Q 037084 356 RIARGMASGLEYLH-MYHRPCIIHRDIKPANVLIDDGM--------------------EARISDFGLAKLMPDGHTRIRI 414 (532)
Q Consensus 356 ~i~~~ia~gl~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~ 414 (532)
.++.|++.||.||| +.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 165 ~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------- 234 (336)
T 2vuw_A 165 SILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------
T ss_pred HHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------
Confidence 99999999999999 898 99999999999999887 899999999986543
Q ss_pred eccccccccccccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCC
Q 037084 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL-LAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGN 493 (532)
Q Consensus 415 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv-l~elltg~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 493 (532)
....||+.|+|||++.+.. +.++||||+|++ .+++++|..||..... ...+ ........... ......
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~---~~~~~~~~~~~----~~~~~~ 303 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYL---TDKMLKQMTFK----TKCNTP 303 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHH---HHHHHHTCCCS----SCCCSH
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh---hhHH---HHhhhhhhccC----cccchh
Confidence 2347999999999998766 899999998877 7789999999853100 0001 11111111110 000111
Q ss_pred CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 494 GYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 494 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
..+.....+.+|+..||+.| |+.+++
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 23456778999999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-31 Score=286.06 Aligned_cols=196 Identities=19% Similarity=0.082 Sum_probs=135.1
Q ss_pred eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCcccceeEEecCC
Q 037084 243 IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLPLQAHVTRPD 321 (532)
Q Consensus 243 ~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 321 (532)
..+.|++|.+..++-.- .|+.+++|++............ ..+...++|.+|+++|+++ .|+||+++++++++.+
T Consensus 241 ~~~~~~~~~h~~~rr~~-fg~~~~~K~~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF-FGEDYVCKFFYYDMPHGILTAE----ESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEEEE-ECSSEEEEEEESSCSTTCSCHH----HHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred ccccCCccccccccccc-ccceeEEEEEecccccccchhh----hhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence 46778887777665433 3889999999765322110000 0144567899999999999 7999999999999999
Q ss_pred ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCC
Q 037084 322 CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401 (532)
Q Consensus 322 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGl 401 (532)
..||||||++|++|.+++.. ..+++.. +|+.||+.||+|+|++| ||||||||+|||++++|++||+|||+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGl 385 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGS 385 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeeccc
Confidence 99999999999999999975 3456654 58999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 037084 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 402 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 456 (532)
|+........ .+..+||++|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 386 Ar~~~~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 386 IVTTPQDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp EESCC---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CeeCCCCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 9977654332 256789999999999876 567789999999998877665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=261.94 Aligned_cols=194 Identities=17% Similarity=0.141 Sum_probs=152.3
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEe
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 318 (532)
...+.||+|+||.||+|... +..+++|............. .....+.+.+|+.++++++||||+++..++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~---~~~~~~k~~~~~~~~~~~~~------~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 409 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL---DFDVIIKERVKKGYRDERLD------ENIRKSRTAREARYLALVKDFGIPAPYIFDV 409 (540)
T ss_dssp ---------CCEEEEEEECS---SCEEEEEEECCCTTSCHHHH------HHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC---CCeEEEEEEecccccchhhh------hHHHHHHHHHHHHHHHhcCCCCcCceEEEEE
Confidence 34568999999999999554 78999998765432222111 1233567899999999999999998877877
Q ss_pred cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEec
Q 037084 319 RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISD 398 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 398 (532)
..+..++|||||++++|.+++.. +..++.|+++||.|||+.+ |+||||||+|||++. .+||+|
T Consensus 410 ~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 410 DLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp ETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred eCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence 88888999999999999999864 4578999999999999998 999999999999999 999999
Q ss_pred cCCcccCCCCCcce-----eeecccccccccccccccc--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 399 FGLAKLMPDGHTRI-----RITTVAGTTGYVAPEYHQT--LTISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 399 FGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
||+++......... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999876542211 1135689999999999987 568888999999999999888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=206.16 Aligned_cols=159 Identities=13% Similarity=0.067 Sum_probs=118.0
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHH----HHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVR----RVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.|.+.+.||+|+||.||+|.+ . +|+.||||.++............. ..........+.+|+.++++++ | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~-~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-E-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-T-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred EEEecCEeccCCCceEEEEEe-C-CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 456779999999999999998 3 599999999976432211000000 0000123567899999999999 5 66
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ ++
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TT
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CC
Confidence 6666544 56799999999999988 421 123468999999999999998 99999999999999 99
Q ss_pred cEEEeccCCcccCCCCCcceeeecccccccccccccccc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT 431 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 431 (532)
.+||+|||+++. +..|.|||++..
T Consensus 230 ~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 230 GIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred cEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999999999863 234678887653
|
| >3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.5e-21 Score=162.02 Aligned_cols=81 Identities=17% Similarity=0.252 Sum_probs=77.2
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhchHHHHHHHHHHHHHHHHHHHhhhhh--ccCChHHHhHHHHHHHHHhhHHHHHHHhhh
Q 037084 26 ESIEAIIQNLESDWLQKFAGEAHIQADLMGWINMLVKISEVVDDAVEK--QMTNPHVKLWLGELQNLACDVEYLFDEFQT 103 (532)
Q Consensus 26 ~~~~~~~~kl~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~dae~~--~~~~~~~~~wl~~l~~~~yd~ed~~d~~~~ 103 (532)
|+++++++||++++.+|+.+++||++|+++|+++|++|+++|.|||++ +.+|+.||.|+++|||++|||||+||+|.+
T Consensus 1 a~v~~ll~KL~~ll~~E~~l~~gv~~~i~~Lk~eL~~m~a~L~da~~~~~~~~d~~vk~W~~~vrdlaYD~ED~iD~f~~ 80 (115)
T 3qfl_A 1 AAISNLIPKLGELLTEEFKLHKGVKKNIEDLGKELESMNAALIKIGEVPREQLDSQDKLWADEVRELSYVIEDVVDKFLV 80 (115)
T ss_dssp CTTCSHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCGGGCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHHHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 467789999999999999999999999999999999999999999998 779999999999999999999999999999
Q ss_pred HHH
Q 037084 104 EAF 106 (532)
Q Consensus 104 ~~~ 106 (532)
+.-
T Consensus 81 ~~~ 83 (115)
T 3qfl_A 81 QVD 83 (115)
T ss_dssp HHH
T ss_pred Hhc
Confidence 864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.3e-20 Score=178.39 Aligned_cols=153 Identities=18% Similarity=0.145 Sum_probs=107.4
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcE--EEEEEcCCCChhhHHHHH----------HHHHHHHHHHHHHHHHHHHHhcC
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKM--IAIKKIDQPPMAATELLN----------VRRVLINRKMRQIKSEIITAGRI 305 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~--vavK~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~E~~~l~~l 305 (532)
|.+.+.||+|+||.||+|.+.. +|+. ||||+++........... ............+.+|+..+.++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 5667899999999999998833 4888 999998654211100000 00000012234678899999999
Q ss_pred CCCCcccceeEEecCCceEEEEEeccC-C----CHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeec
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKN-G----SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLH-MYHRPCIIHR 379 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~ 379 (532)
+|+|+.....+.. +..+|||||+.+ | +|.++... .++.....++.|++.+|.||| +.+ |+||
T Consensus 128 ~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 128 KEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred HhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8886532222222 357899999942 4 77776532 123456788999999999999 888 9999
Q ss_pred CCCCCcEEecCCCcEEEeccCCcccC
Q 037084 380 DIKPANVLIDDGMEARISDFGLAKLM 405 (532)
Q Consensus 380 Dlkp~NIll~~~~~~kl~DFGla~~~ 405 (532)
||||+|||+++ .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.7e-19 Score=177.88 Aligned_cols=154 Identities=13% Similarity=0.087 Sum_probs=103.7
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHH--------HHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNV--------RRVLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
-|.+.++||+|+||.||+|... +|+.||||+++........+... ..............|...|.++.+.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 3788899999999999999875 59999999986532211000000 0000011112234567777777555
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++....-+.. ...+|||||++|++|..+.. .+ ....++.|++.+|.|||+.+ ||||||||.|||+
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------VP--DPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhcc--------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 5433222222 23479999999988855432 11 23467899999999999998 9999999999999
Q ss_pred cCCC----------cEEEeccCCcccCCC
Q 037084 389 DDGM----------EARISDFGLAKLMPD 407 (532)
Q Consensus 389 ~~~~----------~~kl~DFGla~~~~~ 407 (532)
++++ .+.|+||+.+....+
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred eCCCCcccccccccceEEEEeCCcccCCC
Confidence 8877 389999998776443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-12 Score=121.95 Aligned_cols=142 Identities=13% Similarity=0.065 Sum_probs=108.5
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~ 314 (532)
+.|.....+|.|+.+.||++... |..+++|+....... ....+.+|+.+++.+. |.++.+++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~---~~~~vlK~~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~vP~v~ 76 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE---NENLYLKMTDSRYKG--------------TTYDVEREKDMMLWLEGKLPVPKVL 76 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS---SCEEEEEEECGGGTT--------------STTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred ccceeEeeccCCCCCeEEEEECC---CCcEEEEeCCcccCC--------------CHHHHHHHHHHHHHHhcCCCCCeEE
Confidence 35777778888999999999643 689999998742100 0134677888888884 67788899
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH---------------------- 372 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------- 372 (532)
+++...+..|+||||++|.+|.+.+.. ......++.++++++..||+..
T Consensus 77 ~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (263)
T 3tm0_A 77 HFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN 147 (263)
T ss_dssp EEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred EEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence 999988899999999999999876421 1122467889999999999821
Q ss_pred ----------------------------------CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 ----------------------------------RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 ----------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=7.4e-11 Score=113.35 Aligned_cols=128 Identities=14% Similarity=0.118 Sum_probs=93.7
Q ss_pred cccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC--cccceeEEecCCc
Q 037084 245 GVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN--LLPLQAHVTRPDC 322 (532)
Q Consensus 245 G~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~ 322 (532)
+.|..+.||++... +|..+++|....... ..+..|+.+++.+.+.+ +.+++++...++.
T Consensus 29 ~gg~~~~v~~~~~~--~g~~~vlK~~~~~~~-----------------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQ--GRPVLFVKTDLSGAL-----------------NELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp CTTSSCEEEEEECT--TSCCEEEEEECSCTT-----------------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred cCCCCceEEEEecC--CCCeEEEEeCCcccc-----------------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 45666999999653 477899999765411 23567888888875444 4568888888888
Q ss_pred eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 037084 323 HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH------------------------------ 372 (532)
Q Consensus 323 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------ 372 (532)
.++||||++|.+|. ... .+ ...++.+++..+..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp EEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred CEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 89999999998884 211 11 1256777778888888643
Q ss_pred -------------------------CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 -------------------------RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=4.7e-10 Score=113.52 Aligned_cols=142 Identities=16% Similarity=0.198 Sum_probs=105.3
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcC--CCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--CCCcccceeE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKID--QPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--HRNLLPLQAH 316 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~ 316 (532)
.+.|+.|.++.||+.... +..+++|+.. .... ......+.+|..+++.+. +.++++++.+
T Consensus 43 ~~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~-------------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~ 106 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKL-------------LPSAHAIEREYRVMDALAGTDVPVAKMYAL 106 (359)
T ss_dssp EEECCC-CCSCEEEEECS---SCEEEEECCCC-----------------------CHHHHHHHHHHHTTSSSCCCCEEEE
T ss_pred EEEcCCcccceEEEEEEC---CceEEEEeCCCCCCCC-------------CCcHHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 467899999999998764 5688999876 3311 011245678888988886 4557888998
Q ss_pred EecC---CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------
Q 037084 317 VTRP---DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH--------------------- 372 (532)
Q Consensus 317 ~~~~---~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------- 372 (532)
+.+. +..++||||++|.++.+.. -..++...+..++.+++..|+.||+..
T Consensus 107 ~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3dxp_A 107 CEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIE 180 (359)
T ss_dssp ECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHH
T ss_pred CCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHH
Confidence 8776 4579999999988774321 123677888889999999999999731
Q ss_pred ----------------------------------CCCeeecCCCCCcEEecCCCc--EEEeccCCccc
Q 037084 373 ----------------------------------RPCIIHRDIKPANVLIDDGME--ARISDFGLAKL 404 (532)
Q Consensus 373 ----------------------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFGla~~ 404 (532)
...++|+|++|.||+++.++. +.|.||+.+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 181 RWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997653 68999998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=3.9e-10 Score=111.38 Aligned_cols=188 Identities=20% Similarity=0.247 Sum_probs=121.2
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCC--cccceeEE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRN--LLPLQAHV 317 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~ 317 (532)
++.++.|.+..||+. +..+++|..... .....+.+|..+++.+ .+.. +...+.+.
T Consensus 25 i~~~~~G~~n~v~~v------~~~~vlR~~~~~----------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~ 82 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI------NRDFIFKFPKHS----------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTG 82 (304)
T ss_dssp CCEEEECSSEEEEES------TTSEEEEEESSH----------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC
T ss_pred eEecCCCCcceEEEE------CCEEEEEecCCc----------------chHHHHHHHHHHHHHHHhcCCCCCCceEeec
Confidence 356899999999986 356889986532 2235677899999887 3433 33444444
Q ss_pred ecCC---ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------
Q 037084 318 TRPD---CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH---------------------- 372 (532)
Q Consensus 318 ~~~~---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------- 372 (532)
...+ ..|+||++++|.+|.+... ..++...+..++.+++..++.||+..
T Consensus 83 ~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (304)
T 3sg8_A 83 MPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKK 156 (304)
T ss_dssp CCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHH
T ss_pred CCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHH
Confidence 3333 3489999999988875432 13566777778888888888888621
Q ss_pred ---------------------------------CCCeeecCCCCCcEEecC--CCcEEEeccCCcccCCCCCcceeeec-
Q 037084 373 ---------------------------------RPCIIHRDIKPANVLIDD--GMEARISDFGLAKLMPDGHTRIRITT- 416 (532)
Q Consensus 373 ---------------------------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~- 416 (532)
.+.++|+|++|.||++++ +..+.|+||+.+..............
T Consensus 157 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~ 236 (304)
T 3sg8_A 157 IKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED 236 (304)
T ss_dssp HHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT
T ss_pred HHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh
Confidence 235899999999999998 56688999998875322110000000
Q ss_pred -----------ccccccccc-ccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 037084 417 -----------VAGTTGYVA-PEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458 (532)
Q Consensus 417 -----------~~gt~~y~a-PE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~ 458 (532)
.....++.. |+.... ...-.+.|++|.++|.+.+|..+|-
T Consensus 237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 237 DEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred ccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000001111 221111 1223689999999999999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-06 Score=86.71 Aligned_cols=136 Identities=18% Similarity=0.149 Sum_probs=92.0
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC---CcccceeEE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR---NLLPLQAHV 317 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~ 317 (532)
++.++.|....||+. |..+++|+-.. ......+.+|..+|..+.+. .+...+.++
T Consensus 24 v~~l~~G~~n~v~~v------g~~~VlR~~~~----------------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~ 81 (306)
T 3tdw_A 24 VESLGEGFRNYAILV------NGDWVFRFPKS----------------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIG 81 (306)
T ss_dssp EEEEEECSSEEEEEE------TTTEEEEEESS----------------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEE
T ss_pred eeecCCCcceeEEEE------CCEEEEEecCC----------------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeec
Confidence 356889999999997 45688888432 12235688999999998653 355667776
Q ss_pred e-cCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------
Q 037084 318 T-RPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY------------------------- 371 (532)
Q Consensus 318 ~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------------------------- 371 (532)
. ..+..++||||++|.+|.+.... .++......++.+++..|+.||+.
T Consensus 82 ~~~~g~~~~v~e~i~G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~ 155 (306)
T 3tdw_A 82 KRSDGNPFVGYRKVQGQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEA 155 (306)
T ss_dssp ECTTSCEEEEEECCCSEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHH
T ss_pred ccCCCceEEEEeccCCeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHH
Confidence 4 44567899999999888763211 123333444444444444444432
Q ss_pred --------------------------------CCCCeeecCCCCCcEEecC---CCc-EEEeccCCccc
Q 037084 372 --------------------------------HRPCIIHRDIKPANVLIDD---GME-ARISDFGLAKL 404 (532)
Q Consensus 372 --------------------------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFGla~~ 404 (532)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 156 ~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 156 VEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 47999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=8.7e-07 Score=85.40 Aligned_cols=135 Identities=17% Similarity=0.200 Sum_probs=95.0
Q ss_pred eecccCCe-EEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccceeEEecC
Q 037084 243 IIGVGACG-VVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQAHVTRP 320 (532)
Q Consensus 243 ~LG~G~fG-~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 320 (532)
.+..|..| .||+..... ++..+++|+-... ....+.+|...|+.+. +-.+.++++++...
T Consensus 31 ~~~~G~S~~~v~rl~~~~-~~~~~~lk~~~~~-----------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~ 92 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP-NAPELFLKHGKGS-----------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTP 92 (272)
T ss_dssp EEECSSSSCEEEEEECCT-TCCCEEEEEEETH-----------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred EccCCCcCCeEEEEEecC-CCeEEEEEECCCC-----------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEEC
Confidence 45556655 689876543 3678999986543 1235667888887773 33366788999999
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH---------------------------- 372 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------- 372 (532)
+..++|||+++|.++.+..... ......++.+++..|..||+..
T Consensus 93 ~~~~lvme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 93 DDAWLLTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp TEEEEEEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred CeEEEEEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 9999999999998887765431 1122345666666677777421
Q ss_pred ---------------------------CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 ---------------------------RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 ---------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999988777899998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.4e-05 Score=77.81 Aligned_cols=31 Identities=19% Similarity=0.393 Sum_probs=27.5
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4569999999999999888899999999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=7.1e-06 Score=82.45 Aligned_cols=85 Identities=2% Similarity=-0.058 Sum_probs=52.4
Q ss_pred ccee-cccCCeEEEEEEee--CC---CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-C--CCcc
Q 037084 241 LEII-GVGACGVVYKAEVP--GS---YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-H--RNLL 311 (532)
Q Consensus 241 ~~~L-G~G~fG~Vy~~~~~--~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv 311 (532)
.+.| +.|....+|+.... .. ++..+++|.......... .....+.+|+.+++.+. + -.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-----------~~~~~~~~E~~~l~~L~~~~~vpvP 93 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-----------FPTYRLDHQFEVIRLVGELTDVPVP 93 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-----------SSCCCHHHHHHHHHHHHHHCCSCCC
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-----------CchhHHHHHHHHHHHHhhcCCCCCC
Confidence 4668 88999999998653 00 156789998654320000 00023455666666663 2 2466
Q ss_pred cceeEEecC---CceEEEEEeccCCCHH
Q 037084 312 PLQAHVTRP---DCHLLVYEFMKNGSLQ 336 (532)
Q Consensus 312 ~l~~~~~~~---~~~~lV~E~~~~gsL~ 336 (532)
+++.++.+. +..++||||++|.++.
T Consensus 94 ~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 94 RVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred cEEEEccCCCccCCceEEEEecCCCChh
Confidence 778877665 3568999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.2e-05 Score=80.14 Aligned_cols=82 Identities=13% Similarity=0.058 Sum_probs=47.9
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCCh-hhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC--CCcc-cceeE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPM-AATELLNVRRVLINRKMRQIKSEIITAGRIWH--RNLL-PLQAH 316 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv-~l~~~ 316 (532)
.+.||.|.++.||++.... ++..++||....... ..... .....++..|.+++..+.. |..+ .++.+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~--------~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~ 105 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESW--------PLTIDRARIESSALIRQGEHVPHLVPRVFYS 105 (397)
T ss_dssp EEECCSSSSEEEEEEEC-----CEEEEEEECCC-------C--------CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCC--------cCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence 4679999999999997653 267899998764321 00000 0012345567777776632 4433 45443
Q ss_pred EecCCceEEEEEeccCC
Q 037084 317 VTRPDCHLLVYEFMKNG 333 (532)
Q Consensus 317 ~~~~~~~~lV~E~~~~g 333 (532)
+.+..++||||+++.
T Consensus 106 --d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 --DTEMAVTVMEDLSHL 120 (397)
T ss_dssp --ETTTTEEEECCCTTS
T ss_pred --cCCccEEEEEeCCCc
Confidence 345568999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=6.1e-05 Score=74.06 Aligned_cols=139 Identities=13% Similarity=0.160 Sum_probs=90.3
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---CCCcccceeEE
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW---HRNLLPLQAHV 317 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~ 317 (532)
.+.|+.|.+..+|+.... +..+++|+..... ...+..|...|+.|. ...++++++++
T Consensus 41 ~~~l~gG~~n~~y~v~~~---~~~~vlK~~~~~~-----------------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~ 100 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE---VQTVFVKINERSY-----------------RSMFRAEADQLALLAKTNSINVPLVYGIG 100 (312)
T ss_dssp EEEECCSSSSEEEEEESS---SCEEEEEEEEGGG-----------------HHHHHHHHHHHHHHHHTTSSBCCCEEEEE
T ss_pred eEEeCCccceeeeEEEEC---CCeEEEEeCCccc-----------------HHHHHHHHHHHHHHHhhCCCCcceEEEEe
Confidence 467999999999998643 6788999875321 245677888777773 35677888888
Q ss_pred ecCCceEEEEEeccCCCHH--------H---HHhhhcC-CC-----------------CCCCHHHHH---HHHHH-----
Q 037084 318 TRPDCHLLVYEFMKNGSLQ--------D---ILHDVSQ-GR-----------------RELDWLARY---RIARG----- 360 (532)
Q Consensus 318 ~~~~~~~lV~E~~~~gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~~----- 360 (532)
...+..++||||+++.++. . .+|.... .. ..-+|.... ++..+
T Consensus 101 ~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~ 180 (312)
T 3jr1_A 101 NSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICK 180 (312)
T ss_dssp ECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHH
T ss_pred ecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHH
Confidence 8888899999999987642 1 2333211 00 012454322 11111
Q ss_pred -----------HHHH-HHHHHh-cCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 361 -----------MASG-LEYLHM-YHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 361 -----------ia~g-l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..- ...|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 181 ~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 181 EKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1111 223322 2245699999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00033 Score=71.98 Aligned_cols=78 Identities=17% Similarity=0.114 Sum_probs=47.8
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccc--cccccccccccccCC---CCchhhHHHHHHHH
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA--GTTGYVAPEYHQTLT---ISEKSDIYSFGVLL 447 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl 447 (532)
.+.++|+|++|.||+++.++ +.++||+.+..-...... .... -...|.+|+...... .....++.+....+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45599999999999999876 999999988753321110 1111 123466666553211 12234556777777
Q ss_pred HHHHhCC
Q 037084 448 AVLVVGK 454 (532)
Q Consensus 448 ~elltg~ 454 (532)
|+.+++.
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7766653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00034 Score=67.83 Aligned_cols=78 Identities=13% Similarity=0.129 Sum_probs=53.1
Q ss_pred ccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC---Ccccce
Q 037084 238 LASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR---NLLPLQ 314 (532)
Q Consensus 238 ~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~ 314 (532)
+..++.+|.|..+.||+.+.. +|+.+.+|+-....... ...|..|...|+.|.-. -+++.+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~--------------~~~~~~Ea~~L~~L~~~~~vpvP~v~ 80 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELA--DGTPLFVKALPDDAPAL--------------DGLFRAEALGLDWLGRSFGSPVPQVA 80 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCC--------------TTHHHHHHHHHHHHTCSTTCCSCCEE
T ss_pred eEEEEecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcch--------------hhHHHHHHHHHHHHHhhCCCCcceEE
Confidence 344578999999999999886 68999999876542211 13466788888877422 233444
Q ss_pred eEEecCCceEEEEEeccCCCH
Q 037084 315 AHVTRPDCHLLVYEFMKNGSL 335 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL 335 (532)
++. ..++||||++++..
T Consensus 81 ~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 81 GWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp EEE----TTEEEEECCCCCCC
T ss_pred ecc----CceEEEEeecccCC
Confidence 442 34799999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00082 Score=65.54 Aligned_cols=31 Identities=26% Similarity=0.267 Sum_probs=25.9
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
...++|+|+.|.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667789999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.002 Score=63.70 Aligned_cols=33 Identities=30% Similarity=0.342 Sum_probs=28.1
Q ss_pred CCCeeecCCCCCcEEecCC----CcEEEeccCCcccC
Q 037084 373 RPCIIHRDIKPANVLIDDG----MEARISDFGLAKLM 405 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~~~ 405 (532)
...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3469999999999999874 68999999988753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0022 Score=62.93 Aligned_cols=144 Identities=15% Similarity=0.166 Sum_probs=76.3
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-----CCCcccce-
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-----HRNLLPLQ- 314 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~- 314 (532)
.+.|+.|....+|+.... +..+++|....... ...+..|..++..+. -|.++...
T Consensus 27 ~~~i~~G~~n~~~~v~~~---~g~~vlk~~~~~~~----------------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~ 87 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT---KDPLILTLYEKRVE----------------KNDLPFFLGLMQHLAAKGLSCPLPLPRKD 87 (322)
T ss_dssp EEEECC---EEEEEEEES---SCCEEEEEECC-------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred eeccCCCcccceEEEEeC---CccEEEEEeCCCCC----------------HHHHHHHHHHHHHHHHCCCCCCcccCCCC
Confidence 456888999999998764 33788998876210 012334455554442 23333210
Q ss_pred e--EEecCCceEEEEEeccCCCHHH--------------HHhhhcCC-C-C---CC---CHHHHHH------------HH
Q 037084 315 A--HVTRPDCHLLVYEFMKNGSLQD--------------ILHDVSQG-R-R---EL---DWLARYR------------IA 358 (532)
Q Consensus 315 ~--~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~~~~-~-~---~l---~~~~~~~------------i~ 358 (532)
| +....+..+++++|++|.++.. .+|..... . . .. .|...+. +.
T Consensus 88 g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~ 167 (322)
T 2ppq_A 88 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 167 (322)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhH
Confidence 1 1122356789999998865311 12321111 0 0 01 1322110 00
Q ss_pred HHHHHHHHHHHhc----CCCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 359 RGMASGLEYLHMY----HRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 359 ~~ia~gl~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
..+...+..++.. ....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 168 ~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 168 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1134445555532 13459999999999999987666899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0025 Score=62.75 Aligned_cols=30 Identities=20% Similarity=0.207 Sum_probs=25.4
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
...++|+|++|.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999999 4 899999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0027 Score=63.99 Aligned_cols=144 Identities=13% Similarity=0.176 Sum_probs=80.1
Q ss_pred ceecccCCeEEEEEEeeC------CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc-ccce
Q 037084 242 EIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL-LPLQ 314 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~ 314 (532)
+.|..|-...+|+..... .++..+++|+..... .......+|..+++.+.-.++ .+++
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---------------~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---------------QGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---------------chHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 567778888999987642 124789999863321 012334467777777633233 4566
Q ss_pred eEEecCCceEEEEEeccCCCHHH--------------H---HhhhcC-CCCCCC--HHHHHHHHHHHHH-----------
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQD--------------I---LHDVSQ-GRRELD--WLARYRIARGMAS----------- 363 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~--------------~---l~~~~~-~~~~l~--~~~~~~i~~~ia~----------- 363 (532)
+++.+ .+|+||++|.+|.. . +|.... ..+... |.+..++..++..
T Consensus 121 ~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~ 196 (379)
T 3feg_A 121 GVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNL 196 (379)
T ss_dssp EEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCH
T ss_pred EEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhh
Confidence 66653 29999998855431 1 222111 112222 3444444443321
Q ss_pred --------HHHH----HHhc-CCCCeeecCCCCCcEEecCC----CcEEEeccCCccc
Q 037084 364 --------GLEY----LHMY-HRPCIIHRDIKPANVLIDDG----MEARISDFGLAKL 404 (532)
Q Consensus 364 --------gl~~----LH~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DFGla~~ 404 (532)
.+.. |... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 197 ~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 197 LEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2233 3222 23459999999999999876 7899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0017 Score=66.72 Aligned_cols=74 Identities=11% Similarity=0.130 Sum_probs=46.7
Q ss_pred cceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc-ccc
Q 037084 241 LEIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL-LPL 313 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l 313 (532)
++.|+.|....+|++...+. ++..+++|+...... ...+..|..++..+...++ +++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~----------------~~~li~E~~~l~~L~~~g~~P~l 141 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----------------ESHLVAESVIFTLLSERHLGPKL 141 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----------------HHHHHHHHHHHHHHHHTTSSSCE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc----------------HHHHHHHHHHHHHHHhCCCCCcE
Confidence 35688899999999986521 247899999854211 0122356667766643334 456
Q ss_pred eeEEecCCceEEEEEeccCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGS 334 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gs 334 (532)
++.+.+ .+|+||++|.+
T Consensus 142 ~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 142 YGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp EEEETT----EEEECCCCEEE
T ss_pred EEEeCC----CEEEEEeCCcc
Confidence 666542 38999998643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.01 Score=54.19 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=67.4
Q ss_pred CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcce
Q 037084 333 GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412 (532)
Q Consensus 333 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 412 (532)
-||.+.|... +.++++.++|.++.|.+..|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 4899999863 56899999999999999988765221111 1233457899999999888864 1110
Q ss_pred eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 037084 413 RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFP 456 (532)
Q Consensus 413 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p 456 (532)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 3567889999999999988864444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0065 Score=62.87 Aligned_cols=75 Identities=16% Similarity=0.156 Sum_probs=46.6
Q ss_pred cceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc-ccceeEEec
Q 037084 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL-LPLQAHVTR 319 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~ 319 (532)
++.|+.|-...+|+....+ .+..+++|+........ ..-.+|..++..|...++ .++++.+.
T Consensus 113 i~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~~---------------idR~~E~~vl~~L~~~gl~P~ll~~~~- 175 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDEI---------------INREREKKISCILYNKNIAKKIYVFFT- 175 (458)
T ss_dssp EEEECC--CEEEEEEEETT-TTEEEEEEEECC-CCSC---------------SCHHHHHHHHHHHTTSSSBCCEEEEET-
T ss_pred EEEcCCCeEeEEEEEEECC-CCceEEEEECCCChhhh---------------cCHHHHHHHHHHHHhcCCCCCEEEEeC-
Confidence 4678889999999998753 14789999875432110 011367777877765555 45677663
Q ss_pred CCceEEEEEeccCCCH
Q 037084 320 PDCHLLVYEFMKNGSL 335 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL 335 (532)
+ .+|+||++|.+|
T Consensus 176 -~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 176 -N--GRIEEFMDGYAL 188 (458)
T ss_dssp -T--EEEEECCCSEEC
T ss_pred -C--eEEEEeeCCccC
Confidence 2 359999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0024 Score=64.08 Aligned_cols=30 Identities=20% Similarity=0.404 Sum_probs=24.9
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
..++|+|+.|.||+++++. +.++||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4599999999999998655 89999987763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.022 Score=56.32 Aligned_cols=32 Identities=28% Similarity=0.411 Sum_probs=28.0
Q ss_pred CCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 373 RPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 373 ~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34599999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.63 E-value=0.075 Score=54.22 Aligned_cols=30 Identities=20% Similarity=0.420 Sum_probs=26.5
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 45899999999999 8888999999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.96 E-value=0.68 Score=42.21 Aligned_cols=118 Identities=14% Similarity=0.171 Sum_probs=78.8
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCC
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLE-YLHMYHRPCIIHRDIKPA 384 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~-~LH~~~~~~ivH~Dlkp~ 384 (532)
.||.+ -..+-.+.+.+.+.|+.-+++.=...++ ..+...+++++.+++.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 47777 4445566677777777654443333333 3677888998988887665 4443 578899999
Q ss_pred cEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Q 037084 385 NVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461 (532)
Q Consensus 385 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~ 461 (532)
||+++.++.+++.-.|+-. -++|.- .+..-=.-++=|++..++.++..|+...
T Consensus 114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~l~ 166 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFDEYL 166 (219)
T ss_dssp GEEECTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHHHH
T ss_pred eEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 9999999999998766532 233331 2222233467788999999998887543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.39 E-value=0.45 Score=43.27 Aligned_cols=120 Identities=13% Similarity=0.114 Sum_probs=80.0
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPAN 385 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~N 385 (532)
.||+.+.. .+-.+.+...+-|+.-+ +..+|-. -...+...+++++..++....++++ -+|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57877765 45555566555555433 2222211 1347788899999999887765543 4788999999
Q ss_pred EEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCccc
Q 037084 386 VLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462 (532)
Q Consensus 386 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~ 462 (532)
++++.++.+++.-.|+-.. ++|. ..+...=.-.+=|++..+++++..|+....
T Consensus 110 L~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~ 162 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVE 162 (215)
T ss_dssp EEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHH
T ss_pred EEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHc
Confidence 9999999999986665321 2222 223333445677899999999999976544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.38 E-value=0.055 Score=55.97 Aligned_cols=64 Identities=5% Similarity=0.014 Sum_probs=18.2
Q ss_pred ccceecccCCeEEEEEEeeCCCCcEEEE------EEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 240 SLEIIGVGACGVVYKAEVPGSYGKMIAI------KKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~~~~g~~vav------K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+.+.|| ||.||+|.+.+. ..+||| |..+..... ......|.+|..+...++|||+++.
T Consensus 146 l~~~lG---fG~v~~g~~~~~-~~~Vav~~~~~~K~~~~~~~~------------~e~~~~~~rea~l~~~~~H~niv~~ 209 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKK-HMPVLKETHDERDSTGQDGVS------------EKRLTSLVRRATLKENEQIPKYEKI 209 (463)
T ss_dssp STTTSS---BCCC----------CCBGGGC-----------------------------------------------CBC
T ss_pred ccccCC---chhhhccccccc-CCchhhhhccCcccccccccc------------ccccccccccccccccccccccCCC
Confidence 345676 999999999743 468888 665543211 3334568888999999999999999
Q ss_pred eeEEec
Q 037084 314 QAHVTR 319 (532)
Q Consensus 314 ~~~~~~ 319 (532)
+++...
T Consensus 210 h~f~~~ 215 (463)
T 3cxl_A 210 HNFKVH 215 (463)
T ss_dssp CCEEEE
T ss_pred cceEEe
Confidence 887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 532 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-53 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-49 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-41 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-40 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-59
Identities = 66/294 (22%), Positives = 128/294 (43%), Gaps = 38/294 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ IG G+ G VYK + + +A+K ++ ++++ K+E+
Sbjct: 13 GQRIGSGSFGTVYKGK----WHGDVAVKMLN------------VTAPTPQQLQAFKNEVG 56
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N+L + T P +V ++ + SL LH + + + + IAR
Sbjct: 57 VLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A G++YLH IIHRD+K N+ + + + +I DFGLA + + ++G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 421 TGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
++APE + S +SD+Y+FG++L L+ G+ P+ + +N + ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN-------INNRDQIIFMV 222
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
SK+ N + RL+ + C +ERP + + +
Sbjct: 223 -GRGYLSPDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQILASIELLA 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-53
Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 36/287 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G+ G K GK++ K++D + + + + SE+
Sbjct: 9 LYTIGTGSYGRCQKIRRKSD-GKILVWKELD------------YGSMTEAEKQMLVSEVN 55
Query: 301 TAGRIWHRNLLPL-QAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+ H N++ + R + L +V E+ + G L ++ ++ R+ LD R+
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 359 RGMASGLEYLHMYHR--PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT 416
+ L+ H ++HRD+KPANV +D ++ DFGLA+++ +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKA 173
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT Y++PE ++ +EKSDI+S G LL L PF F Q +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
I + ++ + + RPS +++
Sbjct: 234 IPYRYSDELNE-------------IITR----MLNLKDYHRPSVEEI 263
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-53
Identities = 62/302 (20%), Positives = 118/302 (39%), Gaps = 29/302 (9%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
K+D + +G G GVV+K S G ++A K I +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLI-------------HLEIKPAIRN 49
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
QI E+ ++ + E M GSL +L +
Sbjct: 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQI 105
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+++ + GL YL + I+HRD+KP+N+L++ E ++ DFG++ + D
Sbjct: 106 LGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 160
Query: 414 ITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
+ GT Y++PE Q S +SDI+S G+ L + VG++P E+ +
Sbjct: 161 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQ--MRLVLKIAYFCTSDDPEERPS---SKDVRCMLS 528
+ P + L + + + ++ + ++ P + PS S + + ++
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 529 QI 530
+
Sbjct: 280 KC 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-52
Identities = 74/291 (25%), Positives = 122/291 (41%), Gaps = 42/291 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E +G G G V+ G +A+K + Q M+ L E
Sbjct: 18 VERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPDAFLA---------------EAN 60
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H+ L+ L A VT+ ++ + E+M+NGSL D L +L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+A G+ ++ IHRD++ AN+L+ D + +I+DFGLA+L+ D R
Sbjct: 118 IAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFP 173
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
+ APE T + KSD++SFG+LL ++ G+ P+ N+ R R V
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
P L+ C + PE+RP+ +R +L
Sbjct: 234 NCPEELYQ-------------LMRL----CWKERPEDRPTFDYLRSVLEDF 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-50
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 43/287 (14%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
IG G+ VYK + +A ++ R L + ++ K E
Sbjct: 15 IEIGRGSFKTVYKGLDTET-TVEVAWCELQ------------DRKLTKSERQRFKEEAEM 61
Query: 302 AGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
+ H N++ ++ V C +LV E M +G+L+ L + +
Sbjct: 62 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSW 117
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD-GMEARISDFGLAKLMPDGHTRIRITT 416
R + GL++LH P IIHRD+K N+ I +I D GLA L
Sbjct: 118 CRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KA 172
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
V GT ++APE ++ E D+Y+FG+ + + ++P+ + +
Sbjct: 173 VIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE-------CQNAAQIYRR 224
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
++S + D + E ++ C + +ER S KD+
Sbjct: 225 VTSGVKPASFDKVAI----PEVKEIIEG----CIRQNKDERYSIKDL 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-50
Identities = 65/312 (20%), Positives = 117/312 (37%), Gaps = 44/312 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E IG G G V++ + G + +A+K + ++EI
Sbjct: 8 QESIGKGRFGEVWRGKWRG---EEVAVKIFSSR---------------EERSWFREAEIY 49
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL----LVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
+ H N+L A + + LV ++ ++GSL D L+ R + +
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 104
Query: 357 IARGMASGLEYLHM-----YHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG--H 409
+A ASGL +LHM +P I HRD+K N+L+ I+D GLA
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 410 TRIRITTVAGTTGYVAPEY------HQTLTISEKSDIYSFGVLLAVLVVGKFPFD---DF 460
I GT Y+APE + +++DIY+ G++ + D+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYE-EQMRLVLKIAYFCTSDDPEERPS 519
++ + + + + E +R++ KI C + R +
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 520 SKDVRCMLSQIK 531
+ ++ LSQ+
Sbjct: 285 ALRIKKTLSQLS 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 9e-50
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 41/283 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+G G G VY A S ++A+K + + + Q++ E+
Sbjct: 11 GRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEKAG-----------VEHQLRREVE 58
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N+L L + L+ E+ G++ L + D
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 114
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+A+ L Y H +IHRDIKP N+L+ E +I+DFG + P T+ GT
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGT 167
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+ PE + EK D++S GVL +VGK PF+ Y E + +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFPDF 226
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
A D L+ + +P +RP ++V
Sbjct: 227 VTEGARD-------------LISR----LLKHNPSQRPMLREV 252
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 1e-49
Identities = 66/301 (21%), Positives = 124/301 (41%), Gaps = 42/301 (13%)
Query: 236 DSLASLEIIGVGACGVVYKAE--VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
+ ++IG G G V +PG +AIK + + ++ R
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL-------------KSGYTEKQRR 72
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLA 353
SE G+ H N++ L+ VT+ +++ EFM+NGSL L Q + +
Sbjct: 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQ 129
Query: 354 RYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIR 413
+ RG+A+G++YL +HRD+ N+L++ + ++SDFGL++ + D +
Sbjct: 130 LVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 414 ITTVAG---TTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNM 469
T+ G + APE Q + SD++S+G+++ V+ G+ P+ D M
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------MTN 239
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529
+ + +D + ++ C D RP + L +
Sbjct: 240 QDVINAIEQDYRLPPPMDC----------PSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 530 I 530
+
Sbjct: 290 M 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-49
Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 43/288 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ +G GA G VYKA+ + + A K ID ++ EI
Sbjct: 17 IGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSE--------------EELEDYMVEID 61
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H N++ L + ++ EF G++ ++ + R L + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQ 118
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
L YLH IIHRD+K N+L + +++DFG++ R + GT
Sbjct: 119 TLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGT 173
Query: 421 TGYVAPEYHQTLT-----ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
++APE T K+D++S G+ L + + P + +N +R +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-------LNPMRVLLK 226
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ SE P A S+ + K C + + R ++ +
Sbjct: 227 IAKSEPPTLAQPSRW----SSNFKDFLKK----CLEKNVDARWTTSQL 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-49
Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 42/291 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G G GVV + G +AIK I + M+ E + E
Sbjct: 9 LKELGTGQFGVVKYGKWRG--QYDVAIKMIKEGSMSEDEFIE---------------EAK 51
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H L+ L T+ ++ E+M NG L + L + R + +
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKD 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ +EYL +HRD+ N L++D ++SDFGL++ + D
Sbjct: 109 VCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 164
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
+ PE S KSDI++FGVL+ + +GK P++ F ++ + +R
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+ I Y C + +ERP+ K + + +
Sbjct: 225 LASEKVYT-----------------IMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-49
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 37/285 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ +G GA G V A + + +A+K +D IK EI
Sbjct: 10 VQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRAV-------------DCPENIKKEIC 55
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ H + L E+ G L D + + R
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQ 111
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ +G+ YLH I HRDIKP N+L+D+ +ISDFGLA + + + + GT
Sbjct: 112 LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 421 TGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
YVAPE + +E D++S G++L ++ G+ P+D Q ++ + +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---QPSDSCQEYSDWKEKKTY 225
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524
NP + IDS L L+ K ++P R + D++
Sbjct: 226 LNPWKKIDSAPL--------ALLHK----ILVENPSARITIPDIK 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 4e-49
Identities = 66/296 (22%), Positives = 113/296 (38%), Gaps = 40/296 (13%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMI--AIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
E+IG G G VY + + GK I A+K ++ R+ ++ Q +E
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------------RITDIGEVSQFLTEG 79
Query: 300 ITAGRIWHRNLLPLQAHVTRPD-CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
I H N+L L R + L+V +MK+G L++ +
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFG 136
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDG--HTRIRITT 416
+A G+ +HRD+ N ++D+ +++DFGLA+ M D + T
Sbjct: 137 LQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 417 VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
++A E QT + KSD++SFGVLL L+ P ++N +
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYL 247
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+ L + + ++ C E RPS ++ +S I
Sbjct: 248 LQGRRL-------LQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 5e-49
Identities = 60/319 (18%), Positives = 114/319 (35%), Gaps = 56/319 (17%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRK 291
+++ + IG GA G V++A PG M+A+K + +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------------KEEASADM 59
Query: 292 MRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD---------- 341
+ E + N++ L L++E+M G L + L
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 342 ----------VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391
S G L + IAR +A+G+ YL +HRD+ N L+ +
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176
Query: 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV 451
M +I+DFGL++ + A ++ PE + +SD++++GV+L +
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 452 VGKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTS 511
+ ++ ++R+ P E + + C S
Sbjct: 237 SYGLQ---PYYGMAHEEVIYYVRDGNILACP-------------ENCPLELYNLMRLCWS 280
Query: 512 DDPEERPSSKDVRCMLSQI 530
P +RPS + +L ++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 4e-48
Identities = 69/304 (22%), Positives = 124/304 (40%), Gaps = 49/304 (16%)
Query: 223 IFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLN 282
+F K D E + L IG G+ G VY A + +++AIKK+ + E
Sbjct: 7 LFFKDDP-----EKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQSNE--- 57
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
K + I E+ ++ H N + + R LV E+ + +
Sbjct: 58 --------KWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH- 108
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
++ L + + G GL YLH ++ +IHRD+K N+L+ + ++ DFG A
Sbjct: 109 ---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA 162
Query: 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLT---ISEKSDIYSFGVLLAVLVVGKFPFDD 459
+M ++ + GT ++APE + K D++S G+ L K P +
Sbjct: 163 SIMAPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
Query: 460 FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS 519
MN + + ++ +E+P L + E R + C P++RP+
Sbjct: 217 -------MNAMSALYHIAQNESP------ALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
Query: 520 SKDV 523
S+ +
Sbjct: 261 SEVL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-48
Identities = 70/293 (23%), Positives = 110/293 (37%), Gaps = 48/293 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG G G V + G +A+K I + + +E
Sbjct: 12 LQTIGKGEFGDVMLGD---YRGNKVAVKCIKN----------------DATAQAFLAEAS 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHL-LVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
++ H NL+ L + L +V E+M GSL D L S+GR L + +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSL 110
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ +EYL +HRD+ NVL+ + A++SDFGL K T
Sbjct: 111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKL 162
Query: 420 TTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV-VGKFPFDDFFQYTEEMNMVRWMRNVIS 478
+ APE + S KSD++SFG+LL + G+ P+ + + + V
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-------IPLKDVVPRVEK 215
Query: 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531
+G + ++ C D RPS +R L IK
Sbjct: 216 GYKMDAP-------DGCPPAVY---EVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-48
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 42/291 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+G G G V+ G +AIK + M+ L E
Sbjct: 22 EVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPEAFLQ---------------EAQ 64
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H L+ L A V+ ++ V E+M GSL D L + + L +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 121
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ASG+ Y+ +HRD++ AN+L+ + + +++DFGLA+L+ D R
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFP 177
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV-RWMRNVISS 479
+ APE + KSD++SFG+LL L E ++ V R R
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
E P D L+ + C +PEERP+ + ++ L
Sbjct: 238 ECPESLHD-------------LMCQ----CWRKEPEERPTFEYLQAFLEDY 271
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (420), Expect = 6e-48
Identities = 65/310 (20%), Positives = 116/310 (37%), Gaps = 42/310 (13%)
Query: 221 RPIFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATEL 280
P + K ++ + + +G G G VY+ +A+K + + M
Sbjct: 6 SPNYDKWEM----ERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTM----- 55
Query: 281 LNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH 340
++ + E I H NL+ L TR ++ EFM G+L D L
Sbjct: 56 ----------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 105
Query: 341 DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400
+ R+E+ + +A ++S +EYL + IHRD+ N L+ + +++DFG
Sbjct: 106 E--CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG 160
Query: 401 LAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460
L++LM + APE S KSD+++FGVLL +
Sbjct: 161 LSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---P 216
Query: 461 FQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ + + + E P E V ++ C +P +RPS
Sbjct: 217 YPGIDLSQVYELLEKDYRMERP-------------EGCPEKVYELMRACWQWNPSDRPSF 263
Query: 521 KDVRCMLSQI 530
++ +
Sbjct: 264 AEIHQAFETM 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-48
Identities = 62/312 (19%), Positives = 115/312 (36%), Gaps = 57/312 (18%)
Query: 241 LEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
+++G GA G V A G +A+K + + + + +
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-------------KEKADSSEREALM 88
Query: 297 SEIITAGRIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH--------------- 340
SE+ ++ H N++ L T L++E+ G L + L
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 341 ----DVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARI 396
+ + L + A +A G+E+L +HRD+ NVL+ G +I
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI 205
Query: 397 SDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV-VGKF 455
DFGLA+ + + ++APE + KSD++S+G+LL + +G
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 456 PFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPE 515
P+ + N + ++N + P A + + I C + D
Sbjct: 266 PYPGI---PVDANFYKLIQNGFKMDQPFYATEE-------------IYIIMQSCWAFDSR 309
Query: 516 ERPSSKDVRCML 527
+RPS ++ L
Sbjct: 310 KRPSFPNLTSFL 321
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-47
Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 37/292 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+I+G G+ V A + + AIK +++ R ++ K+ + E
Sbjct: 13 GKILGEGSFSTVVLARELAT-SREYAIKILEK-----------RHIIKENKVPYVTRERD 60
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
R+ H + L + + KNG L + +
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-------FDETCTRFY 113
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A + L H IIHRD+KP N+L+++ M +I+DFG AK++ + R + GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
YV+PE + + SD+++ G ++ LV G PF +Y + + +
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-LIFQKIIKLEYDFPEK 232
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+A D LV K D +R +++ H
Sbjct: 233 FFPKARD-------------LVEK----LLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 40/290 (13%)
Query: 244 IGVGACGVVYKAEVP-GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITA 302
+G G G V K K +A+K + ++ +E
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILK------------NEANDPALKDELLAEANVM 62
Query: 303 GRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMA 362
++ + ++ + + + +LV E + G L L R + + ++
Sbjct: 63 QQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVS 117
Query: 363 SGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITT-VAGTT 421
G++YL +HRD+ NVL+ A+ISDFGL+K + + T
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 422 GYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
+ APE S KSD++SFGVL+ G+ P+ + + R +
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
P D L+ C + D E RP V L
Sbjct: 235 CPREMYD-------------LMNL----CWTYDVENRPGFAAVELRLRNY 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-46
Identities = 60/299 (20%), Positives = 121/299 (40%), Gaps = 39/299 (13%)
Query: 236 DSLASLEIIGVGACGVVYKAEVPGSYGKM---IAIKKIDQPPMAATELLNVRRVLINRKM 292
+ ++IG G G VYK + S GK +AIK + + ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-------------KAGYTEKQR 53
Query: 293 RQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
E G+ H N++ L+ +++ +++ E+M+NG+L L + E L
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVL 110
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
+ RG+A+G++Y +HRD+ N+L++ + ++SDFGL++++ D
Sbjct: 111 QLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 413 RITT-VAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
T+ + APE + SD++SFG+++ ++ E M
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---- 223
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+AI+ + + ++ C + RP D+ +L ++
Sbjct: 224 ------------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-46
Identities = 61/291 (20%), Positives = 104/291 (35%), Gaps = 42/291 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ IG G G+V+ +AIK I + M+ + + E
Sbjct: 10 VQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEEDFIE---------------EAE 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H L+ L LV+EFM++G L D L R +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLD 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ G+ YL C+IHRD+ N L+ + ++SDFG+ + + D T
Sbjct: 110 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FP 165
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW-MRNVISS 479
+ +PE S KSD++SFGVL+ + + +E + + R
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 225
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
I C + PE+RP+ + L++I
Sbjct: 226 LASTHVYQ-----------------IMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-46
Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 41/304 (13%)
Query: 231 FLTKEDSLASLEI-IGVGACGVVYKAEVPGSYGKM-IAIKKIDQPPMAATELLNVRRVLI 288
K D+L +I +G G G V + ++ +AIK + ++
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-------------KQGTE 49
Query: 289 NRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRE 348
++ E ++ + ++ L V + + +LV E G L L R E
Sbjct: 50 KADTEEMMREAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVG---KREE 105
Query: 349 LDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-PD 407
+ + ++ G++YL +HRD+ NVL+ + A+ISDFGL+K + D
Sbjct: 106 IPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162
Query: 408 GHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLA-VLVVGKFPFDDFFQYTEE 466
+ + APE S +SD++S+GV + L G+ P+
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK------- 215
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCM 526
M M + + + E L+ C E+RP V
Sbjct: 216 MKGPEVMAFIEQGKRMECPPECP------PELYALMSD----CWIYKWEDRPDFLTVEQR 265
Query: 527 LSQI 530
+
Sbjct: 266 MRAC 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-46
Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 51/307 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKM-IAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI 299
++IG G G V KA + +M AIK++ + R E+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-------------KEYASKDDHRDFAGEL 61
Query: 300 ITAGRIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD------------VSQGR 346
++ H N++ L L E+ +G+L D L +
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 347 RELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMP 406
L A +A G++YL + IHRD+ N+L+ + A+I+DFGL++
Sbjct: 122 STLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 178
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTE 465
+ T ++A E + SD++S+GVLL ++ +G P+
Sbjct: 179 VYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG------ 229
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525
M + + ++ +E L+ + C + P ERPS +
Sbjct: 230 -MTCAELYEKLPQGYRLEKPLNCD------DEVYDLMRQ----CWREKPYERPSFAQILV 278
Query: 526 MLSQIKH 532
L+++
Sbjct: 279 SLNRMLE 285
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 6e-46
Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 40/283 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E IG GA G VY A + G+ +AI++++ K I +EI+
Sbjct: 25 FEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQ--------------PKKELIINEIL 69
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ N++ D +V E++ GSL D++ +D + R
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
LE+LH +IHRDIK N+L+ +++DFG + ++ +T+ GT
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGT 179
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
++APE K DI+S G++ ++ G+ P+ + N +R + + ++
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-------ENPLRALYLIATNG 232
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
P KL + + C D E+R S+K++
Sbjct: 233 TPELQNPEKL----SAIFRDFLNR----CLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-44
Identities = 56/309 (18%), Positives = 107/309 (34%), Gaps = 50/309 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
+ +G GA G V +A G +A+K + + + +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-------------KPSAHLTEREALM 74
Query: 297 SEIITAGRIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHD-------------- 341
SE+ + H N++ L T L++ E+ G L + L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+ LD + +A G+ +L IHRD+ N+L+ G +I DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461
A+ + + + ++APE + +SD++S+G+ L L +
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YP 249
Query: 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
+ + ++ +P A + I C DP +RP+ K
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAE-------------MYDIMKTCWDADPLKRPTFK 296
Query: 522 DVRCMLSQI 530
+ ++ +
Sbjct: 297 QIVQLIEKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 41/303 (13%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGS---YGKMIAIKKIDQPPMAATELLNVRRVLINR 290
KE ++++G GA G VYK +AIK++ R +
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------------REATSPK 53
Query: 291 KMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELD 350
++I E + + ++ L + L+ + M G L L V + + +
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCL---LDYVREHKDNIG 109
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
+A G+ YL ++HRD+ NVL+ +I+DFGLAKL+
Sbjct: 110 SQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV-VGKFPFDDFFQYTEEMNM 469
++A E + +SD++S+GV + L+ G P+D +
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-------IPA 219
Query: 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQ 529
+ E + V I C D + RP +++ S+
Sbjct: 220 SEISSILEKGERLPQP----------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
Query: 530 IKH 532
+
Sbjct: 270 MAR 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-43
Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 38/304 (12%)
Query: 232 LTKEDSLASLEIIGVGACGVVYKAEVPGSYGKM--IAIKKIDQPPMAATELLNVRRVLIN 289
L E L LE +G G+ GVV + E GK +A+K + ++ E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---------- 53
Query: 290 RKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRREL 349
M E+ + HRNL+ L V P + V E GSL D L QG L
Sbjct: 54 -AMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK-HQGHFLL 110
Query: 350 DWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGH 409
L+RY A +A G+ YL IHRD+ N+L+ +I DFGL + +P
Sbjct: 111 GTLSRY--AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165
Query: 410 TRIRITT-VAGTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEM 467
+ + APE +T T S SD + FGV L + G+ P+ +
Sbjct: 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------L 218
Query: 468 NMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCML 527
N + + + E+ + + + C + PE+RP+ +R L
Sbjct: 219 NGSQILHKIDKEGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
Query: 528 SQIK 531
+ +
Sbjct: 270 LEAQ 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (383), Expect = 9e-43
Identities = 66/290 (22%), Positives = 120/290 (41%), Gaps = 37/290 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
EI+G G VV + + K A+K ID + V+ + E+
Sbjct: 8 KEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQEL-----REATLKEVD 61
Query: 301 TAGRI-WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
++ H N++ L+ LV++ MK G L D L + + L +I R
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMR 117
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAG 419
+ + LH + I+HRD+KP N+L+DD M +++DFG + + G ++ V G
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCG 171
Query: 420 TTGYVAPEYHQT------LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473
T Y+APE + ++ D++S GV++ L+ G PF + +
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-------RKQMLML 224
Query: 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
R ++S S + + LV + P++R ++++
Sbjct: 225 RMIMSGNYQ---FGSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAEEA 267
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (385), Expect = 2e-42
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 40/285 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E +G GA GVV++ + G A K + P ++ EI
Sbjct: 31 HEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHE--------------SDKETVRKEIQ 75
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
T + H L+ L + +++YEFM G L + + D ++ R
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ 132
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI--DDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ GL ++H +H D+KP N++ E ++ DFGL + +
Sbjct: 133 VCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTT 186
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478
GT + APE + + +D++S GVL +L+ G PF N +RNV S
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-------ENDDETLRNVKS 239
Query: 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ +D E+ + K DP R +
Sbjct: 240 CDWN---MDDSAFSGISEDGKDFIRK----LLLADPNTRMTIHQA 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 6e-42
Identities = 61/309 (19%), Positives = 113/309 (36%), Gaps = 51/309 (16%)
Query: 241 LEIIGVGACGVVYKAEVPG------SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQ 294
+ +G GA G V AE G + +A+K + + + +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-------------KSDATEKDLSD 64
Query: 295 IKSEIITAGRIW-HRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILH------------D 341
+ SE+ I H+N++ L T+ ++ E+ G+L++ L
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 342 VSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGL 401
+L A +A G+EYL IHRD+ NVL+ + +I+DFGL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 402 AKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFF 461
A+ + + T ++APE + +SD++SFGVLL + +
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PY 238
Query: 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
+ + ++ + P + + + C P +RP+ K
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFK 285
Query: 522 DVRCMLSQI 530
+ L +I
Sbjct: 286 QLVEDLDRI 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 8e-42
Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 38/282 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+++G G+ G V+ AE + + AIK + + + + + + + +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVLMDDDVE----------CTMVEKRV 55
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H L + + V E++ G L + + D A
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAE 111
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL++LH I++RD+K N+L+D +I+DFG+ K G + T GT
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+APE + D +SFGVLL +++G+ PF E + +R
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFYPRW 225
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
A D L++K +PE+R +
Sbjct: 226 LEKEAKD-------------LLVK----LFVREPEKRLGVRG 250
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-41
Identities = 50/302 (16%), Positives = 110/302 (36%), Gaps = 42/302 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
+G G+ G+VY+ G +AIK +++ R+ +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-------------MRERIEFL 71
Query: 297 SEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQG------RRELD 350
+E +++ L V++ L++ E M G L+ L +
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 351 WLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHT 410
++A +A G+ YL+ +HRD+ N ++ + +I DFG+ + + +
Sbjct: 132 LSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 411 RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
+ +++PE + + SD++SFGV+L + +Q ++
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNEQVL 245
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
R++ + P D + ++ C +P+ RPS ++ + +
Sbjct: 246 RFVMEGGLLDKPDNCPDM-------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
Query: 531 KH 532
Sbjct: 293 ME 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 2e-41
Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 41/286 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+++G GA V AE + K++AIK I + + K +++EI
Sbjct: 14 RDVLGTGAFSEVILAEDKRT-QKLVAIKCI-------------AKKALEGKEGSMENEIA 59
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+I H N++ L L+ + + G L D + + + R+
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQ 115
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ ++YLH I+HRD+KP N+L D+ + ISDFGL+K+ G +T
Sbjct: 116 VLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STA 169
Query: 418 AGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
GT GYVAPE S+ D +S GV+ +L+ G PF D N + ++
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-------ENDAKLFEQIL 222
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+E DS + + + DPE+R + +
Sbjct: 223 KAEYE---FDSPYWDDISDSAKDFIRH----LMEKDPEKRFTCEQA 261
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-41
Identities = 59/308 (19%), Positives = 108/308 (35%), Gaps = 49/308 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSY----GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIK 296
+ +G GA G V +A+ G + +A+K + + + + R +
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-------------KEGATHSEHRALM 64
Query: 297 SEIITAGRIWHRNLLPLQAHV--TRPDCHLLVYEFMKNGSLQDILHD------------V 342
SE+ I H + +++ EF K G+L L
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLA 402
+ L + +A G+E+L IHRD+ N+L+ + +I DFGLA
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 403 KLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQ 462
+ + +R ++APE + +SD++SFGVLL +
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 463 YTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
+ + + RA D E + +L C +P +RP+ +
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTT-----PEMYQTMLD----CWHGEPSQRPTFSE 286
Query: 523 VRCMLSQI 530
+ L +
Sbjct: 287 LVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-41
Identities = 57/285 (20%), Positives = 105/285 (36%), Gaps = 41/285 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
E +G G G+V++ S K K + +K EI
Sbjct: 10 AEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVK---------------GTDQVLVKKEIS 53
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
HRN+L L + ++++EF+ + + ++ EL+
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQ 110
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLID--DGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ L++LH I H DI+P N++ +I +FG A+ + G +
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLF 164
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478
Y APE HQ +S +D++S G L+ VL+ G PF + + N+++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-------ETNQQIIENIMN 217
Query: 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+E D + E M V + + + R ++ +
Sbjct: 218 AEYT---FDEEAFKEISIEAMDFVDR----LLVKERKSRMTASEA 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-40
Identities = 59/293 (20%), Positives = 104/293 (35%), Gaps = 41/293 (13%)
Query: 241 LEIIGVGACGVVYKAE--VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298
IG G G V++ P + +AIK + + + E
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-------------KNCTSDSVREKFLQE 58
Query: 299 IITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
+T + H +++ L +T + ++ E G L+ L + LD + A
Sbjct: 59 ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYA 114
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVA 418
+++ L +HRDI NVL+ ++ DFGL++ M D + +
Sbjct: 115 YQLSTAL---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGK 170
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLL-AVLVVGKFPFDDFFQYTEEMNMVRWMRNVI 477
++APE + SD++ FGV + +L+ G PF + R +
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 478 SSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
P L+ K C + DP RP +++ LS I
Sbjct: 231 PPNCPPTLYS-------------LMTK----CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 3e-40
Identities = 60/298 (20%), Positives = 118/298 (39%), Gaps = 39/298 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
EI+G G V+ A + +A+K + + + E
Sbjct: 12 GEILGFGGMSEVHLARDLRL-HRDVAVKVLRADLARDPSFY-----------LRFRREAQ 59
Query: 301 TAGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR 356
A + H ++ + +A +V E++ +L+DI+H +
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIE 115
Query: 357 IARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK-LMPDGHTRIRIT 415
+ L + H + IIHRD+KPAN++I ++ DFG+A+ + G++ +
Sbjct: 116 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
V GT Y++PE + ++ +SD+YS G +L ++ G+ PF + V
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG-------DSPVSVAYQ 225
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS-KDVRCMLSQIKH 532
+ + S + +VLK + +PE R + ++R L ++ +
Sbjct: 226 HVREDPI---PPSARHEGLSADLDAVVLK----ALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 146 bits (369), Expect = 5e-40
Identities = 62/285 (21%), Positives = 106/285 (37%), Gaps = 40/285 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE +G GA GVV++ + G++ K I+ P +K+EI
Sbjct: 34 LEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYP--------------LDKYTVKNEIS 78
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ H L+ L +L+ EF+ G L D + ++ R
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQ 135
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLID--DGMEARISDFGLAKLMPDGHTRIRITTVA 418
GL+++H I+H DIKP N++ + +I DFGLA + T
Sbjct: 136 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--- 189
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478
T + APE + +D+++ GVL VL+ G PF + + ++NV
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG-------EDDLETLQNVKR 242
Query: 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ D + E + +P +R + D
Sbjct: 243 CDWE---FDEDAFSSVSPEAKDFIKN----LLQKEPRKRLTVHDA 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (352), Expect = 5e-38
Identities = 60/292 (20%), Positives = 123/292 (42%), Gaps = 44/292 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L +G G+ G V+ + G+ A+K + + V+ +++ E +
Sbjct: 9 LRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKK-----------EIVVRLKQVEHTNDERL 56
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H ++ + ++ ++++ G L +L + +R + +A++
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFY---- 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A L H II+RD+KP N+L+D +I+DFG AK +PD T+ GT
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGT 164
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+APE T ++ D +SFG+L+ ++ G PF D N ++ ++++E
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-------SNTMKTYEKILNAE 217
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
+ E+ L+ + + D +R + ++ +K+
Sbjct: 218 LRFPPFFN-------EDVKDLLSR----LITRDLSQRLGN--LQNGTEDVKN 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (355), Expect = 5e-38
Identities = 59/281 (20%), Positives = 97/281 (34%), Gaps = 36/281 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
IIG G G VY + GKM A+K +D+ + + + +
Sbjct: 9 HRIIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQ--------GETLALNERIMLS 59
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
++ + PD + + M G L L A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAE 115
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GLE++H +++RD+KPAN+L+D+ RISD GLA GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGT 168
Query: 421 TGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
GY+APE Q + +D +S G +L L+ G PF + ++ + R +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVE 227
Query: 480 ENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
+ + + L+ D R
Sbjct: 228 LPDSFSPELR----------SLLEG----LLQRDVNRRLGC 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-38
Identities = 64/305 (20%), Positives = 119/305 (39%), Gaps = 42/305 (13%)
Query: 223 IFKKRDIAFLTKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLN 282
+F++ ++ +D + E +G G VV K + G A K I + ++
Sbjct: 2 VFRQENV-----DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRRGV 55
Query: 283 VRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV 342
R I+ E+ I H N++ L +L+ E + G L D L +
Sbjct: 56 SRE--------DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE- 106
Query: 343 SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR----ISD 398
+ L + + +G+ + H I H D+KP N+++ D + I D
Sbjct: 107 ---KESLTEEEATEFLKQILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160
Query: 399 FGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFD 458
FGLA + G+ + GT +VAPE + ++D++S GV+ +L+ G PF
Sbjct: 161 FGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 459 DFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP 518
T++ + E+ + + S L + + DP++R
Sbjct: 218 G---DTKQETLANVSAVNYEFEDEYFSNTSALA-------KDFIRR----LLVKDPKKRM 263
Query: 519 SSKDV 523
+ +D
Sbjct: 264 TIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-37
Identities = 63/298 (21%), Positives = 111/298 (37%), Gaps = 38/298 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G G VYKA + +++AIKKI + + + R EI
Sbjct: 3 LDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAK---------DGINRTALREIK 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L LV++FM+ I + L
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLM 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
GLEYLH + I+HRD+KP N+L+D+ +++DFGLAK + T T
Sbjct: 109 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVT 163
Query: 421 TGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPF---DDFFQYT-----------E 465
Y APE D+++ G +LA L++ D Q T E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ + + + ++ ++ + ++ + L+ +P R ++
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG----LFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-37
Identities = 58/297 (19%), Positives = 112/297 (37%), Gaps = 32/297 (10%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ IG GA G V+KA + G+ +A+K++ L+ R + +R +++
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV--AVLRHLET--- 66
Query: 301 TAGRIWHRNLLPL-----QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARY 355
H N++ L + R LV+E + + +
Sbjct: 67 ----FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIK 119
Query: 356 RIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRIT 415
+ + GL++LH ++HRD+KP N+L+ + +++DFGLA++ T
Sbjct: 120 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---T 173
Query: 416 TVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDD---------FFQYTEE 466
+V T Y APE + + D++S G + A + K F
Sbjct: 174 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
W R+V + ++ + + L + C + +P +R S+
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (343), Expect = 6e-37
Identities = 64/299 (21%), Positives = 104/299 (34%), Gaps = 43/299 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
IG G+ G +Y + G+ +AIK + K Q+ E
Sbjct: 12 GRKIGSGSFGDIYLGTDIAA-GEEVAIKLEC----------------VKTKHPQLHIESK 54
Query: 301 TAGRIWHRNLLP-LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIAR 359
+ +P ++ D +++V E + R+ +A
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLAD 110
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLI---DDGMEARISDFGLAKLMPDGHTRIRI-- 414
M S +EY+H IHRD+KP N L+ G I DFGLAK D T I
Sbjct: 111 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 415 ---TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471
+ GT Y + H + S + D+ S G +L +G P+ T+ R
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
+S ++L GY + L C S +++P +R + +
Sbjct: 228 ISEKKMS-------TPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (340), Expect = 2e-36
Identities = 52/300 (17%), Positives = 107/300 (35%), Gaps = 43/300 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
IG G+ GV+++ + + +AIK + Q++ E
Sbjct: 10 GRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPR----------------RSDAPQLRDEYR 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
T + +P + + H ++ + SL+D+L R+ A+
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQ 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGME-----ARISDFGLAKLMPDGHTRIRI- 414
M + ++ +H +++RDIKP N LI + DFG+ K D T+ I
Sbjct: 110 MLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 415 ----TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470
++GT Y++ H S + D+ + G + + G P+ T +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226
Query: 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530
R ++ + L G+ E+ + + + P ++ + S++
Sbjct: 227 RIGEK-------KQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-36
Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 47/288 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++G G G VY +AIK +++ ++ L ++ E++
Sbjct: 9 GPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGEL--------PNGTRVPMEVV 59
Query: 301 TAGRI--WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIA 358
++ ++ L RPD +L+ E + L D R L
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFF 116
Query: 359 RGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIRITTV 417
+ + + H ++HRDIK N+LID + E ++ DFG L+ D T
Sbjct: 117 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDF 169
Query: 418 AGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNV 476
GT Y PE+ + + ++S G+LL +V G PF+ E + + R
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQR 226
Query: 477 ISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524
+SSE L+ C + P +RP+ ++++
Sbjct: 227 VSSE----CQH-------------LIRW----CLALRPSDRPTFEEIQ 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-36
Identities = 58/289 (20%), Positives = 107/289 (37%), Gaps = 44/289 (15%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G+G G V + + + A+K + P A E V ++ + Q
Sbjct: 18 QVLGLGINGKVLQIFNKRT-QEKFALKMLQDCPKARRE------VELHWRASQ------- 63
Query: 302 AGRIWHRNLLPL----QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
+++ + + C L+V E + G L + D +G + I
Sbjct: 64 -----CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEI 116
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME---ARISDFGLAKLMPDGHTRIRI 414
+ + ++YLH I HRD+KP N+L +++DFG AK ++
Sbjct: 117 MKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-- 171
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
T T YVAPE + D++S GV++ +L+ G PF + + M+
Sbjct: 172 -TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS----NHGLAISPGMK 226
Query: 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
I + EE L+ +P +R + +
Sbjct: 227 TRIRMGQYE--FPNPEWSEVSEEVKMLIRN----LLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 63/312 (20%), Positives = 116/312 (37%), Gaps = 51/312 (16%)
Query: 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMR 293
+E S ++IG G+ GVVY+A++ S G+++AIKK+ Q R
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQ------------------DKR 58
Query: 294 QIKSEIITAGRIWHRNLLPLQAHVTRPDCH------LLVYEFMKNGSLQDILHDVSQGRR 347
E+ ++ H N++ L+ LV +++ + H S+ ++
Sbjct: 59 FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQ 117
Query: 348 ELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMP 406
L + + L Y+H I HRDIKP N+L+D D ++ DFG AK +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 407 DGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466
G + + + + D++S G +LA L++G+ F +
Sbjct: 175 RGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 467 MNMVRWM----RNVISSENPHRA-----------IDSKLLGNGYEEQMRLVLKIAYFCTS 511
+ +++ + R I NP+ E + L +
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR----LLE 288
Query: 512 DDPEERPSSKDV 523
P R + +
Sbjct: 289 YTPTARLTPLEA 300
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-34
Identities = 66/299 (22%), Positives = 108/299 (36%), Gaps = 41/299 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+E IG G GVVYKA + G+++A+KKI EI
Sbjct: 7 VEKIGEGTYGVVYKARNKLT-GEVVALKKIR------------LDTETEGVPSTAIREIS 53
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L + + LV+EF+ + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQ 110
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL + H ++HRD+KP N+LI+ +++DFGLA+ T T
Sbjct: 111 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVT 165
Query: 421 TGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
Y APE S DI+S G + A +V + F + + + R +
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 480 ENPH---------------RAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDV 523
P R SK++ E+ L+ + DP +R S+K
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ----MLHYDPNKRISAKAA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 8e-34
Identities = 54/281 (19%), Positives = 96/281 (34%), Gaps = 39/281 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+++G G G V + G+ A+K + + + A + ++ +E
Sbjct: 10 LKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVIIAKD-----------EVAHTVTESR 57
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
H L L+ D V E+ G L L R
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-------RERVFTEERARFY 110
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
A + L H +++RDIK N+++D +I+DFGL K ++ GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
Y+APE + D + GV++ ++ G+ PF + + R ++ E
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-------QDHERLFELILMEE 221
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
S + L+ DP++R
Sbjct: 222 IRFPRTLSPEAKS-------LLAG----LLKKDPKQRLGGG 251
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 8e-34
Identities = 60/302 (19%), Positives = 119/302 (39%), Gaps = 41/302 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG GA G+V A + +AIKKI ++ EI
Sbjct: 13 LSYIGEGAYGMVCSAYDNVN-KVRVAIKKI-------------SPFEHQTYCQRTLREIK 58
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
R H N++ + + P + ++ + L+ + + + L
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLM-PDGHTRIRITTVAG 419
+ GL+Y+H + ++HRD+KP+N+L++ + +I DFGLA++ PD +T
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 420 TTGYVAPEY-HQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR------- 471
T Y APE + ++ DI+S G +LA ++ + F + +++
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 472 ----------WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK 521
++S + ++ ++L N + + L+ K + +P +R +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK----MLTFNPHKRIEVE 290
Query: 522 DV 523
Sbjct: 291 QA 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (319), Expect = 1e-33
Identities = 63/294 (21%), Positives = 104/294 (35%), Gaps = 33/294 (11%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE IG G GVVYKA+ +YG+ A+KKI EI
Sbjct: 7 LEKIGEGTYGVVYKAQ--NNYGETFALKKIR------------LEKEDEGIPSTTIREIS 52
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L + +LV+E + + + L+ +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQ 108
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ +G+ Y H ++HRD+KP N+LI+ E +I+DFGLA+ + +
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTL 164
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
+ S DI+S G + A +V G F + + M + R + S
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSD-----------DPEERPSSKDV 523
P+ K N + DP +R ++K
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 1e-32
Identities = 56/292 (19%), Positives = 113/292 (38%), Gaps = 44/292 (15%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
++ +G G+ G V + S G A+K +D+ ++V+ +++ +E
Sbjct: 46 IKTLGTGSFGRVMLVKHKES-GNHYAMKILDK-----------QKVVKLKQIEHTLNEKR 93
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ L+ L+ +V E++ G + L A
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQ 149
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ EYLH +I+RD+KP N+LID +++DFG AK + R T+ GT
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
+APE + ++ D ++ GVL+ + G PF + + + + +
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRF 257
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIKH 532
H + ++ +L+ D +R + ++ ++ IK+
Sbjct: 258 PSH-----------FSSDLKDLLRN---LLQVDLTKRFGN--LKNGVNDIKN 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 2e-30
Identities = 61/312 (19%), Positives = 102/312 (32%), Gaps = 53/312 (16%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L IG G G V+KA + G+ +A+KK+ + R EI
Sbjct: 15 LAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEKEGFPITALR------------EIK 61
Query: 301 TAGRIWHRNLLPL--------QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWL 352
+ H N++ L + LV++F ++ + + + L +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEI 119
Query: 353 ARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRI 412
R M L L+ HR I+HRD+K ANVLI +++DFGLA+
Sbjct: 120 KRV-----MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 413 --RITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDD---------- 459
R T T Y PE D++ G ++A +
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 460 -------FFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMR-LVLKIAYFCTS 511
+ ++ + + R + +L + L+ K
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK----LLV 290
Query: 512 DDPEERPSSKDV 523
DP +R S D
Sbjct: 291 LDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-30
Identities = 53/295 (17%), Positives = 98/295 (33%), Gaps = 33/295 (11%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
LE IG G G V+KA+ + +++A+K++ EI
Sbjct: 7 LEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDD------------EGVPSSALREIC 53
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H+N++ L + LV+EF QD+ +LD
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
+ GL + H + ++HRD+KP N+LI+ E ++++FGLA+ V
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTL 165
Query: 421 TGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISSE 480
S D++S G + A L P +++ + + + E
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 481 NPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSD------------DPEERPSSKDV 523
L + +P +R S+++
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 1e-29
Identities = 58/311 (18%), Positives = 111/311 (35%), Gaps = 62/311 (19%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEI- 299
+ +G G V++A + + + +K + K ++IK EI
Sbjct: 40 VRKLGRGKYSEVFEAINITN-NEKVVVKILK-----------------PVKKKKIKREIK 81
Query: 300 ITAGRIWHRNLLPLQAHVTRPDCHL--LVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
I N++ L V P LV+E + N + + + L
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFY 134
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIRITT 416
+ L+Y H I+HRD+KP NV+ID + + R+ D+GLA+ G
Sbjct: 135 MYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNV 188
Query: 417 VAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
+ + PE D++S G +LA ++ K P FF + + + +
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLVRIAK 245
Query: 476 VISSENPHRAID----------SKLLGNGYEEQMRLVLKIAYFCTSD------------- 512
V+ +E+ + ID + +LG ++ +
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305
Query: 513 DPEERPSSKDV 523
D + R ++++
Sbjct: 306 DHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 64/301 (21%), Positives = 110/301 (36%), Gaps = 43/301 (14%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ +G GA G V A V G G +AIKK+ +P + ++ E+
Sbjct: 23 LQPVGSGAYGAVCSA-VDGRTGAKVAIKKLYRPFQS------------ELFAKRAYRELR 69
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARG 360
+ H N++ L T + +F +L +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 361 MASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGT 420
M GL Y+ H IIHRD+KP N+ +++ E +I DFGLA+ +T T
Sbjct: 130 MLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVT 181
Query: 421 TGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVISS 479
Y APE + ++ DI+S G ++A ++ GK F + +++ +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 480 ENPHRAID-----------------SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKD 522
D + +L N + L+ K D E+R ++ +
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK----MLVLDAEQRVTAGE 297
Query: 523 V 523
Sbjct: 298 A 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-29
Identities = 60/285 (21%), Positives = 105/285 (36%), Gaps = 37/285 (12%)
Query: 241 LEIIGVGACGVVYKAE--VPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSE 298
L+++G GA G V+ GK+ A+K + + + + ++E
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----------KTTEHTRTE 78
Query: 299 IITAGRIWHR-NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRI 357
I L+ L L+ +++ G L L + + +
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEV 131
Query: 358 ARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTV 417
+ + L H+ II+RDIK N+L+D ++DFGL+K T
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 191
Query: 418 AGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475
GT Y+AP+ + + D +S GVL+ L+ G PF E+ + R
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISRR 247
Query: 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSS 520
++ SE P+ S L L+ + DP++R
Sbjct: 248 ILKSEPPYPQEMSALA-------KDLIQR----LLMKDPKKRLGC 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (271), Expect = 1e-26
Identities = 54/315 (17%), Positives = 114/315 (36%), Gaps = 39/315 (12%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
+ +G G V+ A+ + +A+K + + + ++L R ++
Sbjct: 18 VRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGDKVYTEAAEDEIKLL----QRVNDADNT 72
Query: 301 TAGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYR-IAR 359
+ ++L L H + + + +++L + + L + I++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 360 GMASGLEYLHMYHRPCIIHRDIKPANVLID-DGMEARISDFGLAKLMPDGHTRIRITTVA 418
+ GL+Y+H R IIH DIKP NVL++ + +A L T
Sbjct: 133 QLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 419 GTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPF--DDFFQYTEEMNMVRWMRNV 476
T Y +PE +DI+S L+ L+ G F F D+ YT++ + + + +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 477 ISSENPHRAIDSKLLGNGYEEQ--MRLVLKIAYFCTSD---------------------- 512
+ + + K + + +R + K+ ++ D
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 513 ----DPEERPSSKDV 523
DP +R + +
Sbjct: 311 MLQLDPRKRADAGGL 325
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 69/328 (21%), Positives = 129/328 (39%), Gaps = 55/328 (16%)
Query: 221 RPIFKKRDIAFLTKE--DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAAT 278
RP F ++++ E + +L +G GA G V A + G +A+KK+ +P +
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQSII 59
Query: 279 ELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRPDC-----HLLVYEFMKNG 333
++ E+ + H N++ L T + + +
Sbjct: 60 H------------AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107
Query: 334 SLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393
L +I+ ++L + + GL+Y+H IIHRD+KP+N+ +++ E
Sbjct: 108 DLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 159
Query: 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPE-YHQTLTISEKSDIYSFGVLLAVLVV 452
+I DFGLA+ HT +T T Y APE + ++ DI+S G ++A L+
Sbjct: 160 LKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 453 GKFPFDDFFQYTEEMNMVR-------WMRNVISSENPHRAID----------SKLLGNGY 495
G+ F + ++R + ISSE+ I + +
Sbjct: 215 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGAN 274
Query: 496 EEQMRLVLKIAYFCTSDDPEERPSSKDV 523
+ L+ K D ++R ++
Sbjct: 275 PLAVDLLEK----MLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 4e-26
Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 32/241 (13%)
Query: 241 LEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEII 300
L+ IG GA G+V A + +AIKK+ +P T R E++
Sbjct: 22 LKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYR------------ELV 68
Query: 301 TAGRIWHRNLLPL------QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLAR 354
+ H+N++ L Q + LV E M Q I + ELD
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERM 121
Query: 355 YRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRI 414
+ M G+++LH IIHRD+KP+N+++ +I DFGLA+
Sbjct: 122 SYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--- 175
Query: 415 TTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474
T T Y APE + E DI+S G ++ +V K F + ++ +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 475 N 475
Sbjct: 236 T 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 3e-15
Identities = 25/162 (15%), Positives = 50/162 (30%), Gaps = 17/162 (10%)
Query: 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIIT 301
+++G G V+ +K + ++ R I
Sbjct: 6 KLMGEGKESAVFNCYSEK--FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSV----LAIR 59
Query: 302 AGRIWHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGM 361
+ R R L LQ + P Y + N L +++ R ++ + +
Sbjct: 60 SARNEFRALQKLQ-GLAVPKV----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMI 112
Query: 362 ASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAK 403
+ + I+H D+ NVL+ + I DF +
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 532 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.54 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=421.08 Aligned_cols=263 Identities=22% Similarity=0.388 Sum_probs=205.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|+++ ..||||+++..... ....+.|.+|+.++++++|||||++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~ 69 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPT------------PQQLQAFKNEVGVLRKTRHVNILLF 69 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCC------------TTHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCCCEeee
Confidence 4578999999999999999999764 35999999765433 2235678999999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+ +..++|||||++|+|.++++. .+..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 70 ~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~ 142 (276)
T d1uwha_ 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLT 142 (276)
T ss_dssp EEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSS
T ss_pred eEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCC
Confidence 999865 568999999999999999974 3456999999999999999999999988 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL---TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+||+|||+|+...........+...||+.|+|||++.+. .++.++|||||||++|||+||+.||....... .+.
T Consensus 143 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~ 219 (276)
T d1uwha_ 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QII 219 (276)
T ss_dssp EEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHH
T ss_pred EEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHH
Confidence 999999999887654443334567899999999998643 58999999999999999999999997643311 111
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. ....+...... .......+..+.+++..||+.||++|||++++++.|+.++
T Consensus 220 ~----~~~~~~~~p~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 220 F----MVGRGYLSPDL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp H----HHHHTSCCCCG-----GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHhcCCCCCcc-----hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 11111111000 1112223456889999999999999999999999999885
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=414.32 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=201.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+. +++.||||+++..... .++|.+|+.++++++|||||+++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~~~ 66 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAMS---------------EEDFIEEAEVMMKLSHPKLVQLY 66 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET--TTEEEEEEECCSSSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCCcCc---------------HHHHHHHHHHHHhcCCCCccccc
Confidence 457899999999999999999987 4788999999865322 25688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
|+|..++..++|||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+
T Consensus 67 g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 67 GVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCE
T ss_pred ceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCe
Confidence 999999999999999999999999874 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVG-KFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+|+ .+||..... ..+...+
T Consensus 141 Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~~~i 215 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDI 215 (263)
T ss_dssp EECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHHHHH
T ss_pred EecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHHHHHH
Confidence 999999998775543322 2456789999999999999999999999999999999995 555543221 1222222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. ....+. .+ ...+..+.+++..||+.||++|||++++++.|++|.
T Consensus 216 ~---~~~~~~---~p-------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 216 S---TGFRLY---KP-------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp H---HTCCCC---CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---hcCCCC---Cc-------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 2 211111 11 112345889999999999999999999999999885
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-53 Score=420.05 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=214.7
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|.+.+.||+|+||+||+|.+..+ |+.||||+++..... .++|.+|+.++++++|||||++
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~---------------~~~~~~E~~il~~l~HpnIv~~ 78 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDTME---------------VEEFLKEAAVMKEIKHPNLVQL 78 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGG-TEEEEEEECCTTCSC---------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCC-CeEEEEEEECCccch---------------HHHHHHHHHHHHhCCCCCEecC
Confidence 456799999999999999999998764 889999999765322 3568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
+++|.+++..++|||||++|+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 79 ~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~ 153 (287)
T d1opja_ 79 LGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHL 153 (287)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred CccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCc
Confidence 9999999999999999999999999976 44567999999999999999999999998 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+|+........ ..+...||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+...
T Consensus 154 ~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~- 228 (287)
T d1opja_ 154 VKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL- 228 (287)
T ss_dssp EEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH-
T ss_pred EEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHHHHHH-
Confidence 999999999987654332 22455689999999999999999999999999999999997766643221 1112221
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...+... ......+..+.+|+..||+.||++|||++++++.|+.+.
T Consensus 229 ---i~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 229 ---LEKDYRM---------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp ---HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---HhcCCCC---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111111 111223456889999999999999999999999998764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=415.96 Aligned_cols=259 Identities=24% Similarity=0.360 Sum_probs=199.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||+||+|++..+ |+.||||.+...... +...+.+.+|+.++++++|||||+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~ 69 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSD-GKILVWKELDYGSMT------------EAEKQMLVSEVNLLRELKHPNIVRYY 69 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEECCTTSC------------HHHHHHHHHHHHHTTSCCCTTBCCEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCC-CCEEEEEEEChhhCC------------HHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 36799999999999999999988764 899999999876433 22346788999999999999999999
Q ss_pred eEEec--CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEecC
Q 037084 315 AHVTR--PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH--RPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlkp~NIll~~ 390 (532)
+++.+ .+..|+|||||++|+|.+++......+..+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.
T Consensus 70 ~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp EEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred EEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 99864 45689999999999999999865555678999999999999999999999865 235999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
++.+||+|||+|+........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~~~- 222 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----KEL- 222 (269)
T ss_dssp TSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHH-
T ss_pred CCcEEEeeccceeecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----HHH-
Confidence 999999999999987654322 2467899999999999999999999999999999999999999976432 111
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... +.... + ....+.++.+++.+||+.||++|||+.|+++
T Consensus 223 --~~~i~~-~~~~~-----~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 223 --AGKIRE-GKFRR-----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHHHHH-TCCCC-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHc-CCCCC-----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 122221 11111 1 1112345888999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=413.06 Aligned_cols=254 Identities=25% Similarity=0.361 Sum_probs=205.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||+|+||+||+|++..+ |+.||||+++.... ....+.+.+|+.++++++||||+++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~-~~~vAiK~i~~~~~-------------~~~~~~~~~Ei~~l~~l~HpnIv~~~~ 70 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVT-EEAVAVKIVDMKRA-------------VDCPENIKKEICINKMLNHENVVKFYG 70 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECC--------------------CHHHHHHHHHTCCCTTBCCEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEehhhc-------------chHHHHHHHHHHHHHhCCCCCEeeEee
Confidence 5699999999999999999998764 89999999976532 122356889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||++|+|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+|
T Consensus 71 ~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~K 143 (271)
T d1nvra_ 71 HRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 143 (271)
T ss_dssp EEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEE
T ss_pred eeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEE
Confidence 99999999999999999999999864 457999999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+|+...........+..+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... .... .
T Consensus 144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~~~~----~ 217 (271)
T d1nvra_ 144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEY----S 217 (271)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--SHHH----H
T ss_pred EccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--HHHH----H
Confidence 999999998754433333356789999999999988776 57899999999999999999999753321 1111 1
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......... .........+.+++..||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 218 DWKEKKTYL---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHTTCTTS---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCCC---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111 011122345788999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=413.41 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=208.8
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.+.++|++.+.||+|+||+||+|.++ ++..||||+++..... .+.|.+|+.++++++|||||+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~~~---------------~~~~~~E~~~l~~l~HpnIv~ 72 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQHQRLVR 72 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTSSC---------------HHHHHHHHHHHHHCCCTTBCC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCcCC---------------HHHHHHHHHHHHhCCCCCEeE
Confidence 34578999999999999999999986 4789999999865322 256889999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++|++.+ +..++|||||++|+|.+++... ....+++..++.|+.|+++||.|||+.+ |+||||||+||||++++
T Consensus 73 ~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~ 146 (272)
T d1qpca_ 73 LYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTL 146 (272)
T ss_dssp EEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTS
T ss_pred EEeeecc-CCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeeccc
Confidence 9998865 5679999999999999988652 2346999999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+|+......... .....||+.|+|||++.++.++.++|||||||++|||+||..|+..... ...+.
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~-- 220 (272)
T d1qpca_ 147 SCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVI-- 220 (272)
T ss_dssp CEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH--
T ss_pred ceeeccccceEEccCCcccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHH--
Confidence 99999999999876543322 2456789999999999999999999999999999999996555432211 11122
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........+. .+...+..+.+++..||+.||++|||+++|++.|+++
T Consensus 221 -~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 221 -QNLERGYRMV----------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -HHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHhcCCCC----------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 2222211111 1112334588899999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-52 Score=414.02 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=201.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~ 312 (532)
.++|.+.+.||+|+||+||+|.+..++ ...||||.+..... ....+.|.+|+.++++++|||||+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~ 91 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-------------EKQRRDFLSEASIMGQFDHPNVIH 91 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-------------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC-------------HHHHHHHHHHHHHHHhCCCCCCcc
Confidence 467888999999999999999986542 23689999876532 233567999999999999999999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
++|+|..++..++|||||++|+|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||||+.++
T Consensus 92 l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~ 165 (299)
T d1jpaa_ 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNL 165 (299)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTC
T ss_pred EEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCC
Confidence 99999999999999999999999998874 3456999999999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcce---eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 393 EARISDFGLAKLMPDGHTRI---RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.+||+|||+++......... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+... ..
T Consensus 166 ~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~----~~ 241 (299)
T d1jpaa_ 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN----QD 241 (299)
T ss_dssp CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH
T ss_pred cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH----HH
Confidence 99999999999775543221 1123467899999999999999999999999999999998 8999976432 12
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+.. .......+. ...+.+..+.+|+..||+.||++|||+.+|++.|+++
T Consensus 242 ~~~---~i~~~~~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 242 VIN---AIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHH---HHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHH---HHHcCCCCC----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222 222221111 1122345688899999999999999999999999886
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=408.95 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=207.7
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++.+.||+|+||+||+|+++.+ |+.||+|++....... ......+.+|+.++++++|||||++++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~-~~~vAiK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~~~~ 73 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQS-KFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSHLRHPNILRLYG 73 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCC-CcEEEEEEEchHHccC-----------hHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 4699999999999999999998764 8999999986432111 122467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 74 ~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 74 YFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred EEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEe
Confidence 99999999999999999999999975 346899999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+|+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....
T Consensus 147 l~DFG~a~~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~ 215 (263)
T d2j4za1 147 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKR 215 (263)
T ss_dssp ECCCCSCSCCCCCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHH
T ss_pred ecccceeeecCCCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHH
Confidence 999999987655432 456899999999999999999999999999999999999999975332 111222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .+. .+...+..+.+++..||+.||++|||++|+++
T Consensus 216 i~~~-~~~----------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 216 ISRV-EFT----------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHTT-CCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcC-CCC----------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2221 111 11112345888999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=408.97 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=208.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||+++..... ..+.+.+|+.++++++|||||+++
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~-~~~vAvK~~~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~~ 83 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVAT-GQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIVNYL 83 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTT-CCEEEEEEEEGGGCS--------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCC-CCEEEEEEEecccCh--------------HHHHHHHHHHHHHhCCCCCEeeEe
Confidence 45799999999999999999988764 999999998754221 135688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|+|||||+||+|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++
T Consensus 84 ~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~v 155 (293)
T d1yhwa1 84 DSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSV 155 (293)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCE
T ss_pred EEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcE
Confidence 999999999999999999999998864 35899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +.+.
T Consensus 156 kl~DFG~a~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~ 226 (293)
T d1yhwa1 156 KLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALY 226 (293)
T ss_dssp EECCCTTCEECCSTTCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH
T ss_pred eeccchhheeecccccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHH
Confidence 99999999987554322 25678999999999999999999999999999999999999999753321 1122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......+.. .........+.+++..||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 227 LIATNGTPEL--------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHCSCCC--------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHhCCCCCC--------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222222111 011223456889999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=405.38 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=213.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.++||+|+||+||+|+++ ++..||||+++..... .+.|.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~~~---------------~~~~~~Ev~~~~~l~HpnIv~~~ 65 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQLY 65 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSSSC---------------HHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCcCC---------------HHHHHHHHHHHHhcCCCceeeEE
Confidence 367899999999999999999986 5789999999876432 25688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
|+|.+++..++||||+++|+|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCE
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcE
Confidence 999999999999999999999999864 3456899999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~ 473 (532)
||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... .+ .
T Consensus 140 kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~---~ 211 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ET---A 211 (258)
T ss_dssp EECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HH---H
T ss_pred EECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HH---H
Confidence 99999999876554332 2245679999999999999999999999999999999998 89999864331 11 2
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
........+. . +...+..+.+++..||+.||++|||++++++.|.+|
T Consensus 212 ~~i~~~~~~~---~-------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 212 EHIAQGLRLY---R-------PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHTTCCCC---C-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHhCCCCC---C-------cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2222211111 1 112234688999999999999999999999999765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=414.33 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=212.6
Q ss_pred ccccccCccccceecccCCeEEEEEEeeCCCC----cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-
Q 037084 231 FLTKEDSLASLEIIGVGACGVVYKAEVPGSYG----KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI- 305 (532)
Q Consensus 231 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 305 (532)
+..+.++|.+.+.||+|+||+||+|++.+.+. ..||||.+..... ......|.+|+.++.++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~ 98 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------------SSEREALMSELKMMTQLG 98 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------------HHHHHHHHHHHHHHHHhc
Confidence 33456789999999999999999999875422 3799999876531 22346788999999998
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHH
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ-------------------GRRELDWLARYRIARGMASGLE 366 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~ 366 (532)
+|||||+++++|.+.+..++|||||++|+|.++++.... ....+++..++.++.|+++||+
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ 178 (325)
T d1rjba_ 99 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178 (325)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999976321 1245899999999999999999
Q ss_pred HHHhcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHH
Q 037084 367 YLHMYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVL 446 (532)
Q Consensus 367 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 446 (532)
|||+.+ |+||||||+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+
T Consensus 179 yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvi 255 (325)
T d1rjba_ 179 FLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255 (325)
T ss_dssp HHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHH
Confidence 999998 99999999999999999999999999987765544444456778999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 447 LAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 447 l~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+|||+| |+.||...... ..+.. ....+... ..+...+..+.+|+..||+.||++|||+++|++
T Consensus 256 l~emlt~g~~Pf~~~~~~---~~~~~----~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 319 (325)
T d1rjba_ 256 LWEIFSLGVNPYPGIPVD---ANFYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319 (325)
T ss_dssp HHHHTTTSCCSSTTCCCS---HHHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHH---HHHHH----HHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 89999764331 11112 12121110 111223456889999999999999999999999
Q ss_pred HHh
Q 037084 526 MLS 528 (532)
Q Consensus 526 ~L~ 528 (532)
.|.
T Consensus 320 ~L~ 322 (325)
T d1rjba_ 320 FLG 322 (325)
T ss_dssp HHH
T ss_pred HHh
Confidence 985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=407.66 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=210.2
Q ss_pred ccccCccccce-ecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 233 TKEDSLASLEI-IGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 233 ~~~~~~~~~~~-LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
...++|.+.+. ||+|+||+||+|.++.. ++..||||+++.... ....++|.+|+.++++++||||
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-------------~~~~~~~~~E~~il~~l~HpnI 71 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------------KADTEEMMREAQIMHQLDNPYI 71 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-------------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC-------------HHHHHHHHHHHHHHHhCCCCCE
Confidence 34566777774 99999999999987643 255899999976532 2335679999999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
|+++|+|.. +..|+|||||++|+|.+++.. .+..+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 72 v~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~ 144 (285)
T d1u59a_ 72 VRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVN 144 (285)
T ss_dssp CCEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEE
T ss_pred eeEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeecc
Confidence 999999975 568999999999999999864 3457999999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
++.+||+|||+++......... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..
T Consensus 145 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~ 220 (285)
T d1u59a_ 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PE 220 (285)
T ss_dssp TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HH
T ss_pred CCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH----HH
Confidence 9999999999999876543221 2245578999999999999999999999999999999998 9999986432 11
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
+. ........+. .++..+..+.+|+..||+.||++|||+.+|++.|+.+
T Consensus 221 ~~---~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 221 VM---AFIEQGKRME----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HH---HHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHHcCCCCC----------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 2222222111 1122345688999999999999999999999998764
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=411.10 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=207.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
+++.|++++.||+|+||+||+|++..+ |..||||+++..... ..+.|.+|+.++++++|||||++
T Consensus 10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~l 74 (288)
T d2jfla1 10 PEDFWEIIGELGDGAFGKVYKAQNKET-SVLAAAKVIDTKSEE--------------ELEDYMVEIDILASCDHPNIVKL 74 (288)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECSSSG--------------GGGGTHHHHHHHHHCCCTTBCCE
T ss_pred cccCeEEeEEEeeCCCcEEEEEEECCC-CeEEEEEEECcCCHH--------------HHHHHHHHHHHHHhCCCCCCCeE
Confidence 456789999999999999999998765 899999999765322 23568899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCc
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGME 393 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 393 (532)
++++.+++..++|||||++|+|.+++.+. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 75 ~~~~~~~~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~ 148 (288)
T d2jfla1 75 LDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGD 148 (288)
T ss_dssp EEEEEETTEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred EEEEeeCCeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCC
Confidence 99999999999999999999999998752 356999999999999999999999999 999999999999999999
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQ-----TLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+||+|||+|+....... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... .
T Consensus 149 ~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~ 222 (288)
T d2jfla1 149 IKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----R 222 (288)
T ss_dssp EEECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----G
T ss_pred EEEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----H
Confidence 99999999976543221 124578999999999874 456899999999999999999999999764331 1
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+ +........+. . ......+..+.+++..||+.||++|||++|+++
T Consensus 223 ~---~~~i~~~~~~~-~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 223 V---LLKIAKSEPPT-L-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp H---HHHHHHSCCCC-C-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred H---HHHHHcCCCCC-C-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 12222222111 1 111223456889999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=406.14 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=201.1
Q ss_pred ceecccCCeEEEEEEeeCC-CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEecC
Q 037084 242 EIIGVGACGVVYKAEVPGS-YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTRP 320 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 320 (532)
++||+|+||+||+|.+... .++.||||+++..... ....+.|.+|+.++++++|||||+++++|..
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~- 79 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------------PALKDELLAEANVMQQLDNPYIVRMIGICEA- 79 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC------------HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence 4799999999999987642 3578999999754321 2234679999999999999999999999965
Q ss_pred CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEeccC
Q 037084 321 DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDFG 400 (532)
Q Consensus 321 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG 400 (532)
+..++|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 80 ~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 80 ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchh
Confidence 567899999999999999975 356999999999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHHHHHHHhc
Q 037084 401 LAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVRWMRNVIS 478 (532)
Q Consensus 401 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~~~~~~~~ 478 (532)
+++......... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+... ...
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~---i~~ 225 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAM---LEK 225 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH---HHT
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHH---HHc
Confidence 999775543322 2245678999999999999999999999999999999998 8999976432 122222 222
Q ss_pred cCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 479 SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 479 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...+. .+...+..+.+|+..||+.||++|||+++|++.|+.+
T Consensus 226 ~~~~~----------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 226 GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCC----------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 21111 1122345688899999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=400.95 Aligned_cols=262 Identities=21% Similarity=0.368 Sum_probs=203.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCC---cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYG---KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
.++|...++||+|+||+||+|.++.+++ ..||||+++.... ......|.+|+.++++++|||||
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~il~~l~H~nIv 72 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------------EKQRVDFLGEAGIMGQFSHHNII 72 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-------------hHHHHHHHHHHHHHHhcCCCCEe
Confidence 4568889999999999999999875432 4799999976532 22345789999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++|+|.+.+..++|||||.+|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.+
T Consensus 73 ~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 73 RLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSN 146 (283)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTT
T ss_pred eeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCC
Confidence 999999999999999999999999998875 3457999999999999999999999998 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcc-eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 392 MEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~- 222 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEV- 222 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHH-
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHH-
Confidence 99999999999876544322 122345689999999999999999999999999999999996665543211 1112
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.........+. .+...+..+.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 223 --~~~i~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 223 --MKAINDGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp --HHHHHTTCCCC----------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHHHhccCCCC----------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 22222221111 11223456889999999999999999999999998763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=417.33 Aligned_cols=202 Identities=27% Similarity=0.420 Sum_probs=178.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|++++.||+|+||+||+|++..+ |+.||+|+++..... .....+.+|+.+|++++|||||++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~-~~~vAiK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l 69 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGF 69 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTT-TEEEEEEEEECCCCT-------------THHHHHHHHGGGGGGCCCTTBCCE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEChhhCH-------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 467899999999999999999988764 999999999765321 223578899999999999999999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-HRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++|.+++..|+|||||++|+|.+++.+ ...+++..+..++.|++.||.|||+. + |+||||||+|||+++++
T Consensus 70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~ 142 (322)
T d1s9ja_ 70 YGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRG 142 (322)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCC
Confidence 9999999999999999999999999976 24589999999999999999999974 7 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDF 460 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~ 460 (532)
++||+|||+|+....... +..+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 143 ~vkl~DFGla~~~~~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 143 EIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp CEEECCCCCCHHHHHHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred CEEEeeCCCccccCCCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999986543221 4578999999999999999999999999999999999999999754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=409.67 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=205.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||+||+|.+..+ |+.||||++...... .......+.+|+.++++++||||++++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~ 74 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELAT-SREYAIKILEKRHII-----------KENKVPYVTRERDVMSRLDHPFFVKLY 74 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEehHHcc-----------CHHHHHHHHHHHHHHHHcCCCCeeEEE
Confidence 35799999999999999999988764 899999998643211 022346789999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 75 ~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 75 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCE
T ss_pred EEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceE
Confidence 999999999999999999999999875 346999999999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+|+...............||+.|+|||++.+..++.++||||+||++|||++|+.||...... +...
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~~~~ 220 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-------LIFQ 220 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHH
T ss_pred EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-------HHHH
Confidence 999999999876544333335678999999999999999999999999999999999999999753321 1122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... .+. + +......+.+|+..||+.||++|||++|+++
T Consensus 221 ~i~~~-~~~------~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 221 KIIKL-EYD------F----PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHTT-CCC------C----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHcC-CCC------C----CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 22221 110 1 1112345889999999999999999998743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=395.83 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=199.0
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEe
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 318 (532)
+..+.||+|+||+||+|.+..+ +..||+|.+...... ....+.|.+|++++++++|||||++++++.
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~-~~~va~K~i~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTET-TVEVAWCELQDRKLT------------KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEGGGSC------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCC-CeEEEEEEEchhhCC------------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 5667899999999999988764 889999998764322 233567899999999999999999999986
Q ss_pred c----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec-CCCc
Q 037084 319 R----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID-DGME 393 (532)
Q Consensus 319 ~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 393 (532)
. ....|+|||||++|+|.+++.. ...+++..+..++.|+++||+|||+++ ++|+||||||+|||++ +++.
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~ 153 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGS 153 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSC
T ss_pred eccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCC
Confidence 5 3457999999999999999975 346899999999999999999999874 4599999999999996 5889
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+|+....... ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... .....
T Consensus 154 ~Kl~DFGla~~~~~~~~----~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------~~~~~ 222 (270)
T d1t4ha_ 154 VKIGDLGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIY 222 (270)
T ss_dssp EEECCTTGGGGCCTTSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHH
T ss_pred EEEeecCcceeccCCcc----CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------HHHHH
Confidence 99999999986544322 46789999999999875 699999999999999999999999975322 11122
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
..... +.....++. . ...++.+++..||++||++|||+.|+++
T Consensus 223 ~~i~~-~~~~~~~~~----~----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 223 RRVTS-GVKPASFDK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHTT-TCCCGGGGG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHc-CCCCcccCc----c----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22222 211111111 1 1234788999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-51 Score=405.02 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=205.5
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
++.|+.++.||+|+||+||+|++..+ |+.||||+++...... ......+.+|+.++++++|||||+++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~-----------~~~~~~~~~Ei~il~~l~HpnIv~~~ 81 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRN-SEVVAIKKMSYSGKQS-----------NEKWQDIIKEVRFLQKLRHPNTIQYR 81 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEECCSSCH-----------HHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCC-CcEEEEEEEchhhccC-----------HHHHHHHHHHHHHHHHCCCCCEeeEE
Confidence 44689999999999999999988764 8999999997654322 33456789999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|+|||||++|+|..++.. +.++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~ 154 (309)
T d1u5ra_ 82 GCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154 (309)
T ss_dssp EEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEE
T ss_pred EEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCE
Confidence 999999999999999999999776654 356999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT---LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
||+|||+|+..... ....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .+
T Consensus 155 Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~ 221 (309)
T d1u5ra_ 155 KLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS 221 (309)
T ss_dssp EECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH
T ss_pred EEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HH
Confidence 99999999865442 45679999999998854 4689999999999999999999999975332 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+........+. .. . ...+..+.+++..||+.||++|||+.++++
T Consensus 222 ~~~~i~~~~~~~-~~-----~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 222 ALYHIAQNESPA-LQ-----S---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHSCCCC-CS-----C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCCCC-CC-----C---CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122222222211 11 1 112345888999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-51 Score=404.27 Aligned_cols=266 Identities=23% Similarity=0.334 Sum_probs=215.2
Q ss_pred cccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
+.++|++.+.||+|+||+||+|++++ .+++.||||+++.... ....++|.+|+.++++++|||
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~E~~il~~l~h~n 77 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-------------ADMQADFQREAALMAEFDNPN 77 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-------------HHHHHHHHHHHHHHHTCCCTT
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC-------------hHHHHHHHHHHHHHHhcCCCC
Confidence 56789999999999999999999864 3467899999976532 233567999999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhc--------------------CCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS--------------------QGRRELDWLARYRIARGMASGLEYLH 369 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~ia~gl~~LH 369 (532)
|++++++|...+..+++|||+++|+|.++++... .....+++..++.|+.|++.||+|||
T Consensus 78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH 157 (301)
T d1lufa_ 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157 (301)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence 9999999999999999999999999999997532 12345899999999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHH
Q 037084 370 MYHRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAV 449 (532)
Q Consensus 370 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 449 (532)
+.+ ++||||||+|||++.++.+||+|||+|+...........+...||+.|+|||.+.+..++.++|||||||++||
T Consensus 158 ~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 158 ERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp HTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 998 99999999999999999999999999987654433333356778999999999999999999999999999999
Q ss_pred HHhCC-CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Q 037084 450 LVVGK-FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLS 528 (532)
Q Consensus 450 lltg~-~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~ 528 (532)
|++|. +||..... ..+ .........+. .+...+.++.+|+..||+.+|++|||+.+|+++|+
T Consensus 235 ll~~~~~p~~~~~~----~e~---~~~v~~~~~~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 235 IFSYGLQPYYGMAH----EEV---IYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHTTTCCTTTTSCH----HHH---HHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHccCCCCCCCCCH----HHH---HHHHHcCCCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99985 67765332 122 22222221111 11122345889999999999999999999999999
Q ss_pred hhhC
Q 037084 529 QIKH 532 (532)
Q Consensus 529 ~l~~ 532 (532)
+|+.
T Consensus 298 ~i~~ 301 (301)
T d1lufa_ 298 RMCE 301 (301)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 9863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=399.19 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=201.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL 313 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 313 (532)
..++|++.+.||+|+||.||+|.++ |+.||||+++.+. ..+.|.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~~----------------~~~~~~~E~~~l~~l~HpnIv~~ 65 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQL 65 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC---CeEEEEEEECcHH----------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 3467899999999999999999985 7899999997653 22568899999999999999999
Q ss_pred eeEEec-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 314 QAHVTR-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 314 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+|+|.+ .+..++||||+++|+|.+++... ....+++..+++|+.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 66 ~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~ 140 (262)
T d1byga_ 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDN 140 (262)
T ss_dssp EEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred EEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCC
Confidence 999865 46689999999999999999752 2345899999999999999999999988 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l~~ 471 (532)
.+|++|||+++...... ....+|+.|+|||++.++.++.++|||||||++|||+| |++||..... .++..
T Consensus 141 ~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~ 211 (262)
T d1byga_ 141 VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVP 211 (262)
T ss_dssp CEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHH
T ss_pred CEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHH
Confidence 99999999998654432 34568899999999999999999999999999999998 7888865322 23333
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
++.. ...+ ......+..+.+++.+||+.||++|||+.++++.|++++
T Consensus 212 ~i~~---~~~~----------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 212 RVEK---GYKM----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHTT---TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHc---CCCC----------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 3321 1111 111122345889999999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-51 Score=405.49 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=192.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|++.+.||+|+||+||+|++..+ |+.||||++...... .....+.+|+.++++++|||||+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~ 73 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRT-QKLVAIKCIAKKALE-------------GKEGSMENEIAVLHKIKHPNIVALD 73 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTT-CCEEEEEEEEC-----------------------CHHHHHHHTCCCTTBCCEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCC-CCEEEEEEEchHHhh-------------hHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45699999999999999999988764 899999999765321 1235678999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec---CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID---DG 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~---~~ 391 (532)
+++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++. ++
T Consensus 74 ~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~ 146 (307)
T d1a06a_ 74 DIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDED 146 (307)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred EEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCC
Confidence 999999999999999999999999964 456999999999999999999999998 99999999999994 57
Q ss_pred CcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHH
Q 037084 392 MEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVR 471 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~ 471 (532)
+.+||+|||+|+........ ...+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..
T Consensus 147 ~~vkl~DFG~a~~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----~~--- 216 (307)
T d1a06a_ 147 SKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND----AK--- 216 (307)
T ss_dssp CCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HH---
T ss_pred ceEEEeccceeEEccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH----HH---
Confidence 89999999999876544322 456899999999999999999999999999999999999999975332 11
Q ss_pred HHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 472 WMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 472 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............ .. ...+..+..+.+++..||+.||++|||+.|+++
T Consensus 217 ~~~~i~~~~~~~---~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 217 LFEQILKAEYEF---DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHTTCCCC---CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCC---CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112222221110 11 111223455889999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=400.85 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=202.2
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++.+.||+|+||.||+|+++ ++..||||+++..... .+.|.+|+.++++++|||||+++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~~~~---------------~~~~~~E~~~l~~l~h~nIv~~~ 78 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQLY 78 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcccCC---------------HHHHHHHHHHHHhcccCCEeEEE
Confidence 567999999999999999999987 3578999999866422 25688999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
++|.+ +..++|||||++|+|.+++... ....++|..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 79 g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~ 152 (285)
T d1fmka3 79 AVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVC 152 (285)
T ss_dssp EEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEec-CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcE
Confidence 99965 5689999999999999998763 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++........ ......||+.|+|||++..+.++.++|||||||++|||++|..|+..... ...+...+
T Consensus 153 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~i- 227 (285)
T d1fmka3 153 KVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQV- 227 (285)
T ss_dssp EECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHH-
T ss_pred EEcccchhhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHH-
Confidence 99999999877544322 22456799999999999999999999999999999999997666543221 12222222
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.....+. .....+..+.+++.+||+.||++|||+++|+++|+++
T Consensus 228 --~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 228 --ERGYRMP----------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp --HTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred --HhcCCCC----------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 2211111 1122345688999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3e-50 Score=405.61 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=208.9
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||+||+|++..+ |+.||||++..... ...+.+.+|+.++++++|||||++++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~-g~~vAvK~i~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~~~~ 90 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHE--------------SDKETVRKEIQTMSVLRHPTLVNLHD 90 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTT-TEEEEEEEECCCSH--------------HHHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEcccch--------------hhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 5799999999999999999988764 99999999987642 23467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec--CCCc
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID--DGME 393 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~--~~~~ 393 (532)
++.+.+..|+|||||+||+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.
T Consensus 91 ~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~ 164 (350)
T d1koaa2 91 AFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 164 (350)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCC
T ss_pred EEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCe
Confidence 99999999999999999999999964 3456999999999999999999999999 99999999999995 4688
Q ss_pred EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHH
Q 037084 394 ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWM 473 (532)
Q Consensus 394 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~ 473 (532)
+||+|||+++........ ....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .+.+
T Consensus 165 vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~ 234 (350)
T d1koaa2 165 LKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETL 234 (350)
T ss_dssp EEECCCTTCEECCTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH
T ss_pred EEEeecchheeccccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHH
Confidence 999999999987654332 567899999999999999999999999999999999999999975322 1222
Q ss_pred HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 474 RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 474 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... +.. .....+..+.+++..||+.||++|||+.|+++
T Consensus 235 ~~i~~~~~~~---~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 235 RNVKSCDWNM---DDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHHHHTCCCS---CCG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCC---Ccc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222211110 011 11122345889999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=395.68 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=201.3
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCC--CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSY--GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL 310 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni 310 (532)
...++|++.+.||+|+||.||+|++...+ +..||||.++.... ......|.+|+.++++++||||
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnI 70 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-------------DSVREKFLQEALTMRQFDHPHI 70 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-------------HHHHHHHHHHHHHHHTCCCTTB
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCCE
Confidence 34578999999999999999999886432 35799999875432 2335679999999999999999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++++.+ +..++|||||++|+|.+++.. ....+++..++.++.|+++||.|||+.+ ++||||||+||++++
T Consensus 71 v~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~ 143 (273)
T d1mp8a_ 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSS 143 (273)
T ss_dssp CCEEEEECS-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEE
T ss_pred eeEEEEEec-CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecC
Confidence 999999964 678999999999999998865 3456899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+++......... .+...||+.|+|||++.+..++.++|||||||++|||++ |.+||..... ..+
T Consensus 144 ~~~~Kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~~ 218 (273)
T d1mp8a_ 144 NDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----NDV 218 (273)
T ss_dssp TTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GGH
T ss_pred CCcEEEccchhheeccCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----HHH
Confidence 9999999999998765543322 245678999999999999999999999999999999998 8999976433 222
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...+ .....+. .++..+..+.+|+..||+.||++|||+.+|++.|+++.
T Consensus 219 ~~~i---~~~~~~~----------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 219 IGRI---ENGERLP----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHH---HTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HcCCCCC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2222 2221111 11223456889999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=404.58 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=206.2
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc----EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK----MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRN 309 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~n 309 (532)
..++|+++++||+|+||+||+|.+..+ |+ +||+|.++.... ....+.|.+|+.++++++|||
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~Hpn 72 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATS-------------PKANKEILDEAYVMASVDNPH 72 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC-----------------CTHHHHHHHHHHHHHCCCTT
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCC-CCEEEEEEEEEEeccccC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 345799999999999999999988754 43 699999875421 223467899999999999999
Q ss_pred cccceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 310 LLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 310 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
||+++|+|.++ ..++++||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 73 Iv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~ 145 (317)
T d1xkka_ 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVK 145 (317)
T ss_dssp BCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred EeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeC
Confidence 99999999875 56788999999999998875 3567999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 468 (532)
.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||..... ..
T Consensus 146 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~----~~ 221 (317)
T d1xkka_ 146 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SE 221 (317)
T ss_dssp ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG----GG
T ss_pred CCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH----HH
Confidence 999999999999998766544433345678999999999999999999999999999999998 8899976432 22
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+...+.. ...+. .++..+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 222 ~~~~i~~---~~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 222 ISSILEK---GERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHHHHHH---TCCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHc---CCCCC----------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 2222221 11111 11223356889999999999999999999999988763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.1e-50 Score=404.22 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=209.0
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|++.+.||+|+||+||+|.+..+ |+.||||+++.... .....+.+|+.++++++|||||+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~~~ 92 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKAT-GRVFVAKFINTPYP--------------LDKYTVKNEISIMNQLHHPKLINLH 92 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCSH--------------HHHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC-CCEEEEEEECCcch--------------hHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 35799999999999999999988764 99999999987642 2235678999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec--CCC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID--DGM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~--~~~ 392 (532)
+++.+++..|+|||||+||+|.+++.. ...++++..+..|+.|++.||.|||+.+ |+||||||+|||++ .++
T Consensus 93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~ 166 (352)
T d1koba_ 93 DAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKAS 166 (352)
T ss_dssp EEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCC
T ss_pred EEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCC
Confidence 999999999999999999999988753 3456999999999999999999999998 99999999999998 678
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+|+........ ....||+.|+|||++.+..++.++||||+||++|+|+||+.||..... .. .
T Consensus 167 ~vkL~DFGla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~---~ 236 (352)
T d1koba_ 167 SVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LE---T 236 (352)
T ss_dssp CEEECCCTTCEECCTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HH---H
T ss_pred eEEEeecccceecCCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HH---H
Confidence 9999999999987654332 567899999999999999999999999999999999999999976332 11 1
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+......... +.. ...+..+..+.+|+..||+.||++|||+.|+++
T Consensus 237 ~~~i~~~~~~---~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 237 LQNVKRCDWE---FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHCCCC---CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCC---CCc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222221110 001 111223345889999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=392.05 Aligned_cols=264 Identities=26% Similarity=0.340 Sum_probs=202.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCC--cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLL 311 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv 311 (532)
..++|++.+.||+|+||.||+|++...++ ..||||+++...... ....++|.+|+.++++++||||+
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----------~~~~~~~~~Ei~~l~~l~H~nIv 74 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----------PEAMDDFIREVNAMHSLDHRNLI 74 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-----------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 45679999999999999999999875444 378999987653221 23356799999999999999999
Q ss_pred cceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCC
Q 037084 312 PLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDG 391 (532)
Q Consensus 312 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~ 391 (532)
+++|+|.+ +..++|||||++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 75 ~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~ 147 (273)
T d1u46a_ 75 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATR 147 (273)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET
T ss_pred EEEEEEee-cchheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccc
Confidence 99999976 4678999999999999988752 346999999999999999999999988 9999999999999999
Q ss_pred CcEEEeccCCcccCCCCCcce-eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCcccchhhccH
Q 037084 392 MEARISDFGLAKLMPDGHTRI-RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV-GKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~l 469 (532)
+.+||+|||+++......... ......||..|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+
T Consensus 148 ~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~----~~~ 223 (273)
T d1u46a_ 148 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQI 223 (273)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH
T ss_pred cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH----HHH
Confidence 999999999999876554332 2234567889999999999999999999999999999998 8999975432 122
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+......+.... ..+..+..+.+|+..||+.||++|||+.+|++.|++.+
T Consensus 224 ---~~~i~~~~~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 224 ---LHKIDKEGERLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---HHHHHTSCCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---HHHHHhCCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 222222221111 11122345889999999999999999999999998763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=397.56 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=208.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|.+.+.||+|+||+||+|++..+ |+.||||+++......... ....+.|.+|+.++++++|||||+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~-~~~~AvK~i~~~~~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~ 79 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFIKKRRTKSSRR--------GVSREDIEREVSILKEIQHPNVITLH 79 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEBCSSTTCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCC-CCEEEEEEEEhhhcchhhh--------hHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 46799999999999999999998764 9999999986543221100 11246788999999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC--
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM-- 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 392 (532)
+++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~ 152 (293)
T d1jksa_ 80 EVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVP 152 (293)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSS
T ss_pred EEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCc
Confidence 999999999999999999999999976 246999999999999999999999999 99999999999998776
Q ss_pred --cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 --EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 --~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+|++|||+++........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||......
T Consensus 153 ~~~vkl~DfG~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------- 222 (293)
T d1jksa_ 153 KPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------- 222 (293)
T ss_dssp SCCEEECCCTTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred ccceEecchhhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------
Confidence 4999999999887554322 4568999999999999999999999999999999999999999754321
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+.+......... +.+.. .+..+..+.+++..||+.||++|||++++++
T Consensus 223 ~~~~~i~~~~~~---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 223 ETLANVSAVNYE---FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTTCCC---CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCCC---CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222211110 00001 1122345889999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=395.28 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=201.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCC----CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCC
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGS----YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHR 308 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ 308 (532)
..++|.+.+.||+|+||.||+|.+... +++.||||+++.... ....+.+.+|...+.++ +|+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------------~~~~~~~~~e~~~l~~~~~h~ 77 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------------HSEHRALMSELKILIHIGHHL 77 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------------HHHHHHHHHHHHHHHHHCCCT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------------cHHHHHHHHHHHHHHhhcCCC
Confidence 457899999999999999999998643 246899999975432 22345677888888877 689
Q ss_pred CcccceeEEecC-CceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 309 NLLPLQAHVTRP-DCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHRPC 375 (532)
Q Consensus 309 niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ 375 (532)
||+.+++++.+. +..++|||||++|+|.++++.... ....+++..+..++.|+++||.|||+.+
T Consensus 78 ~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--- 154 (299)
T d1ywna1 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--- 154 (299)
T ss_dssp TBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred eEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 999999998765 468999999999999999976322 1345899999999999999999999998
Q ss_pred eeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhC-C
Q 037084 376 IIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVG-K 454 (532)
Q Consensus 376 ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~ 454 (532)
|+||||||+|||+++++++||+|||+|+...........+...||+.|+|||++.+..++.++|||||||++|||+|| .
T Consensus 155 ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCC
Confidence 999999999999999999999999999877655444333567899999999999999999999999999999999996 5
Q ss_pred CCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 455 FPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 455 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
+||...... ..+.. .+..+.... .....+..+.+++..||+.||++|||+.++++.|+++-
T Consensus 235 ~p~~~~~~~---~~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 235 SPYPGVKID---EEFCR----RLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp CSSTTCCCS---HHHHH----HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHH---HHHHH----HHhcCCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 677653321 11111 111121111 11112345889999999999999999999999999863
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-49 Score=389.93 Aligned_cols=264 Identities=22% Similarity=0.321 Sum_probs=207.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|++..+ |+.||||+++...... ......|.+|+.++++++||||++++
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~~-----------~~~~~~~~~E~~~l~~~~hpniv~~~ 73 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRL-HRDVAVKVLRADLARD-----------PSFYLRFRREAQNAAALNHPAIVAVY 73 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSTTTTC-----------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCC-CCEEEEEEEchhhccC-----------HHHHHHHHHHHHHHHhcCCCCCCccc
Confidence 46799999999999999999988764 9999999997654322 23456799999999999999999999
Q ss_pred eEEecCCc----eEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 315 AHVTRPDC----HLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++...+. .|+|||||+|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 146 (277)
T ss_dssp EEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred ceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCc
Confidence 99976543 7899999999999999875 346999999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCc-ceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHT-RIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
++..+++|||.+........ ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------- 219 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------- 219 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------
Confidence 99999999999876644322 1223567899999999999999999999999999999999999999975332
Q ss_pred HHHHHHHhccCCC-cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhhhhC
Q 037084 470 VRWMRNVISSENP-HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-SSKDVRCMLSQIKH 532 (532)
Q Consensus 470 ~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~ 532 (532)
.+........... .... .+..+..+.+++.+||+.||++|| |++++.+.|.+++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~--------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHCCCCCGGGT--------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCchh--------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 1222222222221 1111 112234588899999999999999 89999999998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=393.05 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=216.6
Q ss_pred ccccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-
Q 037084 231 FLTKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI- 305 (532)
Q Consensus 231 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 305 (532)
+....++|++.+.||+|+||.||+|++.+ .+++.||||+++.... ......|.+|+.+++++
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~E~~~~~~l~ 84 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------------LTEREALMSELKVLSYLG 84 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------------HHHHHHHHHHHHHHHHHC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-------------HHHHHHHHHHHHHHHhcc
Confidence 33456789999999999999999998743 3467999999986542 22346788999999999
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ--------------GRRELDWLARYRIARGMASGLEYLHMY 371 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~LH~~ 371 (532)
+|||||+++++|.+++..++|||||++|+|.++++.... ....+++..+..++.|+++||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 799999999999999999999999999999999986431 234689999999999999999999999
Q ss_pred CCCCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHH
Q 037084 372 HRPCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLV 451 (532)
Q Consensus 372 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 451 (532)
+ ++||||||+||+++.++.+|++|||+++...........+...||+.|+|||.+.++.++.++|||||||++|||+
T Consensus 165 ~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ell 241 (311)
T d1t46a_ 165 N---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241 (311)
T ss_dssp T---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHH
Confidence 8 9999999999999999999999999999887655544446678999999999999999999999999999999999
Q ss_pred h-CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 452 V-GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 452 t-g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
| |.+||...... ..+...+.... .+ ......+..+.+|+.+||+.||++|||+++++++|+++
T Consensus 242 t~g~p~~~~~~~~---~~~~~~i~~~~---~~----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 242 SLGSSPYPGMPVD---SKFYKMIKEGF---RM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TTTCCSSTTCCSS---HHHHHHHHHTC---CC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH---HHHHHHHhcCC---CC----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9 55555443221 11122222111 11 11112235588999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=396.67 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=206.6
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+++.||+|+||.||+|+...+ |+.||||+++..... .......+.+|+.+|++++||||+++++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~-~~~~AiK~i~k~~~~-----------~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 72 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKAT-GRYYAMKILRKEVII-----------AKDEVAHTVTESRVLQNTRHPFLTALKY 72 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEchhhcc-----------CHHHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence 5799999999999999999988764 999999999743211 1223567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+|.+|
T Consensus 73 ~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vk 145 (337)
T d1o6la_ 73 AFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIK 145 (337)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred eeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEE
Confidence 99999999999999999999999976 346889999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+|+........ ....+||+.|+|||++.+..++.++|+||+||++|||++|++||..... ..+ ...
T Consensus 146 l~DFG~a~~~~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~----~~~---~~~ 216 (337)
T d1o6la_ 146 ITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERL---FEL 216 (337)
T ss_dssp ECCCTTCBCSCCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHH---HHH
T ss_pred EeecccccccccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH----HHH---HHH
Confidence 9999999876543322 2567899999999999999999999999999999999999999976432 111 122
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
.... .+. + +...+..+.+|+..||+.||++||+ +.++++
T Consensus 217 i~~~-~~~------~----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 217 ILME-EIR------F----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHC-CCC------C----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HhcC-CCC------C----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2211 111 1 1112345788999999999999995 677654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-49 Score=394.67 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=206.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++++.||+|+||+||+|+++.+ |+.||||+++...... ....+.+.+|+.++++++|||||++++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~-g~~vAvK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~~ 71 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHN-GRYYAMKVLKKEIVVR-----------LKQVEHTNDERLMLSIVTHPFIIRMWG 71 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCC-CCEEEEEEEchHHccC-----------HHHHHHHHHHHHHHHhccCcChhheee
Confidence 4699999999999999999998764 9999999986432110 223567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||+||+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.+|.+|
T Consensus 72 ~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 72 TFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEE
T ss_pred eEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEE
Confidence 99999999999999999999999875 456788888999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+|+...... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .+....
T Consensus 145 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~ 212 (316)
T d1fota_ 145 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEK 212 (316)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHH
T ss_pred EecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHH
Confidence 99999999875543 457899999999999999999999999999999999999999976332 122222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
....... .++..+..+.+++..||+.||.+|| |++++++
T Consensus 213 i~~~~~~-----------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 213 ILNAELR-----------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHCCCC-----------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHcCCCC-----------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2222111 0111234588899999999999996 8888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=389.48 Aligned_cols=265 Identities=24% Similarity=0.313 Sum_probs=211.7
Q ss_pred ccccCccccceecccCCeEEEEEEeeCCC------CcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPGSY------GKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI- 305 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 305 (532)
...++|.+.+.||+|+||.||+|+..+.+ +..||||+++.... .....++.+|+..+.++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~e~~~l~~~~ 76 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-------------EKDLSDLISEMEMMKMIG 76 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-------------HHHHHHHHHHHHHHHHHC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-------------hHHHHHHHHHHHHHHHhc
Confidence 45678999999999999999999876432 35799999976542 23356788899999888
Q ss_pred CCCCcccceeEEecCCceEEEEEeccCCCHHHHHhhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037084 306 WHRNLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQ------------GRRELDWLARYRIARGMASGLEYLHMYHR 373 (532)
Q Consensus 306 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 373 (532)
+|||||+++++|.+++..++|||||++|+|.+++..... ....+++..++.++.|++.||+|||+.+
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~- 155 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 155 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 899999999999999999999999999999999975321 2356899999999999999999999999
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHh-
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVV- 452 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt- 452 (532)
|+||||||+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++
T Consensus 156 --ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 156 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp --CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999999999999999998766544444456789999999999999999999999999999999998
Q ss_pred CCCCCCCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 453 GKFPFDDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 453 g~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
|.+||..... ..+...+ .....+. .+...+..+.+|+.+||+.||++|||+.+|++.|++|
T Consensus 234 g~~p~~~~~~----~~~~~~i---~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 234 GGSPYPGVPV----EELFKLL---KEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp SCCSSTTCCH----HHHHHHH---HTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCH----HHHHHHH---HcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 7888875332 1222222 1111111 1112234588999999999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.9e-49 Score=383.16 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=209.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~ 314 (532)
++|++.+.||+|+||+||+|++.. +|+.||||+++........... .......+.+|+.++++++ ||||++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEE-----VQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHH-----HHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ccCEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHH-----HHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 579999999999999999998765 4999999999765433211111 1334567889999999996 99999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|||||||++|+|.+++.. ..++++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred eecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCe
Confidence 999999999999999999999999975 346999999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeecccccccccccccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT------LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
||+|||+++........ +...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... .
T Consensus 150 kl~DFG~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----~- 221 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----M- 221 (277)
T ss_dssp EECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H-
T ss_pred EEccchheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----H-
Confidence 99999999987654322 55789999999998753 3468899999999999999999999986432 1
Q ss_pred HHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
............. .....+..+..+.+++..||++||++|||+.|+++
T Consensus 222 --~~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 222 --LMLRMIMSGNYQF-------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHHHHHHHTCCCC-------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHhCCCCC-------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112222211110 01112233456889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=392.69 Aligned_cols=266 Identities=18% Similarity=0.310 Sum_probs=217.0
Q ss_pred ccccCccccceecccCCeEEEEEEeeC----CCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCC
Q 037084 233 TKEDSLASLEIIGVGACGVVYKAEVPG----SYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHR 308 (532)
Q Consensus 233 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ 308 (532)
...++|.+.+.||+|+||+||+|.+++ .+++.||||+++.... ......|.+|+.++++++||
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-------------~~~~~~~~~E~~il~~l~h~ 83 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-------------MRERIEFLNEASVMKEFNCH 83 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-------------HHHHHHHHHHHHHGGGCCCT
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC-------------hHHHHHHHHHHHHHHHcCCC
Confidence 345789999999999999999998863 2257899999976532 23346789999999999999
Q ss_pred CcccceeEEecCCceEEEEEeccCCCHHHHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 037084 309 NLLPLQAHVTRPDCHLLVYEFMKNGSLQDILHDVS------QGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIK 382 (532)
Q Consensus 309 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 382 (532)
||++++++|...+..++|||||++|+|.+++.... .....+++..+.+++.|+++||.|||+.+ |+|||||
T Consensus 84 nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk 160 (308)
T d1p4oa_ 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLA 160 (308)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCS
T ss_pred CEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEc
Confidence 99999999999999999999999999999987532 22345799999999999999999999988 9999999
Q ss_pred CCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCcc
Q 037084 383 PANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK-FPFDDFF 461 (532)
Q Consensus 383 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~~~~~ 461 (532)
|+|||+++++++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. +||....
T Consensus 161 ~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 161 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998776554443335567899999999999999999999999999999999985 7776532
Q ss_pred cchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 462 QYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 462 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
. .+..........+. .....+..+.+++..||+.+|++|||+++|++.|++..
T Consensus 241 ~-------~~~~~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 241 N-------EQVLRFVMEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp H-------HHHHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-------HHHHHHHHhCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2 22233333222211 11123356899999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=393.97 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=207.9
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCc--EEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGK--MIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNL 310 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~ni 310 (532)
..++|++.++||+|+||+||+|+++++ |. .||||.++.... ....+.|.+|+.+++++ +||||
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vaiK~~~~~~~-------------~~~~~~~~~E~~~l~~l~~HpnI 73 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKD-GLRMDAAIKRMKEYAS-------------KDDHRDFAGELEVLCKLGHHPNI 73 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEET-TEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTB
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCC-CeEEEEEEEEECcccC-------------hHHHHHHHHHHHHHHhccCCCCE
Confidence 346788999999999999999999864 54 578888765421 22346799999999999 79999
Q ss_pred ccceeEEecCCceEEEEEeccCCCHHHHHhhh------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 037084 311 LPLQAHVTRPDCHLLVYEFMKNGSLQDILHDV------------SQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIH 378 (532)
Q Consensus 311 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 378 (532)
|+++++|.+++..++||||+++|+|.++++.. ......+++..+.+++.|++.||.|||+.+ ++|
T Consensus 74 v~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiH 150 (309)
T d1fvra_ 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIH 150 (309)
T ss_dssp CCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred eeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccc
Confidence 99999999999999999999999999999753 123467999999999999999999999998 999
Q ss_pred cCCCCCcEEecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCC-CCC
Q 037084 379 RDIKPANVLIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGK-FPF 457 (532)
Q Consensus 379 ~Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~p~ 457 (532)
|||||+|||++.++.+||+|||+++........ ....||+.|+|||.+.++.++.++|||||||++|||++|. +||
T Consensus 151 rDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 151 RDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence 999999999999999999999999865443221 3456899999999999999999999999999999999976 567
Q ss_pred CCcccchhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 458 DDFFQYTEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 458 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
..... .+..........+. .....+..+.+|+.+||+.||++|||+++|++.|+++.
T Consensus 228 ~~~~~-------~~~~~~i~~~~~~~----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 228 CGMTC-------AELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp TTCCH-------HHHHHHGGGTCCCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCH-------HHHHHHHHhcCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 54322 22222222222211 11223356889999999999999999999999998864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=387.37 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=203.5
Q ss_pred cceecccCCeEEEEEEeeCCCC--cEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEe
Q 037084 241 LEIIGVGACGVVYKAEVPGSYG--KMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVT 318 (532)
Q Consensus 241 ~~~LG~G~fG~Vy~~~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 318 (532)
.++||+|+||+||+|++...++ ..||||+++.... .....+|.+|+.++++++||||++++|+|.
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 98 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-------------IGEVSQFLTEGIIMKDFSHPNVLSLLGICL 98 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC-------------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC-------------HHHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence 4789999999999999865433 3689999975321 334578999999999999999999999987
Q ss_pred c-CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEe
Q 037084 319 R-PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARIS 397 (532)
Q Consensus 319 ~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 397 (532)
+ ++..++|||||++|+|.+++.. ....+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 99 ~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~ 172 (311)
T d1r0pa_ 99 RSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA 172 (311)
T ss_dssp ETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEe
Confidence 5 4678999999999999999874 3456788999999999999999999998 9999999999999999999999
Q ss_pred ccCCcccCCCCCcce--eeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 398 DFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 398 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|||+++......... ......||+.|+|||.+.++.++.++||||||+++|||+||..||..... ..++..++
T Consensus 173 DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~---~~~~~~~i-- 247 (311)
T d1r0pa_ 173 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYL-- 247 (311)
T ss_dssp SSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH--
T ss_pred cccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC---HHHHHHHH--
Confidence 999999775443221 12345789999999999999999999999999999999998888764221 12222222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
.....+. .+ ...+..+.+|+..||+.||++|||+.||++.|+++.
T Consensus 248 -~~g~~~~---~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 248 -LQGRRLL---QP-------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp -HTTCCCC---CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HcCCCCC---Cc-------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2222111 11 112345888999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=387.31 Aligned_cols=268 Identities=25% Similarity=0.323 Sum_probs=203.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|.+.+.||+|+||.||+|+++ |+.||||+++.... ....+..|+..+.+++||||++++++
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~---g~~vAvK~~~~~~~---------------~~~~~e~ei~~~~~~~HpnIv~~~~~ 65 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR---GEEVAVKIFSSREE---------------RSWFREAEIYQTVMLRHENILGFIAA 65 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET---TEEEEEEEECGGGH---------------HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC---CEEEEEEEECccch---------------hHHHHHHHHHHHhhCCCCcCcceEEE
Confidence 5777889999999999999874 88999999975421 11223356677778999999999999
Q ss_pred EecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCcEE
Q 037084 317 VTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMY-----HRPCIIHRDIKPANVL 387 (532)
Q Consensus 317 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-----~~~~ivH~Dlkp~NIl 387 (532)
|.+.+ ..++|||||++|+|.++++. ..++|..+++++.|++.||+|||+. +..+|+||||||+|||
T Consensus 66 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NIL 140 (303)
T d1vjya_ 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140 (303)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEE
T ss_pred EEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceE
Confidence 98654 57899999999999999975 3589999999999999999999974 1244999999999999
Q ss_pred ecCCCcEEEeccCCcccCCCCCcce--eeeccccccccccccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCC
Q 037084 388 IDDGMEARISDFGLAKLMPDGHTRI--RITTVAGTTGYVAPEYHQTLT------ISEKSDIYSFGVLLAVLVVGKFPFDD 459 (532)
Q Consensus 388 l~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~p~~~ 459 (532)
|++++.+||+|||+++......... ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+..
T Consensus 141 l~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred EcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9999999999999999775543221 224678999999999887643 67799999999999999999988754
Q ss_pred cccchh-------hccHHHHHHHHhccCCCcccccccccCC-CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhhh
Q 037084 460 FFQYTE-------EMNMVRWMRNVISSENPHRAIDSKLLGN-GYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQIK 531 (532)
Q Consensus 460 ~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~ 531 (532)
...... ................. ++.+... ...+.+..+.+++..||+.||++|||+.||++.|++|.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccccchhhcccccchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 221110 01112222322222221 1111111 13456677999999999999999999999999999886
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=389.46 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=206.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+.+.||+|+||+||+|.+..+ |+.||||+++.... ....+.+|+.+|++++|||||+++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~-~~~~AiK~i~~~~~---------------~~~~~~~Ei~il~~l~HpnIv~~~ 67 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFVKVKGT---------------DQVLVKKEISILNIARHRNILHLH 67 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECCCTH---------------HHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCC-CcEEEEEEEcCCcc---------------cHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35799999999999999999988764 89999999987632 224577899999999999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC--CC
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--GM 392 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--~~ 392 (532)
+++.+++..|+|||||+||+|.+++.. .+..+++..+..++.|++.||.|||+.+ |+||||||+|||++. .+
T Consensus 68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~ 141 (321)
T d1tkia_ 68 ESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp EEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCC
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCce
Confidence 999999999999999999999999964 3446999999999999999999999999 999999999999985 45
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRW 472 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~ 472 (532)
.+||+|||+++....... .....||+.|+|||...+..++.++||||+||++|+|++|..||...... +.
T Consensus 142 ~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------~~ 211 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------QI 211 (321)
T ss_dssp CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HH
T ss_pred EEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------HH
Confidence 799999999987755432 24567899999999999999999999999999999999999999764321 11
Q ss_pred HHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 473 MRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 473 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ++..... ..+..+.+++..||+.||++|||+.|+++
T Consensus 212 ~~~i~~~~~~---~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 212 IENIMNAEYT---FDEEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHTCCC---CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCC---CChhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2222221110 1111111 12345789999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=390.76 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=200.0
Q ss_pred ccCccccc-eecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CCCCccc
Q 037084 235 EDSLASLE-IIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WHRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~-~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~ 312 (532)
-++|.+.. .||+|+||+||+|++..+ |+.||||+++.. ..+.+|+.++.++ +|||||+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~-------------------~~~~~E~~~~~~~~~hpnIv~ 69 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRT-QEKFALKMLQDC-------------------PKARREVELHWRASQCPHIVR 69 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEECS-------------------HHHHHHHHHHHHHTTSTTBCC
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCC-CCEEEEEEECCc-------------------HHHHHHHHHHHHhcCCCCCCe
Confidence 35788775 599999999999998764 899999999754 2355788886654 8999999
Q ss_pred ceeEEec----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 313 LQAHVTR----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 313 l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++++.+ ....|+|||||+||+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll 144 (335)
T d2ozaa1 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLY 144 (335)
T ss_dssp EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred EEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccc
Confidence 9999865 3568999999999999999975 33457999999999999999999999999 9999999999999
Q ss_pred cC---CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchh
Q 037084 389 DD---GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTE 465 (532)
Q Consensus 389 ~~---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~ 465 (532)
++ ++.+||+|||+|+........ ....||+.|+|||++.+..++.++|||||||++|+|+||+.||......
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-- 219 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-- 219 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH--
Confidence 85 557999999999877654332 5678999999999999999999999999999999999999999753321
Q ss_pred hccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 466 EMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 466 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.....+......... ..........+..+.+|+..||+.||++|||+.++++
T Consensus 220 --~~~~~~~~~i~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 220 --AISPGMKTRIRMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----------CCCSCSS------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHHHhcCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111111111111110 0001112344567899999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=393.99 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=206.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++++.||+|+||.||+|+++.+ |+.||||++....... ....+.+.+|+.++++++|||||++++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~-g~~~AvK~i~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKILDKQKVVK-----------LKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHHH-----------TTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCC-CCEEEEEEEchHHccC-----------HHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 5799999999999999999998764 9999999986432110 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++||||+.+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+|
T Consensus 109 ~~~~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ccccccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEE
Confidence 999999999999999999999999762 46899999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRN 475 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~ 475 (532)
|+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......
T Consensus 182 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~ 249 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEK 249 (350)
T ss_dssp ECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHH
T ss_pred eeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------HHHHHH
Confidence 99999999775432 456899999999999999999999999999999999999999975322 122222
Q ss_pred HhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 037084 476 VISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERP-----SSKDVRC 525 (532)
Q Consensus 476 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~ 525 (532)
..... +. .+......+.+++..||+.||.+|+ |++++++
T Consensus 250 i~~~~-~~----------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 250 IVSGK-VR----------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHHCC-CC----------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred HhcCC-CC----------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 22221 11 0111234588899999999999994 8888875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-48 Score=390.88 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=201.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+.+.||+|+||.||+|++..+ |+.||||++......... ..........++.+++.++|||||++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t-~~~vAiK~i~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADT-GKMYAMKCLDKKRIKMKQ--------GETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTT-CCEEEEEEEEHHHHHHHT--------CHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCC-CCEEEEEEEchHHcchhh--------HHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 5799999999999999999988764 999999998643211100 0111223345678888899999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+|
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iK 147 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVR 147 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEE
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEE
Confidence 99999999999999999999999976 346889999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+|+....... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... .......+
T Consensus 148 l~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~ 219 (364)
T d1omwa3 148 ISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDR 219 (364)
T ss_dssp ECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS----SCHHHHHH
T ss_pred EeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH
Confidence 999999997765432 45689999999999865 4689999999999999999999999976432 11112122
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
..... .+ .. ....+..+.+++..||+.||++||| ++++++
T Consensus 220 ~~~~~-~~------~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTM-AV------EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSC-CC------CC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccC-CC------CC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111 11 00 1112345888999999999999999 577764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=384.00 Aligned_cols=263 Identities=23% Similarity=0.249 Sum_probs=197.7
Q ss_pred ccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeEEec
Q 037084 240 SLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAHVTR 319 (532)
Q Consensus 240 ~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 319 (532)
.+++||+|+||+||+|++..+ |+.||||+++........ ......+.+|+.++++++|||||++++++..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~~~~---------~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~ 71 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNT-NQIVAIKKIKLGHRSEAK---------DGINRTALREIKLLQELSHPNIIGLLDAFGH 71 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSC-CSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cceEeccCcCeEEEEEEECCC-CcEEEEEEEehhhhhhhh---------HHHHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 357899999999999988764 999999999765322110 1223568899999999999999999999999
Q ss_pred CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEEEecc
Q 037084 320 PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEARISDF 399 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 399 (532)
++..|+|||||+++++..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 72 ~~~~~ivmE~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 72 KSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp TTCCEEEEECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCceeehhhhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccC
Confidence 999999999998877766653 3556888999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHHHHhc
Q 037084 400 GLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMRNVIS 478 (532)
Q Consensus 400 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~~~~~ 478 (532)
|+++......... ...+||+.|+|||++.+. .++.++||||+||++|||++|.+||..... .+...-+.....
T Consensus 145 G~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~----~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 145 GLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFETLG 218 (299)
T ss_dssp GGGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred ccccccCCCcccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH----HHHHHHHHHhcC
Confidence 9998766543322 456899999999988654 579999999999999999999999975432 122222222211
Q ss_pred cCCCccccc---------ccccCCC-----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 479 SENPHRAID---------SKLLGNG-----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 479 ~~~~~~~~d---------~~l~~~~-----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........+ ....... .+.....+.+|+..||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 111000000 0000000 1122456889999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=388.88 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=203.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHh-cCCCCCcccce
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAG-RIWHRNLLPLQ 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~ 314 (532)
++|.+.+.||+|+||+||+|++..+ |+.||||+++..... .......+..|..++. .++|||||+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t-~~~vAvK~i~k~~~~-----------~~~~~~~~~~e~~~l~~~~~hp~Iv~~~ 69 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKT-NQFFAIKALKKDVVL-----------MDDDVECTMVEKRVLSLAWEHPFLTHMF 69 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEEHHHHH-----------HTTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCC-CCEEEEEEEchhhcc-----------ChHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 5699999999999999999998765 999999999743211 0222455667777665 68999999999
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
+++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++++
T Consensus 70 ~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 70 CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCce
Confidence 999999999999999999999999975 345889999999999999999999998 9999999999999999999
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
||+|||+++........ .+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+... . +...
T Consensus 143 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~----~---~~~~ 213 (320)
T d1xjda_ 143 KIADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE----E---ELFH 213 (320)
T ss_dssp EECCCTTCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----H---HHHH
T ss_pred eccccchhhhccccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH----H---HHHH
Confidence 99999999876544332 2567899999999999999999999999999999999999999976432 1 1112
Q ss_pred HHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 037084 475 NVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSK-DVR 524 (532)
Q Consensus 475 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl 524 (532)
.... +.+. .+...+..+.+|+..||+.||++|||+. +++
T Consensus 214 ~i~~-~~~~----------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 214 SIRM-DNPF----------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHHH-CCCC----------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHc-CCCC----------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 2221 1111 0111234588999999999999999996 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=381.55 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=201.3
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++++.||+|+||+||+|.+..+ |+.||||+++..... ......+.+|+.++++++|||||++++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~ 68 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLT-GEVVALKKIRLDTET------------EGVPSTAIREISLLKELNHPNIVKLLD 68 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEC-------------------CCHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCC-CCEEEEEEEehhhcC------------hHHHHHHHHHHHHHHhCCCCcEEEecc
Confidence 5799999999999999999998764 899999999764321 223467889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++.+++..|+|||||.+ ++.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~k 142 (298)
T d1gz8a_ 69 VIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIK 142 (298)
T ss_dssp EEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcce
Confidence 99999999999999955 55555543 34556999999999999999999999999 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||+|+......... ....||+.|+|||.+.... ++.++|+||+||++|+|++|+.||....... .+.....
T Consensus 143 l~DFG~a~~~~~~~~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~ 217 (298)
T d1gz8a_ 143 LADFGLARAFGVPVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFR 217 (298)
T ss_dssp ECSTTHHHHHCCCSBCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred eccCCcceeccCCcccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHH
Confidence 99999998765543322 4568999999999876655 5789999999999999999999997543211 1111111
Q ss_pred HHhc-cCCC-cccc-cc-------cccCCC----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVIS-SENP-HRAI-DS-------KLLGNG----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~-~~~~-~~~~-d~-------~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.... .... .... .+ ...... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1000 0000 0000 00 000000 1122356889999999999999999999987
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=379.77 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=197.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhc---CCCCCcc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGR---IWHRNLL 311 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~---l~H~niv 311 (532)
.++|++++.||+|+||+||+|++..++++.||||+++....... ....+.+|+.+++. .+||||+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~~l~~l~~~~HpnIv 73 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNVV 73 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTBC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch------------HHHHHHHHHHHHHHHhhcCCCCcc
Confidence 46899999999999999999998665577899999865322110 11234456666555 4899999
Q ss_pred cceeEEec-----CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 312 PLQAHVTR-----PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 312 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++++|.. ....++++|||+++++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NI 147 (305)
T d1blxa_ 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 147 (305)
T ss_dssp CEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred eeeeeecccccccCceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEE
Confidence 99999853 346799999998776654443 34566899999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
|+++++.+||+|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......
T Consensus 148 Li~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-- 222 (305)
T d1blxa_ 148 LVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-- 222 (305)
T ss_dssp EECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--
Confidence 999999999999999886544332 256789999999999999999999999999999999999999997643311
Q ss_pred ccHHHHHHHHhccCC----Cc------ccccc---cccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 467 MNMVRWMRNVISSEN----PH------RAIDS---KLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~----~~------~~~d~---~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...-+........ +. ..+.. .............+.+|+.+||+.||++|||+.|+++
T Consensus 223 --~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 223 --QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp --HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111111111000 00 00000 0000111223456788999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.5e-47 Score=373.09 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=200.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|.+++.||+|+||+||+|+++ +|+.||||+++..... ......+.+|+.++++++||||+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~~~~ 67 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKED------------EGIPSTTIREISILKELKHSNIVKLYD 67 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGG------------GCCCHHHHHHHHGGGGCCCTTBCCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcC------------hHHHHHHHHHHHHHHhCCCCcEEeeee
Confidence 57999999999999999999886 5899999999776432 122367889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++..++..++++||+.++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 68 ~~~~~~~~~i~~e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~k 140 (286)
T d1ob3a_ 68 VIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELK 140 (286)
T ss_dssp EEECSSCEEEEEECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ecccCCceeEEEEeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEE
Confidence 9999999999999997766666654 3467999999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
++|||++......... .....|++.|+|||.+.+. .++.++|+||+||++|||++|+.||.+...... +.. +.
T Consensus 141 l~DfG~a~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~-i~ 214 (286)
T d1ob3a_ 141 IADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMR-IF 214 (286)
T ss_dssp ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH-HH
T ss_pred ecccccceecccCccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHH-HH
Confidence 9999999876544322 2455789999999988654 568999999999999999999999976432111 111 11
Q ss_pred HHhccCCCccc---------------ccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHRA---------------IDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~~---------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
........... ..+.......+.....+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 215 RILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111000000 0000001111223456889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=370.63 Aligned_cols=247 Identities=22% Similarity=0.351 Sum_probs=197.3
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC--CCCccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--HRNLLP 312 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~ 312 (532)
.++|++.+.||+|+||+||+|++..+ |+.||||+++......... .....++.+|+.++++++ |||||+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~--------~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSD-NLPVAIKHVEKDRISDWGE--------LPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEEGGGCCCEEE--------CTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCC-CCEEEEEEEehHHccchhh--------hhHHHHHHHHHHHHHHhccCCCCccE
Confidence 35799999999999999999988764 8999999986532111000 001134667999999986 899999
Q ss_pred ceeEEecCCceEEEEEeccC-CCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC-
Q 037084 313 LQAHVTRPDCHLLVYEFMKN-GSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD- 390 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~- 390 (532)
+++++.+++..++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~ 146 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLN 146 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecC
Confidence 99999999999999999975 688888865 346899999999999999999999998 999999999999985
Q ss_pred CCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCcccchhhccH
Q 037084 391 GMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTI-SEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNM 469 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l 469 (532)
++.+||+|||+|+....... +...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....
T Consensus 147 ~~~vkl~DFG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------- 215 (273)
T d1xwsa_ 147 RGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 215 (273)
T ss_dssp TTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCeEEECccccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------
Confidence 57999999999987654432 46789999999999987765 5678999999999999999999975211
Q ss_pred HHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 470 VRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 470 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... .+. . ..+..+.+++.+||+.||++|||++|+++
T Consensus 216 ------i~~~~~---~~~----~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ------IIRGQV---FFR----Q----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------HHHCCC---CCS----S----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------Hhhccc---CCC----C----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111110 001 1 12345888999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=366.68 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=195.9
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.|++++.||+|+||+||+|.+..+ |+.||||+++..... ....+.+.+|+.+|++++|||||+++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~-~~~vAiK~i~~~~~~------------~~~~~~~~~Ei~il~~l~hpniv~l~ 83 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRT-GAKVAIKKLYRPFQS------------ELFAKRAYRELRLLKHMRHENVIGLL 83 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTT-CCEEEEEECSSTTSS------------HHHHHHHHHHHHHHHHCCBTTBCCCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEchhhcC------------hHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 56899999999999999999988764 999999999864322 23456788999999999999999999
Q ss_pred eEEecCC------ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRPD------CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
++|...+ ..|+||||| +++|..+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 84 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAV 154 (346)
T ss_dssp EEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhc
Confidence 9998765 469999999 6788887754 35999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEM 467 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~ 467 (532)
+.++.+|++|||+|+...... +...||+.|+|||.+.+. .++.++||||+||++|+|++|+.||..........
T Consensus 155 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~ 229 (346)
T d1cm8a_ 155 NEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229 (346)
T ss_dssp CTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence 999999999999998765432 567899999999988764 57899999999999999999999997643211110
Q ss_pred cHHHHH----------------HHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMVRWM----------------RNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~~~~----------------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
...... ....... ... ...............+.+|+..||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGL--PEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHS--CCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCCCcHHHHhhhcchhhhhhhccC--Ccc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0000000 000 000000111122345788999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=371.97 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=198.4
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccceeE
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQAH 316 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 316 (532)
+|...++||+|+||+||+|++..+ |+.||||++..... .+.+|+.++++++||||++++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~------------------~~~~Ei~il~~l~h~niv~~~~~ 81 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDS-GELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLRYF 81 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTT-CCEEEEEEEECCSS------------------SCCHHHHHHHHCCCTTBCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCC-CCEEEEEEECccch------------------HHHHHHHHHHhcCCCCCCcEEEE
Confidence 588889999999999999998765 99999999976531 23468999999999999999999
Q ss_pred EecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 317 VTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 317 ~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
|... ...++|||||+++ +.+.+.........+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~ 157 (350)
T d1q5ka_ 82 FYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDP 157 (350)
T ss_dssp EEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECT
T ss_pred EEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEec
Confidence 8543 2468999999765 44444333345567999999999999999999999988 999999999999997
Q ss_pred CC-cEEEeccCCcccCCCCCcceeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 391 GM-EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
++ .+||+|||+++........ ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...........
T Consensus 158 ~~~~~kl~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~ 234 (350)
T d1q5ka_ 158 DTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234 (350)
T ss_dssp TTCCEEECCCTTCEECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH
T ss_pred CCCceeEecccchhhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH
Confidence 65 8999999999877654332 45689999999998764 5789999999999999999999999976433211111
Q ss_pred HHH--------HHHHHhc---cCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HHhhh
Q 037084 469 MVR--------WMRNVIS---SENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC--MLSQI 530 (532)
Q Consensus 469 l~~--------~~~~~~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~l 530 (532)
+.. +...... ......................++.+|+.+||+.||++|||+.|+++ .|+++
T Consensus 235 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 111 1111100 00000000000011111223445888999999999999999999985 34444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-45 Score=360.91 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=200.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccc-e
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPL-Q 314 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l-~ 314 (532)
++|++.+.||+|+||+||+|++..+ |+.||||++...... .++..|++++++++|+|++.. .
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~~~~----------------~~~~~E~~i~~~l~~~~~i~~~~ 69 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAA-GEEVAIKLECVKTKH----------------PQLHIESKIYKMMQGGVGIPTIR 69 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT-TEEEEEEEEESCTTS----------------CCHHHHHHHHHHSTTSTTCCCEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCC-CCEEEEEEEchhccC----------------HHHHHHHHHHHHccCCCcccEEE
Confidence 5699999999999999999988764 899999998765321 346789999999988776554 5
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---C
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD---G 391 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~---~ 391 (532)
+++.+.+..++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +
T Consensus 70 ~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 70 WCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGT
T ss_pred EEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCC
Confidence 5557778889999999 6677777654 3456999999999999999999999999 999999999999864 5
Q ss_pred CcEEEeccCCcccCCCCCcc-----eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh
Q 037084 392 MEARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE 466 (532)
Q Consensus 392 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~ 466 (532)
..+|++|||+|+........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 57999999999987543321 1224567999999999999999999999999999999999999999865443322
Q ss_pred ccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 467 MNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 467 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
.....+........ . +.+. ...+.++.+++..||+.+|++||+++++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~~~--~----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 223 QKYERISEKKMSTP--I----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp --HHHHHHHHHHSC--H----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhhcccCCCC--h----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 22222222211110 0 0011 11234588899999999999999999999988765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=360.59 Aligned_cols=267 Identities=22% Similarity=0.243 Sum_probs=196.8
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
-++|++++.||+|+||+||+|++..+ |+.||||++...... ......+.+|+.+|++++|||+++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~h~nii~~~ 75 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKT-GQKVALKKVLMENEK------------EGFPITALREIKILQLLKHENVVNLI 75 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEC----CT------------TSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCC-CCEEEEEEEehhhcc------------hHHHHHHHHHHHHHHHhcCCCccceE
Confidence 36799999999999999999988754 999999998665322 12235678999999999999999999
Q ss_pred eEEec--------CCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 037084 315 AHVTR--------PDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANV 386 (532)
Q Consensus 315 ~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NI 386 (532)
+++.. .+..++|||||+++.+..... ....++......++.|++.||.|||+.+ |+||||||+||
T Consensus 76 ~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NI 148 (318)
T d3blha1 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 148 (318)
T ss_dssp EEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred eeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchhe
Confidence 99865 346799999998776655443 3556889999999999999999999998 99999999999
Q ss_pred EecCCCcEEEeccCCcccCCCCCcc--eeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 387 LIDDGMEARISDFGLAKLMPDGHTR--IRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 387 ll~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
|++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 149 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~- 227 (318)
T d3blha1 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE- 227 (318)
T ss_dssp EECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred eecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-
Confidence 9999999999999999876543221 122346799999999988765 689999999999999999999999975432
Q ss_pred hhhccHHHHHHHHhccCCCc--cccc-cc--------cc-CCCcHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 464 TEEMNMVRWMRNVISSENPH--RAID-SK--------LL-GNGYEE------QMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~--~~~d-~~--------l~-~~~~~~------~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
......+.......... ...+ .. .. .....+ ....+.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 228 ---QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp ---HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11112222222111100 0000 00 00 000111 1235778999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=360.23 Aligned_cols=265 Identities=22% Similarity=0.286 Sum_probs=196.4
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|.+++.||+|+||+||+|.++.+ |+.||||+++.... ....+.+.+|+.+|++++||||++++
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~-~~~vAvK~i~~~~~-------------~~~~~~~~~Ei~il~~l~hp~iv~~~ 72 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVN-KVRVAIKKISPFEH-------------QTYCQRTLREIKILLRFRHENIIGIN 72 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTT-CSEEEEEEECCTTC-------------HHHHHHHHHHHHHHHHCCCTTBCCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCC-CcEEEEEEEehhcC-------------hHHHHHHHHHHHHHHHcCCCCCCcEE
Confidence 45699999999999999999987654 99999999976432 23346788999999999999999999
Q ss_pred eEEecCC----ceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 315 AHVTRPD----CHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 315 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++.... ..+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++
T Consensus 73 ~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~ 144 (345)
T d1pmea_ 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNT 144 (345)
T ss_dssp EEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred EEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECC
Confidence 9997653 23455566779999999964 35899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccCCcccCCCCCcc-eeeecccccccccccccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 391 GMEARISDFGLAKLMPDGHTR-IRITTVAGTTGYVAPEYHQT-LTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 391 ~~~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
++.+||+|||+++........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||........
T Consensus 145 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--- 221 (345)
T d1pmea_ 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--- 221 (345)
T ss_dssp TCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---
T ss_pred CCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---
Confidence 999999999999876443221 11245679999999998754 4678999999999999999999999976432111
Q ss_pred HHHHHHHHhccCCCccc-------------ccccccCCC----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRA-------------IDSKLLGNG----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~-------------~d~~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
................ ..+...... .+....++.+++..||+.||++|||+.++++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 222 -LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp -HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111100000000 000000000 0111235889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=356.20 Aligned_cols=265 Identities=20% Similarity=0.225 Sum_probs=206.0
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCccccee
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQA 315 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~ 315 (532)
++|++++.||+|+||+||+|++..+ |+.||||+++..... ......+.+|+.++++++||||+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~-~~~vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~h~niv~~~~ 68 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRET-HEIVALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLHD 68 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTT-CCEEEEEEEESSCSS------------TTHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCC-CcEEEEEEEehhhCC------------hHHHHHHHHHHHHHHhcCcCCEEeecc
Confidence 4799999999999999999998764 899999999765322 223567889999999999999999999
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcEE
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEAR 395 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 395 (532)
++...+..++|++++.+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 69 ~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~k 141 (292)
T d1unla_ 69 VLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELK 141 (292)
T ss_dssp EEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEE
T ss_pred ccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCcee
Confidence 99999999999999999999888764 456889999999999999999999998 99999999999999999999
Q ss_pred EeccCCcccCCCCCcceeeeccccccccccccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHHHHHH
Q 037084 396 ISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLT-ISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMVRWMR 474 (532)
Q Consensus 396 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~~~~~ 474 (532)
|+|||.++......... ....+++.|+|||.+.+.. ++.++||||+||++|||++|+.||..... ..+...-+.
T Consensus 142 l~DFG~a~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~---~~~~~~~~~ 216 (292)
T d1unla_ 142 LANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND---VDDQLKRIF 216 (292)
T ss_dssp ECCCTTCEECCSCCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS---HHHHHHHHH
T ss_pred eeecchhhcccCCCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC---HHHHHHHHH
Confidence 99999999876543322 4556788999999887665 68999999999999999999999753221 111111111
Q ss_pred HHhccCCCcc--------------ccc-ccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 475 NVISSENPHR--------------AID-SKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 475 ~~~~~~~~~~--------------~~d-~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.......... ... ..............+.+|+.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111110000 000 00011112233456888999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-44 Score=353.46 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=205.7
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-CCcccc
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH-RNLLPL 313 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l 313 (532)
.++|.+.+.||+|+||+||+|++..+ |+.||||++...... ..+.+|++.+..++| +|++.+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~~~~----------------~~~~~e~~~~~~l~~~~~i~~~ 66 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLN-NQQVAIKFEPRRSDA----------------PQLRDEYRTYKLLAGCTGIPNV 66 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT-TEEEEEEEEECCTTS----------------CCHHHHHHHHHHTTTCTTCCCE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCC-CCEEEEEEEccccCc----------------HHHHHHHHHHHHhcCCCCCCEE
Confidence 35799999999999999999998764 899999998654321 235678888888865 899999
Q ss_pred eeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC---
Q 037084 314 QAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD--- 390 (532)
Q Consensus 314 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~--- 390 (532)
++++..+...++||||+ +++|.+++.. ....+++.....++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 67 ~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~ 139 (293)
T d1csna_ 67 YYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNS 139 (293)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSS
T ss_pred EEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCccc
Confidence 99999999999999999 7899999875 3456899999999999999999999999 999999999999974
Q ss_pred --CCcEEEeccCCcccCCCCCcc-----eeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccc
Q 037084 391 --GMEARISDFGLAKLMPDGHTR-----IRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQY 463 (532)
Q Consensus 391 --~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~ 463 (532)
++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence 578999999999986543221 1124567999999999999999999999999999999999999999764332
Q ss_pred hhhccHHHHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhhh
Q 037084 464 TEEMNMVRWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRCMLSQI 530 (532)
Q Consensus 464 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l 530 (532)
...... ..+........+. .+... .+.++.+++..|++.+|++||+++.+.+.|+++
T Consensus 220 ~~~~~~-~~i~~~~~~~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 220 TNKQKY-ERIGEKKQSTPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHHHH-HHHHHHHHHSCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHHHHH-HHHHhccCCCChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 221111 1111111111111 11111 234578888999999999999999999988765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.3e-44 Score=357.00 Aligned_cols=261 Identities=20% Similarity=0.300 Sum_probs=198.5
Q ss_pred cccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccc
Q 037084 234 KEDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLP 312 (532)
Q Consensus 234 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~ 312 (532)
..++|+++++||+|+||+||+|++..+ |+.||||+++... ..++.+|+.+|++++ ||||++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~-~~~vAiK~i~~~~-----------------~~~~~~Ei~il~~l~~hpnIv~ 94 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITN-NEKVVVKILKPVK-----------------KKKIKREIKILENLRGGPNIIT 94 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSSC-----------------HHHHHHHHHHHHHHTTSTTBCC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCC-CCEEEEEEECHHH-----------------HHHHHHHHHHHHhccCCCCCcE
Confidence 346799999999999999999998764 9999999997642 245778999999995 999999
Q ss_pred ceeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecC
Q 037084 313 LQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDD 390 (532)
Q Consensus 313 l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~ 390 (532)
+++++... ...++|||||++++|.++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 95 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~ 164 (328)
T d3bqca1 95 LADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDH 164 (328)
T ss_dssp EEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcC
Confidence 99999744 5689999999999987653 34899999999999999999999999 999999999999986
Q ss_pred CC-cEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhh-c
Q 037084 391 GM-EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEE-M 467 (532)
Q Consensus 391 ~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~-~ 467 (532)
++ .+||+|||+|+........ ....||+.|+|||.+.+. .++.++|+||+||++|+|++|+.||......... .
T Consensus 165 ~~~~vkl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 165 EHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp TTTEEEECCGGGCEECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred CCCeeeecccccceeccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 54 6999999999877554322 567899999999987765 4799999999999999999999999754321111 0
Q ss_pred cHH---------HHHHHHhccCCC----------cccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 468 NMV---------RWMRNVISSENP----------HRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 468 ~l~---------~~~~~~~~~~~~----------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
.+. .|.........+ ..................++.+|+.+||+.||++|||++|+++
T Consensus 242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 010 111110000000 0000000111112223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=361.35 Aligned_cols=265 Identities=25% Similarity=0.308 Sum_probs=192.6
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|+++++||+|+||+||+|.+..+ |+.||||++...... ......+.+|+.++++++||||++++
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t-~~~vAvK~i~~~~~~------------~~~~~~~~~Ei~il~~l~hpnIv~~~ 82 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQN------------QTHAKRAYRELVLMKCVNHKNIISLL 82 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTT-TEEEEEEEEESTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCC-CCEEEEEEEChhhcC------------HHHHHHHHHHHHHHHhcCCCCeeEEE
Confidence 36799999999999999999988764 999999999765432 23346788999999999999999999
Q ss_pred eEEecC------CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEe
Q 037084 315 AHVTRP------DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLI 388 (532)
Q Consensus 315 ~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll 388 (532)
+++... +..|+|||||.++ +.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 83 ~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~ 152 (355)
T d2b1pa1 83 NVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152 (355)
T ss_dssp EEECSCCSTTTCCEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred EEEecccccccCceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccc
Confidence 999643 6779999999654 445443 24889999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 389 DDGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 389 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
+.++.+|++|||+++....... .+...||+.|+|||++.+..++.++||||+||++|+|++|+.||...........
T Consensus 153 ~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~ 229 (355)
T d2b1pa1 153 KSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 229 (355)
T ss_dssp CTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999999887655432 2567899999999999999999999999999999999999999975432111111
Q ss_pred HH---------------HHHHHHhccCCC------cccccccccCC---CcHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 037084 469 MV---------------RWMRNVISSENP------HRAIDSKLLGN---GYEEQMRLVLKIAYFCTSDDPEERPSSKDVR 524 (532)
Q Consensus 469 l~---------------~~~~~~~~~~~~------~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl 524 (532)
+. ............ ...+....... ........+.+|+.+||+.||++|||++|++
T Consensus 230 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 10 001111111100 00011111111 1234567789999999999999999999997
Q ss_pred H
Q 037084 525 C 525 (532)
Q Consensus 525 ~ 525 (532)
+
T Consensus 310 ~ 310 (355)
T d2b1pa1 310 Q 310 (355)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=361.21 Aligned_cols=258 Identities=23% Similarity=0.329 Sum_probs=201.6
Q ss_pred cCccccceecccCCeEEEEEEee--CCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC-CCccc
Q 037084 236 DSLASLEIIGVGACGVVYKAEVP--GSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH-RNLLP 312 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~--~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~ 312 (532)
++|++++.||+|+||+||+|... ..+|+.||||+++....... ....+.+.+|+.++++++| |||++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~~E~~il~~l~h~pnIv~ 93 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVT 93 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE----------ESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc----------hHHHHHHHHHHHHHHhccCCCeEEE
Confidence 67999999999999999999863 22488999999875421110 1113567889999999966 89999
Q ss_pred ceeEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCC
Q 037084 313 LQAHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGM 392 (532)
Q Consensus 313 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~ 392 (532)
+++++.+....+++|||+.+|+|.+++... ..++......++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 94 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 94 LHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNG 166 (322)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTS
T ss_pred eeeeeccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCC
Confidence 999999999999999999999999999763 35678888999999999999999998 99999999999999999
Q ss_pred cEEEeccCCcccCCCCCcceeeeccccccccccccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhccHH
Q 037084 393 EARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL--TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMNMV 470 (532)
Q Consensus 393 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~l~ 470 (532)
.+||+|||+++.+....... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||...........+
T Consensus 167 ~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i- 244 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI- 244 (322)
T ss_dssp CEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH-
T ss_pred CEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 99999999998765543322 2567899999999988754 4688999999999999999999999765432222211
Q ss_pred HHHHHHhccCCCcccccccccCCCcHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 037084 471 RWMRNVISSENPHRAIDSKLLGNGYEEQMRLVLKIAYFCTSDDPEERPS-----SKDVRC 525 (532)
Q Consensus 471 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~ 525 (532)
........ + .........+.+++..||++||++||| ++|+++
T Consensus 245 --~~~~~~~~-~----------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 --SRRILKSE-P----------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHHHHCC-C----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --HHhcccCC-C----------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111111 1 011123456888999999999999995 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=356.67 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=196.1
Q ss_pred ccCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 235 EDSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 235 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.++|++++.||+|+||+||+|++..+ |+.||||+++..... ......+.+|+.+|++++|||+|+++
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~-~~~vAiK~i~~~~~~------------~~~~~~~~~Ei~il~~l~h~~iv~~~ 83 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKT-GLRVAVKKLSRPFQS------------IIHAKRTYRELRLLKHMKHENVIGLL 83 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTT-TEEEEEEECSCTTSS------------HHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCC-CCEEEEEEECchhcC------------hHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 57899999999999999999987754 999999999865432 22345688999999999999999999
Q ss_pred eEEecC-----CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEec
Q 037084 315 AHVTRP-----DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLID 389 (532)
Q Consensus 315 ~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~ 389 (532)
+++... ...+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 84 ~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~ 155 (348)
T d2gfsa1 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 155 (348)
T ss_dssp EEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred EEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccc
Confidence 999643 344667778889999999853 35999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeccCCcccCCCCCcceeeeccccccccccccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCcccchhhcc
Q 037084 390 DGMEARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTL-TISEKSDIYSFGVLLAVLVVGKFPFDDFFQYTEEMN 468 (532)
Q Consensus 390 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 468 (532)
.++.+|++|||++....... ....||+.|+|||...+. .++.++||||+||++|+|++|+.||...........
T Consensus 156 ~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~ 230 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230 (348)
T ss_dssp TTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999997654332 457899999999986665 468899999999999999999999976432111111
Q ss_pred HHHHHHHHhccCCCcccc------------c--ccccCCC----cHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 037084 469 MVRWMRNVISSENPHRAI------------D--SKLLGNG----YEEQMRLVLKIAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 469 l~~~~~~~~~~~~~~~~~------------d--~~l~~~~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~ 525 (532)
+. ....... .... . ....... .......+.+|+.+||+.||++|||+.|+++
T Consensus 231 i~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 231 IL----RLVGTPG-AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HH----HHHCCCC-HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HH----HhcCCCC-hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11 1100000 0000 0 0000000 0112345788999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-38 Score=323.23 Aligned_cols=264 Identities=20% Similarity=0.219 Sum_probs=191.1
Q ss_pred cCccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC---------
Q 037084 236 DSLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW--------- 306 (532)
Q Consensus 236 ~~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------- 306 (532)
.+|.+++.||+|+||+||+|++..+ |+.||||+++... ...+.+.+|+.++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~-g~~vAvKvi~~~~---------------~~~~~~~~Ei~~l~~l~~~~~~~~~~ 76 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVN-NTHVAMKIVRGDK---------------VYTEAAEDEIKLLQRVNDADNTKEDS 76 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCC-CCEEEEEEEeccc---------------cchHHHHHHHHHHHHhcchhhhhhhh
Confidence 4599999999999999999988754 9999999998762 22345667777777664
Q ss_pred --CCCcccceeEEecC--CceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCC
Q 037084 307 --HRNLLPLQAHVTRP--DCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHM-YHRPCIIHRDI 381 (532)
Q Consensus 307 --H~niv~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dl 381 (532)
|+||+++++++... ...+++++++..+........ ......+++..+..++.|++.||.|||+ .+ |+||||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDl 152 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDI 152 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCC
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccC
Confidence 57899999888643 455677777655543333222 2445678899999999999999999998 66 999999
Q ss_pred CCCcEEecCCCc------EEEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 037084 382 KPANVLIDDGME------ARISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLLAVLVVGKF 455 (532)
Q Consensus 382 kp~NIll~~~~~------~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 455 (532)
||+|||++.++. ++++|||.+....... ....||+.|+|||++.+..++.++|+||+||++++|++|+.
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 999999986653 9999999998654432 45679999999999999999999999999999999999999
Q ss_pred CCCCcccchhhc---cHHHHHHHHhcc------------------CCCcccccc----------cccCCCcHHHHHHHHH
Q 037084 456 PFDDFFQYTEEM---NMVRWMRNVISS------------------ENPHRAIDS----------KLLGNGYEEQMRLVLK 504 (532)
Q Consensus 456 p~~~~~~~~~~~---~l~~~~~~~~~~------------------~~~~~~~d~----------~l~~~~~~~~~~~l~~ 504 (532)
||.......... .+...+.. +.. ......+.. .............+.+
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~-lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIEL-LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CC---------CHHHHHHHHHHH-HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHH-hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 997543211111 11111110 000 000000000 0012234567788999
Q ss_pred HHHHcCCCCCCCCCCHHHHHH
Q 037084 505 IAYFCTSDDPEERPSSKDVRC 525 (532)
Q Consensus 505 l~~~cl~~~P~~RPs~~evl~ 525 (532)
|+..|++.||.+|||++|+++
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHCCCChhHCcCHHHHhc
Confidence 999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.4e-24 Score=196.06 Aligned_cols=183 Identities=14% Similarity=0.081 Sum_probs=121.8
Q ss_pred cccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHH----HHHHHHHHHHHHHHHHHhcCCCCCcccce
Q 037084 239 ASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRR----VLINRKMRQIKSEIITAGRIWHRNLLPLQ 314 (532)
Q Consensus 239 ~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~ 314 (532)
.+.++||+|+||+||+|++. +|+.||||+++............+. ............|...+.++.|+|++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45689999999999999875 5899999998754322111000000 00112234566789999999999999877
Q ss_pred eEEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEecCCCcE
Q 037084 315 AHVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYHRPCIIHRDIKPANVLIDDGMEA 394 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 394 (532)
++. ..+++|||++++.+.+ ++......++.|++.++.|||+.+ |+||||||+|||+++++ +
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-E
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-E
Confidence 653 2379999998765422 333445678999999999999998 99999999999999765 8
Q ss_pred EEeccCCcccCCCCCcceeeeccccccccccccccccCCCCchhhHHHHHHHH
Q 037084 395 RISDFGLAKLMPDGHTRIRITTVAGTTGYVAPEYHQTLTISEKSDIYSFGVLL 447 (532)
Q Consensus 395 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl 447 (532)
+|+|||+|.......... ........ -.+.+ ...|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~~~~---~l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWRE---ILERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTTHHH---HHHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCCcHH---HHHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999999997665432210 00000000 01111 24678889999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=3.6e-07 Score=85.32 Aligned_cols=141 Identities=13% Similarity=0.072 Sum_probs=91.8
Q ss_pred CccccceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-CCCccccee
Q 037084 237 SLASLEIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIW-HRNLLPLQA 315 (532)
Q Consensus 237 ~~~~~~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~ 315 (532)
.|+..+..+-++.+.||+... ++..+.+|+........ ...+.+|...+..+. +--+.+++.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~---~~~~~vlk~~~~~~~~~--------------~~~~~~E~~~l~~l~~~vpvP~vl~ 77 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC---SSCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe---CCCeEEEEEcCCCcccc--------------hhhHHHHHHHHHHHhccCCCCcEEE
Confidence 344444434444578998753 36678888876442111 123456666666653 333567788
Q ss_pred EEecCCceEEEEEeccCCCHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------
Q 037084 316 HVTRPDCHLLVYEFMKNGSLQDILHDVSQGRRELDWLARYRIARGMASGLEYLHMYH----------------------- 372 (532)
Q Consensus 316 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~----------------------- 372 (532)
++..++..++||++++|.++.+.... ... ...++.++++.++.||+..
T Consensus 78 ~~~~~~~~~lv~~~l~G~~~~~~~~~------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 78 FERHDGWSNLLMSEADGVLCSEEYED------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHTTT------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred EEecCCceEEEEEecccccccccccc------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 88888889999999999888665421 011 2234555666666666421
Q ss_pred ---------------------------------CCCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 373 ---------------------------------RPCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 373 ---------------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
...++|+|+.|.||++++++.+-|.||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137999999999999987767799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1e-05 Score=74.69 Aligned_cols=74 Identities=11% Similarity=0.096 Sum_probs=49.8
Q ss_pred eecccCC-eEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC--CCcccceeEEec
Q 037084 243 IIGVGAC-GVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWH--RNLLPLQAHVTR 319 (532)
Q Consensus 243 ~LG~G~f-G~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~ 319 (532)
.+..|.. +.||+.... .|..+++|.-..... ..+..|...++.+.. -.+.++++++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~~-----------------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGAL-----------------NELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp ECSCTTSSCEEEEEECT--TSCCEEEEEECSCTT-----------------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC--CCCEEEEEeCCccCH-----------------hHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 3445543 678998755 467789998765532 124456666665533 235667888888
Q ss_pred CCceEEEEEeccCCCH
Q 037084 320 PDCHLLVYEFMKNGSL 335 (532)
Q Consensus 320 ~~~~~lV~E~~~~gsL 335 (532)
++..++||+|++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8889999999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.54 E-value=7e-05 Score=73.85 Aligned_cols=83 Identities=14% Similarity=0.043 Sum_probs=44.7
Q ss_pred ceecccCCeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcC-CC-C-CcccceeEEe
Q 037084 242 EIIGVGACGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRI-WH-R-NLLPLQAHVT 318 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~H-~-niv~l~~~~~ 318 (532)
+.||.|....||+..... +|+.++||.-........+-. .....+...|...|+.+ .+ | .+++++.+
T Consensus 32 ~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~-------~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-- 101 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESW-------PLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 101 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCC-------CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCC-------CCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--
Confidence 468999999999997654 367899996432110000000 00012233466666555 23 2 34445444
Q ss_pred cCCceEEEEEeccCCC
Q 037084 319 RPDCHLLVYEFMKNGS 334 (532)
Q Consensus 319 ~~~~~~lV~E~~~~gs 334 (532)
+++..++|||++++..
T Consensus 102 d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 102 DTEMAVTVMEDLSHLK 117 (392)
T ss_dssp ETTTTEEEECCCTTSE
T ss_pred cCCCCEEEEeccCCcc
Confidence 4456689999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.00072 Score=64.43 Aligned_cols=137 Identities=15% Similarity=0.156 Sum_probs=73.2
Q ss_pred CeEEEEEEeeCCCCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc-----ccc--eeEEecCC
Q 037084 249 CGVVYKAEVPGSYGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL-----LPL--QAHVTRPD 321 (532)
Q Consensus 249 fG~Vy~~~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~l--~~~~~~~~ 321 (532)
--.||++... +|..+++|+.+....+. .++..|...+..|...++ +.. -..+...+
T Consensus 35 EN~vy~v~~~--dg~~~VlK~~rp~~~s~---------------~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~ 97 (325)
T d1zyla1 35 ENRVYQFQDE--DRRRFVVKFYRPERWTA---------------DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 97 (325)
T ss_dssp SSEEEEECCT--TCCCEEEEEECTTTSCH---------------HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred cceeEEEEcC--CCCEEEEEEeCCCCCCH---------------HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeee
Confidence 3689999775 68899999987653222 334445555555532222 111 11223456
Q ss_pred ceEEEEEeccCCCH-----HH---------HHhhhcC-----CCCCCCHHH-------------------HHHHHHHHHH
Q 037084 322 CHLLVYEFMKNGSL-----QD---------ILHDVSQ-----GRRELDWLA-------------------RYRIARGMAS 363 (532)
Q Consensus 322 ~~~lV~E~~~~gsL-----~~---------~l~~~~~-----~~~~l~~~~-------------------~~~i~~~ia~ 363 (532)
..+.++++++|..+ .. .+|.... .+...++.. +..+...+..
T Consensus 98 ~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (325)
T d1zyla1 98 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 177 (325)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHH
Confidence 67889999976322 11 1221111 111222211 1112222223
Q ss_pred HHHHHHhc----CCCCeeecCCCCCcEEecCCCcEEEeccCCccc
Q 037084 364 GLEYLHMY----HRPCIIHRDIKPANVLIDDGMEARISDFGLAKL 404 (532)
Q Consensus 364 gl~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFGla~~ 404 (532)
.++.+... ....+||+|+.|.|||++++ ..+.||+-+..
T Consensus 178 l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 178 LIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred HHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 33333322 23458999999999999754 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.86 E-value=0.012 Score=57.30 Aligned_cols=74 Identities=12% Similarity=0.145 Sum_probs=46.1
Q ss_pred ceecccCCeEEEEEEeeCC------CCcEEEEEEcCCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc-ccce
Q 037084 242 EIIGVGACGVVYKAEVPGS------YGKMIAIKKIDQPPMAATELLNVRRVLINRKMRQIKSEIITAGRIWHRNL-LPLQ 314 (532)
Q Consensus 242 ~~LG~G~fG~Vy~~~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~ 314 (532)
+.|+-|-.=.+|++..... .+..|.+++...... . ....+|..+++.+.-.++ .+++
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~-~---------------idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-E---------------SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-H---------------HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch-h---------------hHHHHHHHHHHHHHhCCCCCeEE
Confidence 5788888999999987531 235677777653221 1 112356666666633344 4677
Q ss_pred eEEecCCceEEEEEeccCCCH
Q 037084 315 AHVTRPDCHLLVYEFMKNGSL 335 (532)
Q Consensus 315 ~~~~~~~~~~lV~E~~~~gsL 335 (532)
+++.. .+|+||++|.+|
T Consensus 112 ~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT----EEEECCCCEEEC
T ss_pred EEcCC----ceEEEEeccccC
Confidence 77643 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.12 E-value=0.018 Score=53.74 Aligned_cols=30 Identities=27% Similarity=0.296 Sum_probs=26.7
Q ss_pred CCeeecCCCCCcEEecCCCcEEEeccCCcc
Q 037084 374 PCIIHRDIKPANVLIDDGMEARISDFGLAK 403 (532)
Q Consensus 374 ~~ivH~Dlkp~NIll~~~~~~kl~DFGla~ 403 (532)
.++||+|+.+.||+++++...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 359999999999999988777899999875
|